As filed with the Securities and Exchange Commission on June 20, 2023.
Registration No. 333-271270
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment No. 3
to
Form F-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
FIDELIS INSURANCE HOLDINGS LIMITED
(Exact Name of Registrant as Specified in its Charter)
Bermuda | 6331 | Not Applicable | ||
(State or other jurisdiction of incorporation or organization) |
(Primary Standard Industrial Classification Code Number) |
(I.R.S. Employer Identification Number) |
Fidelis Insurance Holdings Limited
Waterloo House,
100 Pitts Bay Road,
Pembroke,
Bermuda, HM08
+1 441 279 2500
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrants Principal Executive Offices)
Puglisi & Associates
850 Library Avenue, Suite 204
Newark, Delaware 19711
Attention: Mr. Donald J. Puglisi
(Address, Including Zip Code, of Registrants agent for service)
Copies to:
Joseph D. Ferraro Jennifer Tait Willkie Farr & Gallagher (UK) LLP Citypoint, 1 Ropemaker Street London EC2Y 9AW United Kingdom Telephone: +44 20 3580 4700 |
Gary D. Boss Benjamin J. Cohen Kirsten Gaeta Latham & Watkins LLP 1271 Avenue of the Americas New York, New York 10020 Telephone: (212) 906-1200 |
Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective.
If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box ☐
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer (Do not check if a smaller reporting company) | ☒ | |||||
Smaller reporting company | ☐ | Emerging growth company | ☐ |
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to Section 8(a), may determine.
The information in this preliminary prospectus is not complete and may be changed. The securities may not be sold until the registration statement filed with the Securities and Exchange Commission is declared effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale of such securities is not permitted.
SUBJECT TO COMPLETION, DATED JUNE 20, 2023
FIDELIS INSURANCE HOLDINGS LIMITED
17,000,000 Common Shares
This is the initial public offering of the common shares, par value $0.01 per share, of Fidelis Insurance Holdings Limited (the Common Shares). We are offering 5,714,286 Common Shares. The selling shareholders named under the caption Principal and Selling Shareholders below (the Selling Shareholders) are offering an additional 11,285,714 Common Shares. We will not receive any of the proceeds from the sale of the Common Shares being sold by the Selling Shareholders in this offering.
Currently, no public market exists for our Common Shares. We have applied to list our Common Shares on the New York Stock Exchange (NYSE) under the symbol FIHL.
We anticipate that the initial public offering price for our Common Shares will be between $16.00 and $19.00 per Common Share.
Investing in our Common Shares involves risks. See Risk Factors beginning on page 33. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
Per Common Share |
Total | |||||||
Initial public offering price |
$ | $ | ||||||
Underwriting discounts and commissions(1) |
$ | $ | ||||||
Proceeds, before expenses, to Fidelis Insurance Holdings Limited |
$ | $ | ||||||
Proceeds, before expenses, to the Selling Shareholders |
$ | $ | ||||||
|
|
|
|
(1) | Please see Underwriting for a description of compensation payable to the underwriters. |
The underwriters also may purchase up to 2,550,000 additional Common Shares from the Selling Shareholders at the initial public offering price less the underwriting discounts and commissions, within 30 days from the date of this prospectus.
The underwriters expect to deliver the Common Shares to purchasers on or about , 2023.
J.P. Morgan | Barclays |
Jefferies |
|
BMO Capital Markets | Citigroup | UBS Investment Bank |
|
Dowling & Partners Securities, LLC |
Prospectus dated , 2023
Page | ||||
1 | ||||
5 | ||||
26 | ||||
33 | ||||
92 | ||||
93 | ||||
94 | ||||
95 | ||||
97 | ||||
99 | ||||
Unaudited Pro Forma Condensed Combined Financial Information |
102 | |||
Managements Discussion and Analysis of Financial Condition and Results of Operations |
111 | |||
159 | ||||
182 | ||||
191 | ||||
197 | ||||
200 | ||||
217 | ||||
226 | ||||
234 | ||||
237 | ||||
251 | ||||
264 | ||||
274 | ||||
275 | ||||
276 | ||||
277 | ||||
F-1 |
i
We and the Selling Shareholders have not authorized anyone to provide any information different from that contained in this prospectus or in any free writing prospectuses prepared by us or on our behalf or to which we have referred prospective investors. We and the Selling Shareholders take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give prospective investors. This prospectus is an offer to sell only the shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is accurate only at the date on the front cover of this prospectus, regardless of the time of delivery of this prospectus or any sale of our Common Shares.
We further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to the registration statement of which this prospectus is a part were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreement, and should not be deemed to be a representation, warranty or covenant made to prospective investors or for the benefit of prospective investors. Moreover, such representations, warranties or covenants were accurate only at the date they were made. Accordingly, such representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.
Except as otherwise indicated, the information in this prospectus assumes the effectiveness of our Amended and Restated Bye-Laws (as defined herein) and the consummation of (i) a number of separation and reorganization transactions, which were completed on January 3, 2023, in order to create two distinct holding companies and businesses: FIHL (as the issuer of the Common Shares sold by the Selling Shareholders in this offering) and Shelf Holdco II Limited (MGU HoldCo) (the Separation Transactions) and (ii) this offering.
Certain Defined Terms
Certain abbreviations and definitions of certain insurance, reinsurance, financial and other terms used in this prospectus are defined in the Glossary of Selected Terms section of this prospectus.
Exchange Control
We intend to apply for and expect to receive consent under the Exchange Control Act 1972 (and its related regulations) from the Bermuda Monetary Authority (the BMA) for the issue and transfer of the Common Shares to and between non-residents of Bermuda for exchange control purposes provided the Common Shares remain listed on an appointed stock exchange, which includes NYSE. In granting such consent, neither the BMA nor any other relevant Bermuda authority or government body accepts any responsibility for our financial soundness or the correctness of any of the statements made or opinions expressed in this prospectus.
Service of Process and Enforcement of Civil Liabilities
We are a Bermuda exempted company. As a result, the rights of holders of our Common Shares will be governed by Bermuda law and our memorandum of association and the Amended and Restated Bye-Laws. The rights of shareholders under Bermuda law may differ from the rights of shareholders of companies incorporated in other jurisdictions. Some of our directors and officers are not residents of the United States, and a substantial portion of our assets are located outside the United States. As a result, it may be difficult for investors to effect service of process on those persons in the United States or to enforce in the United States judgments obtained in U.S. courts against us or those persons based on the civil liability provisions of the U.S. securities laws. It is doubtful whether courts in Bermuda will enforce judgments obtained in other jurisdictions, including the United States, against us or our directors or officers under the securities laws of those jurisdictions or entertain actions in Bermuda against us or our directors or officers under the securities laws of other jurisdictions.
1
Investors Outside the United States
Neither we nor any of the Selling Shareholders have done anything that would permit the possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of our Common Shares and the distribution of this prospectus outside of the United States.
REGISTERED TRADEMARKS AND TRADEMARK APPLICATIONS
We own or have rights to use trademarks, service marks or trade names that we use in connection with the operation of our business. Other trademarks, service marks and trade names appearing in this prospectus are the property of their respective owners. Solely for convenience, the trademarks, service marks, trade names and copyrights referred to in this prospectus are listed without the ©, ® and symbols, but we will assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks, trade names and copyrights.
MARKET AND INDUSTRY DATA AND FORECASTS
Certain market and industry data and forecasts included in this prospectus were obtained from independent market research, industry publications and surveys, governmental agencies and publicly available information. Industry surveys, publications and forecasts generally state that the information contained therein has been obtained from sources believed to be reliable, but that the accuracy and completeness of such information is not guaranteed. We have not independently verified any of the data from third-party sources, nor have we ascertained the underlying assumptions relied upon therein. Similarly, independent market research and industry forecasts, which we believe to be reliable based upon our managements knowledge of the industry, have not been independently verified. While we are not aware of any material misstatements regarding the market or industry data presented herein, our estimates involve risks and uncertainties and are subject to change based on various factors, including those discussed under the heading Risk Factors.
BASIS OF PRESENTATION
Presentation of Financial Information
References to Previous Fidelis refer to Fidelis Insurance Holdings Limited (FIHL) and its consolidated subsidiaries prior to the consummation of the Separation Transactions and this offering. References to Current Fidelis refer to FIHL and its consolidated subsidiaries following the consummation of the Separation Transactions. Unless otherwise indicated, or the context otherwise requires, references herein to Fidelis, Group, we, our, us, and other similar references refer (i) prior to the consummation of the Separation Transactions and this offering to Previous Fidelis and (ii) following the consummation of the Separation Transactions to Current Fidelis. Unless otherwise stated or the context otherwise requires, all information in this prospectus reflects the consummation of the Separation Transactions and the completion of this offering. References to segment(s) and pillar(s) shall have the same meaning as used herein and shall be used interchangeably to refer to each of the three pillars or segments of our business, Bespoke, Specialty and Reinsurance.
See SummaryThe Separation Transactions, SummaryOur Corporate Structure and The Separation Transactions for a more particularized description of the Separation Transactions.
The financial information included herein has been derived from the financial statements and accounting records of Fidelis and has been prepared in accordance with generally accepted accounting principles in the
2
United States (U.S. GAAP). Following this offering, FIHL will operate and control all of the business and affairs and consolidate the financial results of FIHL and its consolidated subsidiaries. Amounts in this prospectus and the financial statements included in this prospectus are presented in U.S. dollars rounded to the nearest million, unless otherwise noted. Certain amounts presented in tables are subject to rounding adjustments and, as a result, the totals in such tables may not sum.
The financial information included herein contains the following measures, which we use to assess the financial performance of our business:
Premiums Written
| Gross premiums written (GPW) means total premiums received; and |
| Net premiums written (NPW) means GPW less reinsurance premiums ceded. |
Premiums written are recorded on inception of the policy. Premiums written include estimates based on information received from insureds, brokers and cedants, and any subsequent differences arising on such estimates are recorded as premiums written in the period in which they are determined.
Earned and Unearned Premiums
Premiums written are earned on a basis consistent with risks covered over the period the coverage is provided. Net premiums written, when earned, are referred to herein as net premiums earned (NPE).
The portion of the premiums written applicable to the unexpired terms of the underlying contracts and policies are recorded as unearned premium (UPR).
Non-U.S. GAAP Financial Measures
Our financial statements included in this prospectus have been prepared in accordance with U.S. GAAP. We have included certain non-U.S. GAAP financial measures in this prospectus, as further described below, that may not be directly comparable to other similarly titled measures used by other companies and therefore may not be comparable among companies. For purposes of Regulation G and Section 10(e) of Regulation S-K, a non-U.S. GAAP financial measure is a numerical measure of a companys historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with U.S. GAAP in the statements of operations, balance sheets, or statement of cash flows of the company; or includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from most directly comparable measure so calculated and presented. Pursuant to the requirements of Regulation G and Section 10(e) of Regulation S-K, we have provided reconciliations of non-U.S. GAAP financial measures to the most directly comparable U.S. GAAP financial measures. These non-U.S. GAAP measures are provided because our management uses these financial measures in monitoring and evaluating our ongoing results and trends.
This prospectus contains non-U.S. GAAP financial measures, including accident year loss ratio excluding catastrophes, large losses and prior year reserve movements, operating net income, and operating return on equity (Operating RoE), which are financial measures that are not required by, or presented in accordance with U.S. GAAP. See Managements Discussion and Analysis of Financial Condition and Results of Operations Performance Measures and Non-U.S. GAAP Financial Measures for an explanation and reconciliations.
We believe that, in addition to our results determined in accordance with U.S. GAAP (that include performance measures such as ratio of losses and loss adjustment expenses to NPE (loss ratio), underwriting
3
ratio, expense ratio, Fidelis MGU commissions ratio, policy acquisition expense ratio, general and administrative expense ratio, combined ratio, net investment return, total investment return, total investment return percentage and return on equity (RoE), certain non-U.S. GAAP measures, including accident year loss ratio excluding catastrophes, large losses and prior year reserve movements, operating net income, and Operating RoE are useful in evaluating our business and the underlying trends that are affecting our performance. Such non-U.S. GAAP measures are primary indicators that our management uses internally to conduct and measure its business and evaluate the performance of its consolidated operations. Our management believes these non-U.S. GAAP financial measures are useful as they provide meaningful analysis of the performance of the business. These non-U.S. GAAP financial measures are used in addition to and in conjunction with results presented in accordance with U.S. GAAP. These non-U.S. GAAP financial measures reflect an additional way of viewing aspects of our operations that, when viewed with our U.S. GAAP results and, where applicable, the accompanying reconciliations to corresponding U.S. GAAP financial measures, provide a more complete understanding of factors and trends affecting our business. A material limitation associated with these non-U.S. GAAP measures compared to the U.S. GAAP measures is that they may not be comparable to other companies with similarly titled items that present related measures differently. The non-U.S. GAAP measures should be considered as a supplement to, and not as a substitute for or superior to, the corresponding measures calculated in accordance with U.S. GAAP.
See Managements Discussion and Analysis of Financial Condition and Results of Operations for a reconciliation of these non-U.S. GAAP financial measures to the most directly comparable financial measures stated in accordance with U.S. GAAP.
4
This summary highlights information contained elsewhere in this prospectus. Because this is only a summary, it does not contain all of the information that you should consider before investing in Common Shares and it is qualified in its entirety by, and should be read in conjunction with, the more detailed information appearing elsewhere in this prospectus. You should read the entire prospectus carefully, including Risk Factors, Cautionary Note Regarding Forward-Looking Statements, and our financial statements and the related notes included elsewhere in this prospectus, before deciding to purchase Common Shares. Unless otherwise indicated, or the context otherwise requires, references herein to Fidelis, Group, we, our, us, and other similar references refer (i) prior to the consummation of the Separation Transactions and this offering to Previous Fidelis and (ii) following the consummation of the Separation Transactions to Current Fidelis.
Certain abbreviations and definitions of certain insurance, reinsurance, financial and other terms used in this prospectus are defined in the Glossary of Selected Terms section of this prospectus.
Our History; Then to Now
Fidelis is a global (re)insurance company, with operations in Bermuda, Ireland and the United Kingdom. FIHL was formed in Bermuda in 2014 by Richard Brindle, under the principles of focused, process-driven and disciplined underwriting and risk selection, strong client and broker relationships and nimble capital deployment. Fidelis completed its initial funding and began underwriting business in June 2015 under the direction of an experienced management team led by Richard Brindle. Since then, Fidelis has assembled a diversified global book of (re)insurance business and achieved scale as a specialty (re)insurer with GPW of $3.0 billion, total revenues of $1.5 billion and net income of $62.3 million for the year ended December 31, 2022. Our growth has continued in 2023, with our GPW increasing to $1.2 billion in the three months ended March 31, 2023 compared to $1.0 billion for the three months ended March 31, 2022.
On January 3, 2023, the Separation Transactions were completed and two distinct holding companies and businesses were created: FIHL and MGU HoldCo. FIHL is the parent holding company for Current Fidelis, is the issuer of the Common Shares sold by the Selling Shareholders in this offering and continues to own all of the insurance operating subsidiaries of Current Fidelis, comprised of Fidelis Insurance Bermuda Limited (FIBL), Fidelis Underwriting Limited (FUL) and Fidelis Insurance Ireland DAC (FIID). Current Fidelis also has its own service company, FIHL (UK) Services Limited, with a branch in Ireland (FIHL (UK) Services).
MGU HoldCo is the parent holding company for the managing general underwriting platform (the Fidelis MGU) that carries on the origination and underwriting activities on behalf of Current Fidelis and is led by Mr. Brindle. MGU HoldCos principal operating subsidiaries are Pine Walk Capital Limited (Pine Walk Capital), Pine Walk Europe SRL (Pine Walk Europe) and Shelf Opco Bermuda Limited, a newly incorporated MGU in Bermuda (Bermuda MGU). The underwriting activities of each of the licensed insurance carriers of Current Fidelis (FIBL, FUL and FIID) are outsourced to the corresponding operating subsidiaries of Fidelis MGU on a jurisdictional basis (Bermuda MGU, Pine Walk Capital and Pine Walk Europe, respectively). Each of the operating subsidiaries of Fidelis MGU has delegated underwriting authority to source and bind contracts for and on behalf of each of FIBL, FUL and FIID, respectively. See Material Contracts and Related Party TransactionsFramework Agreement. MGU HoldCo and its subsidiaries will not be consolidated with FIHL and its subsidiaries.
On December 20, 2022, FIHL and MGU HoldCo entered into a rolling 10-year framework agreement (the Framework Agreement) that governs the ongoing relationship between the two groups of companies (see Our Corporate Structure for additional details). Following the consummation of the Separation Transactions
5
on January 3, 2023, Mr. Brindles employment agreement and the employment agreements of certain other senior management and other employees of Previous Fidelis remained with Fidelis Marketing Limited (FML) (the service company which transferred to and became part of Fidelis MGU as part of the Separation Transactions), and Mr. Brindle is now the Chairman and Chief Executive Officer of Fidelis MGU. See The Separation Transactions.
The Separation Transactions allow FIHL to access the underwriting expertise of Fidelis MGU while allowing Fidelis MGU to attract and retain highly sophisticated underwriting talent, including Mr. Brindle and senior underwriters. We believe that the Separation Transactions and the Framework Agreement have structural benefits for both groups of companies, including increased flexibility to quickly respond to evolving insurance and reinsurance market conditions and to help sustain our strong underwriting results through access to top talent. Our objective following the completion of the Separation Transactions remains to further solidify Fidelis position as a leading bespoke, specialty and property underwriter.
Prior to the Separation Transactions, the Group was assigned an A (Excellent) financial strength rating by A.M. Best Company, Inc. (A.M. Best), the third-highest of 13 rating levels, with a stable outlook on all entities. A.M. Bests ratings range from A+ to D. Each A.M. Best rating category from A+ to C may be designated either an additional plus (+) or a minus (-) sign as a rating notch that reflects a gradation of financial strength within the rating category. Additionally, A.M. Best assigned a BBB long-term issuer credit rating to FIHL, which indicates a good ability to meet ongoing senior financial obligations and a financial strength rating of A (Excellent) and the long-term issuer credit rating of A (Excellent) to FIBL, FUL and FIID. In connection with the Separation Transactions, the Group completed a rating evaluation service with A.M. Best, following which, A.M. Best had placed under review with negative implications the ratings assigned to FIHL, including the Groups financial strength rating of A. On February 3, 2023, A.M. Best removed from under review with negative implications and affirmed the financial strength rating of A (Excellent) and the long-term issuer credit rating of A (Excellent) of FIBL, FUL and FIID. In addition, A.M. Best removed from under review with negative implications and affirmed the long-term issuer credit rating of BBB (Good) of FIHL. The outlook assigned to these ratings remained negative at such date. The negative outlooks acknowledge that A.M. Best has noted that it will continue to monitor the Groups market presence as well as subsequent operating performance now that the Separation Transactions have been consummated.
Prior to the Separation Transactions, the Group was assigned an A- financial strength rating by S&P Global Ratings (S&P), with a positive outlook, which indicates strong capacity to meet financial commitments but somewhat more susceptibility to the adverse effects of changes in circumstances and economic conditions than those in higher-rated categories. S&Ps ratings range from AAA to D. Each S&P rating category from AA to CCC may be modified by the addition of a plus (+) or minus (-) sign to show relative standing within the rating categories. Additionally, S&P has assigned a BBB long term issuer rating to FIHL, which indicates adequate capacity to meet financial commitments but greater susceptibility to adverse economic conditions. In connection with the Separation Transactions, the Group completed a rating evaluation service with S&P, following which, S&P had placed under review the ratings assigned to FIHL, including the Groups financial strength rating of A-. On August 5, 2022, S&P affirmed the Groups ratings, including the A- financial strength rating assigned to the Group and a BBB long term issuer rating to FIHL, but revised its outlook from positive to stable for all entities. Despite the revision, S&P expressed confidence in the Groups future operating earnings and strong capital position, noting in particular the Groups underwriting outperformance of peers between 2017 and 2022.
Following the announcement of the Separation Transactions, on August 1, 2022, Moodys Investors Service (Moodys) assigned a Baa2 long-term issuer rating to FIHL and A3 insurance financial strength ratings to FIBL, FUL and FIID. The outlook for FIHL is stable. Moodys generic rating classifications range from Aaa to C. Each Moodys generic rating classification from Aa to Caa may be modified to append numerical modifiers 1, 2, or 3 to show relative position within the rating categories.
6
Our Company
Fidelis is a leading global provider of bespoke and specialty insurance and reinsurance products. We believe our differentiated underwriting positions us well to generate strong returns across (re)insurance cycles. Current Fidelis is led by Mr. Daniel Burrows who has more than 35 years of experience in the insurance industry and is supported by a highly experienced management team that manages the operations of Current Fidelis based on our founding principles.
Following the Separation Transactions, Current Fidelis is positioned as a global, specialty insurance provider with exclusive right of first access to Fidelis MGUs underwriting business during the term of the Framework Agreement. Based on Fidelis historical experience, we expect this long-term partnership to deliver strong returns to our shareholders, primarily driven by our underwriting results. We aim to be good stewards of capital by effectively balancing capital deployment across market opportunities with capital distributions to our shareholders.
We will continue to benefit from decades of thought and process leadership and innovation through our strategic relationship with Fidelis MGU. The management team of Fidelis MGU, led by Mr. Brindle, has a robust track record built across multiple platforms. Mr. Brindle has more than 38 years of underwriting leadership, including founding Lancashire Holdings Limited (Lancashire) and holding leading roles at Syndicates 488 and 2488 at Lloyds of London (Lloyds). Teams led by Mr. Brindle oversaw Lancashire stock price appreciation of 412.0% from December 16, 2005 (the date of Lancashires initial public offering) to December 31, 2013 (immediately prior to his retirement from Lancashire), significantly exceeding the 71.0% price appreciation from a group of Lancashires publicly traded insurance company peers for the period (including Ace, XL, Arch, Everest, PartnerRe, Axis, Allied World, RenaissanceRe, Validus, Montpelier, Greenlight Re, Third Point Re, Hiscox, Amlin, Catlin, Beazley and Novae). Past performance of Lancashire is no guarantee of future results for Fidelis. Mr. Brindle and his team also outperformed at Lloyds by delivering a 17.5% return on a straight average for Syndicates 488 and 2488 during his time there from 1986 to 1998, compared to Lloyds average return of 0.9% over the same period. Past performance of Syndicates 488 and 2488 is no guarantee of future results for Fidelis. Further, while at Fidelis, between 2017 and 2022 Mr. Brindle and his management team achieved strong, consistent underwriting performance with an average loss ratio of 45.3%, an average combined ratio of 85.8% and an average standard deviation of combined ratio of 6.5% compared with the peer average of 64.3% and 99.5% and 8.1%, respectively. Over this same period, Fidelis average loss ratios for each of its Specialty, Bespoke and Reinsurance pillars was 42.8%, 26.7% and 64.9%, respectively, compared to its peers average loss ratios of 61.4%, 61.4% and 72.1%, respectively. Fidelis combined ratio was 86.0%, 76.3%, 86.6%, 80.6%, 92.9% and 92.1% in 2017, 2018, 2019, 2020, 2021 and 2022, respectively, compared to a peer average combined ratio of 109.4%, 96.9%, 96.7%, 103.7%, 96.6% and 93.5% in 2017, 2018, 2019, 2020, 2021 and 2022, respectively. In the three months ended March 31, 2023, our loss ratio was 41.3% and combined ratio was 79.1% compared with a peer average of 59.3% and 90.5%, respectively. Fidelis peer group includes Arch, Argo, Aspen, Markel, W. R. Berkley, Hiscox, Beazley, Lancashire, Everest Re, Axis Capital and RenaissanceRe (except for the three months ended March 31, 2023 which excludes Aspen, Hiscox, Beazley and Lancashire as the information is not available for this period). In each case, prior underwriting and combined ratio performance is no guarantee of future performance. Each of the Fidelis and financial peer combined ratios is calculated as the sum of losses and loss adjustment expenses, policy acquisition expenses and general and administrative expenses as a percentage of NPE in all periods except 2018. In 2018, the Fidelis combined ratio included a negative $2.1 million adjustment to NPE as a result of the costs to acquire a derivative instrument to protect against Typhoon Jebi losses and a $10 million positive adjustment to investment returns recognized on the derivative. Financial peer combined ratios were calculated as the average of the reported combined ratios of each company.
We will continue to focus on nimble underwriting designed to capitalize on current market trends and dislocations as well as emerging risk solutions. We expect to maintain at a minimum the existing underwriting
7
standards and where appropriate will look for enhancements. The team of underwriters at Fidelis MGU continues to maintain the robust processes and use of technology that have been key to Fidelis historical success at ensuring its underwriting efforts capture recent market developments. We believe this close coordination reduces the likelihood of siloed underwriting and gives us a competitive advantage in our underwriting, risk assessment and ability to offer as many products as possible to clients. A crucial and distinguishing part of those robust processes is daily Underwriting and Marketing Conference Calls (the UMCC) with practice leads and key members of senior management (including risk modeling, actuarial, legal, compliance, contract wordings and claims representatives) to provide live market insights and multiple perspectives to allow underwriters to quickly assess emerging opportunities, achieve strong underwriting and cross-sell across our product range. See Our Competitive Strengths below for further detail.
Since we began underwriting business in 2015, Fidelis has reached an attractive scale in bespoke and specialty insurance and property reinsurance markets while delivering robust results. Our GPW grew from $0.5 billion for the year ended December 31, 2017 to $3.0 billion for the year ended December 31, 2022, a compound annual growth rate of 40.6%, while delivering an average loss ratio of 45.3% and an average combined ratio of 85.8%. Over the same period, our NPE grew from $0.2 billion for the year ended December 31, 2017 to $1.5 billion for the year ended December 31, 2022, a compound annual growth rate of 47.0%. Our GPW continued to grow to $1.2 billion for the three months ended March 31, 2023 compared to $1.0 billion for the three months ended March 31, 2022. Our loss ratio and combined ratio for the three months ended March 31, 2023 were 41.3% and 79.1%, respectively. In addition to earnings growth from the origination of new business, we believe that there is significant embedded earnings potential in previously written business due to the requirements of applicable accounting rules that revenue from written premiums must be recognized when earned over the life of a policy. This is reflected in our gross UPR balance of $3.3 billion at March 31, 2023.
Our scale and access to the highly selective underwriting capabilities of Fidelis MGU via our strategic relationship will allow us to capitalize on current insurance market trends and continue focusing on delivering growth coupled with strong underwriting results.
Fidelis is subject to varying degrees of regulation and supervision in the jurisdictions in which it operates. In particular, the businesses of our three insurance operating subsidiaries, FIBL, FUL and FIID, are authorized by, and subject to insurance laws and regulations that are administered and enforced by, a number of different governmental and non-governmental self-regulatory authorities and associations in each of their respective jurisdictions and internationally. For a summary of the regulatory environment of our insurance operating subsidiaries, primarily in their respective jurisdictions of Bermuda, U.K. and Ireland, see Certain Regulatory Considerations.
Our Commitment to Environmental, Social and Governance Matters
Fidelis is committed to being a leader in the industry with respect to standards for environmental, social and governance (ESG) matters. We are currently committed to transitioning our insurance portfolios to net-zero greenhouse gas emissions by 2050. To work towards this, to the extent possible, we are developing tools to measure the insurance-associated emissions of our insurance portfolios. We have carried out a joint study on approximately $8.2 billion of premiums and 28,500 policies spanning between 2012 and 2021, which demonstrated that higher third-party ESG ratings were generally correlated with lower loss ratios. Fidelis aims to embed ESG factors in its underwriting processes where appropriate. In addition, Fidelis has certain existing underwriting restrictions. These underwriting restrictions include not directly insuring thermal coal (including dedicated infrastructure projects such as ports and railways), tar sand extraction, Arctic oil and gas exploration and drilling and fracking operations. Fidelis will also not provide cover to companies whose revenues from the above-mentioned activities account for more than 20% of their total revenues. Fidelis has been for some time seeking to use policy language to minimize exposure to forced labor and modern slavery in particular in our marine cargo line of business.
8
Furthermore, FIHLs core fixed income investment portfolio (which represents 98.4% of invested assets) is managed in a manner that is consistent with Fidelis sustainability principles and ESG objectives. This includes a requirement that a minimum of 3% of the core fixed income portfolios total assets under management must be invested in green, social and sustainable (GSS) bonds, as classified by Bloomberg pursuant to its proprietary GSS Indices. The GSS Indices utilize the Bloomberg Global Aggregate Index, the Bloomberg Sustainable Finance Groups green, social and sustainability bond indicators and fields that show alignment with the International Capital Market Association Green Bond, Social Bond and Sustainability Bond Principles and Guidelines. At March 31, 2023, 3.9% of Fidelis core fixed income portfolio was invested in GSS bonds. Furthermore, the investment portfolio includes restrictions against holding securities of issuers that have a poor MSCI Inc. (MSCI) ESG rating (with a rating below B or issuers that currently have a red MSCI controversy flag). Securities of these issuers may only be held if the investment manager demonstrates and documents in writing pursuant to company policies a positive forward-looking ESG view of the issuer. Fidelis has also adopted negative screens to limit exposure to certain industries and activities in its investment portfolio. These include screens against holding securities of any issuers involved in thermal coal, oil and gas (though an issuer may derive up to 20% of its annual revenues from oil and gas) or arms (certain types of arms are completely excluded, others such as firearm sales are permitted to comprise up to 10% of annual revenues), and restrictions against those that fail animal welfare and for-profit prisons screens. As a result of such negative screens, Fidelis was able to limit the core fixed income portfolios direct exposure to the securities of companies deriving revenues from fossil fuels to only three companies, which at March 31, 2023 comprised 0.4% of Fidelis core fixed income portfolio. Furthermore, currently Fidelis has no direct exposure in its investment portfolio to energy companies and its exposure to corporate securities identified as utilities comprises 0.6% of the core fixed income portfolio.
Additionally, we have taken action in each year since 2018 to more than offset our operational carbon emissions and we are committed to continuing to do so going forward. In 2018, 2019, 2020, 2021 and 2022, we offset our carbon emissions at 125%, 150%, 200%, 150% and 110%, respectively, on a tons-of-carbon-equivalent basis through the use of carbon credits. We partner with relevant industry specialists to calculate our carbon emissions.
We were awarded carbon credits through investments in Earths forests, including forest protection in investments in the April Salumei area of Papua New Guinea in 2018 and 2019 and reforestation projects in Nicaragua and Tanzania in conjunction with CommuniTree and Hazda Hunter Gatherers, respectively, in 2020, 2021 and 2022.
Diversity, equity and inclusion are integral to Fidelis. We pursue a diversity, equity and inclusion strategy that includes accountability, representation, advancement, culture, outreach and fostering a sense of belonging for all our employees. We employ targeted recruiting strategies to identify diverse candidates and partner with external agencies to advertise vacancies with the goal of increasing the hiring of women and ethnically diverse employees. Where available, we monitor certain diversity, equity and inclusion statistics (gender, ethnicity, age, marital status, religion, caring responsibilities and disability, each as provided by candidates on a voluntary basis) both at the outreach/interview stage and for our employee population so that we can see progress with respect to the diverse candidate pools. Comparative data on diverse candidate sourcing available to us demonstrates an improved diversity mix of approximately 1% across gender and approximately 6.5% across ethnicity from December 31, 2021 to February 1, 2023 (being the latest practicable date), acknowledging that the number of employees following the consummation of the Separation Transactions has been reduced due to staff transfers to Fidelis MGU. In addition, we seek to promote our diverse talent from within, identifying those that have potential to take on more senior roles and fast-tracking them through exposure to a wide range of business opportunities as well as structured training and development.
9
Strategic Relationship with Fidelis MGU
We believe the insurance industry is evolving rapidly and is primed for further value chain disaggregation which will allow specialist underwriters to benefit from access to clients and risks and to provide access to alternate forms of capital.
Following the consummation of the Separation Transactions, MGU HoldCo became a minority investor in FIHL (holding 9.9% of the Common Shares) and entered into the Framework Agreement with FIHL to build a long-term agency relationship that provides strong economic and strategic alignment between the two groups of companies.
The Framework Agreement, under which Current Fidelis secures business from Fidelis MGU, has a rolling initial term of 10 years. Years one to three will roll automatically (each year resetting the term of the Framework Agreement to a new 10-year period) and the notice to roll will be deemed given at the end of years one, two and three (i.e., the years roll automatically and will not be subject to any underwriting target or preconditions to rolling). From year four onwards, the Framework Agreement will roll at the sole written election of FIHL, with such election to be delivered at least 90 days prior to the commencement of the subsequent contract year. Any decision by FIHL to elect not to roll the Framework Agreement on or after year four will mean that the remainder of the 10-year term then in effect will continue in place (i.e., the Framework Agreement will have a further nine years to run in the first year following the election by FIHL not to roll the Framework Agreement). See Material Contracts and Related Party TransactionsFramework Agreement.
Fidelis MGU manages underwriting, origination, outwards reinsurance, actuarial and claims services with close review and oversight from Current Fidelis to ensure adherence with the agreed upon group-level annual plan (the Group Annual Plan), which sets out our underwriting parameters and risk tolerances in respect of our three-pillar underwriting strategy on a gross / net basis for each annual period. While the Framework Agreement establishes the overarching parameters of the outsourced underwriting relationship between Current Fidelis and Fidelis MGU, the relationship is more specifically governed on a jurisdictional basis by a series of Delegated Underwriting Authority Agreements (as defined herein). The parties to each Delegated Underwriting Authority Agreement will prepare their own subsidiary-level annual plans (each, a Subsidiary Annual Plan). See Material Contracts and Related Party TransactionsFramework AgreementSubsidiary Annual Plans. Fidelis MGU provides us with a number of enterprise and support services on a cost-plus basis, such as accounting, other finance and reporting services, IT infrastructure, maintenance and system development services and facilities management services pursuant to the services agreement between FIHL and MGU HoldCo relating to the outsourcing of certain non-underwriting services provided by Fidelis MGU to FIHL and FIHL (UK) Services (the Inter-Group Services Agreement). See Material Contracts and Related Party TransactionsInter-Group Services Agreement.
We will continue to leverage Fidelis MGUs sophisticated underwriting technology and talent and will benefit from our shared history in underwriting principles, strategic visions, and managerial approaches. Our arrangement is governed by arms-length terms for origination and management consistent with industry commission levels, including market overrider commissions, and with a focus on aligning incentives for strong underwriting performance. Ceding commissions payable to Fidelis MGU will be charged for underwriting, claims and actuarial pricing services and will be calculated based on NPW to ensure alignment on reinsurance purchasing. To avoid fee duplication, ceding commissions payable for open market business sourced by Fidelis MGU are set at 11.5% and ceding commissions payable for business sourced by Fidelis MGU via third-party managing general underwriters to whom underwriting authority has been sub-delegated by Fidelis MGU are set at 3.0%. Business that continues to be sourced by subsidiary cells of Pine Walk Capital will continue to follow the fees and commissions set under those agreements. For the year ended December 31, 2022, the fees and commissions attributable to subsidiary cells of Pine Walk Capital were 10.0% on average of the total Pine Walk Capital GPW. Long-term objectives will be
10
further aligned by FIHL paying an ongoing portfolio management fee of 3.0% (Portfolio Management Fee) to Fidelis MGU and a 20.0% profit commission on Operating RoE (Binder Operating RoE) above a hurdle rate of 5.0% calculated on an aggregate basis for Current Fidelis. Binder Operating RoE is defined in the Framework Agreement as FIHLs consolidated net underwriting margin (disregarding any business not underwritten by Fidelis MGU following the date of the Framework Agreement and the effect of any FIHL Procured Outwards Reinsurance, as defined in the Framework Agreement) plus all overriders retained by Current Fidelis (disregarding the effect of any FIHL Procured Outwards Reinsurance), minus an Administrative Expenses Allowance (defined in the Framework Agreement as a sum equating to 2.3% of net premiums written), minus the proportion of FIHLs costs of financing its debt and preference securities included in FIHLs total capital that is deemed to be allocated to Fidelis MGU, minus the total accumulated ceding commission that is payable by Current Fidelis to Fidelis MGU, minus the Portfolio Management Fee relating to business underwritten by Fidelis MGU, divided by the proportion of FIHLs opening common shareholders equity adjusted for dividend and equity raises (as set out in year-end consolidated audited accounts) that is deemed to be allocated to Fidelis MGU. The calculation of such profit commission will include a deficit carry-forward mechanism for a maximum of three years in which the Binder Operating RoE is below zero. For a more detailed discussion of the fees and commissions payable by Current Fidelis in connection with its outsourced relationship with Fidelis MGU, see Material Contracts and Related Party TransactionsFramework AgreementFees and Commissions.
We believe the recently completed Separation Transactions make us a scaled property, bespoke and specialty (re)insurer with long-term access to a sophisticated underwriting team focused distinctively on portfolio optimization and insurance portfolio management. Under this structure, we believe we are well positioned to generate attractive returns, deploy capital toward profitable underwriting opportunities sourced through our strategic arrangement with Fidelis MGU, and grow our business. The strategic arrangement adheres to our long-standing philosophy of writing insurance and reinsurance in areas where deep expertise is required to deliver an attractive risk / reward profile through (re)insurance cycles.
The shareholders agreement entered into by current shareholders who own shares in FIHL following the consummation of the Separation Transactions (the Existing Common Shareholders Agreement) will be amended and restated (the Amended and Restated Common Shareholders Agreement) effective as of the pricing of this offering. The Amended and Restated Common Shareholders Agreement will retain a number of rights granted to MGU HoldCo or other Founders (as defined below) under the Existing Common Shareholders Agreement, such as certain consent rights, minority shareholder protections and board nomination rights. Under the terms of the Amended and Restated Common Shareholders Agreement, for so long as MGU HoldCo beneficially owns at least 4.9% of the Common Shares, the consent of MGU HoldCo will be required for FIHL to undertake certain actions, including effecting any change in the jurisdiction, incorporation or name of FIHL or any member of Current Fidelis, making a material change to the nature or scope of the business underwritten by FIHL and any member of Current Fidelis, effecting any amendments to its constitutional documents that are reasonably likely to have a material adverse effect on Fidelis MGU and making certain acquisitions or dispositions of assets. MGU HoldCo will also enjoy certain subscription and allocation rights in respect of further Common Share issuances or sales. MGU HoldCo will be subject to a prohibition on the sale of its Common Shares provided that the Framework Agreement is in effect. This prohibition shall not apply in the event of a Common Share buyback or other transactions undertaken by FIHL in response to certain adverse regulatory or accounting effects on MGU HoldCo. Additionally, MGU HoldCo will be entitled to nominate one individual to serve as a director on the board of directors of FIHL (the Board), for so long as MGU HoldCo together with its Shareholder Affiliate Transferees beneficially own at least 50% of the Common Shares initially purchased by MGU HoldCo on the consummation of the Separation Transactions (the MGU HoldCo Initial Shares). See Material Contracts and Related Party TransactionsOtherCommon Shareholders Agreement and Description of Share CapitalCertain Provisions of the Amended and Restated Bye-LawsNumber of Directors for a detailed description of these rights and the definition of Shareholder Affiliate Transferees.
11
Our Business; Overview
We focus our business on three pillars: Bespoke, Specialty and Reinsurance (Bespoke, Specialty and Reinsurance, respectively). We believe our three-pillar strategy and capabilities allow us to take advantage of the opportunities presented by evolving (re)insurance markets and proactively shift our business mix across market cycles.
Bespoke
For the year ended December 31, 2022, the portion of the Groups business which focuses on bespoke (re)insurance underwriting for tailored coverage (the Bespoke pillar) accounted for 26.1% of our GPW and 30.2% of our NPW with an underwriting ratio of 68.5% and a loss ratio of 31.3%. In 2022, the Bespoke pillar generated $119.3 million in underwriting income. GPW in the Bespoke pillar grew from $209.9 million for the year ended December 31, 2017 to $783.2 million for the year ended December 31, 2022, a compound annual growth rate of 30.1%, despite our decision to maintain our GPW in 2020 at the same level as in 2019 in light of political and economic uncertainties arising from the COVID-19 pandemic. During the period from 2017 to 2022, our average underwriting ratio was 57.7%. For the three months ended March 31, 2023 our Bespoke GPW grew to $150.8 million compared to $135.0 million for the three months ended March 31, 2022.
The Bespoke pillar focuses primarily on highly tailored and specialized products, including policies covering credit and political risk, political violence and terrorism, limited cyber reinsurance, tax liabilities, title, transactional liabilities and other bespoke products that fit our criteria. Given the increased global conflict in 2022 and national economies shifting further to intellectual property driven value, we believe that the Bespoke pillar continues to see significant opportunity for beneficial pricing and terms and conditions. The relationships we have formed with clients and brokers, the underwriting expertise required, and nature of the underlying risks create a higher barrier to entry and help us maintain our position as a leader in the industry. Typically, these lines do not follow the established (re)insurance cycle and are largely influenced by prevailing economic conditions at a given time. As such, these products require highly specialized pricing and other models tailored to the risk profile. For example, for certain significant risk transfer transactions, pricing is largely driven by counterparty credit quality which has low correlation with the current (re)insurance cycle and high correlation with the overall economy and macro events. As a result, Bespoke policies follow a different and diversified loss pattern relative to our Specialty and Reinsurance pillars.
The Bespoke portfolio has several economic features that we believe are financially attractive. The contracts often have multi-year tenors, and the products generally have expected low and stable attritional loss ratios over the exposure period. The combination of longer tenor and lower expected loss experience creates the potential to capture additional embedded value as premiums are earned over the exposure period under U.S. GAAP. Additionally, the contracts are highly capital-efficient as these risks tend to have little or no correlation to peak natural catastrophe perils driving a higher RoE than other lines. Furthermore, the contracts typically have customized provisions rather than standard market contractual provisions, creating opportunities to optimize pricing and establish proprietary, recurring relationships with clients. The custom and direct nature of the business has allowed us to lead on substantially all of our contracts creating tailored terms, conditions and pricing.
The Bespoke pillar benefits from quota share, aggregate and stop loss and excess of loss retrocessional cover, which helps to reduce volatility.
Our Bespoke pillar is central to our business, and we believe it is one of the key differentiators of our business from that of other specialty insurers. The specialist nature of this business combined with lower levels of market competition result in a less commoditized, more tailor-made product that delivers better and lower
12
volatility underwriting performance with less exposure to the typical (re)insurance cycle. The capital-efficient nature of these products and potential for high RoE allow us to retain sufficient capital to withstand deterioration through (re)insurance cycles while avoiding accumulation of excess capital like many of our competitors focused primarily on high-volatility property reinsurance.
Specialty
For the year ended December 31, 2022, the portion of the Groups business which focuses on traditional specialty business lines (the Specialty pillar) such as aviation, energy, space, marine, contingency and property direct and facultative (D&F) accounted for 53.7% of our GPW and 57.0% of our NPW with an underwriting ratio of 85.4% and a loss ratio of 59.7%. In 2022, the Specialty pillar generated $124.6 million in underwriting income. GPW in the Specialty pillar grew from $70.8 million for the year ended December 31, 2017 to $1,610.7 million for the year ended December 31, 2022, a compound annual growth rate of 86.8%. During the period from 2017 to 2022, our average underwriting ratio was 65.5%. For the three months ended March 31, 2023 our Specialty GPW grew to $834.1 million compared to $543.8 million for the three months ended March 31, 2022. Our Specialty pillar from 2017 to 2022 accounted for 13.0%, 6.4%, 12.2%, 36.7%, 41.0%, and 53.7%, respectively, of our GPW.
The Specialty pillar classes include aviation, energy, space, marine, contingency and property D&F. Given the current position of the reinsurance market in the insurance cycle, we have used our Specialty pillar increasingly to deploy capital targeted to natural catastrophe exposure through property D&F lines of business rather than through our Reinsurance pillar. We further capitalized on market dislocations and associated rate increases in key classes such as marine and aviation to increase the amount of business written. Our aviation, property D&F and marine businesses are among the leading franchise positions in the London market. The Specialty pillar benefits from quota share, aggregate, stop loss and excess of loss retrocessional cover and industry loss warranties, which helps to reduce volatility.
Our Specialty pillar provides us with access to capital-efficient business and facilitates diversification of our exposures. Due to the soft rate environment in years prior to 2020, this pillar has historically been the smallest contributor to our GPW. However, following the significant dislocation in the market beginning in late 2019 when a number of large carriers exited the Specialty market, Fidelis assessed that return hurdles in its Specialty pillar were at levels that had the potential to grow in this segment, and Fidelis increased its Specialty pillar GPW significantly in 2020 and 2021 (representing a 236% per annum GPW growth from 2019 to 2021) and continued to do so in 2022.
In 2022 and in the first quarter of 2023, we experienced further pricing momentum and enhanced terms and conditions as dislocations affected several lines, including war cover for marine and aviation lines driven by the Ukraine Conflict, contingency driven by COVID-19, and property D&F driven by Hurricane Ian.
In the Specialty pillar, we leverage Fidelis MGUs ability to adapt to constantly evolving market dynamics and develop specialized and tailored pricing and aggregation models while maintaining a disciplined underwriting approach. Our underwriters work to form, and via the sophisticated underwriting expertise at Fidelis MGU we continue to develop, collaborative relationships with brokers and clients, offering them the full suite of our existing products as well as working with them to innovate new product ideas. This relationship-driven approach allows our underwriters, and will allow underwriters at Fidelis MGU on our behalf, to identify from existing clients additional underwriting opportunities for providing cover on other related lines of business. We typically seek out capacity-driven layers with attractive pricing, often focusing on dislocated markets, and look to ensure successful and sustainable growth in this pillar through developing and maintaining an excellent broker network.
13
Reinsurance
For the year ended December 31, 2022, the Reinsurance pillar accounted for 20.2% of our GPW and 12.9% of our NPW with an underwriting ratio of 106.2% and a loss ratio of 74.3%. GPW in the Reinsurance pillar grew from $265.2 million for the year ended December 31, 2017 to $606.2 million for the year ended December 31, 2022, a compound annual growth rate of 18.0%. During the period from 2017 to 2022, our average underwriting ratio was 89.2%. For the three months ended March 31, 2023 our Reinsurance GPW was $260.4 million compared to $291.9 million for the three months ended March 31, 2022. Our Reinsurance pillar from 2017 to 2022 accounted for 48.6%, 47.4%, 45.9%, 41.8%, 38.9% and 20.2%, respectively, of our GPW.
Our Reinsurance pillar consists of an actively managed, primarily residential property catastrophe reinsurance book, with closely controlled aggregates using Fidelis MGUs proprietary FireAnt aggregation and analytics system to monitor exposures in real time. The Reinsurance pillar also includes property retrocession and a limited amount of composite and multi-class asset reinsurance. In the context of excess of loss reinsurance products, we focus on underwriting attachment points largely exposed only to true catastrophe events. The portfolio is global in nature with a strong North American concentration and smaller exposures in Japan, Europe, Australasia and elsewhere throughout the world. The Reinsurance pillar benefits from quota share, aggregate, stop loss and excess of loss retrocessional cover, catastrophe bond cover and industry loss warranties, which helps to minimize the potential net losses in the business written. We believe our strategy of pursuing closely controlled aggregates and focusing on residential portfolios in the Reinsurance pillar helps keep volatility lower than a typical catastrophe book.
We benefit from Fidelis MGUs sophisticated analytics capabilities and live aggregation tools, excellent relationships with a blend of regional and nationwide carriers (both in the United States and internationally), and strong retail and wholesale broker relations in the distribution of our products. Since 2021, we have developed a view of risk informed by thorough analysis and discussions with weather and forecasting experts. We have concluded that the effects of climate change on perils such as hurricanes, convective storm, flood and wildfire are not currently represented adequately in current vendor models. As such, we have superimposed our own expectations of frequency and severity on third-party vendor models, which are well in excess of average Bermuda (re)insurers loads, to form a base for exposure and aggregation tracking.
We have taken proactive steps to reduce volatility and reshape our Reinsurance portfolio to focus only on clients with stronger financial and loss adjustment capabilities and the resources to adjust and manage high volumes of claims in-house. As a consequence, the property reinsurance portfolio was reduced for the year ended December 31, 2022 and three months ended March 31, 2023, and subject to opportunities that may develop, is expected to remain at reduced levels for the remainder of 2023, reducing natural catastrophe exposure across the portfolio. We are increasingly deploying reinsurance capital across large-scale, well-resourced national accounts away from smaller regional underwriters, who we believe are less able to adjust and manage large catastrophe events. We have reduced our exposure to the middle layers of treaty accounts which are more exposed to increased frequency and severity of losses as a result of climate change and secondary perils associated with floods and wildfires without commensurate increases in rates. Following Hurricane Ian, we also saw an increased demand for private deals and significant pricing increases during the year-end renewal season. Over time, we expect the impact of these changes to improve the quality of our natural catastrophe-exposed portfolios and reduce volatility. As ever, we will continue to leverage our nimble underwriting abilities and ability to adapt to constantly evolving market dynamics to source business when favorable market conditions are present. If there is an increase in property catastrophe rates, as well as favorable terms and conditions, we would intend to capitalize on those trends and dislocations.
14
Insurance Market Conditions
We believe we have significant market opportunities given our ability to innovate and adapt to evolving market conditions. Global economic and industrial development, population increases, greater product awareness and distribution, as well as inflation continue to drive increased need for insurance and reinsurance. The current insurance and reinsurance market environment has experienced a prolonged period of rate increases, structural enhancements and continued improvement of terms and conditions. However, we believe that the higher loss ratios experienced by many of our competitors in recent years due to the frequency and severity of catastrophes has caused some of them to reevaluate and reduce their catastrophe reinsurance business. As companies exit certain (re)insurance markets and/or reduce the scope of their underwriting activities, capacity has been reducing in certain classes, leading to significant year-on-year rate increases in the (re)insurance market since the end of 2019. Some classes of business that have experienced larger rate increases include property catastrophe, property D&F, specialty markets such as aviation, marine, energy and contingency and casualty markets such as medical malpractice and healthcare (with medical malpractice and healthcare being lines of business which Current Fidelis does not write) which is reflective of the hardening cycle being driven by a lack of underwriting profits rather than capital. We believe that this combination of factors is driving a sustainable favorable market environment, with a focus on risk management, disciplined risk selection, reasonable terms and profitable business, which presents significant market opportunities for us. Global commercial insurance prices rose 4% in the first quarter of 2023, making the first quarter of 2023 the tenth consecutive quarter of price increase since global pricing increases peaked at 22% in the fourth quarter of 20201. Property D&F pricing is at its highest level in two decades, marine cargo prices are at market highs and aviation pricing continues to remain strong. These rate increases are expected to persist throughout 2023 across the lines of business that FIHL focuses on. Rate increases across property D&F, marine, aviation and energy are expected to range between 10% to 40%, 7.5% to 10%, 50% to 100% and 30% to 50%, respectively, in 2023. In particular, we see the emergence of five themes supporting continued rate hardening:
| Climate Change. The frequency and severity of catastrophes is rising as seen by the increases in catastrophes globally in more recent years, requiring rate increases to keep pace. The period between 2017 and 2022, for example, saw three times the number of severe catastrophic weather events and twice the amount of losses caused by these severe events as compared to the period between 2011 and 2016. We believe that the impact of a warming climate and increased atmospheric moisture and changing weather patterns will result in increased frequency and severity of elemental catastrophe losses (elemental risks related to the elements i.e., weather related hail and storms etc.). The frequent incidence of annual industry-wide natural catastrophe losses in excess of $100 billion in the aggregate during the period from 2018 to 2022 has led us to reshape our portfolio and reduce our exposure to certain perils, thereby reducing the volatility traditionally associated with the property reinsurance classes. Many of our competitors have experienced higher loss ratios in the same period than in prior cycles and combined ratios in excess of 100%, causing them to reevaluate their levels of premiums written against catastrophe reinsurance (see BusinessCompetition). Decreased participation has created a lack of supply of reinsurance capacity causing upward pressure on price. We expect this trend to continue, which would allow Fidelis MGU to underwrite select attractive policies on our behalf and position us to deliver strong risk-adjusted returns. |
| Casualty. We believe reserves across the industry remain deficient for accident years from 2013 to 2019 based on prior year adverse developments for several casualty underwriters. Further adverse developments and actual loss payouts may deplete competitors capital and impair their ability to underwrite additional casualty risks. Given Fidelis has made the strategic decision not to write the traditional casualty classes such as general liability, financial lines, directors and officers, and errors and omissions, it is not affected by these potential capital constraining issues, which we believe provides us with a competitive advantage due to our continued position of strength. |
| Cost Inflation. Numerous countries including the United States are experiencing inflation in wages, materials and parts. Real inflation for expert loss adjusters and building materials, exacerbated following a |
1 | Marsh Global Insurance Market Index Q1 2023. |
15
catastrophe, is causing an increase in loss ratios above modeled results for many insurers and complicating future estimates. This effect is increasing losses for multiple areas of the Excess & Surplus, Property & Casualty and reinsurance markets leading to rate increases and decreased appetite. Fidelis incorporates a specific cost inflation factor in its risk modeling to mitigate the effects of inflation. In addition, social inflation driven by changes in societal views on litigation aimed at insurers is a recent and developing risk highlighted by industry leaders and leading to larger claims. See Managements Discussion and Analysis of Financial Condition and Results of OperationsCurrent Outlook, Market Conditions and Rate Trends. |
| Conflict. The escalation of geopolitical tensions and the ongoing invasion of Ukraine by Russia (the Ukraine Conflict) has created uncertainty and potential losses for both global direct insurers and reinsurers. Some lines of business are subject to asymmetrical loss profiles exacerbated by war and armed conflict, which are likely to reduce supply and/or accelerate rate changes. Additionally, aviation, marine, political risk and political violence lines are likely to be particularly impacted as insurers calibrate their losses, reserve, and court proceedings begin on potential claims. Fidelis continues to monitor the Ukraine Conflict to determine the ultimate impact from lines of business which may be exposed to the Ukraine Conflict, including aviation, marine, political risk and political violence contracts. |
| COVID-19. Despite improving case and severity data, we believe industry losses since the beginning of the COVID-19 pandemic have not yet been fully captured. A significant number of outstanding claims and litigation beyond traditional mortality policies persists which may lead to changes in future policies and the risk-appetite of current underwriters. Recent judicial decisions in local markets have made adverse rulings relating to business interruption and treating each case as a separate claim with single claim limits. These rulings could affect the general interpretation of business interruption policies and may increase the level of insurers liability in the relevant markets by reducing their ability to aggregate policyholders losses when applying single claims limits. Fidelis has limited or no exposure to highly impacted businesses (such as U.K. commercial insurance, contingency (which Previous Fidelis began to write after the COVID-19 pandemic began in March 2020) and trade credit), and we continue to believe the effects of the COVID-19 pandemic will impact loss estimates for our competitors, future policies and competitor behavior. |
These market conditions have led to a compelling dislocated underwriting opportunity in numerous specialty areas in which we underwrite.
Our Competitive Strengths
We believe that our competitive advantages are based on the following key strengths:
| Highly experienced, well regarded management team. Our management team consists of industry veterans with many years of relevant experience in insurance, providing FIHL with the necessary functional support, supplemented by the services stipulated under the Framework Agreement and Inter-Group Services Agreement. We are led by Mr. Daniel Burrows, who, prior to joining Fidelis in 2015, was the co-CEO of Aon Benfields Global ReSpecialty (GRS) division. Prior to assuming the CEO role at FIHL, Mr. Burrows had been leading Fidelis Bermuda operations and was most recently the Executive Chairman of FIBL and Group Managing Director. The other members of the management team are a mix of experienced individuals who have had held key roles at Fidelis and have long histories of working with Fidelis MGU, along with other experienced professionals from other industry peers. |
| First choice access to one of the best underwriting teams in the industry. The performance of our business portfolio will be a direct result of the capabilities of the Fidelis MGU management team, led by Richard Brindle, who is the Chairman and CEO of Fidelis MGU. Mr. Brindle brings more than 38 years of experience in the insurance industry and is known for his track record of outperformance across Lloyds syndicates and Lancashire under his leadership. Mr. Brindle was acknowledged by A.M. Best in August 2018 to be one of the most successful underwriters in the worldwide insurance market and has a track record |
16
of outperformance over the past 30 years. From 2017 to 2022, the Fidelis MGU management team has outperformed peers across key profitability and growth metrics. Between 2017 and 2022, Fidelis achieved strong underwriting performance with an average loss ratio of 45.3% and an average combined ratio of 85.8%. In the three months ended March 31, 2023 our loss ratio was 41.3% and combined ratio was 79.1%, respectively. The Fidelis MGU management team brings many years of cumulative experience in broking, underwriting, corporate and actuarial roles as well as long-term client and broker relationships. Mr. Brindle previously founded Lancashire with over $1 billion of start-up capital in December 2005 and grew it into a key player in the (re)insurance market listed on the London Stock Exchange. Under the Framework Agreement, we secure business for a rolling term of 10 years, providing long-term certainty that we will leverage Fidelis MGUs well-established and sophisticated underwriting capabilities. See Material Contracts and Related Party Transactions and The Separation Transactions. |
| Significant scale achieved since establishment and clean platform for growth. We believe our scale achieved since inception and our access to Fidelis MGUs sophisticated underwriting analytics and technology platform will give us a competitive advantage. Since we started underwriting in 2015, we have grown our insurance book significantly through organic business expansion including through increased client penetration, new product development, long-term relationships and new reinsurance partnerships. Between 2017 and 2022, we had extremely strong growth with a compound annual growth rate of 40.6% for GPW and compound annual growth rate of 47.0% for NPE compared to 13.7% and 11.5% respectively from other specialty insurers during the same period (including Arch, W. R. Berkley, Argo, Markel, Aspen, Everest Re, RenaissanceRe, Axis, Beazley, Hiscox, and Lancashire), while delivering top quartile underwriting profitability. Our GPW continued to grow in the three months ended March 31, 2023 to $1.2 billion compared with $1.0 billion in the three months ended March 31, 2022. As our long-tenor business lines (such as Bespoke products) continue to scale, we believe there will be higher convergence of NPE and NPW as prior period UPR continues to earn and have a favorable impact on NPE increasing. |
| Strong capital position. We have a strong balance sheet and are committed to preserving our financial strength. At March 31, 2023, our total assets were $9.4 billion and our total cash and investments (including restricted cash) totaled $3.6 billion, primarily highly rated, liquid fixed maturity assets. Our $2.4 billion total capitalization (which includes our preference securities and issued debt) provides us with the flexibility to engage in attractive underwriting opportunities and scale quickly when market conditions warrant increased business. |
| Nimble approach and focus on bottom line. We take pride in making reasoned decisions to actively enter and grow or reduce and exit specific lines of business as opportunity arises or diminishes, leveraging the UMCC to assess opportunities in real time with all key decision-makers. We believe our nimble approach and firm focus on bottom-line profitability (i.e., net income, as opposed to top-line growth) of each line of business is key to our strategy and success. We will establish our underwriting parameters and risk tolerances in respect of the three-pillar underwriting strategy in the Group Annual Plan, which will be prepared by Fidelis MGU in consultation with Current Fidelis and presented to Current Fidelis for formal approval on a gross/net basis. |
Our strategy is to increase line sizes where appropriate, take the lead in requiring rate changes and establish ourselves as the go to market for solutions through our in-force portfolio and new classes of specialty and bespoke products. Depending on market conditions, Fidelis MGU, with our consent, may exercise its discretion in coordination with us to increase retention by reducing outwards quota shares to take further advantage of the continued hardening of rates. Similarly, we may also coordinate with Fidelis MGU to increase line sizes as conditions warrant. We intend to grow specialty classes by writing large line sizes to further push rate increases and access new classes where there is significant market dislocation. We expect to grow our bespoke and specialty products through a combination of organic growth of our already well-established footprint, systematic cross-selling to clients and innovative new products while maintaining quality underwriting information, high-quality risk selection and multi-line aggregation tools and technology.
17
| Access to well-diversified, multi-line (re)insurance risk. We prioritize pursuing a targeted diversification strategy focused on three pillars Bespoke, Specialty and Reinsurance. We have built a portfolio leveraging our ability to remain agile across market cycles with 74 lines of business across our three pillars at March 31, 2023. Our products serve numerous industries, types of exposure, and geographies. We believe that Fidelis MGUs ability to price and aggregate bespoke risks, adapt to evolving market dynamics in the specialty market, and continually optimize in reinsurance markets uniquely positions us to continue to grow a profitable portfolio. The breadth of our portfolio offering in conjunction with our partnership with Fidelis MGU also allows us to adjust line sizes and retention rates based on prevailing market conditions and achieve optimal economics for the overall portfolio. The three-pillar strategy is central to our growth as it allows us to deliver attractive risk-adjusted returns to shareholders in the long term by managing through (re)insurance cycles and deploying to the most favorable market conditions across the three pillars. |
| Innovative product offering positioned for continued growth. We focus on building first mover advantages across our markets. Our product portfolio evolves in response to client demand for bespoke, tailored products and our market-driven, real-time assessment of risk. Over the past four years, we have grown our book of newly created solutions across a wide range of sectors including airline, intellectual property, marine, and residential mortgage, expanding our business lines to 74 lines at March 31, 2023 from 43 at December 31, 2017. Through this innovation, we have further strengthened our three-pillar strategy and our position as a skilled specialty insurer. |
| Proprietary technology integration with full control of data. We will continue to leverage Fidelis MGUs proprietary and sophisticated technology platform. As a business that was established in 2014, Fidelis had the benefit of building a proprietary underwriting platform free from constrained legacy systems. We believe that the technology platform, which is owned by Fidelis MGU, has significant advantages over our competitors. It is our understanding, that many peers use hybrid platforms built more than a decade ago, that spread between various fragmented modules which reduce their agility and make it difficult to effectively analyze real-time data. Fidelis has a single holistic pricing, aggregation and analytics platform (i.e., FireAnt), which helps us avoid key pitfalls of other systems including: time wasted in duplicating data entry across multiple systems, inconsistency of modeling and pricing approach, inability to raise queries across multiple lines simultaneously, no direct link offered to outwards reinsurance and capital structures, and lag time for those other systems to respond to emerging risks. The technology platform will enable Fidelis MGU to take full control of data with no black box third-party assumptions. We believe that the platform leverages high-quality outside software with custom tools developed purposefully and in-house with the ability to aggregate and analyze data on a real-time basis. This includes third-party risk models and software, Jarvis (a custom integrated group data warehouse), Tyche (third-party capital modeling application), Prequel (a custom policy administrative system) and FireAnt (a custom pricing, simulation, exposure aggregation, and portfolio optimization tool). FireAnt allows for optimization of returns and management of volatility and capacity based on real time data. The highly specialized data capabilities developed and presently in use by Fidelis have driven enhancement in underwriting across Bespoke and Specialty lines including marine, aviation and terrorism where live data is actively analyzed to unlock new opportunities. |
| Embedded ESG initiatives that are core to our business. We believe our commitment to ESG and following the initiatives set out below is core to our success as a business. In order to have a practical and value accretive approach to implementation of ESG considerations, we have adopted the following as key areas of focus: animal welfare, armaments, capital punishment, coal and arctic drilling, anti-slavery/human trafficking and diversity, equity and inclusion. Fidelis MGU will continue to incorporate an ESG assessment into its underwriting on our behalf and is continually refining its process for reviewing individual insurance risks. Fidelis in the U.K. market has promoted the use of a forced labor clause prohibiting the use of any form of forced labor in marine cargo business and is cooperating with the U.K. Independent Anti-Slavery commissioner and Anti-Slavery International, a non-profit organization to develop a commitment to which insurers and brokers can sign up. In 2022, we implemented forced labor clauses in approximately 80% of our marine cargo accounts. |
18
Fidelis MGU is the first U.K. market insurer to sign up to The Poseidon Principles on Marine Insurance which pledges a net zero marine hull insurance portfolio by 2050. We actively support the transition to a net zero global economy by making renewable energy one of our classes of underwriting, including the construction of offshore wind turbine farms. Fidelis and Fidelis MGU are both members of ClimateWise. The ClimateWise Principles require members to disclose their responses to the risks and opportunities of climate change and which principles are aligned with the Task Force on Climate-related Financial Disclosure framework. So long as we remain a member we intend to report annually on actions taken in support of those principles.
We drive employee engagement through opportunities for employees that we believe help them live out their values at work. The employee-led Fidelis Insurance Green Team, which has representatives from each office, suggests ways to reduce our corporate carbon impact and improve recycling rates, such as our carbon usage offset. We support social mobility and diversity in our communities through our support for The Brokerage, a social mobility charity (a number of whose interns have become our full-time employees) and the Afro-Caribbean Insurance Network.
We maintain underwriting and investment restrictions that align with our ESG principles as well as those principles that are consistent with leading to long-term value, such as excluding a number of sectors that we believe pose risks of harm to people, animals and the environment. Furthermore, FIHLs investment portfolio is managed in a manner that is consistent with Fidelis sustainability principles and its ESG objectives. The core fixed maturity portfolio has target GSS investment thresholds, prohibits issuers with poor ESG ratings, and restricts certain industries and behaviors.
Our Strategy
We are set up to be nimble, thoughtful, and efficient decision-makers and we believe that we are able to respond quickly to an ever-changing world and a constantly evolving marketplace. We believe these attributes allow us, together with Fidelis MGU, to target opportunities that we expect to offer a compelling balance of risk and reward for our shareholders. We intend to continue to scale our business when favorable market conditions are present, pursue prudent capital management and profitable underwriting on a loss ratio and combined ratio basis, and target an Operating RoE of approximately 13.0% to 15.0%. Our strategy involves the following:
| Expand our presence in Bespoke and Specialty. We expect to continue to leverage our access to Fidelis MGUs long-standing and trusted relationships with brokers and clients, built over the years by key executives, some of whom have almost 40 years of experience in bespoke and specialty markets. Fidelis MGU intends to continue to follow a structured approach with regard to maintaining such relationships through its participation in industry events and through continuing to hold regularly scheduled meetings with clients and brokers, thereby preserving access to CEOs and senior management teams of its most important business partners. The continued access to such long-standing and trusted relationships coupled with Fidelis MGUs extensive expertise will provide significant opportunity to quote, underwrite and bind attractive niche specialty insurance policies in an efficient manner. By focusing on markets in which Fidelis MGU has particular expertise and in which we can provide new, innovative products, we believe we have a strong ability to capture profitable business. The Bespoke and Specialty pillars have benefited from a hardening pricing environment over recent years which has enhanced our recent profitability ratios. In keeping with our nimble approach and leveraging the UMCC, where all lines of business are considered in real time, we expect Fidelis MGU (and consequentially, Current Fidelis) to be able to pivot quickly to the most attractive opportunities. Currently, we expect a hard property reinsurance market will further continue in 2023 and into 2024 and we are planning to take advantage of reinsurers increased bargaining power in such hard market to reduce our aggregate exposures. As a result, in our Bespoke pillar, in line with the current economic outlook, we expect to limit the growth in traditional mortgage products and focus instead on lines such as intellectual property, political violence, political risk and transactional liabilities. In our Specialty pillar, we expect the aviation market to continue the hardening of previous rates following potential losses from the Ukraine Conflict. Similarly, the |
19
property D&F market is also expected to harden further following losses from Hurricane Ian, which impacted Florida and the American southeast in September 2022. Based on 2022 GPW, Europe is currently our leading market, closely followed by North America, with a smaller portion of our business in Asia and other jurisdictions. The (re)insurance business we write across our Bespoke, Specialty and Reinsurance pillars can be analyzed by geographic region, reflecting the location of the (re)insurer as follows: for the year ended December 31, 2022 our GPW generated for exposures in Europe was 50.6%, in North America was 37.4% and in Asia was 5.9%, while GPW in other jurisdictions was 6.1%. Although we do not expect a significant change to the geographic mix of our business, we will continue to focus on developing new and innovative products in response to market needs, remaining agile and nimble to the developing demands of clients. A recent example of such innovation is the cooperation between Previous Fidelis and Aon in 2021 on developing a product that allows early stage companies to leverage their intellectual property with a credit wrap insurance product to reduce the costs and increase the availability debt finance from lending institutions. Furthermore, in 2022 Previous Fidelis led the development of an aviation product that, once deployed, will provide a real-time quoting service for airlines and airline service providers to reinstate cover if the provision immediately cancelling cover is triggered as a result of a detonation of a nuclear device in their compulsory insurance coverages. |
| Generate underwriting profits. We will continue to focus on underwriting profitably through (re)insurance cycles in partnership with Fidelis MGU. As our insurance portfolio matures and scales, we believe we will also have an opportunity to increase our underwriting leverage. We seek to direct capital to opportunities based on market conditions to address client needs at better pricing opportunities. We will leverage our relationship with Fidelis MGU to continue disciplined underwriting via the use of Fidelis MGUs integrated technology solutions, including monitoring real-time market conditions to best capture unique opportunities. |
Fidelis MGUs robust daily processes will enable it, on our behalf, to maintain a live, dynamic picture of the current underwriting environment that drives daily underwriting decisions, including our daily UMCCs. We believe that our risk selection as a result of these robust processes should allow us to deploy significant line sizes that in turn allow us to be a rate maker rather than a rate taker.
| Maintain diversification and low volatility. We seek to maintain significant diversification in our business lines which limits the correlations to single events. Our strategy has frequently generated better risk-adjusted returns than many of our competitors who focus on specific niches exclusively or have large exposure to natural catastrophe reinsurance. We have taken measures with Fidelis MGU to actively manage and in many cases reshape our natural catastrophe exposure in light of greater severity and frequency of catastrophe events and concerns around global climate change. |
| Uphold a strong balance sheet. We believe as interest rates rise, we will have opportunities to earn a higher yield while maintaining an appropriately conservative investment portfolio to support our business. We maintain robust procedures for setting our reserves and actively managing risk in our portfolio. From January 1, 2017 to March 31, 2023, we had net favorable prior year reserve development of $155.6 million from our reserves. We believe a robust balance sheet best positions us to be a provider of choice for policyholders and take advantage of large or sudden market pricing dislocations. |
| Manage capital prudently. We invest and manage our capital proactively with a goal of generating strong RoE for investors. We believe market conditions will continue to warrant expansion of our premium volume and capital base to take advantage of attractive opportunities. Our goal is for our capital returns program to be focused on ordinary payouts from operating net income and releasing excess capital as appropriate, while balancing any return of capital with the need to take a prudent and efficient approach to capital sufficiency. We believe successful underwriting will allow us to grow our equity and support continued premium growth with an increased ability to fund growth from our own resources and return excess capital to shareholders over time, which may take the form of ordinary dividends, special dividends or share buybacks. Over the full market cycle, we expect to have additional opportunities to manage our capital in order to maintain an appropriate RoE for our shareholders which may include returning excess capital when market opportunities are limited in soft insurance markets. |
20
Summary Risk Factors
Investing in the Common Shares involves risks. Prospective investors should carefully consider the risks described in Risk Factors, below, as well as other information contained in this prospectus before making an investment decision. Any of the factors set forth under Risk Factors could materially adversely affect our business, financial condition, results of operations or cash flows and could impact any forward-looking statements. Prospective investors should note that such risks are not the only ones we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially and adversely affect us in the future. Among these important risks are the following:
| the inherent uncertainties of modeling and reserving processes on which we rely and failure of any risk management and loss limitation methods we employ; |
| the impact of the current global geopolitical environment, including the ongoing COVID-19 pandemic and the Ukraine Conflict, and changing climate conditions; |
| the level of success of our acquisition and investment strategies; |
| the high level of competition and consolidation in our industry; |
| a downgrade or withdrawal of, or other negative action relating to, the financial strength rating(s) by insurance rating agencies; |
| loss of business reputation or negative publicity, including as a result of litigation or coverage disputes; |
| our ability to retain and recruit key personnel; |
| industry and market conditions, volatility and developments, which could impact our investment portfolio; |
| our ability to adjust to developments in the legal, economic, tax or regulatory environment; |
| the volatile, unpredictable and highly cyclical nature of the industry in which we operate; |
| our exposure to low frequency, high severity events; |
| the impact of any deterioration or termination of our relationship with Fidelis MGU; |
| our reliance on third parties for certain critical business operations; and |
| the other factors identified under the heading Risk Factors beginning on page 33 of this prospectus. |
The Separation Transactions
On July 23, 2022, a cooperation agreement was entered into among FIHL, MGU HoldCo and certain third-party investors in Shelf Holdco Ltd., the MGU HoldCo parent company and the ultimate holding company of Fidelis MGU (MGU TopCo) (the Cooperation Agreement) agreeing to cooperate regarding certain matters related to this offering and the furtherance of the Separation Transactions. See Material Contracts and Related Party TransactionsCooperation Agreement. On January 3, 2023, the Separation Transactions were completed and two distinct holding companies and businesses were created: FIHL and MGU HoldCo.
FIHL is the parent holding company for Current Fidelis. It is the issuer of the Common Shares sold by the Selling Shareholders in this offering and owns all of the operating insurance carrier subsidiaries of Current Fidelis, comprising FIBL, FUL and FIID.
MGU HoldCo is the parent holding company for Fidelis MGU that carries on the origination and underwriting activities on behalf of Current Fidelis. MGU HoldCos principal operating subsidiaries are Bermuda MGU, Pine Walk Capital and Pine Walk Europe. The underwriting activities of each of the licensed insurance carriers of Current Fidelis (FIBL, FUL and FIID) are outsourced to the corresponding operating subsidiaries of Fidelis MGU on a jurisdictional basis (Bermuda MGU, Pine Walk Capital and Pine Walk Europe,
21
respectively). Each of the operating subsidiaries of Fidelis MGU has delegated underwriting authority to source and bind contracts for and on behalf of each of FIBL, FUL and FIID, respectively. See Material Contracts and Related Party TransactionsFramework Agreement. MGU HoldCo and its subsidiaries will not be consolidated with FIHL and its subsidiaries.
Current Fidelis also has a U.K. service company, FIHL (UK) Services, with a branch in Ireland. MGU HoldCo owns 100% of the outstanding shares of FML, a U.K. service company (which also has a branch in Ireland).
Our Corporate Structure
The following chart presents a simplified summary overview of the corporate structure for Current Fidelis, which, other than the percentage ownership changes noted at note (1) below, will remain unchanged following the consummation of this offering. For a more detailed description of our organizational structure and an overview of the Separation Transactions see The Separation Transactions.
Current Fidelis Structure
(1) | See Principal and Selling Shareholders for detail of the percentage ownership prior to this offering, as well as the percentage ownership of FIHL following the consummation of this offering (including in the event of a full option exercise) by each of MGU HoldCo, the Founders, other institutional investors, management and other existing shareholders. |
(2) | FUL is a limited liability company incorporated in England and Wales, authorized by the Prudential Regulation Authority (PRA), and supervised by the Financial Conduct Authority (FCA) and the PRA as an insurer. |
(3) | FIBL is a limited liability company incorporated in Bermuda, authorized and supervised by the BMA as an insurer. |
(4) | FIHL (UK) Services is a limited liability company incorporated in England and Wales and is the service company of Current Fidelis. FIHL (UK) Services also has a branch in Ireland. |
(5) | Fidelis European Holdings Limited (FEHL) is a limited liability company incorporated in England and Wales. |
(6) | FIID is a designated activity company incorporated in Ireland, authorized and supervised by the Central Bank of Ireland (CBI) as an insurer. |
22
Director Nomination Rights
Under the terms of the Amended and Restated Common Shareholders Agreement, MGU HoldCo and certain of the existing major investors in FIHL will be entitled to nominate representative directors to the Board, so long as they each beneficially own a specified minimum percentage of our Common Shares. Under the terms of the Amended and Restated Common Shareholders Agreement, the right to nominate one individual (a Nominee) to serve as a director on the Board will be afforded to each of the Crestview Funds (as defined below, see Principal and Selling Shareholders), CVC Falcon Holdings Limited (CVC) and Pine Brook Feal Intermediate L.P. (Pine Brook) (each a Founder and together, the Founders) and to MGU HoldCo, so long as they each beneficially own a specified minimum percentage of our Common Shares. Under the terms of the Amended and Restated Common Shareholders Agreement, if a Nominee is not appointed or elected to the Board because of such persons death, disability, disqualification, withdrawal as a Nominee, failure to be elected or for another reason is unavailable or unable to serve on the Board, the applicable nominating Founder or MGU HoldCo shall be entitled to designate promptly another Nominee, the director position for which the original Nominee was nominated shall not be filled pending such designation and FIHL shall use commercially reasonable efforts and consistent with NYSE corporate governance standards to cause the Board to promptly fill the vacancy with such successor Nominee.
23
The Offering
Issuer: |
Fidelis Insurance Holdings Limited |
Common Shares offered by us |
5,714,286 Common Shares. |
Common Shares offered by the Selling Shareholders |
11,285,714 Common Shares. |
Common Shares outstanding after this offering |
116,486,183 Common Shares. |
Underwriters option to purchase additional Common Shares from the Selling Shareholders |
The Selling Shareholders have granted the underwriters an option to purchase up to an additional 2,550,000 Common Shares at the public offering price less underwriting discounts and commissions, for 30 days after the date of this prospectus. |
Use of proceeds |
We estimate that the net proceeds to us from the sale of Common Shares from this offering will be approximately $87.7 million based upon the assumed initial public offering price of $17.50 per Common Share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, and after deducting the estimated underwriting discounts and estimated offering expenses payable by us. An increase in the offering price above the midpoint of the estimated offering price range set forth on the cover page of this prospectus will result in us selling fewer Common Shares such that our gross proceeds will not exceed $100.0 million. We will not receive any of the proceeds from the sale of our Common Shares in this offering by the Selling Shareholders. |
We intend to use the net proceeds to us from this offering to make capital contributions to our insurance operating subsidiaries, which, together with other sources of liquidity, should enable us to take advantage of the ongoing rate hardening in the key markets in which we participate by writing more business under our planned strategy (as discussed in more detail in BusinessOur Strategy and Managements Discussion and Analysis of Financial Condition and Results of OperationsLiquidity and Capital Resources). See Use of Proceeds for a more complete description of the intended use of proceeds from this offering. |
Dividend Policy |
Any decision to declare and pay dividends in the future will be made at the sole discretion of our Board and will depend on various factors. See Dividend Policy. |
Exchange Symbol |
FIHL. |
Risk Factors |
See Risk Factors beginning on page 33 and other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in our Common Shares. |
Listing |
We have applied to list our Common Shares on NYSE under the symbol FIHL. |
24
Except as otherwise indicated, the number of Common Shares outstanding after this offering:
| excludes 3,654,605 Common Shares (plus an additional number of Common Shares equal to 4.0%, on a fully diluted basis, of the Common Shares sold by us from this offering) reserved for issuance under our long-term 2023 share incentive plan (the Long-Term Incentive Plan); |
| excludes 960,895 Common Shares underlying restricted share unit awards granted under the Long-Term Incentive Plan as of June 9, 2023; |
| gives effect to a 1-for-.92 reverse stock split of our Common Shares effected on June 16, 2023; |
| assumes an initial public offering price of $17.50 per Common Share, which is the midpoint of the price range set forth on the cover page of this prospectus; and |
| assumes the underwriters option to purchase additional Common Shares from the Selling Shareholders will not be exercised. |
25
SUMMARY FINANCIAL AND OPERATING DATA
The tables below present summary financial and operating data at, and for, the periods indicated. The following information is only a summary and should be read in conjunction with the section entitled Managements Discussion and Analysis of Financial Condition and Results of Operations and the audited consolidated financial statements and the accompanying notes included elsewhere in this prospectus.
The summary balance sheet data at March 31, 2023, December 31, 2022 and 2021 and the summary statement of operations data for the three months ended March 31, 2023 and 2022, and for the years ended December 31, 2022, 2021 and 2020 have been derived from our unaudited consolidated financial statements for the three months ended March 31, 2023 and 2022 and audited consolidated financial statements for the years ended December 31, 2022, 2021 and 2020, included elsewhere in this prospectus. We have included, in our opinion, all adjustments necessary to state fairly our results of operations for those periods.
These historical results are not necessarily indicative of the results that may be expected for any future period.
26
SUMMARY STATEMENT OF OPERATIONS DATA
Three months ended March 31, |
Year ended December 31, | |||||||||||||||||||
2023 | 2022 | 2022 | 2021 | 2020 | ||||||||||||||||
($ in millions) | ||||||||||||||||||||
Revenues |
||||||||||||||||||||
Gross premiums written |
$ | 1,245.3 | $ | 970.7 | $ | 3,000.1 | $ | 2,787.7 | $ | 1,576.5 | ||||||||||
Reinsurance premiums ceded |
(585.6 | ) | (485.4 | ) | (1,137.5 | ) | (1,186.6 | ) | (670.9 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net premiums written |
659.7 | 485.3 | 1,862.6 | 1,601.1 | 905.6 | |||||||||||||||
Change in net unearned premiums |
(273.7 | ) | (163.5 | ) | (357.9 | ) | (446.9 | ) | (177.0 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net premiums earned |
386.0 | 321.8 | 1,504.7 | 1,154.2 | 728.6 | |||||||||||||||
Net investment gains/(losses) |
2.8 | (10.2 | ) | (33.7 | ) | 13.5 | 17.9 | |||||||||||||
Net investment income |
20.4 | 5.1 | 40.7 | 20.6 | 26.2 | |||||||||||||||
Net foreign exchange gains |
| | 6.8 | | 1.2 | |||||||||||||||
Other income |
3.5 | 1.0 | 1.9 | 1.0 | 8.7 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total revenues before net gain on distribution of Fidelis MGU |
412.7 | 317.7 | 1,520.4 | 1,189.3 | 782.6 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net gain on distribution of Fidelis MGU |
1,639.1 | | | | | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total revenues |
2,051.8 | 317.7 | 1,520.4 | 1,189.3 | 782.6 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Expenses |
||||||||||||||||||||
Losses and loss adjustment expenses |
159.6 | 178.4 | 830.2 | 696.8 | 324.5 | |||||||||||||||
Policy acquisition expenses(1) |
129.2 | 67.7 | 447.7 | 299.9 | 179.2 | |||||||||||||||
General and administrative expenses |
16.6 | 35.5 | 106.4 | 75.4 | 83.5 | |||||||||||||||
Corporate and other expenses |
1.5 | 1.9 | 20.5 | 2.7 | 18.7 | |||||||||||||||
Net foreign exchange losses |
1.5 | 0.9 | | 0.4 | | |||||||||||||||
Financing costs |
8.6 | 8.8 | 35.5 | 35.4 | 27.9 | |||||||||||||||
Loss on extinguishment of preference securities |
| | | | 25.3 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total expenses |
317.0 | 293.2 | 1,440.3 | 1,110.6 | 659.1 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income before income taxes |
1,734.8 | 24.5 | 80.1 | 78.7 | 123.5 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income tax (expense)/benefit |
(2.2 | ) | (4.7 | ) | (17.8 | ) | (0.4 | ) | 3.1 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income |
1,732.6 | 19.8 | 62.3 | 78.3 | 126.6 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income attributable to non-controlling interests |
| (2.8 | ) | (9.7 | ) | (10.0 | ) | (0.1 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income available to common shareholders |
1,732.6 | 17.0 | 52.6 | 68.3 | 126.5 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
(1) | See note 2 of the unaudited consolidated financial statements for the three months ended March 31, 2023 and 2022. Commissions on ceded business are presented within policy acquisition expenses in the three month periods ended March 31, 2023 and 2022. Commissions on ceded business are presented within general and administrative expenses in the years ended December 31, 2022, 2021 and 2020. |
27
SUMMARY BALANCE SHEET DATA
At March 31, 2023 |
At December 31, | |||||||||||
2022 | 2021 | |||||||||||
($ in millions) | ||||||||||||
Assets |
||||||||||||
Total investments |
$ | 2,840.6 | $ | 2,425.0 | $ | 2,782.6 | ||||||
|
|
|
|
|
|
|||||||
Cash and cash equivalents and restricted cash and cash equivalents |
711.4 | 1,407.9 | 476.0 | |||||||||
|
|
|
|
|
|
|||||||
Reinsurance balances |
||||||||||||
Reinsurance balances recoverable on paid losses |
96.5 | 159.4 | 256.6 | |||||||||
Reinsurance balances recoverable on reserves for losses and loss expenses | 1,032.8 | 976.1 | 795.2 | |||||||||
Deferred reinsurance premiums |
1,191.7 | 823.7 | 676.7 | |||||||||
Other assets |
1,121.7 | 657.7 | 510.7 | |||||||||
Premiums and other receivables |
2,387.5 | 1,862.7 | 1,555.2 | |||||||||
|
|
|
|
|
|
|||||||
Total assets |
$ | 9,382.2 | $ | 8,312.5 | $ | 7,053.0 | ||||||
|
|
|
|
|
|
|||||||
Liabilities, and shareholders equity |
||||||||||||
Liabilities |
||||||||||||
Reserves for losses and loss adjustment expenses |
$ | 2,215.0 | $ | 2,045.2 | $ | 1,386.5 | ||||||
Unearned premiums |
3,260.3 | 2,618.6 | 2,113.7 | |||||||||
Reinsurance balances payable |
1,221.5 | 1,057.0 | 947.8 | |||||||||
Long term debt |
447.7 | 447.5 | 446.9 | |||||||||
Preference securities |
58.4 | 58.4 | 58.4 | |||||||||
Other liabilities |
274.8 | 98.7 | 80.6 | |||||||||
|
|
|
|
|
|
|||||||
Total liabilities |
7,477.7 | 6,325.4 | 5,033.9 | |||||||||
|
|
|
|
|
|
|||||||
Commitments and contingencies |
||||||||||||
Shareholders equity |
||||||||||||
Total shareholders equity including non-controlling interests |
1,904.5 | 1,987.1 | 2,019.1 | |||||||||
|
|
|
|
|
|
|||||||
Total liabilities and shareholders equity |
$ | 9,382.2 | $ | 8,312.5 | $ | 7,053.0 | ||||||
|
|
|
|
|
|
28
OTHER DATA
Three months ended March 31, |
Year Ended December 31, | |||||||||||||||||||
2023 | 2022 | 2022 | 2021 | 2020 | ||||||||||||||||
($ in millions) | ||||||||||||||||||||
Loss ratio(1) |
41.3 | % | 55.4 | % | 55.2 | % | 60.4 | % | 44.5 | % | ||||||||||
Policy acquisition expense ratio(2) |
27.2 | % | 21.0 | % | 29.8 | % | 26.0 | % | 24.6 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Underwriting ratio |
68.5 | % | 76.4 | % | 85.0 | % | 86.4 | % | 69.1 | % | ||||||||||
Fidelis MGU commission ratio(3) |
6.3 | % | | % | | % | | % | | % | ||||||||||
General and administrative expense ratio(4) |
4.3 | % | 11.0 | % | 7.1 | % | 6.5 | % | 11.5 | % | ||||||||||
Combined ratio(5) |
79.1 | % | 87.4 | % | 92.1 | % | 92.9 | % | 80.6 | % | ||||||||||
Net investment gains/(losses) |
$ | 2.8 | $ | (10.2 | ) | $ | (33.7 | ) | $ | 13.5 | $ | 17.9 | ||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment return(6) |
$ | 23.2 | $ | (5.1 | ) | $ | 7.0 | $ | 34.1 | $ | 44.1 | |||||||||
Debt to total capitalization ratio(7) |
21.0 | % | 20.3 | % | 20.2 | % | 20.0 | % | 20.3 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Fully diluted book value per share(8) |
$ | 17.19 | $ | 9.89 | $ | 9.91 | $ | 10.05 | $ | 11.50 | ||||||||||
RoE(9) |
87.6 | % | 0.8 | % | 2.6 | % | 3.5 | % | 11.3 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Operating RoE(10)(11) |
5.4 | % | 1.0 | % | 3.3 | % | 3.6 | % | 14.9 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
(1) | Ratio, in percent, of losses and loss adjustment expenses to NPE. |
(2) | Ratio, in percent, of policy acquisition expenses paid to third parties to NPE. See note 2 of the unaudited consolidated financial statements for the three months ended March 31, 2023 and 2022 included elsewhere in this prospectus. Commissions on ceded business are presented within policy acquisition expenses in the three month periods ended March 31, 2023 and 2022. Commissions on ceded business are presented within general and administrative expenses in the years ended December 31, 2022, 2021 and 2020. |
(3) | Ratio, in percent, of Fidelis MGU commissions to NPE. |
(4) | Ratio, in percent, of general and administrative expenses to NPE. See note (2) above for explanation of the presentation of commissions on ceded business. |
(5) | Ratio, in percent, of the sum of losses and loss adjustment expenses, policy acquisition expenses paid to third parties, Fidelis MGU commissions and general and administrative expenses to NPE. |
(6) | Net investment return includes net investment income plus net investment gains and losses. |
(7) | Ratio, in percent, of total long-term debt and preference securities to total capitalization. The total capitalization comprises shareholders equity including non-controlling interests plus total long-term debt and preference securities. |
(8) | Represents the equity attributable to Fidelis Common Shareholders divided by the sum of the Common Shares outstanding and the dilutive impact of in the money outstanding warrants and RSUs. |
(9) | Ratio, in percent, of net income to opening common shareholders equity. |
(10) | Ratio, in percent, of operating net income to opening common shareholders equity. |
(11) | Operating RoE is a non-U.S. GAAP measure. See Managements Discussion and Analysis of Financial Condition and Results of OperationsPerformance Measures and Non-U.S. GAAP Financial MeasuresOperating Net Income, RoE and Operating RoE for a reconciliation to the most directly comparable financial measure stated in accordance with U.S. GAAP. |
Summary Unaudited Pro Forma Condensed Combined Financial Information
The summary unaudited pro forma condensed combined financial information presented below consists of the summary unaudited pro forma condensed combined balance sheet at December 31, 2022, the summary unaudited pro forma condensed combined statement of income for the year ended December 31, 2022 and the notes thereto. The unaudited pro forma condensed combined financial information should be read in conjunction with the information included under The Separation Transactions, Unaudited Pro Forma Condensed Combined Financial Information and Managements Discussion and Analysis of Financial Condition and Results of Operations and our audited combined financial statements and the accompanying notes included elsewhere in this prospectus. The summary unaudited pro forma condensed combined financial information presented below is useful to investors because it provides a view of our results of operations for the period presented giving effect to the Separation Transactions (which were consummated on January 3, 2023) as if the Separation Transactions had occurred at the beginning of such period. The summary unaudited pro forma
29
condensed combined balance sheet at December 31, 2022 has been prepared to give effect to the Separation Transactions as if these transactions had occurred on December 31, 2022.
The summary unaudited pro forma condensed combined statement of income for the year ended December 31, 2022 has been prepared to give effect to the Separation Transactions as if these transactions had occurred on January 1, 2022.
The unaudited pro forma condensed combined financial information is presented for informational purposes only and does not purport to represent our financial condition or our results of operations had these transactions occurred on or at the dates noted above or to project the results for any future date or period. The unaudited pro forma condensed combined financial information has been prepared in accordance with Regulation S-X. Actual results may differ from the pro forma adjustments.
30
SUMMARY UNAUDITED PRO FORMA CONDENSED COMBINED INCOME STATEMENT
SELECTED STATEMENT OF OPERATIONS DATA
December 31, 2022 Pro Forma Statement of Operations |
||||
$ in millions | ||||
Revenues |
||||
Gross premiums written |
$ | 2,989.8 | ||
Reinsurance premiums ceded |
(1,142.9 | ) | ||
|
|
|||
Net premiums written |
1,846.9 | |||
Change in net unearned premiums |
(357.9 | ) | ||
|
|
|||
Net premiums earned |
1,489.0 | |||
Net investment losses |
(33.7 | ) | ||
Net investment income |
40.6 | |||
Net foreign exchange gains |
4.1 | |||
Net gain on distribution of Fidelis MGU |
1,638.1 | |||
Other income |
0.3 | |||
|
|
|||
Total revenues |
$ | 3,138.4 | ||
|
|
|||
Expenses |
||||
Losses and loss adjustment expenses |
830.2 | |||
Policy acquisition expenses (includes Fidelis MGU commissions of $119.5) |
529.4 | |||
General and administrative expenses |
71.1 | |||
Corporate and other expenses |
18.6 | |||
Financing costs |
35.5 | |||
|
|
|||
Total expenses |
$ | 1,484.8 | ||
|
|
|||
Net income before tax |
1,653.6 | |||
Income tax expense |
(1.3 | ) | ||
|
|
|||
Net income |
$ | 1,652.3 | ||
|
|
|||
Net income attributable to non-controlling interests |
| |||
|
|
|||
Net income available to common shareholders |
$ | 1,652.3 | ||
|
|
|||
Other comprehensive gain (loss) |
||||
Unrealized loss on AFS assets |
(96.5 | ) | ||
Income tax benefit |
8.1 | |||
Currency translation adjustments |
| |||
|
|
|||
Total other comprehensive loss |
$ | (88.4 | ) | |
|
|
|||
Comprehensive gain (loss) attributable to common shareholders |
$ | 1,563.9 | ||
|
|
31
SUMMARY UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET
December 31, 2022 Pro Forma Balance Sheet |
||||
$ in millions | ||||
Assets |
||||
Fixed maturity securities, available-for-sale at fair value |
$ | 2,050.9 | ||
Short-term investments, available-for-sale at fair value |
257.0 | |||
Other investments, at fair value |
117.1 | |||
|
|
|||
Total investments |
2,425.0 | |||
Cash and cash equivalents |
990.5 | |||
Restricted cash and cash equivalents |
185.9 | |||
Derivative assets, at fair value |
6.3 | |||
Accrued investment income |
10.9 | |||
Investments pending settlement |
2.0 | |||
Premiums and other receivables |
1,872.0 | |||
Deferred reinsurance premiums |
823.7 | |||
Reinsurance balances recoverable on paid losses |
159.4 | |||
Reinsurance balances recoverable on reserves for losses and loss adjustment expenses |
976.1 | |||
Deferred policy acquisition costs |
516.0 | |||
Deferred tax asset |
51.2 | |||
Operating right of use assets |
26.8 | |||
Other assets |
25.6 | |||
|
|
|||
Total Assets |
$ | 8,071.4 | ||
|
|
|||
Liabilities and Shareholders equity |
||||
Liabilities |
||||
Reserves for losses and loss adjustment expenses |
2,045.2 | |||
Unearned premiums |
2,618.6 | |||
Reinsurance balances payable |
1,057.0 | |||
Long term debt |
447.5 | |||
Preference securities |
58.4 | |||
Other liabilities |
17.8 | |||
Operating lease liabilities |
28.5 | |||
|
|
|||
Total Liabilities |
$ | 6,273.0 | ||
|
|
|||
Shareholders equity |
||||
Ordinary shares |
1.9 | |||
Additional paid-in capital |
1,942.8 | |||
Accumulated other comprehensive loss |
(99.7 | ) | ||
Accumulated deficit |
(46.6 | ) | ||
|
|
|||
Total shareholders equity attributable to common shareholders |
$ | 1,798.4 | ||
|
|
|||
Non-controlling interests |
| |||
|
|
|||
Total shareholders equity including non-controlling interests |
$ | 1,798.4 | ||
|
|
|||
Total liabilities and shareholders equity |
$ | 8,071.4 | ||
|
|
32
Investing in the Common Shares involves risks. Prospective investors should carefully consider the risks described below, as well as other information contained in this prospectus before making an investment decision. The risks described below are not the only ones we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially and adversely affect us in the future. Any of the following risks could materially adversely affect our business, financial condition, results of operations or cash flows and could impact any forward-looking statements. See Cautionary Note Regarding Forward-Looking Statements. In such case, the trading price of the Common Shares may decline and investors may lose all or part of their original investments.
For the purposes of this section, references to the Group shall refer to (i) prior to the consummation of the Separation Transactions and this offering to Previous Fidelis and (ii) following the consummation of the Separation Transactions to Current Fidelis, as the context requires.
Risks Relating to the Groups Business and Industry
Underwriting of insurance can be volatile and unpredictable. This dynamic, combined with the Groups exposure to low-frequency, high-severity events, may result in substantial losses and insurance underwriting results can vary across the industry and across different years.
The underwriting of insurance risks is, by its nature, a high-risk business. Earnings can be volatile and losses may be incurred that have the effect of significantly reducing the net profit or capital position of the Group. Although the Groups underwriting is generally focused on low-frequency, high-severity losses worldwide, the frequency and unpredictability of such losses has significantly increased in the last couple of years due to, among other things, changing climate conditions. The result of this underwriting strategy is that the Groups results may be subject to unpredictable losses or the potential of more than one loss occurring at the same time.
It is inherent in the nature of the insurance business that it is difficult to forecast short-term trends or returns, including for the Group. The results of companies in the insurance industry worldwide vary widely as do the results of insurers operating within the Bermuda, London and European insurance markets. Even if the Bermuda, London and European insurance markets make an overall profit, some individual insurers or lines of business may incur losses. The past results of the markets and the Groups historical results, as well as the results of the Groups peers, are a historical record only and may not necessarily be a reliable guide to future prospects.
Underwriting risks and reserving for losses are based on probabilities, assumptions and related modeling, which are subject to inherent judgment and uncertainties and may materially impact the Groups business, prospects, financial condition or results of operations.
Underwriting is a matter of judgment, involving important assumptions about matters that by their nature are unpredictable and beyond the control of the Group and for which historical experience and probability analysis may not provide sufficient guidance. One or more catastrophic or other events could result in claims that substantially exceed the Groups modeled loss expectations, which could have a material adverse effect on the Groups business, prospects, financial condition or results of operations. A single event could result in significant losses across multiple classes of the Groups business. Certain risks are harder to model, and the Group estimates the impact of these through aggregate exposure and non-probabilistic modeling. The inherent uncertainties underlying, or incorrect usage or misunderstanding of, both aggregate exposure and non-probabilistic modeling may leave the Group exposed to unanticipated risks relating to certain perils or geographic regions, which could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
33
In the event of a catastrophic event, actual losses of the Group could be substantially different from the losses estimated by the Group using catastrophe models.
The Group underwrites a broadly diversified insurance and reinsurance portfolio across a wide range of risk classes that members of Fidelis MGUs management have successfully underwritten in the past, including property, energy, marine, aviation, political risk, credit and surety and various others, as well as whole account quota shares. There can be no assurance that the Group will not suffer losses from one or more catastrophic events in any one given geographic zone due to several factors, including the inherent uncertainties in estimating the frequency and severity of such events, potential inaccuracies and inadequacies in the data provided by clients and brokers, the limitations and inaccuracies of modeling techniques, the limitations of historical data used to estimate future losses or as a result of a decision to change the percentage of the shareholders equity exposed to a single modeled catastrophic event. The Groups estimated probable maximum loss is determined through the use of modeling techniques, but such estimate does not represent the Groups total potential loss for such exposures.
Catastrophe modeling is a relatively new discipline that utilizes a mix of historical data, scientific theory and mathematical methods. There is considerable uncertainty in the data and parameter inputs for (re)insurance industry catastrophe models. In that regard, there is no universal standard in the preparation of insured data for use in the models and the running of modeling software. The accuracy of the models depends heavily on the availability of detailed insured loss data from actual large catastrophes. Due to the limited number of events and the fact that no two events are precisely the same, there is significant potential for substantial differences between the modeled loss estimate and actual Group experience for a single large catastrophic event.
This potential difference could be even greater for perils without recent loss experience, including natural catastrophe risks such as U.S. earthquakes, or less developed modeled annual severity, such as European windstorms, as well as man-made risks, such as cyber-attacks. Cyber is an example of a peril in respect of which modeling is not yet very developed. In addition, even though wildfires in California and along the western coast of the United States have increased in frequency over recent years, the wildfire models are not as developed as those for peak insured risks.
The Group relies upon Fidelis MGUs catastrophe modeling, which in turn relies upon third-party estimates of industry insured exposures. There could be significant variation between the Groups actual losses and those of the industry following a catastrophic event. In addition, actual losses may increase if the Group has reinsured some or all of its exposures and its reinsurers fail to meet their obligations or the reinsurance protections purchased are exhausted or are otherwise unavailable.
The Group has direct and indirect exposure to substantial insured losses resulting from catastrophic events. The Group is exposed to natural catastrophes such as hurricanes, earthquakes, typhoons, floods, sea surges, fire and severe weather patterns occurring in one or more of the countries in which the Group operates or globally, as well as to human-instigated catastrophic events of terrorism, cyber-attack, war or nuclear-related events and to systemic events such as a global economic crisis. The Group is also exposed to perils that are highly influenced by a combination of natural processes and man-made factors, such as epidemics and pandemics. The predictability, severity, frequency and post-event estimation of such varied events are extremely difficult to assess, under existing models or otherwise. In addition, Fidelis MGU only utilizes industry catastrophe modeling in relation to natural catastrophes and, therefore, the Groups exposure to human-instigated catastrophic events is less well modeled and may be subject to greater uncertainty. Any failures or limitations of models or incorrect estimations by Fidelis MGU could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
The Groups losses may exceed its loss reserves or available liquidity at any time, which could significantly and negatively affect the Groups business.
The Groups results of operations and financial condition depend upon its ability to assess accurately the potential losses associated with the risks that it insures and reinsures and the sufficiency of reserves. Reserves are
34
estimates at a given time of what an insurer or reinsurer ultimately expects to pay on claims, based on facts and circumstances then known, predictions of future events, estimates of future trends in claim frequency and severity and other variable factors such as inflation.
The inherent uncertainties of estimating loss reserves generally are greater for reinsurance business compared to insurance business, primarily due to:
| the significant lapse of time from the occurrence of the event to the reporting and ultimate resolution or settlement of the claim for certain lines of business; |
| the diversity of development patterns among different types of reinsurance treaties or facultative contracts; and |
| the necessary reliance on the ceding insurer for information regarding claims. |
The Groups estimations of reserves (including those based on input from Fidelis MGU) may be unreliable. Actual losses and loss adjustment expenses paid may deviate, perhaps substantially, from the estimated loss reserves and loss expense reserves contained in its financial statements. Going forward, if the Groups loss reserves are determined to be inadequate, the Group will be required to increase its loss reserves with a corresponding reduction in net income in the period in which the Group identifies the deficiency. There can be no assurance that the Groups claims will not exceed its loss reserves or loss expense reserves which may significantly and negatively affect the Groups business for such period and beyond.
The Groups operating results may be adversely affected by an unexpected accumulation of attritional losses.
In addition to the Groups exposures to catastrophes and other large losses as discussed above, the Groups operating results may be adversely affected by unexpectedly large accumulations of attritional losses (i.e., relatively smaller losses arising frequently in the ordinary course of (re)insurance business operations, excluding major losses). The Group seeks to manage this risk by setting out appropriate underwriting parameters and risk tolerances in the Group Annual Plan and in each Subsidiary Annual Plan (each, as defined below; see Material Contracts and Related Party TransactionsFramework AgreementSubsidiary Annual Plans) to guide the pricing, terms and acceptance of risks by Fidelis MGU on behalf of Current Fidelis. These parameters, which may include pricing models, are intended to ensure that premiums received are sufficient to cover the expected levels of attritional losses and a contribution to the cost of catastrophes and large losses where necessary. However, it is possible that the Groups underwriting approaches or the pricing models on which the Group relies may not work as intended or may not capture all sources of potential loss and that actual losses from a class of risks may be greater than expected. These pricing models are also subject to the same limitations as the models used to assess the Groups exposure to catastrophe losses discussed above. Accordingly, these factors could adversely impact the Groups business, prospects, financial condition or results of operations.
The failure of any risk management and loss limitation methods the Group employs could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
The Group employs various risk management and loss limitation methods, including purchasing reinsurance and sponsoring catastrophe bond transactions. The Group seeks to mitigate its loss exposure by writing a number of insurance and reinsurance contracts on an excess of loss basis, such that the Group only pays losses that exceed a specified retention. The Group also seeks to limit certain risks, such as catastrophes and political risks, by geographic diversification. Geographic zone limitations involve significant underwriting judgments, including the determination of zone boundaries and the allocation of policy limits to zones. In the case of proportional (also known as pro rata) property reinsurance treaties, the Group may seek per occurrence limitations to limit the impact of losses from any one event, although the Group may not be able to obtain such limits in certain markets, in which case such treaties may not include any such caps. Various provisions in the Groups policies intended to limit its risks, such as limitations or exclusions from certain coverage and choice of forum, may not always be
35
enforceable. The various loss limitation methods that the Group employs may not respond in the way intended due to the nature of the loss events arising in any given period, as well as disputes relating to coverage terms, exclusions, counterparty credit risk or risks relating to the use of differing basis for loss estimations. For additional information regarding reinsurance and catastrophe bonds, see BusinessOutwards Reinsurance or Retrocessional Coverage. The Group cannot guarantee that any of these loss limitation methods will be effective or that disputes relating to coverage will be resolved in the Groups favor. The failure of any risk management and loss limitation methods the Group employs could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
The Groups retrocessional coverage may be exhausted if a large number of claims occur.
The Group has in place various retrocessional reinsurance contracts protecting the Groups different business segments. See BusinessOutwards Reinsurance or Retrocessional Coverage. In many cases these contracts provide, following a first loss, for one or more reinstatements of the limit recoverable under the contract with such reinstatements sometimes dependent on payment of additional premiums. The Group purchases aggregate coverage contracts, which provide the Group with retrocessional coverage if losses on the relevant business exceed a given attachment point. The Group also seeks outwards retrocessional protection by accessing the capital markets directly through catastrophe bond sponsorship such as the four Herbie Re Ltd. (Herbie Re) catastrophe bonds sponsored by the Group and discussed elsewhere in this prospectus, which provide for multi-year coverage.
However, if several large losses occur or large losses develop adversely, the Group may exhaust portions or the entirety of its outwards retrocession program. Furthermore, the Group cannot be sure that additional retrocessional coverage will continue to be available to it on acceptable terms, or at all. The Groups risk exposure will be materially greater due to higher loss limits and less risk diversity, and the Groups underwriting capacity will therefore be restricted, if it cannot purchase adequate retrocessional coverage.
If actual renewals of the Groups existing policies and contracts do not meet expectations, the Groups GPW in future fiscal periods and its business, prospects, financial condition or results of operations could be materially adversely affected.
Many of the Groups insurance policies and reinsurance contracts are for a one-year term (in particular, across its property reinsurance lines and Specialty segment). The Group makes assumptions about the renewal rate and pricing of its prior years policies and contracts in its financial forecasting process. If actual renewals do not meet commercial expectations or Fidelis MGU does not renew contracts, the Groups GPW in future fiscal periods and its future operating results and financial condition could be materially adversely affected.
In addition, irrespective of the renewal terms, the Group may fail to renew or obtain new insurance or reinsurance business at the desired or profitable rates or at all. There can be no assurance that business will be available to Fidelis MGU for the benefit of the Group on terms or at prices that it considers to be attractive and there cannot be any assurance that if such terms or prices exist at present, they will continue as policies renew. Any failure to renew insurance or reinsurance contracts that are material and profitable to the Group could adversely impact the Groups business, prospects, financial condition or results of operations.
The Groups business, prospects, financial condition or results of operations will fluctuate in line with the (re)insurance industry cycle, and the Group expects to experience periods with excess underwriting capacity and unfavorable premium rates and policy terms and conditions, which could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
The Groups financial performance may be expected to fluctuate in line with the (re)insurance industrys cyclical patterns characterized by periods of significant competition in pricing and underwriting terms and conditions, which is known as a soft insurance market, followed by periods of lessened competition and increasing premium rates, which is known as a hard insurance market.
36
The insurance and reinsurance pricing cycle has historically been a market phenomenon, driven by supply and demand rather than by the actual cost of coverage. The supply of insurance and reinsurance is determined by prevailing prices, the level of insured losses and the level of industry capital surplus which, in turn, may fluctuate, including in response to changes in rates of return on investments being earned in the (re)insurance industry, which are outside of the control of the Group. The upward phase of a cycle was often triggered when a major event or series of events forced insurers and reinsurers to make large claim payments, thereby drawing down capital. This, combined with increased demand for insurance against the risk associated with the event, pushed prices upwards. In the period prior to 2018, the industry had seen a market characterized by increasing surplus capital and relatively lower premium rates, which, in turn, had led to depressed pricing across certain of the Groups lines of business for a sustained period since its inception. Hurricanes Florence and Michael, Typhoons Jebi, Mangkhut and Trami and the California wildfires in 2017 and 2018 led to a modest upward trend in pricing for January 2019 renewals across certain lines of business. In line with expectations, the Group experienced a further hardening of markets at subsequent renewal dates across certain lines of business as a result of increased frequency of catastrophe events, including Hurricanes Dorian, Laura, Sally, Ida and Ian, Typhoons Faxai and Hagibis, the 2020 California wildfires, Winter Storm Uri, Storm Bernd which caused widespread European floods, and industry losses from the COVID-19 pandemic, as well as other factors affecting capacity availability such as the Lloyds Decile-10 review or the Ukraine Conflict.
Although an individual (re)insurance companys financial performance is dependent upon its own specific business characteristics, the profitability of most (re)insurance companies tends to follow this cyclical market pattern, with profitability generally increasing in hard markets and decreasing in soft markets.
Insurers and reinsurers, such as the Group, have experienced significant fluctuations in operating results due to competition, frequency of occurrence or severity of catastrophic events, levels of underwriting capacity, underwriting results of primary insurers, general economic conditions and other factors. Although the Group does not compete entirely on price or targeted market share, negative market conditions may impair the Groups ability to write insurance at rates that it considers appropriate relative to the risk assumed. If the Group cannot write insurance at appropriate rates, this could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
At present, the Group believes that the market remains hard and expects such hard market to continue for the subsequent 2023 renewals. As a result, rates in particular lines of business will continue to present opportunities for the Group, particularly in the Specialty segment and across a number of property lines of business. This belief as to anticipated industry rates is based on the Groups own expertise and opinions of the (re)insurance industry commentators and constitutes a forward-looking statement. All forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of uncertainties and other factors, many of which are outside of the control of the Group and other parties and which could cause actual results to differ materially from such forward-looking statements. In addition, there can be no certainty as to how long these market conditions will last and the cycle may fluctuate as a result of changes in economic, legal, political and social factors, including the ongoing Ukraine Conflict and the impact of sanctions imposed on Russia. See Risks Relating to Recent EventsThe full extent of the impacts of the ongoing Ukraine Conflict on the (re)insurance industry and on the Groups business, financial condition and results of operations, including in relation to claims under the Groups (re)insurance policies, are uncertain and remain unknown. Since cyclicality is due in large part to the collective actions of insurers and reinsurers, general economic conditions and the occurrence of unpredictable events, the Group cannot predict or control the timing or duration of changes in the market cycle, including how long any favorable market conditions will persist. If the Group fails to manage its business appropriately through the cyclical nature of the (re)insurance industry, its business prospects, operating results or financial condition could be materially adversely affected.
37
The business written by the Group, particularly in its Bespoke and Specialty segments, is vulnerable to global economic and geopolitical uncertainty.
A portion of the Groups business focuses on bespoke (re)insurance underwriting for tailored coverage, which we refer to as the Bespoke pillar. Business in the Groups Bespoke pillar includes policies covering credit and political risk, political violence and terrorism, cyber, title, transactional liabilities, mortgage and other bespoke products that fit our criteria. These and other lines of business composed of the Bespoke pillar are particularly susceptible to severe economic downturns or seismic shocks, which could trigger significant losses for this particular area of business compared to business composed of the Groups other (re)insurance business which typically responds to the insurance cycle described above rather than the economic cycle.
The Group saw a general drop in bespoke (re)insurance underwriting deal flow throughout 2020 due to the COVID-19 pandemic. As the economies around the world began to recover, in 2021 the Group saw a higher market appetite for the underlying transactions that these products cover and is cautiously anticipating a continued level of appetite through 2023, subject to economic uncertainty, inflation pressures and monetary actions, the ongoing Ukraine Conflict and the impact of sanctions imposed on Russia. However, to the extent there is further disruption from such public health, economic and geopolitical factors, there may be further delays and uncertainties in relation to those underlying transactions, which could lead to further reductions to deal flow within the Bespoke pillar. Despite the Groups current focus on the Specialty segment discussed below, given the historic size of the Bespoke pillar relative to the Groups wider business, prolonged periods of global economic uncertainty, could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
Another portion of the Groups business, which we refer to as the Specialty pillar, focuses on traditional specialty business lines such as aviation, energy, space, marine, contingency and property D&F. The underlying industries to which the Groups Specialty segment business lines relate, such as marine, energy and in particular aviation, have faced unprecedented challenges resulting in loss of profits, government-imposed restrictions, and a general downturn in business due to recent global economic uncertainty. Despite the Specialty segment historically being our smallest segment due to the historic rating environment, the rates available in certain Specialty classes increased throughout 2020, 2021 and 2022, and have continued to do so in 2023 to date, resulting in a significant increase in GPW attributable to our Specialty segment.
However, given the recent market volatility and ongoing uncertainty resulting from the global economic and geopolitical uncertainty, the Group might be unable to continue its strong growth in Specialty. Additionally, since the onset of the ongoing Ukraine Conflict, the aviation line of business has come under particular strain arising from the indirect impact of sanctions imposed on Russia and western leased aircraft currently located in Russia. Given the novelty of the situation, it is impossible to determine whether and how potential losses may crystallize, which will ultimately depend on multiple interlocking dependencies, including the future behavior of the Russian government and airlines, the interpretation of the coverages in place and the way in which sanctions are interpreted. The spread of possible ultimate outcomes is huge, with scope for scenarios where Russian behavior and/or sanctions mean that no claims emerge, and others in which the (re)insurance market would face its largest ever non-natural catastrophe. As both segments are potentially susceptible to changes in economic activity, any significant and continued economic downturn may impact the Groups Bespoke and Specialty segments and the Groups GPW, as well as have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
Any future acquisitions, strategic investments or new platforms could expose the Group to further risks or turn out to be unsuccessful.
From time to time, and subject to the Framework Agreement (as defined below, see Material Contracts and Related Party TransactionsFramework Agreement) and each respective Delegated Underwriting Authority Agreement, the Group may pursue growth through acquisitions and strategic investments in businesses
38
or new underwriting, insurance-linked securities (ILS) or marketing platforms. The negotiation of potential acquisitions or strategic investments as well as the integration of an acquired business, personnel or underwriting or marketing platforms (including raising alternative capital from reinsurance sidecar finance structures (sidecars)) could result in a substantial diversion of management resources and the emergence of other risks, such as potential losses from unanticipated litigation, a higher level of claims than is reflected in reserves, loss of key personnel in acquired businesses or an inability to generate sufficient revenue to offset acquisition costs.
The Groups ability to manage its growth through acquisitions, strategic investments or new or alternative platforms (including sidecars) will depend, in part, on its success in addressing such risks. While the Group is not currently contemplating any such acquisitions or strategic investments, the Groups nimble approach to capital management based on opportunities presented and sought out means that the Group may opportunistically from time to time pursue such acquisitions, new platforms or strategic investment strategies. Any failure by the Group to implement its acquisitions, new platforms or strategic investment strategies effectively could have a material adverse effect on its business, prospects, financial condition or results of operations.
Competition within the industry may make profitable pricing difficult and the Group may fail to be able to access profitable insurance or reinsurance business.
The insurance industry is highly competitive. In its underwriting activities, the Group may find itself in competition with other insurers and reinsurers that may have an established position in the market or greater financial, marketing and management resources available to them. Competition in the types of business that the Group may underwrite is based on many factors, including premiums charged and other terms and conditions agreed, services provided, financial strength ratings assigned by third-party credit rating agencies and perceived financial strength, speed of claims payment, reputation and experience in the line of business to be written, and continuity, strength of relationship and reputation with clients and brokers. Competition can adversely affect premium levels, including on business written by the Group, by increasing insurance industry capacity, reducing prices in response to favorable loss experience, affecting the pricing of underlying direct coverage and other factors, any of which can develop in a relatively short period of time. In addition, the Group cannot predict the extent to which competition from new competitors (including managing general agents, hedge funds, capital markets products such as catastrophe bonds and new underwriting companies that provide similar products) or existing competitors raising equity, debt or ILS capital could increase (re)insurance capacity and depress premium rates. There may be a divergence of views among market participants on the likely duration and extent of rate improvements, if and when anticipated. Increased competition could result in fewer submissions, lower premium rates or less favorable policy terms and conditions with respect to the Groups products, which could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
Consolidation in the (re)insurance industry could adversely impact the Groups business and results of operations.
Recent years have seen increased consolidation and convergence among companies in the (re)insurance industry resulting in increasingly larger and more diversified competitors with greater capitalization than the Group. As evidenced by merger and acquisition transactions in recent years, the consolidation trend may continue and even accelerate in the near future, which may lead to increased competitive pressure in the Groups business lines from such competitors. In addition, as companies consolidate, the resulting change in the competitive landscape may impact the Groups ability to attract the most talented insurance professionals and to retain and incentivize its existing employees. Any of these risks relating to consolidation within the industry could adversely affect the Groups insurance and reinsurance businesses, prospects, financial condition or results of operations.
As the (re)insurance industry consolidates, the cost, capital and (re)insurance synergies and combined underwriting leverage resulting from consolidation may mean a larger global (re)insurer is able to compete more effectively and also may be more attractive to brokers and agents looking to place business than the Group. These
39
consolidated competitors may try to use their enhanced market power to obtain a larger market share through increased line sizes. Larger (re)insurers also may have lower operating costs and an ability to absorb greater risk while maintaining their financial strength ratings, thereby allowing them to price their products more competitively without impacting rating. If competitive pressures reduce rates or negatively affect terms and conditions considerably, the Group may reduce its future underwriting activities in those lines thus resulting in reduced premiums and a potential reduction in expected earnings.
As the (re)insurance industry consolidates, competition for customers may also become more intense and the importance of properly servicing each customer will increase. Several of the mergers of (re)insurers that compete with the Group were partially driven by strategic plans to write more (re)insurance business. The Group could therefore incur greater expenses relating to customer acquisition and retention, reducing the Groups operating margins. In addition, (re)insurance companies that merge may be able to spread their risks across a consolidated, larger capital base so that they require less outwards reinsurance than the Group. Furthermore, such (re)insurance companies may, as a result of consolidation, purchase less reinsurance and retrocession cover from the Group than they currently do.
There has been a similar trend of increased consolidation of agents and brokers in the (re)insurance industry. As most of the Groups products are distributed by Fidelis MGU through agents and brokers, consolidation could impact relationships with, and fees paid to, some agents and brokers. Consolidation of distributors may also increase the likelihood that distributors will try to renegotiate the terms of existing selling agreements to terms less favorable to the Group. As brokers merge with or acquire each other, any resulting failure or inability of brokers to market the Groups products successfully, or the loss of a substantial portion of the business sourced by one or more of the Groups key brokers, could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
The Group may not be able to write as much premium as expected in the Group Annual Plan with the desired level of projected profitability.
The Group may not write as much premium as expected with the desired level of profitability. Factors which may inhibit or preclude the Group from obtaining the participations on desirable business sufficient to meet the projected premium or profitability levels include, among others:
| the failure of Fidelis MGU to maintain successful relationships with clients, brokers and other intermediaries to distribute the Groups products; |
| insurance and reinsurance pricing not responding positively as has happened in the past to a significant loss event; |
| continued willingness by other market participants to underwrite insurance and reinsurance business at rates, terms or conditions that are at best marginally profitable and are more attractive to customers than the Group is prepared to price at; |
| difficulty penetrating existing program structures due to established relationships between such cedants (or their intermediaries) and reinsurers, or clients (or their intermediaries) and their insurers on programs desired by the Group; |
| intermediaries entering into bilateral or facility arrangements with single carriers or markets, where previously the business was more widely available; and |
| possible unwillingness of prospective cedants (or their intermediaries) or clients (or their intermediaries) to accept the Groups participations based on competitors higher ratings or concerns regarding the Groups investors time horizons and possible exit strategies or ability to maintain its financial strength ratings. |
If the Group is not able to write as much increased business as expected, or at the projected levels of profitability, it may write a lesser volume of business and/or write business at lower projected levels of
40
profitability. This could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
Industry-wide developments could adversely affect the Groups business.
The availability and price of insurance and reinsurance coverage has been affected by factors such as the global economic recession, stock market performance, interest rates, high inflationary environment and the occurrence of global catastrophic events. Recent examples of the latter are Hurricanes Florence, Dorian, Michael, Laura, Sally, Ida and Ian, Typhoons Faxai, Hagibis, Jebi, Mangkhut and Trami, the U.S. Midwest derecho, Winter Storm Uri, the California wildfires in recent years and Storm Bernd, which caused widespread European floods, and the COVID-19 pandemic, as well as the ongoing Ukraine Conflict. Volatility in regional and global economic growth has the potential to reduce the number and the amount of GPW in the Groups business lines such as marine, where such volatility may result in a decline in shipbuilding projects, and aviation lines in the event of a significant reduction in passenger volumes and departures.
Within energy lines, the recent rally in oil prices, brought around by fears of supply issues in light of the ongoing Ukraine Conflict, affects asset prices and may impact on existing and future exploration and extraction projects, also producing broader financial distress within the energy industry. Although Russian energy exports are continuing, the Western nations are exploring their options and seeking alternative energy sources. The Organisation for Economic Cooperation and Development (the OECD) nations responded to the crisis by releasing more barrels from their strategic reserves, which was aimed at stabilizing the prices. Although this move has generally been welcomed, there is no guarantee that it will impact oil prices in any meaningful way as this unprecedented economic and political situation has not been fully modeled yet and the prices are expected to remain extremely volatile. This dynamic in the energy sector may result in increased demand for insurance but limits (particularly in respect of business interruption) may be higher.
Fluctuations in demand for insurance and reinsurance products or over-or under-supply of capacity can result in governmental intervention in the insurance and reinsurance markets, which may affect the risks which may be available for the Group to consider underwriting, or render terms and pricing unattractive. At the same time, threats of further terrorist attacks and political unrest in Europe, the Middle East, North Africa, the U.S., Australasia and Asia, and continued uncertainty arising directly and indirectly from the recent turbulence in the global financial markets, have adversely affected general economic, market and political conditions, increasing many of the risks associated with the Groups business worldwide. See Risks Relating to Recent Events.
A downgrade or withdrawal of, or other negative action relating to, the Groups financial strength rating(s) by insurance rating agencies could adversely affect the volume and quality of business presented to the Group.
Third-party credit rating agencies assess and rate the financial strength of insurers and reinsurers based upon criteria established by those rating agencies. The claims-paying ability ratings assigned by rating agencies to insurance and reinsurance companies represent independent opinions of financial strength and the ability to meet policyholder or other obligations. Ratings reflect the rating agencies respective opinions on the ability of the Group to pay claims and are not evaluations directed to investors in, and are not recommendations to buy, sell or hold, the Groups securities. Insureds, cedants and intermediaries use these ratings as one measure by which to assess the financial strength and quality of insurers and reinsurers. These ratings are often a key factor in the decision by an insured, cedant or an intermediary on whether and in what quantum to place business with a particular insurance or reinsurance provider. Many insureds, cedants and intermediaries maintain a listing of acceptable insurers or reinsurers, generally based upon credit ratings.
Prior to the Separation Transactions, the Group was assigned an A (Excellent) financial strength rating by A.M. Best, the third-highest of 13 rating levels, with a stable outlook on all entities. A.M. Bests ratings range from A+ to D. Each A.M. Best rating category from A+ to C may be designated either an additional plus (+) or a minus (-) sign as a rating notch that reflects a gradation of financial strength within the rating
41
category. Additionally, A.M. Best assigned a BBB long-term issuer credit rating to FIHL, which indicates a good ability to meet ongoing senior financial obligations and a financial strength rating of A (Excellent) and the long-term issuer credit rating of A (Excellent) to FIBL, FUL and FIID. In connection with the Separation Transactions, the Group completed a rating evaluation service with A.M. Best, following which, A.M. Best had placed under review with negative implications the ratings assigned to FIHL, including the Groups financial strength rating of A. On February 3, 2023, A.M. Best removed from under review with negative implications and affirmed the financial strength rating of A (Excellent) and the long-term issuer credit rating of A (Excellent) of FIBL, FUL and FIID. In addition, A.M. Best removed from under review with negative implications and affirmed the long-term issuer credit rating of BBB (Good) of FIHL. The outlook assigned to these ratings remained negative at such date. The negative outlooks acknowledge that A.M. Best has noted that it will continue to monitor the Groups market presence as well as subsequent operating performance now that the Separation Transactions have been consummated.
Prior to the Separation Transactions, the Group was assigned an A- financial strength rating by S&P, with a positive outlook, which indicates strong capacity to meet financial commitments but somewhat more susceptibility to the adverse effects of changes in circumstances and economic conditions than those in higher-rated categories. S&Ps ratings range from AAA to D. Each S&P rating category from AA to CCC may be modified by the addition of a plus (+) or minus (-) sign to show relative standing within the rating categories. Additionally, S&P has assigned a BBB long term issuer rating to FIHL, which indicates adequate capacity to meet financial commitments but greater susceptibility to adverse economic conditions. In connection with the Separation Transactions, the Group completed a rating evaluation service with S&P, following which, S&P had placed under review the ratings assigned to FIHL, including the Groups financial strength rating of A-. On August 5, 2022, S&P affirmed the Groups ratings, including the A- financial strength rating assigned to the Group and a BBB long term issuer rating to FIHL, but revised its outlook from positive to stable for all entities. Despite the revision, S&P expressed confidence in the Groups future operating earnings and strong capital position, noting in particular the Groups underwriting outperformance of peers between 2017 and 2022.
Following the announcement of the Separation Transactions, on August 1, 2022, Moodys assigned a Baa2 long-term issuer rating to FIHL and A3 insurance financial strength ratings to FIBL, FUL and FIID. The outlook for FIHL is stable. Moodys generic rating classifications range from Aaa to C. Each Moodys generic rating classification from Aa to Caa may be modified to append numerical modifiers 1, 2, or 3 to show relative position within the rating categories.
A.M. Best, S&P and Moodys will periodically review the Groups rating and may revise it downward or revoke it at their sole discretion, based primarily on their analysis of the Groups balance sheet strength, operating performance and business profile. Factors that may affect such an analysis include:
| if the Group changes its business practice from the Group Annual Plan in a manner that no longer supports its rating; |
| if unfavorable financial or market trends impact the Group; |
| if the Groups actual losses significantly exceed its loss reserves; |
| if the Group is unable to obtain and retain key personnel; |
| if the Groups investments incur significant losses; and |
| if either A.M. Best or S&P alters its capital adequacy assessment methodology in a manner that would adversely affect the Groups rating. |
An actual or anticipated downgrade or revocation of the Groups financial strength rating, or an announcement that the Groups financial strength rating is under review or other negative action by a rating agency, could provide certain customers with a right to terminate their (re)insurance contracts with the Group
42
and would adversely affect the volume and quality of business presented to the Group and could potentially have a negative effect on the Groups financial condition and results of operations. A downgrade is also a basis for termination of the Framework Agreement by Fidelis MGU, subject to a cure period. A downgrade could also potentially impact the Groups existing letter of credit facilities by triggering a covenant breach, which would have a negative effect on the Groups business.
Additionally, third-party credit rating agencies may increase the levels of capital they require an insurer or reinsurer to hold in order to maintain a certain credit rating. Such changes could result in the Group having to raise additional capital or purchase reinsurance in order to maintain its credit rating. The availability and cost of additional financing or capital depends on a variety of factors, including our credit ratings and credit capacity. If the Group does not raise such additional capital or purchase suitable reinsurance, that could result in a downgrade of its credit rating, which could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
A downgrade in rating could have a material effect on the Groups ability to write business or to maintain business already written and would adversely affect the Groups competitive position in the insurance and reinsurance industries and make it more difficult to market its products. A downgrade could, therefore, result in a substantial loss of business as insureds, ceding companies, agents and brokers that place business with the Group companies might move to other insurers and reinsurers with higher ratings or insist on less favorable terms as a condition of continuing to do business. A credit rating downgrade might also give rise to a right of termination or amendment of the Groups credit facilities. While there can be no assurance that increased levels of capital will not be required in the future, the rating agencies have not made the Group aware of any such increase as part of the rating evaluation service in connection with the Separation Transactions.
Changing climate conditions and under-developed catastrophe modeling tools could lead to worse than expected losses and may adversely affect the Groups operating results, financial condition, profitability or cash flows.
Multiple years of above-average temperatures and drought, poor forest management, and widespread development in the zone between wild land and human development have proved a dangerous combination. The catastrophe modeling tools that insurers and reinsurers use to help manage catastrophe exposures are based on assumptions and judgments that rely on historical trends, are subject to error and may produce estimates that are materially different from actual results. Changing climate conditions could cause catastrophe models to be even less accurate, which could limit the Groups ability to effectively manage its exposures, in particular to perils for which modeling is under-developed, such as wildfires and flooding. Failures or inadequacies in modeling relating to climate change could result in the Groups results of operations or financial condition differing materially from the Groups expectations or any related projections.
The failure to appreciate and respond effectively to the trends and risks associated with ESG initiatives and factors could adversely affect the Groups relationship with stakeholders and its achievement of the Group Annual Plan.
The purpose of a business and the way in which it operates in achieving its objectives, including in relation to ESG matters, are an increasingly material consideration for the Groups key stakeholders in achieving their own ESG objectives and aims. The Group has seen increased focus and scrutiny on ESG-related matters from its key stakeholders, such as its institutional investors, policyholders, employees and suppliers, as well as policymakers, regulators, rating agencies, industry organizations and local communities, which could lead to a change in approach to ESG for the Group and in the general (re)insurance industry as a whole. ESG-related initiatives, trends and risks may directly or indirectly impact the Groups business and the achievement of the Group Annual Plan and consequently those of its key stakeholders. A failure to transparently and consistently implement an ESG strategy, in its key markets and across operational, underwriting and investment activities, may adversely impact the Group Annual Plan, financial results and reputation of the Group and may negatively
43
impact relationships with the Groups stakeholders, all of whom have expectations, concerns and aims related to ESG matters which may differ from the Groups. See BusinessOur Commitment to Environmental, Social and Governance Matters.
Changes in law relating to certain perils could adversely affect the Groups business.
A change in law relating to certain perils for which the Group writes insurance or reinsurance may have a significant impact on the Groups ability to respond to certain events, including the manner and time frame for processing claims, the development of claim severity or the interpretation of the underlying policies. For example, in response to several wildfire events affecting California homeowners, the state has enacted new insurance consumer protection laws for California policyholders that took effect on January 1, 2019 and require insurers to afford certain policy protections to California insureds for future wildfire events. Such changes in law and practice in response to the recent wildfire events, as well as other changes in law and practice relating to other perils for which the Group writes insurance or reinsurance, may have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
Outwards reinsurance is a key part of the Groups strategy, subjecting the Group to the credit risk of its reinsurers and may not be available, affordable or adequate to protect against losses.
A key part of the Groups strategy is to follow the practice of reinsuring and retroceding with other insurance and reinsurance companies and ILS vehicles a portion of the risks under the insurance and reinsurance contracts that it writes in order to protect the Group against the severity of losses on individual claims and unusually serious occurrences in which a number of claims produce a large aggregated loss. Authority to design and place such outwards reinsurance has been delegated to Fidelis MGU. In addition to traditional outwards reinsurance, the Group participates in the catastrophe bond market and has sponsored four series of catastrophe bonds issued by Herbie Re, pursuant to which the Group obtains collateralized retrocessional coverage from capital markets participants. The amount of coverage purchased, either in the traditional or alternative markets, is determined by the Groups risk strategy together with the price, quality and availability of such coverage. Coverage purchased for one year will not necessarily conform to purchases for another year.
There can be no assurance that the Group will be able to obtain reinsurance or to enter into retrocession arrangements (including by renewing its catastrophe bond transactions) at a price, quality or in the amounts which the Group requires. There can be no assurance that the Groups outwards reinsurance or retrocession protection will be sufficient for all eventualities, which could expose the Group to greater risk and greater potential loss, which could in turn have a material adverse effect on its business, prospects, financial condition or results of operations. In particular, if a number of large losses occur in any one year, there is a chance that the Group could exhaust its outwards reinsurance and retrocession program. In this event, it is not certain that further reinsurance and/or retrocessional coverage would be available on acceptable terms, or at all, for the remainder of that year or for future years which could materially increase the risks and losses retained within the Group.
In addition, in the event Fidelis MGU cannot arrange to obtain the amount of reinsurance or retrocessional protection for the Group within the parameters set forth in each of the Subsidiary Annual Plans, then the Group may need to reduce the amount of business it writes accordingly in order to remain within its risk tolerances. Such reduction in the availability of reinsurance or retrocessional protection could also have a significant impact on the Groups capital reserves, by potentially requiring the Group to hold more capital. In particular, under Directive 2009/138/EC (Solvency II), which is also transposed into the U.K.s domestic prudential regime, the relevant operating subsidiaries of the Group are required to have a reasonable expectation that outwards reinsurance will be placeable to future periods.
Collectability of traditional reinsurance and retrocession is dependent upon the solvency of reinsurers or retrocessionaires and their willingness to make payments under the terms of reinsurance or retrocession agreements. In particular, the Group can be exposed to non-coterminous wording risk under such agreements,
44
including interpretations by our reinsurers or retrocessionaires that they may withhold payment for losses. As such, the terms and conditions of the reinsurance purchased by the Group may not provide precise cover for the losses the Group incurs on the underlying insurance or reinsurance which it has sold. A reinsurers insolvency or inability or unwillingness to make payments under the terms of a reinsurance or retrocession arrangement could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
In the case of the Groups catastrophe bond and industry loss warranty transactions, collectability is dependent on whether the relevant coverage is triggered. Each of the Groups catastrophe bond transactions and industry loss warranty transactions to date has utilized an industry loss index trigger, which means that the amount of recoveries paid to the Group is determined by the levels of catastrophe losses to the wider (re)insurance industry rather than by the amount of losses that the Group actually suffers. There can be no guarantee, therefore, that these catastrophe bonds and industry loss warranties will provide adequate protection if the Groups loss experience does not correlate with losses on an industry-wide basis triggering a payment under the relevant contracts.
The Group is exposed to credit loss in the event of nonperformance by its counterparties on derivative agreements. The Group seeks to further reduce the risk associated with such agreements by entering into such agreements with large, well-established financial institutions. In addition, the U.S. Commodity Futures Trading Commission and other regulators require the Group and its swap dealer counterparties to collect and post initial and variation margin with respect to non-cleared swaps. Any initial margin required to be posted to the Groups swap dealer counterparties under these rules is segregated with a third-party custodian. However, there can be no assurance that the Group will not suffer losses in the event a counterparty or custodian fails to perform or is subject to a bankruptcy or similar proceeding.
Cyber threats are an evolving risk area affecting not only the specific cyber insurance market but also the liability coverage the Group provides which may adversely affect the Group.
The Group has introduced processes to manage its potential liabilities as a result of specific cyber coverage and other coverage the Group provides to its (re)insurance policyholders, including for the business sourced by Fidelis MGU. However, given that this is an area where the threat landscape is uncertain and continuing to evolve, there is a risk that increases in the frequency and effectiveness of cyber-attacks on the Groups policyholders could adversely affect (possibly to a material extent) the Groups business, prospects, financial condition or results of operations. This risk is also dependent on the measures the individual policyholders use to protect themselves to keep pace with the emerging threat, as well as the development and issuance of policy terms and conditions which are reactive to the evolving threat landscape.
The Group may write selected quota share reinsurance policies and assume a share of the liabilities of its underlying reinsureds, which may expose it to certain losses.
The Group may write selected quota share reinsurance policies and also insure a share of the liabilities of its underlying reinsureds. The Group may suffer losses arising from the underlying judgment of the staff of reinsureds, underlying pricing, terms and conditions of the business in which it shares risk, sub-optimal claims management and other business administration shortcomings, poor but not contractually actionable information disclosure, failure to observe underwriting guidelines but not to a contractually actionable extent and unexpected catastrophic exposures in the reinsureds own account. These risks are equally applicable to many other types of reinsurance that the Group may write (in addition to quota share reinsurance).
Loss of business reputation or negative publicity could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
The Group is vulnerable to adverse market perception since it operates in an industry where integrity, customer trust and confidence are paramount. In addition, any negative publicity (whether well founded or not)
45
associated with the business or operations of the Group could result in a loss of clients and business. Accordingly, any mismanagement, fraud or failure by its employees or employees of Fidelis MGU to satisfy fiduciary responsibilities, or the negative publicity resulting from such activities or any allegation of such activities and consequential loss of reputation, could have a material adverse effect on the Groups business, prospects, financial condition or results of operations. These issues also relate to regulatory conduct risk, for which see Risks Relating to Regulation of the Group.
The Group is exposed to the risk of litigation which could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
The extent and complexity of the legal and regulatory environment in which the Group operates and the products and services the Group offers mean that many aspects of the business involve substantial risks of liability. Any litigation brought against the Group in the future could have a material adverse effect on the Group. The Groups insurance may not necessarily cover all or any of the claims that clients or others may bring against the Group or may not be adequate to protect it against all the liability that may be imposed.
The Group also may be involved in litigation against third parties in the normal course of business and the probable outcome of all such litigation may be taken into account in the assessment of the Groups liabilities. If the outcome of such litigation is incorrectly estimated, this could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
Coverage disputes can increase expenses and incurred losses, which could have a material adverse effect on the Groups business.
There can be no assurance that various provisions of the Groups insurance policies and reinsurance contracts, such as limitations on, or exclusions from, coverage, will be enforceable in the manner intended. In particular, the ongoing Ukraine Conflict may lead to coverage disputes in relation to, among others, policy language, the impact of sanctions or cancellation notices. Such actions have led to an increase in the risk of uncertainty surrounding emerging claims. See Risks Relating to Recent Events.
This increased risk adds further pressure to an already uncertain area surrounding emerging claims, which has been particularly prominent in the Florida insurance market, which has seen an increase in losses and loss adjustment expenses due to the prevalence of assignment of benefits (AOB) claims. Through AOB, homeowners are increasingly assigning the benefit of their insurance recovery to third parties (including the right to claim back legal fees if they are successful in arguing for a larger than initially offered pay-out). AOB practice in Florida has been characterized by an inflated size and number of claims, increased litigation, interference in the adjustment of claims and the assertion of bad faith actions and one-way attorney fees. There were a large number of AOB claims following Hurricane Irma in 2017, a trend which continued in the wake of Hurricane Michael in 2018. In an effort to stem rising premiums caused by unnecessary litigation and AOB abuse and to curtail any further exponential growth in AOB litigation, Floridas state legislature has signed into law an AOB reform measure, which will, among other provisions, restrict attorney fees on AOB litigation and allow providers to sell AOB exempt policies. However, until the effects of the new legislation become clear, ongoing AOB activity and related potentially fraudulent claims activity may have a material effect by inflating the size of the Groups losses and loss adjustment expenses.
Furthermore, as the Group writes a substantial amount of property D&F across the United States, it is exposed to the risk of emerging bad faith claims, which have recently been successfully brought in several U.S. states. Such claims are not insurer friendly and especially so when the insurer is a non-U.S. insurer. Additionally, due to potential unfamiliarity with the local rules and regulations, a non-U.S. insurer, such as the Group, runs an increased risk of clerical and logistical errors in getting claims and litigation filings in the United States done on time to allow it to respond in a timely manner before a summary judgment is held against it.
46
Although disputes relating to coverage and choice of legal forum can be expected to arise in the ordinary course of the Groups business, particularly if loss claims are material, the rise in the number of AOB and bad faith claims or other coverage disputes could lead to the Group facing a higher volume of claims or quantum of losses than it faced historically. As a result, the Group may incur losses beyond those that it considered might be incurred at the time of underwriting the insurance policy or reinsurance contract, which could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
We have identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or fail to maintain an effective system of internal control over financial reporting, which may result in material misstatements of our consolidated financial statements or cause us to fail to meet our periodic reporting obligations.
In connection with the preparation of our consolidated financial statements for the year ended December 31, 2022, we identified material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected on a timely basis. The material weaknesses were identified in the following areas: (i) the design and operating effectiveness of controls over the secondary review of the accuracy of data input in the policy administration system impacting recording of premiums and acquisition costs, (ii) the necessary resources to consider on a timely basis the application of U.S. GAAP accounting principles where complex accounting judgment exists, and (iii) the design of controls over the completeness and accuracy of reinsurance balances recoverable and payable.
To remedy our identified material weaknesses, we are in the process of adopting several measures intended to improve our internal control over financial reporting. These include strengthening our finance, operations and information technology teams, and implementation of further policies, processes and internal controls relating to our financial reporting. Specifically, those ongoing remediation include the following:
| We have, and will continue to, strengthen our operational resources within the underwriting team to implement additional controls over data input in addition to having expanded the operations team through the provision of specialist third-party resources to assist with data input. Furthermore, in the third quarter of 2022 we engaged a third-party service provider to conduct independent quality control checks over the data in the policy administration system. |
| We have strengthened the reinsurance team by hiring additional accounting and operational resources to help ensure that we have sufficient personnel with skills and experience commensurate with the size and complexity of the organization, who can effectively design and execute our process level controls around reinsurance balances payable and recoverables. We will also be implementing additional technology solutions to replace manual processes where possible. |
| We have hired additional resources in our Group finance team with knowledge and experience of U.S. GAAP, SEC reporting and internal control over financial reporting. |
| Additionally, we have engaged an outside service provider to assist in evaluating and documenting processes and controls, identifying control gaps and strengthening the quality of documentation regarding controls. |
We are committed to maintaining a strong internal control environment, and we expect to continue our efforts to ensure the material weaknesses described above and all control deficiencies are remediated. However, these material weaknesses cannot be considered remediated until the applicable remedial controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.
We can give no assurance that additional material weaknesses or significant deficiencies in our internal control over financial reporting will not be identified in the future. Our failure to implement and maintain
47
effective internal control over financial reporting could result in errors in our financial statements that may lead to a restatement of our financial statements or cause us to fail to meet our reporting obligations. Any failure to implement required new or improved controls, or difficulties encountered in their implementation, could harm our operating results or cause us to fail to meet our reporting obligations. Failure to achieve and maintain an effective internal control environment could cause investors to lose confidence in our reported financial information, which could have a material adverse effect on our Common Share price. Although we are committed to adopting remedial controls, any failure to comply with Section 404 of the Sarbanes-Oxley Act could also potentially subject us to sanctions or investigations by the SEC or other regulatory authorities. Generally, if we fail to achieve and maintain an effective internal control environment, it could result in material misstatements in our financial statements and could also impair our ability to comply with applicable financial reporting requirements and related regulatory filings on a timely basis. As a result, our businesses, financial condition, results of operations and prospects, as well as the trading price of our Common Shares, may be materially and adversely affected. We may also be required to restate our financial statements from prior periods.
We will incur increased costs as a result of operating as a U.S. public company, and our management will be required to devote substantial time to new compliance initiatives and corporate governance practices. We may fail to comply with the rules that apply to public companies, including Section 404 of the Sarbanes-Oxley Act, which could result in sanctions or other penalties that would harm our business.
As a public company that qualifies as a foreign private issuer, we will incur significant legal, accounting, and other expenses that we did not incur as a private company, including costs resulting from public company reporting obligations under the Securities Act of 1933, as amended (the Securities Act), the Securities Exchange Act of 1934, as amended (the Exchange Act), and regulations regarding corporate governance practices. The Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the rules of the SEC, the listing requirements of NYSE, and other applicable securities rules and regulations impose various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. We expect that we will need to hire additional accounting, finance, and other personnel in connection with our becoming listed on the NYSE and our efforts to comply with the requirements of being a public company, and our management and other personnel will need to devote a substantial amount of time towards maintaining compliance with these requirements. These requirements will increase our legal and financial compliance costs and will make some activities more time-consuming and costly. For example, these reporting requirements, rules and regulations, coupled with the increase in potential litigation exposure associated with being a public company, could also make it more difficult for us to attract and retain qualified persons to serve on our Board or board committees or to serve as executive officers, or to obtain certain types of insurance, including directors and officers insurance, on acceptable terms. We are currently evaluating these rules and regulations and cannot predict or estimate the amount of additional costs we may incur or the timing of such costs. These rules and regulations are often subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We cannot predict or estimate the amount of additional costs we may incur as a result of becoming a public company or the timing of such costs. Any changes we make to comply with these obligations may not be sufficient to allow us to satisfy our obligations as a public company on a timely basis, or at all.
Pursuant to Sarbanes-Oxley Act Section 404, we will be required to furnish a report by our management on, among other things, our internal control over financial reporting beginning with our second filing of an Annual Report on Form 20-F with the SEC after we become a public company. In order to maintain effective internal controls, we will need additional financial personnel, systems and resources. To achieve compliance with Sarbanes-Oxley Act Section 404 within the prescribed period, we will be engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants, adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve
48
control processes as appropriate, validate through testing that controls are functioning as documented, and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that we will not be able to conclude, within the prescribed timeframe or at all, that our internal control over financial reporting is effective as required by Sarbanes-Oxley Act Section 404. If we identify one or more material weaknesses, it could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements.
Furthermore, if we identity material weakness in our internal control over financial reporting in the future, we may not detect errors on a timely basis and our financial statements may be materially misstated. We or our independent registered public accounting firm may not be able to conclude on an ongoing basis that we have effective internal control over financial reporting, which could harm our operating results, cause investors to lose confidence in our reported financial information and cause the trading price of our shares to fall. In addition, as a public company we will be required to file accurate and timely reports with the SEC under the Exchange Act. Any failure to report our financial results on an accurate and timely basis could result in sanctions, lawsuits, delisting of our shares from NYSE or other adverse consequences that would materially harm our business and reputation.
The preparation of the Groups financial statements requires it to make many estimates and judgments that are more difficult than equivalent estimates and judgments made by companies operating outside the (re)insurance sector.
The preparation of the Groups audited consolidated financial statements and unaudited interim consolidated financial statements requires the Group to make many estimates and judgments that affect the reported amounts of assets, liabilities (including reserves), revenues and expenses and related disclosures of contingent liabilities. The Group evaluates its estimates on an ongoing basis, including those related to premium recognition, insurance and other reserves, reinsurance recoverables, investment valuations, intangible assets, bad debts, impairments, income taxes, contingencies, derivatives and litigation. The Group bases its estimates on market prices, where possible, and on various other assumptions it believes to be reasonable under the circumstances, which form the basis for the Groups judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.
In particular, estimates and judgments for new (re)insurance lines of business are more difficult to make than those made for more mature lines of business because the Group has more limited historical information on which to base such estimates and judgments. A significant part of the Groups current loss reserves is in respect of incurred but not reported (IBNR) reserves. This IBNR reserve is based almost entirely on estimates involving actuarial and statistical projections of the Groups expectations of the ultimate settlement and administration costs. Accordingly, actual claims and claim expenses paid may deviate, perhaps substantially, from the reserve estimates reflected in the Groups audited consolidated financial statements and unaudited interim consolidated financial statements, which could materially adversely affect the Groups financial results.
If FIHL were deemed to be an investment company under the U.S. Investment Company Act of 1940 (the Investment Company Act), applicable restrictions could make it impractical for the Group to continue with its business as contemplated and could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
FIHL is not, and following this offering will not be, required to be registered as an investment company under the Investment Company Act, and FIHL intends to conduct its operations so that it will not be deemed to be an investment company under the Investment Company Act. The Investment Company Act and the rules and regulations thereunder contain detailed parameters for the organization and operation of investment companies. FIHL does not believe it is an investment company to which the Investment Company Act would apply because it is not and does not hold itself out as being primarily engaged, nor does it propose to engage primarily, in the business of investing, reinvesting, or trading in securities (the primarily engaged test, pursuant to Section
49
3(a)(1)(A) of the Investment Company Act) and it does not own or propose to acquire investment securities (as defined in Section 3(a)(2) of the Investment Company Act) having a value exceeding 40% of the value of its total assets (exclusive of government securities and cash items) on an unconsolidated basis (the 40% Test, pursuant to Section 3(a)(1)(C) of the Investment Company Act).
With respect to the 40% Test, FIHL directly owns all of the outstanding voting securities of FIBL and FUL, with FIBL owning 100% of Fidelis Europe Holdings Limited, which in turn owns 100% of FIID. More than 60% of the value of the total assets (exclusive of government securities and cash items) of FIHL, on an unconsolidated basis, consists of (a) voting securities of FIBL and FUL, and indirectly, via Fidelis Europe Holdings Limited, FIID, and (b) other assets that are not securities within the meaning of the Investment Company Act.
With respect to the primarily engaged test, for the twelve months ended December 31, 2022, the vast majority of the assets of each of FIBL, FUL and FIID were utilized in, or otherwise related to, the writing of insurance or the reinsurance of risks on insurance agreements, and represented either insurance reserves that FIHL has established or capital and surplus which is required to enable FIHL to conduct its business as a reinsurer.
If FIHL were to be deemed to be an investment company under the Investment Company Act, requirements imposed by the Investment Company Act, including limitations on FIHLs capital structure, ability to transact business with affiliates and ability to compensate key employees, would make it impractical for the Group to continue its business as currently conducted, impair the agreements and arrangements between and among the Group and its clients, and materially and adversely affect the Groups business, results of operations and financial condition.
Risks Relating to Recent Events
The full extent of the impacts of the ongoing Ukraine Conflict on the (re)insurance industry and on the Groups business, financial condition and results of operations, including in relation to claims under the Groups (re)insurance policies, are uncertain and remain unknown.
The U.S. and global markets are currently experiencing volatility and disruption following the ongoing Ukraine Conflict. In response to such invasion, the North Atlantic Treaty Organization (NATO) deployed additional military forces to eastern Europe. The United States, the United Kingdom, the European Union and other countries have announced various economic and trade sanctions, export controls and other restrictive actions against Russia, Belarus and related individuals and entities. These include, among other measures, the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication (SWIFT) payment system, the imposition of comprehensive sanctions on certain persons and entities (including financial institutions) in Russia and Belarus and new export control restrictions targeting Russia and Belarus (including measures that restrict the movement of U.S.-regulated aircraft into or within Russia). The Ukraine Conflict and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom, the European Union and other countries have created global security concerns that could have a lasting impact on regional and global economies. Although the severity and duration of the ongoing Ukraine Conflict is impossible to predict, the active conflict could lead to market disruptions, including significant and prolonged volatility in commodity prices, credit and capital markets, as well as supply chain interruptions. Additionally, Russian military actions and the resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.
Further, in December 2022, the members of the G7, including the United States and United Kingdom, joined the E.U. in prohibiting regulated persons from providing a range of services, including issuing maritime insurance, related to the maritime transport of crude oil of Russian Federation origin, unless purchasers bought the oil at or below a price cap. The Group will consider providing insurance for future shipments of seaborne Russian crude oil, in compliance with these restrictions and all other applicable economic and trade sanctions.
50
Although the Group will take measures designed to maintain compliance with applicable sanctions in connection with its activities, the Group cannot guarantee that it will be effective in preventing violations or allegations of violations. Violations, or allegations of violations, could result in civil and criminal penalties, including fines, for the Group or for responsible employees and managers, as well as negative publicity or reputational harm.
Due to the widespread impact of the ongoing Ukraine Conflict, which extends economically, geographically and financially, it is likely to directly or indirectly impact the markets in which the Group operates and some of the lines of business we write. It is possible that the war will create a domino effect, affecting the entirety of the Groups business, including the ultimate premiums and costs of policies, through cost of materials and labor. The impact of some of or all these factors could cause significant disruption to the Groups operations and materially impact its financial performance. The Group has already identified business lines which could suffer losses resulting from the ongoing sanctions. As aviation is a large component of the Groups Specialty segment, any large losses in the aviation line of business could have a material and adverse impact on the performance of the Specialty segment generally. In light of the evolving nature of the Ukraine Conflict, there are a number of complexities and implications that will need to be evaluated and determined on an ongoing basis before the Group can reasonably estimate any potential losses. See Risks Relating to the Groups Business and IndustryIndustry-wide developments could adversely affect the Groups business.
Any of the above mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Ukraine Conflict and subsequent sanctions, could have a material adverse effect on the Groups business, financial condition and results of operations. The extent and duration of the Ukraine Conflict, resulting sanctions and any related market disruptions are impossible to predict, but could be substantial, particularly if current or new sanctions continue for an extended period of time or if geopolitical tensions result in expanded military operations on a global scale. Most of the significant factors arising out of the ongoing Ukraine Conflict are beyond the Groups control and any such disruptions may also have the effect of heightening many of the other risks described in this Risk Factors section. If these disruptions or other matters of global concern continue for an extended period of time, the Groups business, financial condition and results of operations may be materially adversely affected.
We may be subject to litigation which could adversely affect our business.
The Group, in common with the insurance industry in general, is subject to litigation, mediation and arbitration, and regulatory and other sectoral inquiries in the normal course of its business in a number of foreign jurisdictions. For example, as a result of the insurers having denied claims of the aircraft lessors in respect of the unreturned aircraft currently located in Russia as a result of the Ukraine Conflict, aircraft lessors have instituted proceedings in the U.K., the U.S. and Ireland against upwards of 60 (re)insurers, including certain Group entities. Fidelis has been named in multiple proceedings. For additional information, see Managements Discussion and Analysis of OperationsRecent Developments and Activity.
While management believes that these claims will not have a material adverse effect on the Groups financial position, given the large or indeterminate amounts sought in certain of these actions, and the inherent unpredictability of litigation, it is possible that an adverse outcome impacting several of the outstanding claims could, from time to time, have a material adverse effect on the Groups results of operations or cash flows.
Our business, financial condition and results of operations may be adversely affected by an epidemic, pandemic or any other public health crisis and we may face risks related to Severe Acute Respiratory Syndrome (SARS), H1N1 influenza, H5N1 influenza, H7N9 influenza, H3N2 influenza and COVID-19 which could significantly disrupt our operations resulting in material adverse impacts to our business, financial condition and results of operations.
The widespread outbreak of an illness or any other communicable diseases, or any public health crisis that results in economic or trade disruptions could negatively impact our business and the businesses of our policyholders.
51
Our results of operations may be affected by the impact on the global economy and businesses that COVID-19 (or another pandemic or epidemic) has had to date or may have in the future. Global financial markets have suffered downturns and volatility as a result of the COVID-19 pandemic, which may, as a result of the resurgence of existing or the emergence of new COVID-19 strains (or similar pandemics or epidemics), continue to have a sustained impact on businesses across the world. Risks relating to COVID-19 and future pandemics or epidemics may become more expensive or impossible to insure against. If any of the global impacts of COVID-19 (or another pandemic or epidemic) resurge for a sustained period of time or should any of the risks identified above materialize leading to an economic downturn and heightened volatility, it could have a material adverse effect on our business, financial condition and results of operations.
It is possible that a resurgence of COVID-19 (or another pandemic or epidemic) will cause an economic slowdown, and it is possible that it could cause a global recession. There is a significant degree of uncertainty and lack of visibility as to the extent and duration of any such slowdown or recession. Given the significant economic uncertainty and volatility created by COVID-19 (or another pandemic or epidemic), it is difficult to predict the nature and extent of impacts on our business.
For example, economic uncertainty continued throughout 2022 due not only to the COVID-19 pandemic, but also the Ukraine Conflict, energy price rises and cost of living increases. Global economies have recorded low levels of growth as they emerge from the COVID-19 pandemic and the low levels of growth have been further affected by increased geopolitical uncertainty due to the Ukraine Conflict. These events, if worsened, may have a significant impact on the performance on our business, financial condition and results of operations.
Recent events have adversely impacted, and may continue to adversely impact, the value of the Groups investment portfolio and may affect the Groups ability to access liquidity and capital markets financing or receive dividends from its operating subsidiaries.
Recent events, including the outbreak of the ongoing Ukraine Conflict, have introduced financial market volatility that has adversely impacted, and may continue to adversely impact, the value of the Groups investment portfolio and, if these global conditions persist, ongoing market volatility could affect the Groups ability to access liquidity and other capital markets financings. Inflation, rising interest rates, reduced liquidity in financial markets and a continued slowdown in global economic conditions have increased the risk of defaults and downgrades and have increased the volatility in the value of many of the investments the Group holds. In addition, the steps taken by governmental institutions in response to recent events (including the imposition of sanctions on Russia following its invasion of Ukraine), and the costs of such actions, may eventually lead to higher-than-expected inflation and further financial stress on global financial markets, including government bond markets.
The recent market volatility also caused significant increases in credit spreads which, if continuing, may negatively impact the Groups ability to access liquidity and capital markets financing such that it may not be available or may only be available on unfavorable terms. Regulators in certain jurisdictions imposed dividend restrictions on insurance companies, which impact liquidity for holding companies that have insurance subsidiaries in those jurisdictions. For example, the European Insurance and Operational Pensions Authority (EIOPA), the E.U.s insurance regulator, has recommended that any dividend distributions should not exceed thresholds of prudency given the continuing uncertainty over the impact of the pandemic. As a holding company with no direct operations, FIHL relies on dividends and other permitted payments from its subsidiaries and it may be unable to make distributions on its preference securities or principal and interest payments on its debt and to pay dividends to holders of Common Shares if its operating subsidiaries are unable to pay dividends to it. See Risks Relating to Financial Markets and Liquidity.
The current inflationary environment could have a material adverse impact on the Groups operations.
Steps taken by governments throughout the world in response to the recent economic and geopolitical climate, expansionary monetary policies and other factors have led to an inflationary environment. In operating
52
our business, we are experiencing the effects of inflation, including increased labor and construction costs. Furthermore, the Groups operations, like those of other insurers and reinsurers, are susceptible to the effects of inflation because premiums are established before the ultimate amounts of losses and loss adjustment expenses are known. Although the Group considers the potential effects of inflation when setting premium rates, premiums may not fully offset the effects of inflation and thereby essentially result in underpricing the risks insured and reinsured by the Group. Loss reserves include assumptions about future payments for settlement of claims and claims-handling expenses, such as the value of replacing property, associated labor costs for the property business the Group writes, and litigation costs. To the extent inflation causes costs to increase above loss reserves established for claims, the Group will be required to increase loss reserves with a corresponding reduction in net income in the period in which the deficiency is identified, which could have a material adverse effect on the Groups business, prospects, financial condition or results of operations. Unanticipated higher inflation could also lead to higher interest rates, which would negatively impact the value of the Groups fixed maturity securities and potentially other investments.
Risks Relating to the Groups Strategic Relationship with Fidelis MGU
The Group relies on Fidelis MGU for services critical to its underwriting and other operations. The termination of or failure by Fidelis MGU to perform under one or more agreements governing the Groups outsourced relationship with Fidelis MGU may cause material disruption in our business or materially adversely affect our financial results.
On July 23, 2022, FIHL and Fidelis MGU entered into a Cooperation Agreement agreeing to cooperate regarding certain matters relating to this offering and the Separation Transactions. FIHL and Fidelis MGU have also entered into a number of agreements governing the outsourced relationship, including the Framework Agreement, a series of Delegated Underwriting Authority Agreements (as defined below, see Material Contracts and Related Party TransactionsFramework Agreement) and the Inter-Group Services Agreement (see Material Contracts and Related Party TransactionsFramework Agreement).
The Framework Agreement, under which the Group secures business from Fidelis MGU, has a rolling initial term of 10 years. Years one to three will roll automatically (each year resetting for a new 10-year period) and the notice to roll will be deemed given at the end of years one, two and three (i.e., the years roll automatically and will not be subject to any underwriting target or other preconditions to rolling). From year four onwards, the Framework Agreement will roll at the written election of FIHL, with such election to be delivered at least 90 days prior to the commencement of the subsequent contract year. Any decision by FIHL to elect not to roll the Framework Agreement on or after year four will mean that the remainder of the 10-year term then in effect will continue in place (i.e., the Framework Agreement will have a further nine years to run in the first year following the election by FIHL not to roll the Framework Agreement). Additionally, each party has certain rights to terminate the Framework Agreement early. See Material Contracts and Related Party TransactionsFramework Agreement.
Under the terms of the relevant agreements, Fidelis MGU will also provide detailed reporting to the Group on a monthly or quarterly basis, depending on the nature of the report. Such reports will include, among other things, (i) accounting information (i.e., premiums written and earned, fees and loss reserves); (ii) underwriting information (including all insurance business underwritten under the Delegated Underwriting Authority Agreements); and (iii) claims handling information. If Fidelis MGU fails to perform any of its reporting obligations, the Group could be severely impacted, including by FIHL being unable to comply with its own reporting obligations as a listed company.
Due to the Groups dependency on Fidelis MGU and the Groups conduct of business being subject to the parameters and limitations set forth in the Framework Agreement, if the Framework Agreement or any of the Groups agreements with Fidelis MGU are terminated or Fidelis MGU fails to perform any of the services outsourced to it under the Framework Agreement or the other related agreements noted above, the Group may be required to hire staff to provide such services itself or retain a third party to provide such services, and no
53
assurances can be made that the Group would be able to do so in a timely, efficient or cost-effective manner. The Group could therefore suffer, among other things, non-renewals and loss of business, financial loss, disruption of business, liability to third parties, regulatory intervention and reputational damage, any of which could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
Pursuant to the agreements between the Group and Fidelis MGU, the Group retains an oversight and supervisory role over Fidelis MGUs active role in executing the Group Annual Plan and each of the Subsidiary Annual Plans. If the Groups monitoring efforts prove inadequate, this could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
Pursuant to the Framework Agreement, the Delegated Underwriting Authority Agreements and the Inter-Group Services Agreement, certain key underwriting and non-underwriting functions of the Group have been outsourced to Fidelis MGU and Fidelis MGUs employees are authorized to conduct business in accordance with the Group Annual Plan and each of the Subsidiary Annual Plans, as overseen by the Group, whose role is primarily supervisory in nature. The Group relies on established parameters. Although the Group monitors such business on an ongoing basis, its monitoring efforts may not be adequate to prevent Fidelis MGU or the designated employees from exceeding their authority, committing fraud or otherwise failing to comply with the terms of the agreements governing its relationship with the Group, including the Framework Agreement and the Delegated Underwriting Authority Agreements. Over time, such oversight may become cumbersome and lack of familiarity between the two separate groups could lead to operational missteps. To the extent Fidelis MGU exceeds its authority, commits fraud or otherwise fails to comply with the terms of agreements governing its relationship with the Group, the Groups financial condition and results of operations could be materially adversely affected.
Some executive officers and key personnel of Fidelis MGU are critical to the Groups business; Fidelis MGUs failure to retain such key personnel could seriously affect the Groups ability to conduct its business and execute the Group Annual Plan.
The Groups future success depends to a significant extent on the efforts of Richard Brindle and other senior management and key personnel employed by Fidelis MGU and FIHL to implement its business strategy. The majority of senior employees of Previous Fidelis, including Richard Brindle, are now employed by Fidelis MGU. There can be no assurance, however, that such key personnel will remain employed by Fidelis MGU. There are only a limited number of available and qualified executives with substantial experience in the (re)insurance industry and the procurement of new employees could be hindered by factors outside of the Groups control. Accordingly, Fidelis MGUs or FIHLs loss of the services of one or more of the members of the senior management team or other key personnel, including Richard Brindle, could significantly and negatively affect its ability to execute the Group Annual Plan, which could, in turn, have a material adverse effect on the Groups business.
Although each of Fidelis MGU and FIHL has executed employment agreements with respective key personnel, such executives and other senior management are free to resign from their roles, in accordance with the notice and non-compete provisions as set out in their respective employment agreements. Further, Fidelis MGU and FIHL do not currently maintain key man life insurance with respect to any of their respective management. If any member of management or other key employee dies or becomes incapacitated, or leaves Fidelis MGU or FIHL to pursue employment opportunities elsewhere, they would be responsible for locating an adequate replacement for such individual and for bearing any related cost. To the extent that either Fidelis MGU or FIHL is unable to locate an adequate replacement or is unable to do so within a reasonable period of time, the Groups business may be significantly and negatively affected.
54
The Groups historical track record, including the track record of some of the executives of Fidelis MGU, may not be indicative of our future growth.
The Group has experienced rapid growth since its inception, with GPW of $3.0 billion for the year ended December 31, 2022 and GPW increasing to $1.2 billion in the three months ended March 31, 2023 compared to $1.0 billion for the three months ended March 31, 2022, and the Group expects to continue to have access to more opportunities following completion of the Separation Transactions through its partnership with Fidelis MGU. There can be no assurance that the Groups business, or the ability of Fidelis MGU to source underwriting opportunities for the Group, will continue to grow and expand at the same rate since inception, if at all. Various executives that will be executives of Fidelis MGU, including Mr. Brindle, have had success throughout their careers. There is no assurance that the executives track records, including Mr. Brindles track records at Lloyds and Lancashire, will continue after the Separation Transactions. If the Group is unable to increase the amount of premium that is written successfully, or if Fidelis MGU cannot source sufficient opportunities for the Group, this may have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
Any disagreements between the Group and Fidelis MGU could lead to a deterioration of the commercial relationship between the parties, which could result in the Framework Agreement, the Inter-Group Services Agreement or the Delegated Underwriting Authority Agreements being terminated.
Any disagreements between the Group and Fidelis MGU in respect of the Framework Agreement, the Inter-Group Services Agreement, the Delegated Underwriting Authority Agreements, the Group Annual Plan or the Subsidiary Annual Plans could lead to a deterioration of the commercial relationship between the parties.
For example, the base case assumption with respect to the Subsidiary Annual Plans agreed between the Group and Fidelis MGU is that each Subsidiary Annual Plan will be renewed on the basis of premiums written in the prior year, subject to any changes to such Subsidiary Annual Plans agreed between the Group and Fidelis MGU, as permitted. The Group and Fidelis MGU will have the opportunity to agree to certain changes to the Subsidiary Annual Plans during the annual negotiation or through the Mid-Year Change Procedure (as defined herein). The Framework Agreement contains certain provisions aimed at resolving disputes in relation to any proposed changes to the Subsidiary Annual Plans that may arise between the parties. For example, in respect of the annual negotiation, should a particular change to the relevant Subsidiary Annual Plan be requested by a party and denied three years in a row, it will be referred to the non-calculation dispute resolution procedure to be resolved. Such non-calculation dispute resolution procedure may also be used if the parties are unable to agree on the specific parameters of the proposed changes, while being agreeable to such changes in principle. See Material Contracts and Related Party TransactionsFramework AgreementSubsidiary Annual Plans.
To the extent any suggested change to any of the Subsidiary Annual Plan is not agreed to or is strongly contested by either party, this could lead to a deterioration of the commercial relationship between the parties, which could ultimately result in FIHL choosing not to roll the term of the Framework Agreement leading to a termination. If the Framework Agreement is terminated, the Inter-Group Services Agreement or the Delegated Underwriting Authority Agreements which govern the Groups outsourcing arrangements may also terminate altogether or the Groups business model may change materially (if, for example, the Group is forced to find an alternative services provider to carry on its outsourcing strategy). Either of those outcomes could have a material adverse effect on the Groups financial condition and results of operations.
There can be no guarantee that the terms of the Separation Transactions, the Framework Agreement, the Delegated Underwriting Authority Agreements and the other outsourcing agreements and arrangements between the Group and Fidelis MGU are as favorable to the Group as if they had been negotiated with an unaffiliated third party.
There can be no guarantee that the terms of the Separation Transactions, the Framework Agreement and the other outsourcing agreements and arrangements between the Group and Fidelis MGU, including the fees payable to Fidelis MGU, are as favorable to the Group as if they had been negotiated with an unaffiliated third party. In addition, the Groups ongoing relationship with Fidelis MGU may impact how the Group enforces its rights under the agreements.
55
MGU HoldCo owns 9.9% of our Common Shares. Additionally, a number of FIHLs current shareholders are also shareholders in MGU TopCo and, in some cases, employees of Fidelis MGU. As such, conflicts of interest may arise, which could result in decisions being taken that are not in the best interest of the Groups shareholders as a whole.
Conflicts of interest may exist or could arise in the future with Fidelis MGU due to a number of FIHLs current shareholders being employed by Fidelis MGU or holding shares in MGU TopCo. Conflicts may arise with respect to, without limitation: (i) the enforcement of agreements between the Group and Fidelis MGU, (ii) making changes to the Group Annual Plan and each of the Subsidiary Annual Plans, (iii) the management of Fidelis MGU by persons who are shareholders of FIHL, (iv) shareholders who hold shares in both FIHL and MGU TopCo, and (v) conflicts arising from the exercise of the ROFO and ROFR rights (each as defined below, see Material Contracts and Related Party TransactionsFramework AgreementExclusivity, Rights of First Offer and Rights of First Refusal) of the Group and Fidelis MGU. MGU HoldCo owns 9.9% of FIHLs outstanding Common Shares. The foregoing conflicts and the interests of the Group on one hand and Fidelis MGU on the other could result in decisions being taken that are not in the best interest of the Groups shareholders as a whole.
The failure of Fidelis MGU to effectively manage the Groups claims could adversely affect the Groups business, prospects, financial condition or results of operations.
Under the terms of the Framework Agreement and the Delegated Underwriting Authority Agreements, the claims management activities will be managed by Fidelis MGU, with the Group retaining an oversight function. See BusinessClaims. The Group therefore relies on Fidelis MGU to facilitate, oversee and efficiently manage the claims process for the Groups policyholders in line with the parameters set forth in the Framework Agreement and the respective Delegated Underwriting Authority Agreements. To the extent Fidelis MGU exceeds its authority or otherwise fails to comply with the terms of the Framework Agreement and the Delegated Underwriting Authority Agreements and such non-compliance leads to inappropriate or negligent claims management, the Groups business, prospects, financial condition and results of operations may be materially adversely affected. Beyond intentional breaches there are also a number of other factors beyond Fidelis MGUs control that could affect the ability of Fidelis MGU to effectively manage claims of our policyholders.
Any failure by Fidelis MGU to effectively manage the claims process, including failure to pay claims accurately, could lead to material litigation, undermine the Groups reputation in the marketplace or impair the Groups corporate image and adversely affect our ability to renew existing policies or write new policies. Any of the aforementioned factors, or any other negative impact of Fidelis MGUs claims management process could have a material and adverse impact on the Groups business, prospects, financial condition and results of operations.
Risks Relating to the Operations Supporting the Groups Business
The Group depends, in certain cases, on its policyholders evaluations or disclosures of the exposures associated with their insurance underwriting, which may subject the Group to reinsurance disputes, liability, regulatory actions or reputational damage.
The Group does not separately evaluate each of the original individual exposures assumed under some of its reinsurance business (such as quota share contracts in which the Group expects to assume an agreed-upon percentage of each underlying insurance contract being reinsured or excess of loss contracts), including on policyholders bound by another person to whom underwriting authority has been delegated by the Group (such as third-party MGUs) on a non-prior submit basis. In these situations, the Group is largely dependent on the original underwriting decisions made by ceding companies. The Group is subject to the risk that its policyholders may not have adequately evaluated or disclosed the insured exposures and that the premiums ceded may not adequately compensate the Group for the exposures it will assume. The Group may not evaluate separately each of the individual claims that may be made on the underlying insurance contracts under reinsurance contracts. Therefore, the Group may be dependent on the original claims decisions made by its policyholders. To the extent that a
56
customer fails to evaluate adequately the insured exposures or the individual claims made thereunder, the Groups business, prospects, financial condition or results of operations could be significantly and negatively affected.
Certain elements of the Groups business may also be written on the basis of sub-delegated authority (in other words, Fidelis MGU may further delegate underwriting authority to a third-party managing general underwriters or other intermediary), as allowed for in the Framework Agreement and the Delegated Underwriting Authority Agreements. The Group will establish the parameters under which Fidelis MGU can sub-delegate authority and Fidelis MGU will operate and maintain procedures to manage its sub-delegated authority relationships, but nonetheless there are risks associated with such relationships, including but not limited to, fraud by employees or representatives of persons to whom Fidelis MGU sub-delegates authority, information technology failures, failure to comply with referral and escalation procedures, inaccurate or incomplete bordereau reporting, and credit risk. Furthermore, Fidelis MGU and in turn, the Group, relies on the underwriting judgment of such sub-delegated agents and intermediaries, which may be different from the decisions that would be made by the employees of Fidelis MGU acting within the parameters set forth in each Subsidiary Annual Plan or the Delegated Underwriting Authority Agreements.
Operational risk exposures, such as human or systems failures (including outsourcing arrangements), are inherent in the Groups business and may result in losses.
Operational exposures and losses can result from, among other things, errors, failure to document transactions properly or to obtain proper internal authorization, failure to comply with regulatory requirements, information technology failures, bad faith delayed claims payment, fraud and external events, such as political unrest, state emergency or industrial actions which could result in operational outage. The Group relies on Fidelis MGU and other third parties for information technology and application systems and infrastructure, which are exposed to certain limitations and risk of systemic failures. Any such outage could have a material adverse effect on the Groups business, prospects, financial condition or results of operations. In addition, given the Groups outsourced relationship with Fidelis MGU, which could also include writing business on a sub-delegated authority basis with a third-party managing general underwriter or other intermediary, Fidelis MGU or such other sub-delegate could bind the Group on business outside of a designated authority resulting in significant losses.
The Group also relies heavily on third parties, including Fidelis MGU, for information technology and application systems and infrastructure. The Group believes that such information technology and application systems and infrastructure are critical to the Groups business. Such information technology and application systems and infrastructure are an important part of the Groups underwriting process and its ability to compete successfully. The Group also licenses certain of its key systems and data from third parties, including Fidelis MGU, and cannot be certain that it will have continuous access to such third-party systems and data, or those of comparable service providers, or that the Groups information technology or application systems and infrastructure will operate as intended. The third-party modeling software that the Group uses is important to the Group and any substantial or repeated failures in the accuracy or reliability of such software or the human interpretation of its outputs could result in a deviation from the Groups expected underwriting results. Further, the third parties programs and systems may be subject to defects, failures, material updates or interruptions, including those caused by worms, viruses or power failures.
Failures in any of these systems could result in mistakes made in the confirmation or settlement of transactions, or in transactions not being properly booked, evaluated, priced or accounted for or delays in the payment of claims. Any such eventuality could cause the Group to suffer, among other things, financial loss, disruption of business, liability to third parties, regulatory intervention and reputational damage, any of which could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
57
Technology breaches or failures, including those resulting from a malicious cyber-attack on the Group or its business partners or service providers, could disrupt or otherwise negatively impact the business.
The Group relies on information technology systems and infrastructure to process, transmit, store and protect the electronic information, financial data and proprietary models that are critical to the Groups business. Furthermore, a significant portion of the communications between the Groups employees and the Groups business, banking and investment partners depends on information technology and electronic information exchange. Like all companies, the Groups information technology systems are vulnerable to data breaches, interruptions or failures due to events that may be beyond the control of the Group, including, but not limited to, natural disasters, theft, terrorist attacks, computer viruses, hackers and general technology failures. Despite safeguards, disruptions to and breaches of the Groups information technology systems have occurred in the past and may occur in the future, which may negatively impact (possibly to a material extent) the Groups business. See Risks Relating to Regulation of the GroupData protection failures could disrupt the Groups business, damage its reputation and cause losses.
The inability to attract, retain and manage key employees could restrict the Groups ability to implement its business strategy.
The Groups future success depends to a significant extent upon the Groups ability to continue to attract and retain key employees to implement the Groups long-term business strategy. Some new members of the Groups management team may not have worked together prior to their employment with the Group, and the management team may not operate together as efficiently as an otherwise similar management team that has been operating together for a significant amount of time. Within the Groups industry it is common for employers to seek to restrict an employees ability to work for a competitor or to engage in business activities with the customers or staff of a former employer after leaving employment. The extent of any such post-termination restrictions and the extent to which any alleged contractual restrictions are enforceable is highly fact-specific and dependent upon local laws in the applicable jurisdiction.
The Group may also suffer from future events that require governments to introduce similar measures to those imposed during the COVID-19 pandemic, such as social distancing measures, travel restrictions and border closures between the countries in which the Group operates. If such measures are reintroduced, the Groups key employees may be unable to travel freely, or participate in and carry out some of their usual responsibilities. In addition, we operate in a highly competitive labor market which experiences labor shortages and a high rate of employee turnover, which requires us to increase salary and wage rates, bonuses and other incentives in order to attract and retain talented employees. The Groups inability to hire, retain or fully utilize talented and experienced personnel, whether resulting from the foregoing reasons or otherwise, could delay or prevent the Group from fully implementing its business strategy and would significantly and negatively affect its business.
The Groups ability to implement its business strategy could be adversely affected by Bermuda employment restrictions.
Under Bermuda law, non-Bermudians (other than spouses of Bermudians and holders of Permanent Residents Certificates) may not engage in any gainful occupation in Bermuda without a valid government work permit. Except for our Chief Executive Officer and other chief officer positions (where the advertising requirement (see below) is automatically waived) or where otherwise specifically waived, a work permit may be granted or renewed upon showing that, after proper public advertisement, no Bermudian, spouse of a Bermudian, or holder of a Permanent Residents Certificate who meets the minimum standards reasonably required by the employer has applied for the job. A work permit is issued with an expiry date (up to five years) and no assurances can be given that any work permit will be issued or, if issued, renewed upon the expiration of the relevant term. If work permits are not obtained, or are not renewed, for the Group or Fidelis MGU principal employees who are located in Bermuda, the Group would lose its services, which could significantly and negatively affect its business and could also delay or prevent the Group from fully implementing its business
58
strategy. The Group monitors any actual or potential legislative changes regarding the Bermuda Governments immigration policies and any effects this may have on the Groups employment practice, policies and procedures.
The failure to retain a letter of credit facility and/or the need to provide assets directly as collateral may significantly and negatively affect the Groups ability to successfully implement its business strategy.
Certain of the Groups reinsurance customers may require the relevant Group company to post a letter of credit (LOC) and/or provide assets directly as collateral, while collateral may also be required from time to time for regulatory purposes. The Group currently maintains various LOC facilities, with Lloyds Bank plc, Barclays Bank plc, Bank of Montreal and Citibank N.A., London Branch.
An event of default under any of the LOC facilities (including as a result of events that are beyond the Groups control) may require the Group to liquidate assets held in these facilities, have an adverse effect on the Groups liquidity position as the facility providers have a security interest in the collateral posted, or require the Group to take other material actions. Any such forced sale of these investment assets could negatively affect the return on the Groups investment portfolio, which could negatively affect the types and amount of business the Group chooses to underwrite. A default under any of the LOC facilities may cause the facility providers to exercise control over the collateral posted, negatively affecting the Groups ability to earn investment income or to pay claims or other operating expenses. Additionally, a default under any of these facilities may have a negative impact on the Groups relationships with regulators, rating agencies and banking counterparties.
In addition, if the amount of assets the Group has to post as collateral to support cedant demand or regulatory requirements increases beyond a threshold, the Group may be left with insufficient liquid, available assets to support the Group Annual Plan and each of the Subsidiary Annual Plans and/or day-to-day operations. Such risk is increased in relation to FIBL and FUL which, in the event of losing their certified U.S. reinsurer status pursuant to certain excess and surplus licenses, would be required to post a much higher amount of collateral to carry on their business. This consequently could impact the Groups business, prospects, financial condition or results of operations. Further, the inability to renew or maintain the LOC facilities may significantly limit the amount of reinsurance the Group can write, or require the Group to modify its investment strategy. The Group may need additional LOC capacity as it grows, and if the Group is unable to renew, maintain or increase its LOC facilities or is unable to do so on commercially acceptable terms, such a development could significantly and negatively affect the Groups ability to implement its business strategy. In particular, the Group anticipates arranging for additional LOC capacity for its subsidiaries in connection with obligations to post collateral in connection with certain reinsurance transactions. Furthermore, the Group expects to seek renewals of its existing LOC facilities. If the Group is unable to obtain and retain LOC facilities on commercially acceptable terms, this could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
Risks Relating to the Groups Reliance on Third Parties in the Operation of its Business
The Group is reliant on third-party service providers and their IT systems, and their failure could lead to an interruption in the Groups business activities, which could have a material adverse effect on the Groups business.
The Group is reliant on third parties, such as Fidelis MGU, for the provision of important services it needs to run its business, including, without limitation, finance, actuarial and underwriting systems and processes and IT infrastructure and systems including software. Any of these service providers failing to perform at the necessary level may have a significant and adverse impact on the business of the Group and its IT systems.
The Group requires complex and extensive IT systems, which are being updated continuously, to run its business. During any projects to develop the Groups IT systems, it is particularly susceptible to outages or weakness related to such systems. Any failure of these systems or by the Groups service providers could lead to an interruption in the Groups business activities which, in turn, could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
59
The expanding volume and sophistication of computer viruses, hackers and other external hazards such as the use of malware or other malicious code or attack, catastrophic events system failures and disruptions, as well as employee or third-party errors or malfeasance, may also increase the vulnerability of the Groups IT and data systems to security breaches. The Group has previously suffered cyber-attacks on its IT infrastructure and the Group believes it has taken the necessary steps to mitigate any future attacks. The Group has also increased the amount of internal training and is employing stringent IT infrastructure reviews. However, there can be no assurance that these steps will in fact prevent future attacks. These increased risks expose the Group to potential data loss and damages and potentially significant increases in compliance and litigation costs, and such exposure could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
The Group depends on brokers and other intermediaries to distribute its products, and the loss of business provided by brokers and other intermediaries could adversely affect it.
The distribution model for the Groups products is built on long-term relationships with quality clients and respect for the core broker distribution model which is fully outsourced to Fidelis MGU. The Group is therefore indirectly dependent upon brokers and other intermediaries to distribute its products. Brokers and certain other intermediaries are independent and therefore no broker or such other intermediary is committed to recommend or sell the products of the Group. Accordingly, Fidelis MGUs relationships with brokers and other intermediaries distributing its products will be important. A broker assesses which insurance companies are suitable for it and its customers by considering, among other things, the security of claims payment and service, and prospects for future investment returns in the light of a companys product offering, personnel, past investment performance, financial strength and perceived stability, ratings and the quality of the service provided to the broker and its customer. Larger insurers and reinsurers may have more commercial influence with certain insurance and reinsurance brokers, either generally or in certain underwriting lines. A broker then determines which products are most suitable by considering, among other things, product features and price. An unsatisfactory assessment of the Group and its products based on any of these factors could result in the Group generally, or in particular certain of its products, not being actively marketed by brokers to their customers. Failure to maintain a positive relationship with its brokers and competitive distribution network could result in a loss of market share or a reduction of the Groups premium volumes or an increase in policy lapses and withdrawals, which could result in reduced fee and premium income, and, in turn, have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
The involvement of insurance and reinsurance brokers and other intermediaries subjects the Group to their credit risk.
Pursuant to its outsourced relationship with Fidelis MGU, the Group will generally pay all of the amounts owed on claims under its insurance and reinsurance contracts first to Fidelis MGU, who will then pass on the payment to the various brokers or other intermediaries, and these brokers or other intermediaries (as applicable) will, in turn, pay these amounts over to the clients that have purchased insurance or reinsurance from the Group. If Fidelis MGU, a broker or other intermediary fails to make its relevant payment, it is possible that the Group will be liable to the client for the deficiency because of local laws or contractual obligations. Likewise, in certain jurisdictions, when the insured or ceding insurer pays premiums for these policies to brokers or other intermediaries for payment over to the Group, these premiums might be considered to have been paid and the insured or ceding insurer will no longer be liable to the Group for those amounts, whether or not the Group actually receives the premiums up the chain from Fidelis MGU, a broker or other intermediary. Consequently, both the Group and Fidelis MGU assume a high degree of credit risk associated with brokers and other intermediaries, including in relation to any sub-delegation, around the world with respect to most of its insurance and reinsurance business, its inwards premium receivable from insureds and cedants, and on any amounts recoverable in relation to subrogation and salvage and from reinsurers.
Furthermore, the concentration of the Groups business in a small number of key brokers may subject it to reduced premium income. During the year ended December 31, 2022, GPW generated from or placed by Aon plc, Marsh & McLennan Companies and Guy Carpenter & Company LLC (which is also an affiliate of Marsh &
60
McLennan Companies) collectively accounted for 35% of the Groups consolidated GPW, with Aon plc accounting for 15% and Marsh & McLennan Companies, Inc. (and certain of its affiliates) accounting for 20% of our consolidated GPW during 2022. Other key brokers, each of whom has accounted for less than 10% of the GPW generated during the years ended December 31, 2018 to December 31, 2022, include, among others, Willis Towers Watson and TigerRisk Partners, LLC. For more information, see note 13(c) (Commitments and ContingenciesConcentration of credit risk) to the Groups unaudited consolidated financial statements included elsewhere in this prospectus and note 17(d) (Commitments and ContingenciesConcentration of credit risk) to the Groups audited consolidated financial statements included elsewhere in this prospectus. Loss of all or a substantial portion of the business provided by one or more of the Groups key (re)insurance brokers could result in reduced premium income, which, in turn, could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
Risks Relating to Financial Markets and Liquidity
The Groups business, prospects, financial condition or results of operations may be adversely affected by reductions in the aggregate value of the Groups investment portfolio.
The Groups operating results depend in part on the performance of the Groups investment portfolio. The Groups funds are invested by professional investment management firms in accordance with the Groups investment guidelines. The Groups investments are subject to a variety of financial and capital market risks including, but not limited to, changes in interest rates, credit spreads, equity and commodity prices, foreign currency exchange rates, increasing market volatility and risks inherent to particular securities. Prolonged and severe disruptions in the public debt and equity markets, including, among other things, volatility of interest rates, widening of credit spreads, bankruptcies, defaults, significant ratings downgrades, geopolitical instability, and a decline in equity or commodity markets, may cause significant losses in the Groups investment portfolio. Market volatility can make it difficult to value certain securities if their trading becomes infrequent. Depending on market conditions, the Group could incur substantial additional realized and unrealized investment losses in future periods. This could have a material effect on certain of the Groups investments. The investment guidelines currently implemented by the Group focus on investment primarily in fixed maturity and cash products and allow a small portion of the Groups portfolio to be allocated to alternative or other investments. Depending on current and future events and market conditions and their impact on the Groups investments, the investment guidelines are subject to change.
For instance, the Groups investment portfolio (and, specifically, the valuations of investment assets it holds) has been, and may continue to be, adversely affected as a result of market valuations impacted by the COVID-19 pandemic and any other public health crisis, the Ukraine Conflict and other global economic and geopolitical uncertainty regarding their outcomes. These include changes in interest rates, declining credit quality of particular investments, reduced liquidity, fluctuating commodity prices, international sanctions, and related financial market impacts from the sudden, continued slowdown in global economic conditions generally. Further, extreme market volatility, such as the markets are experiencing now as a result of the ongoing Ukraine Conflict, may leave the Group unable to react to market events in a prudent manner consistent with the Groups historical practices in dealing with more orderly markets.
Separately, the occurrence of large claims may force the Group to liquidate securities at an inopportune time, which may cause the Group to realize capital losses. Large investment losses could decrease the Groups asset base and thereby affect the Groups ability to underwrite new business. Additionally, such losses could have a material adverse impact on the Groups shareholders equity, business and financial strength and debt ratings.
The aggregate performance of the Groups investment portfolio also depends to a significant extent on the ability of the Groups investment managers to select and manage appropriate investments. As a result, the Group is also exposed to operational risks which may include, but are not limited to, a failure of the Groups investment managers to perform their services in a manner consistent with the Groups investment guidelines, technological and staffing deficiencies, inadequate disaster recovery plans, interruptions to business operations due to impaired
61
performance or failure or inaccessibility of information or IT systems. The result of any of these operational risks could adversely affect the Groups investment portfolio, financial performance and ability to conduct the Groups business.
The Groups results of operations and investment portfolio may be materially affected by conditions impacting the level of interest rates in the global capital markets and major economies, such as central bank policies on interest rates and the rate of inflation.
As a global insurance and reinsurance company, the Group is affected by the monetary policies of the U.S. Federal Reserve Board, The Bank of England, the European Central Bank and other central banks around the world. Following the financial crisis of 2007 and 2008, and again most recently as a result of the COVID-19 pandemic, these central banks have taken a number of actions to spur economic activity such as keeping interest rates low and enacting quantitative easing. Unconventional monetary policy from the major central banks, the reversal of such policies, a shift to monetary tightening policies and moderate global economic growth remain key uncertainties for markets and the Groups business.
For example, in one of the Groups key markets for its products, the U.S. debt ceiling and budget deficit concerns continue to present the possibility of credit-rating actions, economic slowdowns, or a recession for the U.S. The impact of any negative action regarding the U.S. governments sovereign credit rating could adversely affect the U.S. and global financial markets and economic conditions. In addition, policies that may be pursued by the Biden administration and the legislation that may be introduced by the U.S. Congress and Senate, could result in market volatility in the short term. These developments could cause more volatility in interest rates and borrowing costs, which may negatively impact the Groups ability to access the debt markets on favorable terms. Continued adverse economic conditions could have a material adverse effect on the Groups business, financial condition and results of operations. These and any future developments and reactions of the credit markets toward these developments could cause interest rates and borrowing costs to rise, which may negatively impact the Groups ability to obtain debt financing on favorable terms.
Although the Federal Reserve previously cut interest rates in 2019 and 2020 to stimulate the U.S. economy and address the COVID-19 pandemic, and interest rates remained relatively low throughout 2020 and most of 2021, the Federal Reserve may change its monetary policy at any time. The U.S. economy commenced showings signs of potential recovery due to the fiscal package and government stimulus plans introduced by the Biden administration as well as the Federal Reserves continued engagement in quantitative easing. The Federal Reserve has been steadily increasing the target interest rates throughout 2022 in an effort to help curb inflation, a trend that has continued into 2023 with a further increase to 5.00%-5.25% in May 2023. If the Federal Reserve further raises target interest rates, or if interest rates otherwise rise, the Group may be exposed to unrealized losses on its fixed maturity securities. Similarly, The Bank of Englands Monetary Policy Committee has steadily been increasing rates throughout 2022 and into 2023 with the most recent interest rate increase of 25 basis points to 4.5% on May 11, 2023. Several other central banks, such as the European Central Bank, increased interest rates on main refinancing operations, the marginal lending facility and the deposit facility, each by 25 basis points, on May 10, 2023 and signalled their intention to continue to do so citing, among other factors, underlying price pressures and the high inflationary environment. Interest rates are influenced by matters other than the Federal Reserves monetary policy, for example volatility in the financial markets resulting from escalation of global military conflicts and higher unemployment in the U.S., the U.K. and other key markets for the Group, mean that it may be impossible to reasonably predict the course of action the Federal Reserve may take in relation to changing the federal funds rate, and interest rates may increase even if monetary policy does not change. Changes in Federal Reserve policy may also impact the overall liquidity and efficiency of fixed maturity markets. The Federal Reserve has also started to unwind the quantitative easing measures enacted to combat the effects of the COVID-19 pandemic including a reduction in the amount of assets it holds on its balance sheet. As this quantitative easing is withdrawn, financial markets may react negatively and fixed maturity market liquidity may decline, leading to heightened volatility in fixed maturity investment prices and difficulty in transacting at indicated market values.
The Groups exposure to interest rate risk relates primarily to the changes in market price and cash flow variability of fixed maturity instruments that are associated with changes in interest rates. The Groups
62
investment portfolio contains interest rate sensitive instruments, such as fixed maturity securities which have been, and will likely continue to be, affected by changes in interest rates from central bank monetary policies, domestic and international economic and political conditions, levels of inflation and other factors beyond the Groups control. The Groups fixed maturity portfolio also includes asset classes such as asset-backed securities and investment grade emerging market debt, which are riskier in nature than some of the Groups other fixed maturity instruments and could adversely impact the Groups investment portfolio. Interest rates are highly sensitive to many factors, including governmental monetary policies, inflation, domestic and international economic and political conditions and other factors beyond the Groups control and fluctuations could materially and adversely affect the Groups business, financial condition and results of operations.
Steps that may be taken by central banks to raise interest rates in the future to combat higher inflation than the Group had anticipated could, in turn, lead to unrealized losses on the Groups investments. Changes in the level of inflation could also result in an increased level of uncertainty in the estimation of loss reserves for the Groups lines of business with a long tenor. Such changes in inflation will have the largest impact on the Groups fixed maturity portfolio, which currently has a duration of around two years. As a result of the above factors, the Groups business, financial condition, liquidity or operating results could be adversely affected.
Unexpected volatility or illiquidity associated with some of the Groups investments could significantly and negatively affect the Groups financial results, liquidity or ability to conduct business.
A small portion of the Groups investment portfolio comprises (and may in the future continue to contain) certain investments such as structured notes linked to equities and commodities, publicly traded equities, high- yield bonds, bank loans, emerging market debt, non-agency residential mortgage-backed securities, asset-backed securities, commercial mortgage-backed securities, real estate funds, middle market loans, private credit funds, private equity funds, infrastructure funds and short-term secured products. During the height of the financial crisis of 2007 and 2008, both fixed maturity and equity markets lost significant liquidity and were more volatile than expected. The markets initially responded in a way similar to the COVID-19 pandemic, which resulted in severe falls in indices, extreme volatility and interventions to halt trading. Similar risks are present as markets respond to the ongoing Ukraine Conflict and imposition of sanctions on Russia. If the Group requires significant amounts of cash on short notice in excess of normal cash requirements, the Group may have difficulty selling investments in a timely manner or be forced to sell them for less than the Group otherwise would have been able to realize. If the Group is forced to sell the Groups assets in unfavorable market conditions, there can be no assurance that the Group will be able to sell them for the prices at which the Group has recorded them and the Group may be forced to sell them at significantly lower prices. As a result of the above factors, the Groups business, financial condition, liquidity or operating results could be adversely affected.
The determination of the amount of allowances and impairments taken on the Groups investments is highly subjective and could materially impact the Groups operating results or financial position.
The Group performs reviews of its investments on a regular basis to determine the amount of the decline in fair value below the cost basis which is considered to be the current expected credit losses in accordance with applicable accounting guidance. The process of determining the current expected credit loss (CECL) requires judgment and involves analyzing many factors. Assessing the accuracy of the level of allowances reflected in the Groups financial statements is inherently uncertain, given the subjective nature of the process. Furthermore, additional impairments may need to be taken or allowances provided in the future with respect to events that may impact specific investments. The absence of CECL allowances does not necessarily mean there will not be any in the future. Future material impairments themselves or any error in accurately accounting for them may have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
63
An economic downturn in the U.S. or elsewhere, the default of a large institution, an actual or predicted sovereign default, or a downgrade of U.S. or non-U.S. government securities by credit rating agencies could harm the Groups business, investment portfolio and its liquidity and financial condition.
Weak economic conditions may adversely affect (among other aspects of the Groups business) the demand for, and claims made under, the Groups products; the ability of customers, counterparties and others to establish or maintain their relationships with the Group; the Groups ability to access and efficiently use internal and external capital resources; and the Groups investment performance. Volatility in the U.S. and other financial markets, as a result of the ongoing Ukraine Conflict on global economic conditions or otherwise, may adversely affect both the liquidity and the performance of the Groups investments.
Furthermore, a default by one of several large institutions that are dependent on one another to meet their liquidity or operational needs or are perceived by the market to have similar financial weaknesses, so that a default by one institution causes a series of defaults by or runs on other institutions (sometimes referred to as a systemic risk) or a downgrade of U.S. or non-U.S. government securities by credit rating agencies, may expose the Group to investment losses which could have a material adverse effect on the Groups business, prospects, financial condition or results of operations. For example, in March 2023, Silicon Valley Bank (SVB) and Signature Bank were each unable to continue their operations and the Federal Deposit Insurance Corporation (the FDIC) was appointed as receiver for SVB and Signature Bank. Similarly, in May 2023, the FDIC took control of First Republic Bank (First Republic) and JPMorgan Chase & Co. acquired a substantial amount of assets and liabilities of First Republic. Additionally, in late March 2023, Swiss authorities facilitated a merger between UBS Group AG and Credit Suisse Group AG. Although we do not have any funds deposited with these institutions, such incidents expose potential strains on the banking sector as a whole and demonstrate a heightened risk of systemic failures throughout the financial industry. An actual or predicted sovereign default may also have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
Currency fluctuations could result in exchange losses and negatively impact the Groups business.
The Groups functional currency is the U.S. dollar. However, because the Groups business strategy includes insuring and reinsuring financial obligations created or incurred outside of the U.S., the Group writes a portion of its business and receives premiums in currencies other than the U.S. dollar. Consequently, the Group may experience exchange losses to the extent the Groups foreign currency exposure is not hedged or is not sufficiently hedged, which could significantly and negatively affect the Groups business. The Group operates in a number of countries and therefore the results of its operations are subject to both currency transaction and translation risk. Currency transaction risk arises from the mismatch of cash flows due to currency exchange fluctuations. Translation risk arises because the Group reports in U.S. dollars but a portion of its underlying premiums, reserves, operating expenses and acquisitions are determined in other currencies. The Group makes determinations as to whether and to what extent to hedge its foreign currency exposures on a monthly basis.
The Groups investment portfolio exposures may be materially adversely affected by global climate change regulation and other factors, which could harm the Groups business and its liquidity and financial condition.
World leaders met at the 2015 United Nations Climate Change Conference in December 2015 in Paris and agreed to limit global greenhouse gas emissions in the atmosphere to a level which would not increase the average global temperature by more than 2° Celsius, with an aspiration of limiting such increase to 1.5° Celsius (the Paris Agreement). In order for governments to achieve their existing and future international commitments to limit the concentration of greenhouse gases under the Paris Agreement, there is widespread consensus in the scientific community that a significant percentage of existing proven fossil fuel reserves must not be consumed. In addition, divestment campaigns, which call on asset owners to divest from direct ownership of commingled funds that include fossil fuel equities and bonds, likewise signal a change in societys attitude towards the social and environmental externalities of doing business.
In addition, the 2021 UN Climate Change Conference (COP26) was held in Glasgow and sought to accelerate action towards the goals of the Paris Agreement. The COP26 agreement, although not legally binding,
64
includes pledges to further cut CO2 emissions, reduce the use of coal, and significantly increase the amount of money necessary to help poor countries cope with the effects of climate change. The 2022 UN Climate Change Conference (COP27) was held in Sharm el-Sheikh, Egypt in November 2022. Building on the outcomes and momentum of COP26, nations were expected to demonstrate at COP27 that they are in a new era of implementation by turning their commitments under the Paris Agreement into action.
As a result of the above, energy companies and other companies engaged in the production or storage of fossil fuels may experience unexpected or premature devaluations or write-offs of their fossil fuel reserves. A material change in the asset value of fossil fuels or the securities of energy companies and companies in these related sectors may therefore materially adversely affect the Groups investment portfolio. A material change in the asset value of fossil fuels or the securities of energy companies and companies in related sectors will impact the Fidelis investment portfolio in the event that any change in asset values leads to a shock to the wider economy and overall asset values.
Failure to meet ESG expectations or standards, or achieve ESG goals or commitments could adversely affect the Groups business, prospects, financial condition or results of operations.
In recent years, there has been an increased focus from shareholders, business partners, cedants, regulators, politicians, and the public in general on ESG matters, including greenhouse gas emissions, carbon footprint and climate-related risks, renewable energy, fossil fuels, diversity, equity and inclusion, responsible sourcing and supply chain, human rights, and social responsibility.
The Group has established goals, commitments, and targets, as further discussed in BusinessOur Commitment to Environmental, Social and Governance Matters. Such goals, commitments, and targets reflect the Groups current plans and aspirations and do not guarantee that the Group will be able to achieve them. Evolving shareholder and cedant expectations, regulatory obligations or political pressures and the Groups efforts to manage, report on and accomplish set goals present numerous operational, regulatory, reputational, financial, legal, and other risks, any of which could have a material adverse impact on the Groups reputation, business, prospects, financial condition or results of operations.
The Group may be unable to satisfactorily meet evolving expectations, standards, regulations and disclosure requirements related to ESG. Such matters can affect the willingness or ability of investors to make an investment in FIHL, as well as the Groups ability to meet its regulatory obligations, including compliance with any rules related to carbon footprint and greenhouse gas emissions. Negative perceptions regarding the scope or sufficiency and transparency of the Groups commitment to and reporting on ESG matters and events that give rise to actual, potential, or perceived compliance with social responsibility matters could hurt the Groups reputation and cause cedants to seek alternative business partners. Such loss of reputation could make it difficult and costly for the Group to regain the confidence of its business partners resulting in an adverse effect on the Groups business, prospects, financial condition or results of operations. Further, the Groups failure or perceived failure to satisfy various reporting standards and regulations on a timely basis, or at all, could have similar negative impacts or expose it to government enforcement actions and private litigation.
The management of the Groups investment portfolio as a result of the Groups sustainability principles and ESG objectives could have an adverse impact on the Groups investment portfolio, business, financial condition, liquidity or operating results.
The Groups investment portfolio is designed to be managed consistent with the sustainability principles and ESG objectives adopted by the Group, as further discussed in BusinessOur Commitment to Environmental, Social and Governance Matters. As a result, the Group may forgo certain investment opportunities available to it in order to comply with such investment portfolio management criteria. This may cause the performance of the Groups investment portfolio to differ from what it may otherwise be able to achieve if it was not managed consistent with these sustainability principles and ESG objectives.
65
In addition, there is a risk that the investment opportunities identified by the Groups asset managers as being consistent with the Groups investment criteria do not operate as expected when addressing social and environmental impact and ESG issues. A companys social and environmental impact and ESG performance or the Groups asset managers assessment of a companys social and environmental impact and ESG performance could vary over time, which could cause the Group to be temporarily invested in companies that do not comply with the Groups investment criteria. Furthermore, data availability and reporting with respect to the Groups investment criteria may not always be available or may become unreliable. If the Groups investment decisions do not perform as expected or if the Groups asset managers fail to make investment decisions in a manner consistent with the stated sustainability principles and ESG objectives, the Groups investment portfolio, business, financial condition, liquidity or operating results could be adversely affected.
Risks Relating to Regulation of the Group
If the Group becomes directly subject to insurance statutes and regulations in jurisdictions other than Bermuda, the E.U. or the U.K. or there is a change to the law or regulations or application of the law or regulations of Bermuda, the E.U. or the U.K., this could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
FIBL is a registered Bermuda Class 4 insurer pursuant to the Insurance Act 1978 of Bermuda, as amended (the Bermuda Insurance Act), and as such, it is subject to regulation and supervision in Bermuda by the BMA. FIID operates from the Republic of Ireland and is authorized and regulated by the CBI to carry on certain classes of non-life insurance business. On the basis of its CBI authorization, FIID is able to offer its insurance services into certain European Economic Area (EEA, which is a free trade area including the 27 member states of the E.U. together with Iceland, Liechtenstein, and Norway) jurisdictions on a cross-border basis without the need for separate authorizations in such jurisdictions. FUL operates from the U.K. and is authorized by the PRA and regulated by the PRA and the FCA with permission to underwrite certain classes of general insurance. As FIHL is subject to Group Supervision in Bermuda, it is subject to regulation and supervision by the BMA.
The Group faces new regulatory costs and challenges as a result of the U.K.s departure from the E.U. (Brexit). The U.K. and E.U. insurance prudential regimes are currently broadly identical as both derived from the Solvency II Directive. However, it is likely that the laws and regulations of the U.K. and the E.U. will diverge in the near future, and the Group may be required to utilize additional resources to ensure compliance with the different rules in each regime. In particular, the U.K. has announced that it intends to amend certain Solvency II-derived rules that it has transposed into domestic legislation and the E.U. is currently conducting its own review of the Solvency II Directive.
The U.K. has consulted with industry stakeholders on various Solvency II-derived rules since October 2020. On November 17, 2022, HM Treasury published a finalized package of proposed reforms to its prudential regime, which covers a range of areas including the risk margin, matching adjustment requirements and regulatory reporting obligations. These reforms will be reflected in new U.K. legislation and regulation during the course of 2023 and 2024. Similarly, on September 22, 2021, the European Commission published a package of proposed legislative reforms for amending the existing regulatory framework. The European Council published its agreed position on the European Commissions proposed reforms in June 2022, which it will negotiate with the European Parliament and European Commission. The full extent of the E.U.s changes to Solvency II will only be known once the full package of legislative reforms is finalized.
More generally, the cost of doing business in the U.K., and from the U.K. into other jurisdictions, will likely increase as a result of Brexit, and may include additional capital requirements, including as a result of new or additional laws and regulations across a wide variety of areas potentially including, but not limited to, employment laws, data privacy laws, taxation laws and the terms of commercial activities between the U.K. and the E.U. In addition, due to the potential for less inter-country cooperation between the U.K. and the E.U., both jurisdictions may be facing a less liberal trading regime in the future which could take the form of tariffs or other protectionist measures. It is also unclear how effectively supervisory bodies and regulators from these jurisdictions will continue to cooperate and share information.
66
Bermuda, E.U. and U.K. insurance statutes and the regulations and policies of the BMA, the CBI, the PRA and the FCA may require FIBL, FIID and FUL to, among other things:
| maintain a minimum level of capital, surplus and liquidity; |
| satisfy solvency standards; |
| obtain prior approval of ownership and transfer of shares; |
| maintain a principal office and appoint and maintain a principal representative in Bermuda (for FIBL), the |
| Republic of Ireland (for FIID) and the U.K. (for FUL), respectively; |
| maintain a head office; and |
| comply with legal and regulatory restrictions with respect to their ability to pay dividends and make capital distributions upon which the Group is reliant to provide cash flow required for debt service and dividends to FIHLs shareholders. |
These statutes, regulations and policies may affect the Groups ability to write insurance and reinsurance policies, to distribute funds around the Group and to shareholders, and to pursue its investment strategy.
The Group does not presently intend that it will create a physical presence in any jurisdiction in the U.S. The Group is not licensed to write insurance on an admitted basis in any state in the U.S. but, as an alien insurer and certified reinsurer, FIBL and FUL are eligible to write surplus lines business. However, there can be no assurance that insurance regulators in the U.S. or elsewhere will not review the activities of the Group or related companies or its agents and assert that the Group is subject to such jurisdictions licensing requirements. If any such assertion is successful and the Group is required to obtain a license, it may be subject to taxation in such jurisdiction. In addition, the Group is subject to indirect regulatory requirements imposed by jurisdictions that may limit its ability to provide insurance or reinsurance. For example, the Groups ability to write insurance may be subject, in certain cases, to arrangements satisfactory to applicable regulatory bodies. Proposed legislation and regulations may have the effect of imposing additional requirements upon, or restricting the market for, alien insurers or reinsurers with whom U.S. companies place business.
Bermuda, E.U. and U.K. insurance statutes and regulations applicable to the Group may be different in scope from those that would be applicable if FIBL, FUL and/or FIID were licensed in and governed by the laws of any state in the U.S. In the past, there have been U.S. Congressional and other initiatives in the U.S. regarding proposals to supervise and regulate insurers domiciled outside the U.S. If in the future the Group becomes increasingly subject to any insurance laws of the U.S. or any state thereof or of any other jurisdiction, the Group cannot be certain that it would be in compliance with those laws or that coming into compliance with those laws would not have a significant and negative effect on its business. The process of obtaining licenses in the U.S. and elsewhere is time-consuming and costly, and FIBL, FUL or FIID may not be able to become licensed in a jurisdiction other than Bermuda, the Republic of Ireland or the U.K. should they choose to do so. The modification of the conduct of the Groups business resulting from FIBL, FUL or FIID becoming licensed in certain jurisdictions could significantly and negatively affect its business. In addition, the Groups inability to comply with insurance and reinsurance statutes and regulations could significantly and adversely affect its business by limiting its ability to conduct business as well as subjecting the Group to penalties and fines and having adverse reputational consequences for the Group.
The increased level of regulatory scrutiny in respect of material outsourcing arrangements in Bermuda, the E.U. and the U.K. could have a material adverse effect on the operating costs of the Groups business and could increase the risk of disruption to the Groups operations due to regulatory intervention.
The Framework Agreement, the Delegated Underwriting Authority Agreements and the Inter-Group Services Agreement will be regarded as material outsourcing agreements or outsourcing of critical or
67
important operational functions or activities under the laws and regulation in each of the United Kingdom and the European Union. See Certain Regulatory Considerations for further information on material outsourcing agreements and outsourcing of critical or important operational functions or activities. Accordingly, the Group may incur additional operating costs in establishing the systems and controls required to appropriately oversee and monitor the effective performance of these agreements by Fidelis MGU.
For example, on February 6, 2020, EIOPA issued guidelines on outsourcing to cloud service providers which applied from January 1, 2021 to all cloud outsourcing arrangements entered into or amended on or after that date. Existing cloud outsourcing arrangements relating to critical or important operational functions or activities have also been reviewed and amended to ensure compliance with the guidelines by December 31, 2022. These guidelines could potentially apply to use of the Groups information technology or application systems and infrastructure by Group companies in the EEA. This and any future regulatory developments in relation to cloud outsourcing may result in additional operating costs.
In addition, pursuant to the Insurance Act, FIBL shall not take any steps to effect a material change, including (i) outsourcing all or substantially all of its actuarial, risk management, compliance or internal audit functions, (ii) outsourcing all or a material part of its underwriting activity, and (iii) outsourcing of an officer role, unless it has first served notice on the BMA that it intends to effect such a material change and before the end of 30 days, either the BMA has notified FIBL in writing that it has no objection to such change or that the period has elapsed without the BMA having issued a notice of objection. There is a risk that the BMA may not grant its no-objection to certain new or material changes to the existing outsourcing arrangements that FIBL may propose in the future, including in relation to Framework Agreement, the Delegated Underwriting Authority Agreements or the Inter-Group Services Agreement.
Further, there has been an increased level of regulatory scrutiny of material outsourcing agreements in each jurisdiction generally, which could result in a greater risk of regulatory intervention in respect of these agreements. Such regulatory intervention may include the regulators use of their investigative powers (such as requiring reports to be prepared by senior individuals), the exercise of audit rights against any Group company or Fidelis MGU or requests for documents and information relating to the performance of the agreements.
These regulatory interventions could be disruptive for the Groups business operations, and may result in the Group being required to make further changes to its systems and controls, such as increased reporting to company boards, improving data storage facilities and implementing additional oversight of Fidelis MGU. It is possible that, as a corollary, the Group will incur increased operational costs. The Group could also experience an adverse effect on its business if the regulatory interventions impede the effective operation of the Framework Agreement, the Delegated Underwriting Authority Agreements and the Inter-Group Services Agreement.
Changes to the regulatory systems or loss of authorizations, permits or licenses under which the Group operates or breach of regulatory requirements by the Group could have a material adverse effect on its business.
FIHL and FIBL (both incorporated in Bermuda), FUL (incorporated in England and Wales) and FIID (incorporated in the Republic of Ireland) may be subject to changes of law or regulation in these jurisdictions which may have an adverse impact on their operations, including the imposition of tax liabilities or increased regulatory supervision. The Group is also exposed to changes in accounting standards, some of which may be significant. In addition, FIHL, FIBL, FUL and FIID will be exposed to changes in the political environment in Bermuda, the E.U., the Republic of Ireland and the U.K. The Bermuda insurance and reinsurance regulatory framework has recently become subject to increased scrutiny in many jurisdictions, including in Europe and the U.S. and in various states within the U.S.
The Groups ability to conduct insurance and reinsurance business in different countries generally requires the holding and maintenance of certain licenses, permissions or authorizations, and compliance with rules and
68
regulations promulgated from time to time in these jurisdictions. A principal exception to this is with respect to cross border reinsurance in the U.S. and other countries.
The Group is not licensed to write insurance on an admitted basis in any state in the U.S. but, as an alien insurer and certified reinsurer, FIBL and FUL are eligible to write surplus lines business in all 50 U.S. states, the District of Columbia and other U.S. jurisdictions based on its listing in the Quarterly Listing of Alien Insurers of the International Insurers Department (IID) of the National Association of Insurance Commissioners (NAIC). Pursuant to IID requirements, the Group established a U.S. surplus lines trust fund with a U.S. bank to secure U.S. surplus lines policies. The Group accepts business only through U.S. licensed surplus lines brokers and does not market directly to the public. Failure to maintain its IID listing could have a material adverse effect on the Groups ability to write surplus and excess lines of business in the U.S. For reinsurance there are currently no U.S. licenses required, although the Group operates outside the U.S. and is, in common with other non-U.S. reinsurers, required from time to time to post letters of credit or establish other security in order to enable U.S. cedants to take financial statement credit for liabilities ceded to members of the Group. See Certain Regulatory ConsiderationsUnited States Insurance RegulationFIBLs and FULs U.S. Operations for a more detailed discussion of the regulatory environment in which FIBL and FUL write surplus business lines in the U.S.
A failure to comply with rules and regulations in a jurisdiction could lead to disciplinary action, the imposition of fines or the revocation of the license, permission or authorization necessary to conduct the Groups business in that jurisdiction, which could have a material adverse effect on the continued conduct of business and also adverse reputational consequences for the Group.
It is possible that insurance regulators in the U.S. or elsewhere may review the activities of FIHL, FIBL, FUL and FIID and assert that they are subject to such jurisdictions licensing requirements and require that FIHL, FIBL, FUL and/or FIID comply with additional regulatory obligations. Having to meet such requirements, however, could have a material adverse effect on the results of operations of the Group, FIBL, FUL and/or FIID. Alternatively, or in addition, any necessary changes to operations could subject FIHL, FIBL, FUL and/or FIID to taxation in the U.S. or elsewhere.
In recent years, regulation of the insurance and reinsurance industry in the U.S., the U.K., Bermuda, the E.U. and other markets in which the Group operates has been subject to significant review. These reviews have led to changes in certain legal and regulatory provisions which govern the operations of the Group, and it can be expected that further reviews and changes to applicable laws and regulations will occur in the future. The Group cannot predict the effect that any proposed or future law or regulation may have on the financial condition or results of operations of the Group. Changes in applicable laws or regulations or in their interpretation or enforcement could have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
In particular, changes in regulatory capital requirements in the U.S., the U.K., the E.U. or Bermuda may impact upon the level of capital reserves required to be maintained by individual Group entities or by the Group as a whole.
The Group may be subject to greater regulatory risk than that to which the Group is currently exposed.
In each of the jurisdictions in which the Group operates and in which the Group will operate, it has to comply with laws and regulations applicable to regulated (re)insurers. Each aspect of the regulatory environment in which the Group operates and in which the Group will operate is subject to change, which may be retrospective. Complying, or failing to comply, with existing and new regulations could result in additional costs for the Group, which could have an adverse effect (including to a material extent) on the financial condition or results of operations of the Group.
Data protection failures could disrupt the Groups business, damage its reputation and cause losses.
Since May 25, 2018, the European General Data Protection Regulation (the E.U. GDPR) has been directly applicable in all E.U. member states. The U.K.s General Data Protection Regulation and Data Protection
69
Act 2018 (collectively, the U.K. GDPR) is the retained E.U. law version of E.U. GDPR (the U.K. GDPR and the E.U. GDPR collectively, the GDPR). The Group is subject to the GDPR when offering goods and services to E.U. and/or U.K.-based data subjects, as applicable (regardless of whether through Group companies in the E.U. and/or the U.K.). The GDPR imposes comprehensive data privacy compliance obligations in relation to our collection, processing, sharing, disclosure, transfer and other use of data relating to an identifiable living individual or personal data, as applicable, including: the obligation to appoint data protection officers in certain circumstances; new rights for individuals to be forgotten and rights to data portability; the principle of accountability; and the obligation to make public notification of significant data breaches. The GDPR also retains and adds to existing requirements, including restrictions on transfers of personal data outside of the EEA/U.K., as applicable, and the requirement to include specific data protection provisions in agreements with data processors.
The GDPR also regulates cross-border transfers of personal data out of the EEA and the U.K. Recent legal developments in Europe have created complexity and uncertainty regarding such transfers, in particular in relation to transfers to the United States. On July 16, 2020, the Court of Justice of the European Union (the CJEU) invalidated the E.U.-U.S. Privacy Shield Framework, or Privacy Shield, under which personal data could be transferred from the EEA (and the U.K.) to relevant self-certified U.S. entities. The CJEU further noted that reliance on the standard contractual clauses (a standard form of contract approved by the European Commission as an adequate personal data transfer mechanism and potential alternative to the Privacy Shield) alone may not necessarily be sufficient in all circumstances and that transfers must be assessed on a case-by-case basis. Subsequent European court and regulator decisions have taken a restrictive approach to international data transfers. As the enforcement landscape further develops, and supervisory authorities issue further guidance onand revised standard contractual clauses forinternational data transfers, we could suffer additional costs, complaints and/or regulatory investigations or fines; we may have to stop using certain tools and vendors and make other operational changes which could otherwise affect the manner in which we provide our services, and could adversely affect our business, operations and financial condition.
We are also subject to evolving E.U. and U.K. privacy laws on cookies, tracking technologies and e-marketing. Recent European court and regulator decisions are driving increased attention to cookies and similar tracking technologies. In the E.U. and U.K., informed consent is required for the placement of certain cookies or similar tracking technologies on an individuals device and for direct electronic marketing. Consent is tightly defined and includes a prohibition on pre-checked consents and a requirement to obtain separate consents for each type of cookie or similar technology. If the trend of increasing enforcement by regulators of the strict approach to opt-in consent for all but essential use cases, as seen in recent guidance and decisions continues, this could lead to substantial costs, require significant systems changes, limit the effectiveness of our marketing activities, divert the attention of our technology personnel, adversely affect our margins, and subject us to additional liabilities. In light of the complex and evolving nature of E.U., E.U. member state and U.K. privacy laws on cookies and tracking technologies, there can be no assurances that we will be successful in our efforts to comply with such laws; violations of such laws could result in regulatory investigations, fines, orders to cease/ change our use of such technologies, as well as civil claims including class actions, and reputational damage.
Since we are under the supervision of relevant data protection authorities in both the EEA and the U.K., we may be fined under both the E.U. GDPR and U.K. GDPR for the same breach. Penalties for certain breaches are up to the greater of EUR 20 million/ GBP 17.5 million or 4% of our global annual turnover. In addition to fines, a breach of the GDPR may result in regulatory investigations, reputational damage, orders to cease/ change our data processing activities, enforcement notices, assessment notices for a compulsory audit and/or civil claims (including class actions).
Bermuda introduced the Personal Information Protection Act 2016 (PIPA) in 2016 to regulate and protect the use of personal information. PIPA applies to any organization (meaning any individual, entity or public authority) that uses personal information in Bermuda where that personal information is used by automated or other means which form, or are intended to form, part of a structured filing system. Under PIPA personal information means any information about an identified or identifiable individual (meaning a natural person), and use is broadly defined to include carrying out any operation on or possessing personal information.
70
Only certain limited sections of PIPA came into force in 2016, and at present the only operative sections relate to interpretations, citation and commencement and certain provisions in respect of the establishment and operation of the Privacy Commissioners Office. The principal sections of PIPA, which include: conditions for use and consent to use of personal information, obligations on organizations that use personal information, data transfer and protection obligations and access, rectification and erasure rights for individuals, are not yet in force. The references to PIPA provisions below are provisions which are not yet in force. It is anticipated that such provisions will phase into operation in the near future, and to the extent that the Group uses or holds individuals personal information in Bermuda, the Group will need to comply with such in force PIPA provisions.
In general, an organization must adopt suitable measures and policies to give effect to its obligations and to the rights of individuals set out in PIPA, and may only use an individuals personal information where one or more of the prescribed conditions for use is met. Organizations must designate a privacy officer, and must provide individuals with a clear and easily accessible statement about its personal information practices and policies, which must include: the fact that personal information is being used; the purposes for which personal information is or might be used; the identity and types of individuals or organizations to whom personal information might be disclosed; the identity and location of the organization, including information on how to contact it about its handling of personal information; the name of the privacy officer; and the choices and means the organization provides to an individual for limiting the use of, and for accessing, rectifying, blocking, erasing and destroying, their personal information.
Personal information held by an organization must be adequate, relevant and not excessive in relation to the purposes for which it is used, and must be accurate and kept up to date to the extent necessary for its use. An organization must protect personal information that it holds with appropriate and proportional safeguards against risk, including loss; unauthorized access, destruction, use, modification or disclosure; or any other misuse.
Where an organization engages (by contract or otherwise) the services of a third party in connection with the use of personal information, including transfers to overseas third parties, the organization remains responsible at all times for ensuring compliance with PIPA.
Oversight and enforcement of PIPA is the responsibility of Bermudas Privacy Commissioner. The Privacy Commissioner has certain investigatory, order making and enforcement powers, including issuing formal warnings, public admonishment or disclosure for prosecution for offenses under PIPA, including corporate offenses committed with the consent or connivance of corporate officers, which could result in a fine or imprisonment.
Other than the above, continuing regulatory developments in the national laws and regulations of individual E.U. member states, the U.K. and Bermuda in relation to the processing of personal data, has increased and may continue to increase the Groups compliance obligations and has necessitated and may continue to necessitate the review and implementation of updated policies and processes relating to the Groups collection and use of personal data. Any further and/or ongoing increase in compliance obligations could also lead to increased compliance costs, which may have an adverse impact on the Groups business, prospects, financial condition or results of operations.
If any person, including any of the Groups employees or those with whom the Group shares personal data, negligently disregards or intentionally breaches the Groups established controls with respect to personal data that the Group holds, the Group could be subject to significant monetary damages, regulatory enforcement actions, fines and/or criminal prosecution in one or more jurisdictions. In addition, a data breach could result in negative publicity, which could damage the Groups reputation and have an adverse effect on the Groups business, prospects, financial condition or results of operations.
71
The Group is required to comply with the applicable economic and trade sanctions laws and regulations. The Groups failure to comply with these laws and regulations would have an adverse effect on our business, financial condition and results of operations.
The Group is required to comply with all applicable economic and trade sanctions laws and regulations. Various governmental authorities with jurisdiction over the Groups activities maintain economic and trade sanctions laws and regulations, which restrict the Groups ability to conduct transactions and dealings with certain countries, territories, persons and entities. While the Group maintains policies and procedures designed to maintain compliance with economic and trade sanctions, the Group cannot guarantee that the policies and procedures will be effective in preventing violations or allegations of violations. Violations, or allegations of violations, could result in civil and criminal penalties, including fines for the Group or incarceration for responsible employees and managers, as well as negative publicity or reputational harm.
Risks Relating to TaxationU.S. Tax Risks
For purposes of this discussion, the term U.S. Person means: (i) an individual citizen or resident of the U.S., (ii) a partnership or corporation, created in or organized under the laws of the U.S., or organized under the laws of any political subdivision thereof, (iii) an estate the income of which is subject to U.S. federal income taxation regardless of its source, or (iv) a trust if either (x) a court within the U.S. is able to exercise primary supervision over the administration of such trust and one or more U.S. Persons have the authority to control all substantial decisions of such trust, or (y) the trust has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a U.S. Person for U.S. federal income tax purposes or (z) any other person or entity that is treated for U.S. federal income tax purposes as if it were one of the foregoing. For purposes of this discussion, the term U.S. Holder means a U.S. Person other than a partnership, who beneficially owns Common Shares.
U.S. Tax Reform
The Tax Cuts and Jobs Act (the 2017 Act) was passed by the U.S. Congress and signed into law on December 22, 2017, with certain provisions intended to eliminate certain perceived tax advantages of companies (including insurance companies) that have legal domiciles outside the U.S., but have certain U.S. connections, and U.S. Persons (as defined below) investing in such companies. Among other things, the 2017 Act revised the rules applicable to passive foreign investment companies (PFICs) and controlled foreign corporations (CFCs) in ways that could affect the timing or amount of U.S. federal income taxes imposed on certain investors that are U.S. Persons. Further, it is possible that other legislation could be introduced and enacted by the current Congress or future Congresses that could have an adverse impact on the Group, the Groups operations or U.S. Holders. Additionally, tax laws and interpretations regarding whether a company is engaged in a U.S. trade or business or whether a company is a CFC or a PFIC or has related person insurance income (RPII) are subject to change, possibly on a retroactive basis. The Treasury Department recently issued final and proposed regulations intended to clarify the application of the insurance income exception to the classification of a non-U.S. insurer as a PFIC and provide guidance on a range of issues relating to PFICs, and recently issued proposed regulations that would expand the scope of the RPII rules. New regulations or pronouncements interpreting or clarifying such rules may be forthcoming as well. FIHL cannot be certain if, when, or in what form such regulations or pronouncements may be provided and whether such guidance will have a retroactive effect.
FIHL and/or its non-U.S. subsidiaries may be subject to U.S. federal income taxation.
A non-U.S. corporation that is engaged in the conduct of a U.S. trade or business will be subject to U.S. federal income tax as described below, unless entitled to the benefits of an applicable tax treaty. Whether a trade or business is being conducted in the U.S. is an inherently factual determination. As the Internal Revenue Code of 1986, as amended (the Code), regulations and court decisions fail to identify definitively activities that constitute being engaged in a trade or business in the U.S., the Group cannot be certain that the Internal Revenue Service (IRS) will not contend successfully that FIHL and/or its non-U.S. subsidiaries are or will be engaged
72
in a trade or business in the U.S. A non-U.S. corporation deemed to be so engaged would be subject to U.S. income tax at regular corporate rates on the portion of its income that is treated as effectively connected with the conduct of that U.S. trade or business (ECI), as well as the branch profits tax on its dividend equivalent amount (generally, the ECI (with certain adjustments) deemed withdrawn from the U.S.), unless the corporation is entitled to relief under the permanent establishment provision of an applicable tax treaty. Any such U.S. federal income taxation could result in substantial tax liabilities and could have a material adverse effect on the results of operation of FIHL and its non-U.S. subsidiaries.
Non-U.S. corporations not engaged in a trade or business in the U.S. are nonetheless subject to U.S. income tax imposed by withholding on certain fixed or determinable annual or periodic gains, profits and income derived from sources within the U.S. (such as dividends and certain interest on investments), subject to exemption under the Code or reduction by applicable treaties.
The U.S. also imposes an excise tax on insurance and reinsurance premiums (FET) paid to non-U.S. insurers or reinsurers that are not eligible for the benefits of a U.S. income tax treaty that provides for an exemption from the FET with respect to risks (i) of a U.S. entity or individual, located wholly or partially within the U.S. and (ii) of a non-U.S. entity or individual engaged in a trade or business in the U.S., located within the U.S. The rates of tax are 4% for property casualty insurance premiums and 1% for reinsurance premiums.
U.S. Holders will be subject to adverse tax consequences if FIHL is considered a PFIC for U.S. federal income tax purposes.
In general, a non-U.S. corporation will be a PFIC during a given year if (i) 75% or more of its gross income constitutes passive income (the 75% test) or (ii) 50% or more of its assets produce (or are held for the production of) passive income (the 50% test). If FIHL were characterized as a PFIC during a given year, each U.S. Holder would be subject to a penalty tax at the time of the taxable disposition at a gain of, or receipt of, an excess distribution with respect to, their shares, unless such person is a 10% U.S. Shareholder (as defined below) subject to tax under the CFC rules or such person made a qualified electing fund (QEF) election or, if the Common Shares are treated as marketable stock in such year, such person made a mark-to-market election. In addition, if FIHL were considered a PFIC, upon the death of any U.S. individual owning shares such individuals heirs or estate would not be entitled to a step-up in the basis of the shares that might otherwise be available under U.S. federal income tax laws. In addition, a distribution paid by FIHL to U.S. Holders that is characterized as a dividend and is not characterized as an excess distribution would not be eligible for reduced rates of tax as qualified dividend income if FIHL were considered a PFIC in the taxable year in which such dividend is paid or in the preceding taxable year. A U.S. Person that is a shareholder in a PFIC may also be subject to additional information reporting requirements, including the filing of an IRS Form 8621.
For the above purposes, passive income generally includes interest, dividends, annuities and other investment income. The PFIC rules provide that income derived in the active conduct of an insurance business by a qualifying insurance corporation is not treated as passive income (the insurance income exception). The PFIC provisions also contain a look-through rule under which a foreign corporation will be treated, for purposes of determining whether it is a PFIC, as if it received directly its proportionate share of the income and as if it held its proportionate share of the assets of any other corporation in which it owns at least 25% of the value of the stock (the look-through rule). Under the look-through rule, FIHL should be deemed to own its proportionate share of the assets and to have received its proportionate share of the income of its non-U.S. insurance subsidiaries for purposes of the 75% test and the 50% test. However, the 2017 Act limits the insurance income exception to a non-U.S. insurance company that is a qualifying insurance corporation that would be taxable as an insurance company if it were a U.S. corporation and maintains insurance liabilities of more than 25% of such companys assets for a taxable year (the 25% Test) (or maintains insurance liabilities that at least equal or exceed 10% of its assets, is predominantly engaged in an insurance business and satisfies a facts-and-circumstances test that requires a showing that the failure to exceed the 25% threshold is due to runoff-related or rating-related circumstances (the 10% Test, together with the 25% Test, the Reserve
73
Test)). The Group believes that FIBL has met this Reserve Test and will continue to do so in the foreseeable future, in which case FIHL would not be expected to be a PFIC, although no assurance may be given that FIBL will satisfy the Reserve Test in future years.
Further, the Treasury Department recently issued final and proposed regulations intended to clarify the application of the insurance income exception to the classification of a non-U.S. insurer as a PFIC and provide guidance on a range of issues relating to PFICs, including the application of the look-through rule, the treatment of income and assets of certain U.S. insurance subsidiaries for purposes of the look-through rule and the extension of the look-through rule to 25%-or-more-owned partnerships (the 2020 Regulations). The 2020 Regulations define insurance liabilities for purposes of the Reserve Test, and tighten the Reserve Test as well as place a statutory cap on insurance liabilities, and provide guidance on the runoff-related and rating-related circumstances for purposes of the 10% Test. The 2020 Regulations, which set forth in proposed form certain requirements that must be met to satisfy the active conduct of an insurance business test, also propose that a non-U.S. insurer with no or a nominal number of employees that relies exclusively or almost exclusively upon independent contractors (other than related entities) to perform its core functions will not be treated as engaged in the active conduct of an insurance business. Further, for purposes of applying the 10% Test, the 2020 Regulations: (i) generally limit the rating-related circumstances exception to a non-U.S. corporation: (a) if more than half of such corporations net written premiums for the applicable period are derived from insuring catastrophic risk, or (b) providing certain other insurance coverage that the Group is not expected to engage in, and (ii) reduce a corporations insurance liabilities by the amount of any reinsurance recoverable relating to such liability. The Group believes that, based on the implementation of its business plan and the application of the look-through rule and the exceptions set out under Section 1297 of the Code, none of the income and assets of FIBL should be treated as passive pursuant to the 10% Test, and thus FIHL should not be characterized as a PFIC under current law for the current taxable year or for foreseeable future years to the extent a shareholder makes an election to apply the 10% Test, but because of the legal uncertainties as well as factual uncertainties with respect to the Groups planned operations, there is a risk that FIHL will be characterized as a PFIC for U.S. federal income tax purposes. In addition, because of the legal uncertainties relating to how the 2020 Regulations will be interpreted and the form in which the proposed 2020 Regulations may be finalized, no assurance can be given that FIHL will not qualify as a PFIC under final IRS guidance or any future regulatory proposal or interpretation that may be subsequently introduced and promulgated. If FIHL is considered a PFIC, it could have material adverse tax consequences for an investor that is subject to U.S. federal income taxation. Prospective investors should consult their tax advisors as to the effects of the PFIC rules.
As noted above, the 10% Test will only apply if a U.S. Holder makes a valid election. A U.S. Holder seeking to elect the application of the 10% Test FIBL may do so if the Group provides the holder with, or otherwise makes publicly available, a statement or other disclosure that FIBL meet the requirements of the 10% Test (and contains certain other relevant information). The Group intends to either provide each U.S. investor with such a statement or otherwise make such a statement publicly available. A U.S. Holder may generally make an election to apply the 10% Test by completing a Form 8621 and attaching it to its original or amended U.S. federal income tax return for the taxable year to which the election relates. Investors owning a de minimis amount of FIHL stock may be deemed to have made the election automatically. U.S. Holders are urged to consult their tax advisors regarding electing to apply the 10% Test to FIBL.
U.S. Holders are also urged to consult with their tax advisors and to consider making a protective QEF election with respect to FIHL and each of FIHLs non-U.S. subsidiaries to preserve the possibility of making a retroactive QEF election. If the Group determines that FIHL is a PFIC, the Group intends to use commercially reasonable efforts to provide the information necessary to make a QEF election for FIHL and each non-U.S. subsidiary of FIHL that is a PFIC. A U.S. Person that makes a QEF election with respect to a PFIC is currently taxable on its pro rata share of the ordinary earnings and net capital gain of such company during the years it is a PFIC (at ordinary income and capital gain rates, respectively), regardless of whether or not distributions were received. In addition, any of the PFICs losses for a taxable year will not be available to U.S. Persons and may not be carried back or forward in computing the PFICs ordinary earnings and net capital gain in other taxable
74
years. U.S. Holders are also urged to consult with their tax advisors regarding the availability and consequences of making a mark-to-market election with respect to FIHL, although there can be no assurance that such election will be available, and such election likely would not be available for any subsidiary of FIHL also treated as a PFIC. In general, if a U.S. Holder were to make a timely and effective mark-to-market election, such holder would include as ordinary income each year the excess, if any, of the fair market value of the holders Common Shares at the end of the taxable year over its adjusted basis in the Common Shares. Any gain recognized by such holder on the sale or other disposition of the Common Shares would be ordinary income, and any loss would be an ordinary loss to the extent of the net amount of previously included income as a result of the mark-to-market election and, thereafter, a capital loss. U.S. Holders considering a mark-to-market election for FIHL should consult with their tax advisors regarding making a QEF election for any non-U.S. subsidiary of FIHL treated as a PFIC.
U.S. Holders of 10% or more of FIHLs Common Shares may be subject to U.S. income taxation under the CFC rules.
Each 10% U.S. Shareholder of a non-U.S. corporation that is a CFC during a taxable year and that owns shares in the CFC, directly or indirectly through non-U.S. entities, on the last day of the non-U.S. corporations taxable year that the non-U.S. corporation is a CFC, generally must include in its gross income for U.S. federal income tax purposes its pro rata share of the CFCs subpart F income, and global intangible low taxed income (GILTI) even if the subpart F income or GILTI is not distributed. A non-U.S. corporation is considered a CFC if 10% U.S. Shareholders own (directly, indirectly through non-U.S. entities or by attribution by application of the constructive ownership rules of Section 958(b) of the Code (i.e., constructively)) more than 50% of the total combined voting power of all classes of stock of such non-U.S. corporation, or more than 50% of the total value of all stock of such corporation. For purposes of taking into account insurance income, which is a category of subpart F income, a CFC also includes a non-U.S. corporation that earns insurance income in which more than 25% of the total combined voting power of all classes of stock or more than 25% of the total value of all stock is owned by 10% U.S. Shareholders on any day of the taxable year of such corporation, if the gross amount of premiums or other consideration for the reinsurance or the issuing of insurance or annuity contracts exceeds 75% of the gross amount of all premiums or other consideration in respect of all risks. A 10% U.S. Shareholder is a U.S. Person who owns (directly, indirectly through non-U.S. entities or constructively) at least 10% of the total combined voting power or value of all classes of stock of the non-U.S. corporation.
FIHL believes that because of the anticipated dispersion of ownership of FIHLs Common Shares no U.S. Holder of FIHL should be treated as owning (directly, indirectly through non-U.S. entities or constructively) 10% or more of the total voting power or value of FIHL. However, because FIHLs Common Shares may not be as widely dispersed as the Group believes due to, for example, the application of certain ownership attribution rules, no assurance may be given that a U.S. Person who owns directly, indirectly or constructively, FIHLs Common Shares will not be characterized as a 10% U.S. Shareholder, in which case such U.S. Person may be subject to taxation under the CFC rules.
U.S. Persons who own or are treated as owning Common Shares may be subject to U.S. income taxation at ordinary income rates on their proportionate share of the Groups RPII.
If (i) a non-U.S. subsidiary of FIHL is 25% or more owned (by vote or value) directly, indirectly through non-U.S. entities or constructively by U.S. Persons that hold shares of FIHL directly or indirectly through foreign entities, (ii) the RPII (determined on a gross basis) of the non-U.S. subsidiary were to equal or exceed 20% of the non-U.S. subsidiarys gross insurance income in any taxable year and (iii) direct or indirect insureds (and persons related to those insureds) own directly or indirectly through entities 20% or more of the voting power or value of the non-U.S. subsidiary, then a U.S. Person who owns any shares of the non-U.S. subsidiary (directly or indirectly through non-U.S. entities, including by holding Common Shares) on the last day of the taxable year would be required to include in its income for U.S. federal income tax purposes such persons pro rata share of the non-U.S. subsidiaries RPII for the entire taxable year, determined as if such RPII were distributed
75
proportionately only to U.S. Persons at that date regardless of whether such income is distributed, in which case the U.S. Persons investment could be materially adversely affected. Generally, RPII is any insurance income (as defined below) attributable to policies of insurance or reinsurance with respect to which the person (directly or indirectly) insured is an RPII shareholder (as defined below) or a related person to such RPII shareholder. The amount of RPII earned by the non-U.S. subsidiary (generally, premium and related investment income from the direct or indirect insurance or reinsurance of any RPII shareholder or any person related to such RPII shareholder) will depend on a number of factors, including the identity of persons directly or indirectly insured or reinsured by the non-U.S. subsidiary. FIHL believes that the direct or indirect insureds of its non-U.S. subsidiaries (and related persons), whether or not U.S. Persons, should not directly or indirectly own 20% or more of either the voting power or value of the shares of FIHL or other non-U.S. subsidiaries immediately after the consummation of this offering and FIHL does not expect this to be the case in the foreseeable future (the 20% Ownership Exception). Additionally, FIHL does not expect the gross RPII of any non-U.S. subsidiary to equal or exceed 20% of its gross insurance income in any taxable year for the foreseeable future (the 20% Gross Income Exception), but cannot be certain that this will be the case because some of the factors which determine the extent of RPII may be beyond the Groups control. Further, recently proposed regulations could, if finalized in their current form, substantially expand the definition of RPII to include insurance income of FIHLs non-U.S. subsidiaries with respect to certain affiliate reinsurance transactions. If these proposed regulations are finalized in their current form, it could limit the Groups ability to execute affiliate reinsurance transactions that would otherwise be undertaken for non-tax business reasons in the future and could increase the risk that the 20% Gross Income Exception would not be met for one or more of FIHLs non-U.S. subsidiaries in a particular taxable year, which could result in such RPII being taxable to U.S. Persons that own or are treated as owning Common Shares. Prospective investors are urged to consult their tax advisors with respect to these rules.
U.S. tax-exempt organizations that own Common Shares may recognize unrelated business taxable income.
Tax-exempt entities will be required to treat certain subpart F insurance income, including RPII, that is includable in income by the tax-exempt entity as unrelated business taxable income. Prospective investors that are tax exempt entities are urged to consult their tax advisors as to the potential impact of the unrelated business taxable income provisions of the Code.
U.S. Holders who dispose of shares may be subject to U.S. federal income taxation at the rates applicable to dividends on a portion of such disposition.
Subject to the discussion above relating to the potential application of PFIC rules, Code 1248 may apply to a disposition of Common Shares. Code Section 1248 provides that if a U.S. Person sells or exchanges stock in a non-U.S. corporation and such person owned, directly, indirectly through certain non-U.S. entities or constructively, 10% or more of the voting power of the corporation at any time during the five-year period ending on the date of disposition when the corporation was a CFC, any gain from the sale or exchange of the shares will be treated as a dividend to the extent of the CFCs earnings and profits (determined under U.S. federal income tax principles) during the period that the shareholder held the shares and while the corporation was a CFC (with certain adjustments). FIHL believes that because of the anticipated dispersion of ownership of FIHLs Common Shares and provisions in its organizational documents that are intended to limit voting power in certain circumstances, no U.S. Holder of the Common Shares should be treated as owning (directly, indirectly through non-U.S. entities or constructively) 10% or more of the total voting power of FIHL; to the extent this is the case, the application of Code Section 1248 under the regular CFC rules should not apply to dispositions of the Common Shares. However, because the Common Shares may not be as widely dispersed as FIHL believes due to, for example, the application of certain ownership attribution rules, and the provisions in FIHLs organizational documents described above have not been tested, no assurance may be given that a U.S. Holder will not be characterized as owning, directly, indirectly through certain non-U.S. entities or constructively, 10% or more of the voting power of FIHL, in which case such U.S. Holder may be subject to Code Section 1248 rules.
Additionally, Code Section 1248, in conjunction with the RPII rules, also applies to the sale or exchange of shares in a non-U.S. corporation if the non-U.S. corporation would be treated as a CFC for RPII purposes
76
regardless of whether the shareholder owns, directly, indirectly through certain non-U.S. entities or constructively, 10% or more of the voting power of such non-U.S. corporation or the 20% Gross Income Exception or 20% Ownership Exception applies. Existing proposed regulations do not address whether Code Section 1248 would apply if a non-U.S. corporation is not a CFC but the non-U.S. corporation has a subsidiary that would be treated as a CFC for RPII purposes. FIHL believes, however, that this application of Code Section 1248 under the RPII rules should not apply to dispositions of Common Shares because FIHL will not be directly engaged in the insurance business. FIHL cannot be certain, however, that the IRS will not interpret the proposed regulations in a contrary manner or that the Treasury Department will not amend the proposed regulations to provide that these rules will apply to dispositions of Common Shares. Prospective investors should consult their tax advisors regarding the effects of these rules on a disposition of Common Shares.
Dividends from FIHL may not satisfy the requirements for qualified dividend income, and therefore may not be eligible for the reduced rates of U.S. federal income tax applicable to such income.
Non-corporate U.S. Holders, including individuals, generally will be subject to U.S. federal income taxation at a current maximum rate of 37% (not including the Medicare contribution tax) upon their receipt of dividend income from FIHL unless such dividends constitute qualified dividend income (as defined in the Code) (QDI). QDI received by non-corporate U.S. Holders meeting certain holding requirements from domestic corporations or qualified foreign corporations is subject to tax at long-term capital gains rates (up to a maximum of 20%, not including the Medicare contribution tax). Dividends paid by FIHL generally may constitute QDI if (i) FIHL is able to claim benefits under the income tax treaty between the U.S. and the U.K. (the U.K. Tax Treaty) or the Common Shares are readily tradable on an established securities market in the U.S., and (ii) FIHL is not treated as a PFIC for the taxable year such dividends are paid and the preceding taxable year. Under current U.S. Treasury Department guidance, the Common Shares would be treated as readily tradeable on an established securities market if they are listed on NYSE, as we intend the Common Shares to be after this offering. However, there can be no assurance that our Common Shares will continue to be listed on NYSE or that FIHL will not be treated as a PFIC for any taxable year.
Prospective investors are advised to consult their own tax advisors with respect to the application of these rules.
Information regarding a U.S. Holders identity may be reported to the relevant tax authority to ensure compliance with the U.S. Foreign Account Tax Compliance Act (FATCA) and similar regimes.
Under FATCA, the U.S. imposes a withholding tax of 30% on U.S.-source interest, dividends and certain other types of income which are received by a foreign financial institution (FFI), unless such FFI enters into an agreement with the IRS to obtain certain information as to the identity of the direct and indirect owners of accounts in such institution. Withholding on U.S.-source interest, dividends and certain other types of income applies currently, and proposed U.S. Treasury regulations provide that this withholding will not apply to gross proceeds.
Alternatively, a 30% withholding tax may be imposed on the above payments to certain passive non-financial foreign entities (NFFE) which do not (i) certify to each respective withholding agent that they have no substantial U.S. owners (i.e., a U.S. 10% direct or indirect shareholder), or (ii) provide such withholding agent with the certain information as to the identity of such substantial U.S. owners.
FIHL believes and intends to take the position that it will be an NFFE, and not an FFI, although no assurance can be given that the IRS would not assert, or that a court would not uphold, a different characterization of FIHL.
The U.K. has signed an intergovernmental agreement (IGA) with the U.S. (the U.K. IGA), and Bermuda has signed a Model 2 IGA with the U.S. (the Bermuda IGA) directing Bermuda FFIs to enter into agreements
77
with the IRS to comply with FATCA. FIHL and FUL intend to comply with the U.K. IGA and Bermuda IGA and/or FATCA, as applicable, and FIBL intends to comply with the Bermuda IGA and/or FATCA, as applicable. Each of FIHL, FIBL and FUL will report all necessary information regarding substantial U.S. owners to the relevant authority. Any substantial U.S. owner will be required to use commercially reasonable best efforts to provide such identifying information, subject to reasonable confidentiality provisions that do not prohibit the disclosure of information reasonably required by FIHL, as is required to enable the company to comply. Shareholders who fail to provide such information could be subject to: (i) a forced sale of their Common Shares; or (ii) a redemption of their Common Shares. Should FIHL determine that it is an FFI, FIHL will report all necessary information regarding all U.S. Holders of the Common Shares.
Risks Relating to TaxationU.K. Tax Risks
Any change in FIHLs tax status or any change in U.K. tax laws could materially affect the Groups business, prospects, financial condition or results of operations or ability to provide returns to shareholders.
FIHL is not incorporated in the U.K. but has filed returns for U.K. corporation tax on the basis that it is resident in the U.K. since August 2015. FIHL and the U.K.-incorporated companies within the Group are subject to U.K. tax in respect of their worldwide income and gains (subject to any applicable exemptions), which represent a material portion of the Groups income and operations. Any change in FIHLs tax status or any change in U.K. tax laws could materially affect the Groups business, prospects, financial condition or results of operations or ability to provide returns to shareholders.
FIBL may be subject to U.K. tax, in which case its results of operations could be materially adversely affected.
FIBL is not incorporated in the U.K. and, accordingly, should not be treated as being resident in the U.K. for corporation tax purposes unless its central management and control is exercised in the U.K. The concept of central management and control is indicative of the highest level of control of a company, which is wholly a question of fact. The directors of FIBL intend to manage its affairs so that it is not resident in the U.K. for U.K. tax purposes as a result of the central management and control of FIBL being outside of the U.K.
A company that is not resident in the U.K. for corporation tax purposes can nevertheless be subject to U.K. corporation tax if it carries on a trade through a permanent establishment in the U.K., but, in that situation, the charge to U.K. corporation tax is limited to profits (both revenue profits and capital gains) attributable directly or indirectly to such permanent establishment.
The directors of FIBL intend to operate FIBL in such a manner that FIBL does not carry on a trade through a permanent establishment in the U.K. Nevertheless, because neither case law nor U.K. statute provides a clear definition as to the activities that constitute trading in the U.K. through a permanent establishment, His Majestys Revenue and Customs (HMRC) might contend successfully that FIBL is trading in the U.K. through a permanent establishment in the U.K.
The U.K. has no comprehensive income tax treaty with Bermuda. There are circumstances in which companies that are neither resident in the U.K. nor entitled to the protection afforded by a double tax treaty between the U.K. and the jurisdiction in which they are resident may be exposed to income tax in the U.K. (other than by deduction or withholding) on the profits of a trade carried on in the U.K. even if that trade is not carried on through a permanent establishment. However, the directors of FIBL intend to operate FIBL in such a manner that FIBL will not fall within the charge to income tax in the U.K. (other than by deduction or withholding).
If FIBL were treated as being resident in the U.K. for U.K. corporation tax purposes, or as carrying on a trade in the U.K., the results of the Groups operations could be materially adversely affected.
The U.K. diverted profits tax (DPT) may apply in a situation where (i) an entity carries on activity in the U.K. in connection with the business of a non-U.K. resident company in circumstances where that entity does not
78
constitute a U.K. permanent establishment of the non-U.K. company, (ii) it is reasonable to assume that an entitys activities are designed to ensure that the non-U.K. resident company does not carry on a trade in the U.K. and (iii) one of the main purposes of the arrangements is the avoidance of U.K. corporation tax. DPT is charged at a higher rate than U.K. corporation tax and will remain at a higher rate following the increase in line with the U.K. corporation tax rate on April 1, 2023. If it applies, the results of the Groups operations could be materially adversely affected.
Although the DPT is a relatively new tax and the statute and HMRC guidance are largely untested in the U.K. courts, the Group is of the view that the DPT is not applicable to the Group and does not intend to notify HMRC of any liability to DPT for the current or any preceding years.
Risks Relating to TaxationIrish Tax Risks
FIID may be treated as being resident for tax purposes in a jurisdiction other than Ireland, which could negatively impact the Groups results of operations.
| Under Irish tax law, a company which is incorporated in Ireland is automatically resident for tax purposes in Ireland. The one exception is that an Irish-incorporated company will not be resident for tax purposes in Ireland if it is treated as resident for tax purposes in another jurisdiction under the terms of a double tax treaty which has the force of law. |
| FIID is incorporated in Ireland. As a result, FIID is automatically resident for tax purposes in Ireland, unless it is treated as resident elsewhere under the terms of a double tax treaty. The directors of FIID carry on (and intend to continue to carry on) FIIDs business in a manner which ensures that it is resident for tax purposes solely in Ireland. For example, a majority of FIIDs directors are resident in Ireland and FIIDs board meetings are convened in Ireland, with a majority of such directors in physical attendance. Nevertheless, there can be no guarantee that another jurisdiction will not assert that FIID is tax-resident in their jurisdiction. If FIID were treated as being resident for tax purposes in another jurisdiction, its profits may be subject to comprehensive taxation in that other jurisdiction and the results of the Groups operations could be materially adversely affected. |
| FIIDs directors also carry on (and intend to continue to carry on) FIIDs business in a manner which ensures that it does not have a permanent establishment in any jurisdiction and its profits are only subject to tax in Ireland as a result. It is possible that non-Irish agents or brokers distributing insurance underwritten by FIID could create permanent establishments outside of Ireland if they were not considered agents who are independent of FIID from a legal and economic perspective. The treatment of any agents as dependent agents may result in the creation of permanent establishments outside of Ireland to which FIID must allocate profits for tax purposes, resulting in such profits being subject to comprehensive taxation in that other jurisdiction and the results of the Groups operations being materially adversely affected. |
Any adverse adjustment to Irish tax law or the Irish Revenue Commissioners interpretation of the scope of an Irish value-added tax (VAT) group may give rise to additional irrecoverable Irish VAT cost, which could negatively impact the Groups results of operations.
| The VAT exemption applicable to insurance and reinsurance transactions, including related services performed by insurance brokers and insurance agents has been the subject of a number of decisions of the CJEU which may be interpreted as having clarified a narrower scope of such exemption so as to apply to the supply of core insurance services and to brokerage services whereby prospective insurance clients are introduced to the insurer. In addition, the application of VAT exemption to insurance and reinsurance transactions is currently the subject of a review by the European Commission which may result in material amendments to the application of VAT to such services. Therefore, to the extent that FIID relies on such exemptions, in particular for the receipt or supply of such related or ancillary services, there is a risk that the application and scope of such exemptions may be amended and this could potentially give rise to material |
79
additional irrecoverable VAT costs in the structure. However, in circumstances where any entity in the structure is deemed to be carrying out activities which are subject to VAT (rather than exempt from VAT), such entity should be entitled to deduct any attributable input VAT. |
| In addition, at present FIID may rely upon the existence of an Irish VAT group to result in no Irish VAT arising on supplies received by FIID from establishments outside Ireland of other Irish VAT group members. The Irish Revenue Commissioners have confirmed their interpretation that when an entity joins an Irish VAT group, the entire entity is deemed to be part of the Irish VAT group, which includes overseas establishments. It should be noted that a recent decision of the CJEU suggests that overseas establishments cannot form part of a VAT group and that VAT groups are perhaps limited in effect to supplies between establishments of VAT group members within the E.U. member state of such VAT group. Were Irish law to be amended and/or the Irish Revenue Commissioners to change their interpretation of the scope of an Irish VAT group, services provided by overseas establishments of any members of FIIDs Irish VAT group to other parties in the VAT group may give rise to additional irrecoverable Irish VAT costs in the structure where no VAT exemption applies to such services. |
Any adverse adjustment under the proposed Council Directive to prevent the misuse of shell entities for tax purposes could adversely impact the Groups tax liability.
| On December 22, 2021, the European Commission published a proposal for a Council Directive to prevent the misuse of shell entities for tax purposes (ATAD III). The new ATAD III proposals are aimed at legal entities which have limited substance and economic activity in their jurisdictions of residence. Where the rules apply, the proposal is that such entities should be denied the benefit of double taxation agreements entered into between E.U. member states as well as certain E.U. tax directives, including the Parent Subsidiary Directive and Interest and Royalty Directive. |
| As currently drafted, the proposal contains exemptions for certain entities, including regulated insurance undertakings. There is no certainty that the proposal will be introduced in its current form. The proposal requires the unanimous approval of the E.U. Council before it is adopted. Until the proposal receives approval and a final directive is published, it is not possible to provide definitive guidance on the impact of the proposal on FIIDs Irish tax position (if any). |
Risks Relating to TaxationU.K. and Irish Tax Risks
Any adverse adjustment under the U.K. or Irish transfer pricing regimes, the anti-avoidance regime governing the transfer of corporate profits or the legislation governing the taxation of U.K. tax resident holding companies on the profits of their foreign subsidiaries could adversely impact the Groups tax liability.
All intra-group services provided to or by FIHL or any of the U.K.-incorporated companies, including in particular the reinsurance arrangements between FIBL and FUL, FUL being a wholly owned subsidiary of the FIHL incorporated in England and Wales, are subject to the U.K. transfer pricing regime. In addition, the reinsurance arrangements between FIBL and FIID are subject to the Irish transfer pricing regime.
Consequently, if the reinsurance pursuant to these agreements (or any other intra-group services) is found not to be on arms-length terms and, as a result, a U.K. or Irish tax advantage is being obtained, an adjustment will be required to compute U.K. taxable profits for FUL, or to compute Irish taxable profits for FIID, as if the reinsurance or provision of marketing services were on arms-length terms.
Under section 1305A Corporation Tax Act 2009, where any payment between group companies is, in substance, a payment of all or a significant part of the profits of the business of the payer company, and the main purpose or one of the main purposes is to secure a tax advantage for any person, the payers profits are calculated for U.K. corporation tax purposes as if the profit transfer had not occurred. According to the Technical Note published by HMRC on March 19, 2014, where a company has entered into reinsurance arrangements within a
80
group (for example quota share reinsurance) as part of ordinary commercial arrangements, this would not normally fall within the scope of this measure. This includes cases where the profitability of the ceding company is a factor taken into account in arriving at the premium to be paid.
DPT may apply in circumstances where (i) there is a transaction or series of transactions between a U.K. company and another related company, (ii) as a result of the transaction(s) there is a material reduction in the U.K. corporation tax liability of the U.K. company and (iii) it was reasonable to assume at the time of the transaction(s) that the financial benefits of the tax reduction would not be outweighed by the non-tax benefits.
Any transfer pricing adjustment, or the denial (in whole or in part) on any other basis, of a U.K. tax deduction for premiums paid pursuant to a reinsurance contract between companies in the Group, or the application of the DPT to the same, could adversely impact the Groups U.K. corporation tax liability.
Under the U.K. CFC regime, the income profits of non-U.K. resident companies may in certain circumstances be attributed to controlling U.K.-resident shareholders for U.K. corporation tax purposes. The directors of each of the FIHLS non-U.K. incorporated subsidiaries intend to operate those subsidiaries in such a manner that its profits are not taxed on FIHL under the CFC regime. Any change in the way in which each of the non-U.K. subsidiaries FIBL operates or any change in the CFC regime, resulting in an attribution of any of their income profits to FIHL for U.K. corporation tax purposes, could materially adversely affect the Groups financial condition.
The financial results of the Groups operations may be affected by measures taken in response to the OECD/G20 Two-Pillar Solution to address the tax challenges arising from the digitalization of the economy.
On October 5, 2015, the OECD released the final reports under its action plan on Base Erosion and Profit Shifting (BEPS, the action plan being the BEPS Action Plan). The actions contained in the BEPS Action Plan include a number of areas that could impact the Group, such as updated transfer pricing guidance and a broadened definition of permanent establishment, (both of which, to a certain extent, have been anticipated in the U.K. by the introduction of DPT), and new restrictions on interest deductions.
On October 8, 2021 the OECD/G20 Inclusive Framework on BEPS (the IF) issued a statement on the agreement of a two-pillar solution to address the tax challenges arising from the digitalization of the economy. This statement included the agreed components of the two pillars. Pillar One addresses the broader challenge of a digitalized economy and focuses on the allocation of group profits among taxing jurisdictions based on a market-based concept rather than historical permanent establishment concepts. Pillar One includes explicit exclusions for Regulated Financial Services (as defined therein), so is not expected to have a material impact on insurance and reinsurance groups. Pillar Two addresses the remaining BEPS risk of profit shifting to entities in low-tax jurisdictions by introducing a global minimum tax on large groups (groups with consolidated revenues in excess of 750 million), which would require large groups to calculate the effective tax rate of each group company operating in a relevant jurisdiction and, where a group company has an effective tax rate below 15%, pay an additional top-up tax. In December 2021, the OECD issued Pillar Two model rules for domestic implementation of the global minimum tax and shortly thereafter the European Commission proposed a Directive to implement the Pillar Two rules into E.U. law, which was unanimously agreed in December 2022 and will require E.U. member states to transpose the rules into their national laws by December 31, 2023, with certain measures initially coming into effect from January 1, 2024. The proposals, in particular in relation to Pillar Two, are broad in scope and FIHL is unable to determine at this time whether they would have a material adverse impact on its operations and results or those of any of its subsidiaries.
The U.K. and Ireland are currently legislating for the proposals set out in the IF statement with respect to the two-pillar solution and the final implemented legislation (and any further changes in U.K. or Irish tax law in response to the OECDs initiatives described above) could materially adversely affect the Groups liability to tax.
81
Risks Relating to TaxationBermuda Tax Risks
FIHL and FIBL may become subject to taxes in Bermuda, which could negatively impact the Groups results of operations.
FIHL and FIBL may become subject to taxes on capital gains and/or income in Bermuda after March 31, 2035, which may have a material adverse effect on the Groups business, prospects, financial condition or results of operations. The Bermuda Minister of Finance (the Minister), under the Exempted Undertakings Tax Protection Act 1966 of Bermuda, as amended, has given FIHL and FIBL an assurance that if any legislation is enacted in Bermuda that would impose tax computed on profits or income, or computed on any capital asset, gain or appreciation, or any tax in the nature of estate duty or inheritance tax, then the imposition of any such tax will not be applicable to FIHL and/or FIBL and/or any of their respective operations, shares, debentures or other obligations until March 31, 2035 except insofar as such tax applies to persons ordinarily resident in Bermuda or is payable to FIHL or FIBL in respect of real property owned or leased by FIHL or FIBL in Bermuda. It cannot be certain that FIHL and FIBL will not be subject to any Bermuda tax after March 31, 2035.
The OECDs review of harmful tax competition could adversely affect the Groups tax status in Bermuda and elsewhere.
The OECD has published reports and launched a global dialogue among member and non-member countries on measures to limit harmful tax competition. These measures are largely directed at counteracting the effects of tax havens and preferential tax regimes around the world. Following a review in November 2021 by the OECD of Bermudas economic substance compliance, Bermuda was placed on the OECDs grey list. Bermuda has already addressed the recommendations in practice and formalized these practices by April 2022. Following a formal review in October 2022, Bermuda was removed from the OECDs grey list. However, the Group is not able to predict whether any changes will be made to this classification or whether any such changes will be subject to additional taxes.
The introduction of economic substance requirements in Bermuda required by the E.U. could adversely affect the Group.
During 2017, the E.U. Economic and Financial Affairs Council (the ECOFIN) released a list of non-cooperative jurisdictions for tax purposes. The stated aim of this list, and accompanying report, was to promote good governance worldwide in order to maximize efforts to prevent tax fraud and tax evasion. In an effort to remain off this list, Bermuda committed to address concerns relating to economic substance by December 31, 2018. In accordance with that commitment, Bermuda has enacted the Economic Substance Act 2018 (the ES Act). Pursuant to the ES Act, a registered entity other than an entity which is resident for tax purposes in certain jurisdictions outside Bermuda (non-resident entity) that carries on as a business any one or more of the relevant activities referred to in the ES Act must comply with economic substance requirements. The ES Act may require in scope Bermuda entities which are engaged in such relevant activities to be directed and managed in Bermuda, have an adequate level of qualified employees in Bermuda, incur an adequate level of annual expenditure in Bermuda, maintain physical offices and premises in Bermuda or perform core income-generating activities in Bermuda. The list of relevant activities includes carrying on any one or more of: banking, insurance, fund management, financing, leasing, headquarters, shipping, distribution and service center, intellectual property and holding entities. Any entity that must satisfy economic substance requirements but fails to do so could face automatic disclosure to competent authorities in the E.U. of the information filed by the entity with the Bermuda Registrar of Companies in connection with the economic substance requirements and may also face financial penalties, restriction or regulation of its business activities and/or may be struck off as a registered entity in Bermuda.
On July 19, 2019, the OECDs Forum on Harmful Tax Practices formally reported its approval of Bermudas economic substance legislative framework. As the legislation is new and remains subject to further clarification and interpretation, it is not currently possible to predict the nature and effect of these requirements on the Groups business. The new economic substance requirements may impact the manner in which the Group operates, which could adversely affect the Groups business, prospects, financial condition or results of operations.
82
Risks Relating to the Common Shares and this Offering
FIHLs ability to pay dividends may be constrained by the Groups structure, limitations on the payment of dividends which Bermuda law and regulations impose on the Group and the terms of our indebtedness.
FIHL is a holding company and, as such, has no substantial operations of its own. FIHL does not expect to have any significant operations or assets other than ownership of the shares of operating subsidiaries. Dividends and other permitted distributions and loans from operating subsidiaries are expected to be the sole source of funds to meet ongoing cash requirements, including payment of dividends to shareholders holding Series A Preference Securities, debt service payments and other expenses and to pay dividends, if any, to holders of the Common Shares. The Groups operating subsidiaries are subject to significant regulatory restrictions limiting their ability to declare and pay dividends and make loans to other Group companies. FIHLs ability to pay dividends on Common Shares is also dependent on the availability of distributable reserves. The inability of operating subsidiaries to pay dividends in an amount sufficient to enable FIHL to meet its cash requirements at the holding company level could have a material adverse effect on the Common Shares. As FIHL is subject to Group Supervision by the BMA, it is prohibited from declaring a dividend if it is in breach of its Group Enhanced Capital Requirement or the declaration or payment would cause such a breach. In addition, FIHLs ability to pay dividends is subject to the restrictive covenants of our existing and outstanding indebtedness and may be limited by covenants of any future indebtedness we incur.
FIBL may be prohibited from declaring or paying dividends if it is in breach of its enhanced capital requirement, solvency margin or minimum liquidity ratio or if the declaration or payment of such dividend would cause such a breach. Where an insurer fails to meet its solvency margin or minimum liquidity ratio on the last day of any financial year, it is prohibited from declaring or paying any dividends during the next financial year without the approval of the BMA in its absolute discretion. Further, FIBL may be prohibited from declaring or paying in any financial year any dividend of more than 25% of its total statutory capital and surplus, unless it files with the BMA an affidavit stating that it will continue to meet its solvency margin or minimum liquidity ratio. FIBL will be required to obtain the BMAs prior approval for a reduction by 15% or more of the total statutory capital as set forth in its previous years financial statements.
In addition, the Bermuda Companies Act 1981 (the Companies Act) limits the FIHLs ability to pay dividends to shareholders. Under Bermuda law, when a company issues shares, the aggregate paid in par value of the issued shares comprises the companys share capital account. When shares are issued at a premium the amount paid in excess of the par value must be allocated to and maintained in a capital account called the share premium account. The Companies Act requires shareholder approval prior to any reduction of the FIHLs share capital or share premium account.
Under Bermuda law, FIHL may not declare or pay dividends, or make a distribution out of contributed surplus, if there are reasonable grounds for believing that (i) it is, or would after the payment be, unable to pay its liabilities as they become due; or (ii) the realizable value of its assets would thereby be less than its liabilities.
The PRA regulatory requirements impose no explicit restrictions on the Groups U.K. subsidiaries ability to pay a dividend, but the Group would have to notify the PRA 28 days prior to any proposed dividend payment. Additionally, under the U.K. Companies Act 2006, dividends may only be distributed from profits available for distribution.
With respect to FIID, the Group would have to notify the CBI prior to any proposed dividend payment and FIID would only be permitted to proceed with the dividend if no communication is received from the CBI within 30 days of the notification. Additionally, under Irish company law, dividends may only be distributed from profits available for distribution, which consist of accumulated realized profits less accumulated realized losses.
Any difficulty or FIHLs inability to receive dividends from its operating subsidiaries would have a material adverse effect on the Groups business, prospects, financial condition or results of operations.
83
No market currently exists for our Common Shares, and an active, liquid trading market for our Common Shares may not develop, which may cause our Common Shares to trade at a discount from the initial offering price and make it difficult to sell the Common Shares.
Prior to this offering, there has not been a public trading market for our Common Shares. The Group cannot predict the extent to which investor interest in FIHL will lead to the development of a trading market or how active and liquid that market may become. If an active and liquid trading market does not develop or continue, investors may have difficulty selling their Common Shares at an attractive price or at all. The initial public offering price per Common Share will be determined by negotiations between the Group and the underwriters, and may not be indicative of the price at which Common Shares will trade in the public market following the consummation of this offering. The market price of our Common Shares may decline below the initial offering price and investors may not be able to sell their Common Shares at or above the price they paid in this offering, or at all.
The price per Common Share may change significantly following this offering, and investors may not be able to resell their Common Shares at or above the price they paid or at all, and investors could lose all or part of their investment as a result.
The Group and the underwriters will negotiate to determine the initial public offering price. Investors may not be able to resell their Common Shares at or above the initial public offering price due to a number of factors such as those listed in this Risk Factors section and the following:
| occurrence of a large catastrophic loss; |
| results of operations that vary from the expectations of securities analysts and investors; |
| results of operations that vary from those of the Groups competitors compared to market expectations; |
| changes in expectations as to the Groups future financial performance, including financial estimates and investment recommendations by securities analysts and investors; |
| changes in market valuations of, or earnings and other announcements by, companies in the (re)insurance industry; |
| declines in the market prices of stocks generally, particularly those in the (re)insurance industry; |
| announcements by the Group or its competitors of significant contracts, new products or technologies, acquisitions, joint ventures, other strategic relationships or capital commitments; |
| changes in general economic or market conditions or trends in the (re)insurance industry or the economy as a whole and, in particular, in the softening of rates; |
| changes in business or regulatory conditions which adversely affect the (re)insurance industry, the Group or Fidelis MGU; |
| future issuances, exchanges or sales, or expected issuances, exchanges or sales of the Common Shares or other securities of FIHL; |
| investor perceptions, of or the investment opportunity associated with, the Common Shares relative to other investment alternatives; |
| the markets reaction to the Groups outsourced underwriting arrangements with Fidelis MGU, which is a novel structure among the Groups peers; |
| the markets reaction to the Groups reduced disclosure and other requirements as a result of being treated as a foreign private issuer; |
| the publics response to press releases or other public announcements by the Group or third parties, including the Groups filings with the SEC; |
84
| guidance, if any, that the Group provides to the public, any changes in this guidance or the Groups failure to meet this guidance; |
| the development and sustainability of an active trading market for our Common Shares; and |
| other events or factors, including those resulting from informational technology system failures and disruptions, natural disasters, war, acts of terrorism or responses to these events. |
Furthermore, the stock market has experienced and is likely to continue to experience extreme volatility and significant price and volume fluctuations that, in some cases, have been and may be unrelated or disproportionate to the operating performance of particular companies. These broad market and industry fluctuations may adversely affect the market price of our Common Shares, regardless of our actual operating performance. In addition, price volatility may be greater if the public float and trading volume of our Common Shares is low.
In the past, following periods of market volatility, shareholders have instituted securities class action litigation. If the Group were to become involved in securities litigation, it could have a substantial cost and divert resources and the attention of executive management from our business regardless of the outcome of such litigation.
If securities or industry analysts do not publish research or reports about the Groups business or if they downgrade the Common Shares or the (re)insurance industry generally, or if there is any fluctuation in the Groups ratings, the price of the Common Shares and trading volume could decline.
The trading market for our Common Shares will rely in part on the research and reports that industry or financial analysts publish about the Group and its business. The Group does not control these analysts. Furthermore, if one or more of the analysts who do cover the Group downgrade the Common Shares or the (re)insurance industry, or the stock of any of the Groups competitors, or publish inaccurate or unfavorable research about the Groups business, the price of Common Shares could decline. If one or more of these analysts stop covering the Group or fail to publish reports on it regularly, we could lose visibility in the market, which in turn could cause the price or trading volume of the Common Shares to decline.
Additionally, any fluctuation in the Groups ratings may impact the Groups ability to access debt markets in the future or increase the cost of future debt, which could have a material adverse effect on the Groups operations and financial condition, which in return may adversely affect the trading price of the Common Shares.
As a foreign private issuer, there is less required publicly available information concerning FIHL than there would be if it were a U.S. public company.
FIHL is a foreign private issuer, as defined in the SECs rules and regulations and, consequently, it is not subject to all of the disclosure requirements applicable to public companies organized within the U.S. For example, FIHL is exempt from certain rules under the Exchange Act that regulate disclosure obligations and procedural requirements related to the solicitation of proxies, consents or authorizations applicable to a security registered under the Exchange Act, including the U.S. proxy rules under Section 14 of the Exchange Act. In addition, FIHLs senior management and directors are exempt from the reporting and short-swing profit recovery provisions of Section 16 of the Exchange Act and related rules with respect to their purchases and sales of Common Shares or FIHLs other securities. Moreover, FIHL is not required to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. public companies.
If FIHL or its existing shareholders sell additional Common Shares after this offering or are perceived by the public markets as intending to sell additional Common Shares, the market price of the Common Shares could decline.
The sale of substantial amounts of Common Shares in the public market, or the perception that such sales could occur, could harm the prevailing market price of the Common Shares. These sales, or the possibility that
85
these sales may occur, also might make it more difficult for FIHL to sell Common Shares in the future at a time and at a price that it deems appropriate. Upon consummation of this offering, FIHL will have a total of 116,486,183 Common Shares outstanding. All of the Common Shares sold in this offering will be freely tradable without restriction or further registration under the Securities Act, by persons other than our affiliates, as that term is defined under Rule 144 of the Securities Act. Certain existing holders of our Common Shares and holders of Common Shares issued following the exercise of the outstanding warrants and RSUs have registration rights, pursuant to the Registration Rights Agreement (as defined below), subject to some conditions, to require us to file registration statements covering the sale of their shares or to include their shares in registration statements that we may file for ourselves or other shareholders in the future. In the event that we register the Common Shares for the holders of registration rights, they can be freely sold in the public market upon issuance. See Shares Eligible for Future Sale and Material Contracts and Related Party TransactionsRegistration Rights Agreement.
The Selling Shareholders have agreed, subject to certain exceptions, not to dispose of or hedge any Common Shares for 180 days from the date of this prospectus, except with the underwriters prior written consent. See Underwriting. Upon the expiration of these lock-up agreements, all of such Common Shares will be eligible for resale in the public market, subject, in the case of Common Shares held by our affiliates, to volume, manner of sale and other limitations under Rule 144 and Rule 701. The market price of the Common Shares may decline when the restrictions on resale lapse. A decline in the price of our Common Shares might impede our ability to raise capital through the issuance of additional Common Shares or other equity securities. See Description of Share Capital and Shares Eligible for Future Sale.
Certain securities of FIHL rank senior to the Common Shares.
FIHL has previously issued certain securities that rank senior to the Common Shares. FIHL has in issue a number Series A Preference Securities as well as certain Notes (see Managements Discussion and Analysis of Financial Condition and Results of OperationsCapital Management). Both the Series A Preference Securities and the Notes rank senior to the Common Shares and have prior rights to interest payments, income and capital which may significantly affect FIHLs capital attributable to the Common Shares and the likelihood that the Board will declare dividends payable on Common Shares. At March 31, 2023 FIHL had $58.4 million outstanding in liquidation preference of the Series A Preference Securities. See Description of Share Capital.
The Group may require additional capital in the future, which may not be available to it on satisfactory terms, if at all. Furthermore, the Groups raising of additional capital could dilute the ownership interest of the holders of Common Shares and reduce the value of their investment. The Group may have to raise capital following significant insured losses, potentially resulting in capital being raised at valuations significantly below the original Common Share price.
The Group will require liquidity from sources of cash flows from operating, financing or investing activities to:
| pay claims; |
| fund its operating expenses; |
| to the extent declared, pay dividends (including the payment of dividends to the holders of the Series A Preference Securities); |
| fund liquidity needs caused by investment losses; |
| replace or improve capital in the event of a depletion of the Groups capital as a result of significant reinsurance losses or adverse reserve developments; |
| satisfy unfunded obligations in the event that it cannot obtain recoveries from its outwards reinsurance and retrocessional protection; |
86
| satisfy letters of credit or guarantee bond requirements that may be imposed by its clients or by its regulators; |
| meet rating agency or regulatory capital requirements; |
| respond to competitive pressures; and |
| service its debt, including paying interest due on the Notes. |
To the extent that the cash flow generated by the Groups ongoing operations or investments is insufficient or unavailable, whether due to regulatory or contractual restrictions, underwriting or investment losses or otherwise, to cover its liquidity requirements, the Group may need to raise additional funds through financing. If the Group cannot obtain adequate capital or sources of credit on favorable terms, or at all, its business, results of operations or financial condition could be materially adversely affected.
Financial markets have experienced extreme volatility and disruption due in part to financial stresses affecting the liquidity of the banking system and the financial markets generally. These circumstances have reduced access to the public and private equity and debt markets at such times.
Future offerings of debt or equity securities which would rank senior to the Common Shares may adversely affect the market price of the Common Shares.
If, in the future, FIHL decides to issue debt or equity securities that rank senior to the Common Shares, it is likely that such securities will be governed by an indenture or other instrument containing covenants restricting the Groups operating flexibility. Additionally, any convertible or exchangeable securities that FIHL may issue in the future may have rights, preferences and privileges more favorable than those of the Common Shares and may result in dilution to owners of the Common Shares. FIHL and, indirectly, its shareholders, will bear the cost of issuing and servicing such securities.
The Group takes a proactive approach to capital management based on opportunities presented and sought out. The Group may therefore seek to raise additional funds through opportunistic financings in order to take advantage of market conditions and opportunities to write more business. FIHL may raise such funds by issuing further securities including equity and debt, whether senior or subordinated in ranking.
Because the decision to issue debt or equity securities in any future offering will depend on market conditions and other factors beyond the Groups control, the Group cannot predict or estimate the amount, timing or nature of such future offerings. Thus, holders of Common Shares will bear the risk of future offerings reducing the market price of the Common Shares and diluting the value of their holdings in FIHL.
Prior to the consummation of this offering, the current bye-laws of FIHL (the Existing Bye-Laws) will be amended and restated (the Amended and Restated Bye-Laws). The Amended and Restated Bye-Laws contain provisions that could impede an attempt to replace or remove the Board or delay or prevent the sale of FIHL, which could diminish the value of the Common Shares or prevent holders of Common Shares from receiving premium prices for their Common Shares in an unsolicited takeover.
The Amended and Restated Bye-Laws contain certain provisions that could delay or prevent changes in the Board or a change of control that a shareholder might consider favorable. These provisions may encourage companies interested in acquiring FIHL to negotiate in advance with the Board, since the Board has the authority to overrule the operation of several of the limitations. Even in the absence of a takeover attempt, these provisions may adversely affect the value of the Common Shares if they are viewed as discouraging takeover attempts in the future. For example, provisions in the Amended and Restated Bye-Laws that could delay or prevent a change in the Board or management or change in control include:
| the authorized number of directors may be increased by resolution adopted by the affirmative vote of a simple majority of the Board; |
87
| each of the Founders and MGU HoldCo has the right to nominate one individual to serve as a director on the Board and the Founders jointly, have the right to nominate one individual to serve as a director on the Board, subject to certain conditions; |
| following the listing of the Common Shares on NYSE, the Board will be a classified board in which the directors of the class elected at each annual general meeting hold office for a term of three years, with the term of each class expiring at successive annual general meetings of shareholders. The classified board will be in place until the annual general meeting occurring in 2030, following which, all of the directors shall be of one class and shall serve for a term ending at the next following annual general meeting; |
| shareholders may fill any vacancy on the Board at the meeting at which such director is removed, provided that in the event the vacancy to be filled is for a director nominated by a Founder or MGU HoldCo, then the relevant Founder or MGU HoldCo shall have the right to nominate a person to fill such vacancy and the Board shall promptly fill the vacancy with such successor nominee; it being understood that any such nominee shall serve the remainder of the term of the director whom such nominee replaces; |
| each of the Founders and MGU HoldCo has a consent right before any amendments are made to the Amended and Restated Bye-Laws conferring special rights unto them so long as they each beneficially own a specified minimum percentage of our Common Shares or they have a designated director serving on the Board. These provisions relate to, among other things, the governance rights held by each of the Founders and MGU HoldCo and which are similarly reflected in the Amended and Restated Common Shareholders Agreement; |
| advance notice of shareholders proposals is required in connection with annual general meetings; and |
| a simple majority vote of shareholders is required to effect certain amendments to the Amended and Restated Bye-Laws. |
Any such provision could prevent the shareholders from receiving the benefit from any premium to the market price of the Common Shares offered by a bidder in a takeover context. Moreover, jurisdictions in which the Groups subsidiaries are domiciled have laws and regulations that require regulatory approval of a change in control of an insurer or an insurers holding company. Where such laws apply to the Group, there can be no effective change in our control unless the person seeking to acquire control has filed a statement with the regulators and has obtained prior approval for the proposed change from such regulators. The usual measure for a presumptive change in control pursuant to these laws is the acquisition of 10% or more of the voting power of the insurance company or its parent, although this presumption is rebuttable in some jurisdictions. Consequently, a person may not acquire 10% or more of the Common Shares without the prior approval of insurance regulators in the jurisdiction in which our subsidiaries are domiciled.
The Amended and Restated Common Shareholders Agreement will confer certain consent rights on MGU HoldCo and the Founders, which will allow them to exercise a certain amount of control over FIHL and limit other shareholders ability to influence the outcome of matters submitted to a shareholder vote.
Upon the completion of the Separation Transactions, MGU HoldCo became a 9.9% holder of our Common Shares. Under the terms of the Amended and Restated Common Shareholders Agreement, for so long as MGU HoldCo holds at least 4.9% of our Common Shares, once listed, the consent of MGU HoldCo is required to undertake a number of key corporate actions requiring shareholder approval, thereby having the ability to exercise substantial control over such actions, irrespective of how FIHLs other shareholders may vote. Additionally, in relation to any proposed issuance of further Common Shares, MGU HoldCo has the benefit of an Allocation Right (as defined below; see Material Contracts and Related Party TransactionsConsent Rights and Minority Protections) effectively allowing it to purchase up to its pro rata portion of the Common Shares at a specific price and within a specific period, in accordance with the terms of the Amended and Restated Common Shareholders Agreement. There can be no assurance that courts and regulators will continue to permit consent, director appointment and other rights granted through a shareholders agreement. For the avoidance of doubt, if,
88
following the consummation of this offering, MGU HoldCo sells any of its Common Shares, other than in connection with any stock conversions, buybacks, repurchases, redemptions, or other changes resulting from any stock split, combination or similar recapitalization, or its ownership of FIHLs Common Shares otherwise falls below 4.9% as a consequence of a dilutive action taken by FIHL, MGU HoldCo will no longer be entitled to exercise its consent rights. See Material Contracts and Related Party Transactions. In addition, MGU HoldCo has a Board nomination right that may enable it to exercise a level of control through a director over corporate actions. See Description of Share CapitalCertain Provisions of the Amended and Restated Bye-LawsNumber of Directors.
For so long as the Founders, together with their Shareholder Affiliate Transferees, in the aggregate beneficially own at least 25% of the Common Shares, the Founders shall have the right, by unanimous decision by each Founder that beneficially owns at least 1% of the Common Shares, to restrict FIHL from taking the following actions, except to the extent such actions are required by applicable law: (i) adopt or propose to FIHLs shareholders any amendment, modification or restatement of or supplement to FIHLs organizational documents which have an adverse impact on the rights granted to the Founders, (ii) commence a voluntary case or proceeding under any applicable U.S. or foreign bankruptcy, insolvency, reorganization or similar law or make an assignment for the benefit of creditors, or admit in writing of its or their inability to pay its or their debts generally as they become due, or take any action in furtherance of any such action, (iii) change the size of the Board, (iv) engage in any transaction in which any person or group acquires more than 50% of the then outstanding Common Shares of FIHL or the power to elect a majority of the members of the Board or (v) terminate or hire the chief executive officer of FIHL or any successor or replacement serving in such role.
MGU HoldCos and the Founders consent rights may also adversely affect the trading price for the Common Shares to the extent investors perceive disadvantages in owning shares of a company with shareholders with the ability to exercise a degree of control and influence over such company. For example, MGU HoldCos and the Founders rights may delay, defer or prevent a change in control of FIHL or impede a merger, takeover or other business combination which may otherwise be favorable for the Group.
Any future exercise of the right of the holders of the Series A Preference Securities to convert, some or all of, their outstanding Series A Preference Securities in exchange for Common Shares in the event of a change of control may dilute the ownership interest of the holders of the Common Shares and reduce the value of their investment in FIHL.
The holders of the Series A Preference Securities have a right to convert some or all of their outstanding Series A Preference Securities in exchange for Common Shares in the event of a change of control of FIHL based on a certain conversion ratio. Any future issuance of Common Shares upon exercise of such right could dilute the ownership interests of the holders of the Common Shares. This may make it more difficult for a potential buyer to effectuate a change of control transaction where holders of Common Shares receive a premium on the Common Shares and may impact the price a potential buyer is willing to pay for FIHL.
U.S. persons who own Common Shares may have more difficulty in protecting their interests than U.S. persons who are shareholders of a U.S. corporation.
The Bermuda Companies Act, which applies to FIHL, differs in certain material respects from laws generally applicable to U.S. corporations and their shareholders. See Comparison of Shareholder Rights for a summary of certain significant provisions of the Bermuda Companies Act and the Amended and Restated Bye-Laws that differ in certain respects from provisions of Delaware corporate law.
The enforcement of civil liabilities against the Group may be difficult.
FIHL is a Bermuda company and some of its directors and officers are residents of various jurisdictions outside the U.S. All or a substantial portion of the Groups assets and the assets of those persons may be located
89
outside the U.S. As a result, it may be difficult for a shareholder to effect service of process within the U.S. upon those persons or to enforce in U.S. courts judgments obtained against those persons.
Puglisi & Associates is our agent for service of process with respect to actions based on offers and sales of securities made in the U.S. The Group has been advised by its special Bermuda legal counsel, Conyers Dill & Pearman Limited, that the U.S. and Bermuda do not currently have a treaty providing for reciprocal recognition and enforcement of judgments of U.S. courts in civil and commercial matters and that a final judgment for the payment of money rendered by a court in the U.S. based on civil liability, whether or not predicated solely upon the U.S. federal securities laws, would, therefore, not be automatically enforceable in Bermuda. The Group has been advised by Conyers Dill & Pearman Limited that a final and conclusive judgment obtained in a court in the U.S. under which a sum of money is payable as compensatory damages (i.e., not being a sum claimed by a revenue authority for taxes or other charges of a similar nature by a governmental authority, or in respect of a fine or penalty or multiple or punitive damages) may be the subject of an action on a debt in the Supreme Court of Bermuda under the common law doctrine of obligation.
Such an action should be successful upon proof that the sum of money is due and payable and without having to prove the facts supporting the underlying judgment, as long as: (i) the court which gave the judgment had proper jurisdiction over the parties to such judgment; (ii) such court did not contravene the rules of natural justice of Bermuda; (iii) such judgment was not obtained by fraud; (iv) the enforcement of the judgment would not be contrary to the public policy of Bermuda; (v) no new admissible evidence relevant to the action is submitted prior to the rendering of the judgment by the courts of Bermuda; and (vi) there is due compliance with the correct procedures under Bermuda law.
A Bermuda court may impose civil liability on FIHL or its directors or officers in a suit brought in the Supreme Court of Bermuda against it or such persons with respect to a violation of U.S. federal securities laws, provided that the facts surrounding such violation would constitute or give rise to a cause of action under Bermuda law.
Members of the Board will be permitted to participate in decisions in which they have interests that are different from those of the other shareholders.
Under Bermuda law, directors are not required to recuse themselves from voting on matters in which they have an interest. The directors may have interests that are different from, or in addition to, the interests of the shareholders. Provided the directors disclose their interests in a matter under consideration by the Board in accordance with Bermuda law and the Amended and Restated Bye-Laws, they will be entitled to participate in the deliberation on and vote in respect of that matter, unless the Board by resolution of a simple majority of the Board (which vote shall exclude the interested director) requires such director to abstain from any vote on the conflicted matter.
Shareholders will be limited in their rights relating to FIHLs operations.
FIHL is managed exclusively by the Board. Shareholders do not make decisions with respect to the management, disposition or other realization of any investment, the day-to-day operations of FIHL and/or the Group, or any other decisions regarding the FIHLs and/or the Groups business and affairs, except for limited circumstances. Specifically, shareholders do not have an opportunity to evaluate for themselves the relevant economic, financial and other information regarding investments or underwriting by the Group. Shareholders should expect to rely solely on the ability of the Board with respect to the FIHLs and the Groups operations.
FIHL is permitted to adopt certain home country practices in relation to its corporate governance, which may afford investors less protection.
As a foreign private issuer, FIHL is permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly from the NYSE corporate governance listing standards.
90
These practices may afford less protection to shareholders than they would enjoy if FIHL complied fully with corporate governance listing standards.
As an issuer whose shares will be listed on NYSE, FIHL will be subject to the corporate governance listing standards of NYSE. However, NYSE rules permit a foreign private issuer like FIHL to follow the corporate governance practices of its home country. FIHL may elect not to comply with certain corporate governance requirements of NYSE.
Certain corporate governance practices in Bermuda, which is our home country, may differ significantly from the NYSE corporate governance listing standards. Currently, FIHL intends to comply with all NYSE corporate governance listing standards for a foreign private issuer. See Management and Corporate Governance. If, however, FIHL chose not to comply with certain NYSE corporate governance listing standards and instead rely on the Bermuda requirements, shareholders may be afforded less protection than they otherwise would have.
FIHL may lose its foreign private issuer status which would then require it to comply with the Exchange Acts domestic reporting regime and cause it to incur additional legal, accounting and other expenses.
For so long as FIHL qualifies as a foreign private issuer, it is not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act applicable to U.S. domestic issuers. In order to maintain its current status as a foreign private issuer, either (a) a majority of Common Shares must be either directly or indirectly owned of record by non-residents of the U.S. or (b)(i) a majority of FIHLs executive officers or directors cannot be U.S. citizens or residents, (ii) more than 50% of FIHLs assets must be located outside the U.S. and (iii) FIHLs business must be administered principally outside the U.S.
If FIHL loses its status as a foreign private issuer, it would be required to comply with the Exchange Act reporting and other requirements applicable to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. FIHL may also be required to make changes in its corporate governance practices in accordance with various SEC and NYSE rules. For example, the annual report on Form 10-K requires domestic issuers to disclose executive compensation information on an individual basis with specific disclosure regarding the domestic compensation philosophy, objectives, annual total compensation (base salary, bonus, and equity compensation) and potential payments in connection with change in control, retirement, death or disability, while the annual report on Form 20-F permits foreign private issuers to disclose compensation information on an aggregate basis. FIHL would also have to mandatorily comply with U.S. federal proxy requirements, and its officers, directors, and principal shareholders will become subject to the short-swing profit disclosure and recovery provisions of Section 16 of the Exchange Act.
The regulatory and compliance costs to the Group under U.S. securities laws if FIHL were required to comply with the reporting requirements applicable to a U.S. domestic issuer may be higher than the cost the Group would incur if FIHL remains a foreign private issuer. As a result, we expect that a loss of foreign private issuer status would increase the Groups legal and financial compliance costs and is likely to make some activities highly time consuming and costly.
91
We estimate that the net proceeds to us from the sale of Common Shares in this offering will be approximately $87.7 million, based upon the assumed initial public offering price of $17.50 per Common Share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, and after deducting the estimated underwriting discounts and estimated offering expenses payable by us. An increase in the offering price above the midpoint of the estimated offering price range set forth on the cover page of this prospectus will result in us selling fewer Common Shares such that our gross proceeds will not exceed $100.0 million. We will not receive any of the proceeds from the sale of our Common Shares in this offering by the Selling Shareholders.
A $1.00 decrease in the assumed initial public offering price of $17.50 per Common Share would decrease the net proceeds that we receive from this offering by approximately $5.4 million, assuming that the number of Common Shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and estimated offering expenses payable by us. An increase in the offering price above the midpoint of the estimated offering price range set forth on the cover page of this prospectus will result in us selling fewer Common Shares such that our gross proceeds will not exceed $100.0 million.
We intend to use the net proceeds to us from this offering to make capital contributions to our insurance operating subsidiaries, which, together with other sources of liquidity, should enable us to take advantage of the ongoing rate hardening in the key markets in which we participate by writing more business under our planned strategy (as discussed in more detail in BusinessOur Strategy and Managements Discussion and Analysis of Financial Condition and Results of OperationsLiquidity and Capital Resources).
This expected use of net proceeds from this offering represents our intentions based on our current plans and business conditions, which could change in the future as our plans and business conditions evolve. As a result, our management will have broad discretion over the uses of the net proceeds from this offering and investors will be relying on the judgment of our management regarding the application of the net proceeds from this offering.
92
The declaration, amount and payment of any dividends on our Common Shares will be at the sole discretion of the Board, which may take into account general and economic conditions, our financial condition and results of operations, our available cash and current and anticipated cash needs, capital requirements, contractual, legal, tax and regulatory restrictions and implications on the payment of dividends by us to our shareholders or by our subsidiaries to us, including restrictions under any of our then outstanding indebtedness, and such other factors as the Board may deem relevant. If we elect to pay dividends in the future, we may reduce or discontinue entirely the payment of such dividends at any time. At the Boards discretion, we declare and pay a dividend quarterly on the Series A Preference Securities, which rank senior to and have priority over the Common Shares. The Board approved a dividend of $225.0 per Series A Preference Security with a record date of February 15, 2023, paid on March 15, 2023. The Board also approved a dividend of $225.0 per Series A Preference Security with a record date of May 15, 2023, to be paid on June 15, 2023. For a more detailed description of the Series A Preference Securities see Material Contracts and Related Party TransactionsPreference Securityholders Agreement.
FIHL is a holding company and, as such, has no substantial operations of its own. FIHL does not expect to have any significant operations or assets other than ownership of the shares of its insurance operating subsidiaries. As a result, we will not be able to pay any dividends unless Current Fidelis insurance operating subsidiaries make distributions in an amount sufficient to cover the dividend that may be declared by FIHL. Moreover, Current Fidelis operating subsidiaries are subject to significant regulatory restrictions limiting their ability to declare and pay dividends to other Group companies. FIHLs ability to pay dividends on Common Shares will also be dependent on the availability of distributable reserves.
93
The following table sets forth our consolidated capitalization at March 31, 2023:
| on a historical basis for Current Fidelis; and |
| on an as-adjusted basis to give effect to our issuance and sale of Common Shares in this offering at an assumed initial public offering price of $17.50 per Common Share, the midpoint of the price range set forth on the cover page of this prospectus, after deducting the estimated underwriting discounts and estimated offering expenses payable by us. We will not receive any proceeds from the sale of our Common Shares by the Selling Shareholders. |
You should read the following table in conjunction with the sections entitled Managements Discussion and Analysis of Financial Condition and Results of Operations and Summary Financial and Operating DataSummary Statement of Operations Data, as well as the audited consolidated financial statements and accompanying notes included elsewhere in this prospectus.
The as-adjusted information set forth in the table below is illustrative only and will be adjusted based on the terms of this offering determined at pricing.
($ in millions) | At March 31, 2023 |
As-adjusted following consummation of this offering(1) |
||||||
Long-term debt obligations: |
||||||||
4.875% Senior Notes due 2030 |
$ | 324.5 | $ | 324.50 | ||||
6.625% Fixed Rate Reset Junior Subordinated Notes due 2041 |
123.2 | 123.2 | ||||||
|
|
|
|
|||||
Total long-term debt obligations |
447.7 | 447.7 | ||||||
|
|
|
|
|||||
Preference securities |
58.4 | 58.4 | ||||||
|
|
|
|
|||||
Shareholders equity: |
||||||||
|
|
|
|
|||||
Common Shares of par value $0.01 per share: 110,771,897 issued and outstanding, actual; and 116,486,183 issued and outstanding, as-adjusted following consummation of this offering. |
1.1 | 1.2 | ||||||
Additional paid-in capital |
1,943.5 | 2,031.2 | ||||||
Accumulated other comprehensive loss |
(76.8 | ) | $ | (76.8 | ) | |||
Retained earnings |
36.7 | 36.7 | ||||||
|
|
|
|
|||||
Total shareholders equity |
$ | 1,904.5 | $ | 1,992.3 | ||||
|
|
|
|
|||||
Total capitalization |
$ | 2,410.6 | $ | 2,498.4 | ||||
|
|
|
|
(1) | The As-adjusted following consummation of this offering column reflects the changes in the capital of FIHL on an as-adjusted basis following the consummation of this offering. A $1.00 decrease in the assumed initial public offering price of $17.50 per Common Share would decrease the net proceeds that we receive from this offering by approximately $5.4 million, assuming that the number of Common Shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and estimated offering expenses payable by us. An increase in the offering price above the midpoint of the estimated offering price range set forth on the cover page of this prospectus will result in us selling fewer Common Shares such that our gross proceeds will not exceed $100.0 million. |
94
If you invest in our Common Shares in this offering, your interest will be immediately diluted to the extent of the difference between the initial public offering price per Common Share in this offering and the book value per Common Share after this offering. At March 31, 2023, we had a historical net book value of $1,904.5 million, or $17.19 per Common Share. Our net book value represents total assets less total liabilities, all divided by the number of Common Shares outstanding on such date.
After giving further effect to the sale of 5,714,286 Common Shares in this offering at an assumed initial public offering price of $17.50 per Common Share, the midpoint of the price range set forth on the cover page of this prospectus and after deducting the estimated underwriting discounts and estimated offering expenses payable by us, our as adjusted net book value at March 31, 2023 would have been $1,992.3 million, or $17.10 per Common Share. This represents an immediate decrease in book value of $0.09 per Common Share to existing shareholders and an immediate dilution in book value of $0.40 per Common Share to new investors purchasing Common Shares in this offering. Dilution per Common Share to new investors is determined by subtracting as adjusted book value per Common Share after this offering from the initial public offering price per Common Share paid by new investors. The following table illustrates this per Common Share dilution:
Assumed initial public offering price per Common Share |
$ | 17.50 | ||||||
Historical book value per Common Share at March 31, 2023 |
$ | 17.19 | ||||||
Decrease in book value per Common Share attributable to this offering |
(0.09 | ) | ||||||
|
|
|||||||
As adjusted book value per Common Share after this offering |
17.10 | |||||||
|
|
|||||||
Dilution in book value per Common Share to new investors in this offering |
$ | 0.40 | ||||||
|
|
A $1.00 decrease in the assumed initial public offering price of $17.50 per Common Share, the midpoint of the price range set forth on the cover page of this prospectus, would decrease, our as adjusted book value per Common Share after this offering by $0.05, and would decrease dilution per Common Share to new investors in this offering by $0.95, in each case assuming that the number of Common Shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and estimated offering expenses payable by us. An increase in the offering price above the midpoint of the estimated offering price range set forth on the cover page of this prospectus will result in us selling fewer Common Shares such that our gross proceeds will not exceed $100.0 million.
The following table summarizes, on an as adjusted basis at March 31, 2023, the differences between the number of Common Shares purchased from us, the total consideration paid and the average price per Common Share paid by existing shareholders and to be paid by the new investors purchasing Common Shares in this offering, at the assumed initial public offering price of $17.50 per Common Share, the midpoint of the price range set forth on the cover page of this prospectus, before deducting the estimated underwriting discounts and estimated offering expenses payable by us:
Common Shares purchased | Total consideration | |||||||||||||||||||
Number | Percent | Amount ($ in millions) |
Percent | Average price per share |
||||||||||||||||
Existing investors |
110,771,897 | 95.1 | % | $ | 1,944.6 | 95.1 | % | $ | 17.55 | |||||||||||
New investors in this offering |
5,714,286 | 4.9 | 100.0 | 4.9 | $ | 17.50 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total |
116,486,183 | 100 | % | $ | 2,044.6 | 100.0 | % |
95
Sales by the Selling Shareholders in this offering will reduce the number of Common Shares held by existing shareholders to 99,343,383, or approximately 85.3% of the total Common Shares outstanding after this offering, and will increase the number of Common Shares held by new investors to 17,142,799, or 14.7% of the total Common Shares outstanding after this offering.
The table above assumes no exercise of the underwriters option to purchase additional Common Shares from the Selling Shareholders in this offering. If the underwriters option to purchase additional Common Shares from the Selling Shareholders is exercised in full, the number of Common Shares held by existing shareholders would be reduced to 83.1% of the total number of Common Shares outstanding after this offering, and the number of Common Shares held by new investors purchasing Common Shares in this offering would be increased to 16.9% of the total number of Common Shares outstanding after this offering.
The number of Common Shares that will be outstanding after this offering is based on 110,771,897 Common Shares issued and outstanding immediately prior to the closing of this offering, and excludes 4,615,500 Common Shares reserved for issuance under our 2023 Long-Term Incentive Plan.
96
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus contains forward-looking statements that are intended to enhance the readers ability to assess our future financial and business performance. These statements are based on the beliefs and assumptions of our management, and are subject to known and unknown risks and uncertainties. Generally, statements that are not about historical facts, including statements concerning our possible or assumed future actions or results of operations, are forward-looking statements. Forward-looking statements include, but are not limited to, statements that represent our beliefs, expectations or estimates concerning future operations, strategies, financial results or performance, financings, investments, acquisitions, expenditures or other developments and anticipated trends and competition in the markets in which we operate. Forward-looking statements can also be identified by the use of forward-looking terminology such as may, believes, intends, anticipates, plans, estimates, targets, potential, will, can have, likely, continue, expects, should, could or similar expressions.
Forward-looking statements are not guarantees of performance and we caution prospective investors not to rely on them. We qualify all of our forward-looking statements by these cautionary statements, because these forward-looking statements are based on estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond our control or are subject to change. Actual results or other outcomes could differ materially from those expressed or implied in our forward-looking statements, as a result of several factors, including the following:
| changes to our strategic relationship with MGU HoldCo or the termination by MGU HoldCo or any of its subsidiaries of any of the Framework Agreement, the Delegated Underwriting Authority Agreements or the Inter-Group Services Agreement; |
| our dependence on the Delegated Underwriting Authority Agreements for our underwriting and claims handling operations; |
| our ability to manage risks associated with macroeconomic conditions resulting from the global COVID-19 pandemic or any other public health crisis, current or anticipated military conflict, including the ongoing Ukraine Conflict, terrorism, sanctions, rising energy prices, inflation and interest rates and other geopolitical events globally; |
| our ability to successfully implement our strategy following the Separation Transactions; |
| our limited operating history; |
| fluctuations in the results of our operations; |
| market reaction amongst clients, brokers and reinsurers and other trading partners to the Separation Transactions and this offering; |
| our ability to compete successfully with more established competitors and risks relating to consolidation in the reinsurance and insurance industries; |
| our losses exceeding our reserves; |
| downgrades, potential downgrades or other negative actions by rating agencies; |
| our dependence on key executives and inability to attract qualified personnel and in particular in very competitive hiring conditions, or the potential loss of Bermudian personnel as a result of Bermuda employment restrictions; |
| our dependence on letter of credit facilities that may not be available on commercially acceptable terms; |
| our potential inability to pay dividends or distributions; |
| our potential need for additional capital in the future and the potential unavailability of such capital to us on favorable terms or at all; |
97
| our dependence on clients evaluations of risks associated with such clients insurance underwriting; |
| the suspension or revocation of our subsidiaries insurance licenses; |
| FIHL potentially being deemed an investment company under U.S. federal securities law; |
| the potential characterization of us and/or any of our subsidiaries as a passive foreign investment company, or PFIC; |
| risks associated with our investment strategy being greater than those faced by competitors; |
| changes in the regulatory environment and the potential for greater regulatory scrutiny of the Group going forward as a result of the outsourcing arrangements; |
| a cyclical downturn of the (re)insurance industry; |
| the impact of inflation or deflation in relevant economies in which we operate; |
| our ability to evaluate and measure our business, prospects and performance metrics; |
| the failure of our risk management policies and procedures to be adequate to identify, monitor and manage risks, which may leave us exposed to unidentified or unanticipated risks; |
| operational failures, including the operational risk associated with the outsourcing to Fidelis MGU, failure of information systems or failure to protect the confidentiality of customer information, including by service providers, or losses due to defaults, errors or omissions by third parties and affiliates; |
| FIHLs status as a foreign private issuer means that it will not be subject to U.S. proxy rules and will be subject to Exchange Act reporting obligations that, to some extent, are more lenient and less frequent than those of a U.S. domestic public company; |
| risks relating to our ability to identify and execute opportunities for growth or our ability to complete transactions as planned or realize the anticipated benefits of our acquisitions or other investments; |
| our ability to maintain effective internal controls and changes in U.S. GAAP; |
| our ability to maintain effective internal controls and procedures under the applicable corporate governance requirements of the Sarbanes-Oxley Act of 2002, the rules adopted by the SEC and the NYSE corporate governance rules and listing standards; |
| our ability to maintain the listing of our Common Shares on NYSE or another national securities exchange; |
| our potentially becoming subject to U.S. federal income taxation; |
| our potentially becoming subject to U.S. withholding and information reporting requirements under the U.S. Foreign Account Tax Compliance Act, or FATCA, provisions; and |
| the other risks identified in this prospectus, including, without limitation, those under the sections titled Risk Factors, Managements Discussion and Analysis of Financial Condition and Results of Operations and Business. |
Consequently, such forward-looking statements should be regarded solely as our current plans, estimates or belief as of the date of this prospectus. We do not intend, and do not undertake, any obligation to update any forward-looking statements to reflect future events or circumstances after the date of this prospectus. Given such limitations, prospective investors should not rely on these forward-looking statements in deciding whether to invest in our Common Shares.
Prospective investors should review carefully the section captioned Risk Factors in this prospectus for a more complete discussion of risks and uncertainties relating to an investment in our Common Shares.
98
References to Previous Fidelis refer to FIHL and its consolidated subsidiaries prior to the consummation of the Separation Transactions and this offering. References to Current Fidelis refer to FIHL and its consolidated subsidiaries following the consummation of the Separation Transactions. Unless otherwise indicated, or the context otherwise requires, references herein to Fidelis, Group, we, our, us, and other similar references refer (i) prior to the consummation of the Separation Transactions and this offering to Previous Fidelis and (ii) following the consummation of the Separation Transactions to Current Fidelis.
Overview
On July 23, 2022, FIHL and MGU HoldCo, among others, entered into a Cooperation Agreement (as defined herein) agreeing to cooperate regarding certain matters related to this offering and the furtherance of the Separation Transactions. See Material Contracts and Related Party TransactionsCooperation Agreement. On January 3, 2023, the Separation Transactions were completed and two distinct holding companies and businesses were created: FIHL and MGU HoldCo.
FIHL is the parent holding company for Current Fidelis. It is the issuer of the Common Shares sold by the holders of Common Shares in this offering and it owns all of the operating insurance carrier subsidiaries of Current Fidelis (i.e., FIBL, FUL and FIID).
MGU HoldCo is the parent holding company of Fidelis MGU that carries on the origination and underwriting activities on behalf of Current Fidelis. MGU HoldCos principal operating subsidiaries are Bermuda MGU, Pine Walk Capital and Pine Walk Europe. The underwriting activities of each of the licensed insurance carriers of Current Fidelis (FIBL, FUL and FIID) are outsourced to the corresponding operating subsidiaries of Fidelis MGU on a jurisdictional basis (Bermuda MGU, Pine Walk Capital and Pine Walk Europe, respectively). Each of the operating subsidiaries of Fidelis MGU has delegated underwriting authority to source and bind contracts for and on behalf of each of FIBL, FUL and FIID, respectively. See Material Contracts and Related Party TransactionsFramework Agreement. MGU HoldCo and its subsidiaries will not be consolidated with FIHL and its subsidiaries. The Fidelis MGUs principal investors include the Alfa Entities, SPFM Holdings, LLC and Capital Z and entities affiliated with Capital Z (each, as defined below), Further Global Capital, Barings LLC, Oak Hill Advisors and Blackstone.
Current Fidelis also has a U.K. service company, FIHL (UK) Services, with a branch in Ireland. MGU HoldCo owns 100% of the outstanding shares of FML, a U.K. service company (which also has a branch in Ireland).
The Separation Transactions involved a number of steps to reorganize the structure of Previous Fidelis and to establish Fidelis MGU - a new, stand-alone platform, comprising a series of jurisdiction-specific managing general underwriting entities (i.e., Bermuda MGU, Pine Walk Capital and Pine Walk Europe, as noted above), each of which entered into a Delegated Underwriting Authority Agreement with the relevant operating insurance carrier subsidiary of Current Fidelis for each applicable jurisdiction (i.e., the United Kingdom, Ireland/the EEA and Bermuda). See BusinessStrategic Relationship with the MGU for further detail. In order to effect the Separation Transactions, FIHL transferred its shares in FML, Fidelis U.S. Holdings, LLC (Fidelis U.S.), Pine Walk Capital and Radius Specialty Limited to MGU HoldCo. As part of the new Fidelis MGU, certain new entities or branches of transferring Group companies were established in the relevant jurisdictions, supported by the necessary personnel, and were authorized to operate as managing general underwriters under the applicable regulatory rules.
In connection with the Separation Transactions, certain capabilities of Previous Fidelis, including underwriting and non-underwriting business support services, were transferred to Fidelis MGU. The underwriting relationship between Current Fidelis and Fidelis MGU is governed primarily by the Framework Agreement, which was entered into by FIHL and MGU HoldCo. There are also a series of jurisdiction-specific Delegated Underwriting Authority Agreements, which were entered into between each of Current Fidelis
99
operating insurance carrier subsidiaries and the applicable subsidiaries of Fidelis MGU. See Material Contracts and Related Party TransactionsFramework Agreement.
FIHL and MGU HoldCo have also entered into the Inter-Group Services Agreement in connection with applicable non-underwriting business support services to be provided by Fidelis MGU to either: (i) FIHL and FIHL (UK) Services; or (ii) upon mutual agreement between FIHL and Fidelis MGU, any entity within Current Fidelis. The covered services include accounting services, other finance and reporting services and IT infrastructure maintenance and system development services. Pursuant to the Inter-Group Services Agreement, MGU HoldCo must place relevant source codes for critical proprietary systems (including Prequel, Jarvis, and FireAnt) in an escrow arrangement.
The Framework Agreement, the Delegated Underwriting Authority Agreements and the Inter-Group Services Agreement are of sufficiently critical importance to the business of Current Fidelis that the arrangements are treated as material outsourcing under the PRA rules, the BMA outsourcing guidance and by the CBI under the Solvency II rules for outsourcing critical or important functions or activities. As a result, these agreements were and are subject to certain regulatory notifications and requirements. See Certain Regulatory Considerations for further detail.
Following the consummation of the Separation Transactions, MGU HoldCo became a shareholder of FIHL, holding 9.9% of our Common Shares. See Material Contracts and Related Party Transactions.
Current Fidelis Structure
The diagram below provides a simplified overview of the principal organizational structure of Current Fidelis, which, other than the percentage ownership changes noted at note (1) below, will remain unchanged following the consummation of this offering. Current Fidelis primarily consists of FIHL and its principal operating insurance subsidiaries, FIBL, FUL and FIID, together with its service company, FIHL (UK) Services.
Current Fidelis Structure
100
(1) | See Principal and Selling Shareholders for detail of the percentage ownership prior to this offering, as well as the percentage ownership of FIHL following the consummation of this offering (including in the event of a full option exercise) by each of MGU HoldCo, the Founders, other institutional investors, management and other existing shareholders. |
(2) | FUL is a limited liability company incorporated in England and Wales, authorized by the PRA and supervised by the FCA and the PRA as an insurer. |
(3) | FIBL is a limited liability company incorporated in Bermuda, authorized and supervised by the BMA as an insurer. |
(4) | FIHL (UK) Services is a limited liability company incorporated in England and Wales and is the service company of Current Fidelis. FIHL (UK) Services also has a branch in Ireland. |
(5) | FEHL is a limited liability company incorporated in England and Wales. |
(6) | FIID is a designated activity company incorporated in Ireland, is authorized and supervised by the CBI as an insurer. |
Fidelis MGU
The diagram below provides a simplified overview of Fidelis MGUs principal organizational structure. Fidelis MGU primarily consists of MGU HoldCo and the platforms managing general underwriting entities, Pine Walk Capital in the U.K., Pine Walk Europe, a Belgian company operating via its Ireland and U.K. branches, and Bermuda MGU, together with FML as the service company of Fidelis MGU.
Fidelis MGU Group Structure
101
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
The following unaudited pro forma condensed combined financial information gives effect to the Separation Transactions and the related transaction accounting and autonomous entity adjustments. The unaudited pro forma condensed combined financial information should be read in conjunction with our audited consolidated financial statements and the accompanying notes at and for the year ended December 31, 2022 included elsewhere in this prospectus.
The unaudited pro forma condensed combined statement of income for the year ended December 31, 2022 has been prepared to give effect to the Separation Transactions as if these transactions had occurred on January 1, 2022.
The unaudited pro forma condensed combined balance sheet at December 31, 2022 has been prepared to give effect to the Separation Transactions as if these transactions had occurred on December 31, 2022.
Basis of Pro Forma Presentation
The following unaudited pro forma condensed combined financial information and related notes (the Pro Forma Financial Information) has been prepared in accordance with Article 11 of Regulation S-X, as amended by the final rule, Release No. 33-10786, and has been derived from the historical consolidated financial statements of the Group that were prepared in accordance with U.S. GAAP, adjusted to reflect expected effects of the Separation Transactions.
The unaudited pro forma condensed combined financial information is presented, to give effect to adjustments which are considered necessary to enable an understanding of the entities and their operations after the Separation Transactions, including:
Transaction Accounting Adjustments which include:
| the impact of the Separation Transactions in respect of the distribution of Fidelis MGU to the FIHL shareholders, resulting in the deconsolidation and consequent elimination of the net assets of Fidelis MGU and its subsidiaries, and |
| other adjustments including the acceleration of vesting of restricted stock units, the exercise of warrants, and the related tax impact of these adjustments. |
Autonomous Entity Adjustments which reflect the impact of certain agreements as part of the Separation Transactions. These include:
| the inclusion of commissions and expenses that will be paid to Fidelis MGU for sourcing and managing the insurance business under the Framework Agreement, |
| the impact of additional costs for staff and services that will be required by the Group to undertake certain functions as a standalone entity, |
| the removal of costs in respect of employees and related overheads that have transferred to Fidelis MGU, and |
| the inclusion of costs reflecting the charges set out in the Inter-Group Services Agreement for the services to be provided by Fidelis MGU, and |
| the inclusion of commissions and expenses that will be paid to Fidelis MGU for sourcing and managing the insurance business under the Framework Agreement. |
See Material Contracts and Related Party Transactions for further information on the charges expected to be levied on the Group in accordance with the Framework Agreement and Inter-Group Services Agreement.
102
The unaudited pro forma condensed combined financial information is provided for illustrative and informational purposes only. The pro forma adjustments are based upon available information and certain assumptions that management believes are reasonable, that reflect the impact of the Separation Transactions as if they had been consummated at a prior date. The unaudited pro forma condensed combined financial information is not necessarily indicative of the financial results that would have been obtained had the Separation Transactions occurred on and at the dates referenced above and should not be viewed as indicative of the results of operations or financial position of the Group in future periods.
Fidelis Insurance Holdings Limited
Unaudited Pro Forma Condensed Combined Balance Sheet At December 31, 2022
(Expressed in millions of U.S. dollars)
FIHL at December 31, 2022 |
Transaction Accounting Adjustments |
Autonomous Entity Adjustments |
Pro Forma Balance Sheet |
|||||||||||||
Assets | ||||||||||||||||
Fixed maturity securities, available-for-sale at fair value | $ | 2,050.9 | $ | | $ | | $ | 2,050.9 | ||||||||
Short-term investments, available-for-sale at fair value | 257.0 | 257.0 | ||||||||||||||
Other investments, at fair value | 117.1 | 117.1 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total investments | $ | 2,425.0 | $ | | $ | | $ | 2,425.0 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Cash and cash equivalents | 1,222.0 | (231.5 | ) (a) (b) | 990.5 | ||||||||||||
Restricted cash and cash equivalents | 185.9 | 185.9 | ||||||||||||||
Derivative assets, at fair value | 6.3 | 6.3 | ||||||||||||||
Accrued investment income | 10.9 | 10.9 | ||||||||||||||
Investments pending settlement | 2.0 | 2.0 | ||||||||||||||
Premiums and other receivables | 1,862.7 | 9.3 | (a) | 1,872.0 | ||||||||||||
Deferred reinsurance premiums | 823.7 | 823.7 | ||||||||||||||
Reinsurance balances recoverable on paid losses | 159.4 | 159.4 | ||||||||||||||
Reinsurance balances recoverable on reserves for losses and loss adjustment expenses | 976.1 | 976.1 | ||||||||||||||
Deferred policy acquisition costs | 515.8 | 0.2 | (a) | 516.0 | ||||||||||||
Deferred tax asset | 58.5 | (7.3 | ) (a) | 51.2 | ||||||||||||
Operating right of use assets | 26.8 | 26.8 | ||||||||||||||
Other assets | 37.4 | (11.8 | ) (a) | 25.6 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Assets | $ | 8,312.5 | $ | (241.1 | ) | $ | | $ | 8,071.4 | |||||||
|
|
|
|
|
|
|
|
|||||||||
Total shareholders equity attributable to common shareholders | ||||||||||||||||
Liabilities | ||||||||||||||||
Reserves for losses and loss adjustment expenses | 2,045.2 | 2,045.2 | ||||||||||||||
Unearned premiums | 2,618.6 | 2,618.6 | ||||||||||||||
Reinsurance balances payable | 1,057.0 | 1,057.0 | ||||||||||||||
Long term debt | 447.5 | 447.5 | ||||||||||||||
Preference securities | 58.4 | 58.4 | ||||||||||||||
Other liabilities | 70.2 | (52.4 | ) (a) | 17.8 | ||||||||||||
Operating lease liabilities | 28.5 | 28.5 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Liabilities | $ | 6,325.4 | $ | (52.4 | ) | $ | | $ | 6,273.0 | |||||||
|
|
|
|
|
|
|
|
103
FIHL at December 31, 2022 |
Transaction Accounting Adjustments |
Autonomous Entity Adjustments |
Pro Forma Balance Sheet |
|||||||||||||
Shareholders equity | ||||||||||||||||
Ordinary shares | 1.9 | 1.9 | ||||||||||||||
Additional paid-in capital | 2,075.2 | (132.4 | ) (c) | 1,942.8 | ||||||||||||
Accumulated other comprehensive loss | (100.8 | ) | 1.1 | (d) | (99.7 | ) | ||||||||||
Accumulated deficit | 0.5 | (47.1 | ) (e) | (46.6 | ) | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total shareholders equity attributable to common shareholders | $ | 1,976.8 | $ | (178.4 | ) | $ | | $ | 1,798.4 | |||||||
|
|
|
|
|
|
|
|
|||||||||
Non-controlling interests | 10.3 | (10.3 | ) (f) | | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total shareholders equity including non-controlling interests | 1,987.1 | $ | (188.7 | ) | $ | | $ | 1,798.4 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities and shareholders equity | $ | 8,312.5 | $ | (241.1 | ) | $ | | $ | 8,071.4 | |||||||
|
|
|
|
|
|
|
|
Explanatory notes (a) to (f) are contained within note 4 Transaction Accounting Adjustments of this unaudited pro forma condensed combined financial information.
104
Fidelis Insurance Holdings Limited
Unaudited Pro Forma Condensed Combined Statement of Operations for the year ended December 31, 2022
(Expressed in millions of U.S. dollars except for per share data)
FIHL 2022 |
Transaction Accounting Adjustments |
Autonomous Entity Adjustments |
Pro Forma Statement of Operations |
|||||||||||||
Revenues |
||||||||||||||||
Gross premiums written |
$ | 3,000.1 | $ | $ | (10.3 | ) (i) | $ | 2,989.8 | ||||||||
Reinsurance premiums ceded |
(1,137.5 | ) | (5.4 | ) (m) | (1,142.9 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net premiums written |
1,862.6 | | (15.7 | ) | 1,846.9 | |||||||||||
Change in net unearned premiums |
(357.9 | ) | (357.9 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net premiums earned |
1,504.7 | | (15.7 | ) | 1,489.0 | |||||||||||
Net investment losses |
(33.7 | ) | (33.7 | ) | ||||||||||||
Net investment income |
40.7 | (0.1 | ) (i) | 40.6 | ||||||||||||
Net foreign exchange gains |
6.8 | (2.7 | ) (i) | 4.1 | ||||||||||||
Net gain on distribution of Fidelis MGU | | 1,638.1 | (g) | 1,638.1 | ||||||||||||
Other income | 1.9 | (1.6 | ) (i) | 0.3 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenues | $ | 1,520.4 | $ | 1,638.1 | $ | (20.1 | ) | $ | 3,138.4 | |||||||
|
|
|
|
|
|
|
|
|||||||||
Expenses | ||||||||||||||||
Losses and loss adjustment expenses | 830.2 | 830.2 | ||||||||||||||
Policy acquisition expenses (includes Fidelis MGU commissions of $119.5) |
447.7 | 81.7 | (j) | 529.4 | ||||||||||||
General and administrative expenses | 106.4 | (35.3 | ) (k) | 71.1 | ||||||||||||
Corporate and other expenses | 20.5 | (1.9 | ) (i) | 18.6 | ||||||||||||
Financing costs | 35.5 | 35.5 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total expenses | $ | 1,440.3 | $ | | $ | 44.5 | $ | 1,484.8 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income before tax | 80.1 | 1,638.1 | (64.6 | ) | 1,653.6 | |||||||||||
Income tax expense | (17.8 | ) | 10.7 | (h) | 5.8 | (l) | (1.3 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income | $ | 62.3 | $ | 1,648.8 | $ | (58.8 | ) | $ | 1,652.3 | |||||||
|
|
|
|
|
|
|
|
|||||||||
Net income attributable to non-controlling interests | (9.7 | ) | 9.7 | (f) | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income available to common shareholders | $ | 52.6 | $ | 1,658.5 | $ | (58.8 | ) | $ | 1,652.3 | |||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive gain (loss) | ||||||||||||||||
Unrealized loss on AFS assets | (96.5 | ) | (96.5 | ) | ||||||||||||
Income tax benefit | 8.1 | 8.1 | ||||||||||||||
Currency translation adjustments | (1.1 | ) | 1.1 | (d) | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other comprehensive loss | $ | (89.5 | ) | $ | 1.1 | $ | | $ | (88.4 | ) | ||||||
|
|
|
|
|
|
|
|
|||||||||
Comprehensive gain (loss) attributable to common shareholders | $ | (36.9 | ) | $ | 1,659.6 | $ | (58.8 | ) | $ | 1,563.9 | ||||||
|
|
|
|
|
|
|
|
|||||||||
Per share data | ||||||||||||||||
Earnings per common share: | ||||||||||||||||
Earnings per common share: | 0.27 | 14.91 | ||||||||||||||
Earnings per diluted common share | 0.26 | 14.91 | ||||||||||||||
Weighted average common shares outstanding | 194.3 | 110.8 | ||||||||||||||
Weighted average diluted common shares outstanding | 199.4 | 110.8 |
Explanatory notes (d), (f), (g) and (h) are contained within note 4 Transaction Accounting Adjustments of this unaudited pro forma condensed combined financial information.
Explanatory notes (i) to (m) are contained within note 5 Autonomous Entity Adjustments of this unaudited pro forma condensed combined financial information.
105
Notes To The Unaudited Pro Forma Condensed Combined Financial Information
Note 1. Basis of Presentation
The accompanying unaudited pro forma condensed combined financial information and related notes have been prepared in accordance with Article 11 of Regulation S-X, as amended by the final rule, Release No. 33-10786 and have been derived from the historical combined financial statements of the Group.
The unaudited pro forma condensed combined financial information reflect pro forma adjustments that are described in the accompanying notes and are based on available information and certain assumptions that the Group believes are reasonable. However, actual results may differ from those reflected in these unaudited pro forma condensed combined financial information. In the Groups opinion, all adjustments that are necessary to present fairly the pro forma information have been made. The unaudited pro forma condensed combined financial information does not purport to represent what the Groups financial position or results of operations would have been if the Separation Transactions had actually occurred on the dates indicated above, nor are they indicative of FIHLs future financial position or results of operations. The unaudited pro forma condensed combined financial information should be read in conjunction with the historical financial statements and related notes thereto for the periods presented, as included elsewhere in this prospectus.
Note 2. Unaudited Pro Forma Condensed Combined Balance Sheet
For purposes of preparing the unaudited pro forma condensed combined balance sheet at December 31, 2022, the Separation Transactions will be accounted for as if they had occurred on December 31, 2022. The unaudited pro forma condensed combined balance sheet includes the impact of the Separation Transactions in respect of the distribution of Fidelis MGU to the FIHL shareholders, resulting in the deconsolidation and consequent elimination of the net assets of Fidelis MGU and its subsidiaries. Refer to note 25 (Subsequent Events) of our audited consolidated financial statements contained elsewhere in this prospectus for further information on the accounting treatment of the Separation Transactions.
As discussed in note 25 (Subsequent Events) of our audited consolidated financial statements contained elsewhere in this prospectus, following the consummation of the Separation Transactions, Fidelis MGU acquired 9.9% of the Common Shares of FIHL. Such Common Shares were acquired in private transactions with the Groups shareholders and did not impact the number of issued and outstanding Common Shares or the cash flows of the Group. Accordingly, these sales by shareholders are not reflected within this pro forma condensed combined balance sheet.
Note 3. Unaudited Pro Forma Condensed Combined Statement of Operations
For the purposes of preparing the unaudited pro forma condensed combined statement of operations for the year ended December 31, 2022, the autonomous entity adjustments are accounted for as if they had occurred on January 1, 2022. With respect to the transaction accounting adjustments, we have also taken account of the impact of additional expenses that were incurred from the consummation of the Separation Transactions.
Note 4. Transaction Accounting Adjustments
The unaudited pro forma condensed combined balance sheet and statement of operations include the following transaction accounting pro forma adjustments:
a. | To reflect the removal of the assets and liabilities of Fidelis MGU. |
We note that premiums and other receivables have increased by $9.3 million. This amount represents premiums receivable that were collected by Pine Walk Capital from third parties on or prior to December 31, 2022 but not remitted to the insurance operating subsidiaries of the Group. In the pro forma condensed combined balance sheet, these amounts have been reclassified from cash and cash equivalents to premiums and other receivables.
106
b. | To reflect the impact on cash and cash equivalents of the removal of Fidelis MGU in the amount of $111.6 million plus the payment of various expenses and employee tax on net settled share compensation awards related to the Separation Transactions in the amount of $119.9 million. |
c. | To reflect the impact on additional paid-in capital of the transaction accounting adjustments. |
d. | To reflect the elimination of the currency translation adjustment of Fidelis MGU. |
e. | To reflect the impact on accumulated deficit of the transaction accounting adjustments. The following table shows a reconciliation from our U.S. GAAP accumulated deficit to the pro forma accumulated deficit (amounts expressed in millions of U.S. dollars): |
December 31, 2022 |
||||
Accumulated deficit at December 31, 2022 |
0.5 | |||
Fair value of Fidelis MGU at January 3, 2023 |
1,775.0 | |||
Net assets of Fidelis MGU |
(68.8 | ) | ||
Expenses of Separation Transactions |
(68.1 | ) | ||
|
|
|||
Net gain on distribution of Fidelis MGU |
1,638.1 | |||
|
|
|||
Fair value of Fidelis MGU at January 3, 2023 |
1,775.0 | |||
Net assets of Fidelis MGU |
(68.8 | ) | ||
|
|
|||
Distribution of Fidelis MGU to common shareholders |
(1,706.2 | ) | ||
|
|
|||
Tax impact of Transaction Accounting adjustments |
10.7 | |||
Elimination of non-controlling interests |
10.3 | |||
|
|
|||
Pro forma accumulated deficit |
(46.6 | ) | ||
|
|
f. | To reflect the elimination of the non-controlling interests following the distribution of Pine Walk Capital Limited and its subsidiaries as part of the Separation Transaction. |
g. | To reflect the net gain on distribution of Fidelis MGU. The gain has been calculated as the fair value of Fidelis MGU of $1,775 million, less the net assets of Fidelis MGU of $68.8 million and less the direct costs of the Separation Transactions of $68.1 million. Refer to note 25 (Subsequent Events) of our audited consolidated financial statements contained elsewhere in this prospectus for further information on the accounting treatment of the Separation Transactions. |
We have determined the fair value of Fidelis MGU in accordance with the requirements of Financial Accounting Standards Board Accounting Standards Codification 820 Fair Value Measurements (ASC 820). We have obtained the services of a third-party independent valuation expert in arriving at that determination of fair value. ASC 820 explains the concept of fair value for financial reporting. Under ASC 820, fair value is a market-based measurement, not an entity specific measurement. The objective of ASC 820 is to estimate the price at which an orderly transaction to sell the asset would take place between market participants at the measurement date under current market conditions (that is, an exit price at the measurement date from the perspective of a market participant).
When a price for an identical asset is not observable, a reporting entity measures fair value using another valuation technique that maximizes the use of relevant observable inputs and minimizes the use of unobservable inputs. Fair value is measured using the assumptions that market participants would use when pricing the asset or liability, including assumptions about risk.
For purposes of our valuation of Fidelis MGU, we have used an income approach using a discounted cash flow methodology, and a market approach using comparable listed trading and precedent transaction multiples. These approaches generated a range of values for Fidelis MGU of $1.7 billion to $1.9 billion. Our determined fair value for Fidelis MGU of $1.775 billion was based on the price of the most recent transactions in Fidelis MGU shares, and close to the mid-point of the valuation range. On January 3, 2023, following the distribution of Fidelis MGU to shareholders of the Group, certain
107
shareholders sold their shares, and certain third parties purchased shares, in Fidelis MGU at a price per share determined using a fair value of $1.775 billion.
h. | To reflect the income tax effect of the adjustments discussed above, determined using the applicable statutory tax rates of the United Kingdom, Ireland and Bermuda for the year then ended. |
Note 5. Autonomous Entity Adjustments
The unaudited pro forma condensed combined statement of operations includes the following autonomous entity pro forma adjustments:
i. | To reflect the elimination of Fidelis MGU from our combined statement of operations. This includes the profit commission payable to Fidelis MGU, which was recorded as part of GPW, that was previously eliminated on consolidation. We have also removed the impact of amounts earned and expensed by Fidelis MGU for net investment income, net foreign exchange gains, other income and corporate expenses. |
j. | To reflect the effects of the Framework Agreement. Included in the unaudited pro forma condensed combined statement of operations for the year ended December 31, 2022 is an adjustment that reflects incremental commissions associated with underwriting origination performed by Fidelis MGU. The incremental cost represents commissions payable to Fidelis MGU as a percentage of net premiums written on business originated by Fidelis MGU from January 1, 2022. This also includes commission payable to Fidelis MGU subsidiaries, Pine Walk Capital and Pine Walk Europe, that was previously eliminated on consolidation. The amounts calculated assume the commissions that would have been payable to Fidelis MGU for all business written in 2022. The commission payable is deferred and amortized over the related policy period in line with earned premiums. The commission percentage payable to Fidelis MGU will depend on whether the business was sourced in the open market, was sourced by Fidelis MGU via an existing underwriting origination contract with third-party managing general underwriters or has been placed with the Group from subsidiary cells of Pine Walk Capital and Pine Walk Europe. |
We have also reflected incremental portfolio management fees payable to Fidelis MGU as a percentage of net premiums written. The portfolio management fee payable is deferred and amortized over the related policy period in line with earned premiums.
The total of such commissions and portfolio management fee is $119.5 million.
We have reclassified the commissions on ceded business of $61.7 million from general and administrative expenses to policy acquisition expenses. This adjustment has been made to ensure consistency with the presentation of commissions on ceded business in our unaudited consolidated financial statements for the three months ended March 31, 2023 and 2022 (see note 2, Significant Accounting Policies). We have deducted the proportion of the commissions on ceded business of $23.9 million that will be received by Fidelis MGU. The Framework Agreement provides that in respect of commissions on ceded quota share business the Group shall retain 1.0% of reinsurance premiums ceded and the remainder is to be paid to Fidelis MGU. This adjustment only considers the 2022 year of account as all overrider commissions receivable on business ceded in prior years of account will remain to the account of FIHL.
k. | Included in the unaudited pro forma condensed combined statement of operations for the year ended December 31, 2022 is a net decrease to general and administrative expenses that reflects: |
i. | the elimination of the direct staff costs and costs of services of $122.2 million resulting from the deconsolidation of Fidelis MGU. |
ii. | the incremental costs of additional staff and services of $21.7 million required by FIHL necessary to undertake certain functions as a standalone entity independent of Fidelis MGU. |
108
iii. | the effects of the Inter-Group Services Agreement. This reflects the incremental costs of $3.5 million associated with certain finance, human resources and IT services that will be provided by Fidelis MGU. The level of the service costs payable to Fidelis MGU will ultimately depend on the extent of the services that are to be provided. |
iv. | the reclassification of commissions on ceded business of $61.7 million to policy acquisition expenses. |
l. | To reflect the income tax effect of the autonomous entity adjustments, determined using the applicable statutory tax rates of the United Kingdom, Ireland and Bermuda for the year then ended. |
m. | The elimination of profit commissions incurred on certain existing quota share reinsurance contracts ceded to third party reinsurers that will instead be received by Fidelis MGU. This adjustment relates to the 2022 year of account as all profit commissions receivable on business ceded in prior years of account will be earned by FIHL. |
Note 6. Earnings per share
The Separation Transactions resulted in the accelerated vesting and exercise of all restricted stock units and in-the-money warrants, with an additional 13,553,681 Common Shares being issued on January 3, 2023. The distribution of Fidelis MGU to shareholders of FIHL resulted in the cancellation of 97,327,049 Common Shares, with 110,771,897 Common Shares remaining.
Our earnings per share has been restated to take account of the impact on net income available to common shareholders of the transaction accounting and autonomous entity adjustments. We have also restated our basic and diluted shares to reflect the Common Shares in issuance after the Separation Transactions. As all restricted stock units and warrants were issued and exercised as part of the Separation Transactions, our pro-forma basic and diluted earnings per share are equal.
Note 7. Impact on Performance Measures and non-U.S. GAAP financial measures
Below is a description of our unaudited pro forma performance measures and pro forma non-U.S. GAAP financial measures. Our pro forma non-U.S. GAAP financial measures are not measures of financial performance under U.S. GAAP and should not be construed as a substitute for the most directly comparable pro forma U.S. GAAP measures, which are reconciled below. These measures have limitations as analytical tools, and when assessing our operating performance, you should not consider these measures in isolation or as a substitute for GAAP measures. Other companies may calculate these measures differently than we do, limiting their usefulness as a comparative measure. Please refer to Managements Discussion and Analysis of Financial Condition and Results of Operations Performance Measures and Non-U.S. GAAP Financial Measures for further details as to how we calculate these measures and why we believe they are meaningful.
We have not presented a pro forma net investment return percentage and total investment return percentage as the impact of the pro forma adjustments on these performance measures was 0.0% and 0.1%, respectively.
109
The table below shows the impact on our loss ratio, expense ratio and combined ratio of the pro forma adjustments discussed in notes 4 and 5 above ($ in millions unless stated in percentages):
For the Year Ended December 31, 2022 |
||||
Pro Forma | ||||
Losses and loss adjustment expenses |
$ | 830.2 | ||
Pro forma policy acquisition expenses |
409.9 | |||
Pro forma Fidelis MGU commissions |
119.5 | |||
Pro forma general and administrative expenses |
71.1 | |||
|
|
|||
Pro forma total underwriting expenses |
$ | 600.5 | ||
Net premiums earned |
$ | 1,489.0 | ||
Pro forma loss ratio |
55.8 | % | ||
Pro forma expense ratio |
40.3 | % | ||
Pro forma combined ratio |
96.1 | % |
The table below shows the impact on our operating net income, RoE and our Operating RoE of the pro forma adjustments discussed in notes 4 and 5 above ($ in millions unless stated in percentages):
For the Year Ended December 31, 2022 |
||||
Pro Forma | ||||
Opening common shareholders equity |
2,013.9 | |||
Pro forma net income available to common shareholders |
$ | 1,652.3 | ||
Add back: net foreign exchange gains |
(4.1 | ) | ||
Add back: corporate and other expenses |
18.6 | |||
Add back: net gain on distribution of Fidelis MGU |
(1,638.1 | ) | ||
Tax impact of the above |
(12.2 | ) | ||
|
|
|||
Pro forma operating income |
$ | 16.5 | ||
|
|
|||
Pro forma RoE |
82.0 | % | ||
Pro forma Operating RoE |
0.8 | % |
110
MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following is a discussion and analysis of our financial condition and results of operations. This discussion and analysis should be read in conjunction with the section entitled Unaudited Pro Forma Condensed Combined Financial Information, as well as our audited consolidated financial statements for those respective periods and related notes contained therein, which are contained elsewhere in this prospectus. This discussion and analysis contains forward-looking statements that involve risks and uncertainties and that are not historical facts, including statements about our beliefs and expectations. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those discussed below and in this prospectus under the headings Risk Factors, Business and Cautionary Statement Regarding Forward-Looking Statements.
Overview
Fidelis is a global (re)insurance company, with operations in Bermuda, Ireland and the United Kingdom. FIHL was formed in Bermuda in 2014 by Richard Brindle, under the principles of focused, process-driven and disciplined underwriting and risk selection, strong client and broker relationships and nimble capital deployment. Fidelis completed its initial funding and began underwriting business in June 2015 under the direction of an experienced management team led by Richard Brindle. Since then, Fidelis has assembled a diversified global book of (re)insurance business and achieved scale as a specialty (re)insurer with GPW of $3.0 billion, total revenues of $1.5 billion and net income of $62.3 million for the year ended December 31, 2022.
On January 3, 2023, the Separation Transactions were completed and two distinct holding companies and businesses were created: FIHL and MGU HoldCo. FIHL is the parent holding company for Current Fidelis, is the issuer of the Common Shares sold by the Selling Shareholders in this offering and continues to own all of the insurance operating subsidiaries of Current Fidelis, comprised of FIBL, FUL and FIID. Current Fidelis also has its own service company, FIHL (UK) Services, with a branch in Ireland.
MGU HoldCo is the parent holding company for Fidelis MGU that carries on the origination and underwriting activities on behalf of Current Fidelis and is led by Mr. Brindle. MGU HoldCos principal operating subsidiaries are Bermuda MGU, Pine Walk Capital and Pine Walk Europe. The underwriting activities of each of the licensed insurance carriers of Current Fidelis (FIBL, FUL and FIID) are outsourced to the corresponding operating subsidiaries of Fidelis MGU on a jurisdictional basis (Bermuda MGU, Pine Walk Capital and Pine Walk Europe, respectively). Each of the operating subsidiaries of Fidelis MGU has delegated underwriting authority to source and bind contracts for and on behalf of each of FIBL, FUL and FIID, respectively. See Material Contracts and Related Party TransactionsFramework Agreement. MGU HoldCo and its subsidiaries will not be consolidated with FIHL and its subsidiaries.
FIHL and MGU HoldCo have entered into the Framework Agreement that governs the ongoing relationship between the two groups of companies (see BusinessOur Corporate Structure for additional details). Following consummation of the Separation Transactions on January 3, 2023, Mr. Brindles employment agreement and the employment agreements of certain other senior management and other employees of Previous Fidelis are with FML, and Mr. Brindle is now the Chairman and Chief Executive Officer of Fidelis MGU. See The Separation Transactions.
The Separation Transactions allow FIHL to access the underwriting expertise of Fidelis MGU while allowing Fidelis MGU to attract and retain highly sophisticated underwriting talent, including Mr. Brindle and senior underwriters. We believe that the Separation Transactions and the Framework Agreement have structural benefits for both groups of companies, including increased flexibility to quickly respond to evolving insurance and reinsurance market conditions and help sustain our strong underwriting results through access to top talent. Our objective following the completion of the Separation Transactions remains to further solidify Fidelis position as a sophisticated bespoke and specialty underwriter.
111
History
FIHL was established on August 22, 2014 and in 2015 raised $1.5 billion of ordinary equity capital to support its underwriting plans. Following further capital raises in 2019, 2020 and 2021, at December 31, 2022 Fidelis had $1,976.8 million of shareholders equity, $58.4 million of Series A Preference Securities and $447.5 million of long-term debt.
Through FIBL and FUL, Fidelis has offices in Bermuda and London, which we consider to be the largest specialty (re)insurance hubs globally. Fidelis also accesses the E.U. through FIID, which has an office in Ireland.
FIBL is a wholly owned subsidiary of FIHL and was incorporated as an exempted company under the laws of Bermuda on February 26, 2015 and is registered as a Class 4 insurer. FIBL predominantly writes property insurance and reinsurance on a global basis along with certain Bespoke and Specialty lines. FUL is a wholly owned subsidiary of FIHL and was incorporated on August 28, 2015 under the laws of England and Wales. FUL writes predominantly Bespoke and Specialty insurance on a global basis and writes a smaller portion of property reinsurance business relative to FIBL. FIID is an indirect wholly owned subsidiary of FIHL and was incorporated under the laws of Ireland on December 27, 2017. FIID writes Fidelis European Bespoke and Specialty business. As part of its Brexit planning, on March 29, 2019, FIID accepted non-U.K. E.U. insurance policies from FUL through a Part VII transfer under the U.K.s Financial Services and Markets Act of 2000 in preparation for the U.K.s exit from the E.U.
The following discussion and analysis relates to our historical financial results for periods prior to the completion of the Separation Transactions on January 3, 2023, pursuant to which two distinct holding companies and businesses were created, FIHL and MGU HoldCo. FIHL is the parent holding company for Current Fidelis and owns all of the current operating insurance companies of Current Fidelis and is the issuer of the Common Shares sold by the Selling Shareholders in this offering. MGU HoldCo is the parent holding company for Fidelis MGU, the managing general underwriter platform that will lead the origination and underwriting activities of Current Fidelis. Fidelis MGU is led by Mr. Brindle. See The Separation Transactions for further details.
Strategy
Our strategy is to match adequately priced risks with efficient sources of capital to produce strong returns for shareholders.
Fidelis MGU will originate business from multiple sources including brokers, third-party delegated underwriting, existing capital relationships, and open market business originated by its underwriters. Historically, 70.0% of NPW has been sourced in open market activities, with the remainder sourced equally from the existing Pine Walk Capital relationships and third-party managing general underwriters.
Fidelis business consists of the following reportable segments or pillars: Specialty, Bespoke, and Reinsurance.
Fidelis believes that the most effective operating model for a (re)insurance group is to enter into long-term agreements with strategic outsource providers. This operating model will allow us to manage operating expenses effectively and to access strong underwriting, risk management and information technology systems and data. See BusinessStrategic Relationship with the MGU and Material Contracts and Related Party Transactions for more information.
We have incurred costs engaging external advisors to assist in the planning and execution of the Separation Transactions (the Separation Costs). For further detail on the Separation Transactions, see The Separation Transactions. The Separation Costs include, among other things, legal and professional fees. All Separation Costs were incurred prior to consummation of the Separation Transactions and are not expected to reoccur. See Unaudited Pro Forma Condensed Combined Financial Information for the impact of the Separation Transactions on the consolidated financial statements of FIHL.
112
Fidelis Year in Review for 2022
2022 saw continued growth in our GPW to $3,000.1 million from $2,787.7 million in 2021, driven by our Bespoke and Specialty segments. Following another year of continued elevated catastrophe losses in 2021, we significantly reduced the 2022 GPW in our Reinsurance segment. Our combined ratio was slightly lower than the prior year, at 92.1% in 2022 compared to 92.9% in 2021. This was driven by a decrease in our Reinsurance segment loss ratio to 74.3% from 114.2%, partially offset by large losses of $135 million in relation to the Ukraine Conflict. Increases in interest rates generated realized and unrealized losses on investments in 2022, and our income tax expense increased due to more profits being earned in taxable jurisdictions. Our Operating RoE was 3.3% in 2022 compared with 3.6% in 2021.
Following another year of worldwide natural catastrophe losses in excess of $100 billion we have reduced our Reinsurance GPW along with the related exposure. Working with our underwriting, actuarial and modelling teams, as well as external consultants, we developed a proprietary Fidelis View of Risk, which incorporates a science-based estimation of the impact of climate change on atmospheric perils and has meaningfully increased the modeled losses across a range of coverages such as convective storms, floods and wildfires. As a result, we believe the Fidelis View of Risk has the potential to more accurately reflect potential expected losses, compared to industry models and we consider this when pricing and underwriting our risks.
Additionally, we have looked at lessons learned about the wide variance in ceding insurers loss estimation and adjustment capabilities, as well as financial capacity, and we plan to reduce exposure to property treaty clients who score poorly in these assessments. In 2022 this led us to reduce our catastrophe treaty excess-of-loss writings to deploy less capacity to layers that are more exposed to increased frequency of atmospheric peril losses, and to increase pricing on these lines. With respect to loss handling, we see better alignment with our clients in our property D&F portfolio and we view this as a better way to deploy natural catastrophe capacity at this stage of the (re)insurance cycle.
Our swift action in positioning our portfolio for our view of coming market trends is emblematic of our approach to being proactive in acknowledging and responding to new data and information. 2019 and prior years saw softer market conditions, for instance, in 2019, as a reflection of the soft rate market conditions in specialty, our business mix was allocated 57.5% (by NPW) to our Bespoke pillar and only 11.9% (by NPW) to our Specialty pillar. The hardening Specialty rate environment in 2020 and Bespoke risks associated with the economic cycle and the COVID-19 pandemic drove us to rebalance the portfolio mix with Specialty representing 44.5% of NPW. We believe the reallocation of our Reinsurance appetite offers an attractive risk-adjusted return under current market conditions.
Bespoke and Specialty business accounted for 87.2% of our portfolio (by NPW) in 2022 and we expect to see continued market hardening across most lines. We paused the growth of our Bespoke book in 2020 as we assessed the impact of the downturn in the economy from COVID-19. Our Bespoke products proved resilient to the economic downturn, and as the economy started to pick up again, we saw a resumption in the growth trajectory of our Bespoke business in 2022 and 2021 and are pleased with the performance of our portfolio.
We have continued to build out our operational teams and underwriting tools including our analytical and aggregation system FireAnt (which we license from Fidelis MGU following the consummation of the Separation Transactions).
We have continued our cautious stance on investments, focusing on a high credit quality, short-duration core fixed maturity strategy.
113
Current Outlook, Market Conditions and Rate Trends
The global reinsurance and insurance business is highly competitive, and cyclical by product and market. As such, financial results tend to fluctuate between periods of constrained capital availability and associated higher premium rates and stronger profits followed by periods of abundant capacity, lower rates and constrained profitability. The fluctuation of these market conditions may affect demand for our products, the premiums we charge, the terms and conditions of the (re)insurance policies we write and changes in our underwriting strategy.
A substantial component of our business is influenced by other factors such as the frequency and/or severity of underwriting losses, including natural disasters or other catastrophic events, pandemics, variations in interest rates and financial markets, changes in the legal, regulatory and judicial environments, inflationary pressures and general economic conditions. These factors influence, among other things, the demand for and profitability of our products. Consequently, there will be a degree of volatility in our financial results based upon the frequency and severity of losses that occur and to which we are exposed. See Risk Factors.
Premium Environment and Cycle: Premiums typically rise in response to losses, which leads to higher profitability and in turn attracts new capital into the insurance market to support underwriting. This additional influx of capital then typically leads to reduced rates and softening prices over time.
The global Specialty market rate growth has been strong in recent years. For example, Lloyds risk-adjusted rate change increased by 7.7% for 2022 versus the prior year, and cumulatively increased by 43.9% from 2018. We believe these favorable underwriting conditions are expected to continue in the near term as a result of the interaction between the supply of new capital and continued claims trends and development. See BusinessInsurance Market Conditions.
Claims Experience and Pricing Support: In recent years, climate change has driven an increase in the frequency and severity of catastrophe events which we believe has increased the claims experience of property and specialty (re)insurers, including us. The effects of these claims have been exacerbated by the impact of other climate-related losses such as wildfires and floods.
We believe that claims experience has also been affected by social inflation, which is driving claims costs over and above economic inflation as a result of increasing societal trends towards higher litigation costs and jury awards. Additionally, certain economic, social and political events, such as the COVID-19 pandemic and other public health crises have had a material effect on supply chains affecting the availability and pricing of underlying raw materials, which led to issues for (re)insurance companies paying out on claims. Furthermore, the Ukraine Conflict has led to widespread disruption in the upstream supply chains for oil, gas and certain agricultural commodities, putting further pressure on the challenges facing the (re)insurance industry. While the length and severity of the strain the supply chains are under is unknown, a prolonged period of disruptions may have a material adverse effect on the (re)insurance industrys ability to pay out on claims both in terms of monetary costs as well as availability of the underlying goods and services necessary for the payout. See Risk FactorsRisks Related to Recent Events.
Furthermore, in recent years, we believe favorable prior year claims development and associated loss reserve releases (which is a key driver of recent profitability) have declined. This claims development and reserve release pattern suggests that underwriters will need to maintain underwriting discipline to maintain profitability, which may result in a prolonged hard rate environment.
However, while there is naturally some uncertainty as to future rate developments, we believe that there is sufficient support, driven by a number of factors, to expect continued rate hardening in the near term in many (re)insurance classes in which we participate. With the Ukraine Conflict, for example, a number of lines within Specialty and Bespoke could be exposed to potential losses, adding further momentum to continuing rate increases. See Risk FactorsRisks Relating to Recent Events.
114
COVID-19: We have performed an analysis to estimate potential exposure to property business interruption losses from the COVID-19 pandemic. In general, our property reinsurance portfolio is more focused on residential exposure rather than commercial and the vast majority of cedants have strong exclusions in place. This reduces the potential for losses through property business interruption. At December 31, 2022 we had estimated loss reserves of $15.2 million in our reserves for Business Interruption losses relating to the COVID-19 pandemic. Areas within our financial statements that have a potential to be impacted by the continued uncertainty related to the effects of the COVID-19 pandemic include valuation of the investment portfolio and net reserves for losses and loss adjustment expenses. The potential for losses arising from the COVID-19 pandemic have been and will continue to be monitored.
Effects of Inflation: General economic inflation has increased and there is a risk of inflation remaining elevated for an extended period, which could cause claims and claim expenses to increase, impact the performance of our investment portfolio or have other adverse effects. See Risk FactorsRisks Relating to Recent EventsThe current inflationary environment could have a material adverse impact on the Groups operations.
The impact of inflation on Fidelis results cannot be known with any certainty; however, we have considered the possible effects of inflation in catastrophe loss models and on our investment portfolio. Furthermore, our estimates of the potential effects of inflation are also considered in pricing and in estimating reserves for unpaid claims and claim expenses. The actual effects of inflation on our results cannot be accurately known until claims are ultimately resolved. See Risk FactorsRisks Relating to Recent Events and Risk FactorsRisks Relating to Financial Markets and Liquidity.
Competitive Landscape: While Fidelis market share of the global specialty market is small, we believe Fidelis has an appreciable share of the niche markets in which it participates. This approach is consistent with our strategy of participating in classes where Fidelis believes it has a competitive advantage or sees pricing opportunities.
We deploy large line sizes in these classes opportunistically to extract preferential terms and rates over our peers. The ability to write large line sizes means Fidelis is able to assume a significant exposure under a single insurance policy. These large line sizes are more attractive to brokers as they minimize the number of underwriters with whom they must negotiate and provide us with greater leverage for preferable pricing and terms.
Our management team believes that it is well positioned to take advantage of the ongoing rate hardening in the key markets in which we participate and will continue to address and respond to the ongoing uncertainties presented by the challenges facing the (re)insurance industry.
Recent Developments and Activity
The Ukraine Conflict began on February 24, 2022 and subsequently the E.U. and a number of other countries, including the U.S. and the U.K., placed significant sanctions on Russian institutions and persons that resulted in a devaluation of the ruble and a fall in the value of Russian fixed maturity and equity assets, as well as the prompt withdrawal of certain companies from Russia without securing their assets. Fidelis has potential exposure to losses associated with the Ukraine Conflict through certain lines in its Bespoke and Specialty segments. For example, as a result of the aircraft lessor claims, and related proceedings, on account of the unreturned aircraft in Russia, provision has been made in the Groups reserves as of March 31, 2023 in the amount of $145.6 million for any potential exposures relating to the Ukraine Conflict, the majority of which is related to leased aircraft in Russia. Any related exposure remains subject to a number of complexities and implications subject to ongoing evaluation and determination. For additional information, see the risk factors titled The full extent of the impacts of the ongoing Ukraine Conflict on the (re)insurance industry and on the Groups business, financial condition and results of operations, including in relation to claims under the Groups (re)insurance policies, are uncertain and remain unknown. and We may be subject to litigation which could adversely affect our business.
115
The final cost may be different from the current reserving estimate due to the uncertainty associated with any change in the political situation, the ultimate outcome of the litigation matters, the asset valuation process, the unique issues as to scope of coverage and the outcome of explorative discussions underway between Western aircraft lessors and Russian airline operators for the sale of some of the unreturned aircraft. Based on our knowledge and assessment of current events, we do not believe that the Ukraine Conflict will adversely affect our ability to operate as a going concern.
Performance Measures and Non-U.S. GAAP Financial Measures
In presenting our results, management has included certain non-U.S. GAAP financial measures that we believe are useful to consider, in addition to our U.S. GAAP results, for a more complete understanding of the financial performance and position of FIHL. The key financial U.S. GAAP and non-U.S. GAAP measures that we believe are meaningful in analyzing our performance are summarized below and where applicable a reconciliation of non-U.S. GAAP measures to U.S. GAAP financials is set out. However, any non-U.S. GAAP measures should not be viewed as a substitute for those determined in accordance with U.S. GAAP and our methodology for calculating these measures may be different from the way our industry peers calculate these measures.
| Loss Ratio: is a measure of the losses that have been incurred by the business compared to the premiums that have been recorded to cover those losses and is expressed as a percentage of the losses and loss adjustment expenses divided by NPE. The losses will be affected by the occurrence and frequency of catastrophe events, the volume and severity of non-catastrophe losses and the extent of any outwards reinsurance that has been put in place to mitigate the effect of those losses. The loss ratio in 2022 of 55.2% was primarily impacted by the ongoing Ukraine Conflict. The loss ratio in 2021 of 60.4% was impacted by significant catastrophes that occurred in 2021, including Winter Storm Uri, Hurricane Ida, Storm Bernd and the U.S. Midwest tornados that occurred in December 2021. The loss ratio of 44.5% in 2020 was primarily driven by the impact of Hurricane Laura and the U.S. Midwest derecho and COVID-19 losses. |
| Accident Year Loss Ratio Excluding Catastrophes, Large Losses and Prior Year Reserve Movements: is a non-U.S. GAAP measure of the representation of the loss ratio excluding the impact of catastrophes, large losses and prior year reserve movements, and supports meaningful comparison between periods. Accident year loss ratio excluding catastrophes, large losses and prior year reserve movements is calculated by dividing net incurred losses and loss adjustment expenses excluding catastrophes, large losses and prior year reserve movements by net premiums earned excluding catastrophe-related reinstatement premiums. Our large losses and catastrophe losses in 2022 included Australia floods, European storms, Hurricane Ian and the Russian invasion of Ukraine. Our large losses and catastrophe losses in 2021 included Winter Storm Uri, Hurricane Ida and Storm Bernd. Our large losses and catastrophe losses in 2020 included Hurricane Laura and the U.S. Midwest derecho. Our accident year loss ratio excluding catastrophes, large losses and prior year reserve movements in 2022 was 31.5% compared with 27.4% in 2021. A key factor in the increase in the ratio is the changing underlying mix of our portfolio. In 2022 we grew our Specialty segment and began to reduce our Reinsurance segment exposure. The Specialty segment has a higher attritional loss ratio than the Reinsurance segment, which is more catastrophe exposed. Our accident year loss ratio excluding catastrophes, large losses and prior year reserve movements in 2021 of 27.4% increased from 25.8% in 2020. This was driven by the growth in our Specialty segment over this period and its higher attritional loss ratio than our catastrophe-driven Reinsurance segment. |
| Underwriting Ratio: is a measure of the underwriting performance and is expressed as a percentage of the losses and loss adjustment expenses plus the commissions that are paid to brokers and delegated underwriters that source the business on our behalf divided by earned premium, net of reinsurance. Our underwriting ratio of 85.0% decreased from 86.4% in 2021 driven by a decrease in our Reinsurance segment underwriting ratio. Our underwriting ratio of 86.4% in 2021 increased from 69.1% in 2020, primarily driven by increased natural catastrophe loss activity in 2021. |
116
| Expense Ratio: is a measure of the extent of the commissions that are paid to brokers and delegated underwriters that source the business on our behalf plus the general and administrative expenses that are incurred to run the business compared to the amount of premium that is earned. Overrider income earned on business ceded to third party reinsurers is credited to general and administrative expenses. The expense ratio is expressed as a percentage and is the ratio of policy acquisition expenses (net of ceded reinsurers share of acquisition costs) and general and administrative expenses to net premiums earned. Our expense ratio in 2022 was 36.9% compared with 32.5% in 2021. The increase is partly caused by the increase in net premiums earned in our Bespoke segment which has higher ceding commissions than our other segments, and higher professional fees within our general and administrative expenses. Our expense ratio was 32.5% in 2021 compared with 36.1% in 2020. |
| Combined Ratio: is a measure of our underwriting profitability and is expressed as the sum of the loss ratio and expense ratio. A combined ratio under 100% indicates an underwriting profit, while a combined ratio over 100% indicates an underwriting loss. Our combined ratio decreased to 92.1% in 2022 from 92.9% in 2021, primarily driven by a lower loss ratio in our Reinsurance segment. Our combined ratio of 92.9% in 2021 increased from 80.6% in 2020, primarily driven by increased natural catastrophe loss activity in 2021. |
The table below reconciles our accident year loss ratio excluding catastrophes, large losses and prior year reserve movements to losses and loss adjustment expenses, loss ratio, expense ratio and combined ratio for the years ended December 31, 2022, 2021, and 2020:
Year Ended December 31, | ||||||||||||
2022 | 2021 | 2020 | ||||||||||
($ in millions unless stated in percentages) |
||||||||||||
Catastrophe and large losses |
$ | 378.9 | $ | 389.6 | $ | 175.3 | ||||||
Prior year releases |
(22.1 | ) | (9.6 | ) | (38.4 | ) | ||||||
Attritional losses |
473.4 | 316.8 | 187.6 | |||||||||
|
|
|
|
|
|
|||||||
Losses and loss adjustment expenses |
$ | 830.2 | $ | 696.8 | $ | 324.5 | ||||||
Policy acquisition expenses |
447.7 | 299.9 | 179.2 | |||||||||
General and administrative expenses |
106.4 | 75.4 | 83.5 | |||||||||
Net premiums earned |
1,504.7 | 1,154.2 | 728.6 | |||||||||
Catastrophe and large loss impact on loss ratio |
25.1 | % | 33.8 | % | 24.1 | % | ||||||
Prior year release impact on loss ratio |
(1.5 | %) | (0.8 | %) | (5.3 | %) | ||||||
Accident year loss ratio excluding catastrophes, large losses and prior year reserve movements | 31.5 | % | 27.4 | % | 25.7 | % | ||||||
Loss ratio |
55.1 | % | 60.4 | % | 44.5 | % | ||||||
Underwriting ratio |
85.0 | % | 86.4 | % | 69.1 | % | ||||||
Expense ratio |
36.9 | % | 32.5 | % | 36.1 | % | ||||||
Combined ratio |
92.1 | % | 92.9 | % | 80.6 | % |
Net Investment Return, Total Investment Return and Total Investment Return Percentage
| Net investment return: includes net investment income plus net investment gains and losses. |
| Total investment return: includes net investment return plus unrealized gains and losses on available-for-sale financial assets. |
| Total investment return percentage: is calculated as total investment return divided by total average investible assets (including cash and cash equivalents and restricted cash and cash equivalents). |
117
The table below reconciles our net investment return, total investment return and total investment return percentage to net investment income for the years ended December 31, 2022, 2021 and 2020.
Year Ended December 31, | ||||||||||||
2022 | 2021 | 2020 | ||||||||||
($ millions) | ||||||||||||
Net investment income |
$ | 40.7 | $ | 20.6 | $ | 26.2 | ||||||
|
|
|
|
|
|
|||||||
Net realized and unrealized investment gains |
(33.7 | ) | 13.5 | 17.9 | ||||||||
Net investment return |
$ | 7.0 | $ | 34.1 | $ | 44.1 | ||||||
|
|
|
|
|
|
|||||||
Unrealized (losses)/gains on AFS financial assets |
(96.5 | ) | (36.1 | ) | 12.1 | |||||||
|
|
|
|
|
|
|||||||
Total investment return |
$ | (89.5 | ) | $ | (2.0 | ) | $ | 56.2 | ||||
|
|
|
|
|
|
|||||||
Opening |
||||||||||||
Total investments |
$ | 2,782.6 | $ | 1,752.6 | $ | 1,209.0 | ||||||
Cash and cash equivalents and restricted cash and cash equivalents | 476.0 | 1,238.5 | 450.9 | |||||||||
Derivative assets, at fair value |
1.0 | 0.2 | 0.1 | |||||||||
Accrued investment income |
12.1 | 9.1 | 7.4 | |||||||||
Investment assets pending settlement |
0.5 | 0.5 | 25.2 | |||||||||
Derivative liabilities, at fair value |
(0.8 | ) | (5.4 | ) | (0.8 | ) | ||||||
Investment liabilities pending settlement |
| (21.9 | ) | (9.9 | ) | |||||||
Net investible assets |
$ | 3,271.4 | $ | 2,973.6 | $ | 1,681.9 | ||||||
|
|
|
|
|
|
|||||||
Closing |
||||||||||||
Total investments |
$ | 2,425.0 | $ | 2,782.6 | $ | 1,752.6 | ||||||
Cash and cash equivalents and restricted cash and cash equivalents | 1,407.9 | 476.0 | 1,238.5 | |||||||||
Derivative assets, at fair value |
6.3 | 1.0 | 0.2 | |||||||||
Accrued investment income |
10.9 | 12.1 | 9.1 | |||||||||
Investment assets pending settlement |
2.0 | 0.5 | 0.5 | |||||||||
Derivative liabilities, at fair value |
| (0.8 | ) | (5.4 | ) | |||||||
Investment liabilities pending settlement |
| | (21.9 | ) | ||||||||
Net investible assets |
$ | 3,852.1 | $ | 3,271.4 | $ | 2,973.6 | ||||||
|
|
|
|
|
|
|||||||
Average investible assets |
3,561.8 | 3,122.5 | 2,327.8 | |||||||||
Total investment return percentage |
(2.5 | )% | (0.1 | )% | 2.4 | % | ||||||
|
|
|
|
|
|
Operating net income, RoE and Operating RoE
| Operating net income: is a non-U.S. GAAP measure of our performance which does not consider the impact of certain non-recurring and other items that may not properly reflect the ordinary activities of our business, its performance or its future outlook. This measure is calculated as net income available to holders of Common Shares excluding, net foreign exchange gains and losses, loss on the extinguishment of preference securities, and corporate and other expenses which include warrant costs, reorganization expenses, any non-recurring income and expenses, and the tax impact on these items. |
| Return on equity (or RoE): represents net income divided by opening common shareholders equity. |
| Operating return on equity (or Operating RoE): is a non-U.S. GAAP measure that represents a meaningful comparison between periods of our financial performance expressed as a percentage and is calculated as operating net income divided by opening common shareholders equity. |
118
The table below sets out the calculation of the operating net income, RoE and Operating RoE, based on applicable underwriting ratios, for the years ended December 31, 2022, 2021 and 2020:
Year Ended December 31, | ||||||||||||
2022 | 2021 | 2020 | ||||||||||
($ in millions unless stated in percentages) | ||||||||||||
Opening Common Shareholders Equity |
$ | 2,013.9 | $ | 1,976.2 | $ | 1,118.1 | ||||||
|
|
|
|
|
|
|||||||
Net income attributable to Common Shareholders | 52.6 | 68.3 | 126.5 | |||||||||
Add back: net foreign exchange (gains)/losses |
(6.8 | ) | 0.4 | (1.2 | ) | |||||||
Add back: Corporate and Other expenses |
20.5 | 2.7 | 18.7 | |||||||||
Add back: Loss on extinguishment of preference securities |
| | 25.3 | |||||||||
Tax impact of the above |
0.7 | (0.2 | ) | (2.9 | ) | |||||||
|
|
|
|
|
|
|||||||
Operating net income | $ | 67.0 | $ | 71.2 | $ | 166.4 | ||||||
|
|
|
|
|
|
|||||||
RoE |
2.6 | % | 3.5 | % | 11.3 | % | ||||||
Operating RoE |
3.3 | % | 3.6 | % | 14.9 | % | ||||||
|
|
|
|
|
|
Comparability and Certain Other Matters Impacting Our Financial Results
Currency and Foreign Exchange Contracts: Our functional currency is the U.S. dollar. Transactions in non-U.S. currencies are translated in U.S. dollars at the prevailing exchange rate in effect on the relevant transaction dates. Monetary assets and liabilities in foreign currencies are re-measured at the exchange rate in effect at the relevant reporting date. Foreign exchange gains and losses are included in our consolidated statements of income and comprehensive income. We use foreign exchange contracts to manage foreign currency risk. A foreign exchange contract involves an obligation to purchase or sell a specified currency at a future date at a price set at the time of the contract. Foreign exchange contracts will not eliminate fluctuations in the value of our assets and liabilities denominated in foreign currencies, but rather allow us to establish a rate of exchange for a future point in time.
Critical Accounting Policies and Estimates: The preparation of our consolidated financial statements in accordance with U.S. GAAP requires us to make many estimates and judgments that affect the reported amounts of assets, liabilities (including reserves), revenues and expenses, and related disclosures of contingent liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, insurance and other reserves, reinsurance recoverables, and fair value measurements. We base our estimates on historical experience, where possible, and on various other assumptions that we believe to be reasonable under the circumstances, which form the basis for our judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results will differ from these estimates and such differences may be material. We believe that the significant accounting policies set forth in Note 2 (Significant Accounting Policies) of our audited consolidated financial statements contained elsewhere in this prospectus affect significant estimates used in the preparation of our audited consolidated financial statements as set out in more detail below.
Investments: Our accounting policy classifies all fixed maturity securities acquired from January 1, 2018 as available-for-sale. Fixed maturity securities acquired prior to January 1, 2018 are classified as trading (all of which were disposed by December 31, 2022). Our fixed maturity securities portfolio is comprised primarily of U.S. Treasuries, non-U.S. government bonds, government agency bonds, corporate bonds, mortgage and other asset-backed securities. Investments in fixed maturity securities are reported at estimated fair value in our audited consolidated financial statements.
Our other investments consist of investments in structured notes (see note 4 (Investments) of our audited consolidated financial statements contained elsewhere in this prospectus), the Wellington Opportunistic Fixed maturity UCITS Fund and a residual investment in a hedge fund. These are carried at fair value through the income statement. For the valuation methodologies (see note 4 (Fair Value Measurements) of our audited consolidated financial statements contained elsewhere in this prospectus).
119
Investments with a maturity from three months up to one year from date of purchase are classified as short-term investments and recorded at fair value.
For all fixed maturity securities and other investments, any realized and unrealized gains or losses are determined on the basis of the first-in, first-out method. For all fixed maturity securities classified as available-for-sale, realized gains and losses in the audited consolidated financial statements include allowances for credit losses related to its Available for Sale (AFS) debt securities. This allowance represents the difference between the securitys amortized cost and the amount expected to be collected over the securitys lifetime. Unrealized gains and losses represent the difference between the cost, or the cost as adjusted by amortization of any difference between its cost and its redemption value (amortized cost), of the security and its fair value at the reporting date and are included within other comprehensive income for securities classified as available-for-sale. For securities classified as trading, realized and unrealized gains or losses are included in the audited consolidated financial statements within net investment gains (all such securities were disposed by December 31, 2022).
Premiums and Acquisition Costs: We record premiums written upon inception of the policy. Premiums written include estimates based on information received from insureds, brokers and cedants, and any subsequent differences arising on such estimates are recorded as premiums written in the period in which they are determined. Premiums written are earned on a basis consistent with risks covered over the period during which the coverage is provided. The portion of the premiums written applicable to the unexpired terms of the underlying contracts and policies are recorded as UPR.
Reinstatement premiums are recognized as written and earned after the occurrence of a loss and are recorded in accordance with the contract terms based upon managements estimate of losses and loss adjustment expenses.
Acquisition costs are directly related to the acquisition of insurance premiums and are deferred and amortized over the related policy period. We only defer acquisition costs incurred that are directly attributable to the successful acquisition of new or renewal insurance contracts, including commissions to agents and brokers and premium taxes. All other acquisition-related expenses including indirect costs are expensed as incurred. To the extent that future policy revenues on existing policies are not adequate to cover related costs and expenses, deferred policy acquisition costs are charged to earnings.
We evaluate premium deficiency and the recoverability of deferred acquisition costs by determining if the sum of future earned premiums and anticipated investment return is greater than expected future losses and loss adjustment expenses and acquisition costs.
Reserves for Losses and Loss Adjustment Expenses: Our liability for losses and loss adjustment expenses includes reserves for unpaid losses and for IBNR. These estimates are net of amounts estimated to be recoverable from salvage and subrogation. The reserve for losses and loss adjustment expenses is established by management based on reports from insureds, brokers, ceding companies and the application of generally accepted actuarial techniques and represents the estimated ultimate cost of events or conditions that have been reported to or specifically identified by Fidelis as incurred.
Inherent in the estimates of ultimate losses and loss adjustment expenses are expected trends in claim severity and frequency which may vary significantly as claims are settled. We estimate ultimate losses using various actuarial methods as well as our own loss experience, historical insurance industry loss experience, estimates of pricing adequacy trends and managements professional judgment. The estimated cost of claims includes expenses to be incurred in settling claims and a deduction for the expected value of salvage, subrogation and other recoveries. Ultimate losses and loss adjustment expenses may differ significantly from the amount recorded in the financial statements. These estimates are reviewed regularly and as experience develops and new information becomes known, the reserves are adjusted as necessary. Such adjustments, if any, are recorded in losses and loss adjustment expenses in the periods in which they are determined.
120
Provision is made at the end of each relevant period for the estimated ultimate cost of claims incurred but not settled at the balance sheet date, including the cost of IBNR claims and development of existing reported claims. The estimated cost of claims includes expenses to be incurred in settling claims and a deduction for the expected value of salvage and other recoveries. For further discussion of the actuarial methodologies utilized to perform our losses and loss adjustment expenses reserving analysis, see note 12 (Reserves for Losses and Loss Adjustment Expenses) of our audited consolidated financial statements contained elsewhere in this prospectus.
Reserves for losses and loss adjustment expenses represent our best estimate of the ultimate cost of settling reported and unreported claims and related expenses. As discussed previously, the estimation of losses and loss expense reserves is based on various complex and subjective judgments. Actual losses and settlement expenses which are ultimately required to be paid may deviate, perhaps substantially, from the reserve estimates reflected in our financial statements. Similarly, the timing for payment of our estimated losses is not fixed and is not determinable on an individual or aggregate basis. The assumptions used in estimating the payments due by period are based on industry and peer-group claims payment experience. Due to the uncertainty inherent in the process of estimating the timing of such payments, there is a risk that the amounts paid in any period can be significantly different.
Reinsurance and Retrocession: We seek to reduce the risk of net losses on business written by ceding certain risks and exposures to other reinsurers. Outwards reinsurance contracts do not relieve us of our primary obligation to insureds. Ceded premiums are recognized when the coverage period incepts and are expensed over the contract period in proportion to the coverage. Premiums relating to the unexpired portion of reinsurance ceded are recorded as deferred reinsurance premiums.
Commissions on ceded business are deferred and amortized over the period in which the related ceded premium is recognized. The deferred balance is recorded within deferred reinsurance premiums in our audited consolidated financial statements and the amortization is recognized within general and administrative expenses in our audited consolidated financial statements.
In furtherance of our outwards reinsurance strategy, we entered into a 20% whole account quota share of the substantial majority of our underwriting business with a leading strategic partner, The Travelers Indemnity Company, a subsidiary of The Travelers Companies, Inc. The Travelers Companies, Inc. is the ultimate parent of SPFM Holdings, LLC, one of our shareholders. The quota share arrangement runs for an initial period of twelve months beginning on January 1, 2023, with extensions subject to mutual agreement.
Taxation: FIHL, FUL and FML are tax-resident in the U.K. and therefore subject to relevant taxes in the U.K. Pursuant to the Finance (No. 2) Act 2015, the corporate income tax rate in the U.K. for the years ended December 31, 2022, 2021 and 2020 was 19% and is expected to increase to 25% beginning April 1, 2023. The 2022 and 2021 periods are open tax years in the U.K. for those relevant entities that are either within the statutory time period for examination or subject to open examinations by local tax authorities. We believe that we have made adequate provision for the tax liabilities likely to arise from these periods. However, the ultimate liabilities for such matters may vary from the amounts provided and are dependent upon the outcome of agreements reached with relevant tax authorities.
Under current Bermuda law, FIBL is not required to pay taxes in Bermuda on its income or capital gains. FIBL has received undertakings from the Minister of Finance in Bermuda that, in the event of any taxes being imposed, FIBL will be exempt from taxation in Bermuda until March 2035 under the Tax Assurance Certificates issued pursuant to the Bermuda Exempted Undertakings Tax Protection Act of 1966, as amended.
FIID is tax-resident in Ireland. As such, FIID is subject to Irish corporation tax on its trading profits at a rate of 12.5%. The 2022 and 2021 periods are open tax years in Ireland for those relevant entities that are either within the statutory time period for examination or subject to open examinations by local tax authorities. The Irish Government has also committed to supporting the OECDs global minimum corporation tax rate for large firms that are expected to be implemented in 2024 and which will raise the tax rate for firms generating revenue of more than 750 million in Ireland from 12.5% to 15%.
121
The effective tax rate for a given fiscal period is subject to revision in future periods if circumstances change and depends on the relative profitability of those parts of our business underwritten in Bermuda, the U.K. and Ireland. For a more detailed description of our tax position, see note 23 (Income Taxes) of our audited consolidated financial statements contained elsewhere in this prospectus.
For additional information regarding taxation, see Risk FactorsRisks Relating to Taxation, Certain Tax ConsiderationsUnited States Taxation, and Certain Tax ConsiderationsBermuda Taxation,
Recent accounting pronouncements
In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which becomes effective for the Company during the first quarter of 2023. ASU No. 2021-08 requires contract assets and liabilities accounted for under FASB ASC 606, Revenue from Contracts with Customers, to be recorded at the acquisition date as if the acquirer entered into those contracts itself on the contract inception dates, rather than at fair value. At adoption, ASU No. 2021-08 will not impact the Companys financial position, results of operations or cash flows, but prospectively, this ASU may impact amounts recorded by the Company for assets acquired and liabilities assumed under certain acquisitions.
Reportable Segment(s)
We classify our business into three underwriting segments, namely Bespoke, Specialty and Reinsurance. Specialty primarily comprises property D&F, energy, marine and aviation lines. Bespoke primarily comprises credit and political risk and other tailored solutions for clients including transactional liabilities and credit insurance. Reinsurance primarily comprises property reinsurance.
FIHL does not manage its assets by segment. Accordingly, net investment income and total assets are not allocated to these segments. In addition, general and administrative expenses are not allocated between segments as employees, including underwriters, work across each of the different segments.
Financial Overview
The following overview of our operating results and financial condition for each of the years ended December 31, 2022, 2021 and 2020 is intended to identify important themes and should be read in conjunction with the more detailed discussion further below. See Results of Operations.
Operating Highlights
Gross Premiums Written. The changes in our segments GPW for the years ended December 31, 2022, 2021 and 2020 were as follows:
2022 | 2021 | 2020 | ||||||||||||||||||
GPW | ($ millions) | (% change) | ($ millions) | (% change) | ($ millions) | |||||||||||||||
Bespoke |
$ | 783.2 | 33 | % | $ | 588.0 | 73 | % | $ | 339.1 | ||||||||||
Specialty |
1,610.7 | 44 | % | 1,115.2 | 93 | % | 577.9 | |||||||||||||
Reinsurance |
606.2 | (44 | %) | 1,084.5 | 64 | % | 659.5 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total |
$ | 3,000.1 | 8 | % | $ | 2,787.7 | 77 | % | $ | 1,576.5 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Our GPW in the Specialty segment has continued the trend of significant growth since 2019, primarily as a result of taking advantage of market dislocation on new business, which gave us the opportunity to maintain improved pricing and preferential terms and conditions on both our Specialty renewal book and new business. In
122
each quarter since the fourth quarter of 2019, the Specialty market has shown dislocation across almost all lines and subclasses of business, especially in those that are loss affected. Primarily as a result of this market opportunity, our GPW in the Specialty segment grew 44% to $1,610.7 million in 2022 from $1,115.2 million in 2021. This followed growth of 93% to $1,115.2 million in 2021 from $577.9 million in 2020. The largest increases in 2022 came from the marine and aviation classes.
Our GPW in the Bespoke segment grew 36% to $783.2 million from $588.0 million in 2021. This was led by growth in our bespoke intangibles and contract frustration lines of business. In 2021 our GPW grew 73% to $588.0 million from $339.1 million in 2020.
Our GPW in the Reinsurance segment decreased 44% to $606.2 million in 2022 from $1,084.5 million in 2021. This was caused primarily by a reduction in our exposure to North American property risks and other international risk, notably in Japan. Our 2021 GPW increased to $1,084.5 million from $659.5 million in 2020, which reflected our view on market conditions as we entered 2021.
Loss Ratio. We monitor the ratio of losses and loss adjustment expenses to NPE (the loss ratio) as a measure of relative underwriting performance, where a lower loss ratio represents a better underwriting result than a higher loss ratio. The loss ratios for our business segments for the years ended December 31, 2022, 2021 and 2020 were as follows:
Loss Ratio for the Years Ended December 31, |
||||||||||||
2022 | 2021 | 2020 | ||||||||||
Bespoke |
31.3 | % | 28.3 | % | 33.2 | % | ||||||
Specialty |
59.7 | % | 38.5 | % | 37.7 | % | ||||||
Reinsurance |
74.3 | % | 114.2 | % | 54.9 | % | ||||||
|
|
|
|
|
|
|||||||
Total |
55.2 | % | 60.4 | % | 44.5 | % | ||||||
|
|
|
|
|
|
Our loss ratio was 55.2% in 2022 compared with 60.4% in 2021. The reduction was primarily caused by a reduction in our Reinsurance segment loss ratio to 74.3% in 2022 from 114.2% in 2021. Our catastrophe and large losses were $378.9 million or 25.1% net of reinsurance in 2022, compared with $389.6 million or 33.8% in 2021. The reduction in percentage impact from catastrophe and large losses was caused by a reduction in our NPE in our Reinsurance segment together with the related exposure.
Our loss ratio was 60.4% in 2021 compared with 44.5% in 2020. Our 2021 loss ratio included catastrophe and large losses of $389.6 million or 33.8% net of reinsurance compared with $175.3 million or 24.1% in 2020.
In 2021, the Reinsurance segment was affected by the natural catastrophe events that are summarized below in ReinsuranceLosses and Loss Adjustment Expenses, which resulted in a loss ratio of 114.2%, a significant increase from the loss ratio for the Reinsurance segment of 54.9% in 2020.
Net Investment Income. We believe our investment portfolio continues to be conservatively positioned, with 96.9% of our investment portfolio held in cash and core fixed maturity securities with a short average duration of 1.2 years and average credit quality of AA- at December 31, 2022. This allows us to prioritize taking risk on the underwriting side of our balance sheet. Our net investment return was $7.0 million in 2022 compared with $34.1 million in 2021. Our net investment income increased to $40.7 million in 2022 from $20.6 million in 2021 due to increases in interest rates and investible assets. This increase was more than offset by net realized and unrealized investment losses of $33.7 million in 2022. Our net investment income was $34.1 million in 2021 compared with $44.1 million in 2020. This decrease was caused by reinvesting at lower interest rates during 2021 compared to 2020.
Our total investment return in 2022 was a loss of $89.5 million compared with a loss of $2.0 million in 2021. The reduction in our total investment returns was caused by unrealized losses on our fixed maturity securities resulting from increases in interest rates during 2022. These are expected to unwind quickly due to the
123
short duration of our investment portfolio. Similarly, our negative total investment return for 2021 resulted from the significant upward shift in the yield curve as higher inflation prompted the market to price in more interest rate hikes by the U.S. Federal Reserve and at an accelerated pace.
In 2020, we generated a total investment return of $56.2 million.
Results of Operations
Our audited consolidated financial statements are prepared in accordance with U.S. GAAP. The discussions that follow include tables and discussions relating to our consolidated income statements for each of the years ended December 31, 2022, December 31, 2021 and December 31, 2020. The table below sets out the consolidated statements of income for the years ended December 31, 2022, 2021 and 2020:
Consolidated Income Statements
2022 | 2021 | 2020 | ||||||||||
($ in millions) | ||||||||||||
Revenues |
||||||||||||
Gross premiums written |
$ | 3,000.1 | $ | 2,787.7 | $ | 1,576.5 | ||||||
Reinsurance premiums ceded |
(1,137.5 | ) | (1,186.6 | ) | (670.9 | ) | ||||||
|
|
|
|
|
|
|||||||
Net premiums written |
1,862.6 | 1,601.1 | 905.6 | |||||||||
Change in net unearned premiums |
(357.9 | ) | (446.9 | ) | (177.0 | ) | ||||||
|
|
|
|
|
|
|||||||
Net premiums earned |
1,504.7 | 1,154.2 | 728.6 | |||||||||
Net investment (losses)/gains |
(33.7 | ) | 13.5 | 17.9 | ||||||||
Net investment income |
40.7 | 20.6 | 26.2 | |||||||||
Net foreign exchange gains |
6.8 | | 1.2 | |||||||||
Other income |
1.9 | 1.0 | 8.7 | |||||||||
|
|
|
|
|
|
|||||||
Total revenues |
$ | 1,520.4 | $ | 1,189.3 | $ | 782.6 | ||||||
|
|
|
|
|
|
|||||||
Expenses |
||||||||||||
Losses and loss adjustment expenses |
830.2 | 696.8 | 324.5 | |||||||||
Policy acquisition expenses |
447.7 | 299.9 | 179.2 | |||||||||
General and administrative expenses |
106.4 | 75.4 | 83.5 | |||||||||
Corporate and other expenses |
20.5 | 2.7 | 18.7 | |||||||||
Net foreign exchange losses |
| 0.4 | | |||||||||
Financing costs |
35.5 | 35.4 | 27.9 | |||||||||
Loss on extinguishment of preference securities |
| | 25.3 | |||||||||
|
|
|
|
|
|
|||||||
Total expenses |
$ | 1,440.3 | $ | 1,110.6 | $ | 659.1 | ||||||
|
|
|
|
|
|
|||||||
Income before income taxes |
80.1 | 78.7 | 123.5 | |||||||||
|
|
|
|
|
|
|||||||
Income tax (expense)/benefit |
(17.8 | ) | (0.4 | ) | 3.1 | |||||||
|
|
|
|
|
|
|||||||
Net income |
62.3 | 78.3 | 126.6 | |||||||||
|
|
|
|
|
|
|||||||
Net income attributable to non-controlling interests |
(9.7 | ) | (10.0 | ) | (0.1 | ) | ||||||
|
|
|
|
|
|
|||||||
Net income available to common shareholders |
52.6 | 68.3 | 126.5 | |||||||||
|
|
|
|
|
|
|||||||
Other comprehensive (loss)/income |
||||||||||||
Unrealized (losses)/gain on AFS financial assets |
(96.5 | ) | (36.1 | ) | 12.1 | |||||||
Income tax benefit/(expense), all of which relates to unrealized (loss)/gain on AFS financial assets |
8.1 | 2.4 | (0.7 | ) | ||||||||
Currency translation adjustments |
(1.1 | ) | (0.2 | ) | | |||||||
|
|
|
|
|
|
|||||||
Total other comprehensive (loss)/income |
(89.5 | ) | (33.9 | ) | 11.4 | |||||||
|
|
|
|
|
|
|||||||
Comprehensive (loss)/income attributable to common shareholders |
$ | (36.9 | ) | $ | 34.4 | $ | 137.9 | |||||
|
|
|
|
|
|
124
Years Ended December 31, 2022, 2021 and 2020
Gross Premiums Written: Our GPW for each of the years ended December 31, 2022, December 31, 2021 and December 31, 2020 were as follows:
Gross Premiums Written | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
($ in millions) | % change | ($ in millions) | % change | ($ in millions) | ||||||||||||||||
Bespoke |
$ | 783.2 | 33 | % | $ | 588.0 | 73 | % | $ | 339.1 | ||||||||||
Specialty |
1,610.7 | 44 | % | 1,115.2 | 93 | % | 577.9 | |||||||||||||
Reinsurance |
606.2 | (44 | )% | 1,084.5 | 64 | % | 659.5 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total |
$ | 3,000.1 | 8 | % | $ | 2,787.7 | 77 | % | $ | 1,576.5 | ||||||||||
|
|
|
|
|
|
|
|
|
|
GPW increased 8% to $3,000.1 million in 2022 compared with $2,787.7 million in 2021. GPW increased by 77% to $2,787.7 million in 2021 from $1,576.5 million in 2020.
The growth in GPW in 2022 was led by increases in our Specialty and Bespoke segments of $495.5 million and $195.2 million, respectively, offset by a decrease of $478.3 million in our Reinsurance segment. The growth in our Specialty segment was driven by our marine and aviation and aerospace lines of business. The increase in our Bespoke segment resulted from additional current-year warranty deals and new opportunities in our bespoke intangibles line of business. We reduced our Reinsurance segment GPW as we focused on optimizing our portfolio to respond to our views on climate change and the adequacy of catastrophe pricing.
The growth in 2021 was attributable to all segments and benefited from improved pricing and access to greater capital resources following our capital raises in 2019 and 2020. Our Specialty segment premium increased by 93% to $1,115.2 million in 2021 primarily due to favorable pricing and hard market underwriting opportunities in some of the key Specialty classes, including property D&F, marine and aviation. The growth in our Bespoke segment from 2020 to 2021 was primarily due to new business opportunities in transactional liabilities and credit insurance. The growth in our Reinsurance segment in 2021 resulted primarily from new business and improved pricing conditions on loss-impacted lines of business in Japan, the Southeastern United States and California.
Reinsurance Premiums Ceded: The changes in our ceded written premiums for each of the years ended December 31, 2022, December 31, 2021 and December 31, 2020 were as follows:
Reinsurance Premiums Ceded | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
($ in millions) | % change | ($ in millions) | % change | ($ in millions) | ||||||||||||||||
Bespoke |
$ | 221.5 | 44 | % | $ | 153.4 | 75 | % | $ | 87.9 | ||||||||||
Specialty |
549.9 | 54 | % | 357.0 | 104 | % | 174.8 | |||||||||||||
Reinsurance |
366.1 | (46 | %) | 676.2 | 66 | % | 408.2 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total |
$ | 1,137.5 | (4 | %) | $ | 1,186.6 | 77 | % | $ | 670.9 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Reinsurance premiums ceded decreased 4% to $1,137.5 million in 2022 from $1,186.6 million in 2021. The decrease was caused by our decision to reduce and optimize our Reinsurance segment GPW. Reinsurance premiums ceded increased by 77% in 2021 compared to 2020. This increase was across all segments and reflects the growth of the GPW for each segment. In the fourth quarter of 2020, we entered into a new 20% whole account quota share with National Indemnity Company which enabled us to write more business in a capital efficient manner. In addition, we arranged additional quota share protections by purchasing additional reinsurance and also sponsored four catastrophe bonds through Herbie Re in 2020 ($139.1 million) and 2021 ($108.2 million) to provide us with multi-year protections on an industry-loss basis.
125
Net Premiums Earned: The following table summarizes the overall change in net premiums earned in each of the years ended December 31, 2022, December 31, 2021 and December 31, 2020:
Net Premiums Earned | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
($ in millions) | % change | ($ in millions) | % change | ($ in millions) | ||||||||||||||||
Bespoke |
$ | 379.4 | 34 | % | $ | 251.9 | 19 | % | $ | 212.5 | ||||||||||
Specialty |
852.8 | 37 | % | 535.3 | 212 | % | 171.7 | |||||||||||||
Reinsurance |
272.5 | (35 | %) | 367.0 | 7 | % | 344.4 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total |
$ | 1,504.7 | 23 | % | $ | 1,154.2 | 58 | % | $ | 728.6 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Our NPE increased by $350.5 million to $1,504.7 million in 2022 from $1,154.2 million in 2021. The increase was led by our Specialty segment which grew by $317.5 million in 2022 resulting from the continued increase in net premiums written and the earning of contracts that incepted in prior years. Our NPE increased by $425.6 million, or 58%, in 2021 compared to 2020. Bespoke NPE increased by $39.4 million due to the additional earned premium from prior underwriting years on longer tenor business, such as mortgage contracts. Specialty NPE increased by $363.6 million, or 212%, primarily due to increased written premium due to the hard market conditions in various classes of Specialty business which allowed us to profitably deploy the additional capital raised at the end of 2019 and during 2020. Reinsurance net premiums earned increased by $22.6 million, or 7%, in 2021 compared to 2020 primarily from new business and improved pricing conditions on loss-impacted lines.
Losses and Loss Adjustment Expenses: The table below summarizes the metrics we used to analyze the underwriting performance of the business.
For the Years Ended December 31, | ||||||||||||
2022 | 2021 | 2020 | ||||||||||
Loss ratio |
55.2 | % | 60.4 | % | 44.5 | % | ||||||
Policy acquisition expense ratio |
29.8 | % | 26.0 | % | 24.6 | % | ||||||
General and administrative expense ratio |
7.1 | % | 6.5 | % | 11.5 | % | ||||||
|
|
|
|
|
|
|||||||
Combined ratio |
92.1 | % | 92.9 | % | 80.6 | % | ||||||
|
|
|
|
|
|
Our losses and loss adjustment expenses increased to $830.2 million in 2022 from $696.8 million in 2021. Our loss ratio decreased to 55.2% in 2022 from 60.4% in 2021. The reduction was primarily caused by a reduction in our Reinsurance segment loss ratio to 74.3% in 2022 from 114.2% in 2021.
Our losses and loss adjustment expenses increased to $696.8 million in 2021 from $324.5 million in 2020. The increase in our loss ratio to 60.4% in 2021 compared to the loss ratio of 44.5% in 2020 was due primarily to an increase in catastrophe and large losses of $389.6 million in 2021 compared to $175.3 million in 2020.
Expenses: We monitor our expense ratio as a measure of the cost effectiveness of our policy acquisition expenses and general and administrative expenses. The table above presents the contribution of the policy acquisition expenses and general and administrative expenses for each of the years ended December 31, 2022, December 31, 2021 and December 31, 2020.
Policy acquisition expenses paid to brokers and other intermediaries depends upon the type of business that we write and the terms that are agreed. The expense ratio is calculated as insurance acquisition expenses, net of reinsurers share of acquisition costs, divided by net premiums earned.
126
Policy acquisition expenses increased to $447.7 million in 2022 from $299.9 million in 2021. Our policy acquisition expense ratio increased to 29.8% in 2022 from 26.0% in 2021. This increase was driven by a change in business mix to certain lines of business that have higher expense ratios in our Bespoke and Specialty segments. Our policy acquisition expenses increased to $299.9 million in 2021 from $179.2 million in 2020. The increase in 2021 reflects the increased business volumes that we wrote over this period. Our policy acquisition expense ratio of 26.0% in 2021 increased from the 2020 policy acquisition expense ratio of 24.6%, primarily due to changes in business mix.
Our general and administrative expenses increased to $106.4 million in 2022 from $75.4 million in 2021. Our general and administrative expense ratio, expressed as a measure of general and administrative expenses divided by NPE, increased to 7.1% in 2022 from 6.5% in 2021. The increase was caused primarily by higher employment and related costs, and additional professional fees. Our general and administrative expenses decreased to $75.4 million in 2021 from $83.5 million in 2020 which was primarily driven by higher overrider income (income received from reinsurers for placing and managing the business placed with them) and lower performance-related variable compensation for staff. The decrease in the general and administrative expense ratio from 2020 to 2021 was the result of lower expenses further improved by the impact of higher NPE in 2021.
Combined Ratio: As discussed above, our combined ratio is calculated as the sum of the loss ratio and expense ratio. Our combined ratio decreased to 92.1% in 2022 from 92.9% in 2021. This was caused by the decrease in our loss ratio, partially offset by an increase in our expense ratio. Our combined ratio increased to 92.9% in 2021 from 80.6% in the prior year, which was primarily driven by our loss ratio of 60.4% in 2021 compared to 44.5% in 2020 due to catastrophe and large losses of $389.6 million in 2021 compared to $175.3 million in 2020. Offsetting the increase in the loss ratio was a reduction in the expense ratio to 32.5% in 2021 from 36.1% in 2020.
Corporate and Other Expenses: Corporate and other expenses include reorganization expenses and warrant expenses. Corporate and other expenses were $20.5 million in 2022 compared to $2.7 million in 2021. Corporate and other expenses increased in 2022 due to additional professional fees related to the Separation Transactions. Corporate and other expenses decreased to $2.7 million in 2021 from $18.7 million in 2020 primarily due to higher warrant expenses in 2020. Warrant expenses are incurred when Fidelis raises additional capital or issues additional share options. Warrant issuances in relation to additional capital raises were capped at $2.1 billion in total capital raised, which was achieved in 2021. This resulted in lower corporate and other expenses in 2021.
Net Investment Income: Net investment income includes investment income net of investment management fees. In 2022 our net investment income was $40.7 million compared with $20.6 million in 2021. The increase in our net investment income is due to increases in interest rates during 2022 and the short duration nature of our portfolio which is sensitive to such increases in rates. The increase in our net investment income also results from the increase in total cash and investments. In 2021, we generated net investment income of $20.6 million compared with $26.2 million in 2020. The decrease in net investment income in 2021 was primarily due to the lower interest rate environment and a lower yield earned on our cash balances and the core fixed maturity portfolio. In March 2020, central banks lowered interest rates in response to the impact of the COVID-19 pandemic. As we reinvested the proceeds from maturities along with other cash flows, the purchase yield achieved on these investments was significantly lower than the book yield of the portfolio at March 2020.
Net Investment Gains: Investment gains includes unrealized and realized gains and losses on those investments classified as trading. All investments classified as trading had been disposed by December 31, 2022. In 2022 we had a net investment loss of $33.7 million compared with a net investment gain of $13.5 million in 2021. The loss in 2022 resulted from a fall in value of our risk assets, the increase in interest rates driving realized losses on the disposal of fixed maturity securities, realized losses on derivative instruments and the current expected credit losses (CECL) charge on our AFS securities. In 2021 we generated a net investment gain of $13.5 million compared to a gain of $17.9 million in 2020. Outside of our core fixed maturity portfolio, we also recorded a gain on our risk assets of $14.2 million in 2021 compared with $11.1 million in 2020, primarily as a result of positive returns on
127
equity and commodity-linked structured notes as the economy rebounded with the lifting of COVID-19 restrictions. The opportunistic fixed maturity fund recorded a negative return in 2021, primarily as a result of the upward shift in yields, spread widening and strengthening of the U.S. dollar.
Unrealized Gains/(losses) on Available-For-Sale Financial Instruments: Unrealized losses on fixed maturity securities of $96.5 million in 2022 were caused by increases in interest rates. Due to the short duration of our fixed maturity portfolio, we expect the majority of these unrealized losses to unwind during 2023 and 2024. In 2021, we recorded an unrealized loss of $36.1 million (2020: gain of $12.1 million) on available-for-sale financial instruments, primarily as a result of the changes in yields and credit spreads.
Foreign Exchange Contracts: At December 31, 2022 we held foreign exchange contracts with a notional amount of $44.0 million compared with a notional amount of $3.5 million in 2021. These contracts are used to manage underwriting and non-investment operations. The foreign exchange contracts were recorded as derivatives at fair value in the balance sheet with changes recorded as net foreign exchange losses in the consolidated statements of income and comprehensive income.
Financing Costs: Financing costs were $35.5 million in 2022 compared with $35.4 million in 2021. Our financing costs were similar in both years due to there being no change in our debt levels during both years. Our 2021 financing costs were $35.4 million compared with $27.9 million in 2020. Financing costs increased in 2020 to meet the interest payments on the $330 million 4.875% Senior Notes due 2030 that were issued in June 2020 and July 2020 and the $125.0 million 6.625% Junior Subordinated Notes due 2041 that were issued in October 2020. The dividend paid to the holders of the Series A Preference Securities is also included in financing costs as referred to below, along with the costs associated with our letter of credit facilities as discussed in Note 17b (Commitments and Contingencies - Letter of Credit Facilities) of our audited consolidated financial statements contained elsewhere in this prospectus.
Preference Securities: At December 31, 2022 and 2021, FIHL has 12,102 issued Series A Preference Securities that are classified in our balance sheet as debt. Dividend expense on our outstanding Series A Preference Securities in 2022 and 2021 was $5.3 million and in 2020 was $14.4 million and is included in financing costs.
Income Tax (expense)/benefit: There was an income tax expense of $17.8 million in 2022 compared with an income tax expense of $0.4 million in 2021. The increase in expense was caused by a change in jurisdiction where our net income was earned, with more profits being earned in the U.K. and a loss in Bermuda. In 2021 we incurred an income tax expense of $0.4 million compared to an income tax benefit of $3.1 million in 2020. The tax expense in 2021 benefited from a revaluation of our deferred tax assets due to the increase in the U.K. corporate tax rate from 19% to 25% in 2023 after which we expect to realize those benefits. Our income tax benefit of $3.1 million in 2020 resulted from a loss in the U.K. of $32.7 million.
Net Income: In 2022 we had net income of $62.3 million equivalent to fully diluted earnings per Common Share of $0.26. In 2021, we had net income of $78.3 million, equivalent to fully diluted earnings per Common Share of $0.34. In 2020, we had net income of $126.6 million, equivalent to fully diluted earnings per Common Share of $0.74.
Net Income Attributable to Non-Controlling Interests: The Group holds a majority interest in Pine Walk Capital, and accordingly the financial statements of Pine Walk Capital are included in the consolidated financial statements of the Group. The net income attributable to non-controlling interests reflects the minority shareholders interest in Pine Walk Capital, which totaled $9.7 million, $10.0 million and $0.1 million in 2022, 2021 and 2020, respectively.
Comprehensive Income Attributable to Common Shareholders: Comprehensive income attributable to common shareholders decreased to a loss of $36.9 million in 2022 from income of $34.4 million and income of $137.9 million in 2021 and 2020, respectively.
128
Segment Analysis for the Years Ended December 31, 2022, 2021 and 2020
Specialty
The table below sets out GPW, NPE and the loss ratio for the Specialty segment for the years ended December 31, 2022, 2021 and 2020:
Specialty | ||||||||||||||||||||
For the Year Ended | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
($ in millions) | % change | ($ in millions) | % change | ($ in millions) | ||||||||||||||||
Aviation & Aerospace |
$ | 298.0 | 73 | % | $ | 172.7 | 36 | % | $ | 127.2 | ||||||||||
Energy |
119.3 | 28 | % | 92.9 | 19 | % | 77.8 | |||||||||||||
Marine |
538.2 | 115 | % | 249.9 | 135 | % | 106.3 | |||||||||||||
Property |
19.9 | (33 | %) | 29.7 | 43 | % | 20.7 | |||||||||||||
Property D&F |
611.5 | 12 | % | 543.8 | 140 | % | 226.4 | |||||||||||||
Specialty Other |
23.8 | (9 | %) | 26.2 | 34 | % | 19.5 | |||||||||||||
Total Specialty GPW |
$ | 1,610.7 | 44 | % | $ | 1,115.2 | 93 | % | $ | 577.9 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Reinsurance premiums ceded |
(549.9 | ) | 54 | % | (357.0 | ) | 104 | % | (174.7 | ) | ||||||||||
Net premiums earned |
$ | 852.8 | 59 | % | $ | 535.3 | 212 | % | $ | 171.7 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Losses and loss adjustment expenses |
(508.7 | ) | 147 | % | (206.2 | ) | 218 | % | (64.8 | ) | ||||||||||
Loss ratio |
59.7 | % | 38.5 | % | 37.7 | % | ||||||||||||||
|
|
|
|
|
|
Gross Premiums Written. GPW increased by 44% to $1,610.7 million in 2022 from $1,115.2 million in 2021. The increase was primarily driven by our marine and aviation and aerospace lines of business due to improved pricing, larger line sizes and new business opportunities. Our GPW increased 93% to $1,115.2 million in 2021 from $577.9 million in 2020. The growth in 2021 was primarily driven by the improved pricing in aviation and property D&F insurance which allowed us to deploy the capital we raised in 2019 and in 2020. Growth in marine was driven primarily by a new binding authority in 2021 established with Pine Walk Capitals marine-focused managing general underwriter, Navium. See Capital Management.
Reinsurance Premiums Ceded. Reinsurance premiums ceded increased by 54% to $549.9 million from $357.0 million in 2021. The increase is driven by the increase in GPW. Our reinsurance premiums ceded increased 104% in 2021, driven primarily by growth in our GPW and the addition of a new 20% whole account quota share contract that commenced in the fourth quarter of 2020.
Net Premiums Earned. NPE increased 59% to $852.8 million from $535.3 million in 2021, driven by the increase in our NPW and continued earnings from contracts that incepted in prior years. Our NPE increased 212.0% in 2021.
Losses and Loss Adjustment Expenses. Our loss ratio was 59.7% in 2022 compared to 38.5% in 2021. The main component of the increase in Specialty loss ratio was $117 million of the $135 million loss associated with the Ukraine Conflict that were recorded in the Specialty segment. Our loss ratio in 2021 was 38.5%, similar to the loss ratio of 37.7% in 2020.
129
Bespoke
The table below sets out GPW, NPE and the loss ratio for the Bespoke segment for the years ended December 31, 2022, 2021 and 2020:
Bespoke | ||||||||||||||||||||
For the Year Ended | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
($ in millions) | % change | ($ in millions) | % change | ($ in millions) | ||||||||||||||||
Credit & Political Risk |
$ | 329.8 | 28 | % | $ | 258.1 | 229 | % | $ | 78.5 | ||||||||||
Bespoke |
453.4 | 37 | % | $ | 329.9 | 27 | % | $ | 260.6 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Bespoke GPW |
$ | 783.2 | 33 | % | $ | 588.0 | 73 | % | $ | 339.1 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Reinsurance premiums ceded |
(221.5 | ) | 44 | % | (153.4 | ) | 75 | % | (87.9 | ) | ||||||||||
Net premiums earned |
$ | 379.4 | 51 | % | $ | 251.9 | 19 | % | $ | 212.5 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Losses and loss adjustment expenses |
(118.9 | ) | 67 | % | (71.4 | ) | 1 | % | (70.5 | ) | ||||||||||
Loss ratio |
31.3 | % | 28.3 | % | 33.2 | % | ||||||||||||||
|
|
|
|
|
|
Gross Premiums Written. GPW increased to $783.2 million in 2022 from $588.0 million in 2021. This growth was driven by additional current-year warranty deals and new opportunities in our bespoke intangibles line of business. GPW increased to $588.0 million in 2021 from $339.1 million in 2020. This growth was primarily driven by higher premium rates due to increased appetite for credit-related lines of business following a reduced appetite in 2020 due to the COVID-19 pandemic.
In 2020, new business opportunities within our bespoke other class were offset by the reduction in credit-exposed contracts within credit and political risk.
Reinsurance Premiums Ceded. Reinsurance premiums ceded increased to $221.5 million in 2022 from $153.4 million in 2021, primarily driven by increases in GPW and also higher ceded quota share premiums. Our reinsurance premiums ceded increased to $153.4 million in 2021 from $87.9 million in 2020, primarily as a result of higher gross volumes and the addition of a new 20% whole account quota share contract in the fourth quarter of 2020.
Net Premiums Earned. NPE increased to $379.4 million in 2022 from $251.9 million in 2021. This reflects the 33% increase in GPW together with the continued earning of contracts written in prior years. NPE increased to $251.9 million in 2021 (2020: $212.5 million), primarily due to growth in written premiums and the earn-through of longer tenor business written in prior years.
Losses and Loss Adjustment Expenses. Our loss ratio in 2022 was 31.3% in 2022 compared with 28.3% in 2021. The slight increase was caused by $18 million of our $135 million loss associated with the Ukraine Conflict that was recorded in the Bespoke segment. Our loss ratio was 28.3% in 2021 compared to 33.2% in 2020. The decrease in loss ratio was primarily due to the impact of COVID-19 losses in 2020.
130
Reinsurance
The table below sets out GPW, NPE and the loss ratio for the Reinsurance segment for the years ended December 31, 2022, 2021 and 2020:
Reinsurance | ||||||||||||||||||||
For the Year Ended | ||||||||||||||||||||
2022 | 2021 | 2020 | ||||||||||||||||||
($ in millions) | % change | ($ in millions) | % change | ($ in millions) | ||||||||||||||||
Property Reinsurance |
$ | 556.9 | (45 | %) | $ | 1,004.5 | 66 | % | $ | 604.2 | ||||||||||
Retrocession |
32.5 | (45 | %) | 59.5 | 23 | % | 48.3 | |||||||||||||
Whole Account |
16.8 | (18 | %) | 20.5 | 193 | % | 7.0 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Reinsurance GPW |
$ | 606.2 | (44 | %) | $ | 1,084.5 | 64 | % | $ | 659.5 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Reinsurance premiums ceded |
(366.1 | ) | (46 | %) | (676.2 | ) | 66 | % | (408.2 | ) | ||||||||||
Net premiums earned |
272.5 | (26 | %) | 367.0 | 7 | % | 344.4 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Losses and loss adjustment expenses |
(202.6 | ) | (52 | %) | (419.2 | ) | 122 | % | (189.2 | ) | ||||||||||
Loss ratio |
74.3 | % | 114.2 | % | 54.9 | % | ||||||||||||||
|
|
|
|
|
|
Gross Premiums Written. GPW decreased to $606.2 million in 2022 from $1,084.5 million in 2021, driven by our views of risks relating to climate change and the adequacy of pricing for catastrophe risks. GPW increased to $1,084.5 million in 2021 from $659.5 million in 2020. The growth in 2021 was primarily driven by higher premium rates which allowed us to deploy the additional capital raised at the end of 2019 and during 2020.
Reinsurance Premiums Ceded. Reinsurance premiums ceded decreased to $366.1 million in 2022 from $676.2 million in 2021, which decrease was proportional to the decrease in GPW. Reinsurance premiums increased to $676.2 million in 2021 from $408.2 million in 2020, primarily driven by growth in the GPW and the addition of a new 20% whole account quota share contract in the fourth quarter of 2020.
Net Premiums Earned. NPE decreased to $272.5 million in 2022 from $367.0 million in 2021, driven by the decrease in GPW, partially offset by earned premiums from contracts that incepted in prior years. NPE increased to $367.0 million in 2021 from $344.4 million in 2020, primarily due to growth in GPW.
Losses and Loss Adjustment Expenses. Our loss ratio decreased to 74.3% in 2022 from 114.2% in 2021. This decrease resulted from a decrease in our catastrophe losses to $105.8 million in 2022 from $280.6 million in 2021. Our loss expense was elevated in 2021 from the impact of Winter Storm Uri, Hurricane Ida, and Storm Bernd, whereas the main loss incurred in 2022 was from Hurricane Ian. Our loss ratio increased to 114.2% in 2021 compared to 54.9% in 2020. The increase in loss ratio was primarily due to catastrophe losses of $280.6 million in 2021 from Winter Storm Uri, Hurricane Ida, and Storm Bernd compared to $116.4 million in 2020, relating primarily to Hurricane Laura and the U.S. Midwest derecho. In addition, in 2021 there was a strengthening of prior year reserves of $29.6 million relating to Hurricane Laura and the U.S. Midwest derecho compared to a reserve release of $9.8 million in 2020.
Financial Condition
Total Cash and Investments
Our investment strategy is focused on delivering stable investment income and a reasonable total return through all market cycles while maintaining appropriate portfolio liquidity and credit quality to meet the requirements of our clients, rating agencies and regulators, and to support our underwriting activities.
Our investments consist primarily of a core fixed maturity portfolio which is comprised of a diversified portfolio of high-quality fixed maturity securities (including U.S. Treasuries, non-U.S. government bonds,
131
government agency bonds, corporate bonds, investment-grade emerging market debt, mortgage and other asset-backed securities). Our core fixed maturity assets are managed by external investment managers through individual investment management agreements. We monitor activity and performance of these external managers regularly.
Our net investment return was $7.0 million in 2022 compared with $34.1 million in 2021. Our net investment income increased to $40.7 million in 2022 from $20.6 million in 2021 due to increases in interest rates and investible assets. This increase was more than offset by net realized and unrealized investment losses of $33.7 million in 2022. Our net investment return was $34.1 million in 2021 compared with $44.1 million in 2020. This decrease was caused by reinvesting at lower interest rates during 2021 compared to 2020.
We generated a negative total investment return percentage of 2.5% in 2022 compared to a negative total return of 0.1% in 2021. The decrease was caused by unrealized losses on our core fixed maturity investments resulting from increases in interest rates in 2022. We generated a negative total investment return of 0.1% in 2021 compared to a positive return of 2.4% in 2020. The fall in investment performance in 2021 was primarily due to unrealized losses on our core fixed maturity assets as yields increased.
At December 31, 2022 and December 31, 2021, total cash and cash equivalents (including restricted cash and cash equivalents) and investments (including derivative assets (at fair value), accrued investment income and investments pending settlement) were $3.9 billion and $3.3 billion, respectively. Total cash, cash equivalents and investments increased from 2021 to 2022, primarily as a result of positive operating cash flows. At December 31, 2022, 36.7% (2021 - 14.6%) of our total cash and investments was held in cash and 60.2% (2021 - 76.8%) of our total cash and investments was allocated to our core fixed maturity portfolio. Risk assets represented 3.0% (2021 - 7.7%) of our total cash and investments at December 31, 2022.
At December 31, 2021 and December 31, 2020, total cash and cash equivalents (including restricted cash and cash equivalents) and investments (including derivative assets (at fair value), accrued investment income and investments pending settlement) were $3.3 billion and $3.0 billion, respectively. Total cash, cash equivalents and investments increased from 2020 to 2021, primarily as a result of positive operating cash flows.
Consistent with our current investment approach, we have maintained a diversified portfolio of fixed maturity securities with only a small allocation to risk assets over the last two years. The following tables summarize the fair value of our fixed-maturity investments at December 31, 2022 and December 31, 2021, respectively:
At December 31, 2022 | ||||||||||||||||
Cost | Unrealized Gains |
Unrealized Losses |
Fair Value |
|||||||||||||
($ millions) | ||||||||||||||||
Available-for-sale |
||||||||||||||||
US. Treasuries |
$ | 643.1 | $ | | $ | (27.3 | ) | $ | 615.8 | |||||||
Agencies |
17.5 | | (0.4 | ) | 17.1 | |||||||||||
Non-U.S. government |
115.2 | | (4.3 | ) | 110.9 | |||||||||||
Corporate bonds |
1,078.1 | | (57.8 | ) | 1,020.3 | |||||||||||
Residential mortgage-backed securities |
88.6 | | (8.9 | ) | 79.7 | |||||||||||
Commercial mortgage-backed securities |
8.0 | | (1.2 | ) | 6.8 | |||||||||||
Other asset-backed securities |
209.5 | | (9.2 | ) | 200.3 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, AFS |
$ | 2,160.0 | $ | | $ | (109.1 | ) | $ | 2,050.9 | |||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities |
$ | 2,160.0 | $ | | $ | (109.1 | ) | $ | 2,050.9 | |||||||
|
|
|
|
|
|
|
|
|||||||||
Short-term investments, AFS |
257.0 | 0.1 | (0.1 | ) | 257.0 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity and short-term investments |
$ | 2,417.0 | $ | 0.1 | $ | (109.2 | ) | $ | 2,307.9 | |||||||
|
|
|
|
|
|
|
|
132
At December 31, 2021 | ||||||||||||||||
Cost | Unrealized Gains |
Unrealized Losses |
Fair Value |
|||||||||||||
($ millions) | ||||||||||||||||
Trading |
||||||||||||||||
Corporate bonds |
$ | 13.6 | $ | 0.1 | $ | | $ | 13.7 | ||||||||
Residential mortgage-backed securities |
4.8 | 0.1 | | 4.9 | ||||||||||||
Other asset-backed securities |
8.3 | | | 8.3 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, trading |
$ | 26.7 | $ | 0.2 | $ | | $ | 26.9 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Available-for-sale |
||||||||||||||||
US. Treasuries |
732.8 | 2.5 | (4.5 | ) | 730.8 | |||||||||||
Agencies |
28.0 | | (0.1 | ) | 27.9 | |||||||||||
Non-U.S. government |
140.3 | 0.6 | (0.8 | ) | 140.1 | |||||||||||
Corporate bonds |
1,276.7 | 2.8 | (12.1 | ) | 1,267.4 | |||||||||||
Residential mortgage-backed securities |
56.3 | 0.2 | (1.4 | ) | 55.1 | |||||||||||
Commercial mortgage-backed securities |
57.3 | | (0.8 | ) | 56.5 | |||||||||||
Other asset-backed securities |
214.1 | 0.2 | (1.0 | ) | 213.3 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, AFS |
$ | 2,505.5 | $ | 6.3 | $ | (20.7 | ) | $ | 2,491.1 | |||||||
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities |
$ | 2,532.2 | $ | 6.5 | $ | (20.7 | ) | $ | 2,518.0 | |||||||
|
|
|
|
|
|
|
|
|||||||||
Short-term investments, AFS |
11.5 | | | 11.5 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities |
$ | 2,543.7 | $ | 6.5 | $ | (20.7 | ) | $ | 2,529.5 | |||||||
|
|
|
|
|
|
|
|
Weighted average book yield at December 31, 2022 on our fixed maturity portfolio was 1.6% compared with 0.90% at December 31, 2021. The increase in book yield was a result of purchases of new securities at higher yields as interest rates increased over the course of the year. Our fixed maturity portfolio duration at December 31, 2022 was 1.2 years compared to 1.9 years at December 31, 2021.
At December 31, 2022 and December 31, 2021 the average credit quality of our fixed maturity portfolio was AA- (or its equivalent), with 88.0% and 86.0% (respectively) of the portfolio being rated A- (or its equivalent) or above. Where the credit ratings are split between two rating agencies, the lower rating is used; where the credit ratings are split between three rating agencies, the middle rating is used.
The composition of the fair values of fixed maturity securities by credit rating at December 31, 2022 and 2021 is as follows:
133
In addition to our core fixed maturity portfolio, we also have a small allocation to risk assets of $117.1 million or 4.8% of total investments at December 31, 2022.
In January 2021, we invested a total of $50.0 million in an opportunistic fixed maturity UCITS fund managed by Wellington Investment Management. The fair value of the fund at December 31, 2022 was $43.4 million.
In February 2022, we invested $75.0 million into a one-year equity-market linked structured note. The ultimate return on the structured note is determined based on the relative level of the underlying index on maturity of the structured note compared to the index entry points. The upside return on the structured note is subject to a cap while the structured note includes a buffer protecting the structured note from experiencing any principal loss for up to 10.0% of negative index performance relative to the entry point. If the buffer is breached the structured note will experience a principal loss only for the negative performance that is in excess of the 10.0% buffer. The underlying index of the structured note is a blended index which includes the S&P500, Stoxx Europe 600, TOPIX and a U.S. infrastructure equity exchange- traded fund. The fair value of the structured note at December 31, 2022 was $72.8 million.
Reserves
The following tables detail gross and net reserves for losses and loss adjustment expenses at December 31, 2022 and December 31, 2021:
Total Losses and Loss Adjustment Expenses |
||||||||
At December 31, | ||||||||
2022 | 2021 | |||||||
Reserves for losses and loss adjustment expenses |
$ | 2,045.2 | $ | 1,386.5 | ||||
Reinsurance balances recoverable on reserves for losses and loss adjustment expenses | (976.1 | ) | (795.2 | ) | ||||
|
|
|
|
|||||
Net Reserves for losses and loss adjustment expenses |
$ | 1,069.1 | $ | 591.3 | ||||
|
|
|
|
At December 31, 2022, we had net reserves for losses and loss adjustment expenses of $1,069.1 million, which represented our best estimate of the ultimate liability for payment of losses and loss adjustment expenses, an increase from $591.3 million net reserves for losses and loss adjustment expenses at December 31, 2021. Of the gross reserves for losses and loss adjustment expenses of $2,045.2 million at December 31, 2022, a total of $1,250.1 million, or 61%, represented IBNR claims. Of the gross reserves for losses and loss adjustment expenses of $1,386.5 million at December 31, 2021, a total of $851.7 million, or 61%, represented IBNR claims. The year-on-year increase in gross reserves for losses and loss adjustment expenses is primarily due to premium growth.
134
The breakdown of gross reserves between outstanding claims and IBNR for the relevant period end were as follows:
Total Losses and Loss Adjustment Expenses |
||||||||
At December 31, | ||||||||
2022 | 2021 | |||||||
Gross Outstanding |
$ | 795.1 | $ | 534.8 | ||||
Gross IBNR |
1,250.1 | 851.7 | ||||||
Gross Reserves |
2,045.2 | 1,386.5 | ||||||
% IBNR |
61.1 | % | 61.4 | % | ||||
|
|
|
|
Prior Year Reserves: For the year ended December 31, 2022 there was an overall reduction in our estimate of ultimate net claims to be paid in respect of prior accident years. The reserve releases for each of the years ended December 31, 2022, December 31, 2021 and December 31, 2020 are shown below:
For the Year Ended December 31, |
||||||||||||
2022 | 2021 | 2020 | ||||||||||
Total losses and loss expense reserves releases |
$ | 22.1 | $ | 9.6 | $ | 38.4 | ||||||
|
|
|
|
|
|
For the year ended December 31, 2022, our net reserve release of $22.1 million was primarily driven by our Bespoke and Specialty segments. Both segments experienced a more benign claim experience than our assumptions allowed for, across the majority of classes. This was partially offset by reserve strengthening of $17.8 million in our Reinsurance Segment, largely driven by deterioration on Storm Bernd and Hurricane Laura.
For the year ended December 31, 2021, our net reserve release of $9.6 million was primarily driven by better-than-expected performance of $21.2 million in Bespoke and $18.0 million in Specialty. This was offset by reserve strengthening of $29.6 million in Reinsurance, driven primarily by adverse reserve development from Hurricane Laura and the Midwest Derecho which occurred in 2020.
For the year ended December 31, 2020, our net reserve release of $38.4 million was primarily driven by changes in reserving estimates across the Bespoke, Specialty and Reinsurance segments due to better-than-expected loss experience.
We did not make any significant changes in methodologies used in our reserving process for the periods covered in this prospectus.
Potential Variability in Loss Reserves: The tables below summarize the effect of reasonably likely scenarios on the key actuarial assumptions used to estimate our loss reserves, net of unpaid losses and loss adjustment expenses for our segments at December 31, 2022. The scenarios in these tables summarize the effect of (i) changes to the expected loss ratio selections used at December 31, 2022, which represent loss ratio point increases or decreases to the expected loss ratios used, and (ii) changes to the loss development patterns used in our reserving process at December 31, 2022, which represent claims reporting that is either slower or faster than the reporting patterns used. We believe that the illustrated sensitivities are indicative of the potential variability inherent in the estimation process of those parameters. The results show the impact of varying each key actuarial assumption using the chosen sensitivity on our IBNR reserves, on a net basis and across all accident years.
Each of the impacts summarized in the tables below is estimated individually and without consideration for any correlation among key assumptions or among lines of business. Therefore, it would be inappropriate to take each of the amounts and add them together to estimate total volatility. While we believe the variations in the expected loss ratios and loss development patterns presented could be reasonably expected, our own historical
135
data regarding variability is generally limited and actual variations may be greater or less than these amounts. It is also important to note that the variations are not meant to be a best-case or worst-case series of scenarios and, therefore, it is possible that future variations in our loss reserves may be more or less than the amounts set forth above. While we believe that these are reasonably likely scenarios, we do not believe this sensitivity analysis should be considered an actual reserve range.
Expected Loss Ratio at December 31, 2022 | ||||||||||||
($ in millions) | ||||||||||||
Development Pattern |
||||||||||||
Increase (decrease) in loss reserves, net |
||||||||||||
Reinsurance |
5% Lower | Unchanged | 5% Higher | |||||||||
|
|
|
|
|
|
|||||||
6 Months Shorter |
(34.2 | ) | (33.6 | ) | (33.0 | ) | ||||||
Unchanged |
(3.4 | ) | | 3.4 | ||||||||
6 Months Longer |
31.0 | 37.7 | 44.4 | |||||||||
Specialty |
5% Lower | Unchanged | 5% Higher | |||||||||
|
|
|
|
|
|
|||||||
6 Months Shorter |
(36.0 | ) | (22.3 | ) | (8.7 | ) | ||||||
Unchanged |
(15.6 | ) | | 15.6 | ||||||||
6 Months Longer |
27.3 | 47.5 | 67.6 | |||||||||
Bespoke |
5% Lower | Unchanged | 5% Higher | |||||||||
|
|
|
|
|
|
|||||||
6 Months Shorter |
(33.1 | ) | (22.9 | ) | (12.8 | ) | ||||||
Unchanged |
(12.0 | ) | | 12.0 | ||||||||
6 Months Longer |
3.2 | 17.0 | 30.9 | |||||||||
|
|
|
|
|
|
Liquidity and Capital Resources
Liquidity is a measure of a companys ability to generate cash flows sufficient to meet short-term and long-term cash requirements of its business operations. Management monitors the liquidity of FIHL and of each of our operating insurance subsidiaries. As a holding company, FIHL relies on dividends and other distributions from its operating insurance subsidiaries to provide cash flow to meet ongoing cash requirements, including any future debt service payments and other expenses, and to pay dividends to the holders of our Common Shares and Series A Preference Securities, if any.
During the years ended December 31, 2022 and 2021, FIHL received distributions from subsidiaries of $220.9 million and $83.0 million, respectively. FIID is an indirect wholly owned subsidiary of FIBL and hence does not pay dividends directly to FIHL. FIHL (and not, for the avoidance of doubt, its subsidiaries) held $127.6 million of cash and cash equivalents at December 31, 2022 and $15.1 million at December 31, 2021. Management considers the current cash and cash equivalents, together with dividends declared or expected to be declared by the operating insurance subsidiaries, sufficient to appropriately satisfy the liquidity requirements of FIHL, which are minimal at present.
The ability of the operating insurance subsidiaries to pay dividends or other distributions to FIHL is subject to the laws and regulations applicable in their relevant jurisdictions as well as the applicable operating insurance subsidiarys need to maintain capital amounts adequate to maintain their (re)insurance operations and their financial strength ratings issued by independent rating agencies.
As a Bermuda class 4 (re)insurer, FIBL must maintain available statutory economic capital at a level equal to its enhanced capital requirement (ECR), which is established by reference to the Bermuda Solvency Capital Requirement (BSCR). Under the Bermuda Insurance Act 1978, as amended, FIBL is prohibited from declaring or paying a dividend if it is in breach of its minimum solvency margin, ECR or minimum liquidity ratio or if the declaration or payment of such dividend would cause such a breach. In addition, FIBL is prohibited from declaring or paying in any financial year dividends of more than 25% of its total statutory capital and surplus (as
136
shown on its previous financial years statutory balance sheet) unless it files with the BMA an affidavit stating that it will continue to meet the relevant solvency and liquidity margins. Without the approval of the BMA, FIBL is prohibited from reducing by 15% or more its total statutory capital as set out in its previous years financial statements and any application for such approval must include an affidavit stating that it will continue to meet the required solvency and liquidity margins.
The PRAs regulatory requirements impose no explicit restrictions on FULs ability to pay a dividend, but FUL must notify the PRA 28 days prior to any proposed dividend payment. Under the U.K. Companies Act 2006, as amended, dividends may only be distributed from profits available for distribution under applicable law.
The CBI regulatory requirements impose no explicit restrictions on FIIDs ability to pay a dividend, but FIID must notify the CBI prior to any proposed dividend payment. Under Irish company law, dividends may only be distributed from profits available for distribution under applicable law.
The operating insurance subsidiaries held $1,277.5 million and $320.3 million of unrestricted cash and unrestricted short-term investments at December 31, 2022 and December 31, 2021, respectively. Management monitors the value, currency and duration of cash and investments held by the operating insurance subsidiaries to ensure they are able to meet their (re)insurance and other liabilities as they become due and was satisfied that there was a comfortable margin of liquidity at December 31, 2022 and for the foreseeable future.
On an ongoing basis, the operating insurance subsidiaries sources of funds primarily consist of premiums written, investment income and proceeds from sales and redemptions of investments. Cash is used primarily to pay reinsurance premiums, losses and loss adjustment expenses, brokerage commissions, general and administrative expenses, taxes, interest and dividends, and to purchase new investments. The potential for individual large claims and for accumulations of claims from any given single event(s) means that substantial and unpredictable payments may need to be made within relatively short periods of time. For a discussion of the volatility and liquidity of our investments, see Risk FactorsRisks Relating to Financial Markets and Liquidity.
For all material currencies in which our (re)insurance business is written, we seek to ensure that sufficient cash and short-term investments are held in such currencies to enable us to meet potential claims without having to liquidate long-term investments and adversely affect our investment return. This follows the matching principle that matches our assets and liabilities in currency to mitigate foreign currency risk whenever possible.
We manage these risks by making regular forecasts of the timing and amount of expected cash outflows and ensuring that we maintain sufficient balances in cash and short-term investments to meet these estimates. Notwithstanding this policy, if these cash flow forecasts are incorrect, we could be forced to liquidate investments prior to maturity, potentially at a significant loss. Historically, we have not had to liquidate investments at a significant loss to maintain sufficient levels of liquidity.
137
The liquidity of the operating insurance subsidiaries is also affected by the terms of our contractual obligations to policyholders and by undertakings to certain regulatory authorities to facilitate the issue of letters of credit or maintain certain balances in trust funds for the benefit of policyholders, or restricted for other reasons. The following table shows the forms of collateral or other security provided in respect of these obligations and undertakings at December 31, 2022 and December 31, 2021:
At December 31, | ||||||||
2022 | 2021 | |||||||
($ in millions unless stated in |
||||||||
Regulatory and client trusts and deposits: |
||||||||
Affiliated transactions |
$ | 531.1 | $ | 281.5 | ||||
Third-party |
391.2 | 277.2 | ||||||
Letters of credit |
253.1 | 409.7 | ||||||
|
|
|
|
|||||
Total restricted assets |
$ | 1,175.4 | $ | 968.4 | ||||
|
|
|
|
|||||
Total as percentage of investible assets |
30.5 | % | 29.6 | % | ||||
|
|
|
|
See notes 8 (Restricted Cash and Cash Equivalents) and 9 (Pledged Investments) of our audited consolidated financial statements contained elsewhere in this prospectus for further detail on the restricted assets that we are required to maintain in accordance with contractual obligations to policyholders and in compliance with regulatory requirements.
Consolidated Cash Flows for the Year Ended December 31, 2022: Total net cash provided by our operating activities for 2022 was $742.9 million compared to $367.7 million for 2021. The increase in net cash provided by operating activities was primarily attributable to continued growth in our business partially offset by claims activity. Our cash and cash equivalents (including restricted cash and cash equivalents) increased significantly to $1,407.9 million at December 31, 2022 from $476.0 million at December 31, 2021, primarily due to us holding significant cash in advance of the Separation Transactions. For 2022, total net cash provided by investment activities was $214.4 million and total net cash used in financing activities was $16.2 million.
Consolidated Cash Flows for the Year Ended December 31, 2021: Total net cash provided by our operating activities for the year ended December 31, 2021 was $367.7 million compared to $316.1 million for the year ended December 31, 2020. The increase in net cash provided by operating activities was primarily attributable to the significant growth in our business offset by increased claims activity. Our net cash decreased, primarily due to significant purchases of available-for-sale securities. For the year ended December 31, 2021, total net cash used in investment activities was $1,114.5 million and total net cash used in financing activities was $11.1 million. At December 31, 2021, we had a balance of cash and cash equivalents of (including restricted cash and cash equivalents) $476.0 million.
Consolidated Cash Flows for the Year Ended December 31, 2020: Total net cash provided by our operating activities for the years ended December 31, 2020 was $316.1 million. The increase in net cash provided by operating activities was primarily attributable to the significant growth in our business. For the year ended December 31, 2020, total net cash used in investment activities was $481.3 million and total net cash provided by financing activities was $948.0 million. At December 31, 2020, we had a balance of cash and cash equivalents (including restricted cash and cash equivalents) of $1,238.5 million.
Contractual Obligations and Commitments: The gross unpaid provision for losses and loss adjustment expenses at December 31, 2022 was $2,045.2 million. The gross unpaid provision for losses and loss adjustment expenses at December 31, 2021 was $1,386.5 million. For more information on provision for losses and loss adjustment expenses please refer to note 12 (Reserves for losses and Loss Adjustment Expenses) of our audited consolidated financial statements contained elsewhere in this prospectus.
138
In addition, there are future commitments under various non-cancellable operating leases for Fidelis facilities. These total $28.5 million with $2.5 million due by the end of 2023, $10.0 million due within one to three years, $9.2 million due within three to five years, and $18.5 million due in more than five years.
Letter of Credit Facilities: At December 31, 2022, there were letters of credit outstanding under the Standby Letter of Credit Facility Agreement with Lloyds Bank plc totaling $101.2 million (2021: $162.7 million), secured by collateral in the amount of $92.4 million (2021: $157.3 million). At December 31, 2022, there were letters of credit outstanding under the Master Agreement for the Issuance of Payment Instruments with Citibank N.A., London Branch totaling $100.1 million (2021: $208.9 million), secured by collateral in the amount of $104.4 million (2021: $236.4 million). At December 31, 2022 there were letters of credit outstanding under the Letter of Credit Facility with Barclays Bank plc totaling $88.2 million (2021: $23.4 million), secured by collateral in the amount of $45.7 million (2021: nil) (the Letter of Credit Facility with Barclays Bank plc has both a secured and an unsecured tranche). At December 31, 2022 there were letters of credit outstanding under the letter of credit facility with Bank of Montreal totaling $77.4 million (2021: $45.0 million), secured by collateral in the amount of $10.8 million (2021: $16.0 million).
Capital Management
We maintain our capital at an appropriate level as determined by our Group Board-approved internal risk appetite and the financial strength required by our clients, regulators and rating agencies. We monitor and review the capital and liquidity positions of FIHL and its operating insurance subsidiaries on an ongoing basis.
The principal capital management transactions undertaken during the years ended 2022, 2021 and 2020 were as follows:
| On February 10, 2020 FIHL issued 13,906,464 Common Shares for a total of $142.3 million, net of issuance costs; |
| On June 10, 2020, FIHL issued 34,533,958 Common Shares for a total of $355.0 million, net of issuance costs; |
| On June 18, 2020, we issued $300.0 million aggregate principal amount of 4.875% Senior Notes due 2030 (the Initial Senior Notes) pursuant to that certain Indenture (the Base Senior Notes Indenture), between FIHL, as Issuer, and The Bank of New York Mellon, as Trustee, Registrar, Transfer Agent and Paying Agent (the Trustee), and on July 2, 2020, we issued a further $30.0 million aggregate principal amount of 4.875% Senior Notes due 2030 (the Additional Senior Notes and, together with the Initial Senior Notes, the Senior Notes) issued by FIHL pursuant to that certain Supplemental Indenture No. 1 to the Senior Notes Indenture (together, the Senior Notes Indenture), between FIHL, as Issuer, and the Trustee, as Trustee, Registrar, Transfer Agent and Paying Agent; |
| On July 23, 2020 FIHL issued 13,583,196 Common Shares for a total of $139.0 million, net of issuance costs; |
| On October 16, 2020 we issued $105.0 million aggregate principal amount of 6.625% Fixed-Rate Reset Junior Subordinated Notes due 2041 (the Initial Subordinated Notes) pursuant to that certain Indenture (the Base Subordinated Notes Indenture) between FIHL, as Issuer, and the Trustee, as Trustee, Registrar, Transfer Agent and Paying Agent, and on October 20, 2020 we issued a further $20.0 million aggregate principal amount of 6.625% Fixed-Rate Reset Junior Subordinated Notes due 2041 (the Additional Subordinated Notes and, together with the Initial Subordinated Notes, the Subordinated Notes and, together with the Senior Notes, the Notes) pursuant to that certain Supplemental Indenture No. 1 to the Subordinated Notes Indenture (together, the Subordinated Notes Indenture), between FIHL, as Issuer, and the Trustee, as Trustee, Registrar, Transfer Agent and Paying Agent; |
139
| On December 1, 2020 FIHL issued 4,156,330 Common Shares for a total of $60.6 million, net of issuance costs; |
| On July 15, 2021, FIHL issued 19,874,121 Common Shares for a total of $318.2 million, net of issuance costs; and |
| On August 26, 2021, FIHL repurchased 19,865,920 Common Shares for $318.5 million, including costs of $4.4 million. |
Preference Securities: At December 31, 2022, FIHL has 12,102 Series A Preference Securities outstanding that are classified in our balance sheet as debt.
Long-Term Debt: At December 31, 2022, FIHL has $447.5 million in debt outstanding. Such debt is comprised of the Senior Notes, and the Subordinated Notes, referenced above. Other than the Series A Preference Securities and the Notes, FIHL has no material debt outstanding.
Dividend Payments to the Preference Security Holders: During 2022, 2021 and 2020, we continued to make the quarterly cash dividend payments to our preference security holders. Dividend payments in 2022, 2021 and 2020 were $5.3 million, $5.3 million and $13.7 million, respectively.
Access to Capital: Our business operations are in part dependent on our financial strength and the opinions of the independent rating agencies thereof as discussed above in this prospectus. We believe our financial strength provides us with the flexibility and capacity to obtain funds through debt or equity financing as required from the private markets. Our ability to access the capital markets is dependent on, among other things, our operating results, market conditions, and our perceived financial strength. We regularly monitor our capital and financial position, as well as investment and securities market conditions.
Inflation: We consider the effects of inflation in pricing our contracts and policies through modeled components such as demand surge. Loss reserves are established to recognize likely loss settlements at the date payment is made. Those reserves inherently recognize the effects of inflation. The actual effects of inflation on our results cannot be accurately known, however, until claims are ultimately resolved.
Quantitative and Qualitative Disclosures about Market Risk
We believe that we are principally exposed to three types of market risk: interest rate risk, foreign currency risk and credit risk.
Interest Rate Risk. Our investment portfolio consists primarily of fixed maturity securities. Fluctuations in interest rates have a direct impact on the market valuation of these securities. Accordingly, our primary market risk exposure is to changes in interest rates. As interest rates rise, the market value of our fixed maturity portfolio falls and the converse is also true.
We manage interest rate risk by maintaining a short-to-medium duration portfolio to reduce the effect of interest rate changes on the market value of these securities. We also enter into interest rate derivative contracts in the ordinary course of our investment activities to partially mitigate any negative impact of rises in interest rates on the market value of our fixed maturity portfolio.
At December 31, 2022, our fixed maturity portfolio had an approximate duration of 1.2 years including the duration impact of the interest rate futures that are used to position the fixed maturity portfolio duration within target parameters.
140
The table below depicts interest rate change scenarios and the effect on our interest-rate-sensitive invested assets, including the impact of interest rate swaps:
Foreign Currency Risk: Our reporting currency and functional currency is the U.S. dollar. At December 31, 2022, 97.0% of our cash and investments was held in U.S. dollars compared to 98.2% at December 31, 2021, with the balance of 3.0% held primarily in British Pounds and Euros, compared to 1.8% at December 31, 2021.
Other foreign currency amounts are remeasured to the appropriate functional currency and the resulting foreign exchange gains or losses are reflected in the income statement. Both the remeasurement and translation are calculated using current exchange rates for the balance sheets and monthly exchange rates for the income statements. We may experience exchange losses to the extent that our foreign currency exposure is not properly managed or otherwise hedged, which would in turn adversely affect our results of operations and financial condition. An increase or decrease of 25% in the U.S. dollar would result in additional gain or loss for the year ended December 31, 2022 of $18.9 million compared to $26.3 million for the year ended December 31, 2021 with an equal impact on net assets, assuming all other assumptions remain unchanged.
We will continue to manage our foreign currency risk by seeking to match our liabilities under insurance and reinsurance policies that are payable in foreign currencies with investments that are denominated in those currencies. This may involve the use of foreign exchange contracts from time to time. A foreign exchange contract involves an obligation to purchase or sell a specified currency at a future date at a price set at the time of the contract. Foreign exchange contracts will not eliminate fluctuations in the value of our assets and liabilities denominated in foreign currencies but rather allow us to establish a rate of exchange for a future point in time.
As the foreign exchange contracts settle, the realized gain or loss is included with foreign exchange gains and losses in the income statement. For the year ended December 31, 2022, the amount recognized within foreign exchange gains and losses for settled foreign exchange contracts was a realized gain of $3.5 million compared to a loss of $2.9 million for the year ended December 31, 2021. See Foreign Exchange Contracts above.
Credit Risk: We have exposure to credit risk primarily as a holder of fixed maturity securities and private securities. Our risk management strategy and investment policy are to invest mainly in debt instruments of high credit quality issuers. We also hold a portion of the portfolio in securities that are below investment grade or in other specialty asset classes. We reduce the amount of credit exposure by setting limits with respect to particular ratings categories, business sectors and any one issuer.
We are also exposed to credit risk in respect of premium payments from clients and/or brokers, depending on whether the terms of business agreement with the broker is transfer or non-transfer of risk. In addition, we are exposed to the credit risk of our insurance and reinsurance brokers to whom we make claims payments for our policyholders, as well as to the credit risk of our reinsurers and retrocessionaires who assume business from us. Other than fully collateralized reinsurance, at December 31, 2022 the substantial majority of our reinsurers have a rating by A.M. Best of A (Excellent), the third-highest of 13 rating levels, or better and the minimum rating of any of our material reinsurers is A- (Excellent), the fourth-highest of 13 rating levels, by A.M. Best. The Group evaluates the financial condition of its reinsurers on a regular basis and monitors concentrations of credit risk with reinsurers.
141
At December 31, 2022, the reinsurance balance recoverable on reserves for losses and loss adjustment expenses was $976.1 million (net of allowances for credit losses of $1.0 million), 2021: $795.2 million (net of allowances for credit losses of $0.5 million). The reinsurance balance recoverable on paid losses was $159.4 million (2021: $256.6 million) (net of allowances for credit losses of $nil, 2021: $nil). See Note 13: Reinsurance and retrocessional reinsurance in our audited consolidated financial statements included elsewhere in this prospectus.
Fidelis First Quarter in Review for 2023
The three months ended March 31, 2023 saw continued growth in our GPW to $1,245.3 million from $970.7 million in the prior year period, driven by our Bespoke and Specialty segments. We continue to reduce GPW in our Reinsurance segment as we focus on optimizing our portfolio to respond to our views on climate change and the adequacy of catastrophe pricing. We have increased our premiums written in property D&F within the Specialty segment as rates are currently more attractive within that line of business than within Property Reinsurance. Our combined ratio was lower than the prior year period, at 79.1% for the three months ended March 31, 2023 compared to 87.4% in the prior year period. This was driven by a decrease in our Reinsurance segment loss ratio to 20.3% from 76.7%, primarily due to catastrophe and large losses of $64.1 million in relation to the Ukraine Conflict and European storms in the prior year period. Our Operating RoE was 5.4% in the three months ended March 31, 2023 compared with 1.0% in the prior year period.
Current Outlook, Market Conditions and Rate Trends
Looking ahead, we believe our portfolio is well positioned to benefit from the prevailing hard market conditions that are expected to persist throughout 2023 and beyond. We anticipate that gross premiums written will continue to increase, particularly due to growth in our Bespoke and Specialty segments. In Specialty, we anticipate attractive market conditions across multiple product lines, driven by dislocation in the market. We believe our lead market positioning leaves us well placed to capitalize on new opportunities and achieve differentiated pricing across the Specialty segment. We anticipate our Bespoke pillar will continue to be more insulated from market pricing conditions in other classes. Fidelis is a strong brand, recognized for leading and executing Bespoke products and we will continue to look for opportunities to differentiate. The supply and demand imbalance in the Reinsurance market looks set to drive continued rate increases. We believe our ongoing focus on the optimization and repositioning of that portfolio will lead to continued strong performance.
Our capital position remains a source of strength, with high quality invested assets, significant liquidity and a low fixed cost base. Our diversified global platform with its broad mix of products, distribution and geography is resilient. Inflation continues to be a focus for our industry. We proactively analyze available data and we incorporate emerging trends into our pricing and reserving. We believe that this discipline, coupled with increases in future investment returns and proactive reserving, helps to mitigate the impact of inflation on our business.
Performance Measures and Non-U.S. GAAP Financial Measures
In presenting our results, management has included certain non-U.S. GAAP financial measures that we believe are useful to consider, in addition to our U.S. GAAP results, for a more complete understanding of the financial performance and position of FIHL. The key financial U.S. GAAP and non-U.S. GAAP measures that we believe are meaningful in analyzing our performance are summarized below and where applicable a reconciliation of non-U.S. GAAP measures to U.S. GAAP financials is set out. However, any non-U.S. GAAP measures should not be viewed as a substitute for those determined in accordance with U.S. GAAP and our methodology for calculating these measures may be different from the way our industry peers calculate these measures.
| Loss Ratio: is calculated by dividing losses and loss adjustment expenses by NPE. The losses will be affected by the occurrence and frequency of catastrophe events, the volume and severity of |
142
non-catastrophe losses and the extent of any outwards reinsurance that has been put in place to mitigate the effect of those losses. |
| Accident Year Loss Ratio Excluding Catastrophes, Large Losses and Prior Year Reserve Movements: is a non-U.S. GAAP measure of the representation of the loss ratio excluding the impact of catastrophes, large losses and prior year reserve movements, and supports meaningful comparison between periods. Accident year loss ratio excluding catastrophes, large losses and prior year reserve movements is calculated by dividing net incurred losses and loss adjustment expenses excluding catastrophes, large losses and prior year reserve movements by net premiums earned excluding catastrophe-related reinstatement premiums. |
| Underwriting Ratio: is calculated by dividing losses and loss adjustment expenses and policy acquisition expenses, net, by NPE, or equivalently, by adding the loss ratio and policy acquisition expense ratio. |
| Expense Ratio: is calculated by dividing policy acquisition expenses and general and administrative expenses by NPE, or equivalently, by adding the policy acquisition expense ratio, Fidelis MGU commissions ratio and general and administrative expense ratio. |
| Combined Ratio: is calculated by dividing losses and loss adjustment expenses, policy acquisition expenses and general and administrative expenses by NPE, or equivalently, by adding the loss ratio, policy acquisition expense ratio, Fidelis MGU commissions ratio and general and administrative expense ratio. A combined ratio under 100% indicates an underwriting profit, while a combined ratio over 100% indicates an underwriting loss. |
The table below reconciles our accident year loss ratio excluding catastrophes, large losses and prior year reserve movements to losses and loss adjustment expenses, loss ratio, expense ratio and combined ratio for the three months ended March 31, 2023 and 2022:
March 31, 2023 |
March 31, 2022 |
|||||||
($ in millions) | ||||||||
Catastrophe and large losses |
$ | | $ | 64.1 | ||||
Prior year favorable development |
(2.1 | ) | (4.6 | ) | ||||
Attritional losses |
161.7 | 118.9 | ||||||
|
|
|
|
|||||
Losses and loss adjustment expenses |
159.6 | 178.4 | ||||||
Policy acquisition expenses (third party) |
105.0 | 67.7 | ||||||
Fidelis MGU commissions |
24.2 | | ||||||
General and administrative expenses |
16.6 | 35.5 | ||||||
Net premiums earned |
$ | 386.0 | $ | 321.8 | ||||
Catastrophe and large loss impact on loss ratio |
| % | 20.0 | % | ||||
Prior year release impact on loss ratio |
(0.5 | %) | (1.4 | %) | ||||
Accident year loss ratio excluding catastrophes, large losses and prior year reserve movements |
41.8 | % | 36.8 | % | ||||
Loss ratio |
41.3 | % | 55.4 | % | ||||
Policy acquisition expenses ratio |
27.2 | % | 21.0 | % | ||||
|
|
|
|
|||||
Underwriting ratio |
68.5 | % | 76.4 | % | ||||
Fidelis MGU commissions ratio |
6.3 | % | | % | ||||
General and administrative expenses ratio |
4.3 | % | 11.0 | % | ||||
|
|
|
|
|||||
Combined ratio |
79.1 | % | 87.4 | % | ||||
Policy acquisition expenses ratio |
27.2 | % | 21.0 | % | ||||
Fidelis MGU commissions ratio |
6.3 | % | | % | ||||
General and administrative expenses ratio |
4.3 | % | 11.0 | % | ||||
|
|
|
|
|||||
Expense ratio |
37.8 | % | 32.0 | % |
143
Net Investment Return, Total Investment Return and Total Investment Return Percentage
| Net investment return: includes net investment gains and losses and net investment income. |
| Total investment return: includes net investment return plus unrealized gains and losses on available-for-sale financial assets. |
| Total investment return percentage: is calculated as total investment return divided by total average investible assets (including cash and cash equivalents and restricted cash and cash equivalents). |
The table below reconciles our net investment return, total investment return and total investment return percentage to net investment income for the three months ended March 31, 2023 and 2022.
March 31, 2023 |
March 31, 2022 |
|||||||
($ in millions) | ||||||||
Net investment gains/(losses) |
$ | 2.8 | $ | (10.2 | ) | |||
Net investment income |
20.4 | 5.1 | ||||||
|
|
|
|
|||||
Net investment return |
23.2 | (5.1 | ) | |||||
Unrealized gains/(losses) on available-for-sale investments |
24.9 | (61.2 | ) | |||||
|
|
|
|
|||||
Total investment return |
48.1 | (66.3 | ) | |||||
Opening |
||||||||
Total investments |
2,425.0 | 2,782.6 | ||||||
Cash and cash equivalents and restricted cash and cash equivalents |
1,407.9 | 476.0 | ||||||
Derivative assets, at fair value |
6.3 | 1.0 | ||||||
Accrued investment income |
10.9 | 12.1 | ||||||
Investment assets pending settlement |
2.0 | 0.5 | ||||||
Derivative liabilities, at fair value |
| (0.8 | ) | |||||
|
|
|
|
|||||
Net investible assets |
3,852.1 | 3,271.4 | ||||||
Closing |
||||||||
Total investments |
2,840.6 | 2,501.2 | ||||||
Cash and cash equivalents and restricted cash and cash equivalents |
711.4 | 752.1 | ||||||
Derivative assets, at fair value |
| 3.1 | ||||||
Accrued investment income |
13.3 | 10.6 | ||||||
Investment assets pending settlement |
1.1 | 2.1 | ||||||
Derivative liabilities, at fair value |
(3.6 | ) | (3.1 | ) | ||||
Investment liabilities pending settlement |
(6.2 | ) | | |||||
|
|
|
|
|||||
Net investible assets |
3,556.6 | 3,266.0 | ||||||
|
|
|
|
|||||
Average investible assets |
$ | 3,704.4 | $ | 3,268.7 | ||||
Total investment return percentage |
1.3 | % | (2.0 | %) |
Operating net income, RoE and Operating RoE
| Operating net income: is a non-U.S. GAAP measure of our performance which does not consider the impact of certain non-recurring and other items that may not properly reflect the ordinary activities of our business, its performance or its future outlook. This measure is calculated as net income available to holders of Common Shares excluding, net foreign exchange gains and losses, loss on the extinguishment of preference securities, and corporate and other expenses which include warrant costs, reorganization expenses, any non-recurring income and expenses, and the tax impact on these items. |
144
| Return on equity (or RoE): represents net income divided by opening common shareholders equity. |
| Operating return on equity (or Operating RoE): is a non-U.S. GAAP measure that represents a meaningful comparison between periods of our financial performance expressed as a percentage and is calculated as operating net income divided by adjusted opening common shareholders equity. For the three months ended March 31, 2023, we have adjusted our opening common shareholders equity to reflect the Companys common shareholders equity following the Separation Transactions that occurred on January 3, 2023 (see note 3 of the unaudited consolidated financial statements). |
The table below sets out the calculation of the operating net income, RoE and Operating RoE, based on applicable underwriting ratios, for the three months ended March 31, 2023 and 2022.
Three months ended | ||||||||
March 31, 2023 | March 31, 2022 | |||||||
($ in millions) | ||||||||
Opening Common Shareholders Equity |
$ | 1,976.8 | $ | 2,013.9 | ||||
Adjustments related to the Separation Transactions |
(178.4 | ) | | |||||
|
|
|
|
|||||
Adjusted Opening Common Shareholders Equity |
1,798.4 | 2,013.9 | ||||||
Net income available to common shareholders |
1,732.6 | 17.0 | ||||||
Deduct: net gain on distribution of Fidelis MGU |
(1,639.1 | ) | | |||||
Add back: net foreign exchange (gains)/losses |
1.5 | 0.9 | ||||||
Add back: Corporate and Other expenses |
1.5 | 1.9 | ||||||
Tax impact of the above |
(0.2 | ) | (0.2 | ) | ||||
|
|
|
|
|||||
Operating net income |
$ | 96.3 | $ | 19.6 | ||||
|
|
|
|
|||||
RoE |
87.6 | % | 0.8 | % | ||||
Operating RoE |
5.4 | % | 1.0 | % |
Reportable Segment(s)
We classify our business into three underwriting segments, namely Bespoke, Specialty and Reinsurance. Specialty primarily comprises property D&F, energy, marine and aviation lines. Bespoke primarily comprises credit and political risk and other tailored solutions for clients including transactional liabilities and credit insurance. Reinsurance primarily comprises property reinsurance.
FIHL does not manage its assets by segment. Accordingly, net investment income and total assets are not allocated to these segments. In addition, general and administrative expenses are not allocated between segments as employees, including underwriters, work across each of the different segments. Fidelis MGU commissions are not allocated to segments as they are not included in the measure of segment profit reviewed by the CODM, nor is a segment analysis of such expenses provided in other information reviewed by the CODM.
Financial Overview
The following overview of our operating results and financial condition for the three months ended March 31, 2023 and 2022 is intended to identify important themes and should be read in conjunction with the more detailed discussion further below. See Results of Operations.
145
Operating Highlights
Gross Premiums Written. The changes in our segments GPW for the three months ended March 31, 2023 and 2022 were as follows:
March 31, 2023 |
March 31, 2022 |
|||||||||||
GPW | ($ in millions) | (% change) | ||||||||||
Bespoke |
$ | 150.8 | $ | 135.0 | 12 | % | ||||||
Specialty |
834.1 | 543.8 | 53 | % | ||||||||
Reinsurance |
260.4 | 291.9 | (11 | %) | ||||||||
|
|
|
|
|||||||||
Total |
$ | 1,245.3 | $ | 970.7 | 28 | % | ||||||
|
|
|
|
Our GPW in the Bespoke segment grew 12%, primarily led by growth in our Credit & Political Risk line of business.
Our GPW in the Specialty segment grew 53%, with the largest increases from the Marine, Aviation and Aerospace and property D&F lines of business.
Our GPW in the Reinsurance segment decreased 11%, as we focus on optimizing our portfolio to respond to our views on climate change and the adequacy of catastrophe pricing. We have increased our premiums written in property D&F within the Specialty segment as rates are currently more attractive within that line of business than within Property Reinsurance.
Loss Ratio. We monitor loss ratio as a measure of relative underwriting performance, where a lower loss ratio represents a better underwriting result than a higher loss ratio. The loss ratios for our business segments for the three months ended March 31, 2023 and 2022 were as follows:
March 31, 2023 | March 31, 2022 | |||||||
Bespoke |
14.4 | % | 49.9 | % | ||||
Specialty |
52.9 | % | 51.7 | % | ||||
Reinsurance |
20.3 | % | 76.7 | % | ||||
|
|
|
|
|||||
Total |
41.3 | % | 55.4 | % |
The reduction in our loss ratio compared to the prior year period was primarily a result of no catastrophe and large losses in the three months ended March 31, 2023, compared with $64.1 million, related to the Ukraine Conflict and European storms in the prior year period. This was partially offset by losses in our Specialty segment, primarily in the Energy and Aviation and Aerospace lines of business.
Net Investment Income. We believe our investment portfolio continues to be conservatively positioned, with 86.3% of our investment portfolio held in cash and core fixed maturity securities with a short average duration of 1.4 years and average credit quality of AA- at March 31, 2023. This allows us to prioritize taking risk on the underwriting side of our balance sheet. Our net investment return was $23.2 million in the three months ended March 31, 2023 compared with $(5.1) million in the prior year period, primarily driven by net investment income of $20.4 million.
Our total investment return in the three months ended March 31, 2023 was $48.1 million compared with $(66.3) million in the prior year period. The increase in our total investment return was attributable to increased yields driving increased net investment income combined with the unwind of unrealized losses from 2022. Additionally, the reduction in yields towards the end of the three months ended March 31, 2023, caused by stress in the U.S. banking system, generated unrealized gains at March 31, 2023.
146
Results of Operations
Three months ended March 31, 2023 and 2022
Gross Premiums Written: Our GPW for the three months ended March 31, 2023 and 2022 were as follows:
March 31, 2023 |
March 31, 2022 |
|||||||||||
($ in millions) | % change | |||||||||||
Bespoke |
$ | 150.8 | $ | 135.0 | 12 | % | ||||||
Specialty |
834.1 | 543.8 | 53 | % | ||||||||
Reinsurance |
260.4 | 291.9 | (11 | )% | ||||||||
|
|
|
|
|||||||||
Total |
$ | 1,245.3 | $ | 970.7 | 28 | % | ||||||
|
|
|
|
The growth in GPW in the three months ended March 31, 2023 was led by increases in our Specialty and Bespoke segments, partially offset by a decrease in our Reinsurance segment. The Specialty segment had growth in the Marine, Aviation and Aerospace and property D&F lines of business. The increase in our Bespoke segment resulted from growth in our Credit & Political Risk line of business. We reduced our Reinsurance segment GPW as we focus on optimizing our portfolio to respond to our views on climate change and the adequacy of catastrophe pricing. We have increased our premiums written in property D&F within the Specialty segment as rates are currently more attractive within that line of business than within Property Reinsurance.
Reinsurance Premiums Ceded: Our ceded written premiums for the three months ended March 31, 2023 and 2022 were as follows:
March 31, 2023 | March 31, 2022 | |||||||||||
($ in millions) | % change | |||||||||||
Bespoke |
$ | 69.1 | $ | 43.5 | 59 | % | ||||||
Specialty |
341.1 | 233.1 | 46 | % | ||||||||
Reinsurance |
175.4 | 208.8 | (16 | %) | ||||||||
|
|
|
|
|||||||||
Total |
$ | 585.6 | $ | 485.4 | 21 | % | ||||||
|
|
|
|
The increase in reinsurance premiums ceded was caused by the Specialty segment which saw an increase as result of a higher amount of GPW in the period compared to the prior year period, partially offset by our decision to reduce and optimize our Reinsurance segment GPW. The increase in reinsurance premiums ceded in our Bespoke segment was caused by the finalization in the quarter ended December 31, 2022 of a new proportional cover.
Net Premiums Earned: Our NPE for the three months ended March 31, 2023 and 2022 were as follows:
March 31, 2023 | March 31, 2022 | |||||||||||
($ in millions) | % change | |||||||||||
Bespoke |
$ | 91.2 | $ | 87.2 | 4 | % | ||||||
Specialty |
266.2 | 180.5 | 32 | % | ||||||||
Reinsurance |
28.6 | 54.1 | (89 | %) | ||||||||
|
|
|
|
|||||||||
Total |
$ | 386.0 | $ | 321.8 | 17 | % | ||||||
|
|
|
|
The increase in our NPE was led by our Specialty segment, resulting from the continued increase in net premiums written and the earning of contracts that incepted in prior years. Bespoke NPE increased due to the additional earned premium from prior underwriting years on longer tenor business, such as mortgage contracts. The increases were partially offset by our decision to reduce and optimize our Reinsurance segment GPW.
147
Losses and Loss Adjustment Expenses: The table below summarizes the metrics we used to analyze the underwriting performance of the business.
March 31, 2023 | March 31, 2022 | |||||||
Loss ratio |
41.3 | % | 55.4 | % | ||||
Policy acquisition expense ratio |
27.2 | % | 21.0 | % | ||||
Fidelis MGU commission ratio |
6.3 | % | | % | ||||
General and administrative expense ratio |
4.3 | % | 11.0 | % | ||||
|
|
|
|
|||||
Combined ratio |
79.1 | % | 87.4 | % | ||||
|
|
|
|
Our losses and loss adjustment expenses decreased to $159.6 million for the three months ended March 31, 2023 from $178.4 million in the prior year period. Our loss ratio decreased to 41.3% for the three months ended March 31, 2023 from 55.4% in the prior year period. The reduction was primarily caused by a reduction in our Reinsurance segment loss ratio to 20.3% for the three months ended March 31, 2023 from 76.7% in the prior year period.
Expenses: We monitor our expense ratio as a measure of the cost effectiveness of our policy acquisition expenses, Fidelis MGU commissions and general and administrative expenses. The table above presents the contribution of the policy acquisition expenses, Fidelis MGU commissions and general and administrative expenses for the three months ended March 31, 2023 and 2022.
Policy acquisition expenses from third party brokers and other intermediaries depends upon the type of business that we write and the terms that are agreed. The ratio is calculated as policy acquisition expenses from third parties, net of overrider income, divided by net premiums earned.
Policy acquisition expenses from third parties increased to $105.0 million for the three months ended March 31, 2023 from $67.7 million in the prior year period. Our policy acquisition expense ratio increased to 27.2% for the three months ended March 31, 2023 from 21.0% in the prior year period. This increase in our policy acquisition expense ratio reflects a change in business mix.
Our Fidelis MGU commissions were $24.2 million and our Fidelis MGU commission ratio was 6.3% for the three months ended March 31, 2023, which relate to ceding and profit commissions to Fidelis MGU as part of the Framework Agreement effective from January 1, 2023.
Our general and administrative expenses decreased to $16.6 million for the three months ended March 31, 2023 from $35.5 million in the prior year period. Our general and administrative expense ratio decreased to 4.3% for the three months ended March 31, 2023 from 11.0% in the prior year period. The decrease was primarily related to the reduced headcount following the consummation of the Separation Transactions.
Combined Ratio: Our combined ratio improved to 79.1% for the three months ended March 31, 2023 from 87.4% in the prior year period. This was caused by the decrease in our loss ratio, partially offset by an increase in our expense ratio.
Corporate and Other Expenses: Corporate and other expenses include reorganization expenses and warrant expenses. Corporate and other expenses were $1.5 million in the three months ended March 31, 2023, similar to the expense level of $1.9 million in the prior year period.
Net Investment Income: Net investment income includes investment income net of investment management fees. In the three months ended March 31, 2023 our net investment income was $20.4 million compared with $5.1 million in the prior year period. The increase in our net investment income is due to increases in interest rates during 2022, where the short duration nature of our portfolio is sensitive to such increases in rates. The increase in our net investment income also results from the increase in total cash and investments.
148
Net Investment Gains/(Losses): Investment gains includes realized gains and losses on fixed maturity securities, available for sale, and realized and unrealized gains and losses on other investments and derivatives. In the three months ended March 31, 2023 we had net investment gains of $2.8 million compared with net investment losses of $10.2 million in the prior year period. The gains in the three months ended March 31, 2023 resulted from realized and unrealized gains on our other investments, partially offset by an increase in our allowance for credit losses. The losses in the three months ended March 31, 2022 resulted primarily from a fall in value of our other investments caused by increases in interest rates and weak performance in equity markets, and realized losses on derivative instruments.
Unrealized Gains/(Losses) on Available-For-Sale Financial Instruments: In the three months ended March 31, 2023, our fixed maturity securities generated unrealized gains of $24.9 million compared with unrealized losses of $61.2 million in the prior year period. The unrealized gains on fixed maturity securities in 2023 were caused by the unwind of prior year unrealized losses together with unrealized gains caused by the reduction in yields towards the end of the quarter due to stress in the U.S. banking system. Unrealized losses in the prior year period were caused by a sharp rise in interest rates, together with high inflation and expectations of further interest rate changes.
Foreign Exchange Contracts: At March 31, 2023 we held foreign exchange contracts with a notional amount of $30.0 million compared with a notional amount of $44.0 million at December 31, 2022. These contracts are used to manage foreign currency risks in our underwriting and non-investment operations. The foreign exchange contracts were recorded as derivatives at fair value in the balance sheet with changes recorded as net foreign exchange gains and losses in the consolidated statements of income and comprehensive income.
Financing Costs: Financing costs were $8.6 million in the three months ended March 31, 2023 (2022$8.8 million). Our financing costs were similar in both years due to there being no change in our debt levels during both years. The dividend paid to the holders of the Series A Preference Securities is also included in financing costs as referred to below, along with the costs associated with our letter of credit facilities as discussed in Note 13a (Commitments and ContingenciesLetter of Credit Facilities) of our unaudited consolidated financial statements contained elsewhere in this prospectus.
Preference Securities: At March 31, 2023, FIHL had 12,102 issued Series A Preference Securities that are classified in our balance sheet as long term debt. Dividend expense on our outstanding Series A Preference Securities for the three months ended March 31, 2023 was $1.3 million (2022$1.3 million) and is included in financing costs in the consolidated statements of income.
Income Tax (Expense)/Benefit: There was an income tax expense for the three months ended March 31, 2023 of $2.2 million (2022$4.7 million). The decrease in expense was caused by a higher portion of our profit being earned in FIBL in the current year period compared with the prior year period, together with discrete period benefits related to the expenses of the Separation Transactions.
Net Income Attributable to Non-Controlling Interests: Net income attributable to non-controlling interests was $nil in the three months ended March 31, 2023 (2022$2.8 million). Non-controlling interests in the prior year period related to subsidiaries of Pine Walk, all of which were distributed to shareholders on January 3, 2023 as part of the Separation Transactions.
149
Segment Analysis for the Three Months Ended March 31, 2023 and 2022
Bespoke
The following table below sets out GPW, NPE and the loss ratio for the Bespoke segment for the three months ended March 31, 2023 and 2022:
March 31, 2023 | March 31, 2022 | |||||||||||
($ in millions) | % change | |||||||||||
Credit & Political Risk |
$ | 130.0 | $ | 114.5 | 14 | % | ||||||
Bespoke |
20.8 | $ | 20.5 | 1 | % | |||||||
|
|
|
|
|||||||||
Total Bespoke GPW |
150.8 | 135.0 | 12 | % | ||||||||
Reinsurance premiums ceded |
(69.1 | ) | (43.5 | ) | 59 | % | ||||||
Net premiums earned |
91.2 | 87.2 | 5 | % | ||||||||
|
|
|
|
|||||||||
Losses and loss adjustment expenses |
$ | (13.1 | ) | $ | (43.5 | ) | (70 | %) | ||||
Loss ratio |
14.4 | % | 49.9 | % | ||||||||
|
|
|
|
Gross Premiums Written. The increase was a result of growth in our Credit & Political Risk line of business.
Reinsurance Premiums Ceded. The increase in our reinsurance premiums ceded related to increases in GPW and higher ceded quota share premiums.
Net Premiums Earned. The increase reflects the 12% increase in GPW and the continued earning of contracts written in prior years, partially offset by increased reinsurance premiums ceded.
Losses and Loss Adjustment Expenses. The decrease in our loss ratio primarily related to the absence of large and catastrophe losses in the three months ended March 31, 2023, compared with the Ukraine Conflict losses of $18.2 million recorded in the prior year period. Additionally, favorable prior year development in the current period was $8.8 million, driven by benign prior year experience, compared with $0.5 million in the prior year period.
Specialty
The table below sets out GPW, NPE and the loss ratio for the Specialty segment for the three months ended March 31, 2023 and 2022:
March 31, 2023 | March 31, 2022 | |||||||||||
($ in millions) | % change | |||||||||||
Aviation & Aerospace |
$ | 156.6 | $ | 77.7 | 102 | % | ||||||
Energy |
12.6 | 15.4 | (18 | %) | ||||||||
Marine |
475.6 | 305.3 | 56 | % | ||||||||
Property |
9.2 | 0.4 | 2200 | % | ||||||||
Property D&F |
171.1 | 133.1 | 29 | % | ||||||||
Specialty Other |
9.0 | 11.9 | (24 | %) | ||||||||
|
|
|
|
|||||||||
Total Specialty GPW |
834.1 | 543.8 | 53 | % | ||||||||
Reinsurance premiums ceded |
(341.1 | ) | (233.1 | ) | 46 | % | ||||||
Net premiums earned |
266.2 | 180.5 | 47 | % | ||||||||
Losses and loss adjustment expenses |
$ | (140.7 | ) | $ | (93.4 | ) | 51 | % | ||||
Loss ratio |
52.9 | % | 51.7 | % | ||||||||
|
|
|
|
Gross Premiums Written. GPW increased primarily driven by new business and rate increases in the Marine, Aviation and Aerospace and property D&F lines of business.
150
Reinsurance Premiums Ceded. Reinsurance premiums ceded increased, primarily driven by the increase in GPW.
Net Premiums Earned. NPE increased primarily driven by the increase in our NPW and continued earnings from contracts that incepted in prior years.
Losses and Loss Adjustment Expenses. Our loss ratio increased driven by higher attritional losses, and adverse prior year development of $30.5 million, or 11.5%, compared to favorable prior year development of $5.4 million, or 3.0 points in the prior year period. The adverse development for the three months ended March 31, 2023 related to the deterioration of two energy losses, and adverse development on the Ukraine Conflict of $6.1 million. This was partially offset by a reduction in large losses which were $nil for the three months ended March 31, 2023, compared with $31.3 million in the prior year period, primarily related to the Ukraine Conflict.
Reinsurance
The table below sets out GPW, NPE and the loss ratio for the Reinsurance segment for the three months ended March 31, 2023 and 2022:
March 31, 2023 | March 31, 2022 | |||||||||||
($ in millions) | % change | |||||||||||
Property Reinsurance |
$ | 244.6 | $ | 249.8 | (2 | %) | ||||||
Retrocession |
12.0 | 25.3 | (53 | %) | ||||||||
Whole Account |
3.8 | 16.8 | (77 | %) | ||||||||
|
|
|
|
|||||||||
Total Reinsurance GPW |
260.4 | 291.9 | (11 | %) | ||||||||
Reinsurance premiums ceded |
(175.4 | ) | (208.8 | ) | (16 | %) | ||||||
Net premiums earned |
28.6 | 54.1 | (47 | %) | ||||||||
Losses and loss adjustment expenses |
$ | (5.8 | ) | $ | (41.5 | ) | (86 | %) | ||||
Loss ratio |
20.3 | % | 76.7 | % |
Gross Premiums Written. GPW decreased primarily driven by our views of risks relating to climate change and the adequacy of pricing for catastrophe risks.
Reinsurance Premiums Ceded. Reinsurance premiums ceded decreased, which was proportional to the decrease in GPW.
Net Premiums Earned. NPE decreased primarily driven by the decrease in GPW combined with lower earned premiums from contracts that incepted in prior years.
Losses and Loss Adjustment Expenses. The decrease in our loss ratio was primarily driven by the absence of large and catastrophe losses for the three months ended March 31, 2023, compared with $11.9 million of catastrophe losses and $2.5 million of large losses in the prior year period. Additionally, favorable prior year development in the current period was $23.8 million, driven by positive development on catastrophe losses and benign prior year attritional experience, compared with $1.3 million of adverse development in the prior year period.
Financial Condition
Total Cash and Investments
Our investment strategy is focused on delivering stable investment income and a reasonable total return through all market cycles while maintaining appropriate portfolio liquidity and credit quality to meet the requirements of our clients, rating agencies and regulators, and to support our underwriting activities.
151
Our investments consist primarily of a core fixed maturity portfolio, which is comprised of a diversified portfolio of high-quality fixed maturity securities (including U.S. Treasuries, non-U.S. government bonds, government agency bonds, corporate bonds, investment-grade emerging market debt, mortgage and other asset- backed securities). Our core fixed maturity assets are managed primarily by external investment managers through individual investment management agreements. We monitor activity and performance of these external managers regularly.
Our net investment return was $23.2 million for the three months ended March 31, 2023 compared with $(5.1) million in the prior year period. Our net investment income increased to $20.4 million for the three months ended March 31, 2023 from $5.1 million in the prior year period due to increases in interest rates and investible assets. Additionally, we had net investment gains of $2.8 million in the three months ended March 31, 2023 compared with net investment losses of $10.2 million in the prior year period. The losses in the prior year period were attributable to a fall in value of our other investments caused by increases in interest rates and weak performance in equity markets, and realized losses on derivative instruments.
The table below sets out total cash, restricted cash and cash equivalents and investment at March 31, 2023 and December 31, 2022:
March 31, 2023 | December 31, 2022 | |||||||||||||||
($ in millions) | ||||||||||||||||
Total investments |
$ | 2,840.6 | 80 | % | $ | 2,425.0 | 63 | % | ||||||||
Cash and cash equivalents |
430.7 | 12 | % | 1,222.0 | 32 | % | ||||||||||
Restricted cash and cash equivalents |
280.7 | 8 | % | 185.9 | 5 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash, cash equivalents, restricted cash and investments |
$ | 3,552.0 | 100 | % | $ | 3,832.9 | 100 | % |
We have maintained a diversified portfolio of fixed maturity securities with only a small allocation to risk assets. The following tables summarize the fair value of our fixed-maturity investments at March 31, 2023 and December 31, 2022:
March 31, 2023 | ||||||||||||||||
Amortized Cost |
Unrealized gains |
Unrealized losses |
Fair value |
|||||||||||||
($ in millions) | ||||||||||||||||
Available-for-sale |
||||||||||||||||
US. Treasuries |
$ | 644.7 | $ | 0.4 | $ | (20.6 | ) | $ | 624.5 | |||||||
Agencies |
9.5 | | (0.3 | ) | 9.2 | |||||||||||
Non-U.S. government |
92.7 | 0.1 | (3.2 | ) | 89.6 | |||||||||||
Corporate bonds |
1,377.0 | 3.4 | (50.1 | ) | 1,330.3 | |||||||||||
Residential mortgage-backed |
134.2 | 0.2 | (8.0 | ) | 126.4 | |||||||||||
Commercial mortgage-backed |
15.4 | | (1.1 | ) | 14.3 | |||||||||||
Other asset backed securities |
319.6 | 0.9 | (7.2 | ) | 313.3 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, available-for-sale |
2,593.1 | 5.0 | (90.5 | ) | 2,507.6 | |||||||||||
Short-term investments, available-for-sale |
286.9 | | | 286.9 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity and short-term investments |
$ | 2,880.0 | $ | 5.0 | $ | (90.5 | ) | $ | 2,794.5 | |||||||
|
|
|
|
|
|
|
|
152
December 31, 2022 | ||||||||||||||||
Amortized Cost |
Unrealized gains |
Unrealized losses |
Fair value |
|||||||||||||
($ in millions) | ||||||||||||||||
Available-for-sale |
||||||||||||||||
US. Treasuries |
$ | 643.1 | $ | | $ | (27.3 | ) | $ | 615.8 | |||||||
Agencies |
17.5 | | (0.4 | ) | 17.1 | |||||||||||
Non-U.S. government |
115.2 | | (4.3 | ) | 110.9 | |||||||||||
Corporate bonds |
1,078.9 | | (58.6 | ) | 1,020.3 | |||||||||||
Residential mortgage-backed |
88.6 | | (8.9 | ) | 79.7 | |||||||||||
Commercial mortgage-backed |
8.0 | | (1.2 | ) | 6.8 | |||||||||||
Other asset backed securities |
209.5 | | (9.2 | ) | 200.3 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, available-for-sale |
2,160.8 | | (109.9 | ) | 2,050.9 | |||||||||||
Short-term investments, available-for-sale |
257.0 | 0.1 | (0.1 | ) | 257.0 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity and short-term investments |
$ | 2,417.8 | $ | 0.1 | $ | (110.0 | ) | $ | 2,307.9 | |||||||
|
|
|
|
|
|
|
|
Weighted average book yield at March 31, 2023 on our fixed maturity portfolio was 2.5% (December 31, 20221.6%). Our fixed maturity portfolio duration at March 31, 2023 was 1.4 years (December 31, 20221.2 years).
At March 31, 2023 and December 31, 2022 the average credit quality of our fixed maturity portfolio was AA- (or its equivalent), with 86.3% and 88.0%, respectively, of the portfolio being rated A- (or its equivalent) or above. Where the credit ratings are split between two rating agencies, the lower rating is used; where the credit ratings are split between three rating agencies, the middle rating is used.
The composition of the fair values of fixed maturity securities by credit rating at March 31, 2023 and December 31, 2022 was as follows:
In addition to our core fixed maturity portfolio, we also have a small allocation to risk assets of $46.1 million or 1.6% of total investments at March 31, 2023 (December 31, 2022$117.1 million or 4.8%).
153
Reserves
The following table provides our gross and net reserves for losses and loss adjustment expenses at March 31, 2023 and December 31, 2022:
March 31, 2023 |
December 31, 2022 |
|||||||
($ in millions) | ||||||||
Reserves for losses and loss adjustment expenses |
$ | 2,215.0 | $ | 2,045.2 | ||||
Reinsurance balances recoverable on reserves for losses and loss adjustment expenses |
(1,032.8 | ) | (976.1 | ) | ||||
|
|
|
|
|||||
Net Reserves for losses and loss adjustment expenses |
$ | 1,182.2 | $ | 1,069.1 | ||||
|
|
|
|
At March 31, 2023, we had net reserves for losses and loss adjustment expenses of $1,182.2 million, which represented our best estimate of the ultimate liability for payment of losses and loss adjustment expenses, an increase from $1,069.1 million net reserves for losses and loss adjustment expenses at December 31, 2022. Of the gross reserves for losses and loss adjustment expenses of $2,215.0 million at March 31, 2023, a total of $1,297.7 million, or 58.6%, represented IBNR claims. Of the gross reserves for losses and loss adjustment expenses of $2,045.2 million at December 31, 2022, a total of $1,250.1 million, or 61.1%, represented IBNR claims. The increase in gross reserves for losses and loss adjustment expenses since December 31, 2022 is primarily due to premium growth.
The breakdown of gross reserves between outstanding claims and IBNR for the relevant period end was as follows:
March 31, 2023 |
December 31, 2022 |
|||||||
($ in millions) | ||||||||
Gross Outstanding |
$ | 917.3 | $ | 795.1 | ||||
Gross IBNR |
1,297.7 | 1,250.1 | ||||||
|
|
|
|
|||||
Gross Reserves |
$ | 2,215.0 | $ | 2,045.2 | ||||
% IBNR |
58.6 | % | 61.1 | % |
Prior Year Reserves: For the three months ended March 31, 2023 there was an overall reduction in our estimate of ultimate net claims to be paid in respect of prior accident years.
For the three months ended March 31, 2023, our prior year favorable development of $2.1 million was primarily driven by favorable development of $23.8 million in our Reinsurance segment and $8.8 million in our Bespoke segment. Both segments experienced a more benign claim experience than our assumptions allowed for, across the majority of classes. This was partially offset by adverse development of $30.5 million in our Specialty segment, largely driven by two energy losses, and $6.1 million relating to the Ukraine Conflict.
We did not make any significant changes in methodologies used in our reserving process for the periods covered in this prospectus.
Liquidity and Capital Resources
Liquidity is a measure of a companys ability to generate cash flows sufficient to meet short-term and long- term cash requirements of its business operations. Management monitors the liquidity of FIHL and of each of our operating insurance subsidiaries. As a holding company, FIHL relies on dividends and other distributions from its operating insurance subsidiaries to provide cash flow to meet ongoing cash requirements, including any future debt service payments and other expenses, and to pay dividends to the holders of our Common Shares and Series A Preference Securities, if any.
154
During the three months ended March 31, 2023, FIHL received distributions from subsidiaries of $60.0 million.
Management considers the current cash and cash equivalents, together with dividends declared or expected to be declared by the operating insurance subsidiaries, sufficient to appropriately satisfy the liquidity requirements of FIHL, which are minimal at present.
Consolidated Cash Flows for the three months ended March 31, 2023: The following table summarizes our cash flows from operating, investing and financing activities.
March 31, 2023 |
March 31, 2022 |
|||||||
($ in millions) | ||||||||
Net cash (used in)/provided by operating activities |
$ | (101.7 | ) | $ | 85.5 | |||
Net cash (used in)/provided by investing activities |
(399.2 | ) | 206.0 | |||||
Net cash used in by financing activities |
(196.3 | ) | (14.1 | ) | ||||
Effect of exchange rate changes on foreign currency cash |
0.7 | (1.3 | ) | |||||
|
|
|
|
|||||
Net (decrease)/increase in cash, restricted cash, and cash equivalents |
$ | (696.5 | ) | $ | 276.1 | |||
|
|
|
|
Cash (used in)/provided by operating activities reflected a higher level premium volume than in the prior year period causing increased premiums receivables, together with the prepayment of commissions to Fidelis MGU in 2023.
Cash used in investing activities for the three months ended March 31, 2023 reflected the use of cash to purchase fixed maturity securities. Cash provided by investing activities for the three months ended March 31, 2022 reflected the proceeds on disposal of other investments of $203.0 million.
Cash used in financing activities in the three months ended March 31, 2023 primarily consisted of a cash outflow of $105.5 million from disposal of Fidelis MGU, $50.6 million of employer tax on restricted share units and $34.1 million of cumulative dividends on warrants. Cash used in financing activities in the three months ended March 31, 2022 consisted of the purchase of non-controlling interests.
Letter of Credit Facilities: At March 31, 2023, there were letters of credit outstanding under the Standby Letter of Credit Facility Agreement with Lloyds Bank plc totaling $97.6 million (December 31, 2022: $101.2 million), secured by collateral in the amount of $93.9 million (December 31, 2022: $92.4 million). At March 31, 2023, there were letters of credit outstanding under the Master Agreement for the Issuance of Payment Instruments with Citibank N.A., London Branch totaling $84.6 million (December 31, 2022: $100.1 million), secured by collateral in the amount of $105.7 million (December 31, 2022: $104.4 million). At March 31, 2023 there were letters of credit outstanding under the Letter of Credit Facility with Barclays Bank plc totaling $87.9 million (December 31, 2022: $88.2 million), secured by collateral in the amount of $46.4 million (December 31, 2022: $45.7 million) (the Letter of Credit Facility with Barclays Bank plc has both a secured and an unsecured tranche). At March 31, 2023 there were letters of credit outstanding under the letter of credit facility with Bank of Montreal totaling $85.2 million (December 31, 2022: $77.4 million), secured by collateral in the amount of $8.3 million (December 31, 2022: $10.8 million).
Capital Management
We maintain our capital at an appropriate level as determined by our Group Board-approved internal risk appetite and the financial strength required by our clients, regulators and rating agencies. We monitor and review the capital and liquidity positions of FIHL and its operating insurance subsidiaries on an ongoing basis.
155
The principal capital management transactions undertaken during the three months ended March 31, 2023 were as follows:
| In connection with the completion of the Separation Transactions, 2,359,517 Common Shares were issued upon the exercise, on a cashless basis, net settled for employee taxes, of vested RSUs outstanding under the 2015 Non-Qualified Share Option Plan and the 2018 Non-Qualified Share Option Plan. |
| In connection with the completion of the Separation Transactions, 11,194,164 Common Shares were issued upon the exercise of our in the money warrants, exercised on a cashless basis at their respective exercise price and net settled for employee taxes. Of these, 4,571 Common Shares were issued as a result of the exercise of leaver warrants. |
Preference Securities: At March 31, 2023, FIHL had 12,102 Series A Preference Securities outstanding that are classified in our balance sheet as debt.
Long-Term Debt: At March 31, 2023, FIHL had $447.7 million in debt outstanding. Such debt is comprised of the Senior Notes, and the Subordinated Notes, referenced above. Other than the Series A Preference Securities and the Notes, FIHL has no material debt outstanding.
Dividend Payments to the Preference Security Holders: During the three months ended March 31, 2023 we continued to make the quarterly cash dividend payments to our preference security holders of $1.3 million (2022$1.3 million).
Access to Capital: Our business operations are in part dependent on our financial strength and the opinions of the independent rating agencies thereof as discussed above in this prospectus. We believe our financial strength provides us with the flexibility and capacity to obtain funds through debt or equity financing as required from the private markets. Our ability to access the capital markets is dependent on, among other things, our operating results, market conditions, and our perceived financial strength. We regularly monitor our capital and financial position, as well as investment and securities market conditions.
Inflation: We consider the effects of inflation in pricing our contracts and policies through modeled components such as demand surge. Loss reserves are established to recognize likely loss settlements at the date payment is made. Those reserves inherently recognize the effects of inflation. The actual effects of inflation on our results cannot be accurately known, however, until claims are ultimately resolved.
Quantitative and Qualitative Disclosures about Market Risk
We believe that we are principally exposed to three types of market risk: interest rate risk, foreign currency risk and credit risk.
Interest Rate Risk. Our investment portfolio consists primarily of fixed maturity securities. Fluctuations in interest rates have a direct impact on the market valuation of these securities. Accordingly, our primary market risk exposure is to changes in interest rates. As interest rates rise, the market value of our fixed maturity portfolio falls and the converse is also true.
We manage interest rate risk by maintaining a short-to-medium duration portfolio to reduce the effect of interest rate changes on the market value of these securities. We also enter into interest rate derivative contracts in the ordinary course of our investment activities to partially mitigate any negative impact of rises in interest rates on the market value of our fixed maturity portfolio.
At March 31, 2023, our fixed maturity portfolio had an approximate duration of 1.4 years including the duration impact of the interest rate futures that are used to position the fixed maturity portfolio duration within target parameters.
156
The table below depicts interest rate change scenarios and the effect on our interest-rate-sensitive invested assets, including the impact of interest rate swaps:
Foreign Currency Risk: Our reporting currency and functional currency is the U.S. dollar. At March 31, 2023, 97.1% of our cash and investments was held in U.S. dollars (December 31, 202297.0%), with the balance of 2.9% held primarily in British Pounds and Euros (December 31, 20223.0%).
Other foreign currency amounts are remeasured to the appropriate functional currency and the resulting foreign exchange gains or losses are reflected in the income statement. Both the remeasurement and translation are calculated using current exchange rates for the balance sheets and monthly exchange rates for the income statements. We may experience exchange losses to the extent that our foreign currency exposure is not properly managed or otherwise hedged, which would in turn adversely affect our results of operations and financial condition. An increase or decrease of 25% in the U.S. dollar would result in additional gain or loss for the three months ended March 31, 2023 of $3.1 million.
We will continue to manage our foreign currency risk by seeking to match our liabilities under insurance and reinsurance policies that are payable in foreign currencies with investments that are denominated in those currencies. This may involve the use of foreign exchange contracts from time to time. A foreign exchange contract involves an obligation to purchase or sell a specified currency at a future date at a price set at the time of the contract. Foreign exchange contracts will not eliminate fluctuations in the value of our assets and liabilities denominated in foreign currencies but rather allow us to establish a rate of exchange for a future point in time.
As the foreign exchange contracts settle, the realized gain or loss is included with foreign exchange gains and losses in the income statement. For the three months ended March 31, 2023, the amount recognized within foreign exchange gains and losses for settled foreign exchange contracts was a realized gain of $6.4 million (2022$0.2 million). See Foreign Exchange and Foreign Exchange Contracts above.
Credit Risk: We have exposure to credit risk primarily as a holder of fixed maturity securities and private securities. Our risk management strategy and investment policy are to invest mainly in debt instruments of high credit quality issuers. We also hold a portion of the portfolio in securities that are below investment grade or in other specialty asset classes. We reduce the amount of credit exposure by setting limits with respect to particular ratings categories, business sectors and any one issuer.
We are also exposed to credit risk in respect of premium payments from clients and/or brokers, depending on whether the terms of business agreement with the broker is transfer or non-transfer of risk. In addition, we are exposed to the credit risk of our insurance and reinsurance brokers to whom we make claims payments for our policyholders, as well as to the credit risk of our reinsurers and retrocessionaires who assume business from us. Other than fully collateralized reinsurance, at March 31, 2023 the substantial majority of our reinsurers have a rating by A.M. Best of A (Excellent), the third-highest of 13 rating levels, or better and the minimum rating of any of our material reinsurers is A- (Excellent), the fourth-highest of 13 rating levels, by A.M. Best. The Group evaluates the financial condition of its reinsurers on a regular basis and monitors concentrations of credit risk with reinsurers.
At March 31, 2023, the reinsurance balance recoverable on reserves for losses and loss adjustment expenses was $1,032.8 million, net of allowance for credit losses of $1.0 million, (December 31, 2022: $976.1 million, net
157
of allowance for credit losses of $1.0 million). The reinsurance balance recoverable on paid losses at March 31, 2023 was $96.5 million, net of allowance for credit losses of $nil, (December 31, 2022: $159.4 million, net of allowance for credit losses of $nil). See Note 10: Reinsurance and retrocessional reinsurance in our unaudited consolidated financial statements included elsewhere in this prospectus.
158
References to Previous Fidelis refer to FIHL and its consolidated subsidiaries prior to the consummation of the Separation Transactions and this offering. References to Current Fidelis refer to FIHL and its consolidated subsidiaries following the consummation of the Separation Transactions. Unless otherwise indicated, or the context otherwise requires, references herein to Fidelis, Group, we, our, us, and other similar references refer (i) prior to the consummation of the Separation Transactions and this offering to Previous Fidelis and (ii) following the consummation of the Separation Transactions to Current Fidelis.
Our History; Then to Now
Fidelis is a global (re)insurance company, with operations in Bermuda, Ireland and the United Kingdom. FIHL was formed in Bermuda in 2014 by Richard Brindle, under the principles of focused, process-driven and disciplined underwriting and risk selection, strong client and broker relationships and nimble capital deployment. Fidelis completed its initial funding and began underwriting business in June 2015 under the direction of an experienced management team led by Richard Brindle. Since then, Fidelis has assembled a diversified global book of (re)insurance business and achieved scale as a specialty (re)insurer with GPW of $3.0 billion, total revenues of $1.5 billion and net income of $62.3 million for the year ended December 31, 2022. Our growth has continued in 2023, with our GPW increasing to $1.2 billion in the three months ended March 31, 2023 compared to $1.0 billion for the three months ended March 31, 2022.
On January 3, 2023, the Separation Transactions were completed and two distinct holding companies and businesses were created: FIHL and MGU HoldCo. FIHL is the parent holding company for Current Fidelis, is the issuer of the Common Shares sold by the Selling Shareholders in this offering and continues to own all of the insurance operating subsidiaries of Current Fidelis, comprised of FIBL, FUL and FIID. Current Fidelis also has its own service company, FIHL (UK) Services, with a branch in Ireland.
MGU HoldCo is the parent holding company for Fidelis MGU that carries on the origination and underwriting activities on behalf of Current Fidelis and is led by Mr. Brindle. MGU HoldCos principal operating subsidiaries are Pine Walk Capital, Pine Walk Europe and Bermuda MGU. The underwriting activities of each of the licensed insurance carriers of Current Fidelis (FIBL, FUL and FIID) are outsourced to the corresponding operating subsidiaries of Fidelis MGU on a jurisdictional basis (Bermuda MGU, Pine Walk Capital and Pine Walk Europe, respectively). Each of the operating subsidiaries of Fidelis MGU has delegated underwriting authority to source and bind contracts for and on behalf of each of FIBL, FUL and FIID, respectively. See Material Contracts and Related Party TransactionsFramework Agreement. MGU HoldCo and its subsidiaries will not be consolidated with FIHL and its subsidiaries.
On December 20, 2022 FIHL and MGU HoldCo entered into a rolling 10-year Framework Agreement that governs the ongoing relationship between the two groups of companies (see BusinessOur Corporate Structure for additional details). Following the consummation of the Separation Transactions on January 3, 2023, Mr. Brindles employment agreement and the employment agreements of certain other senior management and other employees of Previous Fidelis remained with FML (the service company which transferred to and became part of Fidelis MGU as part of the Separation Transactions), and Mr. Brindle is now the Chairman and Chief Executive Officer of Fidelis MGU. See The Separation Transactions.
The Separation Transactions allow FIHL to access the underwriting expertise of Fidelis MGU while allowing Fidelis MGU to attract and retain highly sophisticated underwriting talent, including Mr. Brindle and senior underwriters. We believe that the Separation Transactions and the Framework Agreement have structural benefits for both groups of companies, including increased flexibility to quickly respond to evolving insurance and reinsurance market conditions and to help sustain our strong underwriting results through access to top talent. Our objective following the completion of the Separation Transactions remains to further solidify Fidelis position as a leading bespoke, specialty and property underwriter.
159
The Groups ratings are discussed under Ratings below.
Our Company
Fidelis is a leading global provider of bespoke and specialty insurance and property reinsurance products. We believe our differentiated underwriting positions us well to generate strong returns across (re)insurance cycles. Current Fidelis is led by Mr. Daniel Burrows who has more than 35 years of experience in the insurance industry and is supported by a highly experienced management team that manages the operations of Current Fidelis based on our founding principles.
Following the Separation Transactions, Current Fidelis is positioned as a global, specialty insurance provider with exclusive right of first access to Fidelis MGUs underwriting business during the term of the Framework Agreement. Based on Fidelis historical experience, we expect this long-term partnership to deliver strong returns to our shareholders, primarily driven by our underwriting results. We aim to be good stewards of capital by effectively balancing capital deployment across market opportunities with capital distributions to our shareholders.
We will continue to benefit from decades of thought and process leadership and innovation through our strategic relationship with Fidelis MGU. The management team of Fidelis MGU, led by Mr. Brindle, has a robust track record built across multiple platforms. Mr. Brindle has more than 38 years of underwriting leadership, including founding Lancashire and holding leading roles at Syndicates 488 and 2488 at Lloyds. Teams led by Mr. Brindle oversaw Lancashire stock price appreciation of 412.0% from December 16, 2005 (the date of Lancashires initial public offering) to December 31, 2013 (immediately prior to his retirement from Lancashire), significantly exceeding the 71.0% price appreciation from a group of Lancashires publicly traded insurance company peers for the period (including Ace, XL, Arch, Everest, PartnerRe, Axis, Allied World, RenaissanceRe, Validus, Montpelier, Greenlight Re, Third Point Re, Hiscox, Amlin, Catlin, Beazley and Novae). Past performance of Lancashire is no guarantee of future results for Fidelis. Mr. Brindle and his team also outperformed at Lloyds by delivering a 17.5% return on a straight average for Syndicates 488 and 2488 during his time there from 1986 to 1998, compared to Lloyds average return of 0.9% over the same period. Past performance of Syndicates 488 and 2488 is no guarantee of future results for Fidelis. Further, while at Fidelis, between 2017 and 2022 Mr. Brindle and his management team achieved strong, consistent underwriting performance with an average loss ratio of 45.3%, an average combined ratio of 85.8% and an average standard deviation of combined ratio of 6.5% compared with the peer average of 64.3%, 99.5% and 8.1%, respectively. Over this same period, Fidelis average loss ratios for each of its Specialty, Bespoke and Reinsurance pillars was 42.8%, 26.7% and 64.9%, respectively, compared to its peers average loss ratios of 61.4%, 61.4% and 72.1%, respectively. Fidelis combined ratio was 86.0%, 76.3%, 86.6%, 80.6%, 92.9% and 92.1% in 2017, 2018, 2019, 2020, 2021 and 2022, respectively, compared to a peer average combined ratio of 109.4%, 96.9%, 96.7%, 103.7%, 96.6% and 93.5% in 2017, 2018, 2019, 2020, 2021 and 2022, respectively. In the three months ended March 31, 2023, our loss ratio was 41.3% and combined ratio was 79.1% compared with a peer average of 59.3% and 90.5%, respectively. Fidelis peer group includes Arch, Argo, Aspen, Markel, W. R. Berkley, Hiscox, Beazley, Lancashire, Everest Re, Axis Capital and RenaissanceRe (except for the three months ended March 31, 2023 which excludes Aspen, Hiscox, Beazley and Lancashire as the information is not available for this period). In each case, prior underwriting and combined ratio performance is no guarantee of future performance. Each of the Fidelis and financial peer combined ratios is calculated as the sum of losses and loss adjustment expenses, policy acquisition expenses and general and administrative expenses as a percentage of NPE in all periods except 2018. In 2018, the Fidelis combined ratio included a negative $2.1 million adjustment to NPE as a result of the costs to acquire a derivative instrument to protect against Typhoon Jebi losses and a $10 million positive adjustment to investment returns recognized on the derivative. Financial peer combined ratios were calculated as the average of the reported combined ratios of each company.
We will continue to focus on nimble underwriting designed to capitalize on current market trends and dislocations as well as emerging risk solutions. We expect to maintain at a minimum the existing underwriting standards and where appropriate will look for enhancements. The team of underwriters at Fidelis MGU continues
160
to maintain the robust processes and use of technology that have been key to Fidelis historical success at ensuring its underwriting efforts capture recent market developments. We believe this close coordination reduces the likelihood of siloed underwriting and gives us a competitive advantage in our underwriting, risk assessment and ability to offer as many products as possible to clients. A crucial and distinguishing part of those robust processes is daily UMCC with practice leads and key members of senior management (including risk modeling, actuarial, legal, compliance, contract wordings and claims representatives) to provide live market insights and multiple perspectives to allow underwriters to quickly assess emerging opportunities, achieve strong underwriting and cross-sell across our product range. See Our Competitive Strengths below for further detail.
Since we began underwriting business in 2015, Fidelis has reached an attractive scale in bespoke and specialty insurance and property reinsurance markets while delivering robust results. Our GPW grew from $0.5 billion for the year ended December 31, 2017 to $3.0 billion for the year ended December 31, 2022, a compound annual growth rate of 40.6%, while delivering an average loss ratio of 45.3% and a combined ratio of 85.8% over the same period. Over the same period, our NPE grew from $0.2 billion for the year ended December 31, 2017 to $1.5 billion for the year ended December 31, 2022, a compound annual growth rate of 47.0%. Our GPW continued to grow to $1.2 billion for the three months ended March 31, 2023 compared to $1.0 billion for the three months ended March 31, 2022. Our loss ratio and combined ratio for the three months ended March 31, 2023 were 41.3% and 79.1%, respectively. In addition to earnings growth from the origination of new business, we believe that there is significant embedded earnings potential in previously written business due to the requirements of applicable accounting rules that revenue from written premiums must be recognized when earned over the life of a policy. This is reflected in our gross UPR balance of $3.3 billion at March 31, 2023.
Our scale and access to the highly selective underwriting capabilities of Fidelis MGU via our strategic relationship will allow us to capitalize on current insurance market trends and continue focusing on delivering growth coupled with strong underwriting results.
Fidelis is subject to varying degrees of regulation and supervision in the jurisdictions in which it operates. In particular, the businesses of our three insurance operating subsidiaries, FIBL, FUL and FIID, are authorized by, and subject to insurance laws and regulations that are administered and enforced by, a number of different governmental and non-governmental self-regulatory authorities and associations in each of their respective jurisdictions and internationally. For a summary of the regulatory environment of our insurance operating subsidiaries, primarily in their respective jurisdictions of Bermuda, U.K. and Ireland, see Certain Regulatory Considerations.
Our Commitment to Environmental, Social and Governance Matters
Fidelis is committed to being a leader in the industry with respect to standards for ESG matters. We are currently committed to transitioning our insurance portfolios to net-zero greenhouse gas emissions by 2050. To work towards this, to the extent possible, we are developing tools to measure the insurance-associated emissions of our insurance portfolios. We have carried out a joint study on approximately $8.2 billion of premiums and 28,500 policies spanning between 2012 and 2021, which demonstrated that higher third-party ESG ratings were generally correlated with lower loss ratios. Fidelis aims to embed ESG factors in its underwriting processes where appropriate. In addition, Fidelis has certain existing underwriting restrictions. These underwriting restrictions include not directly insuring thermal coal (including dedicated infrastructure projects such as ports and railways), tar sand extraction, Arctic oil and gas exploration and drilling and fracking operations. Fidelis will also not provide cover to companies whose revenues from the above-mentioned activities account for more than 20% of their total revenues. Fidelis has been for some time seeking to use policy language to minimize exposure to forced labor and modern slavery in particular in our marine cargo line of business.
Furthermore, FIHLs core fixed income investment portfolio is managed in a manner that is consistent with Fidelis sustainability principles and ESG objectives. This includes a requirement that a minimum of 3% of the core fixed income portfolios total assets under management must be invested in GSS bonds, as classified by Bloomberg pursuant to its proprietary GSS Indices. The GSS Indices utilize the Bloomberg Global Aggregate Index, the Bloomberg Sustainable Finance Groups green, social and sustainability bond indicators and fields that
161
show alignment with the International Capital Market Association Green Bond, Social Bond and Sustainability Bond Principles and Guidelines. At March 31, 2023, 3.9% of Fidelis core fixed income portfolio was invested in GSS bonds. Furthermore the investment portfolio includes restrictions against holding securities of issuers that have a poor MSCI ESG rating (with a rating below B or issuers that currently have a red MSCI controversy flag). Securities of these issuers may only be held if the investment manager demonstrates and documents in writing pursuant to company policies a positive forward-looking ESG view of the issuer. Fidelis has also adopted negative screens to limit exposure to certain industries and activities in its investment portfolio. These include screens against holding securities of any issuers involved in thermal coal, oil and gas (though an issuer may derive up to 20% of its annual revenues from oil and gas) or arms (certain types of arms are completely excluded, others such as firearm sales are permitted to comprise up to 10% of annual revenues), and restrictions against those that fail animal welfare and for-profit prisons screens. As a result of such negative screens, Fidelis was able to limit the core fixed income portfolios direct exposure to the securities of companies deriving revenues from fossil fuels to only three companies, which at March 31, 2023 comprised 0.4% of Fidelis core fixed income portfolio. Furthermore, currently Fidelis has no direct exposure in its investment portfolio to energy companies and its exposure to corporate securities identified as utilities comprises 0.6% of the core fixed income portfolio.
Additionally, we have taken action in each year since 2018 to more than offset our operational carbon emissions and we are committed to continuing to do so going forward. In 2018, 2019, 2020, 2021 and 2022, we offset our carbon emissions at 125%, 150%, 200%, 150% and 110%, respectively, on a tons-of-carbon-equivalent basis through the use of carbon credits. We partner with relevant industry specialists to calculate our carbon emissions.
We were awarded carbon credits through investments in Earths forests, including forest protection in investments in the April Salumei area of Papua New Guinea in 2018 and 2019 and reforestation projects in Nicaragua and Tanzania in conjunction with CommuniTree and Hazda Hunter Gatherers, respectively, in 2020, 2021 and 2022.
Diversity, equity and inclusion are integral to Fidelis. We pursue a diversity, equity and inclusion strategy that includes accountability, representation, advancement, culture, outreach and fostering a sense of belonging for all our employees. We employ targeted recruiting strategies to identify diverse candidates and partner with external agencies to advertise vacancies with the goal of increasing the hiring of women and ethnically diverse employees. Where available, we monitor certain diversity, equity and inclusion statistics (gender, ethnicity, age, marital status, religion, caring responsibilities and disability, each as provided by candidates on a voluntary basis) both at the outreach/interview stage and for our employee population so that we can see progress with respect to the diverse candidate pools. Comparative data on diverse candidate sourcing available to us demonstrates an improved diversity mix of approximately 1% across gender and approximately 6.5% across ethnicity from December 31, 2021 to February 1, 2023 (being the latest practicable date), acknowledging that the number of employees following the consummation of the Separation Transactions has been reduced due to staff transfers to Fidelis MGU. In addition, we seek to promote our diverse talent from within, identifying those that have potential to take on more senior roles and fast-tracking them through exposure to a wide range of business opportunities as well as structured training and development.
Strategic Relationship with Fidelis MGU
We believe the insurance industry is evolving rapidly and is primed for further value chain disaggregation, which will allow specialist underwriters to benefit from access to clients and risks and to provide access to alternate forms of capital.
Following the consummation of the Separation Transactions, MGU HoldCo became a minority investor in FIHL (holding 9.9% of the Common Shares) and entered into the Framework Agreement with FIHL to build a long-term agency relationship that provides strong economic and strategic alignment between the two groups of companies.
162
The Framework Agreement, under which Current Fidelis secures business from Fidelis MGU, has a rolling initial term of 10 years. Years one to three will roll automatically (each year resetting the term of the Framework Agreement to a new 10-year period) and the notice to roll will be deemed given at the end of years one, two and three (i.e., the years roll automatically and will not be subject to any underwriting target or preconditions to rolling). From year four onwards, the Framework Agreement will roll at the sole written election of FIHL, with such election to be delivered at least 90 days prior to the commencement of the subsequent contract year. Any decision by FIHL to elect not to roll the Framework Agreement on or after year four will mean that the remainder of the 10-year term then in effect will continue in place (i.e., the Framework Agreement will have a further nine years to run in the first year following the election by FIHL not to roll the Framework Agreement). See Material Contracts and Related Party TransactionsFramework Agreement.
Fidelis MGU manages underwriting, origination, outwards reinsurance, actuarial and claims services with close review and oversight from Current Fidelis to ensure adherence with the agreed upon Group Annual Plan, which sets out our underwriting parameters and risk tolerances in respect of our three-pillar underwriting strategy on a gross / net basis for each annual period. While the Framework Agreement establishes the overarching parameters of the outsourced underwriting relationship between Current Fidelis and Fidelis MGU, the relationship is more specifically governed on a jurisdictional basis by a series of Delegated Underwriting Authority Agreements. The parties to each Delegated Underwriting Authority Agreement will prepare their own Subsidiary Annual Plan. See Material Contracts and Related Party TransactionsFramework AgreementSubsidiary Annual Plans. Fidelis MGU provides us with a number of enterprise and support services on a cost plus basis, such as accounting, other finance and reporting services, IT infrastructure, maintenance and system development services and facilities management services pursuant to the Inter-Group Services Agreement between FIHL and MGU HoldCo. See Material Contracts and Related Party TransactionsInter-Group Services Agreement.
We will continue to leverage Fidelis MGUs sophisticated underwriting technology and talent and will benefit from our shared history in underwriting principles, strategic visions, and managerial approaches. Our arrangement is governed by arms-length terms for origination and management consistent with industry commission levels, including market overrider commissions, and with a focus on aligning incentives for strong underwriting performance. Ceding commissions payable to Fidelis MGU will be charged for underwriting, claims and actuarial pricing services and will be calculated based on NPW to ensure alignment on reinsurance purchasing. To avoid fee duplication, ceding commissions payable for open market business sourced by Fidelis MGU are set at 11.5% and ceding commissions payable for business sourced by Fidelis MGU via third-party managing general underwriters to whom underwriting authority has been sub-delegated by Fidelis MGU are set at 3.0%. Business that continues to be sourced by subsidiary cells of Pine Walk Capital will continue to follow the fees and commissions set under those agreements. For the year ended December 31, 2022, the fees and commissions attributable to subsidiary cells of Pine Walk Capital were 10.0% on average of the total Pine Walk Capital GPW. Long-term objectives will be further aligned by FIHL paying an ongoing Portfolio Management Fee to Fidelis MGU and a 20.0% profit commission on Binder Operating RoE above a hurdle rate of 5.0% calculated on an aggregate basis for Current Fidelis. Binder Operating RoE is defined in the Framework Agreement as FIHLs consolidated net underwriting margin (disregarding any business not underwritten by Fidelis MGU following the date of the Framework Agreement and the effect of any FIHL Procured Outwards Reinsurance, as defined in the Framework Agreement) plus all overriders retained by Current Fidelis (disregarding the effect of any FIHL Procured Outwards Reinsurance), minus an Administrative Expenses Allowance (defined in the Framework Agreement as a sum equating to 2.3% of net premiums written), minus the proportion of FIHLs costs of financing its debt and preference securities included in FIHLs total capital that is deemed to be allocated to Fidelis MGU, minus the total accumulated ceding commission that is payable by Current Fidelis to Fidelis MGU, minus the Portfolio Management Fee relating to business underwritten by Fidelis MGU, divided by the proportion of FIHLs opening common shareholders equity adjusted for dividend and equity raises (as set out in year-end consolidated audited accounts) that is deemed to be allocated to Fidelis MGU. The calculation of such profit commission will include a deficit carry-forward mechanism for a maximum of three years in which the Binder Operating RoE is below zero. For a more detailed discussion of the fees and commissions payable by Current
163
Fidelis in connection with its outsourced relationship with Fidelis MGU, see Material Contracts and Related Party TransactionsFramework AgreementFees and Commissions.
We believe the recently completed Separation Transactions make us a scaled property, bespoke and specialty (re)insurer with long-term access to a sophisticated underwriting team focused distinctively on portfolio optimization and insurance portfolio management. Under this structure, we believe we are well positioned to generate attractive returns, deploy capital toward profitable underwriting opportunities sourced through our strategic arrangement with Fidelis MGU, and grow our business. The strategic arrangement adheres to our long-standing philosophy of writing insurance and reinsurance in areas where deep expertise is required to deliver an attractive risk / reward profile through (re)insurance cycles.
The Existing Common Shareholders Agreement will be amended and restated effective as of the pricing of this offering. The Amended and Restated Common Shareholders Agreement will retain a number of rights granted to MGU HoldCo and the Founders under the Existing Common Shareholders Agreement, such as certain consent rights, minority shareholder protections and board nomination rights. Under the terms of the Amended and Restated Common Shareholders Agreement, for so long as MGU HoldCo beneficially owns at least 4.9% of the Common Shares, the consent of MGU HoldCo will be required for FIHL to undertake certain actions, including effecting any change in the jurisdiction, incorporation or name of FIHL or any member of Current Fidelis, making a material change to the nature or scope of the business underwritten by FIHL and any member of Current Fidelis, effecting any amendments to its constitutional documents that are reasonably likely to have a material adverse effect on Fidelis MGU and making certain acquisitions or dispositions of assets. MGU HoldCo will also enjoy certain subscription and allocation rights in respect of further Common Share issuances or sales, MGU HoldCo will be subject to a prohibition on the sale of its Common Shares provided that the Framework Agreement is in effect. This prohibition shall not apply in the event of a Common Share buyback or other transactions undertaken by FIHL in response to certain adverse regulatory or accounting effects on MGU HoldCo. Additionally, MGU HoldCo will be entitled to nominate one individual to serve as a director on the Board, for so long as MGU HoldCo together with its Shareholder Affiliate Transferees beneficially own at least 50% of the MGU HoldCo Initial Shares. See Material Contracts and Related Party TransactionsOtherCommon Shareholders Agreement and Description of Share CapitalCertain Provisions of the Amended and Restated Bye-LawsNumber of Directors for a detailed description of these rights and the definition of Shareholder Affiliate Transferees.
Our Business; Overview
We focus our business on three pillars: Bespoke, Specialty and Reinsurance. We believe our three-pillar strategy and capabilities allow us to take advantage of the opportunities presented by evolving (re)insurance markets and proactively shift our business mix across market cycles.
Bespoke
For the year ended December 31, 2022, the Bespoke pillar accounted for 26.1% of our GPW and 30.2% of our NPW with an underwriting ratio of 68.5% and a loss ratio of 31.3%. In 2022, the Bespoke pillar generated $119.3 million in underwriting income. GPW in the Bespoke pillar grew from $209.9 million for the year ended December 31, 2017 to $783.2 million for the year ended December 31, 2022, a compound annual growth rate of 30.1%, despite our decision to maintain our GPW in 2020 at the same level as in 2019 in light of political and economic uncertainties arising from the COVID-19 pandemic. During the period from 2017 to 2022, our average underwriting ratio was 57.7%. For the three months ended March 31, 2023 our Bespoke GPW grew to $150.8 million compared to $135.0 million for the three months ended March 31, 2022.
The Bespoke pillar focuses primarily on highly tailored and specialized products, including policies covering credit and political risk, political violence and terrorism, limited cyber reinsurance, tax liabilities, title, transactional liabilities and other bespoke products that fit our criteria. Given the increased global conflict in
164
2022 and national economies shifting further to intellectual property driven value, we believe that the Bespoke pillar continues to see significant opportunity for beneficial pricing and terms and conditions. The relationships we have formed with clients and brokers, the underwriting expertise required, and nature of the underlying risks create a higher barrier to entry and help us maintain our position as a leader in the industry. Typically, these lines do not follow the established (re)insurance cycle and are largely influenced by prevailing economic conditions at a given time. As such, these products require highly specialized pricing and other models tailored to the risk profile. For example, for certain significant risk transfer transactions, pricing is largely driven by counterparty credit quality which has low correlation with the current (re)insurance cycle and high correlation with the overall economy and macro events. As a result, Bespoke policies follow a different and diversified loss pattern relative to our Specialty and Reinsurance pillars.
The Bespoke portfolio has several economic features that we believe are financially attractive. The contracts often have multi-year tenors, and the products generally have expected low and stable attritional loss ratios over the exposure period. The combination of longer tenor and lower expected loss experience creates the potential to capture additional embedded value as premiums are earned over the exposure period under U.S. GAAP. Additionally, the contracts are highly capital-efficient as these risks tend to have little or no correlation to peak natural catastrophe perils driving a higher RoE than other lines. Furthermore, the contracts typically have customized provisions rather than standard market contractual provisions, creating opportunities to optimize pricing and establish proprietary, recurring relationships with clients. The custom and direct nature of the business has allowed us to lead on substantially all of our contracts creating tailored terms, conditions and pricing.
The Bespoke pillar benefits from quota share, aggregate and stop loss and excess of loss retrocessional cover, which helps to reduce volatility.
Our Bespoke pillar is central to our business, and we believe it is one of the key differentiators of our business from that of other specialty insurers. The specialist nature of this business combined with lower levels of market competition result in a less commoditized, more tailor-made product that delivers better and lower volatility underwriting performance with less exposure to the typical (re)insurance cycle. The capital-efficient nature of these products and potential for high RoE allow us to retain sufficient capital to withstand deterioration through (re)insurance cycles while avoiding accumulation of excess capital like many of our competitors focused primarily on high-volatility property reinsurance.
Specialty
For the year ended December 31, 2022, the Specialty pillar, the portion of the Groups business which focuses on traditional specialty business lines such as aviation, energy, space, marine, contingency and property direct and facultative, accounted for 53.7% of our GPW and 57.0% of our NPW with an underwriting ratio of 85.4% and a loss ratio of 59.7%. In 2022, the Specialty pillar generated $124.6 million in underwriting income. GPW in the Specialty pillar grew from $70.8 million for the year ended December 31, 2017 to $1,610.7 million for the year ended December 31, 2022, a compound annual growth rate of 86.8%. During the period from 2017 to 2022, our average underwriting ratio was 65.5%. For the three months ended March 31, 2023 our Specialty GPW grew to $834.1 million compared to $543.8 million for the three months ended March 31, 2022. Our Specialty pillar from 2017 to 2022 accounted for 13.0%, 6.4%, 12.2%, 36.7%, 41.0%, and 53.7%, respectively, of our GPW.
The Specialty pillar classes include aviation, energy, space, marine, contingency and property D&F. Given the current position of the reinsurance market in the insurance cycle, we have used our Specialty pillar increasingly to deploy capital targeted to natural catastrophe exposure through property D&F lines of business rather than through our Reinsurance pillar. We further capitalized on market dislocations and associated rate increases in key classes such as marine and aviation to increase the amount of business written. Our aviation, property D&F and marine businesses are among the leading franchise positions in the London market. The Specialty pillar benefits from quota share, aggregate, stop loss and excess of loss retrocessional cover and industry loss warranties, which helps to reduce volatility.
165
Our Specialty pillar provides us with access to capital-efficient business and facilitates diversification of our exposures. Due to the soft rate environment in years prior to 2020, this pillar has historically been the smallest contributor to our GPW. However, following the significant dislocation in the market beginning in late 2019 when a number of large carriers exited the Specialty market, Fidelis assessed that return hurdles in its Specialty pillar were at levels that had the potential to grow in this segment, and Fidelis increased its Specialty pillar GPW significantly in 2020 and 2021 (representing a 236% per annum GPW growth from 2019 to 2021) and continued to do so in 2022. In 2022 and in the first quarter of 2023, we experienced further pricing momentum and enhanced terms and conditions as dislocations affected several lines, including war cover for marine and aviation lines driven by the Ukraine Conflict, contingency driven by COVID-19, and property D&F driven by Hurricane Ian.
In the Specialty pillar, we leverage Fidelis MGUs ability to adapt to constantly evolving market dynamics and develop specialized and tailored pricing and aggregation models while maintaining a disciplined underwriting approach. Our underwriters work to form, and via the sophisticated underwriting expertise at Fidelis MGU we continue to develop, collaborative relationships with brokers and clients, offering them the full suite of our existing products as well as working with them to innovate new product ideas. This relationship-driven approach allows our underwriters, and will allow underwriters at Fidelis MGU on our behalf, to identify from existing clients additional underwriting opportunities for providing cover on other related lines of business. We typically seek out capacity-driven layers with attractive pricing, often focusing on dislocated markets, and look to ensure successful and sustainable growth in this pillar through developing and maintaining an excellent broker network.
Reinsurance
For the year ended December 31, 2022, the Reinsurance pillar accounted for 20.2% of our GPW and 12.9% of our NPW with an underwriting ratio of 106.2% and a loss ratio of 74.3%. GPW in the Reinsurance pillar grew from $265.2 million for the year ended December 31, 2017 to $606.2 million for the year ended December 31, 2022, a compound annual growth rate of 18.0%. During the period from 2017 to 2022, our average underwriting ratio was 89.2%. For the three months ended March 31, 2023 our Reinsurance GPW was $260.4 million compared to $291.9 million for the three months ended March 31, 2022. Our Reinsurance pillar from 2017 to 2022 accounted for 48.6%, 47.4%, 45.9%, 41.8%, 38.9% and 20.2%, respectively, of our GPW.
Our Reinsurance pillar consists of an actively managed, primarily residential property catastrophe reinsurance book, with closely controlled aggregates using Fidelis MGUs proprietary FireAnt aggregation and analytics system to monitor exposures in real time. The Reinsurance pillar also includes property retrocession and a limited amount of composite and multi-class asset reinsurance. In the context of excess of loss reinsurance products, we focus on underwriting attachment points largely exposed only to true catastrophe events. The portfolio is global in nature with a strong North American concentration and smaller exposures in Japan, Europe, Australasia and elsewhere throughout the world. The Reinsurance pillar benefits from quota share, aggregate, stop loss and excess of loss retrocessional cover, catastrophe bond cover and industry loss warranties, which helps to minimize the potential net losses in the business written. We believe our strategy of pursuing closely controlled aggregates and focusing on residential portfolios in the Reinsurance pillar helps keep volatility lower than a typical catastrophe book.
We benefit from Fidelis MGUs sophisticated analytics capabilities and live aggregation tools, excellent relationships with a blend of regional and nationwide carriers (both in the United States and internationally), and strong retail and wholesale broker relations in the distribution of our products. Since 2021, we have developed a view of risk informed by thorough analysis and discussions with weather and forecasting experts. We have concluded that the effects of climate change on perils such as hurricanes, convective storm, flood and wildfire are not currently represented adequately in current vendor models. As such, we have superimposed our own expectations of frequency and severity on third-party vendor models, which are well in excess of average Bermuda (re)insurers loads, to form a base for exposure and aggregation tracking.
166
We have taken proactive steps to reduce volatility and reshape our Reinsurance portfolio to focus only on clients with stronger financial and loss adjustment capabilities and the resources to adjust and manage high volumes of claims in-house. As a consequence, the property reinsurance portfolio was reduced for the year ended December 31, 2022 and three months ended March 31, 2023, and subject to opportunities that may develop, is expected to remain at reduced levels for the remainder of 2023, reducing natural catastrophe exposure across the portfolio. We are increasingly deploying reinsurance capital across large-scale, well-resourced national accounts away from smaller regional underwriters, who we believe are less able to adjust and manage large catastrophe events. We have reduced our exposure to the middle layers of treaty accounts which are more exposed to increased frequency and severity of losses as a result of climate change and secondary perils associated with floods and wildfires without commensurate increases in rates. Following Hurricane Ian, we also saw an increased demand for private deals and significant pricing increases during the year-end renewal season. Over time, we expect the impact of these changes to improve the quality of our natural catastrophe-exposed portfolios and reduce volatility. As ever, we will continue to leverage our nimble underwriting abilities and ability to adapt to constantly evolving market dynamics to source business when favorable market conditions are present. If there is an increase in property catastrophe rates, as well as favorable terms and conditions, we would intend to capitalize on those trends and dislocations.
Insurance Market Conditions
We believe we have significant market opportunities given our ability to innovate and adapt to evolving market conditions. Global economic and industrial development, population increases, greater product awareness and distribution, as well as inflation continue to drive increased need for insurance and reinsurance. The current insurance and reinsurance market environment has experienced a prolonged period of rate increases, structural enhancements and continued improvement of terms and conditions. However, we believe that the higher loss ratios experienced by many of our competitors in recent years due to the frequency and severity of catastrophes has caused some of them to reevaluate and reduce their catastrophe reinsurance business. As companies exit certain (re)insurance markets and/or reduce the scope of their underwriting activities, capacity has been reducing in certain classes, leading to significant year-on-year rate increases in the (re)insurance market since the end of 2019. Some classes of business that have experienced larger rate increases include property catastrophe, property D&F, specialty markets such as aviation, marine, energy and contingency and casualty markets such as medical malpractice and healthcare (with medical malpractice and healthcare being lines of business which Current Fidelis does not write) which is reflective of the hardening cycle being driven by a lack of underwriting profits rather than capital. We believe that this combination of factors is driving a sustainable favorable market environment, with a focus on risk management, disciplined risk selection, reasonable terms and profitable business, which presents significant market opportunities for us. Global commercial insurance prices rose 4% in the first quarter of 2023, making the first quarter of 2023 the tenth consecutive quarter of price increase since global pricing increases peaked at 22% in the fourth quarter of 2020. Property D&F pricing is at its highest level in two decades, marine cargo prices are at market highs and aviation pricing continues to remain strong. These rate increases are expected to persist throughout 2023 across the lines of business that FIHL focuses on. Rate increases across property D&F, marine, aviation and energy are expected to range between 10% to 40%, 7.5% to 10%, 50% to 100% and 30% to 50%, respectively, in 2023. In particular, we see the emergence of five themes supporting continued rate hardening:
| Climate Change. The frequency and severity of catastrophes is rising as seen by the increases in catastrophes globally in more recent years, requiring rate increases to keep pace. The period between 2017 and 2022, for example, saw three times the number of severe catastrophic weather events and twice the amount of losses caused by these severe events as compared to the period between 2011 and 2016. We believe that the impact of a warming climate and increased atmospheric moisture and changing weather patterns will result in increased frequency and severity of elemental catastrophe losses (elemental risks related to the elements i.e., weather related hail and storms etc.). The frequent incidence of annual industry-wide natural catastrophe losses in excess of $100 billion in the aggregate during the period from 2018 to 2022 has led us to reshape our portfolio and reduce our exposure to certain perils, thereby reducing the volatility traditionally associated with the property reinsurance classes. Many of our competitors have experienced higher loss ratios in the same period than in prior cycles and combined ratios in excess of |
167
100%, causing them to reevaluate their levels of premiums written against catastrophe reinsurance (see Competition). Decreased participation has created a lack of supply of reinsurance capacity causing upward pressure on price. We expect this trend to continue, which would allow Fidelis MGU to underwrite select attractive policies on our behalf and position us to deliver strong risk-adjusted returns. |
| Casualty. We believe reserves across the industry remain deficient for accident years from 2013 to 2019 based on prior year adverse developments for several casualty underwriters. Further adverse developments and actual loss payouts may deplete competitors capital and impair their ability to underwrite additional casualty risks. Given Fidelis has made the strategic decision not to write the traditional casualty classes such as general liability, financial lines, directors and officers, and errors and omissions, it is not affected by these potential capital constraining issues, which we believe provides us with a competitive advantage due to our continued position of strength. |
| Cost Inflation. Numerous countries including the United States are experiencing inflation in wages, materials and parts. Real inflation for expert loss adjusters and building materials, exacerbated following a catastrophe, is causing an increase in loss ratios above modeled results for many insurers and complicating future estimates. This effect is increasing losses for multiple areas of the Excess & Surplus, Property & Casualty and reinsurance markets leading to rate increases and decreased appetite. Fidelis incorporates a specific cost inflation factor in its risk modeling to mitigate the effects of inflation. In addition, social inflation driven by changes in societal views on litigation aimed at insurers is a recent and developing risk highlighted by industry leaders and leading to larger claims. See Managements Discussion and Analysis of Financial Condition and Results of OperationsCurrent Outlook, Market Conditions and Rate Trends. |
| Conflict. The Ukraine Conflict has created uncertainty and potential losses for both global direct insurers and reinsurers. Some lines of business are subject to asymmetrical loss profiles exacerbated by war and armed conflict, which are likely to reduce supply and/or accelerate rate changes. Additionally, aviation, marine, political risk and political violence lines are likely to be particularly impacted as insurers calibrate their losses, reserve, and court proceedings begin on potential claims. Fidelis continues to monitor the Ukraine Conflict to determine the ultimate impact from lines of business which may be exposed to the Ukraine Conflict, including aviation, marine, political risk and political violence contracts. |
| COVID-19. Despite improving case and severity data, we believe industry losses since the beginning of the COVID-19 pandemic have not yet been fully captured. A significant number of outstanding claims and litigation beyond traditional mortality policies persists which may lead to changes in future policies and the risk-appetite of current underwriters. Recent judicial decisions in local markets have made adverse rulings relating to business interruption and treating each case as a separate claim with single claim limits. These rulings could affect the general interpretation of business interruption policies and may increase the level of insurers liability in the relevant markets by reducing their ability to aggregate policyholders losses when applying single claims limits. Fidelis has limited or no exposure to highly impacted businesses (such as U.K. commercial insurance, contingency (which Previous Fidelis began to write after the COVID-19 pandemic began in March 2020) and trade credit), and we continue to believe the effects of the COVID-19 pandemic will impact loss estimates for our competitors, future policies and competitor behavior. |
These market conditions have led to a compelling dislocated underwriting opportunity in numerous specialty areas in which we underwrite.
Our Competitive Strengths
We believe that our competitive advantages are based on the following key strengths:
| Highly experienced, well regarded management team. Our management team consists of industry veterans with many years of relevant experience in insurance, providing FIHL with the necessary functional support, supplemented by the services stipulated under the Framework Agreement and Inter-Group Services Agreement. We are led by Mr. Daniel Burrows, who, prior to joining Fidelis in 2015, was the co-CEO of |
168
Aon Benfields GRS division. Prior to assuming the CEO role at FIHL, Mr. Burrows had been leading Fidelis Bermuda operations and was most recently the Executive Chairman of FIBL and Group Managing Director. The other members of the management team are a mix of experienced individuals who have had held key roles at Fidelis and have long histories of working with Fidelis MGU, along with other experienced professionals from other industry peers. |
| First choice access to one of the best underwriting teams in the industry. The performance of our business portfolio will be a direct result of the capabilities of the Fidelis MGU management team, led by Richard Brindle, who is the Chairman and CEO of Fidelis MGU. Mr. Brindle brings more than 38 years of experience in the insurance industry and is known for his track record of outperformance across Lloyds syndicates and Lancashire under his leadership. Mr. Brindle was acknowledged by A.M. Best in August 2018 to be one of the most successful underwriters in the worldwide insurance market and has a track record of outperformance over the past 30 years. From 2017 to 2022 the Fidelis MGU management team has outperformed peers across key profitability and growth metrics. Between 2017 and 2022, Fidelis achieved strong underwriting performance with an average loss ratio of 45.3% and an average combined ratio of 85.8%. In the three months ended March 31, 2023, our loss ratio was 41.3% and combined ratio was 79.1%, respectively. The Fidelis MGU management team brings many years of cumulative experience in broking, underwriting, corporate and actuarial roles as well as long-term client and broker relationships. Mr. Brindle previously founded Lancashire with over $1 billion of start-up capital in December 2005 and grew it into a key player in the (re)insurance market listed on the London Stock Exchange. Under the Framework Agreement, we secure business for a rolling term of 10 years, providing long-term certainty that we will leverage Fidelis MGUs well-established and sophisticated underwriting capabilities. See Material Contracts and Related Party Transactions and The Separation Transactions. |
| Significant scale achieved since establishment and clean platform for growth. We believe our scale achieved since inception and our access to Fidelis MGUs sophisticated underwriting analytics and technology platform will give us a competitive advantage. Since we started underwriting in 2015, we have grown our insurance book significantly through organic business expansion including through increased client penetration, new product development, long-term relationships and new reinsurance partnerships. Between 2017 and 2022, we had extremely strong growth with a compound annual growth rate of 40.6% for GPW and compound annual growth rate of 47.0% for NPE compared to 13.7% and 11.5% respectively from other specialty insurers during the same period (including Arch, W. R. Berkley, Argo, Markel, Aspen, Everest Re, Renaissance Re, Axis, Beazley, Hiscox, and Lancashire), while delivering top quartile underwriting profitability. Our GPW continued to grow in the three months ended March 31, 2023 to $1.2 billion compared with $1.0 billion in the three months ended March 31, 2022. As our long-tenor business lines (such as Bespoke products) continue to scale, we believe there will be higher convergence of NPE and NPW as prior period UPR continues to earn and have a favorable impact on NPE increasing. |
| Strong capital position. We have a strong balance sheet and are committed to preserving our financial strength. At March 31, 2023, our total assets were $9.4 billion and our total cash and investments (including restricted cash) totaled $3.6 billion, primarily highly rated, liquid fixed maturity assets. Our $2.4 billion total capitalization (which includes our preference securities and issued debt) provides us with the flexibility to engage in attractive underwriting opportunities and scale quickly when market conditions warrant increased business. |
| Nimble approach and focus on bottom line. We take pride in making reasoned decisions to actively enter and grow or reduce and exit specific lines of business as opportunity arises or diminishes, leveraging the UMCC to assess opportunities in real time with all key decision-makers. We believe our nimble approach and firm focus on bottom-line profitability (i.e., net income, as opposed to top-line growth) of each line of business is key to our strategy and success. We will establish our underwriting parameters and risk tolerances in respect of the three-pillar underwriting strategy in the Group Annual Plan, which will be prepared by Fidelis MGU in consultation with Current Fidelis and presented to Current Fidelis for formal approval on a gross/net basis. |
169
Our strategy is to increase line sizes where appropriate, take the lead in requiring rate changes and establish ourselves as the go to market for solutions through our in-force portfolio and new classes of specialty and bespoke products. Depending on market conditions, Fidelis MGU, with our consent, may exercise its discretion in coordination with us to increase retention by reducing outwards quota shares to take further advantage of the continued hardening of rates. Similarly, we may also coordinate with Fidelis MGU to increase line sizes as conditions warrant. We intend to grow specialty classes by writing large line sizes to further push rate increases and access new classes where there is significant market dislocation. We expect to grow our bespoke and specialty products through a combination of organic growth of our already well-established footprint, systematic cross-selling to clients and innovative new products while maintaining quality underwriting information, high-quality risk selection and multi-line aggregation tools and technology.
| Access to well-diversified, multi-line (re)insurance risk. We prioritize pursuing a targeted diversification strategy focused on three pillarsBespoke, Specialty and Reinsurance. We have built a portfolio leveraging our ability to remain agile across market cycles with 74 lines of business across our three pillars at March 31, 2023. Our products serve numerous industries, types of exposure, and geographies. We believe that Fidelis MGUs ability to price and aggregate bespoke risks, adapt to evolving market dynamics in the specialty market, and continually optimize in reinsurance markets uniquely positions us to continue to grow a profitable portfolio. The breadth of our portfolio offering in conjunction with our partnership with Fidelis MGU also allows us to adjust line sizes and retention rates based on prevailing market conditions and achieve optimal economics for the overall portfolio. The three-pillar strategy is central to our growth as it allows us to deliver attractive risk-adjusted returns to shareholders in the long term by managing through (re)insurance cycles and deploying to the most favorable market conditions across the three pillars. |
| Innovative product offering positioned for continued growth. We focus on building first mover advantages across our markets. Our product portfolio evolves in response to client demand for bespoke, tailored products and our market-driven, real-time assessment of risk. Over the past four years, we have grown our book of newly created solutions across a wide range of sectors including airline, intellectual property, marine, and residential mortgage, expanding our business lines to 74 lines at March 31, 2023 from 43 at December 31, 2017. Through this innovation, we have further strengthened our three-pillar strategy and our position as a skilled specialty insurer. |
| Proprietary technology integration with full control of data. We will continue to leverage Fidelis MGUs proprietary and sophisticated technology platform. As a business that was established in 2014, Fidelis had the benefit of building a proprietary underwriting platform free from constrained legacy systems. We believe that the technology platform, which is owned by Fidelis MGU, has significant advantages over our competitors. It is our understanding, that many peers use hybrid platforms built more than a decade ago, that spread between various fragmented modules which reduce their agility and make it difficult to effectively analyze real-time data. Fidelis has a single holistic pricing, aggregation and analytics platform (i.e., FireAnt), which helps us avoid key pitfalls of other systems including: time wasted in duplicating data entry across multiple systems, inconsistency of modeling and pricing approach, inability to raise queries across multiple lines simultaneously, no direct link offered to outwards reinsurance and capital structures, and lag time for those other systems to respond to emerging risks. The technology platform will enable Fidelis MGU to take full control of data with no black box third-party assumptions. We believe that the platform leverages high-quality outside software with custom tools developed purposefully and in-house with the ability to aggregate and analyze data on a real-time basis. This includes third-party risk models and software, Jarvis (a custom integrated group data warehouse), Tyche (third-party capital modeling application), Prequel (a custom policy administrative system) and FireAnt (a custom pricing, simulation, exposure aggregation, and portfolio optimization tool). FireAnt allows for optimization of returns and management of volatility and capacity based on real time data. The highly specialized data capabilities developed and presently in use by Fidelis have driven enhancement in underwriting across Bespoke and Specialty lines including marine, aviation and terrorism where live data is actively analyzed to unlock new opportunities. |
170
| Embedded ESG initiatives that are core to our business. We believe our commitment to ESG and following the initiatives set out below is core to our success as a business. In order to have a practical and value accretive approach to implementation of ESG considerations, we have adopted the following as key areas of focus: animal welfare, armaments, capital punishment, coal and arctic drilling, anti-slavery/human trafficking and diversity, equity and inclusion. Fidelis MGU will continue to incorporate an ESG assessment into its underwriting on our behalf and is continually refining its process for reviewing individual insurance risks. Fidelis in the U.K. market has promoted the use of a forced labor clause prohibiting the use of any form of forced labor in marine cargo business and is cooperating with the U.K. Independent Anti-Slavery commissioner and Anti-Slavery International, a non-profit organization to develop a commitment to which insurers and brokers can sign up. In 2022, we implemented forced labor clauses in approximately 80% of our marine cargo accounts. |
Fidelis MGU is the first U.K. market insurer to sign up to The Poseidon Principles on Marine Insurance which pledges a net zero marine hull insurance portfolio by 2050. We actively support the transition to a net zero global economy by making renewable energy one of our classes of underwriting, including the construction of offshore wind turbine farms. Fidelis and Fidelis MGU are both members of ClimateWise. The ClimateWise Principles require members to disclose their responses to the risks and opportunities of climate change and which principles are aligned with the Task Force on Climate-related Financial Disclosure framework. So long as we remain a member we intend to report annually on actions taken in support of those principles.
We drive employee engagement through opportunities for employees that we believe help them live out their values at work. The employee-led Fidelis Insurance Green Team, which has representatives from each office, suggests ways to reduce our corporate carbon impact and improve recycling rates, such as our carbon usage offset. We support social mobility and diversity in our communities through our support for The Brokerage, a social mobility charity (a number of whose interns have become our full-time employees) and the Afro-Caribbean Insurance Network.
We maintain underwriting and investment restrictions that align with our ESG principles as well as those principles that are consistent with leading to long-term value, such as excluding a number of sectors that we believe pose risks of harm to people, animals and the environment. Furthermore, FIHLs investment portfolio is managed in a manner that is consistent with Fidelis sustainability principles and its ESG objectives. The core fixed maturity portfolio has target GSS investment thresholds, prohibits issuers with poor ESG ratings, and restricts certain industries and behaviors.
Our Strategy
We are set up to be nimble, thoughtful, and efficient decision-makers and we believe that we are able to respond quickly to an ever-changing world and a constantly evolving marketplace. We believe these attributes allow us, together with Fidelis MGU, to target opportunities that we expect to offer a compelling balance of risk and reward for our shareholders. We intend to continue to scale our business when favorable market conditions are present, pursue prudent capital management and profitable underwriting on a loss ratio and combined ratio basis, and target an Operating RoE of approximately 13.0% to 15.0%. Our strategy involves the following:
| Expand our presence in Bespoke and Specialty. We expect to continue to leverage our access to Fidelis MGUs long-standing and trusted relationships with brokers and clients, built over the years by key executives, some of whom have almost 40 years of experience in bespoke and specialty markets. Fidelis MGU intends to continue to follow a structured approach with regard to maintaining such relationships through its participation in industry events and through continuing to hold regularly scheduled meetings with clients and brokers, thereby preserving access to CEOs and senior management teams of its most important business partners. The continued access to such long-standing and trusted relationships coupled with Fidelis MGUs extensive expertise will provide significant opportunity to quote, underwrite and bind attractive niche specialty insurance policies in an efficient manner. By focusing on markets in which Fidelis MGU has particular expertise and in which we can provide new, innovative products, we believe we have a |
171
strong ability to capture profitable business. The Bespoke and Specialty pillars have benefited from a hardening pricing environment over recent years which has enhanced our recent profitability ratios. In keeping with our nimble approach and leveraging the UMCC, where all lines of business are considered in real time, we expect Fidelis MGU (and consequentially, Current Fidelis) to be able to pivot quickly to the most attractive opportunities. Currently, we expect a hard property reinsurance market will further continue in 2023 and into 2024 and we are planning to take advantage of reinsurers increased bargaining power in such hard market to reduce our aggregate exposures. As a result, in our Bespoke pillar, in line with the current economic outlook, we expect to limit the growth in traditional mortgage products and focus instead on lines such as intellectual property, political violence, political risk and transactional liabilities. In our Specialty pillar, we expect the aviation market to continue the hardening of previous rates following potential losses from the Ukraine Conflict. Similarly, the property D&F market is also expected to harden further following losses from Hurricane Ian, which impacted Florida and the American southeast in September 2022. Based on 2022 GPW, Europe is currently our leading market, closely followed by North America, with a smaller portion of our business in Asia and other jurisdictions. The (re)insurance business we write across our Bespoke, Specialty and Reinsurance pillars can be analyzed by geographic region, reflecting the location of the (re)insurer as follows: for the year ended December 31, 2022 our GPW generated for exposures in Europe was 50.6%, in North America was 37.4% and in Asia was 5.9%, while GPW in other jurisdictions was 6.1%. Although we do not expect a significant change to the geographic mix of our business, we will continue to focus on developing new and innovative products in response to market needs, remaining agile and nimble to the developing demands of clients. A recent example of such innovation is the cooperation between Previous Fidelis and Aon in 2021 on developing a product that allows early stage companies to leverage their intellectual property with a credit wrap insurance product to reduce the costs and increase the availability debt finance from lending institutions. Furthermore, in 2022 Previous Fidelis led the development of an aviation product that, once deployed, will provide a real-time quoting service for airlines and airline service providers to reinstate cover if the provision immediately cancelling cover is triggered as a result of a detonation of a nuclear device in their compulsory insurance coverages. |
| Generate underwriting profits. We will continue to focus on underwriting profitably through (re)insurance cycles in partnership with Fidelis MGU. As our insurance portfolio matures and scales, we believe we will also have an opportunity to increase our underwriting leverage. We seek to direct capital to opportunities based on market conditions to address client needs at better pricing opportunities. We will leverage our relationship with Fidelis MGU to continue disciplined underwriting via the use of Fidelis MGUs integrated technology solutions, including monitoring real-time market conditions to best capture unique opportunities. |
Fidelis MGUs robust daily processes will enable it, on our behalf, to maintain a live, dynamic picture of the current underwriting environment that drives daily underwriting decisions, including our daily UMCCs. We believe that our risk selection as a result of these robust processes should allow us to deploy significant line sizes that in turn allow us to be a rate maker rather than a rate taker.
| Maintain diversification and low volatility. We seek to maintain significant diversification in our business lines which limits the correlations to single events. Our strategy has frequently generated better risk-adjusted returns than many of our competitors who focus on specific niches exclusively or have large exposure to natural catastrophe reinsurance. We have taken measures with Fidelis MGU to actively manage and in many cases reshape our natural catastrophe exposure in light of greater severity and frequency of catastrophe events and concerns around global climate change. |
| Uphold a strong balance sheet. We believe as interest rates rise, we will have opportunities to earn a higher yield while maintaining an appropriately conservative investment portfolio to support our business. We maintain robust procedures for setting our reserves and actively managing risk in our portfolio. From January 1, 2017 to March 31, 2023, we had net favorable prior year reserve development of $155.6 million from our reserves. We believe a robust balance sheet best positions us to be a provider of choice for policyholders and take advantage of large or sudden market pricing dislocations. |
| Manage capital prudently. We invest and manage our capital proactively with a goal of generating strong RoE for investors. We believe market conditions will continue to warrant expansion of our premium volume |
172
and capital base to take advantage of attractive opportunities. Our goal is for our capital returns program to be focused on ordinary payouts from operating net income and releasing excess capital as appropriate, while balancing any return of capital with the need to take a prudent and efficient approach to capital sufficiency. We believe successful underwriting will allow us to grow our equity and support continued premium growth with an increased ability to fund growth from our own resources and return excess capital to shareholders over time, which may take the form of ordinary dividends, special dividends or share buybacks. Over the full market cycle, we expect to have additional opportunities to manage our capital in order to maintain an appropriate RoE for our shareholders which may include returning excess capital when market opportunities are limited in soft insurance markets. |
Outwards Reinsurance or Retrocessional Coverage
We purchase reinsurance to cover the potential accumulation or aggregation of exposures and to cover specific business written when warranted. At March 31, 2023 we had reinsurance balances recoverable on reserves for losses and loss adjustment expenses of $1,032.8 million (December 31, 2022: $976.1 million) and reinsurance balances recoverable on paid losses of $96.5 million (December 31, 2022: $159.4 million). All reinsurance premiums ceded and reinsurance recoverables are either fully collateralized or placed with reinsurers that are rated A- or greater by A.M. Best or S&P, other than four reinsurers which are rated B++ by A.M. Best. Where an insurer does not have a credit rating, the Group receives full collateral, including letters of credit and trust accounts. At December 31, 2022 the three largest balances by reinsurer accounted for 25.3%, 6.0% and 5.0%, compared to 17.4%, 6.8% and 6.3% at December 31, 2021, of the total balance recoverable from reinsurers on paid and unpaid losses. Please refer to note 10 (Reinsurance and retrocessional reinsurance) of our unaudited consolidated financial statements contained elsewhere in this prospectus and note 13 (Reinsurance and retrocessional reinsurance) of our audited consolidated financial statements contained elsewhere in this prospectus. Under the Framework Agreement, we have delegated authority to design and place such outwards reinsurance to Fidelis MGU in conjunction with the overall management of our book of business.
The amount of reinsurance we desire to purchase and our reasons for purchasing reinsurance will vary over time. We may purchase reinsurance to manage our capital and the volatility of our underwriting results more effectively or otherwise to facilitate the exit of certain business. This may include, inter alia, increasing our protection from underwriting risks, increasing our overall ability to deploy significant line sizes, reducing and spreading the risk of loss on our insurance and reinsurance business and limiting our exposure to multiple claims arising from a single occurrence.
FIHL and MGU HoldCo will agree to the specific parameters for purchasing outwards reinsurance cover for Current Fidelis on an annual basis (the Outwards Reinsurance Strategy). Fidelis MGU is delegated authority to purchase and alter outwards reinsurance cover for and on behalf of the applicable operating subsidiary provided that: (i) the proposed outwards reinsurance cover is consistent with the parameters set out in the Outwards Reinsurance Strategy; and (ii) the underwriting performance of the insurance business in the applicable year is within the pre-agreed parameters set out in the Subsidiary Annual Plan. However, prior to effecting such outwards reinsurance cover, Fidelis MGU must obtain the approval of the relevant operating subsidiarys Chief Underwriting Officer, who must respond to such proposal within two business days. Placements outside of the Outwards Reinsurance Strategy will be subject to a longer turnaround time as there is more substantive review to be conducted.
We purchase significant levels of reinsurance to reduce exposure to large loss events. The reinsurance we purchase takes the form of quota share, aggregate, stop-loss and excess of loss programs, catastrophe bonds and industry loss warranties. We evaluate the financial condition of our reinsurers regularly and monitor concentrations of credit risk with reinsurers. All reinsurance premiums ceded and reinsurance recoverables are either fully collateralized or placed with reinsurers that are rated A- or greater by A.M. Best or S&P, other than four reinsurers which are rated B++ by A.M. Best. In some cases, Fidelis MGU will be afforded discretion to purchase reinsurance for us from a non-rated source, subject to full collateralization of policy limits ceded under
173
such reinsurance (for example, through purchase of industry loss warranties) or seek direct access to capital markets (for example, through catastrophe bonds).
When we purchase reinsurance protection, we cede to reinsurers a portion of our risks and pay premiums based upon the transferred risk or perils of the subject, right or interest protected by the reinsurance. Although the reinsurer will be liable to us in respect of the business ceded, we retain the ultimate liability in the event the reinsurer is unable to meet its obligations at some later date.
When purchasing outwards reinsurance, Fidelis MGU will ensure that the placement of outwards reinsurance is within the defined terms of our counterparty risk appetite in respect of both the related credit exposure and aggregate exposure. It will also ensure that the outwards reinsurance purchased is in line with the Solvency II eligibility requirements for risk mitigation techniques, including but not limited to:
| the contractual arrangements and transfer of risk are legally effective and enforceable in all relevant jurisdictions; |
| all appropriate steps have been taken to ensure the effectiveness of the arrangement and to address the risks related to that arrangement; |
| Current Fidelis is able to monitor the effectiveness of the arrangement and the related risks on an ongoing basis; |
| Current Fidelis has, in the event of a default, insolvency or bankruptcy of a counterparty or other credit event set out in the transaction documentation for the arrangement, a direct claim on that counterparty; |
| that there is effective transfer of risk; and |
| the requirements relating to collateral arrangements and guarantees. |
Underwriting and Risk Management
Our underwriting ethos is to underwrite (re)insurance business subject to a process-driven, disciplined, innovative and analytical approach with a focus on delivering superior solutions for clients and brokers. As part of the underwriting process, the Framework Agreement and the Delegated Underwriting Authority Agreements set out the parameters and robust oversight procedures for Fidelis MGU in assessing: (i) adequacy of underlying rates for a specific class of business and territory; (ii) the reputation of the proposed (re)insured; (iii) the geographic area in which the (re)insured does business, together with our catastrophe exposures and our aggregate exposures in that area; (iv) historical loss data for the (re)insured and, where available, for the industry as a whole in the relevant regions, in order to compare the historical loss experience to industry averages; (v) projections of future loss frequency and severity using its view of risk; (vi) if relevant, the perceived financial strength of the (re)insured; as well as (vii) certain ESG factors.
We focus on four key principles governing our underwriting and risk selection approach and strategy, as prescribed by the underwriting parameters and risk tolerances that will be set forth in the Group Annual Plan:
(1) | Discipline. We will leverage Fidelis MGUs disciplined, analytical underwriting approach, which is focused on real time pre-quote peer review and management of portfolios to allow us to stay ahead of the curve in terms of our offering. As will be set forth in the Group Annual Plan, Fidelis MGU employs robust underwriting controls, including the daily UMCCs. We believe, that the UMCC is unique among our peers. Coming together in this way on daily calls means that there is no siloed underwriting, there is management oversight over all underwriting decisions and there is cohesive portfolio composition across all business lines and pillars. This approach maximizes opportunities for cross-selling and brings a multidisciplinary lens to bear on each underwriting decision and across risk management, exposure management, compliance, contract wordings, actuarial review and claims review. |
(2) | Clients and Brokers. Our primary focus is to aim to deliver superior solutions for our clients and broker partners. We will rely on Fidelis MGUs ability to move quickly in the changing market to |
174
deliver bespoke products meeting a clients demands. Our model is built on the balance of Fidelis MGUs long-term relationships with quality clients and respect for the core broker distribution model. We encourage multi-tier engagement with brokers using consistent data points to measure performance and identify opportunities. |
(3) | Innovation. We recognize that in an ever-changing and competitive market, we must put a lot of emphasis on creativity in bringing new products to market. We intend to benefit from Fidelis MGUs strong ability in development and innovation when creating new products and client-led solutions. Through our development of new coverages such as the Aircraft Finance Insurance Consortium, or need-driven innovations like policies covering Kabul relief flights and COVID-19 loss of hire, Fidelis has demonstrated an ability to work with clients and brokers to understand their needs and be ever-more responsive and relevant to them with the expanded product offering. We focus on being a rate maker rather than a rate taker given our strong position in the industry utilizing significant individual risk line sizes, which we expect Fidelis MGU to perpetuate. We will encourage Fidelis MGU to seek to find growth through first mover advantage in response to client demand for bespoke, innovative and new products, such as its recently developed marine transit COVID-19 quarantine product and a product to support the World Health Organization in its global roll-out of COVID-19 vaccines under its COVAX program. |
(4) | Risk and capital management. In order to optimize our risk and return, we will allow Fidelis MGU flexibility within closely defined risk tolerances and appetites to allocate risk and capital. Through managements focus and the outsourcing model with Fidelis MGU, we expect to be able to actively manage risk on a gross and net basis, results in allowing us to increase our capital efficiency. |
Investment Operations
Our investment strategy is focused on delivering stable investment income and reasonable total return through all market cycles while maintaining appropriate investment portfolio liquidity and credit quality to meet the requirements of our clients, rating agencies and regulators and support our underwriting activities.
Our investments are principally managed by two external investment managers through individual investment management agreements. Our Chief Investment Officer monitors activity and performance of the external managers on a regular basis and reports to the Board on at least a quarterly basis. At March 31, 2023, our investments consisted primarily of a diversified portfolio of core fixed maturity securities (including U.S. Treasuries, non-U.S. government bonds, government agency bonds, corporate bonds, mortgage and other asset-backed securities), and a small allocation to risk assets. See Managements Discussion and Analysis of Financial Condition and Results of OperationsFinancial ConditionTotal Cash and Investments.
The Investment Committee of our Board establishes investment policies and guidelines and supervises our investment activity. The Investment Committee regularly monitors our overall investment results and performance against our investment objectives, benchmarks, risk appetite and guidelines contained in the investment policy. Our current investment policy contains a prescriptive set of permitted investments and prohibited asset classes, guidelines specifying minimum criteria on the overall credit quality (in addition to individual issuer credit quality), ESG parameters, designed to be value accretive, and liquidity characteristics of the portfolio and includes limitations on the size of certain holdings and restrictions on purchasing certain types of securities and other investments. Any material changes to our investment objectives, benchmarks, risk appetite and guidelines would require Board approval, and the Board will also be required to review any such proposed changes in light of their potential impact on Fidelis MGU, its ability to perform underwriting activities and a general compatibility with the Group Annual Plan. See Material Contracts and Related Party TransactionsFramework AgreementSubsidiary Annual Plans.
Our management team and the Investment Committee review our investment performance and assess credit and market risk concentrations and exposures to issuers. We follow an investment strategy designed to emphasize
175
the preservation of capital and provide sufficient liquidity for the prompt payment of claims. Our investment portfolio is diversified across sectors and issuers, and we have taken a number of steps to ensure that we hold sufficient cash available to meet our obligations. At March 31, 2023, 20.0% of our total cash and investments was held in cash and 78.7% of our total cash and investments was invested in core fixed maturity investments (with 13.7% of our total cash and investments rated BBB and no securities rated lower than BBB).
We have minimal direct exposure to Russian equities and minimal exposure to fixed maturity assets impacted by sanctions. We have direct exposure to one bond (held in our own account) which has become subject to sanctions relating to the Ukraine Conflict. The bond is not in possession or control of a U.S. person. The bond has a maturity date of November 21, 2023 and an original cost of $490,000. We also have some limited exposure to Russian bonds and currency forwards through the Groups approximately 5% investment in the Wellington Opportunistic Fixed Income UCITS fund, holding a proportional 5% share of each of the funds investments. We have no material exposure to Russian equities. We consider that our level of credit exposure to securities issued by the Russian Federation is immaterial compared to our business, financial condition and results of operations. Further, the Current Fidelis does not have offices or any physical presence in Russia, Belarus or Ukraine.
Claims
Under the terms of the Framework Agreement and the respective Delegated Underwriting Authority Agreements, the claims management activities are managed by Fidelis MGU, while we retain an oversight function. Fidelis MGU employs a staff of experienced claims professionals who will operate within the parameters set forth in the Framework Agreement and the respective Delegated Underwriting Authority Agreements, which provide for a delegated claims authority up to a maximum monetary threshold. Claims that exceed the delegation threshold must be referred back to us for oversight and involvement in resolution within predefined timelines and claims subject to coverage disputes and/or litigation will be handled by a separately agreed procedure.
The claims professionals employed by Fidelis MGU work closely with its underwriting team to achieve consistency and efficiencies across all lines of business. We are committed to offering prompt and professional claims service to policyholders and service providers and Fidelis MGU has, on our behalf, developed processes and internal business controls for identifying, tracking and settling claims.
The key responsibilities of the claims management departments include:
| Processing, managing and resolving reported insurance or reinsurance claims efficiently and accurately to ensure the proper application of intended coverage and expense; |
| Making timely payments in the appropriate amount on those claims for which Current Fidelis is legally obligated to pay; |
| Selecting appropriate counsel and experts for claims, managing claims-related litigation and regulatory compliance; |
| Contributing to the underwriting process by collaborating with the underwriting teams and senior management in terms of the evolution of policy language and endorsements and providing claim-specific feedback and education regarding legal activity; and |
| Contributing to the analysis and reporting of financial data and forecasts by collaborating with the finance and actuarial functions relating to the drivers of actual claim reserve developments and potential for financial exposures on known claims. |
Reserves for Losses and Loss Adjustment Expenses
Reserve estimates are derived by us after extensive consultation with the underwriters and actuaries employed by Fidelis MGU, actuarial analysis of the loss reserve development, comparison with industry
176
benchmarks and preliminary contract level loss reserve estimates prepared by Fidelis MGU. The reserves for losses and loss adjustment expenses include an amount determined from reported claims and estimates based on historical loss experience and industry statistics for IBNR losses using a variety of actuarial methods. For additional discussion of our reserves, refer to note 12 (Reserves for Losses and Loss Adjustment Expenses) of our audited consolidated financial statements and note 12 (Reserves for Losses and Loss Adjustment Expenses) of our unaudited consolidated financial statements contained elsewhere in this prospectus.
Loss reserves represent estimates, at any given time, of what we ultimately expect to pay on claims, are based on facts and circumstances then known, and it is probable that the ultimate liability may exceed or be less than such estimates. Even actuarially sound methods can lead to subsequent adjustments to reserves that are both significant and irregular due to the nature of the risks written. Loss reserves are inherently subject to uncertainty. In establishing the reserves for losses and loss adjustment expenses, we make various assumptions relating to the pricing of reinsurance contracts and insurance policies and also considering available historical industry experience and current industry conditions. The timing and amounts of actual claim payments related to recorded reserves vary based on many factors, including large individual losses and changes in the legal environment, as well as general market conditions. The ultimate amount of the actual claim payments could differ materially from our estimated amounts. Certain lines of business have loss experience characterized as low frequency and high severity. This may result in significant variability in loss payment patterns and, therefore, may impact the related investment management process in order to be in a position, if necessary, to make these payments. The unpaid reported reserves for losses and loss adjustment expenses are established by management based on reports from brokers, ceding insurers and insureds and represent the estimated ultimate cost of events or conditions that have been reported to, or specifically identified by us. Generally, it is anticipated that reserves will be established without regard to whether we may subsequently contest the claim. Current Fidelis and Fidelis MGU will, pursuant to the Framework Agreement and the respective Delegated Underwriting Authority Agreements, jointly undertake the reserving process with our reserving teams and the claims and actuarial teams at Fidelis MGU. Ultimate ownership and sign-off responsibility over our reserving will remain with us. The reserves for IBNR losses and loss adjustment expenses are established by our management based on actuarially determined estimates of ultimate losses and loss adjustment expenses, and other related data and analysis to be provided to us by Fidelis MGU. Inherent in the estimate of ultimate losses and loss adjustment expenses are expected trends in claim severity and frequency and other factors which may vary significantly as claims are settled, and accordingly, ultimate losses and loss adjustment expenses may differ.
These estimates are reviewed regularly and, as experience develops and new information becomes known, the reserves are adjusted as necessary. Such adjustments, if any, will be recorded in losses and loss adjustment expenses in the period in which they become known. IBNR reserves are calculated on a best estimate basis and are established by our management based on a combination of managements professional judgment and various actuarial methods, growing loss experience, historical (re)insurance industry loss experience, estimates of pricing adequacy trends and other related data and analysis to be provided by Fidelis MGU. Due to the limited historical data available, and limited loss experience available to us due to our relatively short period of operations, reliance is placed upon industry data and a review of individual policies. Estimates are calculated at the lowest level line of business, separately for gross and ceded, and for attritional, extreme and catastrophic claims.
The reserve estimates contain an inherent level of uncertainty, and actual results may vary, potentially significantly, from the estimates we have made. Reserves are reviewed on a quarterly basis and estimates are adjusted to reflect emerging claims experience. We are supported by our external loss reserve specialist, Willis Towers Watson, which reviews our reserves annually.
Other principal actuarial methods, and associated key assumptions, used to perform our loss reserve analysis include paid and incurred chain ladder, paid and incurred Bornhuetter-Ferguson method and credible claims reserves. We may however employ a number of different reserving methods depending on the pillar, the line of business, the availability of historical loss experience and the stability of that loss experience. Over time we may determine to give additional weight to our historical loss experience in our reserving process due to the then- applicable maturation of our reserves, and the increased availability and credibility of the historical experience.
177
Our insurance operating subsidiaries are subject to insurance and reinsurance laws and regulations in the jurisdictions in which they operate, the most significant of which are Bermuda, Ireland and the United Kingdom. We hold capital in excess of the minimum statutory capital and surplus requirements in each of those locations. Please refer to note 19 (Statutory Requirements and Dividend Restrictions) of our audited consolidated financial statements contained elsewhere in this prospectus for further details of the requirements in each jurisdiction.
Competition
The (re)insurance industry is highly competitive and we compete with major insurers, reinsurers and alternative capital managers. While there is no one direct competitor for us given our business strategy, and we may have other categories of peer groups or competitors, our competitors may include multi-line property and specialty (re)insurers such as Arch, Argo, Aspen, Markel, W. R. Berkley, Hiscox, Beazley, Lancashire, Everest Re, Axis Capital, and RenaissanceRe, and diversified insurers such as Berkshire Hathaway. The industry has seen and continues to see a trend of consolidation, and we believe that our unique business model and focus on quality, service and experience over scale differentiates us from our competitors seeking growth from mergers or acquisitions. See Risk Factors Risks Relating to the Groups Business and IndustryConsolidation in the (re)insurance industry could adversely impact our business and results of operations.
Our Corporate Structure
The following chart presents a simplified summary overview of the corporate structure for Current Fidelis, which, other than the percentage ownership changes notes at note (1) below, will remain unchanged following the consummation of this offering. For a more detailed description of our organizational structure and an overview of the Separation Transactions see The Separation Transactions.
Current Fidelis Structure
(1) | See Principal and Selling Shareholders for detail of the percentage ownership prior to this offering, as well as the percentage ownership of FIHL following the consummation of this offering (including in the event of a full option exercise) by each of MGU HoldCo, the Founders, other institutional investors, management and other existing shareholders. |
178
(2) | FUL is a limited liability company incorporated in England and Wales, authorized by the PRA and supervised by the FCA and the PRA as an insurer. |
(3) | FIBL is a limited liability company incorporated in Bermuda, authorized and supervised by the BMA as an insurer. |
(4) | FIHL (UK) Services is a limited liability company incorporated in England and Wales and is the service company of Current Fidelis. FIHL (UK) Services also has a branch in Ireland. |
(5) | FIID is a designated activity company incorporated in Ireland, authorized and supervised by the CBI as an insurer. |
Ratings
Ratings by independent agencies are an important factor in establishing the relative financial and operational strength of (re)insurance companies and are important to our ability to market and sell our products and services. Rating agencies continually review the financial positions of (re)insurers, including us.
Prior to the Separation Transactions, the Group was assigned an A (Excellent) financial strength rating by A.M. Best, the third-highest of 13 rating levels, with a stable outlook on all entities. A.M. Bests ratings range from A+ to D. Each A.M. Best rating category from A+ to C may be designated either an additional plus (+) or a minus (-) sign as a rating notch that reflects a gradation of financial strength within the rating category. Additionally, A.M. Best assigned a BBB long-term issuer credit rating to FIHL, which indicates a good ability to meet ongoing senior financial obligations and a financial strength rating of A (Excellent) and the long-term issuer credit rating of A (Excellent) to FIBL, FUL and FIID. In connection with the Separation Transactions, the Group completed a rating evaluation service with A.M. Best, following which, A.M. Best had placed under review with negative implications the ratings assigned to FIHL, including the Groups financial strength rating of A. On February 3, 2023, A.M. Best removed from under review with negative implications and affirmed the financial strength rating of A (Excellent) and the long-term issuer credit rating of A (Excellent) of FIBL, FUL and FIID. In addition, A.M. Best removed from under review with negative implications and affirmed the long-term issuer credit rating of BBB (Good) of FIHL. The outlook assigned to these ratings remained negative at such date. The negative outlooks acknowledge that A.M. Best has noted that it will continue to monitor the Groups market presence as well as subsequent operating performance now that the Separation Transactions have been consummated.
Prior to the Separation Transactions, the Group was assigned an A- financial strength rating by S&P, with a positive outlook, which indicates strong capacity to meet financial commitments but somewhat more susceptibility to the adverse effects of changes in circumstances and economic conditions than those in higher-rated categories. S&Ps ratings range from AAA to D. Each S&P rating category from AA to CCC may be modified by the addition of a plus (+) or minus (-) sign to show relative standing within the rating categories. Additionally, S&P has assigned a BBB long term issuer rating to FIHL, which indicates adequate capacity to meet financial commitments but greater susceptibility to adverse economic conditions. In connection with the Separation Transactions, the Group completed a rating evaluation service with S&P, following which, S&P had placed under review the ratings assigned to FIHL, including the Groups financial strength rating of A-. On August 5, 2022, S&P affirmed the Groups ratings, including the A- financial strength rating assigned to the Group and a BBB long term issuer rating to FIHL, but revised its outlook from positive to stable for all entities. Despite the revision, S&P expressed confidence in the Groups future operating earnings and strong capital position, noting in particular the Groups underwriting outperformance of peers between 2017 and 2022.
Following the announcement of the Separation Transactions, on August 1, 2022, Moodys assigned a Baa2 long-term issuer rating to FIHL and A3 insurance financial strength ratings to FIBL, FUL and FIID. The outlook for FIHL is stable. Moodys generic rating classifications range from Aaa to C. Each Moodys generic rating classification from Aa to Caa may be modified to append numerical modifiers 1, 2, or 3 to show relative position within the rating categories.
These ratings are intended to provide an independent opinion of our insurance subsidiaries ability to meet their respective obligations to policyholders or of FIHLs ability to meet the terms of its long-term debt obligations in a timely manner, as applicable, but are not ratings of the securities and are not recommendations to buy, sell or hold our securities.
179
Each rating reflects the respective rating agencys opinion of the business, capitalization, results, management and ownership of the entity to which it relates and ratings are not an evaluation directed to investors in our securities or a recommendation to buy, sell or hold our securities. Ratings may be revised or revoked at the sole discretion of A.M. Best, S&P or Moodys.
For a discussion of some potential risks relating to the ratings of Fidelis, see Risk FactorsRisks Relating to the Groups Business and Industry.
Employees
At March 31, 2023, Current Fidelis had 51 permanent employees across our three locations (13, 27 and 11 in Bermuda, London and Dublin, respectively), 4 persons recruited due to start (1, 2 and 1 in Bermuda, London and Dublin, respectively) and a further 24 approved vacancies to be filled (9, 6 and 9 in Bermuda, London and Dublin, respectively). Subject to business conditions, Current Fidelis headcount is expected to be approximately 79 permanent employees. The Inter-Group Services Agreement provides for the outsourcing of corporate services for several corporate functions including finance and accounting services and IT infrastructure services to Fidelis MGU. See Material Contracts and Related Party TransactionsInter-Group Services Agreement.
None of our arrangements with employees are subject to collective bargaining agreements.
Facilities
We lease office space in Bermuda, Ireland and the United Kingdom. We and Fidelis MGU renew and enter into new leases in the ordinary course of business.
The two Bermuda leases are currently held by FIBL and it is expected that one of the leases will be transferred to Bermuda MGU with the provision of a rental guarantee, with FIBL retaining the other lease. In the United Kingdom, we currently occupy two floors of 22 Bishopsgate in London, pursuant to two separate leases held by FML and FIHL (UK) Services. This office space is shared by Current Fidelis and Fidelis MGU. Segregation is implemented through the use of user access control to protect commercially confidential information and related interactions. FIID currently shares office space leased by FML, which is part of Fidelis MGU. During 2023, FIID employees will move to another location in Dublin which it leases and is currently being renovated (it is expected that this lease will be transferred by FIHL (UK) Services, Irish Branch). The existing Pine Walk Capital lease will also remain with Fidelis MGU following the consummation of the Separation Transactions. For further discussion of our leasing commitments at December 31, 2022, see note 17(a) (Commitments and ContingenciesLease Commitments) of our audited consolidated financial statements contained elsewhere in this prospectus.
Information Technology
We require complex and extensive IT systems to run our business and are reliant on third parties for the provision of important services, including finance systems and processes and IT infrastructure including software, claims management and investment management services. We have autonomy over our financial and regulatory reporting, with use of dedicated Oracle Fusion general ledger and Solvency II reporting tools.
The technology platforms have been transferred to Fidelis MGU as part of the Separation Transactions. Although the proprietary tools and systems including the Prequel Policy Administration system, the Jarvis Data Warehouse, and the FireAnt analytics system are owned by Fidelis MGU, they are licensed for use by us as appropriate pursuant to the outsourcing arrangements. See Material Contracts and Related Party TransactionsOtherLicensing Arrangements.
180
Legal Proceedings
Similar to the rest of the insurance and reinsurance industry, we will from time to time be subject to litigation and arbitration in the ordinary course of business. We may also be subject to other potential litigation, disputes and regulatory or governmental inquiry from time to time in the ordinary course of business. While it is not feasible to predict or determine the ultimate outcome of the pending or threatened proceedings, management does not believe that the outcome of these proceedings, including those discussed below, will have a material adverse effect on the financial condition of the Group, after consideration of any applicable reserves.
Following Russias invasion of Ukraine on February 24, 2022, government sanctions were introduced prohibiting various commercial and finance activities in Russia, including leasing of aircraft in the aviation industry to any person in Russia, or for use in Russia. Aircraft lessors issued notices to airlines and lessees in Russia purporting to terminate the leasing of aircraft (and other parts such as spare engines) and requiring that the airlines return the assets. Many of the relevant aviation authorities where the aircraft are registered have also since suspended the certificates of airworthiness of such aircraft. Some aircraft are yet to be returned and aircraft lessors filed various insurance claims under their insurance policies for loss of the unreturned aircraft. The insurers have denied the claims and the lessors have instituted proceedings in the U.K., the U.S. and Ireland against upwards of 60 (re)insurers, including certain Group entities. Fidelis has been named in multiple proceedings. Provision has been made in the Groups reserves of $145.6 million at March 31, 2023 for potential exposures relating to the Ukraine Conflict, considerable majority of which is reserves reflecting our estimate for potential loss claims relating to leased aircraft within Russia, including the related litigation proceedings. See Managements Discussion and Analysis of Financial Condition and Results of OperationsRecent Developments and Activity.
This is an unprecedented event, which is currently anticipated to continue for a protracted period of time and presents unique circumstances and coverage issues in respect of both the gross loss and consequent extent of the reinsurance recoveries, which will continue to be unresolved until the multiple courts rule on the merits of the lawsuits. The situation is continuously evolving, including with respect to explorative discussions ongoing between Western leasing firms and Russian airline operators for the sale of some of the unreturned aircraft to the Russian operators. Such discussions, if successful, may lead to a reduction in any potential exposures under the relevant insurance policies. See Managements Discussion and Analysis of Financial Condition and Results of OperationsRecent Developments and Activity, Risk FactorsRisks Relating to Recent EventsThe full extent of the impacts of the ongoing Ukraine Conflict on the (re)insurance industry and on the Groups business, financial condition and results of operations, including in relation to claims under the Groups (re)insurance policies, are uncertain and remain unknown and We may be subject to litigation which could adversely affect our business.
181
MANAGEMENT AND CORPORATE GOVERNANCE
Executive Officers and Directors
The following table sets forth, as of the date of this prospectus, the names and positions of the individuals who are expected to serve as our directors and executive officers at the time of this offering of our Common Shares as set forth in this prospectus.
Name |
Position | |
Helena Morrissey |
Chair and Non-Executive Director | |
Daniel Burrows |
Group Chief Executive Officer and Executive Director | |
Allan Decleir |
Group Chief Financial Officer and Executive Director | |
Daniel Brand |
Non-Executive Director | |
Charles Collis |
Non-Executive Director | |
Cathy Iberg |
Non-Executive Director | |
Daniel Kilpatrick |
Non-Executive Director | |
Dana LaForge |
Non-Executive Director | |
Hinal Patel |
Fidelis MGU Nominee and Non-Executive Director | |
Warrick Beaver |
Group Chief People Officer | |
Denise Brown-Branch |
Group Chief Operating Officer | |
Ian Houston |
Group Chief Underwriting Officer | |
Dee Pang |
Group Chief Information Security Officer and Chief Technology Officer | |
Michael Pearson |
Group Chief Risk Officer | |
David Smith |
Group Chief Investment Officer | |
Jonathan Strickle |
Group Chief Actuarial Officer | |
Janice Weidenborner |
Group Chief Legal Officer |
Biographical Information
Biographical information on our directors and executive officers is set forth below.
Baroness Helena Morrissey DBE. Baroness Morrissey became the chair of the Board with effect from the consummation of the Separation Transactions. She has over three decades of experience in the financial services sector. Baroness Morrissey has served as non-executive director of Green Park Limited since August 2020. She also served as non-executive chair of AJ Bell plc from July 2021 to September 2022. Since February 2017 Baroness Morrissey has served as a director of Helena Morrissey Ltd. She was lead non-executive director at the Foreign & Commonwealth Office between July 2020 and September 2020, transferring to lead non-executive director of the Foreign, Commonwealth & Development Office until June 2022. Between January 2020 and May 2021 Baroness Morrissey was a non-executive director of St James Place. Prior to this, she was head of personal investing at Legal & General Investment Management between May 2017 and December 2019. Between 2001 and 2016 Baroness Morrissey was CEO of Newton Investment Management. Baroness Morrissey began her career as a global bond analyst at Schroders in the 1980s, later becoming a global bond fund manager. Baroness Morrissey holds a Master of Arts in Philosophy from Cambridge University. Baroness Morrissey is chair of the Diversity Project, a trustee of the Lady Garden Foundation and a fellow and Chair of the Endowment Committee of Eton College. She also serves as an advisory board member of Edelman Communications, Anthemis and UK Fintech Growth Fund and a board member and chair of the Client Service and Advisory Committee of McKinsey Investment Office. Baroness Morrissey was chair of the Investment Association from July 2013 to May 2017 and founded the 30% Club campaign. We believe Baroness Morrissey is qualified to serve as a member of our Board based on our review of her experience, qualifications, attributes and skills, including her executive leadership experience in the financial sector.
Daniel Burrows. Mr. Daniel Burrows has been a director of FIHL since April 2022 and became Group Chief Executive Officer of Current Fidelis on January 3, 2023 upon completion of the Separation Transactions.
182
Mr. Burrows joined Previous Fidelis in 2015 and currently serves as executive director of FIBL and prior to that served as CEO of FUL. Prior to joining Previous Fidelis Mr. Burrows was co-CEO of Aon Benfields Global Re Specialty (GRS) division from 2013 to 2015. Specializing in non-marine retrocession and the aviation, marine and energy sectors, among others, Mr. Burrows supported Aon Benfields business hubs across North America, Europe, the Middle East, Africa and Asia Pacific. Prior to this, he was Deputy CEO of the GRS division from 2008 until 2013. Mr. Burrows began his career as a non-marine property broker at Greig Fester in the 1980s, later joining the retrocession team and then leading that team following a merger with Benfield in 1997. We believe Mr. Burrows is qualified to serve as a member of our Board based on our review of his experience, qualifications, attributes, and skills, including his extensive insurance background and executive leadership experience.
Allan Decleir. Mr. Decleir became Group Chief Financial Officer of Current Fidelis on January 3, 2023 upon completion of the Separation Transactions. Prior to assuming this executive position, Mr. Decleir was a consultant to FIBL from June 1, 2022. He has over 27 years of experience in the (re)insurance industry. Since June 2015, Mr. Decleir has been an independent consultant for ThreeSeas Consulting Ltd, providing management consulting services in the Bermuda (re)insurance market. Mr. Decleir was also a Listings Manager at the Canadian Securities Exchange from February 2019 until March 2022. Prior to this, he was Executive Vice President & Chief Financial Officer of Platinum Underwriters Holdings, Ltd. (Platinum) from June 2010 until March 2015, overseeing SEC, financial and regulatory reporting. He first joined Platinums Class 4 reinsurance subsidiary, Platinum Underwriters Bermuda, Ltd. (Platinum Bermuda), in 2003, and, from 2005 until his promotion to Platinums Group CFO, served as Senior Vice President and Chief Financial Officer. Prior to joining Platinum Bermuda, Mr. Decleir was the Chief Financial Officer of Stockton Reinsurance Limited from June 1996 to May 2003. He began his career at Ernst & Young in 1988, taking on various positions in Canada and Bermuda. Mr. Decleir was granted a National Association of Corporate Directors governance fellowship in 2017 and achieved the Directorship Certified designation in 2022, and earned the Associate in Reinsurance designation from the Insurance Institute of America in 2000. Mr. Decleir holds a Bachelor of Business Administration from Wilfrid Laurier University and is a Chartered Professional Accountant (Chartered Accountant). We believe Mr. Decleir is qualified to serve as a member of our Board based on our review of his experience, qualifications, attributes, and skills, including his extensive financial accounting background, corporate governance and executive leadership experience in the financial and insurance industries.
Daniel Brand. Mr. Brand is the CVC director nominee. Mr. Brand joined CVC in 2009 and is a partner leading CVCs U.S. private equity activities in financial services and co-leading CVCs U.S. private equity activities in business services. Mr. Brand also represents CVC on the boards of directors of CFGI, Medrisk, Republic, Teneo and Worldwide Express. Prior to joining CVC, Mr. Brand worked at DLJ Merchant Banking Partners and Credit Suisse in the investment banking division covering financial institutions. Mr. Brand holds a B.A. in Economics with a Certificate in Finance from Princeton University, and an M.B.A. from Harvard Business School. We believe Mr. Brand is qualified to serve as a member of our Board based on our review of his experience, qualifications, attributes, and skills, including his extensive financial background and directorial experience.
Charles Collis. Mr. Collis was appointed as non-executive director to the Board in May 2023. Mr. Collis is a director of Conyers Dill & Pearman (Conyers) and works in the corporate department of the Bermuda office and is Head of the Bermuda Insurance Practice. Mr. Collis joined Conyers in 1990 and became a partner in 1998. Mr. Collis specializes in insurance and reinsurance, advising on corporate and regulatory matters. Mr. Collis holds a Bachelor of Laws from University College London and a Bachelor of Arts from the University of Toronto. We believe Mr. Collis is qualified to serve as a member of our Board based on our review of his experience, qualifications, attributes, and skills, including his extensive legal background and experience in the insurance industry.
Cathy Iberg. Ms. Iberg was appointed on November 2, 2016, as a prior nominee of the Founders before this offering. Ms. Iberg is Vice President of Investments at the St Davids Foundation, a charitable foundation dedicated to providing and supporting non-profit health related programmes in the US, including the largest
183
scholarship program in Texas for aspiring health professionals, and the largest mobile dental program in the country. Ms. Iberg joined the St Davids Foundation in December 2015. Prior to her role at the Foundation, Ms. Iberg was UTIMCOs (University of Texas Investment Management Company) President and Deputy CIO and retired in August 2014. At UTIMCO she was responsible for investment oversight of $30 billion in investment assets in addition to the management of public equity, fixed income and hedge fund investments. Her employment with the organization dates back to April of 1991 when she joined the U.T. System Office of Asset Management, the predecessor to UTIMCO. Previous to joining U.T. System, Ms. Iberg practiced in the area of public accounting for 15 years. She has a B.Sc. degree in accounting from the Southern Illinois University and is a Certified Public Accountant. We believe Ms. Iberg is qualified to serve as a member of our Board based on our review of her experience, qualifications, attributes, and skills, including her financial accounting background and executive leadership experience in the investments sector.
Daniel Kilpatrick. Mr. Kilpatrick is the Crestview director nominee. Mr. Kilpatrick was appointed on November 15, 2022. Mr. Kilpatrick joined Crestview in August 2009 and is a partner and member of the Crestview Investment Committee. He is also the head of the financial services strategy. Mr. Kilpatrick also is on the boards of directors of AutoLenders, Congruex, DARAG Group, Protect My Car, WildOpenWest, LLC and Venerable Holdings. He was previously on the boards of Accuride Corporation, Camping World Holdings, ICM Partners, Industrial Media, NYDJ Apparel and Symbion. Prior to joining Crestview, Mr. Kilpatrick worked at the Yale Investments Office. Mr. Kilpatrick received an M.B.A. from Stanford Graduate School of Business and a B.A. from Yale University. We believe Mr. Kilpatrick is qualified to serve as a member of our Board based on our review of his experience, qualifications, attributes, and skills, including his extensive financial background and directorial experience.
Dana LaForge. Mr. LaForge is the Pine Brook director nominee. Mr. LaForge was appointed on March 19, 2021. Mr. LaForge joined Pine Brook in June 2020 and is a partner on the financial services investment team and a member of Pine Brooks Investment Committee. Mr. LaForge also represents Pine Brook on the boards of directors of Amedeo Capital Limited, Belmont Green Limited, and Clear Blue Financial Holdings. He also serves as a chairman of the board of a venture philanthropy fund, the Myeloma Investment Fund. Prior to joining Pine Brook, he was the founder and managing director of Colonnade Financial Group from 2002-2020, a spin out from Deutsche Bank created to manage a private equity portfolio. Prior to Colonnade, from 1985-2002 Mr. LaForge served in numerous senior executive roles at Deutsche Bank, Alex Brown and its predecessor companies, Bankers Trust and BT Alex. Brown, also serving as the head of the North American financial institutions group in investment banking. Mr. LaForge holds a Bachelor of Science in Commerce and Accounting from Washington & Lee University and a Master of Business Administration from Harvard Business School. We believe Mr. LaForge is qualified to serve as a member of our Board based on our review of his experience, qualifications, attributes, and skills, including his extensive financial background and directorial experience.
Hinal Patel. Mr. Patel is the MGU HoldCo director nominee. Mr. Patel is the MGU HoldCo director nominee. Mr. Patel joined Previous Fidelis in September 2015 as Group Chief Actuary and served as Group Chief Financial Officer from July 2017 until completion of the Separation Transactions on January 3, 2023, following which Mr. Patel became the Chief Financial Officer of the MGU HoldCo. During his time as Group Chief Financial Officer of Previous Fidelis, Mr. Patel was responsible for the finance, investment, actuarial and corporate finance functions. Prior to joining Previous Fidelis, Mr. Patel spent 12 years at Catlin, where he served in a variety of positions, including Bermuda Chief Actuary overseeing actuarial, catastrophe modelling and capital functions for the Bermuda entity. Prior to joining Catlin, Mr. Patel worked at a number of actuarial consultancies and has over 20 years of experience. Mr. Patel graduated from the London School of Economics and is also Fellow of the Institute of Actuaries. We believe Mr. Patel is qualified to serve as a member of our Board based on our review of his experience, qualifications, attributes, and skills, including his extensive financial accounting background, corporate governance and executive leadership experience in the insurance industry.
184
Warrick Beaver. Mr. Beaver became Chief People Officer of Current Fidelis in March 2023. Prior to that, Mr. Beaver worked as Head of HR at Previous Fidelis, which he joined in August 2022 and, following the completion of the Separation Transactions, Fidelis MGU. From March 2019 until July 2022, Mr Beaver was an independent consultant for Stonehouse HCC Ltd, providing management consulting services to private equity backed specialty (re)insurance brokers. Prior to that, Mr Beaver worked for Thomson Reuters Corporation from November 2010 to December 2018, where he held a number of global Head of HR positions, as well as Managing Director of the Global Financial Crime and Reputational Risk Proposition and Modern-Day Slavery Initiative from November 2014. Mr. Beaver began his career 1995, taking on various HR leadership positions in South Africa, the United States and the United Kingdom. Mr. Beaver graduated with a Bachelor of Arts (Psychology) from University of the Witwatersrand in 1994 and in 2001 became a Chartered Member of the Institute of Personnel and Development.
Denise Brown-Branch. Ms. Brown-Branch was Chief Operating Officer of Previous Fidelis from July 2021 and became Group Chief Operating Officer of Current Fidelis on January 3, 2023 upon consummation of the Separation Transactions. Before becoming Group Chief Operating Officer, Ms. Brown-Branch served in the roles of Strategic Programme Manager (as an independent contractor from July 2015 to September 2020) and Director of Operations (from September 2020 to June 2021) at Previous Fidelis. Ms. Brown-Branch has over 25 years of experience in strategic programme delivery and business change management. Prior to joining Previous Fidelis, Ms. Brown-Branch was a consultant at Bluefin Solutions from August 2011 to July 2015 where she managed a programme of work for Catlin Insurance. Ms. Brown-Branch began her career in the consumer goods industry, where she focused on marketing, IT and global service delivery. Ms. Brown-Branch holds an MBA from Northeastern University and Bachelor of Science degrees in Accounting and Information Systems from Virginia Commonwealth University. She is also certified as a project management professional by the Project Management Institute.
Ian Houston. Mr. Houston became Group Chief Underwriting Officer of Current Fidelis on January 16, 2023. Mr. Houston has over two decades of experience in the insurance industry. Prior to joining FIHL, from January 2018 until January 2023, Mr. Houston was general manager of Partner Re Europe. From August 2010 until April 2016 he was Deputy Head of Specialty Lines and Chief Underwriting Officer at PartnerRe. In this role, he was responsible for the strategy, risk appetite framework, portfolio shaping, and transaction referrals for the specialty lines portfolio. Mr. Houston began his career at various insurance carriers in the late 1980s in London. He is an associate of Chartered Insurance Institute and has attended various training courses such as the ZFS EXED Training course at IBM in Lausanne and Converiums Executive management course in Vitznau and Washington D.C. and Henley Business School. Mr. Houston holds a BA.Hons degree in Business Studies from South Bank University.
Dee Pang. Mr. Pang became Group Chief Information Security Officer & Chief Technology Officer of Current Fidelis in January 2023. Prior to joining Current Fidelis, Mr. Pang was the Chief Information Security Officer of Slaughter and May from January 2018, where he headed their Information Security and Privacy department. Before that, Mr. Pang managed Freshfields Bruckhaus Deringers global cyber security function from February 2015. Mr. Pang has worked in information technology for more than 20 years and has extensive experience in building and operating information technology and information security programmes. In more recent years his focus has been on information and cyber security, and he has implemented and operated cutting-edge cyber security technologies, managed vulnerability and penetration testing programmes, and implemented and maintained information security management systems that have been certified against industry standard security frameworks. Mr. Pang holds a Bachelor of Science Honours degree in Marine and Freshwater Biology from Queen Mary, University of London, and is a Certified Information Systems Security Professional (CISSP).
Michael Pearson. Mr. Pearson became Group Chief Risk Officer of Current Fidelis on January 3, 2023 upon consummation of the Separation Transactions. Prior to this, Mr. Pearson was a consultant to FUL from May 2022, a senior independent non-executive director of FUL from October 2015 to December 2020 and chairman of the FUL board from January 2021 until January 2023. He has over 35 years of experience in the insurance industry and was the Chief Risk Officer at Lancashire from March 2010 until February 2013. Mr. Pearson has
185
held roles as Head of Internal Audit in both the Lloyds and company markets and Chief Risk Officer roles in the UK and Bermuda. He is a chartered accountant and a fellow of the Chartered Insurance Institute.
David Smith. Mr. Smith was Chief Investment Officer of Previous Fidelis from February 2019 until January 2023, and became Group Chief Investment Officer of Current Fidelis on January 3, 2023 upon consummation of the Separation Transactions. Previously, Mr. Smith served as Head of Investments and Treasury at Chaucer Syndicates Limited from June 2013, before being promoted to the position of Head of Risk and Investments in January 2017. Between January 2007 and May 2010, Mr. Smith worked for Harbor Point Re Limited in Bermuda, where he was Vice President of Investments and Treasury. When Harbor Point Re Limited merged with Max Capital in May 2010, Mr. Smith moved to the UK to work as Assistant Director of Investments for Alterra at Lloyds. Between June 2005 and June 2006, Mr. Smith was an International Financial Reporting Standards Project Accountant at the Bank of Ireland. Mr. Smith started his career in June 2001 at KPMG, where he worked as an accountant in both Bermuda and Ireland. Mr. Smith is a member of The Chartered Professional Accountants of Bermuda and is a Chartered Financial Analyst charter holder. He holds a Bachelor of Arts degree from the University of Reading in Accounting and Economics.
Jonathan Strickle. Mr. Strickle held the role of Group Actuary of Previous Fidelis from October 2021 until January 2023, and became Group Chief Actuarial Officer of Current Fidelis on January 3, 2023 upon consummation of the Separation Transactions. Mr. Strickle also held the roles of UK Chief Actuary and Group Head of Reserving over the course of his career at Previous Fidelis, which he joined in March 2020. He joined Previous Fidelis after having spent 3 years as Head of Reserving for China Res Lloyds syndicate, from January 2017. Between September 2009 and January 2017, Mr. Strickle worked as a consultant at EY on a number of actuarial projects. Mr. Strickle is a Fellow of the Institute and Faculty of Actuaries, and holds both a Bachelors and a Masters degree from the University of Warwick.
Janice Weidenborner. Ms. Weidenborner became Group Chief Legal Officer of Current Fidelis on January 23, 2023. Previously, Ms. Weidenborner was Chief Operating Officer and General Counsel at Weston Insurance Management LLC from December 2021 to December 2022. Ms. Weidenborner was Executive Vice President, Group General Counsel and Secretary at Third Point Reinsurance Ltd. between January 2016 and March 2021, adding the role of Head of Human Resources in 2019. Ms. Weidenborner continued on as Executive Vice President overseeing Human Resources at SiriusPoint from March 2021 to July 2021 during a planned integration period following its merger with Third Point Re. From January 2013 to December 2015, Ms. Weidenborner served as General Counsel of Ariel Reinsurance Ltd. Prior to Ariel Re, Ms. Weidenborner served in a number of senior legal roles at the ACE Group of Companies (now Chubb), including Senior Vice President and General Counsel, ACE Financial Solutions International Ltd., Senior Vice President and Associate General Counsel, ACE Bermuda Insurance Ltd and ACE Tempest Re, and Associate General Counsel, ACE USA. Ms. Weidenborner has a Bachelor of Science from Embry-Riddle Aeronautical University, a Master of Business Administration in Finance from Fordham University and a Juris Doctor from Rutgers University School of Law.
Director Independence
As foreign private issuer, under the listing requirements and rules of NYSE we are not required to have independent directors on our board of directors, except to the extent that our audit committee is required to consist fully of independent directors, subject to certain phase-in schedules. The listing standards of NYSE require that, subject to specified exceptions, each member of a listed companys audit, compensation and nominating and corporate governance committees be independent, following a phase-in period. In addition, the listing standards of NYSE require that audit committee members satisfy independence criteria set forth in Rule 10A-3 under the Exchange Act and that compensation committee members satisfy independence criteria set forth in the NYSE Listed Company Manual. Nevertheless, the listing standards further provide that a director will only qualify as an independent director if, in the opinion of that companys board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.
186
The Board has affirmatively determined that each of Charles Collis, Cathy Iberg, Daniel Brand, Daniel Kilpatrick, Dana LaForge and Helena Morrissey meet the definition of independent director under the applicable rules of the NYSE Listed Company Manual. In making this determination, the Board considered the relationships that each such non-employee director has with FIHL and all other facts and circumstances that the Board deemed relevant in determining such directors independence, including beneficial ownership of Common Shares. As a result, in accordance with listing standards of NYSE, a majority of our directors are independent.
Family Relationships
There is no family relationship between any director or executive officer and any other director or executive officer or any person nominated to become a director or executive officer.
Board Composition
FIHLs business and affairs are managed under the direction of the Board.
Upon the listing of our Common Shares on NYSE, the Amended and Restated Bye-Laws provide that the Board will be divided into three classes, designated Class I, Class II and Class III, as nearly equal in number as possible, with the directors in each class serving staggered three-year terms, and one class being elected each year. Our current directors will be divided among the three classes as follows:
| the Class I Directors will be Charles Collis, Cathy Iberg and Hinal Patel, and their initial terms will expire at the first annual general meeting to be held after the consummation of this offering; |
| the Class II Directors will be Allan Decleir, Daniel Brand and Daniel Kilpatrick, and their initial terms will expire at the second annual general meeting to be held after the consummation of this offering; and |
| the Class III Directors will be Daniel Burrows, Dana LaForge and Helena Morrissey, and their initial terms will expire at the third annual general meeting to be held after the consummation of this offering. |
The classified board will be in place until the annual general meeting occurring in 2030, following which, all of the directors shall be of one class and shall serve for a term ending at the next following annual general meeting.
See Description of Share CapitalCertain Provisions of the Amended and Restated Bye-LawsClassified Board.
When considering whether directors and nominees have the experience, qualifications, attributes or skills, taken as a whole, to enable the Board to satisfy its oversight responsibilities effectively in light of our business and structure, the Board focused primarily on each persons background and experience as reflected in the information discussed in each of the directors individual biographies set forth in Biographical Information above. We believe that our directors provide an appropriate mix of experience and skills relevant to the size and nature of our business.
Role of the Board in Risk Oversight
The Board is responsible for overseeing our risk management process. The Board focuses on our general risk management strategy and the most significant risks facing us, as well as oversees the implementation of risk mitigation strategies by management. Our Chief Executive Officer and other executive officers regularly report to our non-executive directors and the audit committee to ensure effective and efficient oversight of our activities and to assist in proper risk management and the ongoing evaluation of management controls.
Foreign Private Issuer Exemption
As a foreign private issuer, as defined by the SEC, FIHL is permitted to follow, and does follow, home country corporate governance practices instead of certain corporate governance practices required for U.S. domestic issuers, provided that FIHL discloses which requirements it is not following and the equivalent requirement in Bermuda (i.e., its home country). FIHL intends to maintain compliance as a foreign private issuer
187
under the applicable corporate governance requirements of the Sarbanes- Oxley Act of 2002, the rules adopted by the SEC, and the NYSE corporate governance rules and listing standards.
FIHL relies on the foreign private issuer exemption to certain of NYSEs corporate governance standards with respect to matters related to its independent director oversight of executive compensation, proxy solicitation, quorum and shareholder approval. FIHL may decide to rely upon the foreign private issuer exemption for purposes of opting out of some or all of the corporate governance rules applicable from time to time to U.S. domestic companies.
Because FIHL is a foreign private issuer, its directors and senior management will not be subject to short-swing profit and insider trading reporting obligations under Section 16 of the Exchange Act. All shareholders, however, will be subject to the obligations to report changes in share ownership under Section 13 of the Exchange Act and related SEC rules.
Committees of the Board
The Board has an audit committee, compensation committee, investment committee, risk committee, and nominating and corporate governance committee. The Board may have such other committees as it shall determine from time to time. Each of the standing committees of the Board has the composition and responsibilities described below. Upon the listing of the Common Shares, copies of each committees charter will be posted on our website, www.fidelisinsurance.com/investors. The reference to our website address does not constitute incorporation by reference of the information contained at or available through our website, and you should not consider it to be a part of this prospectus.
Audit Committee
The Board has established an audit committee, which consists of Dana LaForge, Helena Morrissey and Cathy Iberg. Dana LaForge will serve as the chairperson of our audit committee. The Board has determined that each of Dana LaForge, Helena Morrissey and Cathy Iberg satisfy the criteria for independence under Rule 10A-3 under the Exchange Act and the applicable listing standards established by NYSE. Pursuant to its written charter, our audit committee is responsible for, among other things, preparing the audit committee report and assisting the Board in the oversight of: (i) the audits and integrity of our financial statements; (ii) the effectiveness of our internal control over financial reporting; (iii) our independent auditors qualifications, performance and independence; (iv) the performance of our internal audit function and related compliance; (v) the performance of our compliance function; (vi) the evaluation of related party transactions; (vii) pre-approving audit and non-audit services and fees; and (viii) establishment and maintenance procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls, auditing matters, or federal and state rules and regulations, and the confidential, anonymous submission by our employees of concerns regarding questionable accounting or auditing matters. Our internal audit team reports functionally and administratively to our Chief Financial Officer and directly to the audit committee.
The Board has determined that Dana LaForge qualifies as an audit committee financial expert in accordance with the NYSE listing rules.
Compensation Committee
The Board has established a compensation committee, which consists of Helena Morrissey, Daniel Brand, Daniel Kilpatrick, Dana LaForge and Charles Collis. Helena Morrissey will serve as the chairperson of our compensation committee. The Board has determined that each of Helena Morrissey, Daniel Brand, Daniel Kilpatrick, Dana LaForge and Charles Collis satisfy the criteria for independence under the applicable listing standards established by NYSE. Pursuant to its written charter, our compensation committee, among other things,
188
assists the Board with its responsibility with respect to the oversight of: (i) setting the compensation of our principal executive officers; (ii) reviewing and making recommendations to the Board regarding compensation of our directors, including equity-based and certain incentive compensation plans; (iii) preparing the compensation committee report; (iv) appointing and overseeing any compensation consultants; and (v) performing such other duties and responsibilities as may be consistent with the provisions of its charter.
Nominating and Corporate Governance Committee
The Board has established a nominating and corporate governance committee, which consists of Helena Morrissey, Daniel Brand, Daniel Kilpatrick and Charles Collis. Helena Morrissey will serve as the chairperson of our nominating and corporate governance committee. The Board has determined that each of Helena Morrissey, Daniel Brand, Daniel Kilpatrick and Charles Collis satisfy the criteria for independence under the applicable listing standards established by NYSE. Pursuant to its written charter, the nominating and corporate governance committee will be responsible for, among other things: (i) identifying individuals qualified to become members of the Board and recommending candidates for election to the Board; (ii) reviewing the composition of the Board and its committees; (iii) developing and recommending to the Board corporate governance guidelines that are applicable to us; and (iv) leading the Board in its annual review of performance.
Investment Committee
The Board has established an investment committee, which consists of Daniel Brand, Dana LaForge, Cathy Iberg, Hinal Patel, Daniel Burrows and Allan Decleir. Cathy Iberg will serve as the chairperson of our investment committee. Pursuant to its written charter, the investment committee will be responsible for, among other things: (i) recommending investment strategy, investment risk appetite and investment risk limits to the FIHL Board; (ii) reviewing and approving new material changes to the investment policy or investment managers; (iii) overseeing investment policies, guidelines and benchmarks; (iv) delegation of investment related authorities and responsibilities to sub-committees and management; and (v) monitoring investment risk, compliance, portfolio composition, investment performance and activity.
Risk Committee
The Board has established a risk committee, which consists of Daniel Kilpatrick, Hinal Patel, Daniel Burrows and Allan Decleir. Daniel Kilpatrick will serve as the chairperson of our risk committee. Pursuant to its written charter, the risk committee will be responsible for, among other things: (i) evaluating FIHLs risk appetite and tolerances; (ii) overseeing risk management and related policies and guidelines; (iii) establishing risk policies and guidelines; and (iv) overseeing the Boards responsibilities related to risk management exposure.
Compensation Committee Interlocks and Insider Participation
None of our executive officers currently serves, or in the past fiscal year has served, as a member of the board or compensation committee of another entity that has one or more executive officers serving on the Board or our compensation committee.
Code of Business Conduct and Ethics
The Board has adopted a code of business conduct and ethics applicable to our employees, directors and officers, including our Chief Executive Officer, Chief Financial Officer and other executive and senior officers, in accordance with applicable U.S. federal securities laws and the corporate governance rules of NYSE. This code will be a code of ethics, as defined in Item 406(b) of Regulation S-K under the Securities Act. Upon consummation of this offering, our code of ethics will be available on our website, www.fidelisinsurance.com/investors/. We will make any legally required disclosures regarding amendments to, or waivers of, provisions of
189
our code of ethics on our website. The reference to our website address does not constitute incorporation by reference of the information contained at or available through our website, and you should not consider it to be a part of this prospectus.
190
The following disclosure describes the material elements of the compensation framework for Current Fidelis and the general principles to be followed by Current Fidelis in the administration of its compensation framework, including a long-term incentive plan, and is presented based on the scaled disclosure rules applicable to foreign private issuers under the rules of the SEC. The discussion in this section contains forward-looking statements that are based on current considerations and expectations relating to executive compensation programs and philosophy. As business needs evolve, the compensation programs that we adopt may differ materially from current or planned programs as summarized in this section.
Summary of Compensation
Non-Executive Directors
The non-executive directors of Previous Fidelis, who received compensation from Previous Fidelis, received an annual cash fee for their services as director of $200,000. In the case of directors appointed by shareholders who enjoyed director appointment rights (including the Founders), all compensation is paid directly to such relevant shareholder. Fees related to Mr. Colliss service as a director were paid to the account of Conyers Dill & Pearman Limited, of which Mr. Collis is a partner. The aggregate compensation paid to the non-executive directors of Previous Fidelis in the year ended December 31, 2022 was $1.3 million, in addition to reimbursements for all reasonable and properly documented expenses.
Senior Management
The aggregate compensation, consisting of salaries, annual cash bonuses and equity awards, paid by Previous Fidelis to its executive officers in the year ended December 31, 2022, was $12.9 million. The total amounts set aside or accrued to provide pension, retirement or similar benefits by Previous Fidelis to its executive officers in the year ended December 31, 2022 was $0.5 million. For any executive officer who was also a director of Previous Fidelis in the year ended December 31, 2022, no additional compensation was paid for their service as director.
Legacy Share Compensation
The Board previously approved the following legacy plans: (i) the 2015 Non-Qualified Share Option Plan on February 17, 2016, pursuant to which up to 2% of the diluted Common Share capital of FIHL was reserved for awards thereunder, and (ii) the 2018 Non-Qualified Share Option Plan on November 8, 2018, pursuant to which up to 3% of the diluted Common Share capital of FIHL was reserved for awards thereunder. Under the 2015 Non-Qualified Share Option Plan and the 2018 Non-Qualified Share Option Plan, respectively, FIHL granted options to purchase Common Shares with a nil cost exercise price of $0.01 per Common Share, which were exercisable on a cashless basis and with a 10-year expiration date from the date of issuance. For tax purposes, any such awards granted to U.S. taxpayers were automatically and immediately exercisable upon vesting. Although awards granted under the 2015 Non-Qualified Share Option Plan and the 2018 Non-Qualified Share Option Plan, respectively, were granted as options to purchase Common Shares with a nil cost exercise price, such awards are referred to as RSUs for purposes of this disclosure as they were economically similar to RSUs.
The RSUs granted under the 2015 Non-Qualified Share Option Plan and the 2018 Non-Qualified Share Option Plan, respectively, vested subject to both service and performance conditions. The RSUs subject to service-vesting cliff vest after a three-year period and the remaining portion of RSUs were subject to the satisfaction of certain performance conditions over a three-year performance period based on achievement of pre-established targets for absolute return on equity of Previous Fidelis as well as a relative performance metric compared to certain peer companies.
191
In connection with the Separation Transactions, the compensation committee of the Board exercised its discretion to accelerate the vesting at target of all the outstanding RSUs subject to 2021 and 2022 performance conditions and all outstanding RSUs subject to service conditions, in each case, immediately prior to and conditional upon the consummation of the Separation Transactions. Accordingly, all such vested RSUs were exercised on a cashless basis immediately prior to the consummation of the Separation Transactions.
Post-Offering Compensation Program Overview
Non-Executive Directors
A compensation program will be adopted for the non-executive directors of FIHL upon or following the consummation of this offering to ensure strategic alignment with its shareholders. This is expected to be achieved by progressively moving the mix of compensation between cash fees and equity grants to a position commensurate with our peers and the market more broadly through a market review. In addition to an annual retainer, non-executive directors will also be reimbursed for reasonable and properly documented expenses incurred in relation to the performance of their duties as directors, including travel expenses incurred in connection with their attendance at Board and committee meetings. We also expect to adopt share ownership guidelines for our non-executive directors (other than any non-executive director who is on the Board as a result of the shareholdings of any institution to which they are affiliated and who do not personally receive equity interests as compensation for their service on the Board).
We expect that in the case of directors appointed by the Founders and MGU HoldCo, all compensation will be paid directly to the relevant Founder or MGU HoldCo. The director fees related to service by Mr. Collis will be paid for the account of Conyers Dill & Pearman Limited, of which Mr. Collis is a partner.
Directors who are also executive officers of FIHL upon the consummation of the Separation Transactions and this offering will not receive additional compensation for their service as directors.
Senior Management
We adopted a compensation program for the executive officers of FIHL in anticipation of this offering. Our policies with respect to the compensation of our executive officers will be administered by the compensation committee under delegation from the Board. See Committees of the BoardCompensation Committee. The compensation policies that we plan to follow are intended to provide for compensation that is sufficient to attract, motivate and retain executives of outstanding caliber while also striking an appropriate balance between competitive executive compensation and long-term shareholder value creation.
To help establish compensation levels and to advise on annual and long-term incentive plan design, the existing compensation committee of FIHL has retained the services of Korn Ferry as its independent compensation consultant to adapt the compensation framework for Current Fidelis as described herein.
Philosophy
When establishing and reviewing our compensation philosophy and programs, we design our program to promote strong financial performance both annually and on a Long-Term basis through a combination of base salaries, annual cash bonus awards, and awards granted pursuant to the Long-Term Incentive Plan (the LTIP Awards). We consider whether such programs align the interests of our directors and officers with those of our shareholders and whether such programs encourage unnecessary or excessive risk taking. Base salaries will be fixed in amount and, consequently, we do not see them as encouraging risk taking. Executive officers of FIHL will also be eligible to receive a portion of their total compensation in the form of annual cash bonus awards. While the annual cash bonus awards focus on achievement of annual goals and could encourage the taking of short-term risks at the expense of long-term results, our annual cash bonus awards represent only a portion of each eligible executive officers total compensation, and are tied to both corporate performance measures and the
192
executive officers individual performance, and are at the discretion of the compensation committee. We believe that the annual cash bonus awards will appropriately align the interests of our executive officers with our interests and those of our shareholders, and will encourage eligible executive officers to focus on specific goals important to our success while not encouraging unnecessary or excessive risk-taking.
In the normal course of business, the Chief Executive Officer of FIHL will be tasked with proposing the base salary, the annual cash bonus and the LTIP Awards subject to the Long-Term Incentive Plan for the executive officers, excluding himself. Once proposed, the compensation committee will discuss such proposal and arrive at a conclusion. The compensation committee will also make the decision regarding the Chief Executive Officers compensation, but will ensure that full and proper dialogue with the Chief Executive Officer has taken place before arriving at its conclusion. The compensation committee will also determine the maximum amount of cash bonuses and LTIP Awards that can be paid in any year. All decisions of the compensation committee will be final and binding.
Compensation Components
The following section provides a discussion of the components of the compensation program for Current Fidelis to be administered by the compensation committee under delegation from the Board. See Management and Corporate GovernanceCommittees of the BoardCompensation Committee.
The primary elements of the total compensation package anticipated for our executive officers upon consummation of the Separation Transactions and this offering include base salary, annual cash bonus awards, and LTIP Awards.
Base Salary
We anticipate setting base salary and fixed pay for our executive officers in line with the market median of our major competitors to fairly and competitively compensate executives for their positions and the scope of their responsibilities.
Annual Cash Bonus
The purpose of our annual cash bonus program is to reward executive officers and employees for achievement against key financial and non-financial operational goals that will help drive long-term business strategy and are predicates of shareholder value. The compensation committee will approve the annual bonus payments for the Chief Executive Officer and based upon input from the Chief Executive Officer, for each of the eligible executive officers.
Bonuses will be based on a formulaic calculation, though are entirely discretionary, so that executive officers can be confident that an even-handed approach will be taken, and executive officers will be able to readily understand the effect of financial and personal performance on their bonuses. Two core elements will be assessed by the compensation committee when determining the bonuses: (i) Current Fidelis financial performance (Financial Performance) and (ii) the executive officers and employees strategic and personal performance (Personal Performance). The weighting of each element will be based on pre-determined percentage allocations. For purposes of the annual cash bonus pool calculation, Financial Performance will be based on achievement by Current Fidelis of the business plan then in force (e.g., achieving predetermined RoE targets). Personal Performance will be based upon individual achievement of clearly articulated objectives created and agreed to at the beginning of each financial year. The annual cash bonus is designed to operate in such a way that the Personal Performance element of the bonus will be funded if the predetermined threshold RoE target is met for the Financial Performance element of the annual cash bonus.
The Chief Executive Officer will agree to key goals for each of the eligible executive officers, including himself, which should include specific objectives relating to each executive officers division in respect of the
193
business plan then in force. An overall performance rating will be determined based on achievement of these key objectives and based on the relevant executive officers demonstrated commitment to the Groups culture, and their effectiveness as a manager and leader.
The annual cash bonuses will be proposed by the Chief Executive Officer and approved by the compensation committee towards the beginning of each year when the information necessary to compute the bonuses has been obtained. Once approved, the bonuses will be paid within the first quarter of each year following the relevant fiscal year. In order to receive an annual cash bonus, an executive officer must be employed and not under notice on the day of payment, unless such executive officer has officially retired or been made redundant after the end of the fiscal year but before the payment date for the bonuses. Executive officers who are deemed to be partially meeting requirements or less will not be eligible for any annual cash bonus payment regardless of Current Fidelis financial performance. If the Financial Performance is below the minimum payout level then payment of all annual cash bonuses to any executive officer will be discretionary.
Long-Term Incentive Plan
Based on the unanimous recommendation of the compensation committee, the Long-Term Incentive Plan, was approved by the Board and approved by our shareholders. The number of Common Shares available for LTIP Awards under the Long-Term Incentive Plan is equal to (i) 4,615,500 Common Shares (i.e., 4% of the Common Shares expected to be outstanding prior to the consummation of this offering), plus (ii) an additional number of Common Shares equal to 4%, on a fully diluted basis, of the Common Shares sold by us from this offering). Unless sooner terminated, the Long-Term Incentive Plan will terminate on the day before the 10th anniversary of the date our shareholders approved the Long-Term Incentive Plan. Each current and prospective employee, officer, non-executive director or other individual service provider of Current Fidelis or its affiliates is eligible to participate in the Long-Term Incentive Plan; provided, that any prospective employee may not receive any payment or exercise any right relating to an award thereunder until such person has commenced employment or service with Current Fidelis or its affiliates. The Long-Term Incentive Plan will be administered by the Board, the compensation committee or such other individual or committee of individuals designated to exercise authority under the Long-Term Incentive Plan.
Our Long-Term Incentive Plan seeks to create a strong and long-term alignment between our management team and our shareholders. The size of the LTIP Awards will be determined based upon an individuals prior year performance and will also be based on the individuals role and seniority. LTIP Awards will be determined by the compensation committee and may be delivered in the form of any of: restricted share units, restricted Common Shares, share options, share appreciation rights and other awards which may be denominated in Common Shares or cash. LTIP Awards are anticipated to be split between time- and performance-vesting, dependent on the level of seniority, with the highest proportion of performance-based awards to be awarded to the Chief Executive Officer and the most senior executive officers. All LTIP Awards will be governed by the Long-Term Incentive Plan.
The LTIP Awards relate to our Common Shares and are generally expected to vest over a three-year period. There will be time-based LTIP Awards that are subject to time-based vesting and performance-based LTIP Awards that are subject to performance-based vesting. The initial time-based vesting LTIP Awards vest three years from the effective date of the Separation Transactions, and the initial performance-based vesting LTIP Awards are expected to vest based on Current Fidelis average operating RoE over three years and will have the potential to vest up to a maximum above the target for exceptional performance. In the event of a good leaver termination (i.e., a termination by the Company without cause or as a result of the participants death or disability), and subject to the participants execution, delivery and non-revocation of a general release of claims in a form satisfactory to us, the LTIP Awards will vest pro-rata with respect to time-based vesting LTIP Awards and based on actual performance measured through the fiscal quarter ending immediately prior to such termination with respect to performance-based vesting LTIP Awards.
194
In the event of a change in control (as defined in the Long-Term Incentive Plan), and provided that the LTIP Awards are expressly assumed, substituted or replaced in connection with such change in control, (i) the time-based vesting LTIP Awards will continue to vest in accordance with its terms, provided that the vesting of such LTIP Awards will immediately accelerate on the earliest to occur of (x) a good leaver termination (which in the change in control context, for our executive leadership team, also includes a resignation for good reason), subject to the participants execution, delivery and non-revocation of a general release of claims in a form satisfactory to us, (y) the first anniversary of the change in control, and (z) the date on which such LTIP Awards would have otherwise vested in accordance with their terms; and (ii) the level of attainment with respect to the performance-based vesting LTIP Awards will be measured at the time of a change in control as the greater of actual performance measured through the fiscal quarter ending immediately prior to such change in control and target performance, with the LTIP Awards, based on such level of attainment, vesting on the earliest to occur of (x) a good leaver termination (which in the change in control context, for our executive leadership team, includes a resignation for good reason), subject to the participants execution, delivery and non-revocation of a general release of claims in a form satisfactory to us, (y) the first anniversary of the change in control, and (z) the last day of the original performance period. In the event that the LTIP Awards are not expressly assumed, substituted or replaced in connection with a change in control, our Board or compensation committee will have the discretion, subject to the terms of the Long-Term Incentive Plan, to determine the treatment of such LTIP Awards in connection with the change in control.
Since May 15, 2023, we have granted LTIP Awards in accordance with the terms described above, covering an aggregate of 471,883 Common Shares, including 332,251 Common Shares with respect to members of our executive leadership team that are subject to both time- and performance-based vesting criteria.
In contemplation of this offering and the retention program described under Retention Program below, equity eligible employees received a one-time grant of retention LTIP Awards with a value equal to one times annual base salary (the Retention RSUs). The Retention RSUs approved by our compensation committee cover an aggregate of 489,012 Common Shares, including 206,478 Common Shares with respect to members of our executive leadership team. The Retention RSUs will vest on the first anniversary of the vesting start date, without limiting any other applicable transfer restrictions, and will be subject to transfer restrictions through the 18 month anniversary of the vesting start date. The Retention RSUs will be subject to similar accelerated vesting provisions as apply to the time-based vesting LTIP Awards described above.
Our compensation philosophy is that total compensation including base salary, annual cash bonus awards and LTIP Awards, should have the potential to deliver above-market levels of reward for outstanding performance.
Share Ownership Guidelines
We expect to adopt share ownership guidelines that will be effective on the consummation of the offering with a minimum ownership requirement equal to (i) 6x annual base salary for our Chief Executive Officer, (ii) 3x annual base salary for members of our executive leadership team other than our Chief Executive Officer, and (iii) 1x annual base salary for other senior leaders. Compliance with the guidelines will be measured annually and individuals subject to the guidelines will have five years to achieve his or her minimum ownership requirement after first becoming subject to the guidelines and one year to achieve any heightened minimum ownership requirements that result from an increase in annual base salary. Our compensation committee may consider, in its discretion, whether any actions should be taken in the event that an individual does not achieve (or fails to maintain) his or her minimum ownership requirement, including the payment of a portion of such individuals base salary or bonus in Common Shares.
Retention Program
In connection with the Separation Transactions and this offering, our compensation committee approved a retention program pursuant to which equity eligible employees received the Retention RSUs described
195
under Long-Term Incentive Plan above, and all other employees of Current Fidelis received cash retention awards equal to one times annual base salary, which retention awards are payable 50% in April 2024 and 50% in September 2024, subject to continued employment through the applicable payment date.
We have entered into employment agreements with each of our executive officers. The employment agreements set forth each executive officers initial base salary and eligibility for the annual cash bonus and may include, among other terms and conditions, certain customary severance and change of control arrangements, including as described under Severance below.
The employment agreements also contain limitations on outside activities, confidentiality obligations, and covenants restricting the solicitation of employees and customers, as well as certain non-compete restrictions following termination of employment.
Severance
Based on the recommendation of our compensation committee, the Board has approved amendments to the existing employment agreements with certain members of our executive leadership team to provide for market-competitive severance protections, which severance would be subject to the employees execution, delivery and non-revocation of a general release of claims in a form satisfactory to us, and would be in addition to any mandatory notice and/or severance required by the laws of the relevant jurisdiction.
In the event of a termination of employment by us without cause or by the employee for good reason, not in connection with or within 12 months following a change in control, or due to the employees death or disability, members of our executive leadership team would be entitled to the following severance protections:
| one month of severance for each month of completed service with us, up to a maximum of 12 months of severance, in the form of salary continuation in accordance with normal payroll practices; and |
| a pro-rated bonus for the year in which such termination occurs, based on actual performance and paid at the same time as bonuses are paid to similarly situated employees. |
In the event of a termination of employment by us without cause, or by the employee for good reason, in connection with or within 12 months following a change in control members of our executive leadership team would be entitled to the following severance protections:
| one month of base salary for each month of completed service with us, up to a maximum of 24 months of base salary, in the form of salary continuation in accordance with normal payroll practices; and |
| a lump sum payment equal to one times target bonus for the year in which such termination occurs, paid at the same time as bonuses are paid to similarly situated employees. |
The treatment of LTIP Awards in connection with a termination of employment will be as specified in the individual LTIP Award agreements and as described under Long-Term Incentive Plan above.
Retirement Plans
We offer eligible staff the choice of making contributions into the relevant retirement plans, subject to applicable pension rules. To the extent permitted by the applicable rules in the relevant jurisdiction in which Current Fidelis has participating employees, eligible participants are able to contribute a percentage of their salary and such contributions will be capable of being matched by the relevant operating subsidiary of Current Fidelis, subject to the limitations of the laws of the relevant jurisdiction.
196
PRINCIPAL AND SELLING SHAREHOLDERS
The following table sets forth certain information regarding the beneficial ownership of Common Shares at June 16, 2023 by (i) each person who is known by us to beneficially own more than 5.0% of the Common Shares or is expected by us to beneficially own more than 5.0% of the Common Shares after this offering; (ii) each of our directors; (iii) all of our directors and executive officers as a group; and (iv) the Selling Shareholders (as defined below).
Beneficial ownership for the purposes of the following table is determined in accordance with the rules and regulations of the SEC. These rules generally provide that a person is the beneficial owner of securities if such person has or shares the power to vote or direct the voting of such securities, or to dispose or direct the disposition of such securities, or has the right to acquire such securities or such powers within 60 days.
To our knowledge, except as disclosed in the footnotes to the following table and subject to applicable community property laws, we believe that each beneficial owner identified in the table possesses sole voting and investment power over all Common Shares shown as beneficially owned by such beneficial owner.
For purposes of the table below, the percentage ownership calculations for beneficial ownership are based on 110,771,897 Common Shares outstanding at June 16, 2023. Such beneficial ownership information is presented on the following basis:
| prior to the consummation of this offering; and |
| following the consummation of this offering. |
The information in the table and the footnotes below with respect to each Selling Shareholder has been obtained from that Selling Shareholder. When we refer to the Selling Shareholders in this prospectus, we mean the individuals and entities listed in the table below as offering Common Shares as well as the pledgees, donees, assignees, transferees, successors and others who may hold any of the Selling Shareholders interest.
Unless otherwise indicated in the table or footnotes below, the address for each beneficial owner listed under Certain Executive Officers and Directors is Waterloo House, 100 Pitts Bay Road, Pembroke HM08, Bermuda.
Shares Prior to this Offering |
Shares After this Offering |
Shares After this Offering Including Full Option Exercise |
||||||||||||||||||||||
Number | % | Number | % | Number | % | |||||||||||||||||||
Names of Beneficial Owners 5.0% Shareholders |
||||||||||||||||||||||||
Crestview Funds(1) |
18,526,877 | 16.725 | 16,354,445 | 14.040 | 15,863,584 | 13.618 | ||||||||||||||||||
CVC Falcon Holdings Limited(2) |
20,151,401 | 18.192 | 17,788,476 | 15.271 | 17,254,575 | 14.813 | ||||||||||||||||||
Entities affiliated with Goldman Sachs(3) |
16,548,374 | 14.939 | 14,607,937 | 12.540 | 14,169,497 | 12.164 | ||||||||||||||||||
Pine Brook Feal Intermediate L.P.(4) |
9,205,855 | 8.311 | 8,126,391 | 6.976 | 7,882,486 | 6.767 | ||||||||||||||||||
Platinum Ivy B 2018 RSC Limited(5) |
15,102,014 | 13.633 | 13,331,175 | 11.444 | 12,931,055 | 11.101 | ||||||||||||||||||
SPFM Holdings, LLC(6) |
9,196,193 | 8.302 | 8,117,862 | 6.969 | 7,874,213 | 6.760 | ||||||||||||||||||
MGU HoldCo(7) |
10,966,425 | 9.900 | 10,966,425 | 9.414 | 10,966,425 | 9.414 | ||||||||||||||||||
Certain Executive Officers and Directors |
||||||||||||||||||||||||
Daniel Burrows |
192,289 | * | 192,289 | * | 192,289 | * | ||||||||||||||||||
Hinal Patel |
225,089 | * | 225,089 | * | 225,089 | * | ||||||||||||||||||
Directors and executive officers as a group (11 individuals)(8) |
2,413,726 | 2.179 | 2,413,726 | 2.072 | 2,413,726 | 2.072 |
197
Shares Prior to this Offering |
Shares After this Offering |
Shares After this Offering Including Full Option Exercise |
||||||||||||||||||||||
Number | % | Number | % | Number | % | |||||||||||||||||||
Other Selling Shareholders |
||||||||||||||||||||||||
Alfa Entities(9) |
1,795,133 | 1.621 | 1,584,638 | 1.360 | 1,537,078 | 1.320 | ||||||||||||||||||
Capital Z(10) |
4,384,683 | 3.958 | 3,870,542 | 3.323 | 3,754,372 | 3.223 | ||||||||||||||||||
UDI Partners LLC Series A1(11) |
461,545 | * | 461,545 | * | 461,545 | * | ||||||||||||||||||
Paxton Holdings LLC(12) |
220,618 | * | 194,749 | * | 188,904 | * | ||||||||||||||||||
The Fidelis Foundation |
66,245 | * | 66,245 | * | 66,245 | * | ||||||||||||||||||
Brindle, Richard |
1,894,437 | 1.710 | 1,894,437 | 1.626 | 1,894,437 | 1.626 | ||||||||||||||||||
Coulson, Richard |
191,452 | * | 191,452 | * | 191,452 | * | ||||||||||||||||||
Holden, Richard |
311,731 | * | 275,178 | * | 266,919 | * | ||||||||||||||||||
Mathias, Charles |
101,911 | * | 101,911 | * | 101,911 | * | ||||||||||||||||||
Vandoninck, Philip |
350,863 | * | 309,721 | * | 300,425 | * | ||||||||||||||||||
Other Selling Shareholders(13) |
452,758 | * | 399,672 | * | 387,678 | * |
(*) | Less than 1%. |
(1) | Represents 12,515,680 Common Shares held by Crestview FIHL Holdings, L.P. and Crestview FIHL TE Holdings, Ltd. (together, Crestview Fund III) and 6,011,199 Common Shares held by Crestview IV FIHL Holdings, L.P. and Crestview IV FIHL TE Holdings, LLC (together, Crestview Fund IV and, together with Crestview Fund III, the Crestview Funds). Crestview Fund III is owned by investment funds, the general partner of which is Crestview Partners III GP, L.P. (Crestview III GP), each of which may be deemed beneficial owners of the shares held by Crestview Fund III. Crestview Fund IV is owned by investment funds, the general partner of which is Crestview Partners IV GP, L.P. (Crestview IV GP), each of which may be deemed beneficial owners of the shares held by Crestview Fund IV. Crestview III GP has voting and investment control over shares held by Crestview Fund III, and Crestview IV GP has voting and investment control over shares held by Crestview Fund IV. Decisions by each of Crestview III GP and Crestview IV GP to vote or dispose of such shares require the approval of a majority of members of its respective investment committee and the chairman of such investment committee, each of which is composed of the following individuals: Barry S. Volpert (chairman), Thomas S. Murphy, Jr., Robert V. Delaney, Jr., Brian P. Cassidy, Alexander M. Rose, Adam J. Klein and Daniel G. Kilpatrick. None of the foregoing persons has the power individually to vote or dispose of such shares. Each of the foregoing individuals disclaims beneficial ownership of all such shares. The address of each of the foregoing is c/o Crestview, 590 Madison Avenue, 42nd Floor, New York, NY 10022. |
(2) | CVC is wholly owned by CVC Capital Partners VI (A) L.P, CVC Capital Partners VI (B) L.P, CVC Capital Partners VI (C) L.P, CVC Capital Partners VI (D) S.L.P, CVC Capital Partners VI Associates L.P and CVC Capital Partners Investment Europe VI L.P (collectively, CVC Fund VI). CVC Capital Partners VI Limited is the sole general partner of each of the limited partnerships comprising CVC Fund VI. As a result, each of the foregoing entities may be deemed to share beneficial ownership of the securities held by CVC. The board of directors of CVC exercises voting and investment authority with respect to the Common Shares. CVC Capital Partners VI Limited is managed by a three member board of directors. Each of the foregoing individuals disclaims beneficial ownership of the securities beneficially owned by CVC. The registered address of CVC is at 1 Waverley Place, Union Street, St Helier, Jersey JE1 1SG. |
(3) | Consists of 10,927,076 Common Shares held by Fidelis Investors LP and 5,621,298 Common Shares held by Fidelis Investors Offshore LP (collectively, the Goldman Sachs Entities). FIHL Access Advisors, Ltd. is the general partner of the Goldman Sachs Entities. There are three directors of FIHL Access Advisors, Ltd. There are six members of the applicable investment committee of the Asset Management Division of Goldman Sachs (the GS Investment Committee), none of which are directors of FIHL Access Advisors, Ltd. The directors of FIHL Access Advisors, Ltd. and the GS Investment Committee share the power to invest, but do not hold the power to vote, the Common Shares held by the Goldman Sachs Entities. The mailing address of the Goldman Sachs Entities is c/o Intertrust Corporate Services (Cayman) Limited, One Nexus Way, Camana Bay, Grand Cayman KY1-9005, Cayman Islands. |
(4) | The general partner of Pine Brook Feal Intermediate, L.P. is PBRA (Cayman) Company. PBRA (Cayman) Company may be deemed to have voting or dispositive power over the shares owned by Pine Brook Feal Intermediate, L.P. PBRA (Cayman) Company disclaims beneficial ownership of such shares except to the extent of any indirect pecuniary interest therein. The registered address for Pine Brook Feal Intermediate, L.P. is PO Box 309, Ugland House, Grand Cayman, KY1-1104 Cayman Islands. |
(5) | Represents 15,102,014 Common Shares owned by Platinum Ivy B 2018 RSC Limited (Platinum Ivy), which is a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA). By reason of its ownership of Platinum Ivy and pursuant to the rules and regulations of the SEC, ADIA may be deemed to share investment and voting power over and, therefore, beneficial ownership of, the Common Shares held directly by Platinum Ivy. ADIA is an independent public investment institution owned by the Emirate of Abu Dhabi, founded in 1976, that manages a diversified global investment portfolio across more than two dozen asset classes and sub-categories, including quoted equities, fixed income, real estate, private equity, alternatives and infrastructure. The mailing address for ADIA is 211 Corniche Street, P.O. Box 3600, Abu Dhabi, United Arab Emirates. The mailing address of Platinum Ivy is Level 26, Al Khatem Tower, Abu Dhabi Global Market Square, Al Maryah Island, Abu Dhabi, United Arab Emirates. |
198
(6) | SPFM Holdings, LLC is a Delaware limited liability company, which is governed by a board of directors that has the authority to dispose of and vote the shares held by SPFM Holdings, LLC. The ultimate parent of SPFM Holdings, LLC is The Travelers Companies, Inc. The mailing address of SPFM Holdings, LLC is One Tower Square, Hartford, CT 06183. |
(7) | MGU HoldCo will not sell any of its Common Shares in this offering. |
(8) | Represents, in the case of Richard Brindle, Charles Mathias and Hinal Patel, as former directors and officers of FIHL as part of Previous Fidelis prior to the consummation of the Separation Transactions, 1,894,437 Common Shares held by Richard Brindle, 101,911 Common Shares held by Charles Mathias, 192,289 Common Shares held by Daniel Burrows, and 225,089 Common Shares held by Hinal Patel, respectively, who will not sell any of their respective Common Shares in this offering. |
(9) | Represents 1,795,133 Common Shares held by Alfa General Insurance Corp., Alfa Life Insurance Corp., Alfa Mutual Fire Insurance Co., Alfa Mutual General Insurance Co., Alfa Mutual Insurance Co., Trexis Insurance Corp. and Trexis ONE Insurance Corp. (collectively, the Alfa Entities). Investment and voting decisions with respect to the Common Shares held by the Alfa Entities are made by Alfas Chief Investment Officer. The Alfa Entities are a group within the meaning of Rule 13d-5 of the Exchange Act. The mailing address of the Alfa Entities is 2108 E. South Blvd, Montgomery, AL 36117. |
(10) | The general partner of Capital Z Partners (Fidelis) LP (Capital Z) is Capital Z Partners (Cayman) GP, LP. Its general partner is Capital Z Partners III GP, Ltd. The general partner has appointed Capital Z Partners Management, LLC as the investment manager (the Investment Manager) of Capital Z Partners (Fidelis), LP with effective control under the investment management agreement. Each member of the Investment Manager disclaims ownership of the Common Shares held by Capital Z Partners (Fidelis) LP, except to the extent that such member has a pecuniary interest therein through an investment in the general partner. The mailing address of Capital Z Partners (Fidelis) LP is 4851 Tamiami Trail N, Suite 200, Naples, FL 34103. |
(11) | UDI Partners LLC Series A1 is a Delaware limited liability company, which is governed by a board of managers that has the authority to invest and vote for the shares held by UDI Partners LLC Series A1. The mailing address of UDI Partners LLC Series A1 is 1 Rockefeller Plaza, 20th Floor, New York NY 10020. |
(12) | Paxton Holdings LLC is a Florida limited liability company, which is governed by a board of managers that has the authority to invest and vote for the shares held by Paxton Holdings LLC. The mailing address of Paxton Holdings LLC is 767 Fifth Avenue, 17th Floor, New York, NY 10153. |
(13) | Consists of Selling Shareholders not otherwise listed in this table who collectively beneficially own less than 1% of our Common Shares prior to this offering. |
199
MATERIAL CONTRACTS AND RELATED PARTY TRANSACTIONS
References to Previous Fidelis refer to FIHL and its consolidated subsidiaries prior to the consummation of the Separation Transactions and this offering. References to the Current Fidelis refer to FIHL and its consolidated subsidiaries following the consummation of the Separation Transaction. Unless otherwise indicated, or the context otherwise requires, references herein to Fidelis, Group, we, our, us, and other similar references refer (i) prior to the consummation of the Separation Transactions and this offering to Previous Fidelis and (ii) following the consummation of the Separation Transactions to Current Fidelis.
Cooperation Agreement
On July 23, 2022 FIHL, MGU HoldCo and certain third-party investors in MGU TopCo, including the Alfa Entities, SPFM Holdings, LLC and Capital Z and entities affiliated with Capital Z, and as Existing Shareholders Further Global Capital, Barings LLC, Oak Hill Advisors and Blackstone, entered into the Cooperation Agreement, which provides that the parties thereto will cooperate regarding certain matters related to this offering and the Separation Transactions which closed on January 3, 2023 including, for the avoidance of doubt, the Framework Agreement, the Delegated Underwriting Authority Agreements and the Inter-Group Services Agreement (each as defined below). See The Separation Transactions for a more detailed description of the steps taken to implement the Separation Transactions.
Framework Agreement
The Framework Agreement establishes the overarching parameters of the outsourced underwriting relationship between Current Fidelis and Fidelis MGU, which is more specifically governed on a jurisdictional basis by a series of delegated underwriting authority agreements (the Delegated Underwriting Authority Agreements). See Delegated Underwriting Authority Agreements. FIHL and MGU HoldCo also entered into the Inter-Group Services Agreement, which covers the outsourcing of certain non-underwriting services to be provided by Fidelis MGU to FIHL and FIHL (UK) Services, each of which became effective on January 3, 2023.
Joint Referral Forum
FIHL and MGU HoldCo have agreed to create and maintain a flexible forum that will be used by Current Fidelis and Fidelis MGU to discuss and resolve any issues arising under either the Framework Agreement or under any Delegated Underwriting Authority Agreement (the Joint Referral Forum). The individuals taking part in any such discussions will differ depending upon the nature of the issue and the parties involved.
FIHL and MGU HoldCo must notify the Joint Referral Forum (the JRF Notification) in writing as soon as reasonably practicable if it becomes aware of particular extraordinary events, such as material breach of the Delegated Underwriting Authority Agreement, any event (including actions taken by a regulatory authority) that could materially impact the ability of a subsidiary to perform its obligations under a Delegated Underwriting Authority Agreement, or any insolvency, fraud or a change of license, or voluntary run-off, among other events, of any operating subsidiary that may have an adverse impact on the corresponding Delegated Underwriting Authority Agreement (the Prior Consent Obligation).
Following a JRF Notification, the Joint Referral Forum will, for a period of 30 days (the JRF Deadline), use best endeavors to agree (as applicable): (a) whether it is reasonably practicable to continue a Delegated Underwriting Authority Agreement following an insolvency event;
(b) upon a course of conduct to remedy any material breaches, acts of fraud, or other occurrences that could impact upon a partys performance of the Delegated Underwriting Authority Agreement; or (c) whether FIHLs failure to adhere to its Prior Consent Obligation would materially impact the applicable Fidelis MGU if the applicable Delegated Underwriting Authority Agreement were to continue.
200
If the Joint Referral Forum fails to reach any such agreement by the JRF Deadline, one or more of the parties to the affected Delegated Underwriting Authority Agreements will have termination rights. See Termination.
Term
The Framework Agreement (and each Delegated Underwriting Authority Agreement) has a rolling initial term of 10 years. Years one to three will roll automatically (each year resetting for a new 10-year period). From year four onwards, the Framework Agreement will roll solely at the written election of FIHL, such election to be delivered at least 90 days prior to the commencement of the subsequent contract year, with each year resetting for a new 10-year period. Any decision by FIHL to elect not to roll the Framework Agreement at or after year four will mean that the remainder of the 10-year term then in effect will continue in place (i.e., the Framework Agreement will have a further nine years to run in the first year following the election by FIHL not to roll the Framework Agreement), subject to the termination rights described below.
Termination
The Framework Agreement (and each Delegated Underwriting Authority Agreement) is subject to termination upon the occurrence of certain events, including (i) by either party: (a) immediately after the JRF Deadline, as a result of a material act of fraud on the part of the other party; (b) immediately after the JRF Deadline, if the other party is subject to an insolvency event and the Joint Referral Forum fails to unanimously agree that it is reasonably practicable to continue the affected Delegated Underwriting Authority Agreement; or (c) with 10 business days notice after the JRF Deadline, if the Joint Referral Forum, using best endeavors, fails to agree upon a course of conduct to remedy any material breaches or non-material acts of fraud (and to mitigate the likelihood of future breaches or frauds occurring), or to mitigate the impact of any occurrence that could impact upon a partys performance of the Delegated Underwriting Authority Agreement; and (ii) by Fidelis MGU: (a) after the expiry of six months for a ratings downgrade to below A- by A.M. Best or S&P on the part of FIHL; or (b) within 10 business days notice after the JRF Deadline, if the Joint Referral Forum, using best endeavors, fails to reach an agreement upon a course of action in respect of FIHLs breach of the Prior Consent Obligation.
Group Annual Plan and Group Underwriting Strategy
The parties to the Framework Agreement will agree the following documents on an annual basis: (i) a Group Annual Plan, which will establish Current Fidelis underwriting parameters and risk tolerances in respect of its three-pillar underwriting strategy on a gross and net basis for each annual period; and (ii) a group-level underwriting strategy (the Group Underwriting Strategy), which will establish how Fidelis MGU and Current Fidelis will coordinate the manner in which insurance and reinsurance risks are underwritten pursuant to the Delegated Underwriting Authority Agreements in each annual period.
The parties to each Delegated Underwriting Authority Agreement will have due regard to the latest Group Annual Plan and the Group Underwriting Strategy when preparing their own Subsidiary Annual Plans in respect of each annual period.
Run-Off Services
Upon termination of the Framework Agreement or any Delegated Underwriting Authority Agreement, Fidelis MGU will remain obligated to provide run-off services in respect of live risks at the date of termination (the Run-Off Services), and Current Fidelis will continue to pay fees under the Framework Agreement in exchange for the performance by Fidelis MGU of any Run-Off Services. Following the Separation Transactions, such determination of live risks in run-off will be performed by Fidelis MGU with oversight from Current Fidelis, in accordance with current claims handling and risk management practices and policies which are
201
expected to be substantially retained. The provision of Run-Off Services will be subject to a 24-month review, whereby Current Fidelis will be permitted to give at least six (6) months prior written notice to Fidelis MGU of its intention to rely upon an alternative run-off services provider. No separate termination fee will be payable by the relevant insurance operating subsidiary of Current Fidelis if it elects not to roll the minimum term of the applicable Delegated Underwriting Authority Agreement into another year.
Fidelis MGU will be required to maintain an exit plan for transitioning the Run-Off Services to an alternative run-off services provider, substantially in the form provided for in the Framework Agreement (the Exit Plan). The Exit Plan will contain the following key features governing the provision of Run-Off Services:
| a process for orderly transfer, at Current Fidelis sole discretion, of the business subject to, and requiring the provision of, the Run-Off Services in whole or in part to an alternative provider(s) or to one or more insurance operating subsidiaries of Current Fidelis, subject always to the then-applicable regulatory requirements (the Run-Off Transfer); |
| certain rights, to be exercised at Current Fidelis sole discretion, aimed at ensuring the continuity of the provision of the Run-Off Services during the period required, including the right for any insurance operating subsidiary of Current Fidelis to hire staff from Fidelis MGU (in certain specific circumstances and subject to applicable employment laws) and a right of each insurance operating subsidiary of Current Fidelis to take steps to procure or provide funding to Fidelis MGU; |
| a number of rights and obligations aimed at facilitating (i) the provision of Run-Off Services and the implementation of the Exit Plan, such as obligations on each party to cooperate with the other party and any designated transferee service provider in the event of a Run-Off Transfer and (ii) the alteration of the scope of Run-Off Services, including allowing for an immediate cessation of a specified service (provided that, for the avoidance of doubt, the remainder of services not ceased shall remain in place); and |
| a process for a requisite periodic review and testing of the Exit Plan aimed at ensuring the continuity of the provision of the Run-Off Services subject always to the then-applicable regulatory requirements. |
Run-In Services
Fidelis MGU also performs certain run-in services in respect of business which continue to be live risks following the consummation of the Separation Transactions.
Delegation
The Framework Agreement and the Delegated Underwriting Authority Agreements provide for, on a jurisdictional basis, the delegation of underwriting authority from each of the relevant insurance operating subsidiaries of Current Fidelis to the relevant subsidiaries of Fidelis MGU. Fidelis MGU may not sub-delegate to any third party any of its responsibilities under a Delegate Underwriting Authority Agreement without the prior written consent of Current Fidelis. The Framework Agreement provides a closed initial list of pre-approved managing general underwriters, in respect of which Fidelis MGU will not require Current Fidelis consent prior to sub-delegating responsibilities to them. Otherwise, the relevant operating subsidiary of Fidelis MGU may not sub-delegate to a third party any of its responsibilities under the applicable Delegated Underwriting Authority Agreement without the prior written consent of the corresponding insurance operating subsidiary of Current Fidelis.
Fidelis MGU has full delegation and authority with respect to policy language and will be permitted to sub-delegate underwriting authority to a closed initial list of managing general underwriters.
Subsidiary Annual Plans
Each Subsidiary Annual Plan will be prepared by the parties to each relevant Delegated Underwriting Authority Agreement, who must consider the Group Underwriting Strategy and Group Annual Plan in finalizing
202
this document. Alternatively, FIHL and MGU HoldCo may negotiate any Subsidiary Annual Plan for and on behalf of their respective subsidiaries, provided that the governing bodies of the applicable subsidiaries ultimately approve such Subsidiary Annual Plan.
Each Subsidiary Annual Plan may be subjected to a mid-year review at any point during the year (the Mid-Year Change Procedure) by either party to the applicable Delegated Underwriting Authority Agreement. Initially, any material proposed amendments that are subject to the Mid-Year Change Procedure will be discussed by the Joint Referral Forum and, if accepted, will be formally agreed by the Joint Referral Forum for and on behalf of the relevant parties. If the amendments have not been agreed within the defined timeframe and resolution is not achieved by the Joint Referral Forum, such amendments may be referred to the Chief Executive Officers of the relevant subsidiaries for consideration within a defined timeframe. Following the expiry of such defined timeframe, the parties will consider whether to refer the matter to mediation or arbitration pursuant to the dispute resolution procedures set out below (see Dispute Resolution). Non-material changes to the Delegated Underwriting Authority Agreements can be agreed through the Joint Referral Forum.
During the first annual period, Fidelis MGU will be authorized to write aviation, energy, marine, specialty other, property, credit and political risk, bespoke, property reinsurance, property D&F, retrocession and whole account lines of business, as set out in the Delegated Underwriting Authority Agreements (the Permitted Lines), provided it remains within the risk appetite set by Current Fidelis and A.M. Bests Capital Adequacy Ratio (BCAR) and S&P scores for Current Fidelis. Current Fidelis risk appetite in respect of a specific Permitted Line will be determined by reference to certain pre-determined underwriting parameters that are determined based on various factors including: (i) the LOB premium limit set out in the Group Annual Plan and each Subsidiary Annual Plan; (ii) the aggregate underwriting limit set out in Group Annual Plan and each Subsidiary Annual Plan; (iii) the underwriting risk appetite as defined in the latest version of the applicable approved Risk, Capital & Solvency Appetite document for either Current Fidelis or the applicable operating subsidiary; (iv) FIHLs underwriting exposure management preferences, as defined in the approved Group Annual Plan, or any Subsidiary Annual Plan; and (v) the minimum economic capital headroom necessary to ensure that FIHL will be able to maintain its Minimum BCAR Score and Minimum S&P Surplus (the Underwriting Parameters). If Fidelis MGU wishes to write business in excess of the Underwriting Parameters in a given year, it will be required to submit such request for the corresponding operating subsidiarys consideration, with such approval being initially sought via the Joint Referral Forum.
Each Subsidiary Annual Plan shall be eligible for renewal for successive years in accordance with the same terms as the Subsidiary Annual Plan that the parties approved for the prior year, as adjusted for any changes arising from a Mid-Year Change Procedure relating to the relevant prior years Subsidiary Annual Plan. Unless required as a result of changes to the relevant statutory and regulatory regimes, any other amendments to the Subsidiary Annual Plans shall be subject to annual negotiation by the parties, with advance notice of material changes required to be delivered to the other party in a timely manner. If Fidelis MGU and Current Fidelis do not reach an agreement with respect to any Subsidiary Annual Plan or any portion of the Subsidiary Annual Plan in respect of any given year, such Subsidiary Annual Plan or portion of the Subsidiary Annual Plan from the previous year will be automatically renewed on the same terms as in the prior year. The Framework Agreement contains certain limitations in respect of the permissible amendments to the Subsidiary Annual Plans. For instance, Current Fidelis will be permitted to exit a particular Permitted Line if the specified metrics and underwriting ratios in the Subsidiary Annual Plans for each of the three previous years are triggered. However, if Current Fidelis reasonably considers that an underwriting ratio for any Permitted Line has materially deteriorated, Fidelis MGU must prepare a remediation plan that sets out how it will ensure that the Permitted Line will fall within the underwriting ratio in the subsequent year. Should a change to any Subsidiary Annual Plan be requested by either party and denied three years in a row, it will be referred to the non-calculations dispute resolution procedure to be resolved.
Under each Subsidiary Annual Plan, Current Fidelis will be responsible for ensuring that there is sufficient capital available throughout each annual period to meet such Subsidiary Annual Plan and all rating agency
203
requirements, and for retaining sufficient capital for both the current planned year and the forecasted subsequent year and for meeting all rating agency requirements for the target rating for those periods.
Each Fidelis MGU may, at the request of customers, move their business to third party capital providers if FIHL is placed on negative outlook to below A- by A.M. Best or S&P. Exclusivity provisions contained in the Framework Agreement are suspended for any period that the negative outlook subsists (or becomes a ratings downgrade to below A- by A.M. Best or S&P) after six months.
Fidelis MGU has delegated authority to place outwards reinsurance on Current Fidelis behalf within the parameters of the Subsidiary Annual Plans. Current Fidelis will retain decision-making authority for outwards reinsurance outside the scope of such parameters. The Subsidiary Annual Plans will also ensure that the outwards reinsurance purchased is in line with the Solvency II directive eligibility requirements for risk mitigation techniques. See BusinessReinsurance.
Exclusivity, Rights of First Offer and Rights of First Refusal
Under the terms of the Framework Agreement and the individual Delegated Underwriting Authority Agreements, subject to: (i) certain rights of first offer (ROFO) on the part of Fidelis MGU and rights of first refusal (ROFR) on the part of Current Fidelis; and (ii) any arrangements that Current Fidelis has with third party managing general underwriters that pre-date the Framework Agreement (and which will remain in force) involving the provision of capital that the third party managing general underwriters may use to underwrite business on Current Fidelis behalf, Current Fidelis shall secure its business exclusively from Fidelis MGU and Fidelis MGU shall provide underwriting and support services exclusively to Current Fidelis.
If either Current Fidelis or Fidelis MGU rejects the other partys proposal pursuant to the ROFO process or ROFR process, respectively, the relevant party will not have the right to later request the opportunity to underwrite or provide capacity for (as applicable) the rejected business, which will stay with the relevant third-party insurer or managing general underwriters (as applicable), for so long as such party elects to take it up.
To the extent any ROFO or ROFR process results in Fidelis MGU being allocated increased or differently distributed capacity, such increase will be deemed included in that years relevant Subsidiary Annual Plan and will be included in setting the following years relevant Subsidiary Annual Plan.
Fidelis MGU Additional Capital ROFO
In the event that Current Fidelis identifies capital or risk appetite in excess of the parameters set forth in the relevant Subsidiary Annual Plan (the Excess Risk Opportunity), Fidelis MGU shall have a ROFO to underwrite such Excess Risk Opportunity for and on behalf of Current Fidelis (the Fidelis MGU Capital ROFO).
In order to exercise such Fidelis MGU Capital ROFO, Fidelis MGU will be required to present a detailed business plan to Current Fidelis setting out Fidelis MGUs plan for the underwriting of such Excess Risk Opportunity (the Fidelis MGU ERO Plan). Such Fidelis MGU ERO Plan will be expected to include, without limitation, expected profitability and return on capital on the Excess Risk Opportunity, expected investor reaction and expected capital consumption of the Excess Risk Opportunity, Current Fidelis capital level stress scenarios and how an analysis of any conflicting risks or unfavorable covariance with Fidelis MGUs originated portfolio would be managed (the Minimum Plan Specifics).
Where Current Fidelis (acting reasonably) declines Fidelis MGU Capital ROFO and for all business so sourced from any third parties other than Fidelis MGU, Current Fidelis shall:
| present a detailed business plan to Fidelis MGU containing the Minimum Plan Specifics (the Group ERO Plan); |
204
| consult in good faith with Fidelis MGU to refine the proposed Group ERO Plan to reduce any negative interactions with other business sourced by Fidelis MGU; and |
| agree with Fidelis MGU the format and frequency of reporting that Current Fidelis would be required to provide to Fidelis MGU in respect of such Group ERO Plan. |
Group Additional Capital ROFR
If Fidelis MGU identifies an opportunity to underwrite business that falls outside of Current Fidelis capital or risk appetite parameters set forth in the Subsidiary Annual Plan in force at the relevant time (the Additional Business), Fidelis MGU is contractually required to give Current Fidelis a ROFR on such Additional Business (the Group Capital ROFR).
Specifically, following notice from Fidelis MGU of such opportunity to underwrite Additional Business, if Current Fidelis can accommodate such Additional Business within its available capital, Current Fidelis has seven business days to communicate its desire to accept the terms of the ROFR, and a further 20 calendar days from this date to make a firm commitment of interest (although this period may be extended if a non-objection (or similar) must be obtained from a regulatory authority), at which point such Additional Business will be deemed bound.
If Current Fidelis cannot accommodate such Additional Business within its available capital, it will be allowed a mutually agreed, reasonable amount of time to raise or free up the requisite amount of additional capital. If Current Fidelis does not elect to underwrite the Additional Business pursuant to the Group Capital ROFR, Fidelis MGU will be permitted to do so with a third-party insurer that is not part of Current Fidelis. To the extent that Fidelis MGU is writing such Additional Business with a third-party insurer where there is a risk of adverse selection to Current Fidelis or disclosure or misuse of competitively sensitive information regarding Current Fidelis, Fidelis MGU will demonstrate to the reasonable satisfaction of Current Fidelis that it has taken steps to mitigate against any risk of adverse selection and/or disclosure or misuse of competitively sensitive information.
Fidelis MGU Line of Business ROFO
In the event that Current Fidelis has appetite for a line of business beyond the Permitted Lines (the New LOB), Fidelis MGU shall have a ROFO to originate such New LOB (the Fidelis MGU Line of Business ROFO).
In order to exercise such Fidelis MGU Line of Business ROFO, Fidelis MGU will be required to present a detailed business plan to Current Fidelis setting out Fidelis MGUs plan for how the New LOB capital will be utilized (the Fidelis MGU New LOB Plan). Such Fidelis MGU New LOB Plan must include the Minimum Plan Specifics, as appropriate for such New LOB. Having reviewed the Fidelis MGU New LOB Plan, Current Fidelis will have the option (acting reasonably) to accept Fidelis MGUs proposal or to source an alternative third-party origination for such New LOB.
Where Current Fidelis declines the Fidelis MGU New LOB Plan and for all business so sourced from any third parties other than Fidelis MGU, Current Fidelis shall:
| present a detailed business plan to Fidelis MGU containing the Minimum Plan Specifics (the Group New LOB Plan); |
| consult in good faith with Fidelis MGU to refine the proposed Group New LOB Plan to reduce any negative interactions with other business sourced by Fidelis MGU; and |
| agree with Fidelis MGU the format and frequency of reporting that Current Fidelis would be required to provide to Fidelis MGU in respect of such Group New LOB Plan. |
205
Group Line of Business ROFR
In the event that Fidelis MGU identifies a potential demand for a New LOB, Current Fidelis shall have a ROFR to provide capacity for such new LOB (the Group Line of Business ROFR).
As with the Group Capital ROFO outlined above, following notice from Fidelis MGU of such opportunity to underwrite the New LOB, if Current Fidelis can accommodate the New LOB, Current Fidelis has seven business days to communicate its desire to accept the terms of the Group Line of Business ROFR, and a further 20 days from this date to make a firm commitment of interest (although this period may be extended if a non-objection (or similar) must be obtained from a regulatory authority), at which point the New LOB will be deemed bound.
If Current Fidelis cannot accommodate such New LOB for licensing, available capital or other reasons, it will be allowed a mutually agreed, reasonable amount of time to obtain the necessary license or capital or make other arrangements in order to accommodate such New LOB. If Current Fidelis does not elect to provide capacity for the New LOB pursuant to the Group Line of Business ROFR, Fidelis MGU will be permitted to do so with a third-party insurer that is not part of Current Fidelis. To the extent that Fidelis MGU is writing the New LOB with a third-party insurer where there is a risk of adverse selection to Current Fidelis or disclosure or misuse of competitively sensitive information regarding Current Fidelis, Fidelis MGU will demonstrate to the reasonable satisfaction of Current Fidelis that it has taken steps to mitigate against any risk of adverse selection and/or disclosure or misuse of competitively sensitive information.
Fees and Commissions
The Framework Agreement sets out the calculations for various fees and commissions to be paid by Current Fidelis to Fidelis MGU.
Profit Commissions and Ceding Commissions
Ceding commissions payable to Fidelis MGU will be payable monthly in arrears and will be charged for underwriting, claims and actuarial pricing services. Such ceding commissions will be calculated based on net premiums written (gross of acquisition costs) to facilitate alignment on reinsurance purchasing. To avoid fee duplication, ceding commissions payable for open market business sourced by Fidelis MGU are set at 11.5% and ceding commissions payable for business sourced by Fidelis MGU via third-party managing general agents to whom underwriting authority has been sub-delegated by Fidelis MGU pursuant to newly established third-party managing general agency relationships are set at 3.0%. Business that continues to be sourced by cells of Pine Walk Capital continues to follow the fees and commissions set under those agreements, which fees and commissions are in line with normal market ranges, but without any additional fee levied by Fidelis MGU. For the avoidance of doubt, any premium on such sub-delegated business will be recognized on a look-through basis, i.e., recognizing premium when a particular risk is underwritten by the relevant managing general underwriter not at the inception of the relevant binding authority agreement. There will be no additional fees payable (with the exception of the Fidelis MGU- level portfolio management fee described below).
The sum of 20% of the Operating Profit of FIHL (as defined in the Framework Agreement) above an annual Binder Operating RoE hurdle of 5% hurdle rate will be payable at the end of each fiscal year to ensure alignment with portfolio management value proposition. The profit commission will be payable above a predetermined annual hurdle linked to Operating RoE, calculated on an aggregate basis for Current Fidelis and subsequently allocated proportionally for each of the insurance operating subsidiaries of Current Fidelis for payment to the respective operating subsidiaries of Fidelis MGU. The calculation of such profit commission will include a deficit carry-forward mechanism for a maximum of three years in which the applicable insurance operating subsidiary suffers a loss under the applicable Delegated Underwriting Authority Agreement. Such loss will be carried forward for a maximum of three years. There will be no claw back mechanism applicable.
206
Other Fees and Commissions
A 3.0% portfolio management fee, to be calculated based on net premiums written, will be payable to Fidelis MGU. The portfolio management fee will reflect the value-added services provided by Fidelis MGU when compared with a traditional managing general underwriter model (i.e., Current Fidelis is expected to benefit from Fidelis MGUs expertise in the management of its outwards program, in portfolio optimization matters, in managing the underwriting cycle, and from Fidelis MGUs view of risk and overall portfolio allocation).
Overriding commissions (both ceding commissions and profit commission) will be payable by Current Fidelis to Fidelis MGU on outwards reinsurance quota share arrangements for newly sourced business to cover the cost of origination and the ongoing management of such contracts. This approach is expected to reduce the level of renegotiation required by Current Fidelis with quota share partners. Current Fidelis will retain 1% of all premium ceded under the quota share contracts to cover its tail and credit risk and also retain all overriders paid by the reinsurers to cover acquisition costs in certain lines of business. Current Fidelis is expected to benefit from improved pricing on account of its resulting ability to write larger gross lines.
In addition, a fee will be payable to Fidelis MGU in respect of the Run-Off Services, which will be mutually agreed and/or determined at the time of termination with reference to the scope of ongoing Run-Off Services and percentage of reserves based on available benchmarks.
Underwriting expenses directly related to the placement of an individual (re)insurance contract, including counsel fees or fees relating to third-party diligence, will be recoverable by Fidelis MGU from Current Fidelis.
Reporting
Fidelis MGU will provide detailed reporting to Current Fidelis on a monthly and quarterly basis for business written and control activities, depending on the nature of the report. Such reports will include, among other things, (i) accounting information (i.e., premiums written and earned, fees and loss reserves); (ii) underwriting information (including all insurance business underwritten under the Delegated Underwriting Authority Agreements); and (iii) claims handling information.
Claims Management
Current Fidelis will retain an oversight function over claims management activities, which is part of the services outsourced to Fidelis MGU. The Framework Agreement and the Delegated Underwriting Authority Agreements delegate claims authority up to a maximum monetary threshold. Fidelis MGU will provide Current Fidelis with sufficient oversight of its handling of claims that exceed the delegation threshold, and claims subject to litigation will be collectively handled by Current Fidelis and Fidelis MGU in accordance with Current Fidelis claims management processes. See BusinessClaims.
Dispute Resolution
Claims not relating to technical calculations (e.g., claims related to negligent underwriting, defective portfolio composition or incorrect outwards reinsurance matching) will follow a tiered approach with varying degrees of escalation. Such claims will first be referred to the Joint Referral Forum; failing resolution by the Joint Referral Forum, such matters will be escalated first to mediation; and failing resolution at mediation, to binding arbitration. Claims relating to technical calculations will be referred to the CFO of each respective party and if a resolution cannot be reached, the claim will be escalated to a binding determination by a jointly appointed expert.
Reserving
Current Fidelis will be responsible for performing its own end-to-end reserving process, including its own reserve production and sign-off procedures. Fidelis MGU will provide data in furtherance of Current Fidelis
207
reserving process if required and will review aspects of Current Fidelis reserving process if Current Fidelis deems it appropriate.
Delegated Underwriting Authority Agreements
Certain operating subsidiaries of MGU HoldCo have entered into Delegated Underwriting Authority Agreements with the operating insurance subsidiaries of Current Fidelis on a jurisdictional basis.
Underwriting Services
Fidelis MGU operating subsidiaries perform certain underwriting services in exchange for the payment of the relevant fees and commissions by Current Fidelis including, among other services, advising on product strategy and development, including new products and policy language, and originating and placing policies within the parameters set forth in the Subsidiary Annual Plans, developing business relationships with licensed third-party wholesale insurance brokers, agents, producers and coverholders, selecting, performing diligence on, onboarding and managing brokers, agents, producers and coverholders, reviewing insurance applications and submissions from potential insureds for compliance with applicable letters of authority and soliciting, negotiating and executing placement of policies within risk appetites and rating agency scores by applying prices and rates as appropriate in accordance with rating plans, guidelines and models.
Actuarial Services
Fidelis MGU performs certain actuarial services pursuant to the Delegated Underwriting Authority Agreements including, among other services, providing pricing support and advice to Current Fidelis, advising on pricing strategy and outwards pricing, developing and inputting on capital and pricing models, both internal and external, supporting the underwriting function in policy pricing, pricing live transactions and repricing annual transactions, maintaining a pricing metrics dashboard, performing ad hoc premium rate movement calculations and defining stochastic losses in FireAnt.
Claims Handling
Fidelis MGU performs certain claims handling services pursuant to the Delegated Underwriting Authority Agreements, including, among other services, advising on claims management strategy and implementation, preparation of claims guidelines, reserving philosophy, authority limits and claims acceptance and rejection criteria, performing claims adjustment and payments, managing disputes, litigation, subrogation and recoveries, and managing broker, underwriter, client and third-party administrators.
Ancillary Services
Fidelis MGU performs certain ancillary services pursuant to the Delegated Underwriting Authority Agreements including, among other services, advising on and negotiating contract terms for inwards and outwards contracts, developing and maintaining records of policy language and issuing and executing all of the necessary contractual documentation for new and renewal policies, related endorsements and cancellations.
Outwards Reinsurance Services
Fidelis MGU performs the following outwards reinsurance services pursuant to the Delegated Underwriting Authority Agreements including, among other services, advising on the outwards reinsurance and retrocession (Outwards RI) strategy and preparing the annual Outwards RI purchasing program, advising on the structure of Outwards RI placements and terms, addressing the market and consulting in selecting Current Fidelis panel of reinsurers, undertaking due diligence on Outwards RI counterparties, developing broker and reinsurer relationships, negotiating and executing all treaty Outwards RI and providing sign-off on facultative Outwards RI placements, preparing submissions for treaty Outwards RI, negotiating commutations and non-standard deals and retaining and storing all relevant policy documentation.
208
Inter-Group Services Agreement
FIHL and MGU HoldCo have entered into an Inter-Group Services Agreement, pursuant to which MGU HoldCo is obligated to provide a range of non-underwriting services to Current Fidelis on an outsourced basis. These services will include, but will not be limited to, accounting, other finance and reporting services, IT infrastructure maintenance and system development services and facilities management services.
Recipients of the Inter-Group Services
MGU HoldCo provides all of the non-underwriting services to either: (i) FIHL and FIHL (UK) Services, which they will then pass on to Current Fidelis; or (ii) any subsidiary in Current Fidelis directly, in each case, as FIHL and MGU HoldCo may agree from time to time.
Cross Functional Working Group
The parties have agreed to establish a Cross Functional Working Group (CFWG), which will comprise function heads from each party, and which is intended to facilitate and oversee the execution of activities required to manage the Inter-Group Services Agreement. The CFWG is also intended to act as an escalation point for any issues that may arise under the Inter-Group Services Agreement.
FIHL and MGU HoldCo will be required to notify the CWFG (the CWFG Notification) in writing as soon as reasonably practicable particular extraordinary events, such as material breaches of the Inter-Group Services Agreement, or any insolvency or fraud of any operating subsidiary that may have an adverse impact on the Inter-Group Services Agreement.
Following a CWFG Notification, the CWFG will, for a period of 30 days (the CWFG Deadline), use best endeavors to agree, as applicable: (a) whether it is reasonably practicable to continue the Inter-Group Services Agreement following an insolvency event; or (b) upon a course of conduct to remedy any material breaches or acts of fraud, or to mitigate the impact of any occurrence that could impact upon a party to the Inter-Group Services Agreement.
If the Joint CWFG fails to reach any such agreement by the CWFG Deadline, the innocent party to the Inter- Group Services Agreement will have termination rights. See Termination below.
Fees
Fees under the Inter-Group Services Agreement will generally be charged by MGU HoldCo to FIHL on a costs plus 5% basis, and will be calculated quarterly. The parties will also share costs incurred from instructing third-party suppliers, with such costs being apportioned as a ratio based on each partys respective staff headcount (e.g., if one of the parties had 25 employees and the other 100 employees, such ratio would be 1:4.).
Term
The Inter-Group Services Agreement follows a similar term to the Framework Agreement, as it provides for a minimum ten-year rolling term that will be automatically rolled forward in the first three years. From the fourth year of the agreement, FIHL may unilaterally determine that the minimum term shall not roll into any further year by notifying MGU HoldCo at least 90 days before the next anniversary of the commencement date of the Inter-Group Services Agreement.
Termination
The Inter-Group Services Agreement will be subject to termination by either party upon the occurrence of certain events, including: (i) immediately after the CWFG Deadline, as a result of a material act of fraud on the
209
part of the other party; (ii) immediately after the CWFG Deadline, if the other party is subject to an insolvency event and the CWFG fails to unanimously agree that it is reasonably practicable to continue the Inter-Group Services Agreement; (iii) with 10 business days notice after the CWFG Deadline, if the CWFG, using best endeavors, fails to agree upon a course of conduct to remedy any material breaches or non-material acts of fraud (and to mitigate the likelihood of future breaches or frauds occurring), or to mitigate the impact of any occurrence that could impact upon a partys performance of the Inter-Group Services Agreement; (iv) immediately if the CWFG has agreed upon a course of conduct to remedy a material breach, and the defaulting party does not commence such course of action agreed by the CWFG within ten business days of such course of action being agreed by the CWFG, although this termination right will be automatically revoked if the defaulting party provides the terminating party with evidence to the terminating partys reasonable satisfaction that it has commenced the course of action within the 10 business day termination period and completes the course of action within a cure period agreed by the CWFG; or (v) save where (iv) applies (i.e., other than in the event of a material breach), with 30 business days notice if a defaulting party does not commence any course of action agreed by the CWFG within 20 business days of such course of action being agreed by the CWFG, provided that this termination right will be automatically revoked if the defaulting party provides the terminating party with evidence to the terminating partys reasonable satisfaction that it has commenced the course of action within the 30 business day termination period.
Following termination of the Inter-Group Services Agreement, the parties will comply with the terms of the exit plan, which is intended to ensure the seamless continuation of services by MGU HoldCo until FIHL is able to either bring these functions in-house or transfer them to an alternative provider. MGU HoldCo will receive a commensurate fee for the performance of these run-off services.
Service Standards and Service Credit
MGU HoldCo will be subject to various service standards in the provision of services under the Inter-Group Services Agreement. In addition to general requirements to carry out its obligations in accordance with good industry practice and all reasonable care and skill, the Inter-Group Services Agreement contains a number of prescribed service-level agreements and key performance indicators (KPIs), that apply to a range of services.
If MGU HoldCo fails to remedy breaches of the service-level agreements or KPIs within a reasonable period agreed with FIHL (a Service Shortfall), it shall be eligible for service credits, which will be identified and applied on a quarterly basis and represent a percentage of the fees that MGU HoldCo is entitled to receive under the agreement for the applicable quarter. The applicable percentage that represents the service credit will start from a deduction of 0.5% where five Service Shortfalls occur during the applicable reference period (i.e., day, week or month) and will rise incrementally based upon the number of service credits that occurred during the applicable period.
Material Outsourcing Provisions
As the Inter-Group Services Agreement will be regarded as a material outsourcing agreement under the relevant regulatory rules (see Certain Regulatory Considerations), it contains a number of provisions that are required by applicable law and regulation. In particular, MGU HoldCo will be required to put in place, and to regularly maintain, update and test, plans for operational resilience, business security, cyber security and disaster recovery. MGU HoldCo will also be required to maintain an exit plan (the first version of which will be appended to the Inter-Group Services Agreement), which will provide for a smooth run-off of the services contained within the Inter-Group Services Agreement following termination.
FIHL, as the outsourcing party, will have the right to audit MGU HoldCo in respect of these services, and to test the plans listed above that MGU HoldCo will be required to maintain and test. MGU HoldCo will also be required to provide similar access to regulatory authorities in order to perform audits of the services that it provides under the Inter-Group Services Agreement.
210
Other
Other Existing Outsourcing Arrangements
Current Fidelis has certain other outsourcing arrangements which will be categorized as critical from a regulatory perspective. These arrangements are in place and are either contracted directly by Current Fidelis or via Fidelis MGU, depending on the nature of the support provided. The most critical of these existing arrangements include custodian and administrative services provided by Clearwater Analytics LLC to FIHL in connection with Current Fidelis fixed maturity portfolio; underwriting system support services provided by Imaginera Limited to FML and which form part of the services to be provided by Fidelis MGU to Current Fidelis; claims processing, assessing and administrative services provided by Pro Insurance Solutions Limited to FML and which form part of the services to be provided by Fidelis MGU to Current Fidelis; actuarial modelling and other actuarial support services provided by Dynamo Analytics to FIHL; and cloud data hosting services provided by Oracle Corporation UK Limited to FML and which form part of the services to be provided by Fidelis MGU to Current Fidelis.
Leases
The two Bermuda leases are currently held by FIBL and it is expected that one of the leases will be transferred to Bermuda MGU with the provision of a rental guarantee, with FIBL retaining the other lease. The existing Pine Walk Capital lease will also remain as part of Fidelis MGU following the consummation of the Separation Transactions (see BusinessFacilities). FIID currently shares office space leased by FML, which is part of Fidelis MGU. During 2023, FIID employees will move to another location in Dublin which it leases and is currently being renovated (it is expected that this lease will be transferred by FIHL (UK) Services, Irish Branch).
Licensing Arrangements
As part of the Separation Transactions, existing technology platforms, including Tyche capital models, the Prequel Policy Administration system, the Jarvis Data Warehouse, and the FireAnt Analytics system, were transferred to Fidelis MGU. Fidelis MGU provides Current Fidelis with a license in respect of this technology, so that Current Fidelis can continue to benefit from the use of such technology, or the outputs of it (as applicable), as part of the services that it receives under the Framework Agreement and the Inter-Group Services Agreement. In particular, Current Fidelis has access to outputs from Fidelis MGUs use of the FireAnt Analytics system, a pricing, analytics and portfolio optimization tool, as part of the business modelling services that it receives from Fidelis MGU. Prequel will also continue to be a key supporting system used in Current Fidelis underwriting procedures. Data stored on Jarvis will continue to be used as part of the technical accounting services that Current Fidelis receives. Relevant third-party vendor owned tools and systems will be licensed to Current Fidelis either directly by the vendors or via Fidelis MGU and support will be provided by Fidelis MGU through the Inter-Group Services Agreement. The Fidelis name, certain trademarks in the U.K. and E.U., proprietary branding and other protectable signs are also subject to licensing by Fidelis MGU in favor of Current Fidelis.
Amended and Restated Common Shareholders Agreement
The Existing Shareholders will continue to be shareholders of FIHL, as part of Current Fidelis, following the consummation of this offering. The Existing Shareholders are currently party to the Existing Common Shareholders Agreement, which contains provisions that govern the rights and obligations of the Existing Shareholders, including, but not limited to, transfer restrictions and corporate governance matters. The Amended and Restated Common Shareholders Agreement, which will replace the Existing Common Shareholders Agreement, will be effective as of the pricing of this offering and will only be entered into between FIHL, the Founders and MGU HoldCo.
Under the Amended and Restated Common Shareholders Agreement, the Founders and MGU HoldCo will be entitled to nominate representative directors to the Board, so long as they each beneficially own a specified
211
minimum percentage of our Common Shares. See Description of Share CapitalCertain Provisions of the Amended and Restated Bye-LawsNumber of Directors.
Reserved Matters
Under the terms of the Amended and Restated Common Shareholders Agreement, the following are some matters that will require a simple majority approval of the Board: (i) sourcing business from any party other than Fidelis MGU; (ii) entering into any new lines of business not included in the Permitted Lines, save to the extent such new lines of business are sourced through Fidelis MGU following Current Fidelis exercise of the Line of Business ROFR (see Group Line of Business ROFR); and (iii) approval of business plans for any non-Fidelis MGU business.
Consent Rights and Minority Protections
For so long as MGU HoldCo beneficially owns at least 4.9% of the Common Shares, the consent of MGU HoldCo is required for FIHL to take any of the following actions: (i) to effect any change in the jurisdiction, incorporation or name of FIHL or any member of Current Fidelis; (ii) to make a material change to the nature or scope of the business underwritten by FIHL and any member of Current Fidelis; (iii) to effect any amendments to the Amended and Restated Bye-Laws or the Amended and Restated Common Shareholders Agreement that are reasonably likely to have a material adverse effect on Fidelis MGU, taken as a whole; and (iv) to make any acquisition or disposition of any asset for consideration in excess of 5.0% of the assets of FIHL that is reasonably likely to have a material adverse effect on Fidelis MGU, taken as a whole.
If FIHL authorizes, designates or issues additional Common Shares following the consummation of this offering, FIHL will provide advance notice to MGU HoldCo and MGU HoldCo will have the right to elect to purchase up to its pro rata portion of the Common Shares at the same price as other subscribers and within a specific period, in accordance with the terms of the Amended and Restated Common Shareholders Agreement (the Allocation Right).
If, following the consummation of this offering, MGU HoldCo sells any of its Common Shares, other than in connection with any stock conversions, buybacks, repurchases, redemptions, or other changes resulting from any stock split, combination or similar recapitalization, or its beneficial ownership of the Common Shares otherwise falls below 4.9% as a consequence of a dilutive action taken by FIHL, MGU HoldCo will no longer be entitled to exercise the above mentioned consent rights. Any new class of common shares resulting from any of the foregoing will be similarly restricted.
For so long as the Founders, together with their Shareholder Affiliate Transferees, in the aggregate beneficially own at least 25% of the Common Shares, the Founders shall have the right, by unanimous decision by each Founder that beneficially owns at least 1% of the Common Shares, to restrict FIHL from taking the following actions, except to the extent such actions are required by applicable law: (i) adopt or propose to FIHLs shareholders any amendment, modification or restatement of or supplement to FIHLs organizational documents which have an adverse impact on the rights granted to the Founders, (ii) commence a voluntary case or proceeding under any applicable U.S. or foreign bankruptcy, insolvency, reorganization or similar law or make an assignment for the benefit of creditors, or admit in writing of its or their inability to pay its or their debts generally as they become due, or take any action in furtherance of any such action, (iii) change the size of the Board, (iv) engage in any transaction in which any person or group acquires more than 50% of the then outstanding Common Shares of FIHL or the power to elect a majority of the members of the Board or (v) terminate or hire the chief executive officer of FIHL or any successor or replacement serving in such role.
The Founders consent rights may also adversely affect the trading price for the Common Shares to the extent investors perceive disadvantages in owning shares of a company with a shareholder with an ability to exercise a degree of control and influence over such company. For example, Founders rights may delay, defer,
212
or prevent a change in control of FIHL or impede a merger, takeover or other business combination which may otherwise be favorable for the Group. These rights conferred on the Founders under the terms of the Existing Common Shareholders Agreement will be retained in the Amended and Restated Common Shareholders Agreement that will become effective as of the pricing of this offering.
Registration Rights Agreement
The Existing Shareholders are party to a Registration Rights Agreement dated June 9, 2015, as amended by the First Amendment to the Registration Rights Agreement dated November 25, 2019, the Second Amendment to the Registration Rights Agreement dated February 3, 2020 and the Third Amendment to the Registration Rights Agreement dated as of July 13, 2021 (collectively, the Registration Rights Agreement), which contains provisions that govern the rights and obligations of the Existing Shareholders with respect to any future registration of our Common Shares.
Piggyback Registration Rights
Following the consummation of this offering, if FIHL proposes to file any registration statement under the Securities Act for the purposes of a public offering of its equity securities (including our Common Shares) (the Piggyback Registration), it is obligated to give prompt written notice of the same to the Existing Shareholders, who will have 30 days following receipt of the same to request their Registrable Securities (as defined in the Registration Rights Agreement) be included in such Piggyback Registration (the Piggyback Request) and FIHL will use all commercially reasonable efforts to include the same. If necessary, the number of Registrable Securities subject to a Piggyback Request may be scaled down pro rata as more particularly set out in the Registration Rights Agreement.
FIHL has the right to abandon any Piggyback Registration at any time. Any Existing Shareholder may withdraw its Piggyback Request by giving written notice to FIHL at any time within five business days prior to the anticipated effectiveness of the registration statement in connection therewith. The rights to Piggyback Registration may be exercised on an unlimited number of occasions, provided that a period of 90 days has elapsed between the effective dates of each Piggyback Registration.
Priority Rights of Certain ShareholdersDemand Registration
Two or more Founders (as defined in the Registration Rights Agreement) have the right to request that FIHL effects a registration of all or part of their Registrable Securities under the Securities Act (a Demand Registration), provided, that such request is submitted following the expiration of the underwriter lock-up period and before FIHL has filed a Shelf Registration Statement (as defined below) and the anticipated aggregate offering price is at least $1,000,000. Following receipt of such request, FIHL will be required, not more than once each calendar quarter, to use commercially reasonable efforts to promptly effect the registration.
If the managing underwriter of the Demand Registration advises FIHL and the participating Founders that the total number of Common Shares requested to be registered by the Founders and other Existing Shareholders exceeds the Maximum Number of Securities (as defined below), the Common Shares will be included in the Demand Registration in the following order of priority:
(1) | first, the Common Shares of the Founders and any other Existing Shareholders up to the Maximum Number of Securities, and if the aggregate number of such Registrable Securities exceeds the Maximum Number of Securities, on a pro rata basis based on the amount of Registrable Securities beneficially owned by such Founders and Existing Shareholders; and |
(2) | second, to FIHL (if applicable). |
213
Priority Rights of Certain ShareholdersShelf Registration
Following the consummation of this offering, FIHL will be required to use reasonable commercial efforts to qualify and remain qualified to register the Common Shares under the Securities Act. Any Founder may request in writing that FIHL promptly files a shelf registration statement providing for the registration, and the sale on a continuous or delayed basis, of the Registrable Securities of such Founder(s) and the other Existing Shareholders (a Shelf Registration Statement). Following the filing of such Shelf Registration Statement, FIHL will be required to use commercially reasonable efforts to (i) cause the Shelf Registration Statement to become effective; (ii) maintain the effectiveness of the Shelf Registration Statement; (iii) file a new Shelf Registration Statement upon its expiration; and (iv) amend or supplement the Shelf Registration Statement at the request of such Founder in connection with a shelf take-down, until all of the Registrable Securities have been sold or are no longer outstanding.
If a Shelf Registration Statement covering Registrable Securities is effective, a Founder (the Demanding Founder) may deliver a notice to FIHL (the Take-Down Notice) stating that it intends to effect an underwritten offering of all or part of its Registrable Securities included by it on the Shelf Registration Statement (a Shelf Underwritten Offering). Upon receipt of such Take-Down Notice, FIHL will be required to promptly deliver such Take-Down Notice to all other Existing Shareholders included on such Shelf Registration Statement and such Existing Shareholders, by giving notice within five business days of delivery of the Take-Down Notice, may include their Registrable Securities in the Shelf Underwritten Offering.
If the managing underwriter, as selected by the Demanding Founder, of the Shelf Underwritten Offering advises FIHL and the participating Founders in writing that the total number of Common Shares requested to be registered by the Founders exceeds the Maximum Number of Securities, the securities will be included in the Shelf Registration Statement in the following order of priority:
| first, (A) in the case of the first Shelf Underwritten Offering, the Common Shares of the Founders and any other Existing Shareholders up to the Maximum Number of Securities, and if the aggregate number of such Registrable Securities exceeds the Maximum Number of Securities, on a pro rata basis based on the amount of Registrable Securities beneficially owned by such Founders and Existing Shareholders, and (B) in the case of any subsequent Shelf Underwritten Offerings, the Common Shares of the Founders, Platinum Ivy and SPFM (as those terms are defined in the Registration Rights Agreement) up to the Maximum Number of Securities, and if the aggregate number of such Registrable Securities exceeds the Maximum Number of Securities, on a pro rata basis based on the amount of Registrable Securities beneficially owned by each Founder, Platinum Ivy and SPFM; |
| second, the Registrable Securities requested to be included by other Existing Shareholders up to the Remaining Number of Securities (as defined in the Registration Rights Agreement), and if the aggregate number of such Registrable Securities exceeds the Remaining Number of Securities, on a pro rata share basis based on the amount of Registrable Securities beneficially owned by such Existing Shareholders; and |
| third, to FIHL (if applicable). |
Maximum Number of Securities means, with respect to any Shelf Underwritten Offering or underwritten Piggyback Registration, the maximum number of securities which can be sold in such offering without materially and adversely affecting the marketability of such offering.
Preference Securityholders Agreement
All of the current holders of our Series A Preference Securities are party to a preference securityholders agreement (the Preference Securityholders Agreement), which contains provisions that govern the rights and obligations of the Preference Securityholders as security holders, including, but not limited to, transfer restrictions and corporate governance and other matters as described below and set out in the Preference Securityholders Agreement. See Description of Share Capital for a summary of our Series A Preference Securities and rights attached to them in the Preference Securityholders Agreement.
214
Indemnification and Exculpation of Directors and Officers
Section 98 of the Companies Act provides generally that a Bermuda company may indemnify its directors, officers and auditors against any liability which by virtue of any rule of law would otherwise be imposed on them in respect of any negligence, default, breach of duty or breach of trust, except in cases where such liability arises from fraud or dishonesty of which such director, officer or auditor may be guilty in relation to that company. Section 98 further provides that a Bermuda company may indemnify its directors, officers and auditors against any liability incurred by them in defending any proceedings, whether civil or criminal, in which judgment is awarded in their favor or in which they are acquitted or granted relief by the Supreme Court of Bermuda pursuant to section 281 of the Companies Act.
The Existing Bye-Laws will be amended and restated, conditional on this offering being consummated. The Amended and Restated Bye-Laws provide that we will indemnify, to the fullest extent permitted by applicable law, our officers and directors in respect of their actions and omissions, except in respect of their fraud or dishonesty. The Amended and Restated Bye-Laws provide that holders of our Common Shares and the holders of Series A Preference Securities waive all claims or rights of action that they might have, individually or in right of FIHL, against any of our directors or officers for any act or failure to act in the performance of such directors or officers duties, except in respect of any fraud or dishonesty of such director or officer. Section 98A of the Companies Act permits us to purchase and maintain insurance for the benefit of any officer or Director in respect of any loss or liability attaching to such officer or director in respect of any negligence, default, breach of duty or breach of trust, whether or not we may otherwise indemnify such officer or director. We maintain a directors and officers liability policy for such a purpose.
In connection with the consummation of this offering, we intend to enter into separate indemnification agreements with each of our directors and executive officers, which will contain customary terms for public companies. The form of the indemnification agreements has been filed as an exhibit to the registration statement of which this prospectus forms a part, and this description of the indemnification agreements is qualified in its entirety by reference thereto.
Side Letters with Certain Shareholders
We have agreed with two of our institutional shareholders, SPFM Holdings, LLC and Platinum Ivy B 2018 RSC Limited, that they may continue to appoint an observer who may attend Board and committee meetings following the consummation of this offering, subject to confidentiality and other customary provisions.
Loans to Management
In November 2019, Previous Fidelis provided interest-free loans to certain of its management in the aggregate amount of $4.5 million (the Management Loans), pursuant to the terms of certain loan agreements entered into between certain of FIHLs senior executives as borrowers and FIBL as lender (the Management Loan Agreements). The Management Loans were advanced in order to enable the borrowers to purchase and pay the subscription price for the Common Shares offered by FIHL as part of its rights offering and private placement in late 2019. The obligations of the borrowers under the Management Loan Agreements were secured by a pledge over the Common Shares purchased by each of the borrowers. The Management Loans were fully repaid in January 2023 as part of the Separation Transactions.
IPO Assistance and Lock-Up Agreement
Prior to the pricing of this offering, Richard Brindle, Richard Coulson, Hinal Patel and Charles Mathias (collectively, the MGU Executives and each, an MGU Executive) and Daniel Burrows, Allan Decleir, Denise Brown-Branch and Ian Houston (collectively, the Insurance Group Executives and each, an Insurance Group Executive) and FIHL entered into an initial public offering assistance and lock-up agreement (the IPO
215
Assistance and Lock-Up Agreement). The IPO Assistance and Lock-Up Agreement obligates each MGU Executive and each Insurance Group Executive, in so far as he or she is legally able to do so in his or her capacity as an employee of Current Fidelis or Fidelis MGU, as applicable, to use his or her reasonable efforts to assist FIHL in the consummation of this offering. Under the terms of the IPO Assistance and Lock-Up Agreement, (i) the MGU Executives and Daniel Burrows agree, subject to limited exceptions, not to offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, assign, encumber, pledge, hypothecate, or otherwise transfer or dispose of, directly or indirectly, any of their Common Shares for a period of 18 months after the pricing of this offering, except that 25% of such Common Shares relating to Retention RSUs are released from such lock-up within 180 days after such date of vesting and (ii) the Insurance Group Executives agree, subject to limited exceptions, not to offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, assign, encumber, pledge, hypothecate, or otherwise transfer or dispose of, directly or indirectly, any of the Common Shares that they receive following the vesting of their retention restricted stock units approved by FIHL on May 15, 2023 (the Retention RSUs) for a period of 18 months after the date of vesting of such Retention RSUs (such period end date being October 1, 2025), except that 25% of such Common Shares relating to Retention RSUs are released from such lock-up within 180 days after such date of vesting.
Policies and Procedures for Approval of Related Person Transactions
In connection with this offering, we adopted a related person transactions policy pursuant to which our executive officers, directors and principal shareholders, including their immediate family members, will not be permitted to enter into a related person transaction with us without the consent of our audit committee, another independent committee of our Board or the full Board. Any request for us to enter into a transaction with an executive officer, director, principal shareholder or any of such persons immediate family members, in which the amount involved exceeds $120,000, will be required to be presented to our audit committee for review, consideration and approval. All of our directors, executive officers and employees will be required to report to our audit committee any such related person transaction. In approving or rejecting the proposed transaction, our audit committee will take into account, among other factors it deems appropriate, whether the proposed related person transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances, the extent of the related persons interest in the transaction and, if applicable, the impact on a directors independence. Under the related person transactions policy, if we should discover related person transactions that have not been approved, our audit committee will be notified and will determine the appropriate action, including ratification, rescission or amendment of the transaction.
216
The following description of FIHLs share capital summarizes certain provisions of the Amended and Restated Bye-Laws that will become effective as of the listing of our Common Shares on NYSE. Such summaries do not purport to be complete and are subject to, and are qualified in their entirety by reference to, all of the provisions of the Amended and Restated Bye-Laws, copies of which will be filed as exhibits to the registration statement of which this prospectus forms apart, and applicable Bermuda law. Prospective investors are urged to read the exhibits for a complete understanding of the Amended and Restated Bye-Laws. The descriptions of our Common Shares reflect changes to our capital structure that will occur upon the listing of our Common Shares on NYSE.
General
FIHL is a Bermuda exempted company registered with the Registrar of Companies in Bermuda under registration number 49414. We are incorporated under the name Fidelis Insurance Holdings Limited. Our registered office is at Waterloo House, 100 Pitts Bay Road, Pembroke, Bermuda HM08. Our agent for service of process in the United States in connection with this offering is Puglisi & Associates, 850 Library Avenue, Suite 204, Newark, Delaware 19711.
The objects for which we are formed and incorporated are unrestricted and we have the capacity, rights, powers and privileges of a natural person. We therefore are able to undertake activities without restriction on our capacity.
Share Capital
After the consummation of this offering, our authorized share capital will consist of 600,000,000 Common Shares, par value $0.01 per share and 1,000,000 Series A Preference Securities, par value $0.01 per share, and there will be 116,486,183 of our Common Shares outstanding and 5,800 of our Series A Preference Securities outstanding.
Common Shares
Other than the MGU HoldCos Allocation Right, our Common Shares have no pre-emptive rights or other rights to subscribe for additional shares, and no rights of redemption, conversion or exchange. Under certain circumstances and subject to the provisions of the Amended and Restated Bye-Laws, FIHL may be required to make an offer to repurchase shares held by shareholders. All of our outstanding Common Shares, including the outstanding Common Shares covered by this prospectus, are fully paid and non-assessable. For additional information regarding certain provisions relating to our Common Shares under the Companies Act and our Amended and Restated Bye-Laws, compared to a Delaware corporation, see Comparison of Shareholder Rights.
Common Share Dividend and Distribution Rights
Under Bermuda law, a company may not declare or pay dividends or make a distribution out of contributed surplus if there are reasonable grounds for believing that: (i) it is, or would after the payment be, unable to pay its liabilities as they become due; or (ii) the realizable value of its assets would thereafter be less than its liabilities. Under the Amended and Restated Bye-Laws, each Common Share is entitled to dividends, as and when dividends are declared by the Board, subject to any preference dividend right of the holders of any preference securities, including our Series A Preference Securities.
The boards of directors of the operating subsidiaries have absolute discretion, subject to statutory requirements, regulatory requirements and the terms of our existing indebtedness, to declare dividends at any
217
time. The Board will decide the appropriate use of any funds received by way of dividend from an operating subsidiary, including, possibly, declaration of dividends or share repurchases by FIHL.
See Dividend Policy for more information on our dividend policy.
Voting Rights
Holders of our Common Shares will have one vote for each Common Share held by them and will be entitled to vote, on a non-cumulative basis, at all meetings of the shareholders.
Rights Upon Liquidation
In the event of the liquidation, dissolution or winding up of FIHL, the holders of our Common Shares will be entitled to share equally and ratably in our assets, if any, remaining after the payment of all of our debts and liabilities, subject to the liquidation preference on any issued and outstanding preference securities, including our Series A Preference Securities.
Variation of Rights
If at any time FIHL has more than one class of shares, the rights attaching to any class, unless otherwise provided for by the terms of issue of the relevant class, may be varied with the approval of the Board and with the consent in writing of the holders of a Simple Majority (as defined in the Amended and Restated Bye-Laws) of that class or with the sanction of a resolution passed by a Simple Majority at a separate general meeting of the holders of the shares of the class at which meeting the necessary quorum will be two persons at least holding or representing by proxy a Simple Majority. The Amended and Restated Bye-Laws specify that the creation or issuance of shares ranking pari passu or senior with existing shares will not, unless expressly provided by the terms of issue of existing shares, vary the rights attached to existing shares.
Series A Preference Securities
General
The Series A Preference Securities rank senior to our Common Shares and to any other series of preference securities of FIHL ranking junior in right of payment of dividends and distributions of assets upon liquidation, dissolution or winding up to our Series A Preference Securities (such other shares being Junior Shares) and will rank pari passu with each other series of shares ranking on parity with our Series A Preference Securities with respect to the payment of dividends and distributions of assets upon liquidation, dissolution or winding up. The Series A Preference Securities rank after the claims of creditors with respect to amounts upon liquidation, dissolution or winding up. The Board may from time to time create and issue new Junior Shares without the approval of the holders of Series A Preference Securities and fix their relative rights, preferences and limitations.
We are generally able to pay dividends and distributions upon liquidation, dissolution or winding-up only out of lawfully available funds for such payment (i.e., after satisfaction of indebtedness and other non-equity claims).
Our Series A Preference Securities are fully paid and non-assessable. Our Series A Preference Securities are not subject to any sinking fund, retirement fund, purchase fund or other similar provisions.
Dividends on Our Series A Preference Securities
Dividends on our Series A Preference Securities are cumulative from the date of original issuance. Consequently, if the Board does not authorize and declare a dividend for any dividend period, holders of our Series A Preference Securities will be entitled to receive a dividend for such period, and such undeclared dividend will accumulate and will be payable.
218
Dividends on our Series A Preference Securities are cumulative from the date of original issuance and will be payable in cash when, as and if declared by the Board, quarterly in arrears on the fifteenth day of March, June, September and December of each year (or, if such day is not a business day, the first business day thereafter), commencing September 15, 2015 (each, a Dividend Payment Date). The Board may resolve, for any reason and in its absolute discretion, not to declare or pay in full or in part any dividends on our Series A Preference Securities in respect of one or more dividend periods. Dividends will accumulate in each dividend period from and including the preceding Dividend Payment Date to but excluding the applicable Dividend Payment Date for such dividend period. No interest, or sum of money in lieu of interest, will be payable in respect of any dividend payments on our Series A Preference Securities which may be deferred or in arrears.
Dividends accrue (i) from (and including) September 1, 2015 to (but excluding) September 1, 2025 (the Fixed Rate Period) at 9.00% of the $10,000 per share liquidation preference per annum (equivalent to $900 per share per annum); and (ii) from (and including) September 1, 2025 (the Floating Rate Period), at a floating rate per annum equal to three-month U.S. dollar LIBOR (or such other replacement method) plus 9.773%.
If we have, in the six months prior to any Dividend Payment Date, (a) paid a dividend on our Common Shares or (b) repurchased, retired or otherwise redeemed any of our Common Shares, then the dividend on our Series A Preference Securities payable on such Dividend Payment Date (including, for the avoidance of doubt, any accrued but unpaid dividends) must be declared and paid if the Solvency Condition is met and we have assets legally available therefor (a Mandatory Dividend).
We, in consultation with the BMA or any successor group supervisory body, will not declare dividends, including Mandatory Dividends, on any Dividend Payment Date on which the Solvency Condition is not met. The Solvency Condition means that FIHL and its consolidated insurance regulatory group must have capital of 125% of the prescribed regulatory minimum on and after any payment. At December 31, 2022 FIHL has capital in excess of the Solvency Condition.
During the Fixed Rate Period, dividends payable on our Series A Preference Securities are computed on the basis of a 360-day year consisting of twelve 30-day months. During the Floating Rate Period, dividends payable on our Series A Preference Securities will be computed on the basis of actual days elapsed over a year consisting of 365 days.
Liquidation Rights of Our Series A Preference Securities
Upon any voluntary or involuntary liquidation, dissolution or winding-up of FIHL, holders of Series A Preference Securities are entitled to receive out of our assets legally available for distribution to shareholders, after satisfaction of indebtedness and other non-equity claims, if any, a liquidation preference in the amount of $10,000 per share, plus all accrued and unpaid dividends (whether or not earned or declared), if any, to the date fixed for distribution prior to and in preference to holders of our Common Shares and other class or series of our Junior Shares. Holders of our Series A Preference Securities will not be entitled to any other amounts after they have received their full liquidation preference.
In any such distribution, if the assets of FIHL are not sufficient to pay the liquidation preference in full to all holders of Series A Preference Securities, the amounts paid to the holders of Series A Preference Securities will be paid pro rata in accordance with the respective aggregate liquidation preferences of those holders. If the liquidation preference has been paid in full to all holders of Series A Preference Securities, the holders of any other class of share will be entitled to receive all of its remaining assets according to their respective rights and preferences.
Upon any winding up of FIHL or any of its subsidiaries, no amounts will be paid to the holders of Series A Preference Securities until all obligations of FIHL or the relevant subsidiary (as the case may be) to its policyholders and beneficiaries of policyholders have been met.
219
A consolidation, amalgamation, merger, arrangement or reconstruction involving FIHL or the sale or transfer of all or substantially all of its shares or the property or business of FIHL will not be deemed to constitute a liquidation, dissolution or winding-up of FIHL.
Redemption of Series A Preference Securities
Under Bermuda law, the source of funds that may be used by a company to pay amounts to shareholders on the redemption of their shares in respect of the nominal or par value of their shares is limited to (i) the capital paid up on the shares being redeemed, (ii) funds of the company otherwise available for payment of dividends or distributions or (iii) the proceeds of a new issuance of shares made for purposes of the redemption, and, in respect of the premium over the nominal or par value of their shares, is limited to (A) funds otherwise available for dividends or distributions or (B) amounts paid out of the companys share premium account before the redemption date.
Under Bermuda law, no redemption may be made by FIHL if there are reasonable grounds for believing that FIHL is, or would after the payment be, unable to pay its liabilities as they become due. In addition, if the redemption price is to be paid out of funds otherwise available for dividends or distributions, no redemption may be made if the realizable value of its assets would thereby be less than its liabilities.
Mandatory Redemption
On June 15, 2050, subject to the Solvency Condition being met and with the prior approval of the BMA (as applicable), we will redeem our Series A Preference Securities in whole at a redemption price equal to the stated liquidation preference of $10,000 per share, plus accrued and unpaid dividends, if any, as of such date.
Optional Redemption by FIHL
Any optional redemption by FIHL of our Series A Preference Securities is subject to the prior approval of the applicable regulatory authority (which as of the date of this prospectus would be the BMA) and the satisfaction of the Solvency Condition.
At any time prior to December 15, 2025, our Series A Preference Securities will be redeemable at the option of FIHL, in whole at any time or in part from time to time, upon prior written notice in accordance with the certificate of designations, at a redemption price equal to the Make Whole Amount (as defined below) plus accrued and unpaid dividends, if any, to, but excluding, the date of redemption. The Make Whole Amount for any redemption date will be equal to the greater of (i) the aggregate liquidation preference of our Series A Preference Securities to be redeemed and (ii) the sum of the present values of the aggregate liquidation preference of our Series A Preference Securities to be redeemed and the remaining scheduled payments of dividends on our Series A Preference Securities to be redeemed up to but excluding December 15, 2025 (not including any portion of such payments of dividends accrued to the date of redemption) discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at a rate equal to the treasury rate plus 0.5%.
On and after December 15, 2025, our Series A Preference Securities will be redeemable at the option of FIHL, in whole or in part, upon prior written notice in accordance with the certificate of designations, at a redemption price equal to $10,000 per share, plus accrued and unpaid dividends, if any, to, but excluding, the date fixed for redemption.
Series A Preference Securities Director Appointment Rights
Observer Rights
If the Net Worth (as defined below) is less than 75% of the Total Capitalization (as defined below) (such 75% being the Observer Capitalization Threshold), the holders of Series A Preference Securities, acting as a
220
separate class, will have the right to appoint one observer to the Board (the OCT Appointment Right). The term of office of such observer appointed pursuant to the OCT Appointment Right will terminate if (i) the Net Worth is equal to or greater than the Observer Capitalization Threshold or (ii) upon the appointment by the holders of Series A Preference Securities, acting as a separate class, of a director pursuant to the DCT Appointment Right (as defined below).
Net Worth means, as of the date of determination, the consolidated shareholders equity of FIHL as determined on a pro forma basis (as described below) by the Board, acting in good faith and based on the most recently prepared condensed, consolidated annual audited or unaudited quarterly financial statement prepared in accordance with International Financial Reporting Standards or U.S. GAAP (such statements being Annual or Quarterly Financial Statements).
Total Capitalization means, as of the date of determination, the sum of (i) the Net Worth and (ii) the aggregate principal amount of all outstanding indebtedness of FIHL for borrowed money and the aggregate liquidation preference of all outstanding Series A Preference Securities as determined on a pro forma basis (as described below) by the Board, acting in good faith and based on the most recently prepared Annual or Quarterly Financial Statements.
If FIHL incurs, assumes, redeems, defeases, retires or extinguishes any indebtedness, or issues, redeems or repurchases any Series A Preference Securities or Common Shares subsequent to the date of the most recently prepared Annual or Quarterly Financial Statements for which the Net Worth and the Total Capitalization are being calculated, then the Net Worth and the Total Capitalization will be calculated to give effect to such incurrence, assumption, redemption, defeasance, retirement or extinguishment of indebtedness, or such issuance, redemption or repurchase of Series A Preference Securities or Common Shares, as if the same had occurred prior to such date.
Director Rights
The holders of our Series A Preference Securities may appoint their representative directors to the Board (the Additional Directors) in the following circumstances:
(1) | if the Net Worth is less than 71% of the Total Capitalization (such 71% being the Director Capitalization Threshold) and has not been increased to be equal to or greater than 71% within 90 days, the holders of our Series A Preference Securities, acting as a separate class, will have the right to appoint two directors to the Board (each, a DCT Additional Director) (the DCT Appointment Right). The term of office of each DCT Additional Director will terminate if the Net Worth is equal to or greater than the Director Capitalization Threshold and the number of directors constituting the Board will automatically be reduced accordingly. |
(2) | in the event that dividends on our Series A Preference Securities are not paid in full on four Dividend Payment Dates, whether or not declared and whether or not consecutive, the holders of our Series A Preference Securities, acting as a class with any other holders of our Series A Preference Securities that did not receive dividends for four dividend periods, ranking on a parity with our Series A Preference Securities with respect to dividends, liquidation and voting (the Parity Shares), will have the right to appoint two directors to the Board (each, a Nonpayment Additional Director). The terms of office of such Nonpayment Additional Director will terminate when FIHL has paid or set aside for payment full dividends in arrears for our Series A Preference Securities and such Parity Shares for the current dividend period, and the number of directors constituting the Board will automatically be reduced accordingly. |
Maximum Directors
Notwithstanding the rights of the holders of Series A Preference Securities to appoint two DTC Additional Directors and two Nonpayment Additional Directors, the maximum number of Additional Directors that the
221
holders of Series A Preference Securities shall be entitled to appoint to the Board shall be two Additional Directors at any given time. The rights of the holders of Series A Preference Securities to appoint any director shall be subject to the prior approval of the applicable regulatory authority to the extent any such approval is required.
Rights in the Event of a Change of Control
Subject to prior approval of the applicable regulatory authority, in the event of a Change of Control (as defined below), unless FIHL has exercised its right to redeem our Series A Preference Securities, FIHL will be required to send a change of control notice and each holder of our Series A Preference Securities will have the right to convert immediately prior to the Change of Control (to the extent practicable) some or all of our Series A Preference Securities held by such holder into Common Shares (recognized as being at least equivalent regulatory capital and of equal status to our Series A Preference Securities) based on the conversion ratio prescribed in the certificate of designations in respect of our Series A Preference Securities.
Change of Control means:
(1) | any sale, lease, exclusive license, transfer or other disposition of all or substantially all of the assets of: |
(x) | FIHL; or |
(y) | FIHL and its subsidiaries, taken as a whole, |
to any person (as that term is used in Section 13(d)(3) of the Exchange Act), other than to FIHL, any of its subsidiaries or a permitted parent (Person); or
(2) | any transaction (including a sale of shares, merger or consolidation in which FIHL issues shares of its share capital) in which another Person becomes the beneficial owner of, and the holders of FIHLs outstanding share capital immediately before such transaction cease to beneficially own, shares representing more than 50% of the voting power (i.e., all classes of equity interests normally entitled to vote in the election of directors or all interests in FIHL with the ability to control the management or actions of FIHL) of FIHL (or the continuing or surviving entity of such transaction) as of immediately following the consummation of the transaction; |
provided, however, that an initial public offering or listing, including this offering, will not constitute a Change of Control for the purposes of this definition.
Other Series A Preference Securities Rights
Senior Capital Issuances
We may issue a class or series of shares or any other securities convertible or exchangeable into equity securities of FIHL ranking on a parity with or senior to our Series A Preference Securities in liquidation preference, voting or dividends, or any debt securities, whether senior or subordinated (New Securities); provided that (a) the issuances of such New Securities is part of a bona fide third-party financing and (b) the holders of more than 50% of the combined voting power of our Series A Preference Securities affirmatively consent to the issuance of any New Securities that (x) have a maturity on or prior to December 15, 2025, or an interest step-up or similar provision, which would incentivize FIHL to redeem, repurchase or otherwise repay the New Securities on or prior to December 15, 2025, or (y) would result in Common Shares and the Junior Shares representing in the aggregate less than 75% of the Total Capitalization. For the avoidance of doubt, nothing will prevent FIHL from raising Tier 1 capital (as prescribed by the applicable regulatory authority).
Series A Preference Securities Voting Rights
The holders of our Series A Preference Securities have no voting rights, except:
(1) | in respect of certain fundamental changes that will require the approval of the holders of a majority of our outstanding Series A Preference Securities, voting together as a class. Such fundamental changes |
222
include, without limitation: (i) any amendment of any provision of the memorandum of association of FIHL or the Amended and Restated Bye-Laws affecting a change in the rights, preferences or privileges of our Series A Preference Securities; or (ii) any interested party transaction, unless approved by a majority of the Board (including a majority of disinterested Directors); and |
(2) | on any matters on which holders of otherwise non-voting shares are entitled to vote pursuant to the Companies Act. |
Consent Right
For so long as any Series A Preference Securities are issued and outstanding, in addition to any other vote or consent of shareholders required by law or by the Amended and Restated Bye-Laws, the sanction of a resolution passed by the holders of more than 50% of the combined voting power of the issued and outstanding Series A Preference Securities voting as a separate class, at which a quorum (consisting of the presence, in person or by proxy, of the holders of 50% of the Series A Preference Securities) is present will be necessary for effecting or validating any issuance of New Securities that (a) have a maturity on or prior to December 15, 2025, or an interest step-up or similar provision that would incentivize FIHL to redeem, repurchase or otherwise repay the New Securities on or prior to December 15, 2025, or (b) would result in the Net Worth being less than 75% of the Total Capitalization.
Liquidity Rights
Following the consummation of this offering, FIHL will be required to use its commercially reasonable efforts to (i) cause our Series A Preference Securities to become DTC-eligible, in book-entry only form, with The Depository Trust Company, (ii) obtain an unrestricted CUSIP number for all Series A Preference Securities, and (iii) list our Series A Preference Securities on the same exchange on which our Common Shares are listed; provided that in the event the Board reasonably determines that our Series A Preference Securities do not or will not qualify for such listing requirements, FIHL will use its reasonable best efforts to cause our Series A Preference Securities, in the sole discretion of the Board, to be listed on an alternative market, as specified in the Preference Securityholders Agreement.
Certain Provisions of the Amended and Restated Bye-Laws
Certain provisions of the Amended and Restated Bye-Laws may have an anti-takeover effect and may delay, defer or prevent a tender offer or takeover attempt that a shareholder might consider in its best interest, including an attempt that might result in such shareholders receipt of a premium over the market price for his or her Common Shares. These provisions are also designed, in part, to encourage persons seeking to acquire control of us to first negotiate with the Board, which could result in an improvement of such persons terms. See Risk FactorsRisks Relating to the Common Shares and this OfferingThe current bye-laws of FIHL (the Existing Bye-Laws) will be amended and restated (the Amended and Restated Bye-Laws), conditional on this offering being consummated. The Amended and Restated Bye-Laws contain provisions that could impede an attempt to replace or remove the Board or delay or prevent the sale of FIHL, which could diminish the value of the Common Shares or prevent Shareholders from receiving premium prices for their Common Shares in an unsolicited takeover.
Number of Directors
The Amended and Restated Bye-Laws provide that the Board shall have not fewer than five directors and not more than fifteen directors with the exact number of directors to be determined from time to time by resolution adopted by the affirmative vote of a simple majority of the Board. Immediately prior to this offering, the Board and existing shareholders approved an increase in the size of the Board from nine directors to twelve directors as part of a general review underway to consider broadening the breadth of expertise at the board level. Subject to the rights of each of the Founders and MGU HoldCo in the Amended and Restated Bye-Laws, the vacancies will be filled if the Board approves suitable candidates following the consummation of this offering.
223
The Amended and Restated Common Shareholders Agreement will entitle the Founders to nominate representative directors to the Board, so long as they each beneficially own a specified minimum percentage of our Common Shares. Each Founder will be entitled to nominate its representative director to the Board for so long such Founder, together with its Shareholder Affiliate Transferees (as defined below), beneficially owns at least 7.5% of the Common Shares. MGU HoldCo will also be entitled to nominate its representative director to the Board for so long as MGU HoldCo, together with its Shareholder Affiliate Transferees, beneficially owns at least 50% of the MGU HoldCo Initial Shares. See Management and Corporate GovernanceExecutive Officers and Directors for the details of each of the directors appointed by MGU HoldCo and each of the Founders.
Shareholder Affiliate Transferees means, with respect any Founder or MGU HoldCo, (i) its affiliates, including any person that has a common general partner, managing member, investment manager or governing body with any such Founder or MGU HoldCo or the funds which own such Founder or MGU HoldCo, and (ii) any general or limited partner or member of such Founder or MGU HoldCo or any of its affiliates and any corporation, partnership or other entity that is an affiliate of such general or limited partner or member, so long as such person remains an affiliate thereof; provided, that, CVCs Shareholder Affiliate Transferees do not include (a) any portfolio company of CVC or any of its affiliated investment funds or (b) CVC Credit Partners LP and any of its subsidiaries.
The holders of our Series A Preference Securities also have the right to elect directors to the Board under certain circumstances. See Preference SecuritiesSeries A Preference Securities Director Appointment RightsDirector Rights for further detail.
Upon the listing of our Common Shares on NYSE, in accordance with the terms of the Amended and Restated Bye-Laws, the Board will be divided into three classes, designated Class I, Class II and Class III, with members of each class serving staggered three-year terms. Each director will serve for a term ending on the date of our third annual general meeting next following the annual general meeting at which such director was elected; provided that directors initially designated as Class I directors will serve for an initial term ending on the date of our first annual general meeting next following the annual general meeting at which such directors were elected, directors initially designated as Class II directors will serve for an initial term ending on our second annual general meeting next following the annual general meeting at which such directors were elected; and directors initially designated as Class III directors will serve for an initial term ending on our third annual general meeting next following the annual general meeting at which such directors were elected.
Our classified Board prevents shareholders from electing an entirely new board at an annual general meeting and could have the effect of delaying or discouraging an acquisition of FIHL or a change in management. The classified board will be in place until the annual general meeting occurring in 2030, following which, all of the directors shall be of one class and shall serve for a term ending at the next following annual general meeting.
Removal of Directors
Shareholders representing 80% of the Total Voting Power may, at any general meeting convened and held for such purpose in accordance with the Amended and Restated Bye-Laws, remove a director for certain specified causes, including but not limited to indictment by a court and willful and material failure or refusal to perform his or her duties as a director.
Notice of any such meeting convened for the purpose of removing a director must contain a statement of the intention so to do and be served on such director not less than sixty days before the meeting and at such meeting such director will be entitled to be heard on the motion for such directors removal.
Shareholder Advance Notice Procedures
Notice of an annual general meeting and special general meeting must be given to shareholders at least five days before the date of such meeting, stating the date, place and time at which the meeting is to be held and business to be conducted at the meeting, including, for annual general meetings, the election of directors.
224
A general meeting may be called on shorter notice provided that (i) in the case of an annual general meeting, with the agreement of all of the shareholders entitled to attend and vote at such meeting and (ii) in the case of a special general meeting, with the agreement of a majority in number of the shareholders entitled to attend and vote at such meeting, together holding not less than 95% in nominal value of the shares entitled to be voted at such meeting.
Failure to provide notice of a general meeting to any person entitled to receive notice will invalidate the proceedings conducted at such meeting. The Amended and Restated Bye-Laws contain detailed provisions setting out the manner in which a notice of a general meeting must be served effectively on the shareholders.
Amendments to the Amended and Restated Bye-Laws
The Amended and Restated Bye-Laws provide that no Bye-Law may be rescinded, altered or amended and no new Bye-Law can be made, save in accordance with the Companies Act, unless a resolution is approved by a simple majority of the shareholders, provided that any rescission, alteration or amendment to bye-laws conferring special rights upon each of the Founders and MGU HoldCo, shall require the prior consent of each of the Founders and MGU HoldCo for so long as they each beneficially own a specified minimum percentage of our Common Shares or they have a designated director serving on the Board.
Meetings of Shareholders
Annual General Meetings
An annual general meeting will be held in each year at such time and place as the Board determines, unless FIHL elects to dispense with the holding of annual general meetings in accordance with the Companies Act.
Special General Meetings
The Board may convene a special general meeting whenever in its judgment such a meeting is necessary and in accordance with the advance notice provisions.
Requisitioned General Meetings
Shareholders holding not less than 10% of the paid-up share capital of FIHL carrying the right to vote at general meetings may requisition the Board to convene a special general meeting in accordance with the provisions of the Companies Act and in accordance with the advance notice provisions set out in the Amended and Restated Bye-Laws.
Market Listing
We have applied to list our Common Shares on NYSE under the symbol FIHL.
Transfer Agent and Registrar
Following the listing of our Common Shares on NYSE, the transfer agent and registrar for our Common Shares will be Computershare, Inc.
225
COMPARISON OF SHAREHOLDER RIGHTS
Prospective investors should be aware that the Companies Act, which applies to us, differs in certain material respects from laws generally applicable to U.S. companies incorporated in the State of Delaware and their shareholders. The following is a summary of certain significant differences between the Companies Act (including modifications adopted pursuant to our Amended and Restated Bye-Laws) and Bermuda common law applicable to us and our shareholders, on the one hand, and the provisions of the Delaware General Corporation Law applicable to U.S. companies organized under the laws of Delaware and their shareholders, on the other hand.
Duties of Directors
The Companies Act authorizes the directors of a company, subject to its bye-laws, to exercise all powers of the company except those that are required by the Companies Act or the companys bye-laws to be exercised by the shareholders of the company. Our Amended and Restated Bye-Laws provide that our business is to be managed and conducted by the Board. In accordance with Bermuda common law, members of a board of directors owe a fiduciary duty to the company to act in good faith in their dealings with or on behalf of the company and exercise their powers and fulfill the duties of their office honestly. This duty includes the following essential elements:
(1) | a duty to act in good faith in the best interests of the company; |
(2) | a duty not to make a personal profit from opportunities that arise from the office of director; |
(3) | a duty to avoid situations in which there is an actual or potential conflict between a personal interest or the duties owed; and |
(4) | a duty to exercise powers for the purpose for which such powers were intended. |
The Companies Act imposes a duty on directors and officers of a Bermuda company:
(1) | to act honestly and in good faith with a view to the best interests of the company; and |
(2) | to exercise the care, diligence and skill that a reasonably prudent person would exercise in comparable circumstances. |
The Companies Act also imposes various duties on directors and officers of a company with respect to certain matters of management and administration of such company.
Under Bermuda law, directors and officers generally owe fiduciary duties to the company itself, not to the companys individual shareholders or members, creditors, or any class of shareholders, members or creditors. Our shareholders may not have a direct cause of action against our directors.
Under Delaware law, the business and affairs of a company are managed by or under the direction of its board of directors. In exercising their powers, directors are charged with a fiduciary duty of care to protect the interests of the company and a fiduciary duty of loyalty to act in the best interests of its shareholders. The duty of care requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform himself of, and disclose to shareholders, all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director act in a manner he or she reasonably believes to be in the best interests of the company. He or she must not use his or her corporate position for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that the best interests of the company and its shareholders take precedence over any interest possessed by a director, officer or controlling shareholder and not shared by the shareholders generally. In general, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the company. However, this presumption may be
226
rebutted by evidence of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by a director, a director must prove the procedural fairness of the transaction, and that the transaction was of fair value to the company.
Interested Directors
Bermuda law provides that a transaction entered into by us in which a director has an interest will not be voidable by us and such director will not be liable to us for any profit realized pursuant to such transaction as a result of such interest, provided that the nature of the interest is disclosed at the first opportunity, either at a meeting of directors or in writing to the directors. While we are not aware of any Bermuda case law on the meaning of first opportunity, a Bermuda court will likely employ a practical interpretation of those words.
Subject to the NYSE rules and applicable U.S. securities laws, our Amended and Restated Bye-Laws do not require directors to recuse themselves from any discussion or decision involving any contract or proposed contract or arrangement in which the director is directly or indirectly interested so long as the nature of the interest is disclosed, and such director may be counted in the quorum for such meeting, unless the Board by resolution of a simple majority of the Board (which vote shall exclude the interested director) requires the director to abstain from any vote on the conflicted matter.
Under Delaware law, such transaction would not be voidable if: (i) the material facts as to such interested directors relationship or interests are disclosed or are known to the board of directors and the board in good faith authorizes the transaction by the affirmative vote of a majority of the disinterested directors; (ii) such material facts are disclosed or are known to the shareholders entitled to vote on such transaction and the transaction is specifically approved in good faith by vote of the majority of shares entitled to vote on the matter; or (iii) the transaction is fair as to the company as of the time it is authorized, approved or ratified. Under Delaware law, such interested director could be held liable for a transaction in which such director derived an improper personal benefit.
Voting Rights and Quorum Requirements
Under Bermuda law, the voting rights of our shareholders are regulated by our Amended and Restated Bye-Laws and, in certain circumstances, the Companies Act. Generally, except as otherwise provided in the Amended and Restated Bye-Laws or the Companies Act, any action or resolution requiring approval of the shareholders may be passed by a simple majority of the shareholders. Any individual who is our shareholder and who is present at a meeting may vote in person, as may any corporate shareholder that is represented by a duly authorized representative at a meeting of shareholders. Our Amended and Restated Bye-Laws also permit attendance at general meetings by proxy, provided that the instrument appointing the proxy is in the form specified in the Amended and Restated Bye-Laws or such other form as the Board may determine. The specific voting rights of our Common Shares are set forth in detail under Description of Share CapitalCommon SharesVoting Rights.
Under Delaware law, unless otherwise provided in a companys certificate of incorporation, each shareholder is entitled to one vote for each share of stock held by the shareholder. Delaware law provides that unless otherwise provided in a companys certificate of incorporation or bylaws, a majority of the shares entitled to vote, present in person or represented by proxy, constitutes a quorum at a meeting of shareholders. In matters other than the election of directors, with the exception of special voting requirements related to extraordinary transactions, and unless otherwise provided in a companys certificate of incorporation or bylaws, the affirmative vote of a majority of shares present in person or represented by proxy and entitled to vote at a meeting in which a quorum is present is required for shareholder action, and the affirmative vote of a plurality of shares present in person or represented by proxy and entitled to vote at the meeting is required for the election of directors.
227
Amalgamations, Mergers and Similar Arrangements
The amalgamation or merger of a Bermuda company with another company or corporation (other than certain affiliated companies) requires the amalgamation or merger agreement to be approved by the companys board of directors and by its shareholders. Unless the companys bye-laws provide otherwise, the approval of 75% of the shareholders voting at such meeting is required to approve the amalgamation or merger agreement, and the quorum for such meeting must be two persons holding or representing more than one-third of the issued shares of the company.
Under Bermuda law, in the event of an amalgamation or merger of a Bermuda company with another company or corporation, a shareholder of the Bermuda company who did not vote in favor of the amalgamation or merger and is not satisfied that fair value has been offered for such shareholders shares may, within one month of notice of the shareholders meeting, apply to the Supreme Court of Bermuda to appraise the fair value of those shares.
Under Delaware law, with certain exceptions, a merger, consolidation or sale of all or substantially all the assets of a corporation must be approved by the board of directors and a majority of the issued and outstanding shares entitled to vote on such transaction. A shareholder of a company participating in certain merger and consolidation transactions may, under certain circumstances, be entitled to appraisal rights, such as having a court determine the fair value of the stock or requiring the company to pay such value in cash. However, such appraisal right is not available to shareholders if the stock received in such transaction is listed on a national securities exchange, including NYSE.
Acquisitions
Under Bermuda law, an acquiring party is generally able to acquire compulsorily the common shares of minority holders of a company in the following ways:
(1) | By a procedure under the Companies Act known as a scheme of arrangement. The Companies Act enables the Supreme Court of Bermuda to approve a scheme of arrangement between a company and its shareholders or any class of shareholders. If the requisite majority (being a majority in number of shareholders representing 75% in value) agrees to the acquisition of their shares pursuant to the terms of the scheme, and the Supreme Court sanctions the scheme, the remaining shares can be compulsorily acquired. Schemes may provide for the targets shares to be either transferred or cancelled, but unlike a transfer scheme, a cancellation scheme requires the company to pass a solvency test. In either case, dissenting shareholders do not have express statutory appraisal rights although shareholders have a right to appear at the hearing, and the Supreme Court will only sanction a scheme if the Supreme Court is satisfied that the scheme is fair. Shares owned by the acquirer can be voted to approve the scheme, but the Supreme Court will be concerned to see that the shareholders approving the scheme are fairly representative of the general body of shareholders. |
(2) | If the acquiring party is a company, by acquiring pursuant to a tender offer 90% of the shares or class of shares not already owned by, or by a nominee for, the acquiring party (the offeror), or any of its subsidiaries. If an offeror has, within four months after the making of an offer for all the shares or class of shares not owned by, or by a nominee for, the offeror, or any of its subsidiaries, obtained the approval of the holders of 90% or more of all the shares to which the offer relates, the offeror may, at any time within two months beginning with the date on which the approval was obtained, by notice compulsorily acquire the shares of any non-tendering shareholder on the same terms as the original offer unless the Supreme Court of Bermuda (on application made within a one-month period from the date of the offerors notice of its intention to acquire such shares) orders otherwise. |
(3) | Where the acquiring party or parties hold not less than 95% of the shares or a class of shares of the company, by acquiring, pursuant to a notice given to the remaining shareholders or class of shareholders, the shares of such remaining shareholders or class of shareholders. When this notice is |
228
given, the acquiring party is entitled and bound to acquire the shares of the remaining shareholders on the terms set out in the notice, unless a remaining shareholder, within one month of receiving such notice, applies to the Supreme Court of Bermuda for an appraisal of the value of their shares. This provision only applies where the acquiring party offers the same terms to all holders of shares whose shares are being acquired. |
Delaware law provides that a parent corporation, by resolution of its board of directors and without any shareholder vote, may merge with any subsidiary of which it owns at least 90% of each class of its capital stock. Upon any such merger, and in the event the parent corporation does not own all of the stock of the subsidiary, dissenting shareholders of the subsidiary are entitled to certain appraisal rights. Delaware law also provides, subject to certain exceptions, that if a person acquires 15% of voting stock of a company, the person is an interested shareholder and may not engage in business combinations with the company for a period of three years from the time the person acquired 15% or more of voting stock.
Dissenters Rights of Appraisal
Under Bermuda law, in the event of an amalgamation or merger of a Bermuda company with another company or corporation, a shareholder of the Bermuda company who did not vote in favor of the amalgamation or merger and who is not satisfied that fair value has been offered for such shareholders shares may, within one month of notice of the shareholders meeting, apply to the Supreme Court of Bermuda to appraise the fair value of those shares. Under Bermuda law, each share of an amalgamating or merging company carries the right to vote in respect of an amalgamation or merger whether or not it otherwise carries the right to vote.
In addition, any minority shareholder receiving notice that the holders of 95% or more of a companys shares or class of shares intend to compulsorily acquire the minority shareholders shares may, within one month of receiving the notice, apply to the Supreme Court of Bermuda to appraise the value of the shares.
Appraisal rights are available under Delaware law for any class or series of common shares of a corporation in a merger or consolidation, subject to limited exceptions, such as a merger or consolidation of corporations listed on a national securities exchange in which listed stock is the offered consideration.
Shareholders Suits
Class actions and derivative actions are generally not available to shareholders under Bermuda law. The Bermuda courts, however, would ordinarily be expected to permit a shareholder to commence an action in the name of a company to remedy a wrong to the company where the act complained of is alleged to be beyond the corporate power of the company or illegal, or would result in the violation of the companys memorandum of association or bye-laws.
Furthermore, consideration would be given by a Bermuda court to acts that are alleged to constitute a fraud against the minority shareholders or, for instance, where an act requires the approval of a greater percentage of the companys shareholders than that which actually approved it.
Class actions and derivative actions generally are available to shareholders under Delaware law for, among other things, breach of fiduciary duty, corporate waste and actions not taken in accordance with applicable law. In such actions, the court generally has discretion to permit the winning party to recover attorneys fees incurred in connection with such action.
Indemnification of Directors and Officers
Section 98 of the Companies Act provides generally that a Bermuda company may indemnify its directors, officers and auditors against any liability which by virtue of any rule of law would otherwise be imposed on them
229
in respect of any negligence, default, breach of duty or breach of trust, except in cases where such liability arises from fraud or dishonesty of which such director, officer or auditor may be guilty in relation to the company. Section 98 further provides that a Bermuda company may indemnify its directors, officers and auditors against any liability incurred by them in defending any proceedings, whether civil or criminal, in which judgment is awarded in their favor or in which they are acquitted or granted relief by the Supreme Court of Bermuda pursuant to Section 281 of the Companies Act. Section 98 of the Companies Act further provides that a company may advance moneys to an officer or auditor for the costs, charges and expenses incurred by the officer or auditor in defending any civil or criminal proceedings against them, on condition that the officer or auditor shall repay the advance if any allegation of fraud or dishonesty is proved against them.
We have adopted provisions in our Amended and Restated Bye-Laws that provide that we shall indemnify our officers and directors in respect of their actions and omissions except in respect of fraud or dishonesty. Pursuant to our Amended and Restated Bye-Laws, our shareholders have agreed to waive any claim or right of action such shareholder may have, whether individually or by or in our right, against any director or officer on account of any action taken by such director or officer, or the failure of such director or officer to take any action in the performance of his or her duties with or for us or any of our subsidiaries, provided that such waiver does not extend to any matter in respect of any fraud or dishonesty in relation to us which may attach to such director or officer.
Under Delaware law, a corporation may include in its certificate of incorporation a provision that, subject to the limitations described below, eliminates or limits director liability to the corporation or its shareholders for monetary damages for breaches of their fiduciary duty of care. Under Delaware law, a directors liability cannot be eliminated or limited for: (i) breaches of the duty of loyalty; (ii) acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law; (iii) the payment of unlawful dividends or expenditure of funds for unlawful stock purchases or redemptions; or (iv) transactions from which such director derived an improper personal benefit.
Delaware law provides that a corporation may indemnify a director, officer, employee or agent of the corporation against any liability or expenses incurred in any civil, criminal, administrative or investigative proceeding if they acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal proceeding, had no reasonable cause to believe their conduct was unlawful, except that in any action brought by or in the right of the corporation, such indemnification may be made only for expenses (not judgments or amounts paid in settlement) and may not be made even for expenses if the officer, director or other person is adjudged liable to the corporation (unless otherwise determined by the court). In addition, under Delaware law, to the extent that a director or officer of a corporation has been successful on the merits or otherwise in defense of any proceeding referred to above, he or she must be indemnified against expenses (including attorneys fees) actually and reasonably incurred by that party. Furthermore, under Delaware law, a corporation is permitted to maintain directors and officers insurance.
Meeting of Shareholders
The Companies Act requires an annual meeting of shareholders unless waived by resolution of shareholders. Our Amended and Restated Bye-Laws provide that, subject to an election made by us in accordance with the Companies Act to dispense with the holding of annual general meetings, an annual general meeting will be held in each year at such time and place as the Board determines.
Under our Amended and Restated Bye-Laws, a special general meeting of shareholders may be held when the Board, in its judgment, decides such a meeting is necessary. In addition, the Board shall, on the requisition of shareholders holding at the date of the deposit of the requisition not less than 10% of our paid-up share capital, forthwith proceed to convene a special general meeting and the provisions of the Companies Act shall apply.
Delaware law permits the board of directors or any person who is authorized under a corporations certificate of incorporation or bylaws to call a special meeting of shareholders.
230
Notice of Shareholder Meetings
Bermuda law and our Amended and Restated Bye-Laws require that shareholders be given at least five days advance notice of any general meeting.
Under Delaware law, a company is generally required to give written notice of any meeting not less than ten days or more than sixty days before the date of the meeting to each shareholder entitled to vote at the meeting.
Dividends and Other Distributions
Under Bermuda law, a company may not declare or pay a dividend, or make a distribution out of contributed surplus, if there are reasonable grounds for believing that (i) it is, or would after the payment be, unable to pay its liabilities as they become due; or (ii) the realizable value of its assets would thereafter be less than its liabilities. Contributed surplus is defined for purposes of Section 54 of the Companies Act to include the proceeds arising from donated shares, credits resulting from the redemption or conversion of shares at less than the amount set up as nominal capital, and donations of cash and other assets to the company.
Under Delaware law, subject to any restrictions contained in the companys certificate of incorporation, a company may pay dividends out of surplus or, if there is no surplus, out of net profits for the fiscal year in which the dividend is declared and for the preceding fiscal year. Delaware law also provides that dividends may not be paid out of net profits if, after the payment of the dividend, capital is less than the capital represented by the outstanding stock of all classes having a preference upon the distribution of assets.
Inspection of Corporate Records
Members of the general public have the right to inspect our public documents available at the office of the Registrar of Companies in Bermuda. These documents include our memorandum of association and any charges on our assets. Our shareholders have the additional right to inspect our Amended and Restated Bye-Laws, minutes of general meetings and audited financial statements, all of which must be presented to the annual general meeting of shareholders.
The register of members of a company is also open to inspection by shareholders and members of the general public without charge. The register of members is required to be open for inspection for not less than two hours in any business day (subject to the ability of a company to close the register of members for not more than 30 days in a year). A company is required to maintain its share register in Bermuda but may, subject to the provisions of the Companies Act, establish a branch register outside of Bermuda. A company is required to keep at its registered office a register of directors and officers and a list of its directors must be filed with the Registrar of Companies where it will be available for public inspection. Bermuda law does not, however, provide a general right for shareholders to inspect or obtain copies of any other corporate records.
Delaware law requires that a company, within ten days before a meeting of shareholders, prepare and make available a complete list of shareholders entitled to vote at the meeting. This list must be open to the examination of any shareholder for any purpose relating to the meeting for a period of at least ten days prior to the meeting, either on a reasonably accessible electronic network or during ordinary business hours at the principal place of business of the company. Delaware law also permits a shareholder to inspect the companys books and records if the shareholder can establish that he or she is a shareholder of the company, that the shareholder has complied with Delaware law with respect to the form and manner of making demand for inspection of corporate records, and that the inspection by the shareholder is for a proper purpose.
Shareholder Proposals
Under Bermuda law, upon the requisition in writing of such number of shareholders as is hereinafter specified and at their own expense (unless the company otherwise resolves), the company will be required to:
231
(i) give notice to all shareholders entitled to receive notice of the annual general meeting of any resolution which may properly be moved and is intended to be moved at the next annual general meeting; and/or (ii) circulate to all shareholders entitled to receive notice of any general meeting a statement of not more than one thousand words with respect to the matter referred to in any proposed resolution or any business to be conducted at such general meeting. The number of shareholders necessary for a requisition under the foregoing sentence is (x) either any number of shareholders representing not less than 1/20th of the total voting rights of all members having at the date of the requisition a right to vote at that meeting to which the requisition relates; or (y) not less than one hundred shareholders.
The specific procedures under our Amended and Restated Bye-Laws governing shareholder proposals in relation to our company are set forth under Description of Share CapitalCertain Bye-Law ProvisionsShareholder Advance Notice Procedures.
Delaware law does not include a provision restricting the manner in which nominations for directors may be made by shareholders or the manner in which business may be brought before a meeting, although restrictions may be included in a Delaware corporations certificate of incorporation or bylaws.
Amendment of Memorandum of Association/Certificate of Incorporation
Bermuda law provides that the memorandum of association of a company may be amended by a resolution passed at a general meeting of shareholders of which due notice has been given. Certain amendments to the memorandum of association may require approval of the Bermuda Minister of Finance, who may grant or withhold approval at his or her discretion.
Under Bermuda law, the holders of an aggregate of not less than 20% in par value of a companys issued share capital have the right to apply to the Bermuda courts for an annulment of any amendment of the memorandum of association adopted by shareholders at any general meeting, other than an amendment which alters or reduces a companys share capital as provided in the Companies Act. When such an application is made, the amendment becomes effective only to the extent that it is confirmed by the Bermuda court. An application for an annulment of an amendment of the memorandum of association must be made within 21 days after the date on which the resolution altering the companys memorandum of association is passed and may be made on behalf of persons entitled to make the application by one or more of their designees as such holders may appoint in writing for such purpose. No application may be made by the shareholders voting in favor of the amendment.
Under Delaware law, amendment of the certificate of incorporation, which is the equivalent of a memorandum of association, of a company must be made by a resolution of the board of directors setting forth the amendment, declaring its advisability, and either calling a special meeting of the shareholders entitled to vote or directing that the proposed amendment be considered at the next annual meeting of the shareholders. Delaware law requires that, unless a greater percentage is provided for in the certificate of incorporation, a majority of the outstanding voting power of the corporation is required to approve the amendment of the certificate of incorporation at the shareholders meeting. If the amendment would alter the number of authorized shares or par value or otherwise adversely affect the powers, preferences or special rights of any class of a companys stock, the holders of the issued and outstanding shares of such affected class, regardless of whether such holders are entitled to vote by the certificate of incorporation, are entitled to vote as a class upon the proposed amendment. However, the number of authorized shares of any class may be increased or decreased, to the extent not falling below the number of shares then outstanding, by the affirmative vote of the holders of a majority of the stock entitled to vote, if so provided in the companys original certificate of incorporation.
Amendment of Bye-Laws
Our Amended and Restated Bye-Laws provide that the Amended and Restated Bye-Laws may be amended upon a resolution approved by a simple majority of the Board and by a resolution approved by a simple majority
232
of the shareholders, provided that any rescission, alteration or amendment to bye-laws conferring special rights on each of the Founders and MGU HoldCo (as described in more detail in Description of Share CapitalCertain Provisions of the Amended and Restated Bye-LawsAmendments to the Amended and Restated Bye-Laws) shall require the prior consent of each of the Founders and MGU HoldCo for so long as they each beneficially own a specified minimum percentage of our Common Shares or they have a designated director serving on the Board.
Under Delaware law, unless the certificate of incorporation or bylaws provide for a different vote, holders of a majority of the voting power of a corporation and, if so provided in the certificate of incorporation, the directors of the corporation have the power to adopt, amend and repeal the bylaws of a corporation.
Dissolution
Under Bermuda law, a solvent company may be wound up by way of a shareholders voluntary liquidation. Prior to the company entering liquidation, a majority of the directors are each required to make a statutory declaration, which states that the directors have made a full inquiry into the affairs of the company and have formed the opinion that the company will be able to pay its debts within a period of 12 months of the commencement of the winding-up and must file the statutory declaration with the Registrar of Companies in Bermuda. The general meeting is required to be convened primarily for the purposes of passing a resolution that the company be wound up voluntarily and appointing a liquidator. The winding-up of the company is deemed to commence at the time of the passing of the resolution.
Under Delaware law, a corporation may voluntarily dissolve (i) if a majority of the board of directors adopts a resolution to that effect and the holders of a majority of the issued and outstanding shares entitled to vote thereon vote for such dissolution; or (ii) if all shareholders entitled to vote thereon consent in writing to such dissolution.
233
SHARES ELIGIBLE FOR FUTURE SALE
General
Prior to the listing of our Common Shares on NYSE, there has been no public market for our Common Shares and we cannot assure prospective investors that a significant public market for our Common Shares will develop or be sustained after the initial listing of our Common Shares on NYSE. Trading of our Common Shares on NYSE is expected to commence immediately upon the effective date of the registration statement of which this prospectus forms a part. No prediction can be made as to the effect, if any, that future sales of shares or the availability of shares for future sale will have on the market price of our Common Shares prevailing from time to time. Sales of substantial amounts of our Common Shares in the public market, or the perception that such sales could occur, could adversely affect the prevailing market price of our Common Shares.
Sales of Restricted Securities
Currently, 110,771,897 of our Common Shares are outstanding. We are offering 5,714,286 Common Shares. The Selling Shareholders are offering an additional 11,285,714 Common Shares (or 13,835,714 Common Shares if the underwriters exercise their option to purchase additional Common Shares from the Selling Shareholders in full). After giving effect to the offering, there will be 116,486,183 Common Shares outstanding. 17,000,000 (or 19,550,000 if the underwriters exercise their option to purchase additional Common Shares from the Selling Shareholders in full) will be freely tradable without restriction under the Securities Act, unless purchased by our affiliates, as that term is defined in Rule 144 under the Securities Act. The remaining Common Shares that will be outstanding after this offering are restricted securities within the meaning of Rule 144 under the Securities Act. Restricted securities may be sold in the public market only if registered under the Securities Act or if they qualify for an exemption from registration, including an exemption under Rule 144 or Rule 701, which are summarized below.
Of the 116,486,183 of our Common Shares outstanding immediately following this offering, 99,486,183 Common Shares (or 96,936,183 Common Shares if the underwriters exercise their option to purchase additional Common Shares from the Selling Shareholders in full) are restricted securities, as that term is defined in Rule 144 under the Securities Act, or are subject to lock-up agreements as described herein.
As defined in Rule 144, an affiliate of an issuer is a person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with the issuer.
Lock-up Agreement
Prior to the settlement of this offering, the Selling Shareholders, our executive officers, members of the Board and other holders of our Common Shares, collectively holding approximately 99.9% of our outstanding Common Shares, have agreed, subject to limited exceptions, not to offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise dispose of, directly or indirectly, or enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Common Shares or such other securities for a period of 180 days or more after the date of this prospectus, subject to certain exceptions, and in the case of the underwriters 180-day lock-up, without the prior written consent of the representatives on behalf of the underwriters. These agreements are described below under the section captioned Underwriting, and Material Contracts and Related Party TransactionsIPO Assistance and Lock-Up Agreement, Registration Rights Agreement, and Common Shareholders Agreement.
Registration Rights
The Existing Shareholders will have the right to require us to include their Registrable Securities in any registration statement filed for the purposes of a public offering of our equity securities, subject to the terms of
234
the Registration Rights Agreement. These Registrable Securities will represent 75.7% of our outstanding Common Shares after this offering (or 73.5% if the underwriters exercise their option to purchase additional Common Shares from the Selling Shareholders in full). See Material Contracts and Related Party TransactionsRegistration Rights Agreement.
Rule 144
In general, under Rule 144 as currently in effect, beginning 90 days after the effectiveness of the registration statement of which this prospectus forms a part, a person who is not our affiliate and has not been our affiliate at any time during the preceding three months will be entitled to sell any of our Common Shares that such person has beneficially owned for at least six months, including the holding period of any prior owner other than one of our affiliates, without regard to volume limitations and subject only to the availability of current public information about us. A non-affiliated person who has beneficially owned shares considered to be restricted securities under Rule 144 for at least one year would be entitled to sell those shares without complying with any of the requirements of Rule 144.
Beginning 90 days after the effectiveness of the registration statement of which this prospectus forms a part, an affiliate of ours who has beneficially owned our Common Shares for at least six months would be entitled to sell, within any three-month period, a number of shares that does not exceed the greater of:
| one percent (1%) of our Common Shares then issued and outstanding, which will equal approximately 1.2 million shares immediately after this offering; or |
| the average weekly trading volume of our Common Shares on NYSE during the four calendar weeks preceding the date on which notice of the sale is filed with the SEC. |
Sales under Rule 144 by our affiliates or persons selling our Common Shares on behalf of our affiliates are also subject to any manner of sale provisions, notice requirements and the availability of current public information about us. The sale of these Common Shares, or the perception that sales will be made, could adversely affect the price of our Common Shares after this offering because a great supply of Common Shares would be, or would be perceived to be, available-for-sale in the public market.
We are unable to estimate the number of Common Shares that will be sold under Rule 144 since this will depend on the market price for our Common Shares, the personal circumstances of the shareholder and other factors.
Rule 701
Any of our employees, officers or directors who acquired our Common Shares under a written compensatory plan or contract may be entitled to sell them in reliance on Rule 701. Rule 701 permits affiliates to sell their Rule 701 Common Shares under Rule 144 without complying with the holding period requirements of Rule 144. Rule 701 further provides that non-affiliates may sell these Common Shares in reliance on Rule 144 without complying with the holding period, public information, volume limitation or notice provisions of Rule 144. All holders of Rule 701 Common Shares are required to wait until 90 days after the date of this prospectus before selling such Common Shares. However, our Common Shares issued under Rule 701 that are subject to lock-up agreements will become eligible for sale only when the 180-day lock-up agreements expire.
Regulation S
Regulation S under the Securities Act provides an exemption from registration requirements in the U.S. for offers and sales of securities that occur outside the U.S. Rule 903 of Regulation S provides the conditions to the exemption for a sale by an issuer, a distributor, their respective affiliates or anyone acting on their behalf, while Rule 904 of Regulation S provides the conditions to the exemption for a resale by persons other than those
235
covered by Rule 903. In each case, any sale must be completed in an offshore transaction, as that term is defined in Regulation S, and no directed selling efforts, as that term is defined in Regulation S, may be made in the U.S.
We are a foreign issuer as defined in Regulation S. As a foreign issuer, securities that we sell outside the U.S. pursuant to Regulation S are not considered to be restricted securities under the Securities Act, and, subject to the offering restrictions imposed by Rule 903, are freely tradable without registration or restrictions under the Securities Act, unless the securities are held by our affiliates. Generally, subject to certain limitations, a holder of our restricted securities who is not our affiliate or who is an affiliate by virtue of his status as an officer or director may, under Regulation S, resell his restricted securities in an offshore transaction if none of the seller or its affiliates or any person acting on their behalf engages in directed selling efforts in the U.S. and, in the case of a sale of our restricted securities by an officer or director who is an affiliate of ours solely by virtue of holding such position, no selling commission, fee or other remuneration is paid in connection with the offer or sale other than the usual and customary brokers commission that would be received by a person executing such transaction as agent. Additional restrictions are applicable to a holder of our restricted securities who will be an affiliate of FIHL other than by virtue of his or her status as an officer or director of FIHL.
Form S-8 Registration Statement
Following this offering, we intend to file with the SEC a registration statement on Form S-8 under the Securities Act covering the Common Shares reserved for issuance under our Long-Term Incentive Plan. The registration statement is expected to be filed and become effective as soon as practicable after the completion of this offering. Accordingly, shares registered under the Form S-8 registration statement will be available for sale in the open market following the registration statements effective date, subject to Rule 144 volume limitations and the lock-up agreements described above, if applicable.
236
CERTAIN REGULATORY CONSIDERATIONS
Current Fidelis is subject to varying degrees of regulation and supervision in the jurisdictions in which it operates. In particular, the businesses of Current Fidelis three insurance operating subsidiaries, FIBL, FUL and FIID, are authorized by, and subject to insurance laws and regulations that are administered and enforced by, a number of different governmental and non-governmental self-regulatory authorities and associations in each of their respective jurisdictions and internationally. Each of the insurance operating subsidiaries has entered into a Delegated Underwriting Authority Agreement with the relevant Fidelis MGU operating subsidiary on a jurisdictional basis. In addition, FIHL has entered into the Inter-Group Services Agreement with MGU HoldCo for the provision of certain non-underwriting services. See Material Contracts and Related Party Transactions for further information relating to the contractual matrix forming this structure.
The following is a summary of the core aspects of the regulatory environment of Current Fidelis insurance operating subsidiaries, primarily in their respective jurisdictions of the U.K., Ireland and Bermuda, as well as the authorizations of Fidelis MGU. FIBL and FUL also conduct their business pursuant to the applicable U.S. excess and surplus lines and certified reinsurer authorizations.
The following summary relates predominantly to the insurance regulatory regimes in the U.K., Ireland and Bermuda insofar as they relate to the insurance operating subsidiaries as authorized insurers. However, the following summary also contains various references to the application of domestic insurance regulation to the operating subsidiaries of Fidelis MGU as authorized insurance intermediaries, given their symbiotic relationship with the insurance operating subsidiaries and their integration in the Subsidiary Annual Plans.
Bermuda Insurance Regulation
The following provides a more in-depth discussion of the applicable Bermuda regulation given the FIHLs and FIBLs incorporation in Bermuda and the BMA Group supervision.
General
The Bermuda Insurance Act and related rules and regulations, provides that no person shall carry on insurance business in or from within Bermuda unless registered as an insurer under the Insurance Act by the BMA.
FIBL, a wholly owned subsidiary of FIHL, is registered as a Class 4 Insurer pursuant to the Insurance Act. Certain significant aspects of the Bermuda insurance regulatory framework applicable to Class 4 insurers are set forth below.
Annual Financial Statements
As a Class 4 insurer, FIBL is required to prepare and submit, on an annual basis, audited financial statements which have been prepared under generally accepted accounting principles or international financial reporting standards (GAAP financial statements) and audited statutory financial statements.
The Insurance Act prescribes rules for the preparation and substance of statutory financial statements (which include, in statutory form, a balance sheet, an income statement, a statement of capital and surplus and notes thereto). The statutory financial statements include detailed information and analysis regarding premiums, claims, reinsurance and investments of the insurer.
The insurers annual GAAP financial statements and the auditors report thereon, and the statutory financial statements are required to be filed with the BMA within four months from the end of the relevant financial year (unless specifically extended with the approval of the BMA). The statutory financial statements do not form a part of the public records maintained by the BMA, but the GAAP financial statements are available for public inspection.
237
Annual Statutory Financial Return and Annual Capital and Solvency Return
As a Class 4 insurer, FIBL is required to file with the BMA a statutory financial return no later than four months after its financial year end (unless specifically extended with the approval of the BMA).
The statutory financial return of a Class 4 insurer shall consist of (i) an insurer information sheet, (ii) an auditors report, (iii) the statutory financial statements, and (iv) notes to the statutory financial statements.
In addition, each year the insurer is required to file with the BMA a capital and solvency return along with its annual statutory financial return. The prescribed form of capital and solvency return comprises the insurers BSCR model or an approved internal capital model in lieu thereof (more fully described below), together with such schedules as prescribed by the Insurance (Prudential Standards) (Class 4 and Class 3B Solvency Requirement) Rules 2008, as amended from time to time.
Neither the statutory financial return nor the capital and solvency return is available for public inspection.
Minimum Liquidity Ratio
The Insurance Act provides a minimum liquidity ratio for general business insurers. A Class 4 insurer engaged in general business is required to maintain the value of its relevant assets at not less than 75% of the amount of its relevant liabilities.
Minimum Solvency Margin and Enhanced Capital Requirements
The Insurance Act provides that the value of the statutory assets of an insurer must exceed the value of its statutory liabilities by an amount greater than its prescribed minimum solvency margin (MSM).
The MSM that must be maintained by a Class 4 insurer with respect to its general business is the greater of (i) $100 million, or (ii) 50% of net premiums written (with a credit for reinsurance ceded not exceeding 25% of GPW) or (iii) 15% of net losses and loss adjustment expenses provisions and other insurance reserves or (iv) 25% of the ECR (as defined below) as reported at the end of the relevant year.
Class 4 insurers are also required to maintain available statutory economic capital and surplus at a level equal to or in excess of its ECR which is established by reference to either the BSCR model or an approved internal capital model.
The BSCR model is a risk-based capital model which provides a method for determining an insurers capital requirements (statutory economic capital and surplus) by taking into account the risk characteristics of different aspects of the insurers business. The BSCR formula establishes capital requirements for ten categories of risk: fixed maturity investment risk, equity investment risk, interest rate/liquidity risk, currency risk, concentration risk, premium risk, reserve risk, credit risk, catastrophe risk, and operational risk. For each category, the capital requirement is determined by applying factors to asset, premium, reserve, creditor, probable maximum loss and operation items, with higher factors applied to items with greater underlying risk and lower factors for less risky items.
Eligible Capital
To enable the BMA to better assess the quality of the insurers capital resources, a Class 4 insurer is required to disclose the makeup of its capital in accordance with the recently introduced 3-tiered eligible capital system. Under this system, all of the insurers capital instruments will be classified as either basic or ancillary capital which in turn will be classified into one of three tiers based on their loss absorbency characteristics. Highest-quality capital will be classified as Tier 1 Capital, and lesser-quality capital will be classified as either Tier 2 Capital or Tier 3 Capital. Under this regime, up to certain specified percentages of Tier 1, Tier 2 and Tier 3 Capital may be used to support the Class 4 insurers MSM, ECR and target capital level.
238
The characteristics of the capital instruments that must be satisfied to qualify as Tier 1, Tier 2 and Tier 3 Capital are set out in the Insurance (Eligible Capital) Rules 2012, and amendments thereto. Under these rules, Tier 1, Tier 2 and Tier 3 Capital may, until January 1, 2026, include capital instruments that do not satisfy the requirement that the instrument is non-redeemable or settled only with the issuance of an instrument of equal or higher quality upon a breach, or if it would cause a breach, of the ECR.
Where the BMA has previously approved the use of certain instruments for capital purposes, the BMAs consent will need to be obtained if such instruments are to remain eligible for use in satisfying the MSM and the ECR.
Code of Conduct
The Insurance Code of Conduct (the Code of Conduct) prescribes the duties, standards, procedures, and sound business principles with which all insurers registered under the Insurance Act must comply, including any activities which are delegated or outsourced. With respect to outsourcing, the Code of Conduct provides that where the insurer outsources functions, the board of the insurer should ensure that there is oversight and clear accountability for all outsourced functions as if these functions were performed internally and subject to the insurers own standards on governance and internal controls. The board of the insurer must also ensure that the service agreement includes terms on compliance with jurisdictional laws and regulations, cooperation with the BMA, and access to data and records in a timely fashion. Where a function is outsourced or proposed to be outsourced, the board must assess the impact on the insurer and should not outsource a function which may adversely affect the insurers ability to operate in a prudent manner.
The BMA will assess an insurers compliance with the Code of Conduct in a proportional manner relative to the nature, scale and complexity of its business. Failure to comply with the requirements of the Code of Conduct will be taken into account by the BMA in determining whether an insurer is conducting its business in a sound and prudent manner as prescribed by the Insurance Act may result in the BMA exercising its powers of intervention and investigation (see below) and will be a factor in calculating the operational risk charge under the insurers BSCR or approved internal model.
Cyber Risk Code of Conduct
The BMA has recognized that cyber incidents can cause significant financial losses and/or reputational impacts across the insurance industry and has implemented the Insurance Sector Operational Cyber Risk Management Code of Conduct (the Cyber Risk Code) to ensure that those operating in the Bermuda insurance sector can mitigate such risks. The Cyber Risk Code prescribes the duties, requirements, standards, procedures and principles which all insurers, insurance managers and insurance intermediaries (agents, brokers and insurance marketplace providers) registered under the Insurance Act must comply. The Cyber Risk Code is designed to promote the stable and secure management of information technology systems of regulated entities and requires that all registrants implement their own technology risk programs, determine what their top risks are and develop an appropriate risk response. This requires all registrants to develop a cyber risk policy which is to be delivered pursuant to an operational cyber risk management program and appoint an appropriately qualified member of staff or outsourced resource to the role of Chief Information Security Officer. The role of the Chief Information Security Officer is to deliver the operational cyber risk management program.
Reduction of Capital
No Class 4 insurer may reduce its total statutory capital by 15% or more, as set out in its previous years financial statements unless it has received the prior approval of the BMA. Total statutory capital consists of the insurers paid-in share capital, its contributed surplus (sometimes called additional paid-in capital), and any other fixed capital designated by the BMA as statutory capital (such as letters of credit).
239
Notification by Registered Person of Change of Controllers and Officers
All registered insurers are required to give written notice to the BMA of the fact that a person has become, or ceased to be, a controller or officer of the registered insurer within 45 days of becoming aware of such fact. An officer in relation to a registered insurer means a director, chief executive or senior executive performing duties of underwriting, actuarial, risk management, compliance, internal audit, finance or investment matters.
Notification of Material Changes
All registered insurers are required to give notice to the BMA of their intention to effect a material change within the meaning of the Insurance Act. For the purposes of the Insurance Act, the following changes are material: (i) the transfer or acquisition of insurance business being part of a scheme falling under section 25 of the Insurance Act or section 99 of the Companies Act, (ii) the amalgamation with or acquisition of another firm, (iii) engaging in unrelated business that is retail business, (iv) the acquisition of a controlling interest in an undertaking that is engaged in non-insurance business which offers services and products to persons who are not affiliates of the insurer, (v) outsourcing all or substantially all of the companys actuarial, risk management, compliance or internal audit functions, (vi) outsourcing all or a material part of an insurers underwriting activity, (vii) the transfer, other than by way of reinsurance, of all or substantially all of a line of business, (viii) the expansion into a material new line of business, (ix) the sale of an insurer, and (x) outsourcing of an officer role.
No registered insurer shall take any steps to give effect to a material change unless it has first served notice on the BMA that it intends to effect such material change and before the end of 30 days, either the BMA has notified such company in writing that it has no objection to such change or that period has elapsed without the BMA having issued a notice of objection.
Before issuing a notice of objection, the BMA is required to serve upon the person concerned a preliminary written notice stating the BMAs intention to issue a formal notice of objection. Upon receipt of the preliminary written notice, the person served may, within 28 days, file written representations with the BMA which will be taken into account by the BMA in making its final determination.
The entry into a Delegated Underwriting Authority Agreement between FIBL and Bermuda MGU, which was approved, constituted a material change.
Group Supervision
The BMA may, in respect of an insurance group, determine whether it is appropriate for it to act as its group supervisor and has done so for FIHL. An insurance group is defined as a group of companies that conducts insurance business. The BMA may make such determination where it ascertains that (i) the group is headed by a specified insurer (that is to say, it is headed by either a Class 3A, Class 3B or Class 4 general business insurer or a Class C, Class D or Class E long-term insurer or another class of insurer designated by order of the BMA); or (ii) where the insurance group is not headed by a specified insurer, where it is headed by a parent company which is incorporated in Bermuda or (iii) where the parent company of the group is not a Bermuda company, in circumstances where the BMA is satisfied that the insurance group is directed and managed from Bermuda or the insurer with the largest balance sheet total is a specified insurer.
Where the BMA determines that it should act as the group supervisor, it shall designate a specified insurer that is a member of the insurance group to be the designated insurer (the Designated Insurer).
As group supervisor, the BMA will perform a number of supervisory functions including (i) coordinating the gathering and dissemination of relevant or essential information for going concerns and emergency situations, including the dissemination of information which is of importance for the supervisory task of other competent authorities; (ii) carrying out supervisory reviews and assessments of the insurance group; (iii) carrying out
240
assessments of the insurance groups compliance with the rules on solvency, risk concentration, intra-group transactions and good governance procedures; (iv) planning and coordinating through regular meetings held at least annually (or by other appropriate means) with other competent authorities, supervisory activities in respect of the insurance group, both as a going concern and in emergency situations; (v) coordinating enforcement actions that may need to be taken against the insurance group or any of its members; and (vi) planning and coordinating meetings of colleges of supervisors in order to facilitate the carrying out of the functions described above.
FIBL was designated by the BMA as a Designated Insurer on March 17, 2016 and as such is currently subject to group supervision. As a result, FIHL is required to maintain available statutory economic capital and surplus at a level equal to its Group Enhanced Capital Requirement, which is established by reference to the Group Bermuda Solvency and Capital Requirement model.
Restrictions on Dividends and Distributions
A Class 4 insurer is prohibited from declaring or paying a dividend if it is in breach of its MSM, ECR or minimum liquidity ratio or if the declaration or payment of such dividend would cause such a breach. Where an insurer fails to meet its MSM or minimum liquidity ratio on the last day of any financial year, it will be prohibited from declaring or paying any dividends during the next financial year without the approval of the BMA.
In addition, a Class 4 insurer is prohibited from declaring or paying in any financial year dividends of more than 25% of its total statutory capital and surplus (as shown on its previous financial years statutory balance sheet) unless it files (at least seven days before payment of such dividends) with the BMA an affidavit signed by at least two directors (one of whom must be a Bermuda resident director if any of the insurers directors are resident in Bermuda) and the principal representative stating that it will continue to meet its solvency margin and minimum liquidity ratio. Where such an affidavit is filed, it shall be available for public inspection at the offices of the BMA.
As FIHL is subject to Group Supervision by the BMA, it is prohibited from declaring or paying a dividend if it is in breach of its Group Enhanced Capital Requirement or the declaration or payment of a dividend would cause such a breach.
Bermuda Insurance Regulation of Intermediaries
General
The Insurance Act defines an insurance agent as a person that, with the authority of an insurer, acts on an insurers behalf in relation to any or all of the following matters: the initiation and receipt of proposals, the issue of policies and the collection of premiums, being proposals, policies and premiums relating to insurance business. The Insurance Act provides that no person may in or from within Bermuda carry on business as an insurance agent unless registered as an insurance agent under the Insurance Act by the BMA.
In October 2022, the Bermuda MGU received approval from the BMA to be registered as an insurance agent. Certain significant aspects of the Bermuda insurance regulatory framework applicable to insurance agents are set forth below.
The Insurance Brokers and Insurance Agents Code of Conduct
The Insurance Brokers and Insurance Agents Code of Conduct (the IBA Code) prescribes the duties, requirements, standards, procedures and practices with which all insurance agents registered under the Insurance Act must comply. The IBA Code provides that insurance agents must conduct their business in a sound and prudent manner. The BMA will assess an insurance agents compliance with the IBA Code in a proportional
241
manner relative to the nature, scale and complexity of its business. Failure to comply with the requirements of the IBA Code will be taken into account by the BMA in determining whether an insurance agent is conducting its business in a sound and prudent manner as prescribed by the Insurance Act and may result in the BMA exercising its powers of intervention and investigation.
Notification to the BMA
Every insurance agent is required to forthwith notify the BMA on it coming to the knowledge of the insurance agent, or where the insurance agent has reason to believe, that it has failed to comply with a condition imposed upon it by the BMA. Within 14 days of such notification, the insurance agent must also furnish the BMA with a written report setting out all of the particulars that are available to it.
United Kingdom Insurance Regulation
General
The financial services industry in the U.K. is currently dual-regulated by the FCA and the PRA (collectively, the U.K. Regulators). The PRA authorizes dual-regulated firms such as insurers (e.g., FUL) and performs the prudential regulation and supervision in respect of these entities. The FCA authorizes and performs the prudential regulation and supervision for all solo-regulated firms such as insurance intermediaries (e.g., Pine Walk Capital and FML) and is the conduct regulator for all regulated firms in the U.K.
The primary statutory objectives of the PRA in relation to its supervision of insurers are: (i) to promote their safety and soundness; and (ii) to contribute to the securing of an appropriate degree of protection for policyholders or those who may become policyholders. The PRA also has a secondary objective to facilitate effective competition in the markets for services provided by PRA-authorized firms. Further, the FCA has a general objective to secure an appropriate degree of protection for consumers, along with the further general objectives to protect and enhance the integrity of the U.K. financial system and to promote effective competition for the benefit of consumers.
The U.K. Regulators have extensive powers to intervene in the affairs of the insurance businesses and insurance mediation activities that they regulate and to monitor compliance with their objectives. Their enforcement tools include: amending (including by imposing restrictions on) or withdrawing a firms authorization, prohibiting, restricting or suspending firms or individuals from carrying on or undertaking regulated activities, and publicly censuring and warning, fining or requiring compensation from firms and individuals who break their rules.
U.K.-authorized insurers and insurance intermediaries must comply with the PRAs requirements (as set out in the PRA Rulebook) and the FCAs requirements (as set out in the FCA Handbook), which include the PRAs Fundamental Rules and the FCAs Principles. In particular, under both Fundamental Rule 7 and Principle 11, firms must deal with the U.K. Regulators in an open and cooperative way, and must disclose to the U.K. Regulators anything of which they would reasonably expect notice. Such notifications may include where the firm has reason to believe that it has materially failed to comply with any requirement or if a senior manager is involved in any prohibited activity.
U.K.-authorized insurers and insurance intermediaries must also adhere to a wide range of U.K. insurance legislation. The most notable of such legislation is the Financial Services and Markets Act 2000 (FSMA), which includes the requirements for becoming authorized to conduct regulated insurance activities, regulated and prohibited activities of an insurance company and insurance intermediary, the approval process for the acquisition or disposal of control of insurance companies and insurance intermediaries, rules on financial promotions, transfers of insurance portfolios, and market abuse provisions. This is complemented by a range of statutory instruments on certain subjects; for example, the authorization or exemption process. Legislation based
242
on Solvency II is also relevant (as described in more detail in the U.K. Prudential Regime for Insurers section below). In addition, U.K. companies carrying out insurance activities must comply with general legislation, such as the U.K. Companies Act 2006.
U.K. Authorized Firms in Current Fidelis and Fidelis MGU
Current Fidelis and Fidelis MGU contain several firms that are authorized to carry on regulated activities in the U.K. FUL is authorized by the PRA to effect and carry out contracts of insurance in respect of a number of classes of general (non-life) insurance business. Pine Walk Capital and FML are both authorized and regulated by the FCA as insurance intermediaries.
U.K. Prudential Regime for Insurers
FUL, as a U.K.-authorized insurer, is subject to the U.K.s domestic prudential regime, which derives from Solvency II and has largely been transposed into U.K. law by FSMA and The Solvency 2 Regulations 2015. Further, in order to ensure the continuing application of Solvency II regulatory framework in the U.K. following Brexit, pursuant to the European Union (Withdrawal) Act 2018, as amended, the U.K. has transposed all directly applicable E.U. legislation relating to Solvency II into U.K. law, including the European Commissions Delegated Regulation (EU) 2015/35 (commonly known as the Delegated Acts). Secondary legislation, such as the Solvency II and Insurance (Amendments) (EU Exit) Regulations 2019, was passed by the U.K. Parliament in order to address any deficiencies in this retained E.U. law following Brexit.
Following Brexit, the U.K.s domestic prudential regime is likely to change in the near future. In particular, the U.K.s on November 17, 2022, HM Treasury published a finalized package of proposed reforms to its prudential regime, which covers a range of areas including the risk margin, matching adjustment requirements and regulatory reporting obligations. These reforms will be reflected in new U.K. legislation and regulation during the course of 2023 and 2024. HM Treasury has stated that these changes will ensure that the U.K.s domestic prudential regime will: (i) be better tailored to the needs of the U.K. insurance market; (ii) encourage effective competition in the U.K. insurance market; and (iii) provide the PRA with a greater degree of discretion when supervising U.K. firms. A number of these changes may be beneficial for FUL; for example, if they result in an overall decrease in FULs capital requirements and otherwise reduce FULs regulatory burden. However, these rule changes also present a potential risk to FUL, as the nature and extent of their impact to the U.K.s domestic prudential regime are not fully known at this stage.
Material Outsourcing Requirements
The Framework Agreement, Delegated Underwriting Authority Agreement between FUL and Pine Walk Capital (the U.K. Delegated Underwriting Authority Agreement) and the Inter-Group Services Agreement (in such context only, the U.K. Material Outsourcing Agreements) each constitute a material outsourcing arrangement under U.K. insurance regulation. Under U.K. insurance regulation, an outsourcing arrangement is material if it is of such importance that weakness, or failure, of the service provider would cast serious doubt upon the firms continuing satisfaction of the U.K. Regulators threshold conditions for authorization and their Fundamental Rules/Principles. The U.K. Regulators require insurers to apply adequate governance and controls in respect of material outsourcing agreements.
The most prominent material outsourcing rules that apply to FUL are set out in the PRAs recent supervisory statements, Outsourcing and third party risk management (SS2/21) and Operational resilience: Impact tolerances for important business services (SS1/21). FUL is also subject to a number of related rules that derive from Solvency II and the Delegated Acts.
Pursuant to these rules, certain rights pertaining to FUL must be included in the U.K. Delegated Underwriting Authority Agreement and the Inter-Group Services Agreement, including: (i) the right for FUL to
243
receive information from the service provider about the performance of the services; (ii) the right for FUL to instruct the service provider in respect of these functions; and (iii) the right for FUL, its external auditor and the U.K. Regulators to audit the service provider. FUL was also required to present the U.K. Material Outsourcing Agreements and will be required (on a go-forward basis) to present any material amendments to them, to the PRA and obtain its non-objection in relation to them before they can be executed or be materially amended by the parties.
FUL must ensure that its board of directors and senior management set appropriate risk management policies, systems and controls in respect of FULs outsourcing and third-party arrangements and must ensure that they are properly carried out. In particular, these individuals should receive clear, consistent, robust and timely management information relating to each service providers performance of the U.K. Delegated Underwriting Authority Agreement, which will enable them to effectively oversee these activities and provide challenge in relation to them. If a service provider does not adhere to predetermined performance standards, FUL must be able to implement effective remediation procedures or exit strategies. Similar requirements must also be applied under the terms of the Inter-Group Services Agreement.
FUL must also ensure that its systems and controls specifically identify and prioritize important business services, and consider and monitor whether it has dedicated appropriate resources to ensure that it has sufficient operational resilience in the event of any potential material disruption to the services provider (for example, by preparing and maintaining a business continuity or disaster recovery plan covering such circumstances).
In light of these new rules and supervisory statements, we expect that the U.K. Material Outsourcing Agreements will be subject to a significant degree of regular and periodic focus from the PRA. FUL submitted the U.K. Material Outsourcing Agreements to the PRA for its review and consideration in connection with the Separation Transactions and, in late 2022, the PRA provided its non-objection to the Separation Transactions to FUL and to the FCA.
Capital Requirements under the U.K. Prudential Regime
Under the U.K.s domestic prudential regime, insurers are required to maintain a minimum margin of solvency equivalent to their Solvency Capital Requirement (SCR) at all times, the calculation of which depends on the type and amount of insurance business written as well as reserve, credit, market and operational risks. The financial resources that an insurer retains in support of the SCR must be adequate, both as to amount and quality, to ensure that there is no significant risk that an entitys liabilities cannot be met as they fall due. FUL calculates its SCR in accordance with a standard formula prescribed in accordance with Solvency II. If the PRA considers that FUL does not hold sufficient capital resources, it can impose additional requirements in relation to the amount and quality of the resources it considers necessary. Any failure to comply with such requirements introduced by the PRA can result in intervention by the PRA or imposition of sanctions, which could have an adverse effect on FULs results and financial position.
In addition, FUL is required to submit quarterly and annual filings with the PRA, including an annual Solvency and Financial Condition Report (SFCR), which must be posted on Current Fidelis website. FUL must also submit an annual Own Risk and Solvency Assessment (ORSA) to the PRA. The ORSA report is produced annually and provides a summary of all of the activity and processes during the preceding year to assess and report on risks and ensure that our overall solvency needs are met at all times, and which will include a forward-looking assessment. It also explains the linkages between business strategy, business planning and capital and risk management processes. Further, FUL may need to perform an additional ORSA, and submit the corresponding ORSA report to the PRA, following any significant change in its risk profile.
Restrictions on Dividend Payments by Insurers
The U.K. Companies Act 2006 prohibits U.K. companies, including FUL, from declaring dividends to their shareholders unless they have profits available for distribution. The determination of whether a company has
244
profits available for distribution is based on its accumulated realized profits and other distributable reserves less its accumulated realized losses. While the U.K. insurance regulatory rules impose no statutory restrictions on a general insurers ability to declare a dividend, the PRAs rules require each authorized insurer within its jurisdiction to maintain its solvency margin at all times. Accordingly, FUL may not pay a dividend if the payment of such dividend would result in its SCR coverage ratio falling below certain levels. In addition, any future changes regarding regulatory requirements, including those described above, may restrict the ability of FUL to pay dividends in the future. FUL would be required to notify the PRA if it intended to make any dividend payments to its shareholders.
Data Protection
FUL and Pine Walk Capital must also comply with generally applicable data privacy legislation, including the E.U. GDPR. This regulations goal is to impose increased individual rights and protections for all personal data located in or originating from the E.U. The Data Protection Act 2018 and the U.K. GDPR regulate data protection for all individuals within the U.K.
The GDPR and the Data Protection Act 2018 are extraterritorial in that they apply to all businesses in the E.U. and the U.K., respectively and any businesses outside the E.U. and the U.K. that process E.U. and/or U.K. personal data of individuals in the E.U. and/or the U.K. Moreover, there are significant fines associated with non-compliance. In particular, U.K. incorporated companies need to monitor compliance with all relevant member states laws and regulations, including any permitted derogations from the GDPR and the Data Protection Act 2018. The introduction of the GDPR and the Data Protection Act 2018, and any resultant changes in E.U. member states or U.K. national laws and regulations, has increased compliance obligations and has necessitated the review and implementation of policies and processes relating to collection and use of data, and has required change to business practices regarding these matters. See Risk FactorsRisks Relating to Regulation of the GroupData protection failures could disrupt the Groups business, damage its reputation and cause losses.
Ireland Insurance Regulation
General
The CBI has primary responsibility for the prudential supervision and regulation of insurance and reinsurance undertakings and insurance intermediaries authorized in Ireland, including FIID. The CBIs statutory objectives include (i) the stability of the financial system overall; (ii) the proper and effective regulation of financial service providers and markets, while ensuring that the best interests of consumers of financial services are protected; and (iii) the resolution of financial difficulties in credit institutions.
The CBI carries out its supervisory role through (i) processing applications for financial services authorizations in Ireland; (ii) monitoring compliance with prudential standards, primarily through examining prudential returns (weekly, monthly and annual), financial statements and annual reports, conducting regular review meetings and on-site inspections; (iii) developing systems and procedures to monitor activities and detect non-compliance by financial service providers; (iv) issuing guidance notes to enhance supervisory oversight due to continued growth and changes in financial markets; and (v) supporting the development of domestic legislation and implementing E.U. regulations and international standards.
The CBI has extensive powers to intervene in the affairs of insurance undertakings and insurance distribution activities that it regulates and to monitor compliance. In particular, the CBIs administrative sanctions regime provides it with the power to administer sanctions in relation to prescribed contraventions by regulated financial service providers and by persons presently or formerly concerned in their management who have participated in the prescribed contraventions. Sanctions under the administrative sanctions regime include (i) cautions or reprimands; (ii) directions to refund or withhold monies charged or paid; (iii) monetary penalties
245
up to 10,000,000 or 10% of turnover (or up to 1,000,000 for individuals); (iv) suspension or revocation of authorization; and (v) disqualification of individuals from being concerned in the management of a regulated financial service provider.
Insurance undertakings are primarily regulated under the European Union (Insurance and Reinsurance) Regulations 2015 (the 2015 Regulations), which transposes Solvency II into Irish law. The 2015 Regulations include the approval process for the acquisition or disposal of holdings in insurance undertakings, governance and reporting standards, capital and solvency requirements and rules regarding the procedure for the transfer of insurance portfolios. Insurance intermediaries are primarily regulated under the European Union (Insurance Distribution) Regulations 2018 (the 2018 Regulations), which transpose the Insurance Distribution Directive 2016/97 (IDD) into Irish law. In addition, Irish companies carrying out insurance activities must comply with general legislation in Ireland, such as the Irish Companies Act 2014.
Irish Authorized firms in Current Fidelis and Fidelis MGU
Current Fidelis Irish-authorized firm, FIID, is an insurance company incorporated under the laws of Ireland and duly authorized by the CBI as an insurance undertaking to carry on the following classes of non-life insurance business in accordance with the 2015 Regulations: 5 (Aircraft), 6 (Ships), 7 (Goods in Transit), 8 (Fire and Natural Forces), 9 (Other Damage to Property), 11 (Aircraft Liability), 12 (Liability for Ships), 13 (General Liability), 14 (Credit), 15 (Suretyship), and 16 (Miscellaneous Financial Loss).
Fidelis MGU includes Pine Walk Europe, which is incorporated in Belgium and is authorized by the Belgian Financial Services and Markets Authority to conduct insurance distribution activities. Pine Walk Europe carries on insurance distribution activities in Ireland through an Irish-registered branch pursuant to the passporting rights. Under the IDD, insurance intermediaries have passporting rights which permit them to use an insurance intermediary authorization in their home EEA member state to carry on insurance distribution activities in other EEA member states. An insurance intermediary exercises this right by notifying its home member state regulator of its intention to carry on business in another EEA member state and the home member state regulator in turn notifies the competent authority in the host member state. Pine Walk Europe received regulatory approval from the Belgian Financial Services and Markets Authority to perform regulated insurance distribution activities on October 5, 2022 and was able to commence trading in Ireland on a freedom of establishment basis via its Irish branch on January 1, 2023.
Where an insurance intermediary regulated in an EEA member state exercises its right to passport into Ireland, it remains prudentially regulated by the regulator in its home member state and will be regulated by the CBI for conduct-of-business rules. Therefore, Pine Walk Europe is primarily regulated by the Belgian Financial Services and Markets Authority.
Irish Regulation of Insurance Undertakings
As FIID is authorized in Ireland as an insurance undertaking, the Irish prudential insurance regulatory framework and requirements apply to it, including the following significant aspects:
Solvency Requirements
FIID is required to meet economic risk-based solvency requirements under Solvency II (as transposed into Irish law by the 2015 Regulations). Solvency II prescribes (i) the minimum amount of capital that FIID is required to have in order to cover the risks to which it is exposed and (ii) the principles that guide its overall risk management and regulatory reporting.
Under Solvency II, FIID is required to maintain a minimum margin of solvency equivalent to its SCR at all times, the calculation of which depends on the type and amount of insurance business written as well as reserve,
246
credit, market and operational risks. The financial resources that an insurer retains in support of the SCR must be adequate, both as to amount and quality, to ensure that there is no significant risk that its liabilities cannot be met as they fall due.
Under Solvency II, the SCR may be calculated by an approved internal capital model or by a standard formula prescribed by EIOPA in accordance with the terms of Solvency II. FIID calculates its SCR in accordance with a standard formula prescribed in accordance with Solvency II.
The CBI has a regulatory expectation that insurance undertakings will maintain an appropriate buffer above the SCR that is appropriate to the risk profile and type of business written and FIID duly maintains a level of capital which is above the SCR.
Reporting Requirements
FIID must file and submit annual audited financial statements in accordance with International Financial Reporting Standards and related reports to the Irish Companies Registration Office (CRO) together with an annual return of certain core corporate information. Changes to core corporate information during the year must also be notified to the CRO. FIID must also file and submit annual certifications to the CBI, including certifications of compliance with:
| the applicable CBIs Corporate Governance Requirements for Insurance Undertakings 2015; |
| the Fitness & Probity Standards (Code issued under Section 50 of the Central Bank Reform Act 2010); and |
| Solvency II. |
In addition, FIID is required to submit quarterly and annual filings with the CBI, including Quantitative Reporting Templates, an annual SFCR and an annual ORSA. The SFCR must be made publicly available and will include information on FIIDs business performance, system of governance, risk profile, and capital management. The ORSA report provides a summary of all the activity and processes during the preceding year to assess and report on risks and ensure that FIIDs overall solvency needs are met on an ongoing basis, including a forward-looking assessment. The ORSA report also explains the linkages between business strategy, business planning and capital and risk management processes.
In addition, FIID must submit a Regular Supervisory Report every three years, as well as an annual summary report setting out material changes that have occurred over the given financial year.
Dividends and Distributions
Pursuant to Irish company law, FIID is only able to declare dividends out of profits available for distribution. Profits available for distribution are, broadly, a companys accumulated realized profits less its accumulated realized losses. Such profits may not include profits previously utilized.
Outsourcing of Critical or Important Operational Functions or Activities
The Framework Agreement, Delegated Underwriting Authority Agreement between FIID and Pine Walk Europe (the Irish Delegated Underwriting Authority Agreement) and the Inter-Group Services Agreement (in such context only, the Irish Material Outsourcing Agreements) each constitute an outsourcing of critical or important operational functions or activities under Irish insurance regulation. The 2015 Regulations, Solvency II and the Delegated Acts, along with EIOPA and CBI guidelines, set out the obligations which FIID must comply with in respect of the outsourcing of critical or important functions or activities. In general, a function is to be regarded as critical or important if failure or inadequate provision of the function would have an adverse impact on the operational continuity of the core business line or critical business function.
247
Pursuant to the relevant legislation and guidelines, certain rights pertaining to FIID must be included in the Irish Delegated Underwriting Authority Agreement and the Inter-Group Services Agreement, including: (i) the right for FIID to receive information from the applicable outsourced service provider about the outsourced functions; (ii) the right for FIID to instruct the applicable outsourced service provider in respect of these functions; and (iii) the right for FIID, its external auditor and the CBI to audit the applicable outsourced service provider. FIID must also notify (and obtain approval from) the CBI at least six weeks before entering into the Irish Delegated Underwriting Authority Agreement and the Inter-Group Services Agreement and regarding subsequent material developments with respect to the Irish Material Outsourcing Agreements.
FIID must ensure that its board of directors and senior management set appropriate risk management policies, systems and controls in respect of FIIDs outsourcing arrangements and must ensure that they are properly carried out. In particular, these individuals should receive clear, consistent, robust and timely management information relating to each service providers performance of the Irish Delegated Underwriting Authority Agreement and the Inter-Group Services Agreement, which will enable them to effectively oversee these activities and provide challenge in relation to them. If a service provider does not adhere to predetermined performance standards, FIID must be able to implement effective remediation procedures or exit strategies.
FIID must also ensure continuity of services through robust disaster recovery and business continuity management. In particular, FIID must document and implement business continuity plans in relation to its critical and important outsourced functions and ensure that these plans are tested and updated on a regular basis. FIID must also ensure that each service provider has and regularly tests a business continuity plan, which includes the resources required to fulfill FIIDs critical or important outsourcing arrangements. FIIDs board of directors and senior management must take remedial action to address any deficiencies identified in a service providers performance, either as part of coordinated testing of FIIDs business continuity measures, or via results of the service providers own business continuity plan testing.
FIID has submitted the terms of the Irish Material Outsourcing Agreements to the CBI for its review and consideration and, in late 2022, the CBI provided its approval.
Restrictions on Change of Business Plan
As part of the authorization process, insurance undertakings, such as FIID, must submit a detailed business plan to the CBI which describes the business they propose to conduct. The standard conditions of authorization typically issued by the CBI specify that any subsequent material change to the business plan requires the prior approval of the CBI.
Data Protection
FIID and Pine Walk Europe must comply with the GDPR, which took effect in May 2018. The Data Protection Act 2018 is the Irish legislation that gives effect to certain aspects of the data protection in Ireland. The GDPR regulates data protection for all individuals within the E.U., including foreign companies processing data of E.U. residents. The GDPR sets out individuals rights, and provides complex and far-reaching company obligations and significant penalties in the case of violation. The GDPR sets out a number of requirements that FIID must comply with when handling personal data, including: the obligation to appoint data protection officers in certain circumstances, the principle of accountability and the obligation to make public notification of significant data breaches.
The interpretation and application of data protection laws in Ireland, Europe and elsewhere are developing and remain uncertain and in flux in some respects. It is possible that these laws or cybersecurity regulations may be interpreted and applied in a manner that is inconsistent with existing data protection or security practices. If so, in addition to the possibility of fines, this will result in an order requiring that we change our data practices, which could have an adverse effect on our business and results of operations. The introduction of the GDPR and
248
resultant changes in E.U. member states national laws and regulations, has increased our compliance obligations and has necessitated the review and implementation of policies and processes relating to our collection and use of data, and has required us to change our business practices regarding these matters.
United States Insurance Regulation
FIBLs and FULs U.S. Operations
As stated above, although the Group is not licensed to write insurance on an admitted basis in any state in the U.S., FIBL and FUL, due to their inclusion in the NAIC Quarterly Listing of Alien Insurers of the International Insurers Department (IID), are eligible to write surplus lines business as alien, non-admitted insurers in 50 U.S. states, the District of Columbia and other NAIC jurisdictions such as Puerto Rico in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the Dodd-Frank Act). The laws of most states regulate or prohibit the sale of insurance and reinsurance within their jurisdictions by non-admitted insurers and reinsurers. We do not intend that FIBL or FUL maintain an office or solicit, advertise, settle claims or conduct other insurance activities in any jurisdiction other than their respective jurisdictions of incorporation where the conduct of such activities would require FIBL or FUL to be so admitted. Neither FIBL nor FUL maintains an office in the U.S. but each of FIBL and FUL writes excess and surplus lines business as an eligible, but non-admitted, alien surplus lines insurer. Each of FIBL and FUL accepts business only through U.S. licensed surplus lines brokers and does not market directly to the public. Although neither FIBL nor FUL underwrites or handles claims directly in the U.S., each of FIBL and FUL may grant limited underwriting authorities to U.S. licensed surplus lines brokers and retain third-party claims administrators, duly licensed, for the purpose of facilitating U.S. business.
Each of FIBL and FUL maintain a NAIC U.S. trust fund to support its surplus lines business, in accordance with the rules of the IID. The total market value of assets in each of the FIBL and FUL NAIC trusts were $5.6 million and $28.5 million, respectively, at March 31, 2023 and $5.5 million and $28.4 million, respectively, at December 31, 2022.
As a result of the Dodd-Frank Act, only a ceding insurers state of domicile can dictate the credit for reinsurance requirements. Other NAIC jurisdictions in which a ceding insurer is licensed are no longer able to require additional collateral from non-admitted reinsurers or otherwise impose their own credit for reinsurance laws on ceding insurers domiciled in other states. In 2011, the NAIC adopted revisions to its Credit for Reinsurance Model Law and Model Regulation (together the Amended Credit for Reinsurance Model Act). Under the Amended Credit for Reinsurance Model Act, qualifying non-admitted reinsurers domiciled in qualified jurisdictions who meet certain minimum rating and capital requirements are, upon application to and approval by the state Insurance Departments, permitted to post less than the 100% collateral currently required with respect to a cedant domiciled in that state, insurers that have been granted approval to post reduced collateral are known as certified reinsures. The U.K. and Bermuda are among the approved qualified jurisdictions which allows U.S. states that have adopted the Amended Credit for Reinsurance Model Act to implement reduced collateral requirements with respect to reinsurers domiciled in Bermuda and the U.K., such as FIBL and FUL. FIBL and FUL have been approved by Florida as the lead state for treatment as a certified reinsurer to post reduced collateral i.e., 50% versus 100%), and have both passported into multiple other U.S. states. Each of FIBL and FUL obtains letters of credit for the benefit of its U.S. cedants so that the cedants are able to take full financial statement credit for reinsurance.
In addition, during 2022, FIBL and FUL have been approved by Colorado as the lead state for treatment as a reciprocal reinsurer, and each is in the process of passporting into other U.S. states. Reciprocal jurisdiction reinsurer status will allow cedants in such states to continue to obtain credit for reinsurance by FIBL and FUL, without either company being required to post any collateral so long as they continue to maintain such status.
249
Additional Regulation
FIBL and FUL write business outside of their respective jurisdiction of incorporation predominantly on a non-admitted basis. However, in respect of jurisdictions where FIBL and FUL are unable to rely on the relevant exemptions for non-admitted (re)insurers or a relevant license is requested by the underwriters, FIBL and FUL each hold a number of licenses. FIBL is licensed to write reinsurance in China, Argentina, Ecuador and Mexico. FUL is licensed to write reinsurance in Argentina, Brazil, Chile, Ecuador, Guatemala, Honduras, Mexico, Panama, Paraguay and Egypt and insurance in French Polynesia. We do not regard the effect of these licenses to be material to us at this time.
250
The following summary of the taxation of Current Fidelis and its shareholders is based upon current U.S. and Bermuda law and is for general information only. Legislative, judicial or administrative changes may be forthcoming that could affect this summary. Prospective investors should consult their own tax advisors with respect to their particular circumstances.
United States Taxation
Certain U.S. Tax Consequences
The following legal discussion (including and subject to the matters and qualifications set forth in such summary) is based upon the advice of Willkie Farr & Gallagher LLP. The advice of such firm does not include any factual or accounting matters, determinations or conclusions, including amounts and computations of RPII and amounts of components thereof or facts relating to Current Fidelis business or activities. The tax treatment of a holder of Common Shares, or of a person treated as a holder of Common Shares for U.S. federal income, state, local or non-U.S. tax purposes, may vary depending on the holders particular tax situation. Statements contained herein as to the beliefs, expectations and conditions of FIHL and its subsidiaries as to the application of such tax laws or facts represent the view of management as to the application of such laws and do not represent the opinions of counsel.
PROSPECTIVE INVESTORS SHOULD CONSULT THEIR OWN TAX ADVISORS WITH RESPECT TO THEIR PARTICULAR CIRCUMSTANCES CONCERNING THE U.S. FEDERAL, STATE, LOCAL AND NON-U.S. TAX CONSEQUENCES OF OWNING COMMON SHARES.
U.S. Tax Reform
The 2017 Act was passed by the U.S. Congress and signed into law on December 22, 2017, with certain provisions intended to eliminate certain perceived tax advantages of companies (including insurance companies) that have legal domiciles outside the United States, but have certain U.S. connections, and U.S. Persons (as defined below) investing in such companies. Among other things, the 2017 Act revised the rules applicable to PFICs and CFCs in ways that could affect the timing or amount of U.S. federal income taxes imposed on certain investors that are U.S. Persons. Further, it is possible that other legislation could be introduced and enacted by the current Congress or future Congresses that could have an adverse impact on Current Fidelis, Current Fidelis operations or U.S. Holders. Additionally, tax laws and interpretations regarding whether a company is engaged in a U.S. trade or business or whether a company is a CFC or a PFIC or has RPII are subject to change, possibly on a retroactive basis. The U.S. Treasury Department recently issued final and proposed regulations intended to clarify the application of the insurance income exception to the classification of a non-U.S. insurer as a PFIC and provide guidance on a range of issues relating to PFICs, and recently issued proposed regulations that would expand the scope of the RPII rules. New regulations or pronouncements interpreting or clarifying such rules may be forthcoming as well. FIHL cannot be certain if, when, or in what form such regulations or pronouncements may be provided and whether such guidance will have a retroactive effect.
Taxation of Current Fidelis
The following discussion is a summary of material U.S. federal income tax considerations relating to Current Fidelis operations. A non-U.S. corporation that is engaged in the conduct of a U.S. trade or business will be subject to U.S. federal income tax as described below, unless entitled to the benefits of an applicable tax treaty. Whether a trade or business is being conducted in the U.S. is an inherently factual determination. Because the Code, regulations and court decisions fail to identify definitively activities that constitute being engaged in a trade or business in the U.S., FIHL cannot be certain that the IRS will not contend successfully that it or any of its non-U.S. subsidiaries are or will be engaged in a trade or business in the U.S. A non-U.S. corporation deemed
251
to be so engaged would be subject to U.S. income tax at regular corporate rates, as well as the branch profits tax, on its income which is treated as effectively connected with the conduct of that trade or business unless the corporation is entitled to relief under the permanent establishment provision of an applicable tax treaty, as discussed below. Such income tax on effectively connected income, if imposed, would be computed in a manner generally analogous to that applied to the income of a U.S. corporation, except that a non-U.S. corporation is generally entitled to deductions and credits only if it timely files a U.S. federal income tax return. Each of FIHL, FIBL, FIID, FML, Fidelis European Holdings Limited and FUL files protective U.S. federal income tax returns on a timely basis in order to preserve the right to claim income tax deductions and credits if it is ever determined that it is subject to U.S. federal income tax. The highest marginal federal income tax rates currently are 21% for a corporations effectively connected income and 30% for the additional branch profits tax. In addition, certain corporations with effectively connected income may be subject to a corporate alternative minimum tax of 15 percent of the corporations adjusted financial statement income.
If FIBL is entitled to the benefits under the income tax treaty between Bermuda and the U.S. (the Bermuda Treaty), FIBL would not be subject to U.S. income tax on any income found to be effectively connected with a U.S. trade or business unless that trade or business is conducted through a permanent establishment in the U.S. Similarly, if FIHL or any U.K. subsidiary of FIHL is entitled to the benefits under the U.S. income tax treaty with the U.K. (the U.K. Treaty) (discussed below), it would not be subject to U.S. income tax on any income found to be effectively connected with U.S. trade or business unless that trade or business is conducted through a permanent establishment in the U.S. FIBL, FIHL and the U.K. subsidiaries of FIHL each currently intend to conduct their activities so that they do not have a permanent establishment in the U.S., although FIHL cannot be certain that this result will be achieved.
An insurance enterprise resident in Bermuda generally will be entitled to the benefits of the Bermuda Treaty if (i) more than 50% of its shares are owned beneficially, directly or indirectly, by individual residents of the U.S. or Bermuda or U.S. citizens; and (ii) its income is not used in substantial part, directly or indirectly, to make disproportionate distributions to, or to meet certain liabilities of, persons who are neither residents of either the U.S. or Bermuda nor U.S. citizens. No regulations interpreting the Bermuda Treaty have been issued. FIHL cannot be certain that FIBL will be eligible for Bermuda Treaty benefits because of factual and legal uncertainties regarding the residency and citizenship of the companys shareholders. Accordingly, FIBL intends to conduct substantially all of its operations outside the U.S. and to limit its U.S. contacts so that FIBL would not be treated as engaged in the conduct of a trade or business in the U.S.
Under the U.K. Treaty, a U.K. resident company is entitled to the benefits of the treaty only if certain requirements can be satisfied, for example where: (i) the principal class of its shares is listed or admitted to dealings on certain recognized stock exchanges and is regularly traded on one or more recognized stock exchanges, (ii) shares representing at least 50 percent of the aggregate voting power and value of such company are owned directly or indirectly by five or fewer companies entitled to the benefits of the U.K. Treaty, (iii) such company is owned more than 50 percent, by vote and by value, by qualified persons (broadly speaking, certain U.S. and U.K. tax residents) during a requisite portion of the relevant taxable period, or (iv) such company is engaged in the active conduct of a trade or business in the U.K. and the income, profit or gain derived from the United States is derived in connection with, or is incidental to, that trade or business, and the company satisfies certain other conditions. Provided that FIHL is successfully listed and regularly traded on NYSE and its U.K. subsidiaries successfully carry out their intended business plan, each such entity expects to qualify for benefits under the U.K. Treaty, although FIHL cannot be certain it will achieve this result. If each of FIHL and its U.K. subsidiaries qualifies for treaty benefits, each of FIHL and its U.K. subsidiaries should be subject to U.S. federal income tax on its income found to be effectively connected with a U.S. trade or business only if such income is attributable to the conduct of a trade or business carried on through a permanent establishment in the U.S. FIHL and its U.K. subsidiaries have conducted and intend to conduct their activities in a manner so that none of them should have a permanent establishment in the U.S., although FIHL cannot be certain that they will achieve this result.
252
Under the U.K. Treaty, the additional U.S. branch profits tax may be imposed at a rate of up to five percent (5%) absent an applicable exception to the extent a U.K. resident company has a permanent establishment in the U.S.
Non-U.S. insurance companies carrying on an insurance business within the U.S. have a certain minimum amount of effectively connected net investment income, determined in accordance with a formula that depends, in part, on the amount of U.S. risk insured or reinsured by such companies. If FIBL or FUL is considered to be engaged in the conduct of an insurance business in the U.S. and it is not entitled to the benefits of an income tax treaty with the U.S. in general, the Code could subject a significant portion of FIBL or FULs investment income to U.S. income tax. In addition, while the Bermuda Treaty clearly applies to premium income, it is uncertain whether the Bermuda Treaty applies to other income such as investment income. If FIBL is considered engaged in the conduct of an insurance business in the U.S. and is entitled to the benefits of the Bermuda Treaty in general, but the Bermuda Treaty is interpreted to not apply to investment income, a significant portion of FIBLs investment income could be subject to U.S. income tax.
Non-U.S. corporations not engaged in a trade or business in the U.S. are nonetheless subject to U.S. income tax imposed by withholding on certain fixed or determinable annual or periodic gains, profits and income derived from sources within the U.S. (such as dividends and certain interest on investments), subject to exemption under the Code or reduction by applicable treaties. Generally, under the U.K. Treaty the withholding rate is reduced (i) on dividends from less than ten percent (10%) owned corporations to 15%; (ii) on dividends from 10% or more owned corporations to five percent (5%) (and is eliminated in some cases); and (iii) on interest to zero percent (0%). The Bermuda Treaty does not reduce the U.S. withholding rate on U.S.-sourced investment income.
The U.S. also imposes FET on insurance premiums paid to non-U.S. insurers with respect to (i) risks of a U.S. entity or individual, located wholly or partly within the U.S. and (ii) risks of a non-U.S. entity or individual engaged in trade or business in the U.S., located within the U.S. (U.S. Situs Risks) and on reinsurance premiums for any reinsurance policy covering any such risks. The rates of FET applicable to premiums paid are four percent (4%) for direct property and casualty insurance premiums and one percent (1%) for reinsurance premiums or life insurance premiums, subject to elimination pursuant to a U.S. income tax treaty. The U.K. Treaty provides for the elimination of the FET on insurance or reinsurance premiums paid to U.K. residents, otherwise entitled to the benefits of the treaty, with respect to U.S. Situs Risks, provided that the U.K. resident does not cede the risks in a transaction characterized as part of a conduit arrangement for purposes of the U.K. Treaty. If FUL is entitled to the benefit of the FET exemption in the U.K. Treaty, but it cedes business with respect to U.S. Situs Risks in transactions that are characterized as conduit arrangements for purposes of the U.K. Treaty, it would not be entitled to the U.K. Treaty FET exemption with respect to these U.S. Situs Risks. The Bermuda Treaty does not eliminate the FET on premiums ceded to Bermuda residents with respect to U.S. Situs Risks.
Taxation of the Shareholders
The following summary sets forth the material U.S. federal income tax considerations related to the purchase, ownership and disposition of the Common Shares sold in this offering. Unless otherwise stated, this summary deals only with U.S. Holders who hold their Common Shares as capital assets within the meaning of section 1221 of the Code. The following discussion is only a discussion of the material U.S. federal income tax matters as described herein and does not purport to address all of the U.S. federal income tax consequences that may be relevant to a particular shareholder in light of such shareholders specific circumstances. In addition, the following summary does not address the U.S. federal income tax consequences that may be relevant to special classes of shareholders, such as financial institutions, insurance companies, regulated investment companies, real estate investment trusts, dealers or traders in securities, tax exempt organizations, U.S. expatriates, individual retirement accounts or other tax-deferred accounts, persons liable for alternative minimum tax, investors in pass through entities, persons who are considered with respect to FIHL or its subsidiaries as United States
253
shareholders for purposes of the CFC rules of the Code (generally, a U.S. Person, as defined below, who owns or is deemed to own 10% or more of the total combined voting power of all classes of the companys or its subsidiaries shares entitled to vote, or 10% or more of the value of all classes of the companys or its subsidiaries shares (that is, 10% U.S. Shareholders)), U.S. accrual method taxpayers subject to special tax accounting rules as a result of any item of gross income with respect to the Common Shares being taken into account in an applicable financial statements (as described in Section 451(b) of the Code), persons subject to the alternative minimum tax or persons who hold their shares as part of a hedging or conversion transaction or as part of a short-sale or straddle or in currency other than the U.S. dollar, who may be subject to special rules or treatment under the Code. This discussion is based upon the Code, the Treasury Regulations promulgated thereunder and any relevant administrative rulings or pronouncements or judicial decisions, all as in effect on the date hereof and as currently interpreted, and does not take into account possible changes in such tax laws or interpretations thereof, which may apply retroactively. This discussion does not include any description of the tax laws of any state or local governments within the U.S. or of any non-U.S. government. Persons considering making an investment in the Common Shares should consult their own tax advisors concerning the application of the U.S. federal tax laws to their particular situations as well as any tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction, prior to making such investment.
If an entity or arrangement treated as a partnership for U.S. federal income tax purposes holds Common Shares, the tax treatment of the partners will generally depend on the status of the partner and the activities of the partnership. If a potential investor in Common Shares is such a partnership or a partner of such a partnership, it should consult its tax advisors.
For purposes of this discussion, the term U.S. Person means: (i) a citizen or resident of the U.S.; (ii) a partnership or corporation, created or organized in or under the laws of the U.S., or organized under the laws of any political subdivision thereof; (iii) an estate the income of which is subject to U.S. federal income taxation regardless of its source; (iv) a trust if either (a) a court within the U.S. is able to exercise primary supervision over the administration of such trust and one or more U.S. Persons have the authority to control all substantial decisions of such trust or (b) the trust has a valid election in effect to be treated as a U.S. Person for U.S. federal income tax purposes or (v) any other person or entity that is treated for U.S. federal income tax purposes as if it were one of the foregoing.
Taxation of Distributions
Subject to the discussion below regarding passive foreign investment companies, controlled foreign corporations and related person insurance income, cash distributions paid with respect to the Common Shares will constitute ordinary dividend income to the extent paid out of the companys current or accumulated earnings and profits (as determined using U.S. federal income tax principles), and the U.S. Holders generally will be subject to U.S. federal income tax upon its receipt of such dividends. If the holder is not a corporation or an entity treated as a corporation under U.S. federal income tax law, dividends paid to it will generally be taxable at the rate applicable for long-term capital gains (at a maximum rate of 20% currently) if: (1) the dividends constitute qualified dividend income, and (2) it holds the Common Shares for more than 60 days out of the 121-day period that begins 60 days before the ex-dividend date and meets other holding period requirements. Any dividends paid on the Common Shares generally will be qualified dividend income, provided that: (i) the Common Shares are readily tradable on an established securities market in the United States in the year in which the shareholder receives the dividend, or FIHL is eligible for the benefits of a comprehensive income tax treaty with the United States, and, in either case, (ii) FIHL is not considered to be a PFIC in either the year of the distribution or the preceding taxable year. Under current U.S. Treasury Department guidance, the Common Shares would be treated as readily tradeable on an established securities market if they are listed on NYSE, as we intend the Common Shares to be after this offering. However, there can be no assurance that our Common Shares will continue to be listed on NYSE or that FIHL will not be treated as a PFIC for any taxable year. Dividends paid on the Common Shares to a corporate shareholder generally will not be eligible for the dividends received deduction.
254
Classification of FIHL or its Non-U.S. Subsidiaries as Controlled Foreign Corporations
Each 10% U.S. Shareholder (as defined below) of a non-U.S. corporation that is a CFC at any time during a taxable year and that owns shares in the non-U.S. corporation, directly or indirectly through non-U.S. entities, on the last day of the non-U.S. corporations taxable year on which it is a CFC must include in its gross income for U.S. federal income tax purposes its pro rata share of the CFCs subpart F income and global intangible low taxed income (GILTI), even if the subpart F income or GILTI is not distributed. Subpart F income of a non-U.S. insurance corporation typically includes foreign personal holding company income (such as interest, dividends and other types of passive income), as well as insurance and reinsurance income (including underwriting and investment income), and GILTI is generally business income of the CFC (other than Subpart F income and certain other categories of income) reduced by 10% of the adjusted tax basis of the CFCs depreciable tangible personal property (based on a computation that generally aggregates all of a 10% U.S. Shareholders GILTI from its investments in CFCs) that is potentially subject to further reductions depending on the nature of the applicable 10% U.S. Shareholder. The amount of any subpart F income inclusion would be limited by such 10% U.S. Shareholders share of the CFCs current-year earnings and profits as reduced by the 10% U.S. Shareholders share, if any, of certain prior-year deficits in earnings and profits, and a 10% U.S. Shareholder recognizing subpart F or GILTI income would increase the basis in its shares by the amount of subpart F or GILTI income included in income. Amounts distributed out of previously taxed subpart F or GILTI income would be excluded from the 10% U.S. Shareholders income, and the 10% U.S. Shareholders basis in the shares would be reduced by the amount so excluded. In addition, as discussed below, gain recognized by a 10% U.S. Shareholder on the sale of stock of a CFC will be re-characterized as a dividend and taxed as ordinary income rather than as capital gain to the extent of the 10% U.S. Shareholders share of the CFCs earnings and profits. Such dividend income would not be eligible for the reduced rate of tax on qualified dividends.
A non-U.S. corporation is considered a CFC if 10% U.S. Shareholders own (directly, indirectly through non-U.S. entities or by attribution by application of the constructive ownership rules of section 958(b) of the Code (that is constructively)) more than 50% of the total combined voting power of all classes of voting stock of such non-U.S. corporation, or more than 50% of the total value of all stock of such corporation. For purposes of taking into account insurance income, a CFC also includes a non-U.S. insurance company in which more than 25% of the total combined voting power of all classes of stock or more than 25% of the total value of all stock is owned by 10% U.S. Shareholders on any day of the taxable year of such corporation, if the gross amount of premiums or other consideration for the reinsurance or the issuing of insurance or annuity contracts (other than certain insurance or reinsurance related to same country risks written by certain insurance companies) exceeds 75% of the gross amount of all premiums or other consideration in respect of all risks. A 10% U.S. Shareholder is a U.S. Person who owns (directly, indirectly through non-U.S. entities or constructively) at least 10% of the total combined voting power of all classes of stock entitled to vote or 10% of the value of the non-U.S. corporation. The 2017 Act expanded the definition of 10% U.S. Shareholder to include ownership by value (rather than just vote), so provisions in the companys organizational documents that cut back voting power to potentially avoid 10% U.S. Shareholder status will no longer mitigate the risk of 10% U.S. Shareholder status.
FIHL believes that because of the anticipated dispersion of its share ownership, no U.S. Person who owns the Common Shares of FIHL directly or indirectly through one or more non-U.S. entities should be treated as owning (directly, indirectly through non-U.S. entities, or constructively) 10% or more of the total voting power or value of all classes of shares of FIHL or any of its non-U.S. subsidiaries. However, the companys shares may not be as widely dispersed as Current Fidelis believes due to, for example, the application of certain ownership attribution rules, and no assurance may be given that a U.S. Person who owns the Companys shares will not be characterized as a 10% U.S. Shareholder.
The RPII CFC Provisions
The following discussion generally is applicable only if neither the 20% Gross Income Exception nor the 20% Ownership Exception (as such terms are defined below) is met for a taxable year. Although FIHL cannot be
255
certain, it believes that each of its non-U.S. insurance subsidiaries should meet either the 20% Ownership Exception or the 20% Gross Income Exception for each taxable year for the foreseeable future.
RPII is any insurance income (as defined below) attributable to policies of insurance or reinsurance with respect to which the person (directly or indirectly) insured is an RPII shareholder (as defined below) or a related person (as defined below) to such RPII shareholder. In general, and subject to certain limitations, insurance income is income (including premium and investment income) attributable to the issuing of any insurance or reinsurance contract which would be taxed under the portions of the Code relating to insurance companies if the income were the income of a U.S. insurance company. For purposes of inclusion of the RPII of a non-U.S. insurance subsidiary of FIHL in the income of RPII shareholders, unless an exception applies, the term RPII shareholder means any U.S. Person who owns (directly or indirectly through non-U.S. entities) any amount of the Companys shares. Generally, the term related person for this purpose means someone who controls or is controlled by the RPII shareholder or someone who is controlled by the same person or persons which control the RPII shareholder. Control is measured by either more than 50% in value or more than 50% in voting power of stock applying certain constructive ownership principles. A corporations pension plan is ordinarily not a related person with respect to the corporation unless the pension plan owns, directly or indirectly through the application of certain constructive ownership rules, more than 50% measured by vote or value, of the stock of the corporation. Each non-U.S. insurance subsidiary should be treated as a CFC under the RPII provisions if RPII shareholders are treated as owning (directly, indirectly through non-U.S. entities or constructively) 25% or more of the shares of FIHL by vote or value.
RPII Exceptions
The special RPII rules do not apply to each non-U.S. insurance subsidiary of FIHL for a taxable year if (i) direct and indirect insureds and persons related to such insureds, whether or not U.S. Persons, are treated as owning (directly or indirectly through entities) less than 20% of the voting power and less than 20% of the value of the shares of FIHL at any time during the taxable year (the 20% Ownership Exception); (ii) the gross RPII of the non-U.S. subsidiary is less than 20% of its gross insurance income for the taxable year (the 20% Gross Income Exception); (iii) the non-U.S. insurance subsidiary elects to be taxed on its RPII as if the RPII were effectively connected with the conduct of a U.S. trade or business, and to waive all treaty benefits with respect to RPII and meet certain other requirements; or (iv) the non-U.S. insurance subsidiary elects to be treated as a U.S. corporation and waives all treaty benefits and meets certain other requirements. No non-U.S. insurance subsidiary of FIHL intends to make either of these elections. Where none of these exceptions applies to a non-U.S. insurance subsidiary, each U.S. Person owning (directly or indirectly through non-U.S. entities) any shares in FIHL (and therefore, indirectly, the non-U.S. insurance subsidiary) on the last day of such companys taxable year will be required to include in its gross income for U.S. federal income tax purposes its share of the RPII of the non-U.S. insurance subsidiary for the portion of the taxable year during which the non-U.S. insurance subsidiary was a CFC under the RPII provisions, determined as if all such RPII were distributed proportionately only to such U.S. Persons at that date, but limited by each such U.S. Persons share of the companys current-year earnings and profits as reduced by the U.S. Persons share, if any, of certain prior-year deficits in earnings and profits. Each non-U.S. insurance subsidiary of FIHL intends to operate in a manner that is intended to ensure that it qualifies for the 20% Gross Income Exception or 20% Ownership Exception. However, it is possible that they will not be successful in qualifying under these exceptions because some of the factors which determine the extent of RPII may be beyond Current Fidelis control.
Computation of RPII
In order to determine how much RPII a non-U.S. insurance subsidiary of FIHL has earned in each taxable year, each non-U.S. insurance subsidiary may obtain and rely upon information from its insureds and reinsureds to determine whether any of the insureds, reinsureds or persons related thereto own (directly or indirectly through non-U.S. entities) shares of FIHL and are U.S. Persons. A non-U.S. insurance subsidiary of FIHL may not be able to determine whether any of their underlying direct or indirect insureds are shareholders or related persons
256
to such shareholders, and, consequently, may not be able to determine accurately the gross amount of RPII earned by it in a given taxable year. For any year in which the 20% Gross Income Exception and the 20% Ownership Exception do not apply, FIHL may also seek information from its shareholders as to whether beneficial owners of shares at the end of the year are U.S. Persons so that the RPII may be determined and apportioned among such persons; to the extent FIHL is unable to determine whether a beneficial owner of shares is a U.S. Person, FIHL may assume that such owner is not a U.S. Person, thereby increasing the per share RPII amount for all known RPII shareholders.
If, as expected, for each taxable year each non-U.S. insurance subsidiary of FIHL meets the 20% Gross Income Exception or 20% Ownership Exception, RPII shareholders will not be required to include RPII in their taxable income. The amount of RPII includable in the income of an RPII shareholder is based upon the net RPII income for the year after deducting related expenses such as losses, loss reserves and operating expenses.
Apportionment of RPII to U.S. Holders
Every RPII shareholder who owns shares on the last day of any taxable year of FIHL in which both the 20% Ownership Exception and the 20% Gross Income Exception do not apply to a non-U.S. insurance subsidiary of FIHL should expect that for such year it will be required to include in gross income its share of such subsidiarys RPII for the portion of the taxable year during which the non-U.S. insurance subsidiary was a CFC under the RPII provisions, whether or not distributed, even though such shareholder may not have owned the shares throughout such period. An RPII shareholder who owns shares during such taxable year but not on the last day of the taxable year is not required to include in gross income any part of the RPII of a non-U.S. insurance subsidiary of FIHL.
Basis Adjustments
An RPII shareholders tax basis in its shares will be increased by the amount of any RPII that such shareholder includes in income. The RPII shareholder may exclude from income the amount of any distributions by FIHL out of previously taxed RPII income. The RPII shareholders tax basis in its shares will be reduced by the amount of such distributions that are excluded from income.
Uncertainty as to Application of RPII
The RPII provisions have never been interpreted by the courts or the U.S. Treasury Department in final regulations, and regulations interpreting the RPII provisions of the Code exist only in proposed form. Accordingly, the meaning of the RPII provisions and the application thereof to a non-U.S. insurance subsidiary of FIHL is uncertain. In addition, FIHL cannot be certain that the amount of RPII or the amounts of the RPII inclusions for any particular RPII shareholder, if any, will not be subject to adjustment based upon subsequent IRS examination. Further, recently proposed regulations could, if finalized in their current form, substantially expand the definition of RPII to include insurance income of our non-U.S. subsidiaries with respect to certain affiliate reinsurance transactions. If these proposed regulations are finalized in their current form, it could limit Current Fidelis ability to execute affiliate reinsurance transactions that would otherwise be undertaken for non-tax business reasons in the future and could increase the risk that the 20% Gross Income Exception would not be met for one or more of FIHLs non-U.S. subsidiaries in a particular taxable year, which could result in such RPII being taxable to U.S. Persons that own or are treated as owning Common Shares directly or indirectly through non-U.S. entities. U.S. Persons owning or treated as owning Common Shares should consult their tax advisors as to the effect of these uncertainties.
Information Reporting
Under certain circumstances, U.S. Persons owning shares in a non-U.S. corporation are required to file IRS Form 5471 with their U.S. federal income tax returns. Generally, information reporting on IRS Form 5471 is
257
required by (i) a person who is treated as an RPII shareholder; (ii) a 10% U.S. Shareholder of a non-U.S. corporation that is a CFC at any time during any tax year of the non-U.S. corporation and who owned the stock on the last day of that year; and (iii) under certain circumstances, a U.S. Person who acquires stock in a non-U.S. corporation and as a result thereof owns 10% or more of the voting power or value of such non-U.S. corporation, whether or not such non-U.S. corporation is a CFC. FIHL will provide to all U.S. Persons registered as shareholders of its shares the relevant information necessary to complete IRS Form 5471 in the event FIHL determines this is necessary. Failure to file IRS Form 5471 may result in penalties.
U.S. Holders should consider their possible obligation to file FinCEN Form 114, Report of Foreign Bank and Financial Accounts, with respect to the Common Shares. Additionally, such U.S. Holders should consider their possible obligations to annually report certain information with respect to the Form with their U.S. federal income tax returns. Certain U.S. Holders who are individuals (and certain entities) that hold an interest in specified foreign financial assets (which may include the Common Shares) are required to report information (on IRS Form 8938) relating to such assets, subject to certain exceptions (including an exception for Common Shares held in accounts maintained by certain financial institutions). U.S. Holders who fail to report the required information could be subject to substantial penalties, and, in such circumstances, the statute of limitations for assessment of tax could be suspended, in whole or part. Shareholders should consult their tax advisors with respect to these or any other reporting requirements which may apply with respect to their purchase, holding and sale of the Common Shares.
Certain shareholders may be required to file an IRS Form 926 (Return of a U.S. Transferor of Property to a Foreign Corporation) to report a transfer of property, including cash, to FIHL. Substantial penalties may be imposed on a shareholder that fails to comply with this reporting requirement. Each shareholder is urged to consult with its own tax advisors regarding this reporting obligation.
Tax-Exempt Shareholders
Tax-exempt entities will be required to treat certain subpart F insurance income, including RPII, that is includible in income by the tax-exempt entity as unrelated business taxable income. Prospective investors that are tax exempt entities are urged to consult their tax advisors as to the potential impact of the unrelated business taxable income provisions of the Code. A tax-exempt organization that is treated as a 10% U.S. Shareholder or an RPII Shareholder also must file IRS Form 5471 in the circumstances described above.
Dispositions of the Common Shares
Subject to the discussions below relating to the potential application of the Code section 1248 and PFIC rules, U.S. Holders generally should recognize capital gain or loss for U.S. federal income tax purposes on the sale, exchange or other disposition of the Common Shares in the same manner as on the sale, exchange or other disposition of any other shares held as capital assets. If the holding period for these shares exceeds one year, any gain will be subject to tax at a current maximum marginal tax rate of 20% for individuals and a rate of 21% for corporations. Moreover, gain, if any, generally will be U.S.-source gain and generally will constitute passive category income for foreign tax credit limitation purposes.
Code section 1248 provides that if a U.S. Person sells or exchanges stock in a non-U.S. corporation and such person owned, directly, indirectly through certain non-U.S. entities or constructively, 10% or more of the voting power of the corporation at any time during the five (5)-year period ending on the date of disposition when the corporation was a CFC, any gain from the sale or exchange of the shares will be treated as a dividend to the extent of the CFCs earnings and profits (determined under U.S. federal income tax principles) during the period that the shareholder held the shares and while the corporation was a CFC (with certain adjustments). FIHL believes that because of the anticipated dispersion of its share ownership, no U.S. Person that owns Common Shares directly or through non-U.S. entities in FIHL should be treated as owning (directly, indirectly through non-U.S. entities or constructively) 10% or more of the total voting power of FIHL; to the extent this is the case,
258
the application of Code Section 1248 under the regular CFC rules should not apply to dispositions of the Common Shares. However, no assurance can be given in this regard.
A 10% U.S. Shareholder may in certain circumstances be required to report a disposition of shares of a CFC by attaching IRS Form 5471 to the U.S. federal income tax or information return that it would normally file for the taxable year in which the disposition occurs. In the event this is determined necessary, FIHL will, upon request, provide the relevant information necessary to complete IRS Form 5471.
Code Section 1248 in conjunction with the RPII rules also applies to the sale or exchange of shares in a non-U.S. corporation if the non-U.S. corporation would be treated as a CFC for RPII purposes regardless of whether the shareholder owns, directly, indirectly through certain non-U.S. entities or constructively, 10% or more of the voting power of such non-U.S. corporation or whether the 20% Gross Income Exception or the 20% Ownership Exception applies. Existing proposed regulations do not address whether Code Section 1248 would apply if a non-U.S. corporation is not a CFC but the non-U.S. corporation has a subsidiary that would be treated as a CFC for RPII purposes. FIHL believes, however, that this application of Code Section 1248 under the RPII rules should not apply to dispositions of Common Shares because FIHL will not be directly engaged in the insurance business. FIHL cannot be certain, however, that the IRS will not interpret the proposed regulations in a contrary manner or that the U.S. Treasury Department will not amend the proposed regulations to provide that these rules will apply to dispositions of the Common Shares. Prospective investors should consult their tax advisors regarding the effects of these rules on a disposition of the Common Shares.
PFIC
In general, a non-U.S. corporation will be a PFIC during a given taxable year if (i) the 75% test is met for such taxable year; or (ii) the 50% test is met for such taxable year. Once characterized as a PFIC, the shares of the non-U.S. corporation will generally retain status as shares in a PFIC for future taxable years with respect to U.S. shareholders that held such shares in the taxable year of the initial PFIC characterization.
If FIHL were characterized as a PFIC during a given year, each U.S. Person holding the Common Shares would be subject to a penalty tax at the time of the taxable disposition at a gain of, or receipt of an excess distribution with respect to, their Common Shares, unless such person (i) is a 10% U.S. Shareholder and FIHL is a CFC or (ii) made a QEF or mark-to-market election. It is uncertain whether FIHL would be able to provide its shareholders with the information necessary for a U.S. Person to make the QEF election or whether a U.S. Person will be eligible to make a mark-to-market election with respect to the Common Shares, and a mark-to-market election likely will not be available for any shares of FIHLs non-U.S. subsidiaries. In addition, if FIHL were considered a PFIC, upon the death of any U.S. individual owning shares, such individuals heirs or estate would not be entitled to a step-up in the basis of their Common Shares that might otherwise be available under U.S. federal income tax laws. In general, a shareholder receives an excess distribution if the amount of the distribution is more than 125% of the average distribution with respect to the shares during the three (3) preceding taxable years (or shorter period during which the taxpayer held the Common Shares). In general, the penalty tax is equivalent to an interest charge on taxes that are deemed due during the period the shareholder owned the Common Shares, computed by assuming that the excess distribution or gain (in the case of a taxable disposition) with respect to the Common Shares was taken in equal portion at the highest applicable tax rate on ordinary income throughout the shareholders period of ownership. The interest charge is equal to the applicable rate imposed on underpayments of U.S. federal income tax for such period. In addition, a distribution paid by FIHL to U.S. shareholders that is characterized as a dividend and is not characterized as an excess distribution would not be eligible for reduced rates of tax as qualified dividend income if FIHL were considered a PFIC in the taxable year in which such dividend was paid or in the preceding taxable year. A U.S. Person that is a shareholder in a PFIC may also be subject to additional information reporting requirements, including the annual filing of IRS Form 8621.
For the above purposes, passive income generally includes interest, dividends, annuities and other investment income. The PFIC rules provide that income derived in the active conduct of an insurance business by
259
a qualifying insurance corporation, as amended by the 2017 Act, is not treated as passive income. The PFIC provisions also contain a look-through rule under which a non-U.S. corporation will be treated as if it received directly its proportionate share of the income and as if it held its proportionate share of the assets of any other corporation in which it owns at least 25% of the value of the stock (the look-through rule).
Under the look-through rule, FIHL should be deemed to own its proportionate share of the assets and to have received its proportionate share of the income of its non-U.S. insurance subsidiaries for purposes of the 75% test and the 50% test. However, the 2017 Act limits the insurance income exception to a non-U.S. insurance company that is a qualifying insurance corporation that would be taxable as an insurance company if it were a U.S. corporation and satisfies the Reserve Test by satisfying either the 25% Test or the 10% Test (each as defined above). Current Fidelis believes that FIBL has met this Reserve Test and will continue to do so in the foreseeable future, although no assurance may be given that FIBL will satisfy the Reserve Test in future years.
Further, the 2020 Regulations define insurance liabilities for purposes of the Reserve Test, tighten the Reserve Test as well as place a statutory cap on insurance liabilities, and provide guidance on the runoff-related and rating-related circumstances for purposes of the 10% Test. The 2020 Regulations, which set forth in proposed form certain requirements that must be met to satisfy the active conduct of an insurance business test, also propose that a non-U.S. insurer with no or a nominal number of employees that relies exclusively or almost exclusively upon independent contractors (other than related entities) to perform its core functions will not be treated as engaged in the active conduct of an insurance business. Further, for purposes of applying the 10% Test, the 2020 Regulations: (i) generally limit the rating-related circumstances exception to a non-U.S. corporation: (a) if more than half of such corporations net written premiums for the applicable period are derived from insuring catastrophic risk, or (b) providing certain other insurance coverage that Current Fidelis is not expected to engage in, and (ii) reduce a corporations insurance liabilities by the amount of any reinsurance recoverable relating to such liability. Current Fidelis believes that, based on the implementation of its business plan and the application of the look-through rule and the exceptions set out under Section 1297 of the Code, none of the income and assets of FIBL should be treated as passive pursuant to the 10% Test, and thus, FIHL should not be characterized as a PFIC under current law for its current taxable year and foreseeable future years to the extent a shareholder makes an election to apply the 10% Test with respect to each non-U.S. insurance subsidiary, but because of the legal uncertainties as well as factual uncertainties with respect to Current Fidelis planned operations, there is a risk that FIBL and therefore FIHL will be characterized as a PFIC for U.S. federal income tax purposes. In addition, because of the legal uncertainties relating to how the 2020 Regulations will be interpreted and the form in which the proposed 2020 Regulations may be finalized, no assurance can be given that FIHL will not qualify as a PFIC under final IRS guidance or any future regulatory proposal or interpretation that may be subsequently introduced and promulgated. If FIHL is considered a PFIC, it could have material adverse tax consequences for an investor that is subject to U.S. federal income taxation. Prospective investors should consult their tax advisors as to the effects of the PFIC rules.
As noted above, the 10% Test will only apply if a U.S. Holder makes a valid election. A U.S. Holder seeking to elect the application of the 10% Test to FIBL may do so if Current Fidelis provides the holder- with, or otherwise makes publicly available, a statement or other disclosure that FIBL meets the requirements of the 10% Test (and contains certain other relevant information). Current Fidelis intends to either provide each U.S. Holder with such a statement or otherwise make such a statement publicly available. A U.S. Holder may generally make an election to apply the 10% Test by completing a Form 8621 and attaching it to its original or amended U.S. federal income tax return for the taxable year to which the election relates. Investors owning a de minimis amount of FIHL stock may be deemed to have made the election automatically. U.S. investors are urged to consult their tax advisors regarding electing to apply the 10% Test to FIHLs non-U.S. insurance subsidiaries.
U.S. investors are also urged to consult with their tax advisors and to consider making a protective QEF election with respect to FIHL and each of FIHLs non-U.S. subsidiaries to preserve the possibility of making a retroactive QEF election. If the Group determines that FIHL is a PFIC, the Group intends to use commercially reasonable efforts to provide the information necessary to make a QEF election for FIHL and each non-U.S.
260
subsidiary of FIHL that is a PFIC. A U.S. Person that makes a QEF election with respect to a PFIC is currently taxable on its pro rata share of the ordinary earnings and net capital gain of such company during the years it is a PFIC (at ordinary income and capital gain rates, respectively), regardless of whether or not distributions were received. In addition, any of the PFICs losses for a taxable year will not be available to U.S. Persons and may not be carried back or forward in computing the PFICs ordinary earnings and net capital gain in other taxable years. A U.S. Person generally increases the basis of its PFIC shares, and the basis of any other property of the U.S. Person by reason of which such U.S. Person is considered to indirectly own PFIC shares, by amounts included in such U.S. Persons gross income pursuant to the QEF election. Therefore, an electing shareholder will generally increase the basis of its Common Shares by amounts included in the shareholders gross income pursuant to the QEF election.
In lieu of making a QEF election, if FIHL is a PFIC for any taxable year and the Common Shares are treated as marketable stock in such year, then a U.S. Person may avoid the unfavorable rules described above by making a mark-to-market election with respect to such holders Common Shares. The Common Shares will be marketable if they are regularly traded on certain qualifying stock exchanges, including NYSE; however, there can be no assurance that trading in the Common Shares will be sufficiently regular for the shares to qualify as marketable stock, and a mark-to-market election likely would not be available for any subsidiary of FIHL also treated as a PFIC. In general, if a U.S. Holder were to make a timely and effective mark-to-market election, such holder would include as ordinary income each year the excess, if any, of the fair market value of the holders Common Shares at the end of the taxable year over its adjusted basis in the Common Shares. Any gain recognized by such holder on the sale or other disposition of the Common Shares would be ordinary income, and any loss would be an ordinary loss to the extent of the net amount of previously included income as a result of the mark-to-market election and, thereafter, a capital loss. U.S. Holders considering a mark-to-market election for FIHL should consult with their tax advisors regarding making a QEF election for any non-U.S. subsidiary of FIHL treated as a PFIC.
A U.S. Holder will be required to file an IRS Form 8621 (which is a form that is required to be filed by holders of equity in a PFIC) for each tax year that it holds Common Shares and FIHL is characterized as a PFIC, regardless of whether such U.S. Person has a QEF election in effect or receives any excess distribution.
Medicare Contribution Tax
A U.S. Person that is an individual, estate or a trust that does not fall into a special class of trusts that is exempt from such tax will be subject to a 3.8% tax on the lesser of (i) the U.S. Persons net investment income (or undistributed net investment income in the case of estates and trusts) for the relevant taxable year and (ii) the excess of the U.S. Persons modified adjusted gross income for the taxable year over a certain threshold. A U.S. Holders net investment income will generally include its dividend income and its net gains from the disposition of Common Shares, unless such dividend income or net gains are derived in the ordinary course of the conduct of a trade or business (other than a trade or business that consists of certain passive or trading activities). Under certain proposed United States Treasury Regulations, an inclusion of subpart F income by a 10% U.S. Shareholder will not be treated as a dividend for purposes of calculating this 3.8% tax on net investment income. However, actual distributions with respect to such income, which as previously taxed income will not be subject to U.S. federal income tax, and will be treated as dividends for purposes of calculating net investment income and this 3.8% tax.
Foreign Tax Credit
Dividends on Common Shares, and current income inclusions under the CFC, RPII and PFIC rules generally will constitute foreign source income for foreign tax credit limitation purposes, and generally will constitute passive category income. If U.S. Persons in the aggregate own a majority of the shares of FIHL, under certain circumstance only a portion of the current income inclusions, if any, under the CFC, RPII and PFIC rules and of dividends paid by FIHL (including any gain from the sale of the Common Shares that is treated as a dividend
261
under section 1248 of the Code) will be treated as foreign source income for purposes of computing a shareholders U.S. foreign tax credit limitations. FIHL will consider providing shareholders with information regarding the portion of such amounts constituting foreign source income to the extent such information is reasonably available. There are additional significant and complex limits on a U.S. Persons ability to claim foreign tax credits, and recently issued U.S. Treasury regulations that apply to foreign income taxes paid or accrued in taxable years beginning on or after December 28, 2021 further restrict the availability of any such credit based on the nature of the tax imposed by the foreign jurisdiction. Thus, it may not be possible for shareholders to utilize excess foreign tax credits to reduce U.S. tax on such income. The rules relating to the determination of the U.S. foreign tax credit are complex, and U.S. Holders should consult their tax advisors regarding the availability of a foreign tax credit in their particular circumstances and the possibility of claiming an itemized deduction (in lieu of the foreign tax credit) for any foreign taxes paid or withheld.
Information Reporting and Backup Withholding on Distributions and Disposition Proceeds
Information returns may be filed with the IRS in connection with distributions on the Common Shares and the proceeds from a sale or other disposition of the Common Shares unless the holder of the Common Shares establishes an exemption from the information reporting rules. A holder of the Common Shares that does not establish such an exemption may be subject to U.S. backup withholding tax on these payments if the holder is not a corporation or fails to provide its taxpayer identification number or otherwise comply with the backup withholding rules. The amount of any backup withholding from a payment to a U.S. Holder will be allowed as a credit against the U.S. Holders U.S. federal income tax liability and may entitle the U.S. Holder to a refund, provided that the required information is furnished to the IRS.
Bermuda Taxation
Taxation of FIHL and FIBL
At the present time, there is no Bermuda income or profits tax, withholding tax, capital gains tax, capital transfer tax, estate duty or inheritance tax payable by FIHL or FIBL in respect of the Common Shares. FIHL has obtained an assurance from the Minister of Finance of Bermuda under the Exempted Undertakings Tax Protection Act 1966 that, in the event that any legislation is enacted in Bermuda imposing any tax computed on profits or income, or computed on any capital asset, gain or appreciation or any tax in the nature of estate duty or inheritance tax, such tax will not, until March 31, 2035, be applicable to us or to any of our operations or to the Common Shares, debentures or other obligations except insofar as such tax applies to persons ordinarily resident in Bermuda or is payable by FIHL in respect of real property owned or leased by it in Bermuda. The same assurance has been obtained with respect to FIBL. Given the limited duration of any assurance by the Minister of Finance, neither FIHL nor FIBL can be certain that it will not be subject to any Bermuda taxes after March 31, 2035. Each of FIHL and FIBL pays an annual Bermuda Government fee and an insurance license fee, as applicable. In addition, all entities employing individuals in Bermuda are required to pay a payroll tax and there are other sundry taxes payable, directly or indirectly, to the Bermuda Government.
Pursuant to the Payroll Tax Act 1995 and the Payroll Tax Rates Act 1995 of Bermuda (together, the Payroll Tax Act), an employer is required to pay payroll tax on remuneration paid by it to each employee or deemed employee for services rendered by the employee or deemed employee during that tax period wholly or mainly in Bermuda (provided that any remuneration paid by the employer to the employee or deemed employee in excess of $900,000 per annum is disregarded) and may, within certain parameters, make deductions from remuneration paid to each employee and deemed employee in each tax period in respect of a certain portion of the payroll tax paid by the employer in respect of that employee or deemed employee in that tax period. For the purposes of the Payroll Tax Act, any gain obtained by the exercise, assignment or release of any option awarded under any of our option plans will constitute actual remuneration.
In addition, the OECD has published reports and launched a global dialogue among member and non-member countries on measures to limit harmful tax competition. These measures are largely directed at
262
counteracting the effects of tax havens and preferential tax regimes in countries around the world. According to the OECD, Bermuda is a jurisdiction that has substantially implemented the internationally agreed tax standard. However, neither FIHL nor FIBL is able to predict whether any changes will be made to this classification or whether any such changes will subject FIHL or FIBL to additional taxes.
Taxation of Shareholders
At the present time, there is no Bermuda income or profits tax, withholding tax, capital gains tax, capital transfer tax, estate duty or inheritance tax payable by our shareholders in respect of our Common Shares. FIHL has obtained an assurance from the Minister of Finance of Bermuda under the Exempted Undertakings Tax Protection Act 1966 that, in the event that any legislation is enacted in Bermuda imposing any tax computed on profits or income, or computed on any capital asset, gain or appreciation or any tax in the nature of estate duty or inheritance tax, such tax will not, until March 31, 2035, be applicable to the Common Shares except insofar as such tax applies to persons ordinarily resident in Bermuda. The same assurance has been obtained with respect to FIBL. Given the limited duration of any assurance by the Minister of Finance, we cannot be certain that the shareholders will not be subject to any Bermuda taxes after March 31, 2035.
263
Under the terms and subject to the conditions in an underwriting agreement dated the date of this prospectus, the underwriters named below, for whom J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC are acting as representatives, have severally agreed to purchase, and we and the Selling Shareholders have agreed to sell to them the number of shares indicated below:
Name |
Shares | |||
J.P. Morgan Securities LLC |
||||
Barclays Capital Inc. |
||||
Jefferies LLC |
||||
Keefe, Bruyette & Woods, Inc. |
||||
BMO Capital Markets Corp. |
||||
Citigroup Global Markets Inc. |
||||
UBS Securities LLC |
||||
JMP Securities LLC |
||||
Dowling & Partners Securities, LLC |
||||
|
|
|||
Total: |
17,000,000 | |||
|
|
The underwriters and the representatives are collectively referred to as the underwriters and the representatives, respectively. The underwriters are offering the Common Shares subject to their acceptance of the Common Shares from us and the Selling Shareholders and subject to prior sale. The underwriting agreement provides that the obligations of the several underwriters to pay for and accept delivery of the Common Shares offered by this prospectus are subject to the approval of certain legal matters by their counsel and to certain other conditions. The underwriters are obligated to take and pay for all of the Common Shares offered by this prospectus if any such Common Shares are taken. However, the underwriters are not required to take or pay for the Common Shares covered by the underwriters over-allotment option described below.
The underwriters initially propose to offer part of the Common Shares directly to the public at the offering price listed on the cover page of this prospectus and part to certain dealers at a price that represents a concession not in excess of $ per Common Share under the public offering price. After the initial offering of the Common Shares, the offering price and other selling terms may from time to time be varied by the representatives.
The Selling Shareholders have granted to the underwriters an option, exercisable for 30 days from the date of this prospectus, to purchase up to 2,550,000 additional Common Shares at the public offering price listed on the cover page of this prospectus, less underwriting discounts and commissions. The underwriters may exercise this option solely for the purpose of covering over-allotments, if any, made in connection with the offering of the Common Shares offered by this prospectus. To the extent the option is exercised, each underwriter will become obligated, subject to certain conditions, to purchase about the same percentage of the additional Common Shares as the number listed next to the underwriters name in the preceding table bears to the total number of Common Shares listed next to the names of all underwriters in the preceding table.
The following table shows the per share and total public offering price, underwriting discounts and commissions, and proceeds before expenses to us and the Selling Shareholders. These amounts are shown assuming both no exercise and full exercise of the underwriters option to purchase up to an additional 2,550,000 Common Shares from the Selling Shareholders.
264
Total | ||||||||||||
Per Common Share |
No Exercise |
Full Exercise |
||||||||||
Public offering price |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Underwriting discounts and commissions to be paid by us |
$ | $ | $ | |||||||||
Proceeds, before expenses, to us |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Proceeds, before expenses, to the Selling Shareholders |
$ | $ | $ | |||||||||
|
|
|
|
|
|
The estimated offering expenses payable by us, exclusive of the underwriting discounts and commissions, are approximately $5.3 million. We have also agreed to reimburse the underwriters for certain of their expenses in an amount up to $35,000.
We have applied to list our Common Shares on NYSE under the trading symbol FIHL.
We have agreed that, without the prior written consent of J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC on behalf of the underwriters, we and they will not, and will not publicly disclose an intention to, during the period ending 180 days after the date of this prospectus (the restricted period):
| offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the SEC a registration statement under the Securities Act relating to, any Common Shares or any securities convertible into or exercisable or exchangeable for Common Shares |
| enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Common shares or any such other securities whether any such transaction described above is to be settled by delivery of Common Shares or such other securities, in cash or otherwise. |
The restrictions described above do not apply to;
(i) | the offer, issuance, sale and disposition of the Common Shares in connection with this offering, |
(ii) | the issuance of Common Shares or securities convertible into or exercisable for Common Shares pursuant to the conversion or exchange of convertible or exchangeable securities or the exercise of warrants or options (including net exercise) or the settlement of RSUs (including net settlement), in each case outstanding as of the pricing of this offering, |
(iii) | grants of options, stock awards, restricted stock, RSUs, or other equity awards and the issuance of Common Shares or securities convertible into or exercisable or exchangeable for Common Shares (whether upon the exercise of options or otherwise) to the Companys employees, officers, directors, advisors, or consultants pursuant to the terms of an equity compensation plan in effect as of the closing of this offering and described herein, provided that such recipients enter into a lock-up agreement with the underwriters, |
(iv) | the issuance of up to 5% of the outstanding shares of Common Shares, or securities convertible into, exercisable for, or which are otherwise exchangeable for, Common Shares, immediately following the closing of this offering, in acquisitions or other similar strategic transactions, provided that such recipients enter into a lock-up agreement with the underwriters, or |
(v) | the filing of any registration statement on Form S-8 relating to securities granted or to be granted pursuant to any plan in effect as of the pricing of this offering and described herein or any assumed benefit plan pursuant to an acquisition or similar strategic transaction. |
265
Our directors and officers and substantially all of our other securityholders have agreed that, without the prior written consent of J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC on behalf of the underwriters, we and they will not, and will not publicly disclose an intention to, during the restricted period:
| offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any Common Shares or any securities convertible into or exercisable or exchangeable for Common Shares, |
| enter into any hedging, swap or other agreement or transaction that transfers, in whole or in part, any of the economic consequences of ownership of the Common Shares or any securities convertible into or exercisable or exchangeable for Common Shares, or |
| make any demand for, or exercise any right with respect to, the registration of any Common Shares or any securities convertible into or exercisable or exchangeable for Common Shares. |
The restrictions described in the immediately preceding paragraph do not apply to certain transfers, dispositions or transactions, including:
(i) | as a bona fide gift or gifts, or for bona fide estate planning purposes, |
(ii) | by will or intestacy, |
(iii) | to any trust for the direct or indirect benefit of the holder or the immediate family of the holder, or if the holder is a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust, |
(iv) | to a partnership, limited liability company or other entity of which the holder and the immediately family of the holder are the legal and beneficial owner of all of the outstanding equity securities or similar interests, |
(v) | to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i) through (iv) above, |
(vi) | if the holder is a corporation, partnership, limited liability company, trust or other business entity, (A) to another corporation, partnership, limited liability company, trust or other business entity that is an affiliate (as defined in Rule 405 promulgated under the Securities Act of the holder, or to any investment fund or other entity controlling, controlled by, managing or managed by or under common control with the holder or affiliates of the holder, or (B) as part of a distribution to members or shareholders of the undersigned, |
(vii) | by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation agreement, |
(viii) | to the Company from an employee of the Company upon death, disability or termination of employment, in each case, of such employee |
(ix) | as part of a sale of the holders Common Shares or any securities convertible into or exercisable or exchangeable for Common Shares acquired in open market transactions after the closing of this offering, |
(x) | to the Company in connection with the vesting, settlement or exercise of restricted stock units, options, warrants or other rights to purchase Common Shares (including, in each case, by way of net or cashless exercise), including for the payment of exercise price and tax and remittance payments due as a result of the vesting, settlement, or exercise of such restricted stock units, options, warrants or rights, |
(xi) | pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction that is approved by the Board of Directors and made to all holders of the Companys capital stock the result of which is that any person (as defined in Section 13(d)(3) of the Exchange Act), or group of |
266
affiliated persons, would hold at least a majority of the outstanding voting securities of the Company (or the surviving entity), or |
(xii) | with the prior written consent of J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC on behalf of the underwriters. |
J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC, in their sole discretion, may release the Common Shares and other securities subject to the lock-up agreements described above in whole or in part at any time. When determining whether or not to release common stock and other securities from lock-up agreements, J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC will consider, among other factors, the holders reasons for requesting the release, the Common Shares and other securities for which the release is being requested and market conditions at the time. At least three business days before the effectiveness of any release or waiver of any of the restrictions described above with respect to an officer or director of the Company, J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC will notify us of the impending release or waiver and we have agreed to announce the impending release or waiver by press release through a major news service at least two business days before the effective date of the release or waiver.
Each of the MGU Executives and the Insurance Group Executives have agreed with the company to abide by certain restrictions of sales of Common Shares for a period of time. See Material Contracts and Related Party TransactionsIPO Assistance and Lock-Up Agreement for more information.
In order to facilitate the offering of the Common Shares, the underwriters may engage in transactions that stabilize, maintain or otherwise affect the price of the Common Shares. Specifically, the underwriters may sell more shares than they are obligated to purchase under the underwriting agreement, creating a short position. A short sale is covered if the short position is no greater than the number of shares available for purchase by the underwriters under the over-allotment option. The underwriters can close out a covered short sale by exercising the over-allotment option or purchasing shares in the open market. In determining the source of shares to close out a covered short sale, the underwriters will consider, among other things, the open market price of shares compared to the price available under the over-allotment option. The underwriters may also sell shares in excess of the over-allotment option, creating a naked short position. The underwriters must close out any naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the Common Shares in the open market after pricing that could adversely affect investors who purchase in this offering. As an additional means of facilitating this offering, the underwriters may bid for, and purchase, Common Shares in the open market to stabilize the price of the Common Shares. These activities may raise or maintain the market price of the Common Shares above independent market levels or prevent or retard a decline in the market price of the Common Shares. The underwriters are not required to engage in these activities and may end any of these activities at any time.
We, the Selling Shareholders and the underwriters have agreed to indemnify one and other against certain liabilities, including liabilities under the Securities Act.
A prospectus in electronic format may be made available on websites maintained by one or more underwriters, or selling group members, if any, participating in this offering. The representatives may agree to allocate a number of Common Shares to underwriters for sale to their online brokerage account holders. Internet distributions will be allocated by the representatives to underwriters that may make Internet distributions on the same basis as other allocations.
The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Certain of the underwriters and their respective affiliates have, from time to time, performed, and may in the future perform, various financial advisory and investment banking services for us, for which they received or will
267
receive customary fees and expenses. In particular, affiliates of Barclays Capital Inc. and BMO Capital Markets Corp. provide letters of credit facilities to us.
In addition, in the ordinary course of their various business activities, the underwriters and their respective affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers and may at any time hold long and short positions in such securities and instruments. Such investment and securities activities may involve our securities and instruments. The underwriters and their respective affiliates may also make investment recommendations or publish or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long or short positions in such securities and instruments.
Pricing of the Offering
Prior to this offering, there has been no public market for our Common Shares. The initial public offering price was determined by negotiations between us and the representatives. Among the factors considered in determining the initial public offering price were our future prospects and those of our industry in general, our sales, earnings and certain other financial and operating information in recent periods, and the price-earnings ratios, price-sales ratios, market prices of securities, and certain financial and operating information of companies engaged in activities similar to ours.
Selling Restrictions
European Economic Area
In relation to each member state of the European Economic Area (each an EEA State), no shares have been offered or will be offered pursuant to the offering to the public in that EEA State prior to the publication of a prospectus in relation to the shares which has been approved by the competent authority in that EEA State or, where appropriate, approved in another EEA State and notified to the competent authority in that EEA State, all in accordance with the E.U. Prospectus Regulation, except that it may make an offer to the public in that EEA State of any shares at any time under the following exemptions under the E.U. Prospectus Regulation:
| to any legal entity which is a qualified investor as defined under the E.U. Prospectus Regulation; |
| to fewer than 150 natural or legal persons (other than qualified investors as defined under the E.U. Prospectus Regulation), subject to obtaining the prior consent of the representatives for any such offer; or |
| in any other circumstances falling within Article 1(4) of the E.U. Prospectus Regulation, provided that no such offer of the shares shall require us or any of our representatives to publish a prospectus pursuant to Article 3 of the E.U. Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the E.U. Prospectus Regulation. |
For the purposes of this provision, the expression an offer to the public in relation to the Common Shares offered by this prospectus in any EEA State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares of our Common Shares to be offered so as to enable an investor to decide to purchase or subscribe for any of the Common Shares offered by this prospectus and the expression E.U. Prospectus Regulation means Regulation (EU) 2017/1129.
United Kingdom
In relation to the United Kingdom, no shares have been offered or will be offered pursuant to the offering to the public in the United Kingdom prior to the publication of a prospectus in relation to the shares which has been approved by the Financial Conduct Authority in accordance with the U.K. Prospectus Regulation, except that it
268
may make an offer to the public in the United Kingdom of any shares at any time under the following exemptions under the U.K. Prospectus Regulation:
| to any legal entity which is a qualified investor as defined under the U.K. Prospectus Regulation; |
| to fewer than 150 natural or legal persons (other than qualified investors as defined under the U.K. Prospectus Regulation), subject to obtaining the prior consent of the representatives for any such offer; or |
| in any other circumstances falling within Article 1(4) of the U.K. Prospectus Regulation, provided that no such offer of the shares shall require us or any of our representatives to publish a prospectus pursuant to Article 3 of the U.K. Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the U.K. Prospectus Regulation. |
In the United Kingdom, the offering is addressed only to, and is directed only at, qualified investors within the meaning of Article 2(e) of the U.K. Prospectus Regulation, who are also (i) persons having professional experience in matters relating to investments who fall within the definition of investment professionals in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the Order); (ii) high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Order; or (iii) persons to whom it may otherwise lawfully be communicated (all such persons being referred to as relevant persons). This document must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this document relates is available only to relevant persons and will be engaged in only with relevant persons.
For the purposes of this provision, the expression an offer to the public in relation to the shares in the United Kingdom means the communication in any form and by any means of sufficient information on the terms of the offering and any shares to be offered so as to enable an investor to decide to purchase or subscribe for any shares, and the expression U.K. Prospectus Regulation means the U.K. version of Regulation (EU) No 2017/1129 as amended by The Prospectus (Amendment etc.) (EU Exit) Regulations 2019, which is part of U.K. law by virtue of the European Union (Withdrawal) Act 2018.
Canada
The Common Shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the Common Shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.
Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchasers province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchasers province or territory for particulars of these rights or consult with a legal advisor.
Pursuant to section 3A.3 (or, in the case of securities issued or guaranteed by the government of a non-Canadian jurisdiction, section 3A.4) of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.
Australia
No placement document, prospectus, product disclosure statement, or other disclosure document has been lodged with the Australian Securities and Investments Commission in relation to this offering. This prospectus
269
does not constitute a prospectus, product disclosure statement, or other disclosure document under the Corporations Act 2001 (the Corporations Act), and does not purport to include the information required for a prospectus, product disclosure statement, or other disclosure document under the Corporations Act.
Any offer in Australia of our Common Shares may only be made to persons (Exempt Investors) who are sophisticated investors (within the meaning of section 708(8) of the Corporations Act), professional investors (within the meaning of section 708(11) of the Corporations Act), or otherwise pursuant to one or more exemptions contained in section 708 of the Corporations Act so that it is lawful to offer our Common Shares without disclosure to investors under Chapter 6D of the Corporations Act.
The Common Shares applied for by Exempt Investors in Australia must not be offered for sale in Australia in the twelve-month period after the date of allotment under the offering, except in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be required pursuant to an exemption under section 708 of the Corporations Act or otherwise or where the offer is pursuant to a disclosure document which complies with Chapter 6D of the Corporations Act. Any person acquiring securities must observe such Australian on-sale restrictions.
This prospectus contains general information only and does not take account of the investment objectives, financial situation, or particular needs of any particular person. It does not contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in this prospectus is appropriate to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.
Switzerland
We have not and will not register with the Swiss Financial Market Supervisory Authority (the FINMA) as a foreign collective investment scheme pursuant to Article 119 of the Federal Act on Collective Investment Scheme of 23 June 2006, as amended (CISA), and accordingly the securities being offered pursuant to this prospectus have not and will not be approved, and may not be licensable, with FINMA. Therefore, the securities have not been authorized for distribution by FINMA as a foreign collective investment scheme pursuant to Article 119 CISA and the securities offered hereby may not be offered to the public (as this term is defined in Article 3 CISA) in or from Switzerland. The securities may solely be offered to qualified investors, as this term is defined in Article 10 CISA, and in the circumstances set out in Article 3 of the Ordinance on Collective Investment Scheme of 22 November 2006, as amended (the CISO), such that there is no public offer. Investors, however, do not benefit from protection under CISA or CISO or supervision by FINMA. This prospectus and any other materials relating to the securities are strictly personal and confidential to each offeree and do not constitute an offer to any other person. This prospectus may only be used by those qualified investors to whom it has been handed out in connection with the offer described herein and may neither directly nor indirectly be distributed or made available to any person or entity other than its recipients. It may not be used in connection with any other offer and will in particular not be copied or distributed to the public in Switzerland or from Switzerland. This prospectus does not constitute an issue prospectus as that term is understood pursuant to Article 652a or 1156 of the Swiss Federal Code of Obligations. We have not applied for a listing of the securities on the SIX Swiss Exchange or any other regulated securities market in Switzerland, and consequently, the information presented in this prospectus does not necessarily comply with the information standards set out in the listing rules of the SIX Swiss Exchange and corresponding prospectus schemes annexed to the listing rules of the SIX Swiss Exchange.
Japan
No registration pursuant to Article 4, paragraph 1 of the Financial Instruments and Exchange Law of Japan (Law No. 25 of 1948, as amended, the FIEL) has been made or will be made with respect to the solicitation of the application for the acquisition of the Common Shares.
270
Accordingly, the Common Shares have not been, directly or indirectly, offered or sold and will not be, directly or indirectly, offered or sold in Japan or to, or for the benefit of, any resident of Japan (which term as used herein means any person resident in Japan, including any corporation or other entity organized under the laws of Japan) or to others for re-offering or re-sale, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan except pursuant to an exemption from the registration requirements, and otherwise in compliance with, the FIEL and the other applicable laws and regulations of Japan.
Qualified Institutional Investors (QII):
Please note that the solicitation for newly issued or secondary securities (each as described in Paragraph 2, Article 4 of the FIEL) in relation to the Common Shares constitutes either a QII only private placement or a QII only secondary distribution (each as described in Paragraph 1, Article 23-13 of the FIEL). Disclosure regarding any such solicitation, as is otherwise prescribed in Paragraph 1, Article 4 of the FIEL, has not been made in relation to the Common Shares. The Common Shares may only be transferred to QIIs.
Non-QII Investors:
Please note that the solicitation for newly issued or secondary securities (each as described in Paragraph 2, Article 4 of the FIEL) in relation to the Common Shares constitutes either a small number private placement or a small number private secondary distribution (each as is described in Paragraph 4, Article 23-13 of the FIEL). Disclosure regarding any such solicitation, as is otherwise prescribed in Paragraph 1, Article 4 of the FIEL, has not been made in relation to the Common Shares. The Common Shares may only be transferred en bloc without subdivision to a single investor.
Dubai International Finance Centre
This prospectus relates to an Exempt Offer in accordance with the Offered Securities Rules of the Dubai Financial Services Authority (the DFSA). This prospectus is intended for distribution only to persons of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus nor taken steps to verify the information set forth herein and has no responsibility for the prospectus. The Common Shares to which this prospectus relates may be illiquid or subject to restrictions on its resale. Prospective purchasers of the Common Shares offered should conduct their own due diligence on the Common Shares. If you do not understand the contents of this prospectus, you should consult an authorized financial advisor.
Hong Kong
Shares of our Common Shares may not be offered or sold by means of any document other than (i) in circumstances which do not constitute an offer to the public within the meaning of the Companies Ordinance (Cap.32, Laws of Hong Kong), (ii) to professional investors within the meaning of the Securities and Futures Ordinance (Cap.571, Laws of Hong Kong) and any rules made thereunder, or (iii) in other circumstances which do not result in the document being a prospectus within the meaning of the Companies Ordinance (Cap.32, Laws of Hong Kong), and no advertisement, invitation, or document relating to shares of our Common Shares may be issued or may be in the possession of any person for the purpose of issue (in each case, whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to shares of our Common Shares which are or are intended to be disposed of only to persons outside Hong Kong or only to professional investors within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder.
271
Singapore
This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or materials in connection with the offer or sale, or invitation for subscription or purchase, of shares of our Common Shares may not be circulated or distributed, nor may the shares of our Common Shares be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor under Section 274 of the Securities and Futures Act, Chapter 289 of Singapore (the Singapore SFA), (ii) to a relevant person, or any person pursuant to Section 275(1A), and in accordance with the conditions specified in Section 275 of the Singapore SFA, or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the Singapore SFA.
Where shares of our Common Shares are subscribed to or purchased under Section 275 by a relevant person which is: (i) a corporation (which is not an accredited investor) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or (ii) a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary is an accredited investor, shares, debentures and units of shares and debentures of that corporation or the beneficiaries rights and interest in that trust will not be transferable for six (6) months after that corporation or that trust has acquired shares of our Common Shares under Section 275 except: (x) to an institutional investor under Section 274 of the Singapore SFA or to a relevant person, or any person pursuant to Section 275(1A), and in accordance with the conditions specified in Section 275 of the Singapore SFA; (y) where no consideration is given for the transfer; or (z) by operation of law.
Brazil
No securities may be offered or sold in Brazil, except in circumstances that do not constitute a public offering or unauthorized distribution under Brazilian laws and regulations. The securities have not been, and will not be, registered with the Comissão de Valores Mobiliários.
China
This prospectus does not constitute a public offer of shares, whether by sale or subscription, in the Peoples Republic of China (the PRC). The shares are not being offered or sold directly or indirectly in the PRC to or for the benefit of legal or natural persons of the PRC.
Further, no legal or natural persons of the PRC may directly or indirectly purchase any of the Common Shares offered by this prospectus or any beneficial interest therein without obtaining all prior PRC governmental approvals that are required, whether statutorily or otherwise. Persons who come into possession of this document are required by the issuer and its representatives to observe these restrictions.
France
Neither this prospectus nor any other offering material relating to the shares described in this prospectus has been submitted to the clearance procedures of the Autorité des Marchés Financiers or of the competent authority of another member state of the European Economic Area and notified to the Autorité des Marchés Financiers. The shares have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France. Neither this prospectus nor any other offering material relating to the shares has been or will be (1) released, issued, distributed or caused to be released, issued or distributed to the public in France; or (2) used in connection with any offer for subscription or sale of the shares to the public in France.
272
Such offers, sales and distributions will be made in France only:
| to qualified investors (investisseurs estraint) and/or to a restricted circle of investors (cercle estraint dinvestisseurs), in each case investing for their own account, all as defined in, and in accordance with, articles L.411-2, D.411-1, D.411-2, D.734-1, D.744-1, D.754-1 and D.764-1 of the French Code monétaire et financier; |
| to investment services providers authorized to engage in portfolio management on behalf of third parties; or |
| in a transaction that, in accordance with article L.411-2-II-1° -or-2° -or 3° of the French Code monétaire et financier and article 211-2 of the General Regulations (Réglement Général) of the Autorité des Marchés Financiers, does not constitute a public offer (appel public á lépargne). |
The shares may be resold, directly or indirectly, only in compliance with articles L.411-1, L.411-2, L412-1 and L.621-8 through L.621-8-3 of the French Code monétaire et financier.
Kuwait
Unless all necessary approvals from the Kuwait Capital Markets Authority pursuant to Law No. 7/2010, its Executive Regulations, and the various Resolutions and Announcements issued pursuant thereto or in connection therewith have been given in relation to the marketing of and sale of the shares described in this prospectus, the shares may not be offered for sale, nor sold, in Kuwait. Neither this prospectus nor any of the information contained herein is intended to lead to the conclusion of any contract of whatsoever nature within Kuwait. With regard to the contents of this document, we recommend that you consult a licensee pursuant to applicable law and specialized in giving advice about the purchase of shares and other securities before making the subscription decision.
Qatar
The shares described in this prospectus have not been, and will not be, offered, sold or delivered, at any time, directly or indirectly, in the State of Qatar (including the Qatar Financial Centre) in a manner that would constitute a public offering. This prospectus has not been, and will not be, registered with or approved by the Qatar Financial Markets Authority, the Qatar Central Bank, the Qatar Financial Centre Regulatory Authority or any other relevant Qatar governmental body or securities exchange, and may not be publicly distributed. This prospectus is intended for the original recipient only and must not be provided to any other person. It is not for general circulation in the State of Qatar and may not be reproduced or used for any other purpose.
Saudi Arabia
This document may not be distributed in the Kingdom of Saudi Arabia except to such persons as are permitted under the Offers of Securities Regulations as issued by the board of the Saudi Arabian Capital Market Authority (the CMA) pursuant to resolution number 2-11-2004 dated 4 October 2004 as amended by resolution number 1-28-2008, as amended. The CMA does not make any representation as to the accuracy or completeness of this document and expressly disclaims any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this document. Prospective purchasers of the securities offered hereby should conduct their own due diligence on the accuracy of the information relating to the securities. If you do not understand the contents of this document, you should consult an authorized financial advisor.
273
Our principal legal advisors in the United States and United Kingdom are Willkie Farr & Gallagher (UK) LLP, located at CityPoint, 1 Ropemaker Street, EC2Y 9AW London, United Kingdom. Our principal legal advisors in Bermuda are Conyers Dill & Pearman Limited (Conyers), located at Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda. Certain Bermuda legal matters relating to this offering will be passed upon by Conyers. Charles Collis is a partner and director at Conyers, as well as a director of the Company. Certain legal matters relating to this offering will be passed upon for the underwriters by Latham & Watkins LLP, located at 1271 Avenue of the Americas, New York, New York 10020.
274
The consolidated financial statements of Fidelis Insurance Holdings Limited as of December 31, 2022 and 2021, and for each of the years in the three-year period ended December 31, 2022 have been included in this prospectus in reliance upon the report of KPMG Audit Limited, an independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing.
275
WHERE PROSPECTIVE INVESTORS CAN FIND ADDITIONAL INFORMATION
We have filed with the SEC a registration statement on Form F-1, including exhibits, schedules and amendments thereto, of which this prospectus is a part, under the Securities Act with respect to our Common Shares covered by this prospectus. This prospectus does not contain all of the information set forth in the registration statement and exhibits and schedules to the registration statement. For further information with respect to our company and the Common Shares covered by this prospectus, reference is made to the registration statement, including the exhibits and schedules thereto. Statements contained in this prospectus as to the contents of any contract or other document referred to in this prospectus are not necessarily complete and, where that contract or other document has been filed as an exhibit to the registration statement, each statement in this prospectus is qualified in all respects by the exhibit to which the reference relates. Our SEC filings, including our registration statement, are also available to prospective investors, free of charge, on the SECs website, www.sec.gov.
Upon the effectiveness of the registration statement of which this prospectus forms a part, we will become subject to the information and periodic reporting requirements of the Exchange Act applicable to foreign private issuers including audited annual financial statements. These periodic reports and other information will be available on the website of the SEC referred to above.
We maintain a website at https://www.fidelisinsurance.com/. Following the initial listing of our Common Shares on NYSE, we will make the information filed with or furnished to the SEC available free of charge through our website as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Information contained on, or accessible through our website is not incorporated by reference into and does not constitute a part of this prospectus or any other report or documents we file with or furnish to the SEC.
276
2015 Non-Qualified Share Option Plan |
the FIHL Non-Qualified Share Option Plan, adopted as of June 9, 2015, as amended |
2018 Non-Qualified Share Option Plan |
the FIHL Non-Qualified Share Option Plan, adopted as of November 8, 2018, as amended |
Amended and Restated Common Shareholders Agreement |
the Existing Common Shareholders Agreement that will be amended and restated effective as of the consummation of this offering |
Bermuda MGU |
Shelf Opco Bermuda Limited |
Bespoke pillar |
a portion of the Groups business which focuses on bespoke (re)insurance underwriting for tailored coverage |
BMA |
the Bermuda Monetary Authority |
Board |
the board of directors of FIHL |
CBI |
the Central Bank of Ireland |
Code |
the Internal Revenue Code of 1986, as amended |
Common Shareholders |
holders of Common Shares |
Common Shareholders Equity |
ratio, in percent, of net income to opening equity of the Common Shares |
Companies Act |
Bermuda Companies Act 1981 |
Cooperation Agreement |
the Cooperation Agreement, dated as of July 23, 2022 among FIHL, MGU HoldCo and certain third-party investors in MGU TopCo |
Crestview Funds |
Crestview FIHL Holdings LP, Crestview FIHL TE Holdings Ltd, Crestview IV FIHL Holdings LP and Crestview IV FIHL TE Holdings LLC |
Current Fidelis |
FIHL and its consolidated subsidiaries following the consummation of the Separation Transactions |
CVC |
CVC Falcon Holdings Limited |
EEA |
European Economic Area |
EEA State |
each member state of the European Economic Area |
EIOPA |
European Insurance and Operational Pensions Authority |
ESG |
environmental, social and governance |
Exchange Act |
the Securities Exchange Act of 1934, as amended |
277
Existing Bye-Laws |
the current bye-laws of FIHL, to be replaced by the Amended and Restated Bye-Laws in connection with this offering |
Existing Common Shareholders Agreement |
the current common shareholders agreement of FIHL entered into by the Existing Shareholders, to be replaced by the Amended and Restated Common Shareholders Agreement effective as of the consummation of this offering |
Existing Shareholders |
all of the shareholders who currently own shares in FIHL prior to the consummation of this offering |
FCA |
Financial Conduct Authority |
FIBL |
Fidelis Insurance Bermuda Limited |
Fidelis MGU |
the managing general underwriting platform for which MGU HoldCo is the parent company |
Fidelis U.S. |
Fidelis U.S. Holdings, Inc. |
FIHL |
Fidelis Insurance Holdings Limited |
FIHL (UK) Services |
FIHL (UK) Services Limited |
FIID |
Fidelis Insurance Ireland DAC |
FML |
Fidelis Marketing Limited |
Founder(s) |
each of the Crestview Funds, CVC and Pine Brook |
Framework Agreement |
the 10-year framework agreement entered into between FIHL and MGU HoldCo on December 20, 2022 relating to delegation of underwriting activities |
FUL |
Fidelis Underwriting Limited |
GPW |
gross premiums written |
Group Annual Plan |
the group-level annual plan |
Group Underwriting Strategy |
Group-level underwriting strategy |
HMRC |
His Majestys Revenue and Customs |
IBNR |
incurred but not reported |
Inter-Group Services Agreement |
a separate services agreement between FIHL and MGU HoldCo relating to the outsourcing of certain non-underwriting services to be provided by Fidelis MGU to FIHL and FIHL (UK) Services, dated January 3, 2023 |
Irish Delegated Underwriting Authority Agreement |
the Delegated Underwriting Authority Agreement between FIID and Pine Walk Europe |
278
IRS |
Internal Revenue Service |
Lancashire |
Lancashire Holdings Limited |
Lloyds |
Lloyds of London |
Long-Term Incentive Plan |
FIHLs long-term incentive plan, to be adopted on or immediately following the consummation of the Separation Transactions |
loss ratio |
is a financial performance measure that represents the ratio of losses and loss adjustment expenses to NPE. See Managements Discussion and Analysis of Financial Condition and Results of OperationsPerformance Measures and Non-U.S. GAAP Financial Measures for a description as to how loss ratio is calculated |
LTIP Awards |
the RSU awards granted pursuant to the 2023 Long-Term Incentive Plan |
MGU HoldCo |
Shelf Holdco II Limited |
New LOB |
any line of business beyond the Permitted Lines for which Current Fidelis has appetite |
Notes |
the Subordinated Notes and the Senior Notes, collectively |
NPE |
net premiums earned |
NPW |
net premiums written |
Operating RoE |
is a non-U.S. GAAP financial measure that represents a meaningful comparison between periods of our financial performance expressed as a percentage and is calculated as operating net income divided by opening Common Shareholders Equity in a given period. See Managements Discussion and Analysis of Financial Condition and Results of OperationsPerformance Measures and Non-U.S. GAAP Financial Measures for a description as to how Operating RoE is calculated |
Outwards Reinsurance Strategy |
purchasing outwards reinsurance cover for Current Fidelis on an annual basis |
Outwards RI |
outwards reinsurance services pursuant to the Delegated Underwriting Authority Agreements including, among other services, advising on the outwards reinsurance and retrocession |
Person |
any person (as that term is used in Section 13(d)(3) of the Exchange Act), other than to FIHL, any of its subsidiaries or a permitted parent |
Pine Brook |
Pine Brook Feal Intermediate, L.P. |
Pine Walk Capital |
Pine Walk Capital Limited |
Pine Walk Europe |
Pine Walk Europe SRL |
279
Platinum Ivy |
Platinum Ivy B 2018 RSC Limited |
PRA |
Prudential Regulation Authority |
Previous Fidelis |
FIHL and its consolidated subsidiaries prior to the consummation of the Separation Transactions and this offering |
RoE |
return on equity |
RSUs |
restricted stock units |
SCR |
Solvency Capital Requirement |
SEC |
United States Securities and Exchange Commission |
Securities Act |
Securities Act of 1933, as amended |
Senior Notes |
$330.0 million aggregate principal amount of 4.875% Senior Notes due 2030 |
Senior Notes Indenture |
the Indenture (the Base Senior Notes Indenture), dated as of June 18, 2020, between FIHL, as Issuer, and The Bank of New York Mellon, as Trustee, Registrar, Transfer Agent and Paying Agent, as supplemented by the Supplemental Indenture No. 1 (the Supplemental Senior Notes Indenture), dated as of July 2, 2020, between FIHL, as Issuer, and The Bank of New York Mellon, as Trustee, Registrar, Transfer Agent and Paying Agent, collectively constituting the Senior Notes |
Separation Transactions |
the completion of a number of separation and reorganization transactions in order to create two distinct holding companies and businesses: FIHL and MGU HoldCo. MGU HoldCo and its subsidiaries will not be consolidated with FIHL and its subsidiaries |
Series A Preference Securities |
FIHLs 9.00% non-convertible and cumulative preference securities, par value $0.01 per share |
Solvency II |
Directive 2009/138/EC |
Specialty pillar |
a portion of the Groups business which focuses on traditional specialty business lines such as aviation, energy, space, marine, contingency and property D&F |
Subordinated Notes |
$125.0 million aggregate principal amount of 6.625% Fixed-Rate Reset Junior Subordinated Notes due 2041 |
Subordinated Notes Indenture |
the Indenture (the Base Subordinated Notes Indenture), dated as of October 16, 2020, between FIHL, as Issuer, and The Bank of New York Mellon, as Trustee, Registrar, Transfer Agent and Paying Agent, as supplemented by the Supplemental Indenture No. 1 (the Supplemental Subordinated Notes Indenture), dated as of October 20, 2020, between FIHL, as Issuer, and The Bank of New York Mellon, as Trustee, Registrar, Transfer Agent and Paying Agent, collectively constituting the Subordinated Notes |
280
Subsidiary Annual Plan |
subsidiary-level annual plans prepared pursuant to each Delegated Underwriting Authority Agreement |
U.K. Delegated Underwriting Authority Agreement |
the Delegated Underwriting Authority Agreement between FUL and Pine Walk Capital |
U.K. Regulators |
the FCA and the PRA |
U.S. Holder |
a U.S. Person, other than a partnership, who beneficially owns Common Shares |
Ukraine Conflict |
the escalation of geopolitical tensions and the ongoing invasion of Ukraine by Russia |
UMCC |
Underwriting and Marketing Conference Calls |
UPR |
unearned premium |
281
INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS
Page | ||||
Unaudited Consolidated Financial Statements of Fidelis Insurance Holdings Limited and its subsidiaries: |
||||
Unaudited Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022 |
F-3 | |||
F-4 | ||||
F-5 | ||||
Unaudited Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2023 and 2022 |
F-6 | |||
F-7 | ||||
Audited Consolidated Financial Statements of Fidelis Insurance Holdings Limited and its subsidiaries: |
||||
F-33 | ||||
F-34 | ||||
Consolidated Balance Sheets as of December 31, 2022 and December 31, 2021 |
F-36 | |||
F-37 | ||||
F-38 | ||||
F-39 | ||||
F-41 | ||||
Schedules: |
||||
Schedule ISummary of InvestmentsOther Than Investments in Related Parties |
F-95 | |||
F-96 | ||||
F-99 | ||||
F-100 | ||||
Schedule VISupplementary Information for Property and Casualty Insurance Underwriters |
F-101 |
Schedules other than those listed above are omitted for the reason that they are not applicable
F-1
FIDELIS INSURANCE HOLDINGS LIMITED
Unaudited Consolidated Financial Statements
For the Three Months Ended March 31, 2023 and 2022
F-2
FIDELIS INSURANCE HOLDINGS LIMITED (FIHL)
At March 31, 2023 (Unaudited) and December 31, 2022
(Expressed in millions of U.S. dollars)
March 31, 2023 |
December 31, 2022 |
|||||||
Assets |
||||||||
Fixed maturity securities, available-for-sale (amortized cost: $2,593.1, 2022: $2,160.8) (net of allowance for credit losses of $2.5, 2022: $1.1) |
$ | 2,507.6 | $ | 2,050.9 | ||||
Short-term investments, available-for-sale (amortized cost: $286.9, 2022: $257.0) (net of allowance for credit losses of $nil, 2022: $nil) |
286.9 | 257.0 | ||||||
Other investments, at fair value (amortized cost: $51.1, 2022: $126.3) |
46.1 | 117.1 | ||||||
|
|
|
|
|||||
Total investments |
2,840.6 | 2,425.0 | ||||||
Cash and cash equivalents |
430.7 | 1,222.0 | ||||||
Restricted cash and cash equivalents |
280.7 | 185.9 | ||||||
Accrued investment income |
13.3 | 10.9 | ||||||
Premiums and other receivables (net of allowance for credit losses of $9.7, 2022: $8.8) |
2,387.5 | 1,862.7 | ||||||
Amounts due from Fidelis MGU (net of allowance for credit losses of $nil, 2022: $nil) |
181.0 | | ||||||
Deferred reinsurance premiums |
1,191.7 | 823.7 | ||||||
Reinsurance balances recoverable on paid losses (net of allowances for credit losses of $nil, 2022: $nil) |
96.5 | 159.4 | ||||||
Reinsurance balances recoverable on reserves for losses and loss adjustment expenses (net of allowance for credit losses of $1.0, 2022: $1.0) |
1,032.8 | 976.1 | ||||||
Deferred policy acquisition costs (includes deferred Fidelis MGU commissions $67.4, 2022: $nil) |
733.8 | 515.8 | ||||||
Other assets |
193.6 | 131.0 | ||||||
|
|
|
|
|||||
Total assets |
$ | 9,382.2 | $ | 8,312.5 | ||||
|
|
|
|
|||||
Liabilities and shareholders equity |
||||||||
Liabilities |
||||||||
Reserves for losses and loss adjustment expenses |
$ | 2,215.0 | $ | 2,045.2 | ||||
Unearned premiums |
3,260.3 | 2,618.6 | ||||||
Reinsurance balances payable |
1,221.5 | 1,057.0 | ||||||
Amounts due to Fidelis MGU |
216.9 | | ||||||
Long term debt |
447.7 | 447.5 | ||||||
Preference securities |
58.4 | 58.4 | ||||||
Other liabilities |
57.9 | 98.7 | ||||||
|
|
|
|
|||||
Total liabilities |
7,477.7 | 6,325.4 | ||||||
|
|
|
|
|||||
Commitments and contingencies |
||||||||
Shareholders equity |
||||||||
Common shares ($0.01 par, issued and outstanding: 110,771,897; 2022 - 194,545,370) |
1.1 | 1.9 | ||||||
Additional paid-in capital |
1,943.5 | 2,075.2 | ||||||
Accumulated other comprehensive loss |
(76.8 | ) | (100.8 | ) | ||||
Retained earnings |
36.7 | 0.5 | ||||||
|
|
|
|
|||||
Total shareholders equity attributable to common shareholders |
1,904.5 | 1,976.8 | ||||||
|
|
|
|
|||||
Non-controlling interests |
| 10.3 | ||||||
|
|
|
|
|||||
Total shareholders equity including non-controlling interests |
1,904.5 | 1,987.1 | ||||||
|
|
|
|
|||||
Total liabilities, non-controlling interests and shareholders equity |
$ | 9,382.2 | $ | 8,312.5 | ||||
|
|
|
|
See accompanying notes to the financial statements
F-3
FIDELIS INSURANCE HOLDINGS LIMITED
Consolidated Statements of Income and Comprehensive Income (Unaudited)
For the three months ended March 31, 2023 and 2022
(Expressed in millions of U.S. dollars except for per share data)
March 31, 2023 | March 31, 2022 | |||||||
Revenues |
||||||||
Gross premiums written |
$ | 1,245.3 | $ | 970.7 | ||||
Reinsurance premiums ceded |
(585.6 | ) | (485.4 | ) | ||||
|
|
|
|
|||||
Net premiums written |
659.7 | 485.3 | ||||||
Change in net unearned premiums |
(273.7 | ) | (163.5 | ) | ||||
|
|
|
|
|||||
Net premiums earned |
386.0 | 321.8 | ||||||
Net investment gains/(losses) |
2.8 | (10.2 | ) | |||||
Net investment income |
20.4 | 5.1 | ||||||
Other income |
3.5 | 1.0 | ||||||
|
|
|
|
|||||
Total revenues before net gain on distribution of Fidelis MGU |
412.7 | 317.7 | ||||||
|
|
|
|
|||||
Net gain on distribution of Fidelis MGU |
1,639.1 | | ||||||
|
|
|
|
|||||
Total revenues |
2,051.8 | 317.7 | ||||||
|
|
|
|
|||||
Expenses |
||||||||
Losses and loss adjustment expenses |
159.6 | 178.4 | ||||||
Policy acquisition expenses (includes Fidelis MGU commissions $24.2, 2022: $nil) |
129.2 | 67.7 | ||||||
General and administrative expenses |
16.6 | 35.5 | ||||||
Corporate and other expenses |
1.5 | 1.9 | ||||||
Net foreign exchange losses |
1.5 | 0.9 | ||||||
Financing costs |
8.6 | 8.8 | ||||||
|
|
|
|
|||||
Total expenses |
317.0 | 293.2 | ||||||
|
|
|
|
|||||
Income before income taxes |
1,734.8 | 24.5 | ||||||
|
|
|
|
|||||
Income tax expense |
(2.2 | ) | (4.7 | ) | ||||
|
|
|
|
|||||
Net income |
1,732.6 | 19.8 | ||||||
|
|
|
|
|||||
Net income attributable to non-controlling interests |
| (2.8 | ) | |||||
|
|
|
|
|||||
Net income available to common shareholders |
$ | 1,732.6 | $ | 17.0 | ||||
|
|
|
|
|||||
Other comprehensive income/(loss) |
||||||||
Unrealized gains/(losses) on available-for-sale investments |
$ | 24.9 | $ | (61.2 | ) | |||
Income tax (expense)/benefit, all of which relates to unrealized gains/(losses) on available-for-sale investments |
(2.0 | ) | 4.1 | |||||
Currency translation adjustments |
| (0.2 | ) | |||||
|
|
|
|
|||||
Total other comprehensive income/(loss) |
22.9 | (57.3 | ) | |||||
|
|
|
|
|||||
Comprehensive income/(loss) attributable to common shareholders |
$ | 1,755.5 | $ | (40.3 | ) | |||
|
|
|
|
|||||
Per share data |
||||||||
Earnings per common share: |
||||||||
Earnings per common share |
$ | 15.64 | $ | 0.09 | ||||
Earnings per diluted common share |
$ | 15.64 | $ | 0.09 | ||||
Weighted average common shares outstanding |
110,771,897 | 194,106,267 | ||||||
Weighted average diluted common shares outstanding |
110,771,897 | 198,723,646 |
See accompanying notes to the financial statements
F-4
FIDELIS INSURANCE HOLDINGS LIMITED
Consolidated Statements of Changes in Shareholders Equity (Unaudited)
For the three months ended March 31, 2023 and 2022
(Expressed in millions of U.S. dollars)
March 31, 2023 | March 31, 2022 | |||||||
Common shares |
||||||||
Balancebeginning of period |
$ | 1.9 | $ | 1.9 | ||||
Issue of common shares |
0.1 | | ||||||
Shares cancelled upon distribution of Fidelis MGU |
(0.9 | ) | | |||||
|
|
|
|
|||||
Balanceend of period |
1.1 | 1.9 | ||||||
|
|
|
|
|||||
Additional paid-in capital |
||||||||
Balancebeginning of period |
2,075.2 | 2,075.4 | ||||||
Share compensation expense |
21.0 | 3.3 | ||||||
Shares withheld for employee taxes on restricted stock vesting |
(50.6 | ) | | |||||
Cumulative dividends on warrants |
(34.1 | ) | | |||||
Distribution of Fidelis MGU net assets to shareholders |
(67.9 | ) | | |||||
Issue of common shares, net of issuance costs |
(0.1 | ) | | |||||
Purchase of non-controlling interest |
| (10.7 | ) | |||||
|
|
|
|
|||||
Balanceend of period |
1,943.5 | 2,068.0 | ||||||
|
|
|
|
|||||
Accumulated other comprehensive loss, net of tax |
||||||||
Unrealized losses on available-for-sale securities, net of tax |
||||||||
Balancebeginning of period |
(99.7 | ) | (11.3 | ) | ||||
Unrealized gains/(losses) arising during the period |
22.9 | (57.1 | ) | |||||
|
|
|
|
|||||
Balanceend of period |
(76.8 | ) | (68.4 | ) | ||||
|
|
|
|
|||||
Currency translation reserve |
||||||||
Balancebeginning of period |
(1.1 | ) | | |||||
Movement during the period |
1.1 | (0.2 | ) | |||||
|
|
|
|
|||||
Balanceend of period |
| (0.2 | ) | |||||
|
|
|
|
|||||
Balanceend of period |
(76.8 | ) | (68.6 | ) | ||||
|
|
|
|
|||||
Retained earnings/(accumulated deficit) |
||||||||
Balancebeginning of period |
0.5 | (52.1 | ) | |||||
Net income available to common shareholders |
1,732.6 | 17.0 | ||||||
Net fair value of Fidelis MGU distributed to shareholders |
(1,696.4 | ) | | |||||
|
|
|
|
|||||
Balanceend of period |
36.7 | (35.1 | ) | |||||
|
|
|
|
|||||
Total shareholders equity attributable to common shareholders |
1,904.5 | 1,966.2 | ||||||
|
|
|
|
|||||
Non-controlling interests |
||||||||
Balancebeginning of the period |
10.3 | 5.2 | ||||||
Distribution of Fidelis MGU |
(10.3 | ) | | |||||
Net profit attributable to non-controlling interests |
| 2.8 | ||||||
Dividends paid to non-controlling interest |
| (3.0 | ) | |||||
Non-controlling interest arising from acquisition of a subsidiary |
| (0.4 | ) | |||||
|
|
|
|
|||||
Balanceend of period |
| 4.6 | ||||||
|
|
|
|
|||||
Total shareholders equity including non-controlling interests |
$ | 1,904.5 | $ | 1,970.8 | ||||
|
|
|
|
See accompanying notes to the financial statements
F-5
FIDELIS INSURANCE HOLDINGS LIMITED
Consolidated Statements of Cash Flows (Unaudited)
For the three months ended March 31, 2023 and 2022
(Expressed in millions of U.S. dollars)
March 31, 2023 | March 31, 2022 | |||||||
Operating activities |
||||||||
Net income |
$ | 1,732.6 | $ | 19.8 | ||||
Adjustments to reconcile net profit after tax to net cash provided by operating activities: |
||||||||
Revaluation of Fidelis MGU |
(1,707.1 | ) | | |||||
Share compensation expense |
21.0 | 3.3 | ||||||
Depreciation |
0.1 | 0.6 | ||||||
Net unrealized loss on investments and derivatives |
7.9 | 29.1 | ||||||
Net realized gain on investments and derivatives |
(1.0 | ) | (17.3 | ) | ||||
Net changes in assets and liabilities: |
||||||||
Accrued investment income |
(2.4 | ) | 1.5 | |||||
Premiums and other receivables |
(507.1 | ) | (473.5 | ) | ||||
Amounts due from Fidelis MGU |
(183.4 | ) | | |||||
Deferred reinsurance premiums |
(368.0 | ) | (294.5 | ) | ||||
Reinsurance balances recoverable on paid claims |
63.6 | (21.9 | ) | |||||
Reinsurance balances recoverable on unpaid claims |
(54.3 | ) | (2.8 | ) | ||||
Deferred policy acquisition costs |
(217.8 | ) | 19.8 | |||||
Other assets |
(73.3 | ) | (4.0 | ) | ||||
Reserves for losses and loss adjustment expenses |
162.5 | 141.9 | ||||||
Unearned premiums |
641.7 | 458.0 | ||||||
Reinsurance balances payable |
159.6 | 186.1 | ||||||
Amounts due to Fidelis MGU |
216.9 | | ||||||
Other liabilities |
6.8 | 39.4 | ||||||
|
|
|
|
|||||
Net cash (used in)/provided by operating activities |
(101.7 | ) | 85.5 | |||||
Investing activities |
||||||||
Proceeds from the sale of investments, trading |
| 3.3 | ||||||
Purchase of available-for-sale securities |
(798.3 | ) | (124.0 | ) | ||||
Proceeds from sale of available-for-sale securities |
324.8 | 229.1 | ||||||
Purchase of other investments |
| (100.0 | ) | |||||
Proceeds from sale of other investments |
75.2 | 203.0 | ||||||
Purchase of fixed assets |
(0.9 | ) | (5.4 | ) | ||||
|
|
|
|
|||||
Net cash (used in)/provided by investing activities |
(399.2 | ) | 206.0 | |||||
Financing activities |
||||||||
Non-controlling interest share transactions |
(6.1 | ) | (14.1 | ) | ||||
Net cash used in disposal of subsidiary |
(105.5 | ) | | |||||
Cumulative dividends on warrants |
(34.1 | ) | | |||||
Taxes paid on withholding shares |
(50.6 | ) | | |||||
|
|
|
|
|||||
Net cash used in financing activities |
(196.3 | ) | (14.1 | ) | ||||
Effect of exchange rate changes on foreign currency cash |
0.7 | (1.3 | ) | |||||
Net (decrease)/increase in cash, restricted cash, and cash equivalents |
(696.5 | ) | 276.1 | |||||
Cash, restricted cash, and cash equivalents, beginning of period |
1,407.9 | 476.0 | ||||||
|
|
|
|
|||||
Cash, restricted cash, and cash equivalents, end of period |
$ | 711.4 | $ | 752.1 | ||||
|
|
|
|
|||||
Cash, restricted cash, and cash equivalents comprise the following: |
||||||||
Cash and cash equivalents |
$ | 430.7 | $ | 522.9 | ||||
Restricted cash and cash equivalents |
280.7 | 229.2 | ||||||
|
|
|
|
|||||
Cash, restricted cash, and cash equivalents |
$ | 711.4 | $ | 752.1 | ||||
|
|
|
|
See accompanying notes to the financial statements
F-6
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
1. | Nature of Operations |
Fidelis Insurance Holdings Limited (Fidelis and together with its subsidiaries, the Group) is a holding company which was incorporated under the laws of Bermuda on August 22, 2014. The Group provides Bespoke, Specialty and Property insurance and reinsurance. Fidelis principal operating subsidiaries are:
| Fidelis Insurance Bermuda Limited (FIBL), is a Class 4 Bermuda domiciled company which writes most of the Groups Reinsurance business, as well as writing Specialty and Bespoke lines. FIBL is regulated by the Bermuda Monetary Authority. |
| Fidelis Underwriting Limited (FUL), is a UK domiciled company which principally writes Specialty and Bespoke insurance, as well as Reinsurance. FUL is regulated by the Prudential Regulation Authority (PRA). |
| Fidelis Insurance Ireland DAC (FIID), is a Republic of Ireland domiciled company that writes Specialty and Bespoke insurance and reinsurance within the European Economic Area. FIID is regulated by the Central Bank of Ireland. |
| FIHL (UK) Services Limited (FIHL (UK) Services), a UK service company that also has a branch in Ireland. |
On January 3, 2023, the Group completed a series of transactions pursuant to which (i) it distributed its investment in Fidelis Marketing Limited (FML) and Pine Walk Capital Limited (Pine Walk) to shareholders to form a new managing general underwriter business (Fidelis MGU) and (ii) Fidelis MGU was acquired by a consortium of investors (together known as the Separation Transactions). FML was previously the service company for the UK and Ireland operations of the Group and is now the service company for Fidelis MGU. Pine Walk held the Groups investments in eight managing general agents (MGAs).
The financial statements of Pine Walk, the eight MGAs and FML have been deconsolidated from January 3, 2023.
Through various long-term contractual agreements, effective from January 1, 2023 Fidelis MGU manages origination, underwriting, underwriting administration and claims handling under delegated authority agreements with the Group. Other services provided by Fidelis MGU to the Group include sourcing and administering outwards reinsurance, and support with business planning, capital management, insurance contract accounting and information technology.
Further information can be found at Note 3, Separation Transactions and Note 14, Related Party Transactions.
2. | Significant Accounting Policies |
Basis of presentation
The accompanying unaudited consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (U.S. GAAP) for interim financial information and Article 10 of Regulation S-X and include the results of Fidelis Insurance Holdings Limited and its subsidiaries. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the year ended December 31, 2022 included within this prospectus.
F-7
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
All intercompany balances and transactions have been eliminated on consolidation. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. In the opinion of management, the accompanying unaudited interim consolidated financial statements reflect all adjustments (consisting of normally recurring accruals) necessary for a fair statement of results on an interim basis. The results of any interim period are not necessarily indicative of the results for a full year or any future periods. The consolidated financial statements have been prepared on a going concern basis.
Reporting currency
The financial information is reported in United States dollars (U.S. dollars or $), expressed in millions, except for share and per share amounts.
Reclassification
In the three months ended March 31, 2023 and 2022, commissions on ceded business of $16.2 million and $12.2 million, respectively, have been presented within policy acquisition expenses. Commissions on ceded business are paid by a reinsurer to a cedant on proportional contracts to offset the underwriting and administrative expenses of the underlying business. In the current period, we have netted the cost of such commissions against policy acquisition expenses and reclassified the prior year commissions on ceded business from general and administrative expenses to conform to the current period presentation.
To facilitate comparison of information across periods, certain other reclassifications have been made to prior period amounts to conform to the current periods presentation.
Significant Accounting Policies
There were no notable changes to the Groups significant accounting policies subsequent to December 31, 2022.
3. | Separation Transactions |
All share and per share information in this note have been retroactively adjusted to reflect the reverse share split of the Companys common shares for all periods presented refer to Note 20.b, Subsequent Events for additional detail.
On January 3, 2023, the Group completed a transaction pursuant to which (i) Pine Walk and its investments in the MGAs, together with FML, were distributed to shareholders to form a new managing general underwriting business, Fidelis MGU and (ii) Fidelis MGU was acquired by a consortium of investors. Following the consummation of the Separation Transactions, Fidelis MGU acquired 9.9% of the common shares in the Group.
The Separation Transactions resulted in certain shareholders receiving cash in lieu of their interest in Fidelis MGU. As a result, the distribution of Fidelis MGU was recorded at its fair value of $1,775.0 million. The fair value was determined in accordance with the requirements of Financial Accounting Standards Board Accounting Standards Codification 820 Fair Value Measurements (ASC 820). We have obtained the services of a third-party independent valuation expert in arriving at that determination of fair value. ASC 820 explains the concept of fair value for financial reporting. Under ASC 820, fair value is a market-based measurement, not an entity specific measurement. The objective of ASC 820 is to estimate the price at which an orderly transaction to sell the asset would take place between market participants at the measurement date under current market conditions (that is, an exit price at the measurement date from the perspective of a market participant).
F-8
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
When a price for an identical asset is not observable, a reporting entity measures fair value using another valuation technique that maximizes the use of relevant observable inputs and minimizes the use of unobservable inputs. Fair value is measured using the assumptions that market participants would use when pricing the asset or liability, including assumptions about risk.
For purposes of our valuation of Fidelis MGU, we have used an income approach using a discounted cash flow methodology, and a market approach using comparable listed trading and precedent transaction multiples. These approaches generated a range of values for Fidelis MGU of $1.7 billion to $1.9 billion. Our determined fair value for Fidelis MGU of $1,775.0 million was based on the price of the most recent transactions in Fidelis MGU shares, and close to the mid-point of the valuation range. On January 3, 2023, following the distribution of Fidelis MGU to shareholders of the Group, certain shareholders sold their shares, and certain third parties purchased shares, in Fidelis MGU at a price per share determined using a fair value of $1,775.0 million.
Immediately prior to the consummation of the Separation Transactions, the Group accelerated the vesting of all unvested Restricted Stock Units (RSUs). This resulted in the acceleration of compensation expense of $21.0 million and an employer payroll tax expense of $17.3 million in the three months ended March 31, 2023. The RSUs and warrants (refer to Note 17, Share Compensation for additional detail) were exercised on the date of the Separation Transactions, resulting in the issuance of 13,553,681 common shares. The RSUs were net settled, resulting in a $50.6 million reduction of additional paid-in capital for the employees tax obligations with respect to these awards. The exercise of the warrants triggered the payment of cumulative dividends of $34.1 million.
The distribution of Fidelis MGU to shareholders of the Group resulted in the deconsolidation of net assets of $67.9 million, and the cancellation of 97,327,049 common shares in the Group. Following the Separation Transactions there were 110,771,897 common shares issued and outstanding. The distribution resulted in the elimination of our non-controlling interests, all of which related to the subsidiaries of Pine Walk.
In connection with the successful consummation of the Separation Transactions, the Group incurred professional fees of $28.6 million during the three months ended March 31, 2023.
The net gain on distribution of Fidelis MGU of $1,639.1 million has been calculated as the fair value of Fidelis MGU of $1,775.0 million, less the net assets of Fidelis MGU of $67.9 million and less the direct costs of the Separation Transactions of $68.0 million. Direct costs primarily related to professional fees of $28.6 million, acceleration of compensation expense of $21.0 million and an employer payroll tax expense of $17.3 million. Within operating activities on the Consolidated Statement of Cash Flows, the revaluation of Fidelis MGU of $1,707.1 million, being the fair value of Fidelis MGU of $1,775.0 million less the net assets of $67.9 million, is shown as a non-cash adjustment to reconcile net income to net cash used in operating activities.
On January 3, 2023, the financial statements of Pine Walk, the eight MGAs and FML have been deconsolidated and the non-controlling interests were disposed upon consummation of the Separation Transactions.
4. | Segments |
The chief operating decision maker (CODM) reviews the Groups ongoing underwriting operations across three operating segments: Bespoke, Specialty, and Reinsurance. In determining how to allocate resources and assess the performance of the Groups underwriting results, management considers many factors including the nature of the insurance product offered, the risks that are covered and the nature of the client.
F-9
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
The Bespoke segment is highly specialized in nature providing customized risk solutions for clients which includes Credit & Political Risk and other specific risk transfer opportunities.
The Specialty segment comprises a specialized portfolio of niche risks that includes Aviation and Aerospace, Energy, Marine, Property Direct & Facultative (D&F) business and other specialty risks.
The Reinsurance segment comprises a property catastrophe book which includes Property Reinsurance, Retrocession and Whole Account reinsurance.
Assets are not allocated to segments, nor are general and administrative expenses allocated between segments as employees, including underwriters, may work across different segments. Fidelis MGU commissions are not allocated to segments as they are not included in the measure of segment profit reviewed by the CODM, nor is a segment analysis of such expenses provided in other information reviewed by the CODM.
F-10
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
The following tables summarize the Groups segment disclosures
Three months ended March 31, 2023 | ||||||||||||||||||||
Bespoke | Specialty | Reinsurance | Other | Total | ||||||||||||||||
Gross premiums written |
$ | 150.8 | $ | 834.1 | $ | 260.4 | | $ | 1,245.3 | |||||||||||
Net premiums written |
81.7 | 493.0 | 85.0 | | 659.7 | |||||||||||||||
Net premiums earned |
91.2 | 266.2 | 28.6 | | 386.0 | |||||||||||||||
Losses and loss adjustment expenses |
(13.1 | ) | (140.7 | ) | (5.8 | ) | | (159.6 | ) | |||||||||||
Policy acquisition expenses |
(33.3 | ) | (66.3 | ) | (5.4 | ) | (24.2 | ) | (129.2 | ) | ||||||||||
General and administrative expenses |
| | | (16.6 | ) | (16.6 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Underwriting income/(loss) |
44.8 | 59.2 | 17.4 | (40.8 | ) | 80.6 | ||||||||||||||
Net investment gains |
2.8 | |||||||||||||||||||
Net investment income |
20.4 | |||||||||||||||||||
Other income |
3.5 | |||||||||||||||||||
Net gain on distribution of Fidelis MGU |
1,639.1 | |||||||||||||||||||
Corporate and other expenses |
(1.5 | ) | ||||||||||||||||||
Net foreign exchange losses |
(1.5 | ) | ||||||||||||||||||
Financing costs |
(8.6 | ) | ||||||||||||||||||
|
|
|||||||||||||||||||
Income before income taxes |
1,734.8 | |||||||||||||||||||
|
|
|||||||||||||||||||
Income tax expense |
(2.2 | ) | ||||||||||||||||||
|
|
|||||||||||||||||||
Net income |
1,732.6 | |||||||||||||||||||
|
|
|||||||||||||||||||
Net income attributable to non-controlling interests |
| |||||||||||||||||||
|
|
|||||||||||||||||||
Net income available to common shareholders |
$ | 1,732.6 | ||||||||||||||||||
|
|
|||||||||||||||||||
Losses and loss adjustment expenses incurredcurrent year |
(21.9 | ) | (110.2 | ) | (29.6 | ) | $ | (161.7 | ) | |||||||||||
Losses and loss adjustment expenses incurredprior accident years |
8.8 | (30.5 | ) | 23.8 | 2.1 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Losses and loss adjustment expenses incurredtotal |
$ | (13.1 | ) | $ | (140.7 | ) | $ | (5.8 | ) | $ | (159.6 | ) | ||||||||
Loss ratiocurrent year |
24.0 | % | 41.4 | % | 103.5 | % | 41.8 | % | ||||||||||||
Loss ratioprior accident years |
(9.6 | %) | 11.5 | % | (83.2 | %) | (0.5 | %) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Loss ratiototal(1) |
14.4 | % | 52.9 | % | 20.3 | % | 41.3 | % | ||||||||||||
Policy acquisition expense ratio(2) |
36.5 | % | 24.9 | % | 18.9 | % | 27.2 | % | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Underwriting ratio(3) |
50.9 | % | 77.8 | % | 39.2 | % | 68.5 | % | ||||||||||||
Fidelis MGU commissions ratio(4) |
6.3 | % | ||||||||||||||||||
General & administrative expense ratio(5) |
4.3 | % | ||||||||||||||||||
|
|
|||||||||||||||||||
Combined ratio(6) |
79.1 | % | ||||||||||||||||||
|
|
(1) | Loss ratio: is calculated by dividing losses and loss adjustment expenses by net premiums earned. Current year loss ratio includes losses incurred in the current accident year, whilst prior accident years loss ratio considers how losses incurred in prior years have developed. |
(2) | Policy acquisition expense ratio: is calculated by dividing policy acquisition expenses from third parties by net premiums earned. |
(3) | Underwriting ratio: is calculated by dividing losses and loss adjustment expenses and policy acquisition expenses by net premiums earned, or equivalently, by adding the loss ratio and policy acquisition expense ratio. |
(4) | Fidelis MGU commissions ratio: is calculated by dividing Fidelis MGU commissions by net premiums earned. |
(5) | General and administrative expense ratio: is calculated by dividing general and administrative expenses by net premiums earned. |
(6) | Combined ratio: is calculated by dividing losses and loss adjustment expenses, policy acquisition expenses from third parties, Fidelis MGU commissions and general and administrative expenses by net premiums earned, or equivalently, by adding the loss ratio, policy acquisition expense ratio, Fidelis MGU commissions ratio and general and administrative expense ratio. |
F-11
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
Three months ended March 31, 2022 | ||||||||||||||||||||
Bespoke | Specialty | Reinsurance | Other | Total | ||||||||||||||||
Gross premiums written |
$ | 135.0 | $ | 543.8 | $ | 291.9 | $ | | $ | 970.7 | ||||||||||
Net premiums written |
91.5 | 310.7 | 83.1 | | 485.3 | |||||||||||||||
Net premiums earned |
87.2 | 180.5 | 54.1 | | 321.8 | |||||||||||||||
Losses and loss adjustment expenses |
(43.5 | ) | (93.4 | ) | (41.5 | ) | | (178.4 | ) | |||||||||||
Policy acquisition expenses |
(23.6 | ) | (35.3 | ) | (8.8 | ) | | (67.7 | ) | |||||||||||
General and administrative expenses |
| | | (35.5 | ) | (35.5 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Underwriting income/(loss) |
20.1 | 51.8 | 3.8 | (35.5 | ) | 40.2 | ||||||||||||||
Net investment losses |
(10.2 | ) | ||||||||||||||||||
Net investment income |
5.1 | |||||||||||||||||||
Other income |
1.0 | |||||||||||||||||||
Corporate and other expenses |
(1.9 | ) | ||||||||||||||||||
Net foreign exchange losses |
(0.9 | ) | ||||||||||||||||||
Financing costs |
(8.8 | ) | ||||||||||||||||||
|
|
|||||||||||||||||||
Income before income taxes |
24.5 | |||||||||||||||||||
|
|
|||||||||||||||||||
Income tax expense |
(4.7 | ) | ||||||||||||||||||
|
|
|||||||||||||||||||
Net income |
19.8 | |||||||||||||||||||
|
|
|||||||||||||||||||
Net income attributable to non-controlling interests |
(2.8 | ) | ||||||||||||||||||
|
|
|||||||||||||||||||
Net income available to common shareholders |
$ | 17.0 | ||||||||||||||||||
|
|
|||||||||||||||||||
Losses and loss adjustment expenses incurredcurrent year |
(44.0 | ) | (98.8 | ) | (40.2 | ) | $ | (183.0 | ) | |||||||||||
Losses and loss adjustment expenses incurredprior accident years |
0.5 | 5.4 | (1.3 | ) | 4.6 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Losses and loss adjustment expenses incurredtotal |
$ | (43.5 | ) | $ | (93.4 | ) | $ | (41.5 | ) | $ | (178.4 | ) | ||||||||
Loss ratiocurrent year |
50.5 | % | 54.7 | % | 74.3 | % | 56.8 | % | ||||||||||||
Loss ratioprior accident years |
(0.6 | %) | (3.0 | %) | 2.4 | % | (1.4 | %) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Loss ratiototal(1) |
49.9 | % | 51.7 | % | 76.7 | % | 55.4 | % | ||||||||||||
Policy acquisition expense ratio(2) |
27.1 | % | 19.6 | % | 16.3 | % | 21.0 | % | ||||||||||||
Underwriting ratio(3) |
77.0 | % | 71.3 | % | 93.0 | % | 76.4 | % | ||||||||||||
General & administrative expense ratio(4) |
11.0 | % | ||||||||||||||||||
|
|
|||||||||||||||||||
Combined ratio(5) |
87.4 | % | ||||||||||||||||||
|
|
(1) | Loss ratio: is calculated by dividing losses and loss adjustment expenses by net premiums earned. Current year loss ratio includes losses incurred in the current accident year, whilst prior accident years loss ratio considers how losses incurred in prior years have developed. |
(2) | Policy acquisition expense ratio: is calculated by dividing policy acquisition expenses by net premiums earned. |
(3) | Underwriting ratio: is calculated by dividing losses and loss adjustment expenses and policy acquisition expenses by net premiums earned, or equivalently, by adding the loss ratio and policy acquisition expense ratio. |
(4) | General and administrative expense ratio: is calculated by dividing general and administrative expenses by net premiums earned. |
(5) | Combined ratio: is calculated by dividing losses and loss adjustment expenses, policy acquisition expenses, and general and administrative expenses by net premiums earned, or equivalently, by adding the loss ratio, policy acquisition expense ratio, and general and administrative expense ratio. |
F-12
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
5. | Investments |
At March 31, 2023, the Groups investments are substantially all managed by external investment managers through individual investment management agreements. The Group monitors activity and performance of the external managers on an ongoing basis.
a. | Fixed maturity securities |
The following table summarizes the fair value of fixed maturity investments managed by external investment managers:
March 31, 2023 | ||||||||||||||||
Amortized Cost |
Unrealized gains |
Unrealized losses |
Fair value |
|||||||||||||
Available-for-sale |
||||||||||||||||
US. Treasuries |
$ | 644.7 | $ | 0.4 | $ | (20.6 | ) | $ | 624.5 | |||||||
Agencies |
9.5 | | (0.3 | ) | 9.2 | |||||||||||
Non-U.S. government |
92.7 | 0.1 | (3.2 | ) | 89.6 | |||||||||||
Corporate bonds |
1,377.0 | 3.4 | (50.1 | ) | 1,330.3 | |||||||||||
Residential mortgage-backed |
134.2 | 0.2 | (8.0 | ) | 126.4 | |||||||||||
Commercial mortgage-backed |
15.4 | | (1.1 | ) | 14.3 | |||||||||||
Other asset backed securities |
319.6 | 0.9 | (7.2 | ) | 313.3 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, available-for-sale |
$ | 2,593.1 | $ | 5.0 | $ | (90.5 | ) | $ | 2,507.6 | |||||||
|
|
|
|
|
|
|
|
December 31, 2022 | ||||||||||||||||
Amortized Cost |
Unrealized gains |
Unrealized losses |
Fair value |
|||||||||||||
Available-for-sale |
||||||||||||||||
US. Treasuries |
$ | 643.1 | | (27.3 | ) | 615.8 | ||||||||||
Agencies |
17.5 | | (0.4 | ) | 17.1 | |||||||||||
Non-U.S. government |
115.2 | | (4.3 | ) | 110.9 | |||||||||||
Corporate bonds |
1,078.9 | | (58.6 | ) | 1,020.3 | |||||||||||
Residential mortgage-backed |
88.6 | | (8.9 | ) | 79.7 | |||||||||||
Commercial mortgage-backed |
8.0 | | (1.2 | ) | 6.8 | |||||||||||
Other asset backed securities |
209.5 | | (9.2 | ) | 200.3 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, available-for-sale |
$ | 2,160.8 | $ | | $ | (109.9 | ) | $ | 2,050.9 | |||||||
|
|
|
|
|
|
|
|
F-13
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
Review of the fixed maturity securities is performed on a regular basis to consider concentration, credit quality and compliance with established guidelines. For individual fixed maturity securities, nationally recognized statistical rating organizations (NRSROs) are used and the lower of two or middle of three ratings is taken. The composition of the fair values of fixed maturity securities by credit rating is as follows:
March 31, 2023 | December 31, 2022 | |||||||||||||||
Available-for-sale | Fair Value | % | Fair Value | % | ||||||||||||
AAA |
$ | 990.4 | 40 | % | $ | 915.1 | 45 | % | ||||||||
AA |
171.2 | 7 | % | 150.2 | 7 | % | ||||||||||
A |
962.1 | 38 | % | 703.1 | 34 | % | ||||||||||
BBB |
383.9 | 15 | % | 282.5 | 14 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, available-for-sale |
$ | 2,507.6 | 100 | % | $ | 2,050.9 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
The contractual maturities for fixed maturity securities are listed in the following table:
March 31, 2023 | December 31, 2022 | |||||||||||||||
Available-for-sale | Amortized Cost |
Fair Value |
Amortized Cost |
Fair Value |
||||||||||||
Due in one year or less |
$ | 677.6 | $ | 665.3 | $ | 701.7 | $ | 688.1 | ||||||||
Due after one year through five years |
1,560.5 | 1,499.4 | 1,237.6 | 1,156.9 | ||||||||||||
Due after five years through ten years |
162.7 | 160.4 | 94.8 | 90.6 | ||||||||||||
Due after ten years |
192.3 | 182.5 | 126.7 | 115.3 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, available-for-sale |
$ | 2,593.1 | $ | 2,507.6 | $ | 2,160.8 | $ | 2,050.9 | ||||||||
|
|
|
|
|
|
|
|
Expected maturities may differ from contractual maturities as borrowers may have the right to call or repay obligations with or without call or prepayment penalties. Additionally, lenders may have the right to put the securities back to the borrower.
b. | Short-term investments |
The following investments were included in short-term investments managed by external investment managers and are classified as available-for-sale:
March 31, 2023 | ||||||||||||||||
Available-for-sale | Amortized Cost |
Unrealized gains |
Unrealized losses |
Fair value |
||||||||||||
U.S. Treasuries |
$ | 101.0 | $ | | $ | | $ | 101.0 | ||||||||
Non-U.S. government |
11.5 | | | 11.5 | ||||||||||||
Corporate bonds |
174.4 | | | 174.4 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments |
$ | 286.9 | $ | | $ | | $ | 286.9 | ||||||||
|
|
|
|
|
|
|
|
December 31, 2022 | ||||||||||||||||
Available-for-sale | Amortized Cost |
Unrealized gains |
Unrealized losses |
Fair value |
||||||||||||
U.S. Treasuries |
$ | 228.4 | $ | 0.1 | $ | | $ | 228.5 | ||||||||
Non-U.S. government |
23.2 | | (0.1 | ) | 23.1 | |||||||||||
Corporate bonds |
5.4 | | | 5.4 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments |
$ | 257.0 | $ | 0.1 | $ | (0.1 | ) | $ | 257.0 | |||||||
|
|
|
|
|
|
|
|
F-14
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
The composition of the fair values of short-term investments by credit rating is as follows:
March 31, 2023 | December 31, 2022 | |||||||||||||||
Available-for-sale | Fair Value | % | Fair Value | % | ||||||||||||
AAA |
$ | 241.9 | 84 | % | $ | 251.6 | 98 | % | ||||||||
AA |
| | % | 4.4 | 2 | % | ||||||||||
A |
45.0 | 16 | % | 1.0 | | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term fixed maturity securities, available-for-sale |
$ | 286.9 | 100 | % | $ | 257.0 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
c. | Allowance for Expected Credit LossesAvailable-for-sale |
The following table provides a roll forward of the allowance for expected credit losses of the Groups securities classified as available-for-sale:
Book Value |
Unrealized Gain |
Unrealized Loss |
Market Value |
Loss allowance |
||||||||||||||||
Three months ended March 31, 2023 |
||||||||||||||||||||
Balance at beginning of period |
$ | 2,417.8 | $ | 0.1 | $ | (110.0 | ) | $ | 2,307.9 | $ | (1.1 | ) | ||||||||
Change in period |
462.2 | 4.9 | 19.5 | 486.6 | (1.4 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at March 31, 2023 |
$ | 2,880.0 | $ | 5.0 | $ | (90.5 | ) | $ | 2,794.5 | $ | (2.5 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|
Book Value |
Unrealized Gain |
Unrealized Loss |
Market Value |
Loss allowance |
||||||||||||||||
Three months ended March 31, 2022 |
||||||||||||||||||||
Balance at beginning of period |
$ | 2,517.1 | $ | 6.3 | $ | (20.8 | ) | $ | 2,502.6 | $ | (2.2 | ) | ||||||||
Change in period |
(86.5 | ) | (4.9 | ) | (58.5 | ) | (149.9 | ) | | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at March 31, 2022 |
$ | 2,430.6 | $ | 1.4 | $ | (79.3 | ) | $ | 2,352.7 | $ | (2.2 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|
The Group assesses each quarter whether the decline in the fair value of an available-for-sale investment below its amortized cost is the result of a credit loss. All available-for-sale securities with unrealized losses are reviewed. The Group considers many factors to determine whether a credit loss exists, including the extent to which fair value is below cost, the implied yield to maturity, rating downgrades of the security and whether or not the issuer has failed to make scheduled principal or interest payments. The Group also takes into consideration information about the financial condition of the issuer and industry factors that could negatively impact the capital markets.
If the decline in fair value of an available-for-sale security below its amortized cost is considered to be the result of a credit loss, the Group compares the estimated present value of the cash flows expected to be collected to the amortized cost of the security. The extent to which the estimated present value of the cash flows expected to be collected is less than the amortized cost of the security represents the expected credit loss, which is recorded as an allowance and recognized in net income. The allowance is limited to the difference between the fair value and the amortized cost of the security. The Group recognized a $1.4 million increase to credit related impairments in the three months ended March 31, 2023 (2022: $nil).
F-15
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
d. | Other investments, at fair value |
At March 31, 2023, other investments consisted of a credit hedge fund managed by York Capital Management (York) and an opportunistic fixed income UCITS fund managed by Wellington Investment Management (Wellington).
March 31, 2023 | December 31, 2022 | |||||||||||||||
Other investments | Fair Value | % | Fair Value | % | ||||||||||||
York Funds |
$ | 0.9 | 2 | % | $ | 0.9 | 1 | % | ||||||||
Equity structured notes |
| | % | 72.8 | 62 | % | ||||||||||
Wellington Funds |
45.2 | 98 | % | 43.4 | 37 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other investments at fair value |
$ | 46.1 | 100 | % | $ | 117.1 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
At the end of 2019 York suspended redemptions in its credit hedge fund while the underlying assets of the fund are liquidated and proceeds distributed to investors. The fair value of the residual investment in York at March 31, 2023 was $0.9 million (cost: $1.1 million) (December 31, 2022$0.9 million (cost: $1.3 million)). The Group has recorded its investment in the York Fund at reported net asset value. There are currently no outstanding commitments to the York Fund.
At December 31, 2022 the fair value of the equity market linked structured note was $72.8 million (cost $75.0 million). The equity market linked note matured in February 2023 at par value of $75.0 million. The Group had recorded these investment at fair value using the income valuation approach.
In 2021 the Group invested $50.0 million in Wellington. The fair value of the investment in the UCITS fund at March 31, 2023 was $45.2 million (December 31, 2022$43.4 million).
e. | Net Investment Income and Net Realized Gains |
The components of net investment return are as follows:
Three months ended | ||||||||
March 31, 2023 | March 31, 2022 | |||||||
Net interest and dividend income |
$ | 21.3 | $ | 5.8 | ||||
Investment expenses |
(0.9 | ) | (0.7 | ) | ||||
|
|
|
|
|||||
Net investment income |
20.4 | 5.1 | ||||||
Net realized losses on fixed maturity securities, available for sale |
| (1.3 | ) | |||||
Net realized gains on other investments |
2.2 | 27.7 | ||||||
Change in net unrealized gains/(losses) on other investments |
2.0 | (31.5 | ) | |||||
Provision for expected credit losses |
(1.4 | ) | | |||||
Net realized losses on interest rate contracts |
| (3.3 | ) | |||||
Change in net unrealized losses on fixed maturity securities, trading |
| (0.3 | ) | |||||
Change in net unrealized losses on interest rate contracts |
| (1.5 | ) | |||||
|
|
|
|
|||||
Net investment gains/(losses) |
2.8 | (10.2 | ) | |||||
|
|
|
|
|||||
Net investment return |
$ | 23.2 | $ | (5.1 | ) | |||
|
|
|
|
F-16
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
6. | Fair Value Measurements |
FASB ASC 820-10, Fair Value Measurements and Disclosures, defines fair value, establishes a consistent framework for measuring fair value and requires disclosures about fair value measurements. The standard requires the Group to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
Fair value hierarchy
FASB ASC 820-10 specifies a hierarchy of inputs based on whether the inputs are observable or unobservable. Observable inputs are developed using market data and reflect market participant assumptions, while unobservable inputs reflect the Groups market assumptions. The fair value hierarchy is as follows:
| Level 1: Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities traded in active markets. The fair value is determined by multiplying the quoted price by the quantity held by the Group. |
| Level 2: Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices (e.g. interest rates, yield curves, prepayment spreads, default rate, etc.) for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability or can be corroborated by observable market data. |
| Level 3: Inputs to the valuation methodology are unobservable for the asset or liability and are significant to the fair value measurement. Significant management assumptions can be used to establish managements best estimate of the assumptions used by other market participants in determining the fair value of the asset or liability. |
As required under the fair value hierarchy, the Group considers relevant and observable market inputs in its valuations where possible. The frequency of transactions, the size of the bid-ask spread and the amount of adjustment necessary when comparing similar transactions are all factors in determining the liquidity of markets and the relevance of observable prices in those markets.
The Groups policy with respect to transfer between levels of the fair value hierarchy is to recognize transfers into and out of each level as of the end of the reporting period.
Determination of fair value
The following section describes the valuation methodologies used by the Group to measure assets and liabilities at fair value, including an indication of the level within the fair value hierarchy in which each asset or liability is generally classified.
Fixed maturity securities
Fair values for all securities in the fixed income investment portfolio are independently provided by the investment administrator, investment custodians, and investment managers, each of which utilize internationally recognized independent pricing services. Refinitiv Limited (Refinitiv) is the main pricing service utilized to estimate the fair value measurements for the Groups fixed maturity securities for asset backed fixed maturity securities, and corporate and government bonds.
For determining the fair value of securities that are not actively traded, in general, pricing services use matrix pricing in which the independent pricing service uses observable market inputs including, but not
F-17
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
limited to, reported trades, benchmark yields, broker-dealer quotes, interest rates, prepayment spreads, default rates and such other inputs as are available from market sources to determine a reasonable fair value.
The following describes the techniques generally used to determine the fair value of the Groups fixed maturity securities by asset class.
| U.S. Treasuries are bonds issued by the U.S. government. The significant inputs used to determine the fair value of these securities are based on quoted prices in active markets for identical assets and are therefore classified within Level 1. |
| Agency securities consists of securities issued by U.S. and non-U.S. government sponsored agencies such as the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, government development banks and other agencies which are not mortgage pass-through. The fair values of these securities are classified as Level 2. |
| Non-U.S. government securities consist of bonds issued by non-U.S. governments and supranationals. The significant inputs used to determine the fair value of these securities include the spread above the risk-free yield curve, reported trades and broker-dealer quotes. These are considered to be observable market inputs and, therefore, the fair values of these securities are classified within Level 2. |
| Corporate bonds consist primarily of investment-grade debt of a wide variety of corporate issuers and industries. When available, significant inputs are used to determine the fair value of these securities and are based on quoted prices in active markets for similar assets. When not available, the fair values of these securities are determined using the spread above the risk-free yield curve, reported trades, broker-dealer quotes, benchmark yields, and industry and market indicators. The fair values of these securities are classified as Level 2. |
| Residential mortgage-backed securities includes agency mortgage-backed securities and agency collateralised mortgage obligations. These are individually evaluated using option adjusted spreads (OAS) and nominal spreads. The OAS valuations use a third-party prepayment model and OAS. Spreads are based upon tranche type and average life volatility. These spreads are gathered from dealer quotes, trade prices, and the new issue market. The fair values of these securities are classified as Level 2. |
| Commercial mortgage-backed securities consist of investment grade bonds backed by pools of loans with underlying collateral. Securities held in this sector are primarily priced by pricing services. Inputs to the valuation process include broker-dealer quotes and other available trade information, prepayment speeds, current price data, the swap curve as well as cash settlement. The fair values of these securities are classified as Level 2. |
| Other asset-backed securities consist of investment grade bonds backed by pools of loans with underlying collateral. The underlying collateral for asset-backed securities consists mainly of student loans, automobile loans and credit card receivables. These securities are primarily priced by index providers and pricing vendors. Inputs to the valuation process include broker-dealer quotes and other available trade information, prepayment speeds, tranche type, interest rate data and credit spreads. The Company classifies these securities within Level 2. |
Short-term investments
The Groups short-term investments consist of commercial paper and bonds with maturities of 90 days or greater but less than one year at the time of purchase. The significant inputs used to determine the fair value of these securities include the spread above the risk-free yield curve, reported trades and broker-dealer quotes. These are considered to be observable market inputs and, therefore, the fair values of these securities are classified within Level 1 and Level 2.
F-18
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
Derivative assets and liabilities
Exchange-traded derivatives, measured at fair value using quoted prices in active markets, where available are classified as Level 1 of the fair value hierarchy.
Derivatives without quoted prices in an active market and derivatives executed over the counter are valued using internal valuations techniques that consider the time value of money, volatility, the current market and contractual prices of underlying financial instruments. These derivative instruments are classified as either Level 2 or Level 3 depending upon the observability of the significant inputs to the model. The valuation techniques and key inputs depend on the type of derivative and the nature of the underlying instrument.
Other investments
The Group values its investment in the York fund at fair value, which is estimated based on the Groups share of the net asset value (NAV) as provided by the investment manager of the underlying investment fund. The Group has elected to use the practical expedient method to record the fair value of the investment at net asset value and has therefore not assigned levels to these investments in the fair value hierarchy.
The fair value of UCITS is based on unadjusted quoted market prices in active markets, therefore, the fair value of this security is classified as Level 1.
The following table presents the financial instruments measured at fair value on a recurring basis at March 31, 2023 and December 31, 2022:
March 31, 2023 | ||||||||||||||||
Assets | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Cash equivalents |
$ | 236.9 | $ | | $ | | $ | 236.9 | ||||||||
Investment pending settlement |
1.1 | | | 1.1 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Fixed maturity securities |
||||||||||||||||
U.S. Treasuries |
624.5 | | | 624.5 | ||||||||||||
Agencies |
| 9.2 | | 9.2 | ||||||||||||
Non-U.S. government |
| 89.6 | | 89.6 | ||||||||||||
Corporate bonds |
| 1,330.3 | | 1,330.3 | ||||||||||||
Residential mortgage-backed |
| 126.4 | | 126.4 | ||||||||||||
Commercial mortgage-backed |
| 14.3 | | 14.3 | ||||||||||||
Other asset backed securities |
| 313.3 | | 313.3 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities |
624.5 | 1,883.1 | | 2,507.6 | ||||||||||||
Short-term investments |
||||||||||||||||
Corporate bonds |
| 174.4 | | 174.4 | ||||||||||||
Non-U.S. government |
| 11.5 | | 11.5 | ||||||||||||
U.S. Treasuries |
101.0 | | | 101.0 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments |
101.0 | 185.9 | | 286.9 | ||||||||||||
Other investments* |
45.2 | | | 45.2 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Assets |
$ | 1,008.7 | $ | 2,069.0 | $ | | $ | 3,077.7 | ||||||||
|
|
|
|
|
|
|
|
* | excludes investments in the York Funds |
F-19
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
March 31, 2023 | ||||||||||||||||
Liabilities | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Derivative liabilities |
$ | | $ | (3.6 | ) | $ | | $ | (3.6 | ) | ||||||
Investments pending settlement |
(6.2 | ) | | | (6.2 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Liabilities |
$ | (6.2 | ) | $ | (3.6 | ) | $ | | $ | (9.8 | ) | |||||
|
|
|
|
|
|
|
|
There were no transfers into or out of Level 1 and Level 2 during the three months ended March 31, 2023.
December 31, 2022 | ||||||||||||||||
Assets | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Cash equivalents |
$ | 685.2 | $ | | $ | | $ | 685.2 | ||||||||
Investment pending settlement |
2.0 | | | 2.0 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Fixed maturity securities |
||||||||||||||||
U.S. Treasuries |
615.8 | | | 615.8 | ||||||||||||
Agencies |
| 17.1 | | 17.1 | ||||||||||||
Non-U.S. government |
| 110.9 | | 110.9 | ||||||||||||
Corporate bonds |
| 1,020.3 | | 1,020.3 | ||||||||||||
Residential mortgage-backed |
| 79.7 | | 79.7 | ||||||||||||
Commercial mortgage-backed |
| 6.8 | | 6.8 | ||||||||||||
Other asset backed securities |
| 200.3 | | 200.3 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities |
615.8 | 1,435.1 | | 2,050.9 | ||||||||||||
Short-term investments |
||||||||||||||||
Corporate bonds |
| 5.4 | | 5.4 | ||||||||||||
Non-U.S. government |
| 23.1 | | 23.1 | ||||||||||||
U.S. Treasuries |
228.5 | | | 228.5 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments |
228.5 | 28.5 | | 257.0 | ||||||||||||
Other investments* |
43.4 | 72.8 | | 116.2 | ||||||||||||
Derivative assets |
| 6.3 | | 6.3 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Assets |
$ | 1,574.9 | $ | 1,542.7 | $ | | $ | 3,117.6 | ||||||||
|
|
|
|
|
|
|
|
* | excludes investments in the York Funds |
There were no transfers into or out of Level 1 and Level 2 during the three months ended March 31, 2022.
7. | Total cash, cash equivalents, restricted cash and restricted investments |
The Group is required to maintain certain levels of cash in segregated accounts with prime brokers and derivative counterparties. The amount of restricted cash held by derivative counterparties is cash collateral to support the current value of any amounts that may be due to the counterparty based on the value of the underlying financial instrument.
The Group also has cash in trust funds which support the insurance business written on certain lines of business with reinsurers and insurers.
The Group has investments in segregated portfolios primarily to provide collateral for letters of credit, which support its (re)insurance business.
F-20
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
The following table provides a summary of cash and cash equivalents, restricted cash and restricted investments at March 31, 2023 and December 31, 2022:
March 31, 2023 |
December 31, 2022 |
|||||||
Cash and cash equivalents |
$ | 430.7 | $ | 1,222.0 | ||||
Restricted cash securing letter of credit facilities |
13.5 | 21.2 | ||||||
Restricted cash securing reinsurance contracts |
267.2 | 164.7 | ||||||
|
|
|
|
|||||
Total cash, cash equivalents and restricted cash |
711.4 | 1,407.9 | ||||||
|
|
|
|
|||||
Restricted investments securing reinsurance contracts and letter of credit facilities |
1,079.7 | 989.4 | ||||||
|
|
|
|
|||||
Total cash, cash equivalents, restricted cash and restricted investments |
$ | 1,791.1 | $ | 2,397.3 | ||||
|
|
|
|
8. | Derivative Financial Instruments |
The Group enters into derivative instruments such as futures and forward contracts primarily for duration, interest rate and foreign currency exposure management. The Groups derivative instruments are generally traded under International Swaps and Derivatives Association master agreements, which establish the terms of the transactions entered into with the Groups derivative counterparties. In the event one party becomes insolvent or otherwise defaults on its obligations, a master agreement generally permits the non-defaulting party to accelerate and terminate all outstanding transactions and net the transactions marked-to-market values so that a single sum in a single currency will be owed by, or owed to, the non-defaulting party. Effectively, this contractual close-out netting reduces credit exposure from gross to net exposure.
The following tables identify the listing currency, fair value and notional amounts of derivative instruments included in the Consolidated Balance Sheets, categorized by primary underlying risk.:
March 31, 2023 | ||||||||||||
Listing currency(1) | Notional amounts(2) |
Fair value | ||||||||||
Derivative liabilities by primary underlying risk |
||||||||||||
Forwards(3) |
AUD/CAD/EUR/GBP/JPY | $ | 30.0 | $ | (3.6 | ) | ||||||
|
|
|
|
|||||||||
Total derivatives liabilities |
$ | 30.0 | $ | (3.6 | ) | |||||||
|
|
|
|
(1) | AUD = Australian Dollar, CAD = Canadian Dollar, EUR = Euro, GBP = British pound and JPY = Japanese Yen. |
(2) | The absolute notional exposure represents the Groups derivative activity at March 31, 2023, which is representative of the volume of derivatives held during the year. |
(3) | Contracts used to manage foreign currency risks in underwriting and non-investment operations. |
F-21
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
December 31, 2022 | ||||||||||||
Listing currency(1) | Notional amounts(2) |
Fair value | ||||||||||
Derivative assets by primary underlying risk |
||||||||||||
Forwards(3) |
AUD/CAD/EUR/GBP/JPY | $ | (44.0 | ) | $ | 6.3 | ||||||
|
|
|
|
|||||||||
Total derivatives assets |
$ | (44.0 | ) | $ | 6.3 | |||||||
|
|
|
|
(1) | AUD = Australian Dollar, CAD = Canadian Dollar, EUR = Euro, GBP = British pound and JPY = Japanese Yen. |
(2) | The absolute notional exposure represents the Groups derivative activity at December 31, 2022, which is representative of the volume of derivatives held during the year. |
(3) | Contracts used to manage foreign currency risks in underwriting and non-investment operations. |
The following table presents derivative instruments by major risk type, the Groups net realized gains/(losses) and change in net unrealized gains/(losses) relating to derivative trading activities for the three months ended March 31, 2023 and 2022. Net realized gains/(losses) and net unrealized gains/(losses) related to derivatives are included in net investment return and net foreign exchange gains and losses in the Consolidated Statements of Income.
March 31, 2023 | March 31, 2022 | |||||||||||||||
Derivatives | Net realized gains/(losses) |
Change in net unrealized gains/(losses) |
Net realized gains/(losses) |
Change in net unrealized gains/(losses) |
||||||||||||
Interest rate contracts |
||||||||||||||||
Futures(1) |
$ | | $ | | $ | (3.3 | ) | $ | (1.5 | ) | ||||||
|
|
|
|
|
|
|
|
|||||||||
Total interest rate contracts |
| | (3.3 | ) | (1.5 | ) | ||||||||||
Foreign exchange contracts |
||||||||||||||||
Forwards(2) |
6.4 | (9.9 | ) | 0.2 | 0.9 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total foreign exchange contracts |
6.4 | (9.9 | ) | 0.2 | 0.9 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 6.4 | $ | (9.9 | ) | $ | (3.1 | ) | $ | (0.6 | ) | |||||
|
|
|
|
|
|
|
|
(1) | Contracts used to manage interest rate risks in investments operations. |
(2) | Contracts used to manage foreign currency risks in underwriting and non-investment operations. |
The Group obtains/provides collateral from/to counterparties for OTC derivative financial instruments in accordance with bilateral credit facilities.
The Group does not offset its derivative instruments and presents all amounts in the Consolidated Balance Sheets on a gross basis. Unrealized gains are included within other assets and unrealized losses are included within other liabilities. The Group has pledged cash collateral to counterparties to support the current value of amounts due to the counterparties based on the value of the underlying security.
F-22
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
9. | Reserves for Losses and Loss Adjustment Expenses |
The following table presents a reconciliation of unpaid losses and loss adjustment expenses for the three months ended March 31, 2023 and 2022:
March 31, 2023 | March 31, 2022 | |||||||
Gross unpaid losses and loss adjustment expenses, beginning of period |
$ | 2,045.2 | $ | 1,386.5 | ||||
Reinsurance recoverable on unpaid losses |
(976.1 | ) | (795.2 | ) | ||||
|
|
|
|
|||||
Net unpaid losses and loss adjustment expenses, beginning of period |
1,069.1 | 591.3 | ||||||
Net losses and loss adjustment expenses incurred in respect of losses occurring in: |
||||||||
Current year |
161.7 | 183.0 | ||||||
Prior years |
(2.1 | ) | (4.6 | ) | ||||
|
|
|
|
|||||
Total incurred |
159.6 | 178.4 | ||||||
Net losses and loss adjustment expenses paid in respect of losses occurring in: |
||||||||
Current year |
(2.2 | ) | (0.6 | ) | ||||
Prior years |
(48.6 | ) | (57.1 | ) | ||||
|
|
|
|
|||||
Total Paid |
(50.8 | ) | (57.7 | ) | ||||
Foreign exchange |
4.3 | 11.7 | ||||||
Net unpaid losses and loss adjustment expenses, end of period |
1,182.2 | 723.7 | ||||||
Reinsurance recoverable on unpaid losses |
1,032.8 | 794.0 | ||||||
|
|
|
|
|||||
Gross unpaid losses and loss adjustment expenses, end of period |
$ | 2,215.0 | $ | 1,517.7 | ||||
|
|
|
|
As a result of the changes in estimates of insured events in prior years, the reserves for losses and loss adjustment expenses net of reinsurance recoveries decreased by $2.1 million for the three months ended March 31, 2023 (2022: $4.6 million).
Net favorable development for the three months ended March 31, 2023 resulted from better than expected loss development in the Reinsurance and Bespoke segments, partially offset by net adverse development in the Specialty segment.
The favorable development in the Reinsurance segment related to better than expected loss emergence. The favorable development in the Bespoke segment was primarily driven by the Credit & Political Risk line of business as a result of better than expected loss emergence. The adverse development in the Specialty segment related primarily to increased estimates on two contracts in the Energy line of business.
Net favorable development for the three months ended March 31, 2022 resulted from better than expected loss experience on the Specialty and Bespoke segments, partially offset by slight deterioration on the Reinsurance segment.
The favorable development on the Specialty and Bespoke segments was driven by the Credit & Political Risk and Marine lines of business. The adverse development on the Reinsurance segment was driven by an increase in reserves for 2021 European floods.
F-23
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
10. | Reinsurance and Retrocessional Reinsurance |
The Group is exposed to the credit risk of the reinsurer, or the risk that one of its reinsurers becomes insolvent or otherwise unable or unwilling to pay policyholder claims. This credit risk is generally mitigated by either selecting well capitalized, highly rated authorized capacity providers or requiring that the capacity provider post substantial collateral to secure the reinsured risks, which, in some instances, exceeds the related reinsurance recoverable. Allowances are established for amounts deemed uncollectible.
The Group evaluates the financial condition of its reinsurers on a regular basis and monitors concentrations of credit risk with reinsurers. At March 31, 2023, the reinsurance balance recoverable on reserves for losses and loss adjustment expenses was $1,032.8 million (December 31, 2022: $976.1 million) and the reinsurance balance recoverable on paid losses was $96.5 million (December 31, 2022: $159.4 million). All reinsurance premiums ceded and reinsurance recoverables are either fully collateralized or placed with reinsurers that are rated A- or greater by A.M. Best or S&P, other than four reinsurers which are rated B++. Where an insurer does not have a credit rating, the Group has received collateral, including letters of credit and trust accounts. Collateral related to these reinsurance agreements is available, without restriction, when the Group pays losses covered by the reinsurance agreements.
Although the Group has not experienced any credit losses to date, an inability of its reinsurers or retrocessionaires to meet their obligations to it over the relevant exposure periods for any reason could have a material adverse effect on its financial condition and results of operations.
The following table provides a roll forward of the allowance for expected credit losses of the Groups reinsurance recoverables due from third parties on unpaid claims.
Three months ended March 31, 2023 | Three months ended March 31, 2022 | |||||||||||||||
Reinsurance recoverable on unpaid claims |
Allowance for expected credit losses |
Reinsurance recoverable on unpaid claims |
Allowance for expected credit losses |
|||||||||||||
Balance at the beginning of period |
$ | 976.1 | $ | 1.0 | $ | 795.2 | $ | 0.5 | ||||||||
Change during the period |
56.7 | | (1.2 | ) | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance at the end of period |
$ | 1,032.8 | $ | 1.0 | $ | 794.0 | $ | 0.5 | ||||||||
|
|
|
|
|
|
|
|
The following table provides a roll forward of the allowance for expected credit losses of the Groups reinsurance recoverables due from third parties on paid claims.
Three months ended March 31, 2023 | Three months ended March 31, 2022 | |||||||||||||||
Reinsurance recoverable on paid claims |
Allowance for expected credit losses |
Reinsurance recoverable on paid claims |
Allowance for expected credit losses |
|||||||||||||
Balance at the beginning of period |
$ | 159.4 | $ | | $ | 256.6 | $ | | ||||||||
Change during the period |
(62.9 | ) | | 19.5 | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance at the end of period |
$ | 96.5 | $ | | $ | 276.1 | $ | | ||||||||
|
|
|
|
|
|
|
|
11. | Long term debt |
On June 18, 2020, the Group issued $300.0 million and on July 2, 2020 the Group issued a further $30.0 million of its 4.875% Senior Notes due June 30, 2030 (collectively, the Senior Notes), with interest
F-24
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
payable on June 30 and December 30 of each year, commencing on December 30, 2020. The Senior Notes are redeemable at the applicable redemption price, subject to the terms described in the indenture for the Senior Notes. However, the Senior Notes may not be redeemed prior to December 31, 2023 without approval from the Bermuda Monetary Authority (the BMA) and may not be redeemed at any time prior to their maturity if enhanced capital requirements, as established by the BMA, would be breached immediately before or after giving effect to the redemption of such notes, unless, in each case, the Group replaces the capital represented by the Senior Notes to be redeemed with capital having equal or better capital treatment as the notes under applicable BMA rules. The Senior Notes contain covenants, including limitations on liens on the stock of certain designated subsidiaries, limitations on consolidations, mergers, amalgamations and sales of substantially all assets and certain reporting obligations.
On October 16, 2020, the Group issued $105.0 million, and on October 20, 2020, the Group issued a further $20.0 million of its 6.625% Fixed-Rate Reset Junior Subordinated Notes due April 1, 2041 (collectively, the Junior Notes) with interest payable on April 1 and October 1 of each year, commencing on April 1, 2021. The interest rate is reset on April 1, 2026 at the US five-year treasury rate on the reset interest determination date plus 6.323%, and every five years thereafter. The Junior Notes are redeemable at par value for six months after each interest rate reset date. The Junior Notes contain covenants, including limitations on liens on the stock of certain designated subsidiaries, limitations on consolidations, mergers, amalgamations and sales of substantially all assets and certain reporting obligations.
The following table sets forth the principal amount of the debt issued as well as the unamortized discount and debt issuance costs at March 31, 2023 and December 31, 2022:
March 31, 2023 | December 31, 2022 | |||||||||||||||
Principal | Unamortized discount and debt issuance costs |
Principal | Unamortized discount and debt issuance costs |
|||||||||||||
4.875% Senior notes due 2030 |
$ | 330.0 | $ | (5.5 | ) | $ | 330.0 | $ | (5.6 | ) | ||||||
6.625% Fixed Rate Reset Junior Subordinated notes due 2041 |
125.0 | (1.8 | ) | 125.0 | (1.9 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 455.0 | $ | (7.3 | ) | $ | 455.0 | $ | (7.5 | ) | ||||||
|
|
|
|
|
|
|
|
Preference Securities
In 2015, the Group issued 30,400 shares of cumulative 9% preference securities with a redemption price equal to $10,000 per share, plus all declared and unpaid dividends (the preference securities). Holders of preference securities are entitled to receive dividend payments only when, and if, declared by the Groups Board of Directors. To the extent declared, these dividends will accumulate, with respect to each dividend period, in the amount per share equal to 9% of the $10,000 liquidation preference per annum. Currently the holders of all preference securities do not have any voting rights.
During the three months ended March 31, 2023, the Group paid quarterly preference dividends totaling $1.3 million (2022: $1.3 million) to holders of the Groups preference securities. At March 31, 2023, dividends
F-25
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
payable of $0.2 million (December 31, 2022: $0.2 million) are included in other liabilities. No other outstanding amounts are payable to holders of the Preference Securities.
March 31, 2023 |
December 31, 2022 |
|||||||
Preference securities, par value $0.01 per share |
||||||||
Authorized |
1,000,000 | 1,000,000 | ||||||
|
|
|
|
|||||
Issued and outstanding: |
||||||||
9% cumulative preference shares |
5,800 | 5,800 | ||||||
|
|
|
|
12. | Variable Interest Entities |
Upon consummation of the Separation Transactions on January 3, 2023, the Group deconsolidated its investment in Pine Walk and its eight MGA subsidiaries. Previously, Pine Walk, Oakside Surety Limited, Perigon Product Recall Limited, Navium Marine Limited, OPEnergy Limited and Pernix Specialty Limited were deemed to be variable interest entities as their equity was deemed insufficient to finance operations without additional subordinated support in the form of a loan. At December 31, 2022, the loan balance to each entity was $nil, $nil, $0.4 million, $1.2 million, $0.8 million, and $1.2 million, respectively. Due to a de facto agent relationship with each entity, the Group was considered the primary beneficiary and consolidated the entities up to January 3, 2023.
Pine Walk Europe S.R.L. (Pine Walk Europe) was also deemed to be a variable interest entity as certain entities had a right to a share of its profits but no voting rights. The Group was deemed to be the primary beneficiary due to it either controlling or being the primary beneficiary of the entities with an interest in Pine Walk Europe. The Group deconsolidated Pine Walk Europe on January 3, 2023 as a result of the Separation Transactions.
13. | Commitments and Contingencies |
a. | Letter of credit facilities |
At March 31, 2023, the Group had the following letter of credit facilities:
| A Standby Letter of Credit Facility Agreement with Lloyds Bank plc (Lloyds), under which Lloyds committed to make available to the Group a letter of credit facility in the amount of $175.0 million was renewed on September 21, 2021 for a 24 month term. The renewal was amended to reduce the unsecured tranche to $25.0 million and retain the secured tranche of $150.0 million. An additional secured accordion of $25.0 million was triggered prior to December 31, 2021. Letters of credit can be issued under the facility for the purposes of 1) the provision of Funds at Lloyds and 2) supporting insurance and reinsurance obligations. At March 31, 2023, there were letters of credit outstanding under this facility totaling $97.6 million (December 31, 2022: $101.2 million), secured by collateral in the amount of $93.9 million (December 31, 2022: $92.4 million). |
| A Master Agreement for the Issuance of Payment Instruments with Citibank NA London Branch (Citibank), under which Citibank committed to make available a letter of credit facility in the amount of $250.0 million, was amended on December 13, 2022, effective December 31, 2022. The letter of credit facility was reduced to $100.0 million, with the provision that the Group can request, from time to time, additional increments in $50.0 million, not to exceed $150.0 million. The facility is available until December 31, 2024. An additional uncommitted facility was also agreed on October 6, 2021, for |
F-26
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
$200.0 million. At March 31, 2023, there were letters of credit outstanding under this facility totaling $84.6 million (December 31, 2022: $100.1 million), secured by collateral in the amount of $105.7 million (December 31, 2022: $104.4 million). |
| On September 17, 2021, the Letter of Credit Facility with Barclays Bank plc was renewed until September 15, 2023. The secured facility was amended to $60 million a the unsecured tranche amended to $60.0 million. The borrowers of the facility continue to be Fidelis Insurance Bermuda Limited and Fidelis Underwriting Limited, with the guarantor continuing to be Fidelis Insurance Holdings Limited. A secured accordion of $100.0 million was triggered prior to December 31, 2021. At March 31, 2023 there were letters of credit outstanding under this facility totaling $87.9 million (December 31, 2022: $88.2 million), secured by collateral in the amount of $46.4 million (December 31, 2022: $45.7 million). |
| On September 17, 2021 the letter of credit facility with Bank of Montreal was renewed as a $120.0 million facility, with a $60.0 million secured tranche and a $60.0 million unsecured tranche ending September 17, 2023. Fidelis Insurance Bermuda Limited is the borrower and Fidelis Insurance Holdings Limited is the guarantor. A secured accordion of $80.0 million was triggered prior to December 31, 2021. At March 31, 2023, there were letters of credit outstanding under this facility totaling $85.2 million (December 31, 2022: $77.4 million), secured by collateral in the amount of $8.3 million (December 31, 2022: $10.8 million). |
| A $50.0 million Standby Letter of Credit Facility Agreement with Lloyds, dated December 10, 2021 was made available to Fidelis Insurance Holdings Limited as parent, account party and guarantor, to provide regulated capital in respect of Ancillary Own Funds (AOF). The facility was amended and restated on March 14, 2023 increasing the size of the facility to $75.0 million. The amended facility is for the benefit of Fidelis Underwriting Limited and for a four-year period. This new letter of credit entirely replaces the $50.0 million letter of credit issued under the previous facility. |
b. | Legal proceedings |
From time to time in the normal course of business, the Group may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation, the outcomes of which determine the rights and obligations of the Group under the Groups (re)insurance contracts, and other contractual agreements, or other matters as the case may be. In some disputes, the Group may seek to enforce its rights under an agreement or to collect funds owing to it. In other matters, the Group may resist attempts by others to collect funds or enforce alleged rights. While the final outcome of legal disputes that may arise cannot be predicted with certainty, the Group does not believe that the eventual outcome of any specific litigation, arbitration or alternative dispute resolution proceedings to which the Group is currently a party will have a material adverse effect on the financial condition of the Groups business as a whole.
c. | Concentration of credit risk |
Credit risk arises out of the failure of a counterparty to perform according to the terms of the contract. The Group underwrites all of its (re)insurance business through brokers and as a result credit risk exists should any of these brokers be unable to fulfil their contractual obligations with respect to the payments of premium or failure to pass on claims, if there is risk transfer, to the Group.
The Group has policies and standards in place to manage and monitor the credit risk of intermediaries with a focus on day-to-day monitoring of the largest positions. Note 10, Reinsurance and Retrocessional Reinsurance describes the credit risk related to the Groups reinsurance recoverables.
F-27
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
14. | Related Party Transactions |
On January 3, 2023, Fidelis MGU acquired 9.9% of the common shares of the Group. Certain directors, executive officers and management of Fidelis MGU also own common shares of the Group.
On December 20, 2022, the Group and Fidelis MGU entered into a rolling 10-year framework agreement (the Framework Agreement), effective January 1, 2023, that governs the ongoing relationship between the two groups. Years one to three will roll automatically, whereas from year four onwards, the Framework Agreement will roll at the sole written election of the Group, with such election to be delivered at least 90 days prior to the commencement of the subsequent contract year. Any decision by FIHL to elect not to roll the Framework Agreement will mean that the remainder of the 10-year terms then in effect will continue in place.
The underwriting activities of FIBL, FUL and FIID have been outsourced to the corresponding operating subsidiaries of Fidelis MGU on a jurisdictional basis. Each of FIBL, FUL and FIID have delegated underwriting authority to source and bind contracts to Shelf Opco Bermuda Limited, Pine Walk and Pine Walk Europe, respectively. Fidelis MGU manages origination, underwriting, underwriting administration and claims handling under delegated authority agreements with the Group. Other services provided by Fidelis MGU to the Group include sourcing and administering the outwards reinsurance program, and support with business planning, capital management, insurance contract accounting and information technology. The Framework Agreement provides for the payment of the following fees with effect from January 1, 2023:
a. | Ceding commissions: (i) a ceding commission of 11.5% of net premiums written of open market business procured by Fidelis MGU on or after January 1, 2023; (ii) a ceding commission of 3% of net premiums written of business sourced by Fidelis MGU via third-party managing general underwriters on or after January 1, 2023; and (iii) a portfolio management fee of 3.0% of net premiums written of the business sourced by Fidelis MGU. |
b. | Profit commission: a profit commission of 20.0% of the aggregate operating profit generated on the sourced business, subject to a hurdle rate of return of 5.0% of underwriting return on equity. |
For insurance contracts that were sourced by Pine Walk MGAs for FUL, FIBL or FIID on or prior to December 31, 2022, the fees and commissions will continue to follow the arrangements set under the pre-existing agreements, and will not attract additional commissions under the terms of the Framework Agreement.
The following table summarizes Fidelis MGU commissions, which are included in policy acquisition expenses in the consolidated statements of income:
For the three months ended | ||||||||
March 31, 2023 | March 31, 2022 | |||||||
Ceding commission expense |
$ | 12.1 | $ | | ||||
Profit commission expense |
12.1 | | ||||||
|
|
|
|
|||||
Total Fidelis MGU commissions |
$ | 24.2 | $ | | ||||
|
|
|
|
Amounts receivable from Fidelis MGU at March 31, 2023 of $181.0 million consist primarily of amounts collected by Fidelis MGU on behalf of the Group that were not remitted prior to the end of the quarter and prepaid portfolio management fees. Amounts payable to Fidelis MGU at March 31, 2023 of $216.9 million consist primarily of amounts payable to Fidelis MGU for ceding and profit commissions and claims paid by Fidelis MGU on the Groups behalf.
F-28
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
The Framework Agreement provides that from January 1, 2023, in respect of commissions on ceded quota share business the Group shall retain 1.0% of reinsurance premiums ceded and the remainder is to be paid to Fidelis MGU. Commissions on ceded business for the three months ended March 31, 2023 were $16.2 million, of which $2.8 million were paid to Fidelis MGU.
Certain of the insurance contracts sourced by Pine Walk on or prior to December 31, 2022 contain profit commissions based on the results of each individual contract. The expense for the three months ended March 31, 2023 was $8.9 million and is included within policy acquisition expenses.
Fidelis MGU also provides the Group with certain support services on a cost-plus basis, such as insurance contract accounting, other finance and reporting services, IT infrastructure, maintenance and developments services and facilities management pursuant to a services agreement. Included within general and administrative expenses for the three months ended March 31, 2023 is a charge of $1.0 million from Fidelis MGU for such services.
Fidelis MGU sub-leases office space in London and Dublin to FUL and FIID for which it charged $0.4 million in the three months ended March 31, 2023. FIBL sub-leases office space in Bermuda to Fidelis MGU for which it charged $0.5 million in the three months ended March 31, 2023. These amounts are included within general and administrative expenses.
During 2019, the Group made interest free loans to management of $4.5 million which were recorded within other assets in the Consolidated Balance Sheets. At March 31, 2023 there was no outstanding balance (December 31, 2022: $4.5 million) as these loans were fully repaid in January 2023 as part of the Separation Transactions.
15. | Earnings Per Share |
All share and per share information in this note have been retroactively adjusted to reflect the reverse share split of the Companys common shares for all periods presented (refer to Note 20.b, Subsequent Events for additional detail).
March 31, 2023 | March 31, 2022 | |||||||
Earnings per common share |
||||||||
Net profit available to Fidelis Insurance Holdings Limited common shareholders |
$ | 1,732.6 | $ | 17.0 | ||||
Weighted average common shares outstanding |
110,771,897 | 194,106,267 | ||||||
Earnings per common share |
$ | 15.64 | $ | 0.09 | ||||
Earnings per diluted common share |
||||||||
Net profit available to Fidelis Insurance Holdings Limited common shareholders |
$ | 1,732.6 | $ | 17.0 | ||||
Weighted average common shares outstanding |
110,771,897 | 194,106,267 | ||||||
Share-based compensation plans |
| 4,617,379 | ||||||
Weighted average diluted common shares outstanding |
110,771,897 | 198,723,646 | ||||||
Earnings per diluted common share |
$ | 15.64 | $ | 0.09 |
F-29
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
16. | Share Capital Authorized and Issued |
All share and per share information in this note have been retroactively adjusted to reflect the reverse share split of the Companys common shares for all periods presented (refer to Note 20.b, Subsequent Events for additional detail).
The following sets out the number and par value of shares authorized, issued and outstanding:
March 31, 2023 | December 31, 2022 | |||||||
Common shares, par value $0.01 per share |
||||||||
Authorized |
600,000,000 | 600,000,000 | ||||||
|
|
|
|
|||||
Issued and outstanding |
||||||||
Common shares |
110,771,897 | 194,545,370 | ||||||
|
|
|
|
Common shares
On January 3, 2023, consummation of the Separation Transactions resulted in the issuance of 13,553,681 common shares upon exercise of outstanding warrants and accelerated vesting of restricted stock units.
The distribution of Fidelis MGU to shareholders on January 3, 2023 resulted in the cancellation of 97,327,049 common shares in the Group.
No cash dividends were declared in the three months ended March 31, 2023 or 2022.
The consummation of the Separation Transactions triggered the payment of cumulative dividends on warrants of $34.1 million. These dividends related to declarations made in 2019 and prior years. The warrant dividends, together with the net assets distributed to shareholders discussed in note 3, Separation Transactions, were recorded in additional paid-in capital as our retained earnings on January 3, 2023 was $0.5 million.
On January 3, 2023 the excess fair value of the net assets distributed to shareholders of $1,696.4 million was recorded in retained earnings as the gain on revaluation of Fidelis MGU was recorded in the Consolidated Statement of Income as a component of the net gain on distribution of Fidelis MGU. The excess fair value is calculated as the fair value of Fidelis MGU of $1,775 million less the book value of the Fidelis MGU net assets and less the non-controlling interest share of Pine Walk.
17. | Share Compensation |
All share and per share information in this note have been retroactively adjusted to reflect the reverse share split of the Companys common shares for all periods presented (refer to Note 20.b, Subsequent Events for additional detail).
Warrants
In 2015, the Group reserved for issuance of warrants to purchase common shares, in the aggregate, up to 16.5% of the diluted shares: Founders warrants, Basic warrants, and Ratchet warrants.
At December 31, 2022, the Group had outstanding 21,229,070 Founders warrants, 16,080,384 Basic warrants and 1,670,480 Ratchet warrants.
F-30
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
Upon consummation of the Separation Transactions, the warrants were exercised on a cashless basis resulting in the issuance of 11,194,164 ordinary shares. The exercise of the warrants triggered the payment of cumulative dividends of $34.1 million.
At March 31, 2023, there were no outstanding warrants.
Restricted stock units
On February 17, 2016, the 2015 Non-Qualified Share Option Plan was approved by the Board of Directors. The Group reserved up to 2% of the diluted shares to the issuance of RSUs to purchase common shares. The RSUs were granted with a $0.01 exercise price and expired 10 years from the date of issuance.
On November 8, 2018, the 2018 Non-Qualified Share Option Plan was approved by the Board of Directors. The Group reserved up to 3% of the diluted shares to the issuance of RSUs to purchase common shares. The RSUs were granted with a $0.01 exercise price and expired 10 years from the date of issuance.
At December 31, 2022 the Group had 4,305,650 outstanding RSUs. Upon consummation of the Separation Transactions on January 3, 2023, the RSUs were exercised resulting in the issuance of 2,359,517 ordinary shares. This resulted in the acceleration of compensation expense of $21.0 million and an employer payroll tax expense of $17.3 million. The awards were net settled, resulting in a $50.6 million reduction of additional paid-in capital for the employees tax obligations with respect to these awards.
The Group has authorized the 2023 Share Incentive Plan, with a grant date in May 2023 (refer to Note 20, Subsequent Events for further information). There are no outstanding RSUs at March 31, 2023.
For the three months ended March 31, 2023, total compensation expense of $21.0 million relating to the RSUs was included in net gain on distribution of Fidelis MGU in the Consolidated Statements of Income. For the three months ended March 31, 2022, total compensation of $3.7 million was included in general and administrative expenses. An income tax benefit of $2.7 million (2022: $0.4 million) was recorded in the Consolidated Statements of Income. At March 31, 2022, there was a remaining unamortized balance of $nil (2022: $21.0 million), which will be recognized over the remaining service period.
18. | Income Taxes |
The Groups income tax expense for the three months ended March 31, 2023 resulted in an effective tax rate of 0.1% (2022: 19.2%). The income tax expense for the three months ended March 31, 2023 of $2.2 million (2022: $4.7 million) was net of discrete income tax benefits of $6.2 million (2022: $nil). The discrete tax items in the three months ended March 31, 2023 primarily related to the tax allowable costs of the Separation Transactions of $38.3 million. Additionally, the gross gain on distribution of Fidelis MGU (before deduction of the direct transaction costs) is exempt from taxation under the substantial shareholding exemption in Schedule 7AC to the U.K. Taxation of Chargeable Gains Act 1992.
The Groups income tax expense may fluctuate from period to period based on the relative mix of income or loss reported by jurisdiction and the varying tax rates in each jurisdiction.
19. | Ukraine Conflict |
On February 24, 2022, the Russian Federation invaded Ukraine resulting in armed conflict in Ukraine and the Black Sea (Ukraine Conflict). Subsequently a number of countries, including the United States of America,
F-31
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements (unaudited)
(Expressed in millions of U.S. dollars)
the United Kingdom, and those in the European Union, placed significant sanctions on Russian institutions and persons which resulted in a devaluation of the Ruble and a fall in the value of Russian fixed income and equity assets, and the prompt withdrawal of companies from Russia without securing their assets. Fidelis has minimal direct exposure to Russian equities and minimal exposure to fixed income assets impacted by sanctions. It had now been over a year since the commencement of the Ukraine Conflict. Fidelis has potential exposure to losses associated with the conflict in Ukraine and the Black Sea through certain lines in the Bespoke and Specialty segments. Fidelis, in common with the rest of the London Aviation Insurance Market, is the subject of various litigation proceedings brought by Aircraft Lessors in the United States of America, the United Kingdom, and those in the European Union. Notwithstanding this, Fidelis continues to believe the impact of the Ukraine Conflict will not adversely affect the Groups ability to operate as a going concern.
20. | Subsequent Events |
Subsequent events have been evaluated up to the issuance of these unaudited consolidated financial statements.
a. | 2023 Share Incentive Plan |
On May 15, 2023, shareholders approved the establishment of the 2023 Share Incentive Plan (the 2023 Plan). The 2023 Plan authorizes the issuance of options, restricted shares, restricted share units, share appreciation rights or other share-based awards to the Groups employees and directors. The total number of shares available under the Plan is 4,615,500 (plus an additional number of Common Shares equal to 4%, on a fully diluted basis, of the Common Shares sold by the Group in connection with an initial public offering). The following awards were granted in May 2023:
i. | Time-vested awardsshare settled |
The Company granted 489,012 restricted share units that cliff vest on March 31, 2024 and 179,831 restricted share units that cliff vest on December 31, 2025.
ii. | Performance-vested awardsshare settled |
The Company granted 285,151 restricted share units that cliff vest on December 31, 2025, subject to the achievement of established performance criteria and continued service during the applicable performance period.
b. | Reverse Share Split |
On June 14, 2023, the Companys Board of Directors approved a 1-for-0.92 reverse share split of the Companys common shares. The reverse share split became effective on June 16, 2023. All share and per share information and the amounts presented for common shares and additional paid-in capital included in the consolidated balance sheets, consolidated statements of income and comprehensive income, consolidated statements of changes in shareholders equity, and Notes 3, 15, 16 and 17 have been retroactively adjusted to reflect the reverse share split of the Companys common shares for all periods presented.
F-32
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors
Fidelis Insurance Holdings Limited:
Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated balance sheets of Fidelis Insurance Holdings Limited and subsidiaries (the Company) as of December 31, 2022 and 2021, the related consolidated statements of income and comprehensive income, changes in shareholders equity, and cash flows for each of the years in the three-year period ended December 31, 2022, and the related notes and financial statement schedules I to VI (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.
Basis for Opinion
These consolidated financial statements are the responsibility of the Companys management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which they relate.
Estimate of reserves for losses and loss adjustment expenses
As discussed in notes 2 and 12 to the consolidated financial statements, the Company records reserves for losses and loss adjustment expenses (reserves) calculated on a best estimate basis and are estimated using various actuarial methods as well as the Companys own loss experience, historical insurance industry loss experience, estimates of pricing adequacy trends and expert professional judgment. As of December 31, 2022, the Company recorded $2,045.2 million of reserves for losses and loss adjustment expenses.
F-34
We identified the evaluation of the estimates of reserves as a critical audit matter. Specifically, subjective and complex auditor judgement, including specialized skills and knowledge, was involved in evaluating the methods and actuarial assumptions used in estimating reserves. Assumptions included the weighting of actuarial methods, loss development factors and initial expected loss ratios.
The following are the primary procedures we performed to address the critical audit matter. We involved actuarial professionals with specialized skills and knowledge who assisted in:
a. | assessing the Companys actuarial methodologies used in estimating reserves by comparing to generally accepted actuarial practices and evaluating the Companys actuarial assumptions for the weighting of actuarial methods, loss development factors and initial expected loss ratios |
b. | developing an independent range of estimated reserves and comparing to the Companys estimate of reserves for selected lines of business. |
/s/ KPMG Audit Limited
We have served as the Companys auditor since 2015.
Hamilton, Bermuda
April 6, 2023, except Note 25 as to which the date is June 20, 2023 relating to the reverse share split and the 2023 Share Incentive Plan
F-35
FIDELIS INSURANCE HOLDINGS LIMITED (FIHL)
Consolidated Balance Sheets
At December 31, 2022 and December 31, 2021
(Expressed in millions of U.S. dollars)
2022 | 2021 | |||||||
Assets |
||||||||
Fixed maturity securities, available-for-sale at fair value (amortized cost: $2,160.8, 2021: $2,505.6) (net of allowances for credit losses of $1.1, 2021: $2.2) |
$ | 2,050.9 | $ | 2,491.1 | ||||
Fixed maturity securities, trading at fair value (amortized cost: $nil, 2021: $26.7) |
| 26.9 | ||||||
Short-term investments, available-for-sale at fair value (amortized cost: $257.0, 2021: $11.5) |
257.0 | 11.5 | ||||||
Other investments, at fair value (amortized cost: $126.3, 2021: $226.5) |
117.1 | 253.1 | ||||||
|
|
|
|
|||||
Total investments |
$ | 2,425.0 | $ | 2,782.6 | ||||
Cash and cash equivalents |
1,222.0 | 325.1 | ||||||
Restricted cash and cash equivalents |
185.9 | 150.9 | ||||||
Derivative assets, at fair value |
6.3 | 1.0 | ||||||
Accrued investment income |
10.9 | 12.1 | ||||||
Investments pending settlement |
2.0 | 0.5 | ||||||
Premiums and other receivables (net of allowances for credit losses of $8.8, 2021: $4.8) |
1,862.7 | 1,555.2 | ||||||
Deferred reinsurance premiums |
823.7 | 676.7 | ||||||
Reinsurance balances recoverable on paid losses (net of allowances for credit losses of $nil, 2021: $nil) |
159.4 | 256.6 | ||||||
Reinsurance balances recoverable on reserves for losses and loss adjustment expenses (net of allowances for credit losses of $1.0, 2021: $0.5) |
976.1 | 795.2 | ||||||
Deferred policy acquisition costs |
515.8 | 403.3 | ||||||
Deferred tax asset |
58.5 | 40.3 | ||||||
Operating right of use assets |
26.8 | 29.9 | ||||||
Other assets |
37.4 | 23.6 | ||||||
|
|
|
|
|||||
Total assets |
$ | 8,312.5 | $ | 7,053.0 | ||||
|
|
|
|
|||||
Liabilities, and shareholders equity |
||||||||
Liabilities |
||||||||
Reserves for losses and loss adjustment expenses |
2,045.2 | 1,386.5 | ||||||
Unearned premiums |
2,618.6 | 2,113.7 | ||||||
Reinsurance balances payable |
1,057.0 | 947.8 | ||||||
Long term debt |
447.5 | 446.9 | ||||||
Preference securities |
58.4 | 58.4 | ||||||
Other liabilities |
70.2 | 48.4 | ||||||
Operating lease liabilities |
28.5 | 31.4 | ||||||
Derivative liabilities, at fair value |
| 0.8 | ||||||
|
|
|
|
|||||
Total liabilities |
$ | 6,325.4 | $ | 5,033.9 | ||||
|
|
|
|
|||||
Commitments and contingencies |
||||||||
Shareholders equity |
||||||||
Common shares ($0.01 par, issued and outstanding: 194,545,370; 2021 - 194,023,401) |
1.9 | 1.9 | ||||||
Additional paid-in capital |
2,075.2 | 2,075.4 | ||||||
Accumulated other comprehensive loss |
(100.8 | ) | (11.3 | ) | ||||
Retained earnings/(accumulated deficit) |
0.5 | (52.1 | ) | |||||
|
|
|
|
|||||
Total shareholders equity attributable to common shareholders |
$ | 1,976.8 | $ | 2,013.9 | ||||
|
|
|
|
|||||
Non-controlling interests |
10.3 | 5.2 | ||||||
|
|
|
|
|||||
Total shareholders equity including non-controlling interests |
$ | 1,987.1 | $ | 2,019.1 | ||||
|
|
|
|
|||||
Total liabilities and shareholders equity |
$ | 8,312.5 | $ | 7,053.0 | ||||
|
|
|
|
See accompanying notes to the financial statements
F-36
FIDELIS INSURANCE HOLDINGS LIMITED
Consolidated Statements of Income and Comprehensive Income
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars except for per share data)
2022 | 2021 | 2020 | ||||||||||
Revenues |
||||||||||||
Gross premiums written |
$ | 3,000.1 | $ | 2,787.7 | $ | 1,576.5 | ||||||
Reinsurance premiums ceded |
(1,137.5 | ) | (1,186.6 | ) | (670.9 | ) | ||||||
|
|
|
|
|
|
|||||||
Net premiums written |
1,862.6 | 1,601.1 | 905.6 | |||||||||
Change in net unearned premiums |
(357.9 | ) | (446.9 | ) | (177.0 | ) | ||||||
|
|
|
|
|
|
|||||||
Net premiums earned |
1,504.7 | 1,154.2 | 728.6 | |||||||||
Net investment (losses)/gains |
(33.7 | ) | 13.5 | 17.9 | ||||||||
Net investment income |
40.7 | 20.6 | 26.2 | |||||||||
Net foreign exchange gains |
6.8 | | 1.2 | |||||||||
Other income |
1.9 | 1.0 | 8.7 | |||||||||
|
|
|
|
|
|
|||||||
Total revenues |
$ | 1,520.4 | $ | 1,189.3 | $ | 782.6 | ||||||
|
|
|
|
|
|
|||||||
Expenses |
||||||||||||
Losses and loss adjustment expenses |
830.2 | 696.8 | 324.5 | |||||||||
Policy acquisition expenses |
447.7 | 299.9 | 179.2 | |||||||||
General and administrative expenses |
106.4 | 75.4 | 83.5 | |||||||||
Corporate and other expenses |
20.5 | 2.7 | 18.7 | |||||||||
Net foreign exchange losses |
| 0.4 | | |||||||||
Financing costs |
35.5 | 35.4 | 27.9 | |||||||||
Loss on extinguishment of preference securities |
| | 25.3 | |||||||||
|
|
|
|
|
|
|||||||
Total expenses |
$ | 1,440.3 | $ | 1,110.6 | $ | 659.1 | ||||||
|
|
|
|
|
|
|||||||
Income before income taxes |
$ | 80.1 | $ | 78.7 | $ | 123.5 | ||||||
|
|
|
|
|
|
|||||||
Income tax (expense)/benefit |
(17.8 | ) | (0.4 | ) | 3.1 | |||||||
|
|
|
|
|
|
|||||||
Net income |
$ | 62.3 | $ | 78.3 | $ | 126.6 | ||||||
|
|
|
|
|
|
|||||||
Net income attributable to non-controlling interests |
(9.7 | ) | (10.0 | ) | (0.1 | ) | ||||||
|
|
|
|
|
|
|||||||
Net income available to common shareholders |
$ | 52.6 | $ | 68.3 | $ | 126.5 | ||||||
|
|
|
|
|
|
|||||||
Other comprehensive (loss)/income |
||||||||||||
Unrealized (losses)/gain on AFS financial assets |
(96.5 | ) | (36.1 | ) | 12.1 | |||||||
Income tax benefit/(expense), all of which relates to unrealized (loss)/gain on AFS financial assets |
8.1 | 2.4 | (0.7 | ) | ||||||||
Currency translation adjustments |
(1.1 | ) | (0.2 | ) | | |||||||
|
|
|
|
|
|
|||||||
Total other comprehensive (loss)/income |
$ |
(89.5 |
) |
$ | (33.9 | ) | $ | 11.4 | ||||
|
|
|
|
|
|
|||||||
Comprehensive (loss)/income attributable to common shareholders |
$ | (36.9 | ) | $ | 34.4 | $ | 137.9 | |||||
|
|
|
|
|
|
|||||||
Per share data |
||||||||||||
Earnings per common share: |
||||||||||||
Earnings per common share |
$ | 0.27 | $ | 0.35 | $ | 0.76 | ||||||
Earnings per diluted common share |
$ | 0.26 | $ | 0.34 | $ | 0.74 | ||||||
Weighted average common shares outstanding |
194.3 | 195.5 | 166.9 | |||||||||
Weighted average diluted common shares outstanding |
199.4 | 200.4 | 171.8 |
See accompanying notes to the financial statements
F-37
FIDELIS INSURANCE HOLDINGS LIMITED
Consolidated Statement of Changes in Shareholders Equity
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
2022 | 2021 | 2020 | ||||||||||
Common shares |
||||||||||||
Balance - beginning of year |
$ | 1.9 | $ | 1.9 | $ | 1.3 | ||||||
Common stock repurchased |
| (0.2 | ) | | ||||||||
Issue of common shares |
| 0.2 | 0.6 | |||||||||
|
|
|
|
|
|
|||||||
Balance - end of year |
$ | 1.9 | $ | 1.9 | $ | 1.9 | ||||||
|
|
|
|
|
|
|||||||
Additional paid-in capital |
||||||||||||
Balance - beginning of year |
$ | 2,075.4 | $ | 2,072.1 | $ | 1,348.4 | ||||||
Repurchase of shares |
| (320.7 | ) | (0.8 | ) | |||||||
Share compensation expense |
10.8 | 9.8 | 32.6 | |||||||||
Purchase of non-controlling interest |
(11.0 | ) | (3.8 | ) | | |||||||
Issue of common shares, net of issuance costs |
| 318.0 | 691.9 | |||||||||
|
|
|
|
|
|
|||||||
Balance - end of year |
$ | 2,075.2 | $ | 2,075.4 | $ | 2,072.1 | ||||||
|
|
|
|
|
|
|||||||
Accumulated other comprehensive (loss)/income, net of tax |
||||||||||||
Unrealized losses on available-for-sale securities held at fair value, net of tax |
||||||||||||
Balance - beginning of year |
$ | (11.3 | ) | $ | 22.4 | $ | 11.0 | |||||
Unrealized (losses)/income arising during the year |
(88.4 | ) | (33.7 | ) | 11.4 | |||||||
|
|
|
|
|
|
|||||||
Balance - end of year |
$ | (99.7 | ) | $ | (11.3 | ) | $ | 22.4 | ||||
|
|
|
|
|
|
|||||||
Currency translation reserve |
||||||||||||
Balance - beginning of year |
| 0.2 | 0.2 | |||||||||
Movement during the year |
(1.1 | ) | (0.2 | ) | | |||||||
|
|
|
|
|
|
|||||||
Balance - end of year |
$ | (1.1 | ) | $ | | $ | 0.2 | |||||
|
|
|
|
|
|
|||||||
Balance - end of year |
$ | (100.8 | ) | $ | (11.3 | ) | $ | 22.6 | ||||
|
|
|
|
|
|
|||||||
Retained earnings/(accumulated deficit) |
||||||||||||
Balance - beginning of year |
$ | (52.1 | ) | $ | (120.4 | ) | $ | (242.8 | ) | |||
Net income available to common shareholders |
52.6 | 68.3 | 126.5 | |||||||||
Common dividend |
| | (4.1 | ) | ||||||||
|
|
|
|
|
|
|||||||
Balance - end of year |
$ | 0.5 | $ | (52.1 | ) | $ | (120.4 | ) | ||||
|
|
|
|
|
|
|||||||
Total shareholders equity attributable to common shareholders |
$ | 1,976.8 | $ | 2,013.9 | $ | 1,976.2 | ||||||
|
|
|
|
|
|
|||||||
Non-controlling interests |
||||||||||||
Balance - beginning of the year |
$ | 5.2 | $ | | $ | 0.5 | ||||||
Net profit attributable to non-controlling interests |
9.7 | 10.0 | 0.1 | |||||||||
Investment in subsidiaries by non-controlling interests |
| | 0.2 | |||||||||
Dividends paid to non-controlling interest |
(3.9 | ) | (2.6 | ) | (0.8 | ) | ||||||
Sale of subsidiary |
| (2.2 | ) | | ||||||||
Non-controlling interest arising from acquisition of a subsidiary |
(0.7 | ) | | | ||||||||
|
|
|
|
|
|
|||||||
Balance - end of year |
$ | 10.3 | $ | 5.2 | $ | | ||||||
|
|
|
|
|
|
|||||||
Total shareholders equity including non-controlling interests |
$ | 1,987.1 | $ | 2,019.1 | $ | 1,976.2 | ||||||
|
|
|
|
|
|
See accompanying notes to the financial statements
F-38
FIDELIS INSURANCE HOLDINGS LIMITED
Consolidated Statements of Cash Flows
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
2022 | 2021 | 2020 | ||||||||||
Operating activities |
||||||||||||
Net income |
$ | 62.3 | $ | 78.3 | $ | 126.6 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||||||
Share compensation expense |
10.8 | 9.8 | 32.6 | |||||||||
Depreciation |
3.9 | 4.5 | 2.6 | |||||||||
Net unrealized loss/(gain) on investments and derivatives |
11.8 | (17.5 | ) | (7.4 | ) | |||||||
Net realized loss on investments and derivatives |
8.5 | 24.1 | (3.4 | ) | ||||||||
Deferred tax benefit |
(10.4 | ) | (26.4 | ) | (6.0 | ) | ||||||
Net changes in assets and liabilities: |
||||||||||||
Accrued investment income |
1.2 | (3.0 | ) | (1.7 | ) | |||||||
Premiums and other receivables |
(342.0 | ) | (479.1 | ) | (412.7 | ) | ||||||
Deferred reinsurance premiums |
(147.0 | ) | (261.3 | ) | (273.9 | ) | ||||||
Reinsurance balances recoverable on paid claims |
89.5 | (156.4 | ) | 26.1 | ||||||||
Reinsurance balances recoverable on unpaid claims |
(195.5 | ) | (421.9 | ) | 65.0 | |||||||
Deferred policy acquisition costs |
(112.5 | ) | (126.8 | ) | (75.3 | ) | ||||||
Operating right of use assets |
3.1 | (20.1 | ) | 0.2 | ||||||||
Other assets |
0.7 | 19.6 | 2.0 | |||||||||
Reserves for losses and loss adjustment expenses |
695.3 | 592.3 | 72.2 | |||||||||
Unearned premiums |
504.9 | 708.2 | 450.9 | |||||||||
Reinsurance balances payable |
134.3 | 453.7 | 287.1 | |||||||||
Operating lease liabilities |
(0.9 | ) | 20.9 | (0.5 | ) | |||||||
Other liabilities |
24.9 | (31.2 | ) | 31.7 | ||||||||
|
|
|
|
|
|
|||||||
Net cash provided by operating activities |
$ | 742.9 | $ | 367.7 | $ | 316.1 | ||||||
|
|
|
|
|
|
|||||||
Investing activities |
||||||||||||
Purchase of investments, trading |
| | (0.1 | ) | ||||||||
Proceeds from the sale of investments, trading |
27.8 | 56.1 | 116.7 | |||||||||
Purchase of available-for-sale securities |
(1,595.8 | ) | (2,122.2 | ) | (1,161.9 | ) | ||||||
Proceeds from sale of available-for-sale securities |
1,678.8 | 1,111.6 | 631.6 | |||||||||
Purchase of other investments |
(100.0 | ) | (125.2 | ) | (100.0 | ) | ||||||
Purchase of investments to cover short sales |
| | (3.7 | ) | ||||||||
Proceeds for sale of other investments |
223.9 | 1.3 | 1.4 | |||||||||
Change in investments pending settlement - assets |
(1.5 | ) | | 24.7 | ||||||||
Change in investments pending settlement - liabilities |
| (21.9 | ) | 12.0 | ||||||||
Net cash from disposal of subsidiary |
| (7.1 | ) | | ||||||||
Purchase of fixed assets |
(18.8 | ) | (7.1 | ) | (2.0 | ) | ||||||
|
|
|
|
|
|
|||||||
Net cash provided by/(used in) investing activities |
$ | 214.4 | $ | (1,114.5 | ) | $ | (481.3 | ) | ||||
|
|
|
|
|
|
|||||||
Financing activities |
||||||||||||
Proceeds from issuance of debt, net of issuance of costs |
| | 445.7 | |||||||||
Proceeds from issuance of common stock, net of issuance costs |
| 318.2 | 691.8 | |||||||||
Non-controlling interest share transactions |
(15.7 | ) | (6.3 | ) | (0.6 | ) | ||||||
Repurchase of common shares |
| (320.9 | ) | |
F-39
FIDELIS INSURANCE HOLDINGS LIMITED
Consolidated Statements of Cash Flows
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
2022 | 2021 | 2020 | ||||||||||
Dividends on common shares |
(0.5 | ) | (2.1 | ) | (5.1 | ) | ||||||
Repurchase of preference securities |
| | (183.8 | ) | ||||||||
|
|
|
|
|
|
|||||||
Net cash (used in)/provided by financing activities |
$ | (16.2 | ) | $ | (11.1 | ) | $ | 948.0 | ||||
Effect of exchange rate changes on foreign currency cash |
$ | (9.2 | ) | $ | (4.6 | ) | $ | 4.8 | ||||
Net increase/(decrease) in cash, restricted cash, and cash equivalents |
931.9 | (762.5 | ) | 787.6 | ||||||||
Cash, restricted cash, and cash equivalents, beginning of year |
476.0 | 1,238.5 | 450.9 | |||||||||
|
|
|
|
|
|
|||||||
Cash, restricted cash, and cash equivalents, end of year |
$ | 1,407.9 | $ | 476.0 | $ | 1,238.5 | ||||||
|
|
|
|
|
|
|||||||
Cash and cash equivalents comprise the following: |
||||||||||||
Cash and cash equivalents at bank |
1,222.0 | 325.1 | 967.2 | |||||||||
Restricted cash and cash equivalents |
185.9 | 150.9 | 271.3 | |||||||||
|
|
|
|
|
|
|||||||
Cash, restricted cash, and cash equivalents |
$ | 1,407.9 | $ | 476.0 | $ | 1,238.5 | ||||||
|
|
|
|
|
|
|||||||
Supplemental disclosure of cash flow information: |
||||||||||||
Net cash paid during the year for income taxes |
11.9 | 24.1 | | |||||||||
Cash paid during the year for interest |
24.4 | 29.3 | 22.3 |
F-40
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
1. | Nature of Operations |
Fidelis Insurance Holdings Limited (Fidelis and together with its subsidiaries, the Group) is a holding company which was incorporated under the laws of Bermuda on August 22, 2014. The Group provides Property, Specialty and Bespoke insurance and reinsurance. Fidelis principal operating subsidiaries are:
| Fidelis Insurance Bermuda Limited (FIBL), is a Class 4 Bermuda domiciled company which writes most of the Groups Reinsurance business, as well as writing Specialty and Bespoke lines. FIBL is regulated by the Bermuda Monetary Authority. |
| Fidelis Underwriting Limited (FUL), is a UK domiciled company which principally writes Specialty and Bespoke insurance, as well as Reinsurance. FUL is regulated by the Prudential Regulation Authority (PRA). |
| Fidelis Insurance Ireland DAC (FIID), is a Republic of Ireland domiciled company that writes Specialty and Bespoke insurance and reinsurance within the European Economic Area. FIID is regulated by the Central Bank of Ireland. |
| Fidelis Marketing Limited (FML), a management company which acts as an insurance intermediary to provide marketing services and is authorized by the Financial Conduct Authority (FCA). |
Fidelis has invested in a number of Managing General Agents (MGAs) through Pine Walk Capital Limited (Pine Walk) which holds the investment in the MGAs and provides them with administrative support. There are 8 MGAs:
| Radius Specialty Limited (Radius) which focuses on niche specialty treaty reinsurance business. |
| Oakside Surety Limited (Oakside) which focuses on surety bonds and guarantees. |
| Kersey Specialty Limited (Kersey) which focuses on upstream energy business. |
| Perigon Product Recall Limited (Perigon) which focuses on product recall and product contamination. |
| Navium Marine Limited (Navium) which focuses on marine business. |
| OPEnergy Limited (OPEnergy) which focuses on energy liabilities. |
| Pine Walk Europe S.R.L. which is licensed to write insurance business in the European Economic Area (EEA). |
| Pernix Specialty Limited (Pernix) which focuses on credit and political risk business. Pernix was incorporated on December 7, 2021. |
The financial statements of Pine Walk and the 8 MGAs have been included in the consolidated financial statements of the Group. During 2022, the Group purchased additional shares in Pine Walk Capital Limited.
Further information can be found at Note 15, Variable Interest Entities and Note 16, Non-Controlling Interests. Note 25, Subsequent Events provides details of changes to the Group structure that occurred in January 2023.
2. | Significant Accounting Policies |
Basis of presentation
The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (U.S. GAAP) and include the results of Fidelis Insurance Holdings
F-41
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Limited and its subsidiaries. All intercompany balances and transactions have been eliminated on consolidation. The consolidated financial statements have been compiled on a going concern basis.
Certain 2021 and 2020 amounts have been reclassified in the Consolidated Statements of Cash Flows to conform with the 2022 presentation.
Reporting currency
The financial information is reported in United States dollars (U.S. dollars or $), expressed in millions, except for share and per share amounts.
Use of estimates, risks and uncertainties
The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported and disclosed amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
The most significant estimates reflected in the financial statements include, but are not limited to, gross and net reserves for losses and loss adjustment expenses and estimates of written and earned premiums.
Cash and cash equivalents
Cash and cash equivalents consist of cash held in banks, money market funds and other short-term, highly liquid investments with original maturity dates of 90 days or less.
Restricted cash and cash equivalents
Restricted cash and cash equivalents consist of cash held in segregated or trust accounts, which is unavailable for immediate use by the Group, primarily to provide collateral for letters of credit and to support the current value of any amounts that may be due to counterparties based on the value of underlying financial instruments
Investments
Our accounting policy classifies all fixed maturity securities acquired prior to January 1, 2018 as trading, whilst fixed maturity securities acquired from January 1, 2018 are classified as available for-sale which reflects the Groups intention to hold the vast majority of these assets to maturity. At December 31, 2022, all securities classified as trading have matured.
Our fixed-income securities portfolio comprises securities issued by governments and government agencies, corporate bonds, and asset-backed securities. Investments in fixed-income securities are reported at estimated fair value in our audited consolidated financial statements.
Our other investments (Risk Assets) consist of a residual investment in a hedge fund, investments in structured notes as described above (refer to Note 4, Investments for further details) and the Wellington Opportunistic Fixed-Income UCITS Fund. These are carried at fair value and realized and unrealized gains or losses included in net investment gains and losses on the Consolidated Statement of Income. For the valuation methodologies refer to Note 5.
F-42
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Investments with a maturity from three months up to one year from date of purchase are classified as short-term investments and recorded at fair value.
For all fixed maturity securities and other investments, any realized and unrealized gains or losses are determined on the basis of the first-in, first-out method. For all fixed maturity securities classified as available for sale, realized gains and losses in the audited consolidated financial statements include allowances for expected credit losses related to its Available for Sale (AFS) debt securities. This allowance represents the difference between the securitys amortized cost and the amount expected to be collected over the securitys lifetime. Unrealized gains and losses represent the difference between the cost, or the cost as adjusted by amortization of any difference between its cost and its redemption value (amortized cost), of the security and its fair value at the reporting date and are included within other comprehensive income for securities classified as available for sale. For securities classified as trading realized and unrealized gains or losses are included in the audited consolidated financial statements within net investment gains and losses.
Net investment income
Net investment income includes amounts received and accrued in respect of periodic interest (coupons) payable to the Group by the issuer of fixed income securities and interest credited on cash and cash equivalents. It also includes amortization of premium and accretion of discount in respect of fixed income securities. Investment management, custody, and investment administration fees are charged against net investment income reported in the Consolidated Statement of Income. Investment transactions are recorded on a trade date basis.
Derivative assets and liabilities
All derivatives are recognized in the Consolidated Balance Sheets at fair value on a gross basis and not offset against any collateral pledged or received. Unrealized gains and losses resulting from changes in fair value are included in net investment gains and losses or net foreign exchange gains and losses in the Consolidated Statements of Income. The Groups derivative financial instrument assets are included in derivative assets and derivative financial instrument liabilities are included in derivative liabilities in the Consolidated Balance Sheets. None of the Groups derivatives are designated as accounting hedges for financial reporting purposes. Pursuant to the International Swaps and Derivatives Association (ISDA) master agreements and other derivative agreements, the Group and its counterparties typically have the ability to settle on a net basis. In addition, in the event a party to one of the ISDA master agreements or other derivative agreements defaults, or a transaction is otherwise subject to termination, the non-defaulting party generally has the right to set off against payments owed to the defaulting party or collateral held by the defaulting party.
The Group enters into derivative transactions to manage duration risk, foreign currency exchange risk, or other exposure risks. The Group also sometimes enters catastrophe swap derivatives to manage its exposure to catastrophe events. Derivative transactions typically include futures, options, swaps and forwards. Derivative assets represent financial contracts whereby, based upon the contracts current fair value, the Group will be entitled to receive payments upon settlement. Derivative liabilities represent financial contracts whereby, based upon the contracts current fair value, the Group will be obligated to make payments upon settlement.
The Group looks to manage foreign currency exposure by substantively balancing assets with liabilities for certain major non-U.S. dollar currencies, or by entering into currency forward contracts. However, there is no guarantee that this will effectively mitigate exposure to foreign exchange gains and losses.
F-43
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Where a contract includes an embedded derivative, the embedded derivative is recognized separately only if the contract is not recognized at fair value, or the economic characteristics and risks of the embedded derivative are not clearly and closely related to those of the host contract.
Investments pending settlement
Investments pending settlement include receivables and payables from unsettled trades with brokers. Receivables and payables from unsettled trades are carried at fair value based on quoted prices in active markets for identical assets or derived based on inputs that are observable.
Premiums and acquisition costs
Premiums written are recorded on inception of the policy. Premiums written include estimates based on information received from insureds, brokers and cedants, and any subsequent differences arising on such estimates are recorded as premiums written in the period they are determined. Premiums written are earned on a basis consistent with risks covered over the period the coverage is provided. The portion of the premiums written applicable to the unexpired terms of the underlying contracts and policies is recorded as unearned premium.
Reinstatement premiums are recognized as written and earned after the occurrence of a loss and are recorded in accordance with the contract terms based upon managements estimate of losses and loss adjustment expenses.
Policy acquisition expenses are directly related to the acquisition of insurance premiums and are deferred and amortized over the related policy period in line with earned premium. The Group only defers acquisition costs incurred that are directly related to the successful acquisition of new or renewal insurance contracts, including commissions to agents, brokers and premium taxes. All other acquisition related expenses including indirect costs are expensed as incurred. To the extent that future policy revenues on existing policies are not adequate to cover related costs and expenses, deferred policy acquisition costs are charged to earnings.
The Group evaluates premium deficiency and the recoverability of deferred acquisition costs by determining if the sum of future earned premiums and anticipated investment return is greater than expected future losses and loss adjustment expenses and policy acquisition expenses.
Reinsurance and retrocession
The Group seeks to reduce the risk of net losses on business written by reinsuring certain risks and exposures with other reinsurers. Ceded reinsurance contracts do not relieve the Group of its primary obligation to insureds. Ceded premiums are recognized when the coverage period incepts and are expensed over the contract period in proportion to the coverage period or, when the coverage period does not align to the risk exposure, in proportion to the underlying risk exposure. Premiums relating to the unexpired portion of reinsurance ceded are recorded as deferred reinsurance premiums.
Commissions on ceded business are deferred and amortized over the period in which the related ceded premium is recognized. The deferred balance is recorded within deferred policy acquisition costs on the Consolidated Balance Sheets and the amortization is recognized within general and administrative expenses in the Consolidated Statement of Income.
F-44
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Losses and loss adjustment expenses
The liability for losses and loss adjustment expenses includes reserves for unpaid reported losses and for losses incurred but not reported (IBNR). These estimates are reported net of amounts estimated to be recoverable from salvage and subrogation. The reserve for losses and loss adjustment expenses is established by management based on reports from insureds, brokers, and ceding companies and the application of generally accepted actuarial techniques and represents the estimated ultimate cost of events or conditions that have been reported to or specifically identified by the Group as incurred.
The Group estimates ultimate losses using various actuarial methods as well as the Groups own growing loss experience, historical insurance industry loss experience, estimates of pricing adequacy trends and managements professional judgement. The estimated cost of claims includes expenses to be incurred in settling claims and a deduction for the expected value of salvage, subrogation and other recoveries. Ultimate losses and loss adjustment expenses may differ significantly from the amount recorded in the financial statements. These estimates are reviewed regularly and as experience develops and new information becomes known, the reserves are adjusted as necessary. Such adjustments, if any, are recorded in losses and loss adjustment expenses in the periods in which they are determined.
The principal actuarial methods, and associated key assumptions including the weighting of actuarial methods, loss development factors and initial expected loss ratios, used to perform the Groups loss reserve analysis include:
Initial expected loss ratio
To estimate ultimate losses, the Group multiplies earned premiums by an expected loss ratio. The expected loss ratio is determined using a combination of benchmark data, the business plan, and expert judgement.
Paid and incurred chain ladder
This method estimates ultimate losses by calculating past paid and incurred loss development factors and applying them to exposure periods with further expected paid loss development. The main underlying assumption of this method is that historical loss development patterns are indicative of future loss development patterns.
Paid and incurred Bornhuetter-Ferguson (BF)
This method combines features of the chain ladder and initial expected loss ratio method by using both reported and paid losses as well as an a priori expected loss ratio to arrive at an ultimate loss estimate. The weighting between these two methods depends on the maturity of the business. This means that for more recent years a greater weight is placed on the initial expected loss ratio, while for more mature years a greater weight is placed on the loss development patterns.
Benktander: Credible claims reserves
The Benktander method is similar to the Bornhuetter-Ferguson but replaces the initial loss ratio used within the BF method with the loss estimate from the BF method. The credibility factor is increased as claims develop. It gives more weight to:
| Emerged losses than the BF; and |
| Initial expected loss ratio rather than the chain ladder. |
F-45
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Case-by case
Given the nature of the business written, some of the lines of business may consist of a small number of policies. Where appropriate, the loss reserves will be calculated explicitly for a particular contract using expert judgement and documented appropriately. Salvage is recorded based on estimated realizable value and is deducted from the reserve for losses and loss adjustment expenses. It is the responsibility of the actuarial function to apply the relevant actuarial methodologies and judgements to the calculation of loss reserves. The Group Actuary presents the recommendations of the actuarial review of the reserves to the Reserving Committee for review, challenge and recommendation, the results of which are included in the Group Actuarys Reserving Report for approval by the Audit Committee.
Reserves for losses and loss adjustment expenses represent our best estimate of the ultimate cost of settling reported and unreported claims and related expenses. As discussed previously, the estimation of losses and loss adjustment expense reserves is based on various complex and subjective judgments. Actual losses and settlement expenses which are ultimately required to be paid may deviate, perhaps substantially, from the reserve estimates reflected in our financial statements. Similarly, the timing for payment of our estimated losses is not fixed and is not determinable on an individual or aggregate basis. The assumptions used in estimating the payments due by period are based on industry and peer-group claims payment experience. Due to the uncertainty inherent in the process of estimating the timing of such payments, there is a risk that the amounts paid in any period can be significantly different than the amounts discussed above.
Premiums receivable
Premiums receivable includes amounts receivable from insureds, net of brokerage costs, which represent premiums that are both currently due and amounts not yet due on insurance and reinsurance policies. Premiums for insurance policies are generally due at inception. Premiums for reinsurance policies generally become due over the period of coverage based on the policy terms. Contract periods can be several years in length with premiums received in annual or quarterly installments.
The Group monitors the credit risk associated with premiums receivable, taking into consideration the fact that in certain instances credit risk may be reduced by the Groups right to offset loss obligations against premiums receivable. The Group establishes an allowance for credit losses based upon the life of the receivables which is charged to net income. Changes in the estimate of (re)insurance premiums written will also result in an adjustment to premiums receivable in the period they are determined.
The following table provides the allowance for expected credit losses of the Groups premium receivables due from third parties on unpaid claims that is due greater than 180+ days.
$ millions | ||||||||
Year ended December 31, 2022 |
Premium receivable due greater than 180+ days |
Allowance for Expected Credit Losses |
||||||
Balance at the end of year |
35.2 | 8.8 |
$ millions | ||||||||
Year ended December 31, 2021 |
Premium receivable due greater than 180+ days |
Allowance for Expected Credit Losses |
||||||
Balance at the end of year |
19.2 | 4.8 |
F-46
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Reinsurance balances recoverable
Amounts recoverable from reinsurers are estimated based on the terms and conditions of the reinsurance contracts in a manner consistent with the underlying liability reinsured. The Group evaluates the financial condition of its reinsurers and monitors concentration of credit risk to minimize its exposure to significant losses from individual reinsurers. The ceding of insurance does not legally discharge the Group from its primary liability for the full amount of the policies, and the Group will be required to pay the loss and bear collection risk if the reinsurer fails to meet its obligations under the reinsurance or retrocessional agreement. To further reduce credit exposure on reinsurance recoverables, the Group has received collateral, including letters of credit and trust accounts, from certain reinsurers. Collateral related to these reinsurance agreements is available, without restriction, when the Group pays losses covered by the reinsurance agreements.
An allowance is established for credit losses expected to be incurred over the life of the reinsurance recoverable, which is recorded net of this allowance. The allowance is charged to net income in the period the recoverable is recorded and revised in subsequent periods to reflect changes in the Groups estimate of expected credit losses. Further details are set out at Note 13, Reinsurance and Retrocessional Insurance.
Long term debt
Debt is initially measured at fair value less issuance costs incurred and subsequently held at amortized cost. Interest expense is recognized over the term of the notes using the effective interest method.
Leases
The Group assesses whether a contract contains a lease at the inception of the contract, determining at that point whether any leases identified are operating leases or finance leases. The Group does not currently have any finance leases.
For operating leases with a lease term in excess of 12 months, a lease liability and corresponding operating right-of-use asset is recognized. The lease liability takes into account any renewal options that are deemed to be reasonably certain and is discounted using the Groups incremental borrowing rate, where the rate implicit in the lease is not available.
The unwind of the discount is recognized in general and administrative expenses. The operating right-of-use asset is amortized straight line over the term of the lease and recognized in general and administrative expenses in the Consolidated Statement of Income and Comprehensive income.
Corporate and other expenses
Corporate and other expenses include reorganization expenses, warrant expenses and other one-off expenses. Corporate and other expenses have been separated from general and administrative costs to separately show these costs from the administrative costs associated with running the day-to-day activities of the Group.
Income taxes
Income taxes have been provided for those operations that are subject to income taxes based on tax laws and rates enacted in those jurisdictions. Current and deferred taxes are charged or credited to income tax expense.
F-47
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Deferred tax assets and liabilities result from temporary differences between the amounts recorded in the consolidated financial statements and the tax basis of the Groups assets and liabilities. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income tax expense in the Consolidated Statement of Income in the period that includes the enactment date.
A valuation allowance is provided to reduce deferred tax assets to the amount management deem more likely than not to be be realized.
The Group recognizes the benefit from a tax position taken or expected to be taken in income tax returns only if it is more likely than not that the tax position will be sustained upon examination by taxing authorities, based on the technical merits of the position. Tax positions that meet the more likely than not threshold are measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. The Group recognizes interest and penalties related to income taxes in income tax expense.
Share compensation
The Group has issued warrants to purchase common shares. The warrants expire 10 years from the date of grant and consist of Founders warrants that were issued to the initial investors, and Basic and Ratchet warrants that have been issued to Fidelis Management (the management warrants).
Warrants are valued using the Black-Scholes option-pricing model and the fair value of these warrants is recorded in equity as additional paid-in capital when performance conditions are met.
Founder warrants require certain performance conditions to be met. Basic warrants are subject to a service condition only and the Ratchet warrants subject to a service and performance condition.
The portion of the warrants that is considered probable of vesting is recognized in corporate and other expenses in the Consolidated Statement of Income and Comprehensive Income.
Share compensation for management warrants considered probable of vesting is expensed over the vesting period on a graded vesting basis. The probability of the management warrants vesting is evaluated at each reporting period. When the management warrants are considered probable of vesting, the Group records an adjustment to the share compensation expense from the grant date (service inception date) to the current reporting period end based on the fair value of the warrant contracts at grant date.
Restricted stock units (RSUs) granted contain both a service and performance condition and are recognized as share compensation expense only for the portion considered likely to vest. The fair value of the RSUs is estimated at the latest price at which the Group raised capital. Where no recent capital transaction has occurred, the fair value is determined by the Board. Share compensation expense is recognized on a straight-line basis over the vesting period, adjusted for the impact of any performance vesting conditions. At each balance sheet date, the Group revises the share compensation expense based on its estimate of the number of RSUs that are expected to vest. It recognizes the impact of the revision of original estimates, if any, in the Consolidated Statement of Income and Comprehensive Income and a corresponding adjustment is made to additional paid-in capital in shareholders equity on the Consolidated Balance Sheets. The Group recognizes forfeitures when they occur. For further information, see Note 22, Share Compensation.
F-48
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Share issuance costs
Issuance costs incurred in connection with the capital raise, which included financial advisors fees, legal and accounting fees, printing and other fees are deducted from the gross proceeds of the offering. The proceeds from the issuance of shares, net of offering costs, is included in additional paid-in capital in shareholders equity.
Foreign exchange
The Group has entities with U.S. Dollar, U.K. Sterling and Euro functional currencies. The functional and reporting currency is U.S. Dollar. Transactions in foreign currencies are translated in U.S. dollars at the exchange rate in effect on the transaction date. Monetary assets and liabilities in foreign currencies are re-measured at the exchange rates in effect at the reporting date. Foreign exchange gains and losses are included in the Consolidated Statement of Income and Comprehensive Income. Non-monetary assets and liabilities are remeasured to the functional currency at historic exchange rates.
In translating the financial results of those entities whose functional currency is other than the U.S. Dollar reporting currency, assets and liabilities are converted into U.S. Dollars using the rates of exchange in effect at the reporting date, and revenues and expenses are converted using the average foreign exchange rates for the period. The effect of translation adjustments are reported in the Consolidated Balance Sheets and Consolidated Statements of Changes in Shareholders Equity as a foreign currency translation adjustment, a separate component of Accumulated Other Comprehensive Income.
Variable interest entities
Variable Interest Entities (VIE) are entities that have either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristic of a controlling financial interest.
The Group is deemed to have a controlling financial interest and be the primary beneficiary if it has both of the following characteristics:
| power to direct the activities of the VIE that most significantly impact the entitys economic performance; and |
| an obligation to absorb losses of the entity that could potentially be significant to the VIE, or a right to receive benefits from the entity that could potentially be significant to the VIE. |
The determination of whether an entity is a VIE requires judgment and depends on facts and circumstances specific to that entity.
VIEs for which the Group is deemed to have a controlling financial interest and be the primary beneficiary are consolidated and all significant inter-company transactions are eliminated.
If the Group is not deemed to have a controlling financial interest or be the primary beneficiary, then the investment is not consolidated and is recognized according to the facts and circumstances of the relationship. For further information see Note 15, Variable Interest Entities.
The Group determines on an ongoing basis whether an entity is a VIE or if the Group is the primary beneficiary based on an analysis of the Groups level of involvement in the VIE, the contractual terms, the overall structure of the VIE and funding requirements.
F-49
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Non-controlling interests
Non-controlling shareholders interests are presented separately in the Groups Consolidated Balance Sheets and Consolidated Statements of Changes in Shareholders Equity. The net income attributable to non-controlling interests is presented separately in the Groups Consolidated Statement of Income.
Comprehensive income
Comprehensive income represents all changes in equity that result from recognized transactions and other economic events during the period. Other comprehensive income refers to revenues, expenses, gains and losses that under U.S. GAAP are included in comprehensive income but excluded from net income, such as unrealized gains or losses on available-for-sale investments and foreign currency translation adjustments.
Recent accounting pronouncements
Accounting Standards recently adopted
Effective January 1, 2020, the Group adopted ASC 326, Financial InstrumentsCredit Losses. This new standard replaced the incurred loss model used to measure impairment losses for financial assets measured at amortized cost with a current expected credit loss (CECL) model and also made changes to the impairment model for available-for-sale investments. Under the CECL model, allowances are established for expected credit losses to be recognized over the life of financial assets. Application of the CECL model impacted certain of the Groups financial assets, including investments, reinsurance recoverables and receivables. The CECL model did not impact the Groups investment portfolio, which is measured at fair value. However, ASC 326 replaced the OTTI model with an impairment allowance model, subject to reversal, for available-for-sale investments.
As a result of adopting ASC 326, the Group established allowances for credit losses related to its available-for-sale investments of $1.1 million and $2.2 million in 2022 and 2021 respectively. See note 4, Investments for further information.
In addition, the Group established allowances for credit losses related to unpaid reinsurance recoverables of $1.0 million in 2022 and $0.5 million in 2021. See note 13, Reinsurance and Retrocessional Reinsurance for further information.
In March 2020 ASU 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting, was issued. This ASU provides optional expedients and exceptions for applying GAAP to investments, derivatives, or other transactions that reference the London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued because of reference rate reform. Along with the optional expedients, the amendments include a general principle that permits an entity to consider contract modifications due to reference reform to be an event that does not require contract re-measurement at the modification date or reassessment of a previous accounting determination. This standard was effective immediately and may be elected over time through December 31, 2024 as reference rate reform activities occur. The guidance did not have a material effect on the Groups consolidated financial statements.
Accounting Standards not yet adopted
In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which becomes effective for the Group
F-50
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
during the first quarter of 2023. ASU No. 2021-08 requires contract assets and liabilities accounted for under FASB ASC 606, Revenue from Contracts with Customers, to be recorded at the acquisition date as if the acquirer entered into those contracts itself on the contract inception dates, rather than at fair value. At adoption, ASU No. 2021-08 will not impact the Groups financial position, results of operations or cash flows, but prospectively, this ASU may impact amounts recorded by the Group for assets acquired and liabilities assumed under certain acquisitions.
3. | Segments |
The chief operating decision maker reviews the Groups ongoing underwriting operations across three operating segments: Specialty, Bespoke, and Reinsurance. In determining how to allocate resources and assess the performance of the Groups underwriting results, management considers many factors including the nature of the insurance product offered, the risks that are covered and the nature of the client.
Each operating segment has a dedicated Chief Underwriting Officer that is responsible for managing the portfolio of risks within their own segment.
Bespoke business is highly specialized in nature providing customized risk solutions for clients which includes Credit & Political Risk and other specific risk transfer opportunities. Bespoke business includes the majority of Fidelis delegated business with third party MGAs.
The Specialty segment comprises a specialized portfolio of niche risks that includes Aviation and Aerospace, Energy, Marine, Property Direct & Facultative (D&F) business and other specialty risks
The Reinsurance segment comprises a highly focused property catastrophe book which includes Property Reinsurance, Retrocession and Whole Account reinsurance. The Reinsurance segment relies on broker relationships for distribution which is typical for this business.
Loss reserves and loss developments triangles are identified and disclosed by Segment and are set out in note 12, Reserves for Losses and Loss Adjustment Expenses. Assets are not allocated to segments, nor are general and administrative expenses allocated between segments as employees, including underwriters, may work across different segments.
F-51
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
a) The following tables summarize the Groups segment disclosures
Year ended December 31, 2022 | ||||||||||||||||||||
Bespoke | Specialty | Reinsurance | Other | Total | ||||||||||||||||
Gross premium written |
$ | 783.2 | 1,610.7 | 606.2 | | 3,000.1 | ||||||||||||||
Net premium written |
561.7 | 1,060.8 | 240.1 | | 1,862.6 | |||||||||||||||
Net premium earned |
379.4 | 852.8 | 272.5 | | 1,504.7 | |||||||||||||||
Losses and loss adjustment expenses |
(118.9 | ) | (508.7 | ) | (202.6 | ) | | (830.2 | ) | |||||||||||
Policy acquisition expenses |
(141.2 | ) | (219.5 | ) | (87.0 | ) | | (447.7 | ) | |||||||||||
General and administrative expenses |
| | | (106.4 | ) | (106.4 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Underwriting income/(loss) |
$ | 119.3 | 124.6 | (17.1 | ) | (106.4 | ) | 120.4 | ||||||||||||
Net investment income |
40.7 | |||||||||||||||||||
Net investment losses |
(33.7 | ) | ||||||||||||||||||
Other income |
1.9 | |||||||||||||||||||
Corporate and other expenses |
(20.5 | ) | ||||||||||||||||||
Net foreign exchange gains |
6.8 | |||||||||||||||||||
Financing costs |
(35.5 | ) | ||||||||||||||||||
|
|
|||||||||||||||||||
Net income before taxes |
80.1 | |||||||||||||||||||
|
|
|||||||||||||||||||
Income tax expense |
(17.8 | ) | ||||||||||||||||||
|
|
|||||||||||||||||||
Net income |
62.3 | |||||||||||||||||||
|
|
|||||||||||||||||||
Net income attributable to non-controlling interests |
(9.7 | ) | ||||||||||||||||||
|
|
|||||||||||||||||||
Net income available to common shareholders |
52.6 | |||||||||||||||||||
|
|
|||||||||||||||||||
Losses and loss adjustment expenses incurred - current year |
$ | (147.8 | ) | (519.7 | ) | (184.8 | ) | (852.3 | ) | |||||||||||
Losses and loss adjustment expenses incurred - prior accident years |
$ | 28.9 | 11.0 | (17.8 | ) | 22.1 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Losses and loss adjustment expenses incurred - total |
$ | (118.9 | ) | (508.7 | ) | (202.6 | ) | (830.2 | ) | |||||||||||
Loss ratio - current year |
38.9 | % | 61.0 | % | 67.8 | % | 56.7 | % | ||||||||||||
Loss ratio - prior accident years |
(7.6 | %) | (1.3 | %) | 6.5 | % | (1.5 | %) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Loss ratio - total(1) |
31.3 | % | 59.7 | % | 74.3 | % | 55.2 | % | ||||||||||||
Policy acquisition expense ratio(2) |
37.2 | % | 25.7 | % | 31.9 | % | 29.8 | % | ||||||||||||
Underwriting ratio(3) |
68.5 | % | 85.4 | % | 106.2 | % | 85.0 | % | ||||||||||||
General & administrative expense ratio(4) |
7.1 | % | ||||||||||||||||||
|
|
|||||||||||||||||||
Combined ratio(5) |
92.1 | % | ||||||||||||||||||
|
|
(1) | Loss ratio: is a measure of the losses that have been incurred by the business compared to the premiums that have been recorded to cover those losses and is expressed as a percentage of the losses and loss adjustment expenses divided by earned premiums, net of reinsurance. Current year loss ratio includes losses incurred in the current accident year, whilst prior accident years loss ratio considers how losses incurred in prior years have developed |
(2) | Policy acquisition expense ratio: is a measure of the extent of the commissions that are paid to brokers and delegated underwriters that source the business on the Groups behalf and is expressed as a percentage of these commissions divided by earned premiums all net of reinsurance |
(3) | Underwriting ratio: is a measure of the underwriting performance and is expressed as a percentage of the losses and loss adjustment expenses plus the commissions that are paid to brokers and delegated underwriters that source the business on our behalf divided by earned premiums, net of reinsurance |
F-52
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
(4) | General and administrative expense ratio: is a measure of the extent of the general and administrative expenses that are incurred to run the business and is expressed as a percentage of these expenses divided by earned premiums net of reinsurance. Commission income earned on business ceded to third party reinsurers is recorded within general and administrative expenses. |
(5) | Combined ratio: is a measure of our underwriting profitability and is expressed as the sum of the loss ratio, policy acquisition expense ratio and the general and administrative expense ratio |
Year ended December 31, 2021 | ||||||||||||||||||||
Bespoke | Specialty | Reinsurance | Other | Total | ||||||||||||||||
Gross premium written |
$ | 588.0 | 1,115.2 | 1,084.5 | | 2,787.7 | ||||||||||||||
Net premium written |
434.6 | 758.2 | 408.3 | | 1,601.1 | |||||||||||||||
Net premium earned |
251.9 | 535.3 | 367.0 | | 1,154.2 | |||||||||||||||
Losses and loss adjustment expenses |
(71.4 | ) | (206.2 | ) | (419.2 | ) | | (696.8 | ) | |||||||||||
Policy acquisition expenses |
(84.6 | ) | (127.3 | ) | (88.0 | ) | | (299.9 | ) | |||||||||||
General and administrative expenses |
| | | (75.4 | ) | (75.4 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Underwriting income/(loss) |
$ | 95.9 | 201.8 | (140.2 | ) | (75.4 | ) | 82.1 | ||||||||||||
Net investment income |
20.6 | |||||||||||||||||||
Net investment gains |
13.5 | |||||||||||||||||||
Other income |
1.0 | |||||||||||||||||||
Corporate and other expenses |
(2.7 | ) | ||||||||||||||||||
Net foreign exchange losses |
(0.4 | ) | ||||||||||||||||||
Financing costs |
(35.4 | ) | ||||||||||||||||||
|
|
|||||||||||||||||||
Net income before taxes |
78.7 | |||||||||||||||||||
|
|
|||||||||||||||||||
Income tax expense |
(0.4 | ) | ||||||||||||||||||
|
|
|||||||||||||||||||
Net income |
78.3 | |||||||||||||||||||
|
|
|||||||||||||||||||
Net income attributable to non-controlling interests |
(10.0 | ) | ||||||||||||||||||
|
|
|||||||||||||||||||
Net income available to common shareholders |
68.3 | |||||||||||||||||||
|
|
|||||||||||||||||||
Losses and loss adjustment expenses incurred - current year |
$ | (92.6 | ) | (224.2 | ) | (389.6 | ) | (706.4 | ) | |||||||||||
Losses and loss adjustment expenses incurred - prior accident years |
21.2 | 18.0 | (29.6 | ) | 9.6 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Losses and loss adjustment expenses incurred - total |
$ | (71.4 | ) | (206.2 | ) | (419.2 | ) | (696.8 | ) | |||||||||||
Loss ratio - current year |
36.7 | % | 41.9 | % | 106.1 | % | 61.2 | % | ||||||||||||
Loss ratio - prior accident years |
(8.4 | %) | (3.4 | %) | 8.1 | % | (0.8 | %) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Loss ratio - total(1) |
28.3 | % | 38.5 | % | 114.2 | % | 60.4 | % | ||||||||||||
Policy acquisition expense ratio(2) |
33.6 | % | 23.8 | % | 24.0 | % | 26.0 | % | ||||||||||||
Underwriting ratio(3) |
61.9 | % | 62.3 | % | 138.2 | % | 86.4 | % | ||||||||||||
General & administrative expense ratio(4) |
6.5 | % | ||||||||||||||||||
|
|
|||||||||||||||||||
Combined ratio(5) |
92.9 | % | ||||||||||||||||||
|
|
(1) | Loss ratio: is a measure of the losses that have been incurred by the business compared to the premiums that have been recorded to cover those losses and is expressed as a percentage of the losses and loss adjustment expenses divided by earned premiums, net of reinsurance. Current year loss ratio includes losses incurred in the current accident year, whilst prior accident years loss ratio considers how losses incurred in prior years have developed |
F-53
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
(2) | Policy acquisition expense ratio: is a measure of the extent of the commissions that are paid to brokers and delegated underwriters that source the business on the Groups behalf and is expressed as a percentage of these commissions divided by earned premiums, net of reinsurance |
(3) | Underwriting ratio: is a measure of the underwriting performance and is expressed as a percentage of the losses and loss adjustment expenses plus the commissions that are paid to brokers and delegated underwriters that source the business on our behalf divided by earned premiums, net of reinsurance |
(4) | General and administrative expense ratio: is a measure of the extent of the general and administrative expenses that are incurred to run the business and is expressed as a percentage of these expenses divided by earned premiums net of reinsurance. Commission income earned on business ceded to third party reinsurers is recorded within general and administrative expenses. |
(5) | Combined ratio: is a measure of our underwriting profitability and is expressed as the sum of the loss ratio, policy acquisition expense ratio and the general and administrative expense ratio |
Year ended December 31, 2020 | ||||||||||||||||||||
Bespoke | Specialty | Reinsurance | Other | Total | ||||||||||||||||
Gross premium written |
$ | 339.1 | 577.9 | 659.5 | | 1,576.5 | ||||||||||||||
Net premium written |
251.2 | 403.1 | 251.3 | | 905.6 | |||||||||||||||
Net premium earned |
212.5 | 171.7 | 344.4 | | 728.6 | |||||||||||||||
Losses and loss adjustment expenses |
(70.5 | ) | (64.8 | ) | (189.2 | ) | | (324.5 | ) | |||||||||||
Policy acquisition expenses |
(66.8 | ) | (36.5 | ) | (75.9 | ) | | (179.2 | ) | |||||||||||
General and administrative expenses |
| | | (83.5 | ) | (83.5 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Underwriting income/(loss) |
$ | 75.2 | 70.4 | 79.3 | (83.5 | ) | 141.4 | |||||||||||||
Net investment income |
26.2 | |||||||||||||||||||
Net investment losses |
17.9 | |||||||||||||||||||
Other income |
8.7 | |||||||||||||||||||
Corporate and other expenses |
(18.7 | ) | ||||||||||||||||||
Net foreign exchange gains |
1.2 | |||||||||||||||||||
Financing costs |
(27.9 | ) | ||||||||||||||||||
Loss on extinguishment of preference securities |
(25.3 | ) | ||||||||||||||||||
|
|
|||||||||||||||||||
Net income before taxes |
123.5 | |||||||||||||||||||
|
|
|||||||||||||||||||
Income tax benefit |
3.1 | |||||||||||||||||||
|
|
|||||||||||||||||||
Net income |
126.6 | |||||||||||||||||||
|
|
|||||||||||||||||||
Net income attributable to non-controlling interests |
(0.1 | ) | ||||||||||||||||||
|
|
|||||||||||||||||||
Net income available to common shareholders |
126.5 | |||||||||||||||||||
|
|
|||||||||||||||||||
Losses and loss adjustment expenses incurred - current year |
$ | (90.5 | ) | (73.4 | ) | (199.0 | ) | (362.9 | ) | |||||||||||
Losses and loss adjustment expenses incurred - prior accident years |
$ | 20.0 | 8.6 | 9.8 | 38.4 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Losses and loss adjustment expenses incurred - total |
$ | (70.5 | ) | (64.8 | ) | (189.2 | ) | (324.5 | ) | |||||||||||
Loss ratio - current year |
42.6 | % | 42.7 | % | 57.7 | % | 49.8 | % | ||||||||||||
Loss ratio - prior accident years |
(9.4 | %) | (5.0 | %) | (2.8 | %) | (5.3 | %) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Loss ratio - total(1) |
33.2 | % | 37.7 | % | 54.9 | % | 44.5 | % | ||||||||||||
Policy acquisition expense ratio(2) |
31.4 | % | 21.3 | % | 22.0 | % | 24.6 | % | ||||||||||||
Underwriting ratio(3) |
64.6 | % | 59.0 | % | 76.9 | % | 69.1 | % | ||||||||||||
General & administrative expense ratio(4) |
11.5 | % | ||||||||||||||||||
|
|
|||||||||||||||||||
Combined ratio(5) |
80.6 | % | ||||||||||||||||||
|
|
F-54
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
(1) | Loss ratio: is a measure of the losses that have been incurred by the business compared to the premiums that have been recorded to cover those losses and is expressed as a percentage of the losses and loss adjustment expenses divided by earned premiums, net of reinsurance. Current year loss ratio includes losses incurred in the current accident year, whilst prior accident years loss ratio considers how losses incurred in prior years have developed |
(2) | Policy acquisition expense ratio: is a measure of the extent of the commissions that are paid to brokers and delegated underwriters that source the business on the Groups behalf and is expressed as a percentage of these commissions divided by earned premiums, net of reinsurance |
(3) | Underwriting ratio: is a measure of the underwriting performance and is expressed as a percentage of the losses and loss adjustment expenses plus the commissions that are paid to brokers and delegated underwriters that source the business on our behalf divided by earned premiums, net of reinsurance |
(4) | General and administrative expense ratio: is a measure of the extent of the general and administrative expenses that are incurred to run the business and is expressed as a percentage of these expenses divided by earned premiums net of reinsurance. Commission income earned on business ceded to third party reinsurers is recorded within general and administrative expenses. |
(5) | Combined ratio: is a measure of our underwriting profitability and is expressed as the sum of the loss ratio, policy acquisition expense ratio and the general and administrative expense ratio |
b) The following table summarizes net earned premiums by major product grouping within each underwriting segment.
For the year ended December 31, | ||||||||||||
2022 | 2021 | 2020 | ||||||||||
Bespoke |
||||||||||||
Credit & Political Risk |
$ | 137.8 | 103.0 | 98.0 | ||||||||
Bespoke Other |
241.6 | 148.9 | 114.5 | |||||||||
|
|
|
|
|
|
|||||||
Total Bespoke |
$ | 379.4 | $ | 251.9 | $ | 212.5 | ||||||
|
|
|
|
|
|
|||||||
Specialty |
||||||||||||
Aviation and Aerospace |
$ | 155.6 | 108.5 | 45.7 | ||||||||
Energy |
38.4 | 24.4 | 15.3 | |||||||||
Marine |
284.4 | 99.8 | 34.3 | |||||||||
Property |
11.6 | 13.8 | 11.0 | |||||||||
Property D&F |
352.8 | 278.9 | 62.8 | |||||||||
Specialty Other |
10.0 | 9.9 | 2.6 | |||||||||
|
|
|
|
|
|
|||||||
Total Specialty |
$ | 852.8 | $ | 535.3 | $ | 171.7 | ||||||
|
|
|
|
|
|
|||||||
Reinsurance |
||||||||||||
Property Reinsurance |
$ | 246.0 | 330.8 | 311.6 | ||||||||
Retrocession |
17.5 | 27.3 | 28.4 | |||||||||
Whole Account |
9.0 | 8.9 | 4.4 | |||||||||
|
|
|
|
|
|
|||||||
Total Reinsurance |
$ | 272.5 | $ | 367.0 | $ | 344.4 | ||||||
|
|
|
|
|
|
c) The following table presents gross premiums written by the geographical location of the Groups subsidiaries
For the year ended December 31, | ||||||||||||
2022 | 2021 | 2020 | ||||||||||
Bermuda |
$ | 707.6 | $ | 1,147.5 | $ | 662.4 | ||||||
United Kingdom |
1,745.7 | 1,288.4 | 729.4 | |||||||||
Republic of Ireland |
546.8 | 351.8 | 184.7 | |||||||||
|
|
|
|
|
|
|||||||
Total |
$ | 3,000.1 | $ | 2,787.7 | $ | 1,576.5 | ||||||
|
|
|
|
|
|
F-55
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
The information presented above is after allocation of consolidation adjustments. Amounts relating to intergroup reinsurance are not included in the above table.
4. | Investments |
At December 31, 2022, the Groups investments are managed by external investment managers through individual investment management agreements. The Group monitors activity and performance of the external managers on an ongoing basis.
a. | Fixed maturity securities |
The following table summarizes the fair value of fixed maturity investments managed by external investment managers:
At December 31, 2022 | ||||||||||||||||
Amortized Cost | Unrealized gains |
Unrealized losses |
Fair value |
|||||||||||||
Available-for-sale |
||||||||||||||||
US. Treasuries |
$ | 643.1 | $ | | $ | (27.3 | ) | $ | 615.8 | |||||||
Agencies |
17.5 | | (0.4 | ) | 17.1 | |||||||||||
Non-U.S. government |
115.2 | | (4.3 | ) | 110.9 | |||||||||||
Corporate bonds |
1,078.9 | | (58.6 | ) | 1,020.3 | |||||||||||
Residential mortgage-backed |
88.6 | | (8.9 | ) | 79.7 | |||||||||||
Commercial mortgage-backed |
8.0 | | (1.2 | ) | 6.8 | |||||||||||
Other asset backed securities |
209.5 | | (9.2 | ) | 200.3 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, available-for-sale |
$ | 2,160.8 | $ | | $ | (109.9 | ) | $ | 2,050.9 | |||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities |
$ | 2,160.8 | $ | | $ | (109.9 | ) | $ | 2,050.9 | |||||||
|
|
|
|
|
|
|
|
At December 31, 2021 | ||||||||||||||||
Amortized Cost | Unrealized gains |
Unrealized losses |
Fair value |
|||||||||||||
Trading |
||||||||||||||||
Corporate bonds |
$ | 13.6 | $ | 0.1 | $ | | $ | 13.7 | ||||||||
Residential mortgage-backed |
4.8 | 0.1 | | 4.9 | ||||||||||||
Other asset backed securities |
8.3 | | | 8.3 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, trading |
$ | 26.7 | $ | 0.2 | $ | | $ | 26.9 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Available-for-sale |
||||||||||||||||
US. Treasuries |
$ | 732.8 | 2.5 | (4.5 | ) | 730.8 | ||||||||||
Agencies |
28.0 | | (0.1 | ) | 27.9 | |||||||||||
Non-U.S. government |
140.3 | 0.6 | (0.8 | ) | 140.1 | |||||||||||
Corporate bonds |
1,276.8 | 2.8 | (12.2 | ) | 1,267.4 | |||||||||||
Residential mortgage-backed |
56.3 | 0.2 | (1.4 | ) | 55.1 | |||||||||||
Commercial mortgage-backed |
57.3 | | (0.8 | ) | 56.5 | |||||||||||
Other asset backed securities |
214.1 | 0.2 | (1.0 | ) | 213.3 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, available-for-sale |
$ | 2,505.6 | $ | 6.3 | $ | (20.8 | ) | $ | 2,491.1 | |||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities |
$ | 2,532.3 | $ | 6.5 | $ | (20.8 | ) | $ | 2,518.0 | |||||||
|
|
|
|
|
|
|
|
F-56
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Review of the fixed maturity securities is performed on a regular basis to consider concentration, credit quality and compliance with established guidelines. For individual fixed income securities, nationally recognized statistical rating organizations (NRSROs) are used and the lower of two or middle of three ratings is taken. The composition of the fair values of fixed income securities by credit rating is as follows:
2022 | 2021 | |||||||||||||||
Trading | Fair Value | % | Fair Value | % | ||||||||||||
AAA |
$ | | | % | $ | 14.4 | 54 | % | ||||||||
AA |
| | % | 1.6 | 6 | % | ||||||||||
A |
| | % | 8.4 | 31 | % | ||||||||||
BBB |
| | % | 2.5 | 9 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, trading |
$ | | | % | $ | 26.9 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
2022 | 2021 | |||||||||||||||
Available-for-sale | Fair Value | % | Fair Value | % | ||||||||||||
AAA |
$ | 915.1 | 45 | % | $ | 1,100.2 | 44 | % | ||||||||
AA |
150.2 | 7 | % | 184.3 | 7 | % | ||||||||||
A |
703.1 | 34 | % | 858.9 | 35 | % | ||||||||||
BBB |
282.5 | 14 | % | 346.7 | 14 | % | ||||||||||
BB |
| | % | 1.0 | | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, available-for-sale |
$ | 2,050.9 | 100 | % | $ | 2,491.1 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
The contractual maturities for fixed maturity securities are listed in the following table:
2022 | 2021 | |||||||||||||||
Trading | Amortized Cost | Fair Value | Amortized Cost | Fair Value | ||||||||||||
Due in one year or less |
$ | | $ | | $ | 20.2 | $ | 20.3 | ||||||||
Due after one year through five years |
| | 0.1 | 0.1 | ||||||||||||
Due after five years through ten years |
| | | | ||||||||||||
Due after ten years |
| | 6.4 | 6.5 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, trading |
$ | | $ | | $ | 26.7 | $ | 26.9 | ||||||||
|
|
|
|
|
|
|
|
2022 | 2021 | |||||||||||||||
Available-for-sale | Amortized Cost | Fair Value | Amortized Cost | Fair Value | ||||||||||||
Due in one year or less |
$ | 701.7 | $ | 688.1 | $ | 191.3 | $ | 192.0 | ||||||||
Due after one year through five years |
1,236.8 | 1,156.9 | 2,067.6 | 2,055.0 | ||||||||||||
Due after five years through ten years |
94.8 | 90.6 | 102.5 | 102.3 | ||||||||||||
Due after ten years |
126.7 | 115.3 | 144.1 | 141.8 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed maturity securities, available-for-sale |
$ | 2,160.0 | $ | 2,050.9 | $ | 2,505.5 | $ | 2,491.1 | ||||||||
|
|
|
|
|
|
|
|
Expected maturities may differ from contractual maturities as borrowers may have the right to call or repay obligations with or without call or prepayment penalties. Additionally, lenders may have the right to put the securities back to the borrower.
F-57
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
b. | Short-term investments |
The following investments were included in short-term investments managed by external investment managers and are classified as available-for-sale:
At December 31, 2022 | ||||||||||||||||
Available-for-sale | Amortized Cost | Unrealized gains |
Unrealized losses |
Fair value |
||||||||||||
U.S. Treasuries |
$ | 228.4 | $ | 0.1 | $ | | $ | 228.5 | ||||||||
Non-U.S. government |
23.2 | | (0.1 | ) | 23.1 | |||||||||||
Corporate bonds |
5.4 | | | 5.4 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments |
$ | 257.0 | $ | 0.1 | $ | (0.1 | ) | $ | 257.0 | |||||||
|
|
|
|
|
|
|
|
At December 31, 2021 | ||||||||||||||||
Available-for-sale | Amortized Cost | Unrealized gains |
Unrealized losses |
Fair value |
||||||||||||
U.S. Treasuries |
$ | 8.9 | $ | | $ | | $ | 8.9 | ||||||||
Corporate bonds |
2.6 | | | 2.6 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments |
$ | 11.5 | $ | | $ | | $ | 11.5 | ||||||||
|
|
|
|
|
|
|
|
The composition of the fair values of short-term investments by credit rating is as follows:
2022 | 2021 | |||||||||||||||
Available-for-sale | Fair Value | % | Fair Value | % | ||||||||||||
AAA |
$ | 251.6 | 98 | % | $ | 8.9 | 77 | % | ||||||||
AA |
4.4 | 2 | % | | | % | ||||||||||
A |
1.0 | | % | | | % | ||||||||||
BBB |
| | % | 2.6 | 23 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term fixed maturity securities, available-for-sale |
$ | 257.0 | 100 | % | $ | 11.5 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
F-58
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
c. | Allowances for Expected Credit LossesAvailable-for-sale |
The following table provides a roll forward of the allowance for expected credit losses of the Groups securities classified as available-for-sale:
Book Value | Unrealized Gain |
Unrealized Loss |
Market Value | Loss allowance |
||||||||||||||||
Year ended December 31, 2022 |
||||||||||||||||||||
Balance at beginning of year |
$ | 2,517.1 | $ | 6.3 | $ | (20.8 | ) | $ | 2,502.6 | $ | (2.2 | ) | ||||||||
Change in year |
(99.3 | ) | (6.2 | ) | (89.2 | ) | (194.7 | ) | 1.1 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at end of year |
$ | 2,417.8 | $ | 0.1 | $ | (110.0 | ) | $ | 2,307.9 | $ | (1.1 | ) |
Book Value | Unrealized Gain |
Unrealized Loss |
Market Value | Loss allowance |
||||||||||||||||
Year ended December 31, 2021 |
||||||||||||||||||||
Balance at beginning of year |
$ | 1,530.1 | $ | 23.9 | $ | (0.5 | ) | $ | 1,553.5 | $ | (0.4 | ) | ||||||||
Change in year |
987.0 | (17.6 | ) | (20.3 | ) | 949.1 | (1.8 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at end of year |
$ | 2,517.1 | $ | 6.3 | $ | (20.8 | ) | $ | 2,502.6 | $ | (2.2 | ) |
The Group assesses each quarter whether the decline in the fair value of an available-for-sale investment below its amortized cost is the result of a credit loss. All available-for-sale securities with unrealized losses are reviewed. The Group considers many factors to determine whether a credit loss exists, including the extent to which fair value is below cost, the implied yield to maturity, rating downgrades of the security and whether or not the issuer has failed to make scheduled principal or interest payments. The Group also takes into consideration information about the financial condition of the issuer and industry factors that could negatively impact the capital markets.
If the decline in fair value of an available-for-sale security below its amortized cost is considered to be the result of a credit loss, the Group compares the estimated present value of the cash flows expected to be collected to the amortized cost of the security. The extent to which the estimated present value of the cash flows expected to be collected is less than the amortized cost of the security represents the expected credit loss, which is recorded as an allowance and recognized in net income. The allowance is limited to the difference between the fair value and the amortized cost of the security. The Group recognized a $1.1 million reduction to credit related impairments in 2022 (2021: $1.8 million increase).
d. | Other investments, at fair value |
At December 31, 2022, other investments consisted of a residual balance invested in a credit hedge fund managed by York Capital Management (York), equity and commodity linked structured notes, and an opportunistic fixed income UCITS fund managed by Wellington Investment Management (Wellington).
2022 | 2021 | |||||||||||||||
Other investments | Fair Value | % | Fair Value | % | ||||||||||||
York Funds |
$ | 0.9 | 1 | % | $ | 0.9 | | % | ||||||||
Equity and Commodity structured notes |
72.8 | 62 | % | 85.2 | 34 | % | ||||||||||
Equity Index structured notes |
| | % | 118.0 | 47 | % | ||||||||||
Wellington Funds |
43.4 | 37 | % | 49.0 | 19 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other investments at fair value |
$ | 117.1 | 100 | % | $ | 253.1 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
F-59
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
At the end of 2019 York suspended redemptions in its credit hedge fund while the underlying assets of the fund are liquidated and proceeds distributed to investors. The fair value of the residual investment in York at December 31, 2022 was $0.9 million (cost: $1.3 million) compared to a prior year fair value of $0.9 million (cost: $1.3 million) at December 31, 2021. The Group has recorded its investment in the York Fund at reported net asset value. There are currently no outstanding commitments to the York Fund. During 2022, the Group received $0.2 million (2021: $1.3 million) of distributions from York.
In 2020 the Group invested $100.0 million in two tranches of a two-year, S&P500 index linked structured note (S&P500 note). During 2022 both tranches of the S&P500 note redeemed at the maximum potential redemption value of $118.0 million. The fair value of the S&P500 note at December 31, 2021 was $118.0 million.
In 2021 the Group invested $75.2 million into a blended equity market linked structured note and four commodity linked structured notes (equity and commodity notes). All five structured notes were initially invested for a two-year term. At December 31, 2021 the equity and commodity notes had a fair market value of $85.2 million.
In 2022 the Group increased the total funds invested in the equity and commodity notes to $100.0 million and the notes were restructured. The blended equity market linked note (performance is based on the weighted performance of the S&P500, Eurostoxx600, Topix and Infrastructure equities) was restructured to include a hard buffer (negative protection) of 10.0% while the potential upside return was capped at 10.5%. The four commodity linked structured notes (linked to the spot price of industrial metals) were combined into one note and the note was also restructured to include a hard buffer (negative protection) of 10.0% while the potential upside return was capped at 22.0%. The remaining term for both notes after restructure was one year as the ultimate redemption date was kept consistent with the redemption date of the original equity and commodity notes. In October 2022, the Group exited the commodity linked note for proceeds of $20.8 million (cost $25.0 million). At December 31, 2022 the fair value of the equity market linked structured note was $72.8 million (cost $75.0 million). The equity market linked note will redeem in February 2023. The Group has recorded these investment at fair value using the income valuation approach.
In 2021 the Group invested $50.0 million in Wellington. The fair value of the investment at December 31, 2022 was $43.4 million compared to the prior year fair value of $49.0 million at December 31, 2021. The Group has recorded this investment at reported net asset value.
F-60
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
e. | Net Investment Income and Net Realized Gains |
The components of net investment return are as follows:
2022 | 2021 | 2020 | ||||||||||
Net interest and dividend income |
$ | 44.0 | $ | 24.0 | $ | 28.1 | ||||||
Investment expenses |
(3.3 | ) | (3.4 | ) | (1.9 | ) | ||||||
Net investment Income |
40.7 | 20.6 | 26.2 | |||||||||
Net realized gains on fixed maturity securities, trading |
| 0.9 | 0.1 | |||||||||
Net realized (losses)/gains on fixed maturity securities, available for sale |
(2.5 | ) | 1.2 | 3.6 | ||||||||
Net realized (losses)/gains on other investments |
27.6 | (1.5 | ) | (0.2 | ) | |||||||
Net realized (losses)/gains on derivatives |
(20.3 | ) | 1.0 | 2.3 | ||||||||
Change in net unrealized (losses)/gains on fixed maturity securities, trading |
(0.5 | ) | (1.1 | ) | 1.0 | |||||||
Change in net unrealized (losses)/gains on other investments |
(39.8 | ) | 15.7 | 11.3 | ||||||||
Change in net unrealized (losses)/gains on derivatives |
0.7 | (0.9 | ) | 0.2 | ||||||||
Provision for expected credit losses |
1.1 | (1.8 | ) | (0.4 | ) | |||||||
|
|
|
|
|
|
|||||||
Net investment (losses)/gains |
(33.7 | ) | 13.5 | 17.9 | ||||||||
|
|
|
|
|
|
|||||||
Net investment return |
$ | 7.0 | $ | 34.1 | $ | 44.1 | ||||||
|
|
|
|
|
|
5. | Fair Value Measurements |
FASB ASC 820-10, Fair Value Measurements and Disclosures, defines fair value, establishes a consistent framework for measuring fair value and requires disclosures about fair value measurements. The standard requires the Group to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
Fair value hierarchy
FASB ASC 820-10 specifies a hierarchy of inputs based on whether the inputs are observable or unobservable. Observable inputs are developed using market data and reflect market participant assumptions, while unobservable inputs reflect the Groups market assumptions. The fair value hierarchy is as follows:
| Level 1: Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities traded in active markets. The fair value is determined by multiplying the quoted price by the quantity held by the Group. |
| Level 2: Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices (e.g. interest rates, yield curves, prepayment spreads, default rate, etc.) for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability or can be corroborated by observable market data. |
| Level 3: Inputs to the valuation methodology are unobservable for the asset or liability and are significant to the fair value measurement. Significant management assumptions can be used to establish managements best estimate of the assumptions used by other market participants in determining the fair value of the asset or liability. |
As required under the fair value hierarchy, the Group considers relevant and observable market inputs in its valuations where possible. The frequency of transactions, the size of the bid-ask spread and the amount of
F-61
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
adjustment necessary when comparing similar transactions are all factors in determining the liquidity of markets and the relevance of observable prices in those markets.
The Groups policy with respect to transfer between levels of the fair value hierarchy is to recognize transfers into and out of each level as of the end of the reporting period.
Determination of fair value
The following section describes the valuation methodologies used by the Group to measure assets and liabilities at fair value, including an indication of the level within the fair value hierarchy in which each asset or liability is generally classified.
Fixed maturity securities
The Groups fixed maturity income securities portfolio is managed by external investment managers with oversight from the Groups Chief Investment Officer, the Groups Chief Financial Officer, and the Groups Board of Directors. Fair values for all securities in the fixed income investments portfolio are independently provided by the investment administrator, investment custodians, and investment managers, each of which utilize internationally recognized independent pricing services. Refinitiv Limited (Refinitiv) is the main pricing service utilized to estimate the fair value measurements for the Groups fixed income securities for asset backed fixed income securities, and corporate and government bonds.
For determining the fair value of securities that are not actively traded, in general, pricing services use matrix pricing in which the independent pricing service uses observable market inputs including, but not limited to, reported trades, benchmark yields, broker-dealer quotes, interest rates, prepayment spreads, default rates and such other inputs as are available from market sources to determine a reasonable fair value.
The following describes the techniques generally used to determine the fair value of the Groups fixed maturity securities by asset class.
| U.S. Treasuries are bonds issued by the U.S. government. The significant inputs used to determine the fair value of these securities are based on quoted prices in active markets for identical assets and are therefore classified within Level 1. |
| Agency securities consists of securities issued by U.S. and non-U.S. government sponsored agencies such as the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, government development banks and other agencies which are not mortgage pass-through. The fair values of these securities are classified as Level 2. |
| Non-U.S. government securities consist of bonds issued by non-U.S. governments and supranationals. The significant inputs used to determine the fair value of these securities include the spread above the risk-free yield curve, reported trades and broker-dealer quotes. These are considered to be observable market inputs and, therefore, the fair values of these securities are classified within Level 2. |
| Corporate bonds consist primarily of investment-grade debt of a wide variety of corporate issuers and industries. When available, significant inputs are used to determine the fair value of these securities and are based on quoted prices in active markets for similar assets. When not available, the fair values of these securities are determined using the spread above the risk-free yield curve, reported trades, broker-dealer quotes, benchmark yields, and industry and market indicators. The fair values of these securities are classified as Level 2. |
F-62
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
| Residential mortgage-backed securities includes agency mortgage-backed securities and agency collateralised mortgage obligations. These are individually evaluated using option adjusted spreads OAS and nominal spreads. The OAS valuations use a third-party prepayment model and OAS. Spreads are based upon tranche type and average life volatility. These spreads are gathered from dealer quotes, trade prices, and the new issue market. The fair values of these securities are classified as Level 2. |
| Commercial mortgage-backed securities consist of investment grade bonds backed by pools of loans with underlying collateral. Securities held in this sector are primarily priced by pricing services. Inputs to the valuation process include broker-dealer quotes and other available trade information, prepayment speeds, current price data, the swap curve as well as cash settlement. The fair values of these securities are classified as Level 2. |
| Other asset-backed securities consist of investment grade bonds backed by pools of loans with underlying collateral. The underlying collateral for asset-backed securities consists mainly of student loans, automobile loans and credit card receivables. These securities are primarily priced by index providers and pricing vendors. Inputs to the valuation process include broker-dealer quotes and other available trade information, prepayment speeds, tranche type, interest rate data and credit spreads. The Company classifies these securities within Level 2. |
Short-term investments
The Groups short-term investments consist of commercial paper and bonds with maturities of 90 days or greater but less than one year at the time of purchase. The significant inputs used to determine the fair value of these securities include the spread above the risk-free yield curve, reported trades and broker-dealer quotes. These are considered to be observable market inputs and, therefore, the fair values of these securities are classified within Level 1 and Level 2.
Derivative assets and liabilities
Exchange-traded derivatives, measured at fair value using quoted prices in active markets, where available are classified as Level 1 of the fair value hierarchy.
Derivatives without quoted prices in an active market and derivatives executed over the counter are valued using internal valuations techniques that consider the time value of money, volatility, the current market and contractual prices of underlying financial instruments. These derivative instruments are classified as either Level 2 or Level 3 depending upon the observability of the significant inputs to the model. The valuation techniques and key inputs depend on the type of derivative and the nature of the underlying instrument.
Other investments
The Group values its investment in the residual hedge fund at fair value, which is estimated based on the Groups share of the net asset value (NAV) as provided by the investment manager of the underlying investment fund. The Group has elected to use the practical expedient method to record the fair value of the investment at net asset value and has therefore not assigned levels to these investments in the fair value hierarchy.
The Group measures the fair value of its structured notes investments using a market valuation approach which is based entirely on observable inputs. The structured notes are comprised of a package of embedded derivatives (call and put options) which will determine the notes redemption value at maturity, and a zero-coupon bond (the
F-63
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
host contract) which will mature at par. The Group has elected to account for the entire contract at fair value which is based upon a quoted price from J.P.Morgan Securities Ltd. This price is deemed to be an accurate indication of the fair market value of the structured notes for the following factors.
| J.P.Morgan Securities Ltds pricing methodology is used to make markets in similar products on an active basis |
| All inputs are observable |
| J.P.Morgans pricing is provided daily to Bloomberg to provide a an active price which is observable on a daily basis. |
The fair value of UCITS is based on unadjusted quoted market prices in active markets, therefore, the fair value of this security is classified as Level 1.
The following table presents the financial instruments measured at fair value on a recurring basis at December 31, 2022 and 2021:
At December 31,2022 | ||||||||||||||||
Assets | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Cash equivalents |
$ | 685.2 | $ | | $ | | $ | 685.2 | ||||||||
Investment pending settlement |
2.0 | | | 2.0 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Fixed income securities |
||||||||||||||||
U.S. Treasuries |
615.8 | | | 615.8 | ||||||||||||
Agencies |
| 17.1 | | 17.1 | ||||||||||||
Non-U.S.government |
| 110.9 | | 110.9 | ||||||||||||
Corporate bonds |
| 1,020.3 | | 1,020.3 | ||||||||||||
Residential mortgage-backed |
| 79.7 | | 79.7 | ||||||||||||
Commercial mortgage-backed |
| 6.8 | | 6.8 | ||||||||||||
Other asset backed securities |
| 200.3 | | 200.3 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed income securities |
$ | 615.8 | 1,435.1 | | 2,050.9 | |||||||||||
Short-term investments |
||||||||||||||||
Corporate bonds |
| 5.4 | | 5.4 | ||||||||||||
Non-U.S.government |
| 23.1 | | 23.1 | ||||||||||||
U.S. Treasuries |
228.5 | | | 228.5 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments |
$ | 228.5 | 28.5 | | 257.0 | |||||||||||
Other investments* |
43.4 | 72.8 | | 116.2 | ||||||||||||
Derivative assets |
| 6.3 | | 6.3 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Assets |
$ | 1,574.9 | $ | 1,542.7 | $ | | $ | 3,117.6 | ||||||||
|
|
|
|
|
|
|
|
* | excludes investments in the York Funds |
F-64
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
There were no transfers into or out of Level 1 and Level 2 during 2022.
At December 31,2021 | ||||||||||||||||
Assets | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Cash equivalents |
$ | 154.8 | $ | | $ | | $ | 154.8 | ||||||||
Investment pending settlement |
0.5 | | | 0.5 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Fixed income securities |
||||||||||||||||
U.S. Treasuries |
730.8 | | | 730.8 | ||||||||||||
Agencies |
| 27.9 | | 27.9 | ||||||||||||
Non-U.S.government |
| 140.1 | | 140.1 | ||||||||||||
Corporate bonds |
| 1,281.1 | | 1,281.1 | ||||||||||||
Residential mortgage-backed |
| 60.0 | | 60.0 | ||||||||||||
Commercial mortgage-backed |
| 56.5 | | 56.5 | ||||||||||||
Other asset backed securities |
| 221.6 | | 221.6 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fixed income securities |
730.8 | 1,787.2 | | 2,518.0 | ||||||||||||
Short-term investments |
||||||||||||||||
Corporate bonds |
| 2.6 | | 2.6 | ||||||||||||
U.S. Treasuries |
8.9 | | | 8.9 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments |
8.9 | 2.6 | | 11.5 | ||||||||||||
Other investments* |
49.1 | 203.1 | | 252.2 | ||||||||||||
Derivative assets |
0.1 | 0.9 | | 1.0 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Assets |
$ | 944.2 | $ | 1,993.8 | $ | | $ | 2,938.0 | ||||||||
|
|
|
|
|
|
|
|
* | excludes investments in the York Funds |
At December 31,2021 | ||||||||||||||||
Liabilities | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Derivative liabilities |
(0.8 | ) | | | (0.8 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Liabilities |
$ | (0.8 | ) | $ | | $ | | $ | (0.8 | ) | ||||||
|
|
|
|
|
|
|
|
There were no transfers into or out of Level 1 and Level 2 during 2021.
6. | Investments Pending Settlement |
The Group has receivables and payables from financials instruments sold and purchased from prime brokers and external managers which arise in the ordinary course of business. The Group is exposed to risk of loss from the inability of brokers to pay for purchases or to deliver the financial instruments pending transfer, in which case the Group would have to sell or purchase the financial instruments at prevailing market prices. Credit risk is reduced to the extent that an exchange or clearing organization acts as a counterparty to the transaction and replaces the prime broker. At December 31, 2022, the Group recognized a receivable of $2.0 million (2021: $0.5 million).
F-65
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
7. | Cash and Cash Equivalents |
2022 | 2021 | |||||||
Cash at bank |
$ | 384.8 | $ | 258.8 | ||||
Cash held with brokers/custodians |
337.9 | 62.4 | ||||||
Cash held in money market funds |
685.2 | 154.8 | ||||||
|
|
|
|
|||||
Total cash and cash equivalents |
$ | 1,407.9 | $ | 476.0 | ||||
|
|
|
|
8. | Restricted Cash and Cash Equivalents |
The Group is required to maintain certain levels of cash in segregated accounts with prime brokers and derivative counterparties. The amount of restricted cash held by derivative counterparties is cash collateral to support the current value of any amounts that may be due to the counterparty based on the value of the underlying financial instrument.
The Group also has cash in trust funds which support the insurance business written on certain lines of business with reinsurers and insurers.
The Group is also required to hold cash as collateral for credit card limits which support general business activities.
The following table presents the restricted cash and cash equivalents at December 31, 2022 and 2021:
2022 | 2021 | |||||||
Restricted cash |
$ | 0.1 | $ | 2.0 | ||||
Letters of Credit collateral |
21.2 | 27.9 | ||||||
Cash in trust funds |
164.6 | 120.9 | ||||||
Credit card collateral |
| 0.1 | ||||||
|
|
|
|
|||||
Total restricted cash and cash equivalents |
$ | 185.9 | $ | 150.9 | ||||
|
|
|
|
9. | Pledged Investments |
The Group has investments in segregated portfolios primarily to provide collateral for Letters of Credit, which support its (re)insurance business.
At December 31, 2022, $nil (2021: $11.4 million) of trading fixed maturity securities and $989.4 million (2021: $806.2 million) of available-for-sale fixed income securities were on deposit with a custodian in respect of the Groups letter of credit facilities and trust accounts.
10. | Derivative Financial Instruments |
The Group enters into derivative instruments such as futures and forward contracts primarily for duration, interest rate and foreign currency exposure management. The Groups derivative instruments are generally traded under International Swaps and Derivatives Association master agreements, which establish the terms of the transactions entered into with the Groups derivative counterparties. In the event one party becomes insolvent or otherwise defaults on its obligations, a master agreement generally permits the non-defaulting party to accelerate and terminate all outstanding transactions and net the transactions marked-to-market values so that a single sum in a single currency will be owed by, or owed to, the non-defaulting party. Effectively, this contractual close-out netting reduces credit exposure from gross to net exposure.
F-66
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
The following tables identify the listing currency, fair value and notional amounts of derivative instruments included in the Consolidated Balance Sheets, categorized by primary underlying risk. Balances are presented on a gross basis:
At December 31, 2022 |
||||||||||
Listing currency(1) |
Notional amount of underlying instruments(2) |
Fair Value of net assets on derivatives |
||||||||
Derivative assets by primary underlying risk |
||||||||||
Foreign exchange contracts |
||||||||||
Forwards(3) |
AUD/CAD/EUR/GBP/JPY | $ | (44.0 | ) | $ | 6.3 | ||||
|
|
|
|
|||||||
Total derivatives assets |
$ | (44.0 | ) | $ | 6.3 | |||||
|
|
|
|
(1) | AUD = Australian Dollar, CAD = Canadian Dollar, EUR = Euro, GBP = British pound, JPY = Japanese Yen and USD = US Dollar. |
(2) | The absolute notional exposure represents the Groups derivative activity at December 31, 2022, which is representative of the volume of derivatives held during the year. |
(3) | Contracts used to manage foreign currency risks in underwriting and non-investment operations. |
At December 31, 2021 |
||||||||||
Listing currency(1) |
Notional amount of underlying instruments(2) |
Fair Value of net assets on derivatives |
||||||||
Derivative assets by primary underlying risk |
||||||||||
Interest rate contracts |
||||||||||
Futures |
USD | $ | 1.3 | $ | 0.1 | |||||
Foreign exchange contracts |
||||||||||
Forwards(3) |
AUD/CAD/EUR/GBP/JPY | 3.5 | 0.9 | |||||||
|
|
|
|
|||||||
Total derivatives assets |
$ | 4.8 | $ | 1.0 | ||||||
|
|
|
|
At December 31, 2021 |
||||||||||
Listing currency(1) |
Notional amount of underlying instruments(2) |
Fair Value of net assets on liabilities |
||||||||
Derivative liabilities by primary underlying risk |
||||||||||
Interest rate contracts |
||||||||||
Futures |
USD | $ | 206.5 | $ | (0.7 | ) | ||||
Foreign exchange contracts |
||||||||||
Forwards(3) |
AUD/CAD/EUR/GBP/JPY | (7.0 | ) | (0.1 | ) | |||||
|
|
|
|
|||||||
Total derivatives liabilities |
$ | 199.5 | $ | (0.8 | ) | |||||
|
|
|
|
(1) | AUD = Australian Dollar, CAD = Canadian Dollar, EUR = Euro, GBP = British pound, JPY = Japanese Yen and USD = US Dollar. |
(2) | The absolute notional exposure represents the Groups derivative activity at December 31, 2021, which is representative of the volume of derivatives held during the year. |
(3) | Contracts used to manage foreign currency risks in underwriting and non-investment operations. |
F-67
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
The following table presents derivative instruments by major risk type, the Groups net realized gains/(losses) and change in net unrealized gains/(losses) relating to derivative trading activities for the years ended December 31, 2022, 2021 and 2020. Net realized gains/(losses) and net unrealized gains/(losses) related to derivatives are included in net investment return and net foreign exchange gains and losses in the Consolidated Statement of Income.
2022 | 2021 | 2020 | ||||||||||||||||||||||
Derivatives | Net realized gains/(losses) |
Change in net unrealized gains/(losses) |
Net realized gains/(losses) |
Change in net unrealized gains/(losses) |
Net realized gains/(losses) |
Change in net unrealized gains/(losses) |
||||||||||||||||||
Interest rate contracts |
||||||||||||||||||||||||
Futures(1) |
$ | (20.3 | ) | $ | 0.7 | $ | 1.0 | $ | (0.9 | ) | $ | 2.3 | $ | 0.2 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total interest rate contracts |
(20.3 | ) | 0.7 | 1.0 | (0.9 | ) | 2.3 | 0.2 | ||||||||||||||||
Foreign exchange contracts |
||||||||||||||||||||||||
Forwards(2) |
3.5 | 5.3 | (2.9 | ) | 6.3 | (1.5 | ) | (4.8 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total foreign exchange contracts |
3.5 | 5.3 | (2.9 | ) | 6.3 | (1.5 | ) | (4.8 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total |
$ | (16.8 | ) | $ | 6.0 | $ | (1.9 | ) | $ | 5.4 | $ | 0.8 | $ | (4.6 | ) | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Contracts used to manage interest rate risks in investments operations. |
(2) | Contracts used to manage foreign currency risks in underwriting and non-investment operations. |
The Group obtains/provides collateral from/to counterparties for OTC derivative financial instruments in accordance with bilateral credit facilities.
The Group does not offset its derivative instruments and presents all amounts in the Consolidated Balance Sheets on a gross basis. The Group has pledged cash collateral to counterparties to support the current value of amounts due to the counterparties based on the value of the underlying security.
11. | Deferred Policy Acquisition Costs |
The following table represents a reconciliation of beginning and ending deferred policy acquisition costs for the years ended December 31, 2022 and 2021:
For the year ended December 31, | ||||||||
2022 | 2021 | |||||||
Balance at the beginning of the period |
$ | 403.3 | $ | 276.5 | ||||
Acquisition costs deferred |
577.2 | 446.2 | ||||||
Amortization of deferred policy acquisition costs |
(447.7 | ) | (299.9 | ) | ||||
Other movements |
(17.0 | ) | (19.5 | ) | ||||
|
|
|
|
|||||
Balance at the end of the period |
$ | 515.8 | $ | 403.3 | ||||
|
|
|
|
12. | Reserves for Losses and Loss Adjustment Expenses |
The reserves for losses and loss adjustment expenses include an amount determined from reported claims and estimates based on historical loss experience and industry statistics for losses incurred but not reported using a variety of actuarial methods.
F-68
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
The unpaid reported reserves for losses and loss adjustment expenses are established by management based on reports from brokers, ceding companies and insureds and represents the estimated ultimate cost of events or conditions that have been reported to, or specifically identified by the Group.
The reserves for IBNR losses and loss adjustment expenses are established by management based on actuarially determined estimates of ultimate losses and loss adjustment expenses. Inherent in the estimate of ultimate losses and loss adjustment expenses are expected trends in claim severity and frequency and other factors which may vary significantly as claims are settled. Accordingly, ultimate losses and loss adjustment expenses may differ materially from the amounts recorded in the consolidated financial statements.
These estimates are reviewed regularly and, as experience develops and new information becomes known, the reserves are adjusted as necessary. Such adjustments, if any, will be recorded in losses and loss adjustment expenses in the period in which they become known. IBNR reserves are calculated on a best estimate basis and are estimated by management using various actuarial methods as well as the Groups own growing loss experience, historical insurance industry loss experience, estimates of pricing adequacy trends and managements professional judgement. Due to the limited historical data available, reliance is placed upon industry data and a review of individual policies. Estimates are calculated at the lowest level line of business, separately for gross and ceded, and for attritional, extreme and catastrophic claims.
The reserve estimates contain an inherent level of uncertainty and actual results may vary, potentially significantly, from the estimates the Group has made. Reserves are reviewed on a quarterly basis and estimates are adjusted to reflect emerging claims experience.
The Group estimates reserves for unallocated claims adjustment expenses (ULAE) based on a percentage of loss reserves as determined by management. However, this may be overridden in exceptional circumstances where this approach is not deemed appropriate. There were no material changes made to the Groups methodology for calculating reserves for unallocated claims adjustment expenses for the year ended December 31, 2022.
F-69
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
The following table presents a reconciliation of unpaid losses and loss adjustment expenses for the years ended December 31, 2022, 2021 and 2020:
2022 | 2021 | 2020 | ||||||||||
Gross unpaid losses and loss adjustment expenses, beginning of year |
$ | 1,386.5 | $ | 818.0 | $ | 730.7 | ||||||
Reinsurance recoverable on unpaid losses |
(795.2 | ) | (382.2 | ) | (442.7 | ) | ||||||
|
|
|
|
|
|
|||||||
Net unpaid losses and loss adjustment expenses, beginning of year |
591.3 | 435.8 | 288.0 | |||||||||
Net losses and loss adjustment expenses incurred in respect of losses occurring in: |
||||||||||||
Current year |
852.3 | 706.4 | 362.9 | |||||||||
Prior years |
(22.1 | ) | (9.6 | ) | (38.4 | ) | ||||||
|
|
|
|
|
|
|||||||
Total incurred |
830.2 | 696.8 | 324.5 | |||||||||
Net losses and loss adjustment expenses paid in respect of losses occurring in: |
||||||||||||
Current year |
(82.5 | ) | (216.7 | ) | (80.6 | ) | ||||||
Prior years |
(242.2 | ) | (311.9 | ) | (104.5 | ) | ||||||
|
|
|
|
|
|
|||||||
Total Paid |
(324.7 | ) | (528.6 | ) | (185.1 | ) | ||||||
Foreign exchange |
(27.7 | ) | (12.7 | ) | 8.0 | |||||||
Net unpaid losses and loss adjustment expenses, end of year |
1,069.1 | 591.3 | 435.4 | |||||||||
Reinsurance recoverable on unpaid losses |
976.1 | 795.2 | 382.6 | |||||||||
|
|
|
|
|
|
|||||||
Gross unpaid losses and loss adjustment expenses, end of year |
$ | 2,045.2 | $ | 1,386.5 | $ | 818.0 | ||||||
|
|
|
|
|
|
As a result of the changes in estimates of insured events in prior years, the 2022 reserves for losses and loss adjustment expenses net of reinsurance recoveries decreased by $22.1 million (2021: $9.6 million, 2020: $38.4 million).
Reserve releases in 2022 have resulted from better than expected loss experience in the Bespoke and Specialty segments. Reserves for the Reinsurance segment were strengthened in 2022 due to deterioration on Hurricane Laura and the 2021 European Floods.
Reserve releases in 2021 have resulted from better than expected loss experience across the Bespoke and Specialty pillars, offset by deterioration on Hurricane Laura and the Mid-West Derecho in the Reinsurance segment.
Reserve releases in 2020 have resulted from changes in reserving estimates following better than expected loss experience across the Bespoke, Specialty and Reinsurance segments.
a. | Incurred and paid loss development tables by accident year |
The Groups loss reserve analysis is based primarily on underwriting year data. The preparation of the below accident year development tables required an allocation of underwriting year data to the corresponding accident year.
Allocations are performed using accident year loss payment and reporting patterns, which are derived from Group specific loss data. Ultimate reserves are allocated based on reserve movement splits between prior and current year and reflects the movement in earned premium by underwriting year.
F-70
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
The following tables present the Groups total losses and loss adjustment expenses incurred, net of reinsurance and paid losses and loss adjustment expenses by accident year, net of reinsurance. The information has been provided separately for the bespoke, specialty and reinsurance segments.
The reporting of cumulative claims frequency has been measured by counting the number of unique, individual claims where a claims reference has been established. For certain policies, claims are managed by MGAs and these have been included based upon information provided by the MGA and allocated to the year of loss based upon the best available information.
Incurred losses and loss adjustment expenses net of reinsurance
Bespoke
For the year ended December 31, 2022 |
At December 31, 2022 | |||||||||||||||||||||||||||||||||||||||
Accident year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total of plus expected |
Cumulative number of reported losses |
||||||||||||||||||||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
|
|
|
|||||||||||||||||||||||||||||||
2015 |
0.4 | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | | | 20 | ||||||||||||||||||||||||||||||
2016 |
9.3 | 5.8 | 5.1 | 8.0 | 9.5 | 2.4 | 2.1 | | 41 | |||||||||||||||||||||||||||||||
2017 |
18.5 | 12.2 | 10.2 | 9.6 | 9.2 | 8.0 | 0.8 | 85 | ||||||||||||||||||||||||||||||||
2018 |
35.4 | 21.7 | 14.3 | 19.9 | 19.5 | 3.7 | 431 | |||||||||||||||||||||||||||||||||
2019 |
39.9 | 26.4 | 34.5 | 24.4 | 5.6 | 2,189 | ||||||||||||||||||||||||||||||||||
2020 |
90.0 | 62.6 | 67.5 | (137.3 | ) | 2,023 | ||||||||||||||||||||||||||||||||||
2021 |
93.7 | 72.0 | 49.1 | 481 | ||||||||||||||||||||||||||||||||||||
2022 |
146.1 | 134.9 | 2 | |||||||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||||
Total |
339.6 | 56.80 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
F-71
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Cumulative paid losses and loss adjustment expenses, net of reinsurance
For the year ended December 31, 2022 |
||||||||||||||||||||||||||||||||
Accident year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | ||||||||||||||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
|
|||||||||||||||||||||||||
2015 |
| | | | | | | | ||||||||||||||||||||||||
2016 |
| 1.3 | 2.6 | 2.8 | 2.6 | 2.2 | 2.3 | |||||||||||||||||||||||||
2017 |
1.7 | 2.0 | 3.5 | 4.8 | 6.1 | 6.1 | ||||||||||||||||||||||||||
2018 |
0.3 | 2.5 | 3.0 | 12.6 | 14.9 | |||||||||||||||||||||||||||
2019 |
1.9 | 6.5 | 12.4 | 15.6 | ||||||||||||||||||||||||||||
2020 |
18.7 | 185.5 | 189.6 | |||||||||||||||||||||||||||||
2021 |
12.5 | 19.9 | ||||||||||||||||||||||||||||||
2022 |
7.2 | |||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
255.6 | ||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
Reserve FX |
6.8 | |||||||||||||||||||||||||||||||
ULAE |
1.6 | |||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
Liabilities for losses and loss adjustment expenses, net of reinsurance |
|
92.4 | ||||||||||||||||||||||||||||||
|
|
(1) | The total of IBNR plus expected development on reported losses for the 2020 accident year in the Bespoke segment includes amounts for salvage totaling $144.2 million for which the Group has paid gross losses to the insured and expects to recover amounts paid via the sale of the repossessed property. |
Specialty
For the year ended December 31, 2022 |
At December 31, 2022 | |||||||||||||||||||||||||||||||||||||||
Accident year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total of plus expected |
Cumulative number of reported losses |
||||||||||||||||||||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
|
|
|
|||||||||||||||||||||||||||||||
2015 |
2.2 | 1.0 | 0.2 | | | | | | | 2 | ||||||||||||||||||||||||||||||
2016 |
10.2 | 4.6 | 3.5 | 3.3 | 2.1 | 2.2 | 1.8 | 0.1 | 110 | |||||||||||||||||||||||||||||||
2017 |
8.8 | 5.7 | 2.3 | 2.1 | 1.1 | 1.8 | | 506 | ||||||||||||||||||||||||||||||||
2018 |
10.2 | 13.8 | 11.6 | 13.0 | 11.9 | (0.9 | ) | 557 | ||||||||||||||||||||||||||||||||
2019 |
28.8 | 23.8 | 26.1 | 41.0 | (1.5 | ) | 360 | |||||||||||||||||||||||||||||||||
2020 |
72.9 | 52.1 | 47.3 | 5.8 | 685 | |||||||||||||||||||||||||||||||||||
2021 |
222.4 | 202.1 | 9.8 | 706 | ||||||||||||||||||||||||||||||||||||
2022 |
514.4 | 313.6 | 249 | |||||||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||||
Total |
820.3 | 326.9 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
F-72
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Cumulative paid losses and loss adjustment expenses, net of reinsurance
For the year ended December 31, 2022 |
||||||||||||||||||||||||||||||||
Accident year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | ||||||||||||||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
|
|||||||||||||||||||||||||
2015 |
| | | | | | | | ||||||||||||||||||||||||
2016 |
| 0.1 | 1.7 | 1.8 | 1.9 | 2.1 | 1.7 | |||||||||||||||||||||||||
2017 |
| 0.4 | 0.6 | 1.5 | 2.2 | 1.6 | ||||||||||||||||||||||||||
2018 |
| 3.1 | 10.0 | 11.3 | 9.9 | |||||||||||||||||||||||||||
2019 |
5.2 | 17.1 | 16.0 | 24.0 | ||||||||||||||||||||||||||||
2020 |
7.2 | 32.0 | 30.9 | |||||||||||||||||||||||||||||
2021 |
36.7 | 98.9 | ||||||||||||||||||||||||||||||
2022 |
52.8 | |||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
219.8 | ||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
Reserve FX |
(17.7 | ) | ||||||||||||||||||||||||||||||
ULAE |
8.7 | |||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
Liabilities for losses and loss adjustment expenses, net of reinsurance |
|
591.5 | ||||||||||||||||||||||||||||||
|
|
Reinsurance
For the year ended December 31, 2022 |
At December 31, 2022 | |||||||||||||||||||||||||||||||||||||||
Accident year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total of IBNR plus expected development on reported losses |
Cumulative number of reported losses |
||||||||||||||||||||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
|
|
|
|||||||||||||||||||||||||||||||
2015 |
9.0 | 7.3 | 6.4 | 4.3 | 4.2 | 4.2 | 4.2 | 2.8 | (0.1 | ) | 1 | |||||||||||||||||||||||||||||
2016 |
74.0 | 60.8 | 52.8 | 49.9 | 46.7 | 42.9 | 40.3 | 16.9 | 33 | |||||||||||||||||||||||||||||||
2017 |
86.8 | 59.0 | 56.2 | 59.9 | 64.6 | 55.1 | 14.0 | 43 | ||||||||||||||||||||||||||||||||
2018 |
95.4 | 103.9 | 101.0 | 100.6 | 92.3 | 4.7 | 74 | |||||||||||||||||||||||||||||||||
2019 |
71.5 | 64.1 | 62.9 | 53.7 | 4.4 | 424 | ||||||||||||||||||||||||||||||||||
2020 |
198.2 | 228.5 | 248.8 | 39.7 | 1,943 | |||||||||||||||||||||||||||||||||||
2021 |
384.5 | 413.0 | 4.5 | 3,561 | ||||||||||||||||||||||||||||||||||||
2022 |
185.3 | 138.4 | 4,151 | |||||||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||||
Total |
1,091.3 | 222.5 | ||||||||||||||||||||||||||||||||||||||
|
|
|
|
F-73
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Cumulative paid losses and loss adjustment expenses, net of reinsurance
For the year ended December 31, 2022 |
||||||||||||||||||||||||||||||||
Accident year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | ||||||||||||||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
|
|||||||||||||||||||||||||
2015 |
| 0.5 | 2.7 | 2.8 | 2.8 | 2.7 | 2.8 | 2.9 | ||||||||||||||||||||||||
2016 |
2.4 | 11.9 | 20.0 | 21.4 | 21.4 | 22.6 | 22.9 | |||||||||||||||||||||||||
2017 |
26.5 | 45.2 | 47.5 | 51.4 | 53.7 | 35.8 | ||||||||||||||||||||||||||
2018 |
25.1 | 37.4 | 66.1 | 74.4 | 78.4 | |||||||||||||||||||||||||||
2019 |
3.0 | 49.0 | 51.7 | 43.6 | ||||||||||||||||||||||||||||
2020 |
54.7 | 142.9 | 179.9 | |||||||||||||||||||||||||||||
2021 |
167.5 | 310.5 | ||||||||||||||||||||||||||||||
2022 |
22.5 | |||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
696.5 | ||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
Reserve FX |
(19.7 | ) | ||||||||||||||||||||||||||||||
ULAE |
10.1 | |||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
Liabilities for losses and loss adjustment expenses, net of reinsurance |
|
385.2 | ||||||||||||||||||||||||||||||
|
|
b. | Reconciliation of loss development information to the reserves for losses and loss adjustment expenses |
The table below reconciles the loss development information to the Groups reserves for losses and loss adjustment expenses at December 31, 2022 and 2021:
2022 | 2021 | |||||||
Reserves for losses and loss adjustment expenses, net of reinsurance |
||||||||
Bespoke |
$ | 90.8 | $ | (7.7 | ) | |||
Specialty |
582.8 | 216.0 | ||||||
Reinsurance |
375.1 | 369.1 | ||||||
|
|
|
|
|||||
Total reserves for losses and loss adjustment expenses, net of reinsurance |
1,048.7 | 577.4 | ||||||
|
|
|
|
|||||
Reinsurance recoverable on unpaid losses |
||||||||
Bespoke |
65.3 | 12.6 | ||||||
Specialty |
278.5 | 111.9 | ||||||
Reinsurance |
632.3 | 670.7 | ||||||
|
|
|
|
|||||
Total reserves for losses and loss adjustment expenses, net of reinsurance |
976.1 | 795.2 | ||||||
|
|
|
|
|||||
Unallocated loss adjustment expenses |
20.4 | 13.9 | ||||||
|
|
|
|
|||||
Total gross liability for unpaid losses and loss adjustment expenses |
$ | 2,045.2 | $ | 1,386.5 | ||||
|
|
|
|
F-74
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
c. | Historical loss duration |
The following table presents the Groups historical average annual percentage payout of losses and loss adjustment expenses incurred, net of reinsurance by age at December 31, 2022.
The Group was incorporated on August 22, 2014 and commenced underwriting in 2015. As a result, the Group has limited historical data and is unable to present a full cycle of loss payments beyond year four as movements beyond this time horizon are not meaningful and may be misleading to the users of the financial statements.
December 31, 2022 (Unaudited) |
||||||||||||||||
Years |
1 | 2 | 3 | 4 | ||||||||||||
Bespoke |
12 | % | 46 | % | 11 | % | 26 | % | ||||||||
Specialty |
12 | % | 20 | % | 6 | % | 18 | % | ||||||||
Reinsurance |
28 | % | 29 | % | 16 | % | 2 | % |
13. | Reinsurance and Retrocessional Reinsurance |
The Group uses reinsurance and retrocessional reinsurance from time to time to manage its net retention on individual risks as well as overall exposure to losses while providing it with the ability to offer policies with sufficient limits to meet policyholder needs. In a reinsurance transaction, an insurance company transfers, or cedes, all or part of its exposure in return for a portion of the premium. In a retrocessional reinsurance transaction, a reinsurance company transfers, or cedes, all or part of its exposure in return for a portion of the premium. The ceding of insurance does not legally discharge the Group from its primary liability for the full amount of the policies, and the Group will be required to pay the loss and bear collection risk if the reinsurer fails to meet its obligations under the reinsurance or retrocessional agreement.
The following tables summarize the effect of reinsurance and retrocessional reinsurance on premiums written and earned and on losses and loss adjustment expenses for the years ended December 31, 2022, 2021 and 2020.:
2022 | ||||||||||||
Premiums | Premiums earned |
Losses and loss adjustment expenses |
||||||||||
Direct |
$ | 2,069.1 | $ | 1,482.9 | $ | 732.6 | ||||||
Assumed |
931.0 | 1,012.3 | 619.0 | |||||||||
Ceded |
(1,137.5 | ) | (990.5 | ) | (521.4 | ) | ||||||
|
|
|
|
|
|
|||||||
Net |
$ | 1,862.6 | $ | 1,504.7 | $ | 830.2 | ||||||
|
|
|
|
|
|
2021 | ||||||||||||
Premiums | Premiums earned |
Losses and loss adjustment expenses |
||||||||||
Direct |
$ | 1,498.7 | $ | 851.7 | $ | 338.6 | ||||||
Assumed |
1,289.0 | 1,227.8 | 1,140.5 | |||||||||
Ceded |
(1,186.6 | ) | (925.3 | ) | (782.3 | ) | ||||||
|
|
|
|
|
|
|||||||
Net |
$ | 1,601.1 | $ | 1,154.2 | $ | 696.8 | ||||||
|
|
|
|
|
|
F-75
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
2020 | ||||||||||||
Premiums | Premiums earned |
Losses and loss adjustment expenses |
||||||||||
Direct |
$ | 721.5 | $ | 372.8 | $ | 106.4 | ||||||
Assumed |
855.0 | 752.7 | 385.0 | |||||||||
Ceded |
(670.9 | ) | (396.9 | ) | (166.9 | ) | ||||||
|
|
|
|
|
|
|||||||
Net |
$ | 905.6 | $ | 728.6 | $ | 324.5 | ||||||
|
|
|
|
|
|
The Group is exposed to the credit risk of the reinsurer, or the risk that one of its reinsurers becomes insolvent or otherwise unable or unwilling to pay policyholder claims. This credit risk is generally mitigated by either selecting well capitalized, highly rated authorized capacity providers or requiring that the capacity provider post substantial collateral to secure the reinsured risks, which, in some instances, exceeds the related reinsurance recoverable. Allowances are established for amounts deemed uncollectible.
The Group evaluates the financial condition of its reinsurers on a regular basis and monitors concentrations of credit risk with reinsurers. At December 31, 2022, the reinsurance balance recoverable on reserves for losses and loss adjustment expenses was $976.1 million (2021: $795.2 million) and the reinsurance balance recoverable on paid losses was $159.4 million (2021: $256.6 million). All reinsurance premiums ceded and reinsurance recoverables are either fully collateralized or placed with reinsurers that are rated A- or greater by A.M. Best or S&P, other than four reinsurers which are rated B++. Where an insurer does not have a credit rating, the Group has received collateral, including letters of credit and trust accounts. Collateral related to these reinsurance agreements is available, without restriction, when the Group pays losses covered by the reinsurance agreements.
At December 31, 2022 the three largest balances by reinsurer accounted for 25.3%, 6.0% and 5.0% (2021: 17.4%, 6.8% and 6.3%) of the total balance recoverable from reinsurers on paid and unpaid losses.
Although the Group has not experienced any credit losses to date, an inability of its reinsurers or retrocessionaires to meet their obligations to it over the relevant exposure periods for any reason could have a material adverse effect on its financial condition and results of operations.
The following table provides a roll forward of the allowance for expected credit losses of the Groups reinsurance recoverables due from third parties on unpaid claims.
Year ended December 31, 2022 | ||||||||
Reinsurance recoverable on unpaid claims |
Allowance for Expected Credit Losses |
|||||||
Balance at the beginning of year |
$ | 795.2 | $ | 0.5 | ||||
Change during the year |
180.9 | 0.5 | ||||||
|
|
|
|
|||||
Balance at the end of year |
$ | 976.1 | $ | 1.0 | ||||
|
|
|
|
F-76
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Year ended December 31, 2021 | ||||||||
Reinsurance recoverable on unpaid claims |
Allowance for Expected Credit Losses |
|||||||
Balance at the beginning of year |
$ | 382.6 | $ | | ||||
Change during the year |
412.6 | 0.5 | ||||||
|
|
|
|
|||||
Balance at the end of year |
$ | 795.2 | $ | 0.5 | ||||
|
|
|
|
The following table provides a roll forward of the allowance for expected credit losses of the Groups reinsurance recoverables due from third parties on paid claims.
Year ended December 31, 2022 | ||||||||
Reinsurance recoverable on paid claims |
Allowance for Expected Credit Losses |
|||||||
Balance at the beginning of year |
$ | 256.6 | $ | | ||||
Change during the year |
(97.2 | ) | | |||||
|
|
|
|
|||||
Balance at the end of year |
$ | 159.4 | $ | | ||||
|
|
|
|
Year ended December 31, 2021 | ||||||||
Reinsurance recoverable on paid claims |
Allowance for Expected Credit Losses |
|||||||
Balance at the beginning of year |
$ | 105.7 | $ | 0.3 | ||||
Change during the year |
150.9 | (0.3 | ) | |||||
|
|
|
|
|||||
Balance at the end of year |
$ | 256.6 | $ | | ||||
|
|
|
|
Intercompany Retrocessional Reinsurance Arrangements
The Group has entered into various internal quota share retrocession agreements between its insurance carriers through which Fidelis Underwriting Limited (FUL) and Fidelis Insurance Bermuda Limited (FIBL) cedes some of its business to Fidelis Insurance Bermuda Limited (FIBL) each year on a risk attaching basis.
14. | Long term debt |
On June 18, 2020, the Group issued $300.0 million and on July 2, 2020 the Group issued a further $30.0 million of its 4.875% Senior Notes due June 30, 2030 (collectively, the Senior Notes), with interest payable on June 30 and December 30 of each year, commencing on December 30, 2020. The Senior Notes are redeemable at the applicable redemption price, subject to the terms described in the indenture for the Senior Notes. However, the Senior Notes may not be redeemed prior to December 31, 2023 without approval from the Bermuda Monetary Authority (the BMA) and may not be redeemed at any time prior to their maturity if enhanced capital requirements, as established by the BMA, would be breached immediately before or after giving effect to the redemption of such notes, unless, in each case, the Group replaces the capital represented by the Senior Notes to be redeemed with capital having equal or better capital treatment as the notes under applicable BMA rules. The Senior Notes contain covenants, including limitations on liens on the stock of certain designated subsidiaries, limitations on consolidations, mergers, amalgamations and sales of substantially all assets and certain reporting obligations.
F-77
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
On October 16, 2020, the Group issued $105.0 million, and on October 20, 2020, the Group issued a further $20.0 million of its 6.625% Fixed-Rate Reset Junior Subordinated Notes due April 1, 2041 (collectively, the Junior Notes) with interest payable on April 1 and October 1 of each year, commencing on April 1, 2021. The interest rate is reset on April 1, 2026 at the US five-year treasury rate on the reset interest determination date plus 6.323%, and every five years thereafter. The Junior Notes are redeemable at par value for six months after each interest rate reset date. The Junior Notes contain covenants, including limitations on liens on the stock of certain designated subsidiaries, limitations on consolidations, mergers, amalgamations and sales of substantially all assets and certain reporting obligations.
The following table sets forth the principal amount of the debt issued as well as the unamortized discount and debt issuance costs at December 31, 2022 and 2021:
March 31, 2022 | December 31, 2022 | |||||||||||||||
Principal | Unamortized discount and debt issuance costs |
Principal | Unamortized discount and debt issuance costs |
|||||||||||||
4.875% Senior notes due 2030 |
330.0 | (5.5 | ) | 330.0 | (5.6 | ) | ||||||||||
6.625% Fixed Rate Reset Junior Subordinated notes due 2041 |
125.0 | (1.8 | ) | 125.0 | (1.9 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
455.0 | (7.3 | ) | 455.0 | (7.5 | ) | ||||||||||
|
|
|
|
|
|
|
|
Preference Securities
In 2015, the Group issued 30,400 shares of cumulative 9% preference securities with a redemption price equal to $10,000 per share, plus all declared and unpaid dividends (the preference securities). Holders of preference securities are entitled to receive dividend payments only when, and if, declared by the Groups Board of Directors. To the extent declared, these dividends will accumulate, with respect to each dividend period, in the amount per share equal to 9% of the $10,000 liquidation preference per annum. Currently the holders of all preference securities do not have any voting rights.
During the year, the Group paid quarterly preference dividends totaling $5.3 million (2021: $5.3 million, 2020: $14.4 million) to holders of the Groups preference securities. At December 31, 2022, dividends payable of $0.2 million (2021: $0.2 million) are included in other liabilities. No other outstanding amounts are payable to holders of the Preference Securities.
During 2020, the Group repurchased 18,388 preference securities for a total of $209.1 million.
At December 31, | ||||||||
2022 | 2021 | |||||||
Preference securities, par value $0.01 per share |
||||||||
Authorized (thousands) |
1,000 | 1,000 | ||||||
|
|
|
|
|||||
Issued and outstanding: |
||||||||
9% cumulative preference shares (thousands) |
5.8 | 5.8 | ||||||
|
|
|
|
15. | Variable Interest Entities |
At times, the Group has utilized VIEs both indirectly and directly in the ordinary course of the Groups business.
F-78
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
During 2017, the Group, along with another investor, formed Pine Walk to provide administrative support to managing general agents. Pine Walk is deemed to be a variable interest entity as the equity is insufficient to finance operations without additional subordinated support in the form of a loan. At December 31, 2022, the current balance of the loan is $nil (2021: $1.2 million). Fidelis holds a majority interest in Pine Walk and has a majority of the board of director seats. Accordingly, the financial statements of Pine Walk have been included in the consolidated financial statements of the Group. Refer to Note 16, Non Controlling Interests for a summary of the non-controlling interests held in Pine Walk and other subsidiaries.
During 2017, Pine Walk, along with another investor, formed Firestone Surety Limited, which was renamed Oakside Surety Limited during 2018 (Oakside), a managing general agent that writes (re)insurance for FUL and FIID, focusing on surety bonds predominantly in the United Kingdom. Oakside is deemed to be a variable interest entity as the equity is insufficient to finance operations without additional subordinated support in the form of a loan. As of December 31, 2022, the current balance of the loan is $nil (2021: $0.4 million). Fidelis holds a minority interest in Oakside through Pine Walk. However, due to a de facto agent relationship the Group is considered to be the primary beneficiary, and the financial statements of Oakside have been consolidated in our consolidated financial statements.
During May 2018, Socium Re Limited (Socium), a Bermuda domiciled special purpose insurer, was formed to provide additional collateralized capacity to support the Groups business through retrocession agreements. Socium is regulated as a segregated cell structure by the BMA with its capital substantially provided by third party capital providers. The Group is not the primary beneficiary of the segregated account of Socium and therefore records its investment within other assets on the Groups Consolidated Balance Sheets. At December 31, 2022 the carrying value of the Groups investment in Socium was $0.7 million, compared to the carrying value of $0.8 million at December 31, 2021, which is the maximum loss exposure to the Group.
During 2019, Pine Walk, along with another investor, formed Perigon Product Recall Limited (Perigon), a managing general agent that writes (re)insurance for FUL and FIID focusing on product recall and product contamination. Perigon is deemed to be a variable interest entity as the equity is insufficient to finance operations without additional subordinated support in the form of a loan. At December 31, 2022, the current balance of the loan is $0.4 million (2021: $0.6 million). Due to a de facto agent relationship with Perigon, Fidelis is considered to be the primary beneficiary and as such the financial statements of Perigon have been consolidated in our consolidated financial statements.
During 2020, Pine Walk formed Pine Walk Europe S.R.L. (PWE), a managing general agent that writes EEA business on behalf of Kersey, Oakside, Perigon and Navium . Through Pine Walk, Fidelis has a majority interest in PWE and can appoint the Directors. PWE meets the definition of a VIE as the companies that it writes business on behalf of have a right to profits from the entity but have no voting rights. As Fidelis either controls or is the primary beneficiary of the entities that have an interest in PWE, Fidelis is deemed to be the primary beneficiary of PWE and as such the financial statements of PWE have been consolidated in our consolidated financial statements.
During 2021, Pine Walk, along with another investor, formed Navium Marine Limited (Navium), a managing general agent that writes on FIID and FULs balance sheets focusing on Marine insurance. Navium is deemed to be a variable interest entity as the equity is insufficient to finance operations without additional subordinated support in the form of a loan. At December 31, 2022, the current balance of the loan is $1.2 million (2021: $1.3 million). Due to a de facto agent relationship with Navium, Fidelis is considered to be the primary beneficiary and as such the financial statements of Navium have been consolidated in our consolidated financial statements.
F-79
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
During 2021, Pine Walk, along with another investor, formed OPEnergy Limited (OPEnergy), a managing general agent that writes insurance for FUL focusing on Energy Liability insurance. OPEnergy is deemed to be a variable interest entity as the equity is insufficient to finance operations without additional subordinated support in the form of a loan. At December 31, 2022, the current balance of the loan is $0.8 million (2021: $0.7 million). Due to a de facto agent relationship with OPEnergy, the Group is considered to be the primary beneficiary and as such the financial statements of OPEnergy have been consolidated in our consolidated financial statements.
During 2021, Pine Walk, along with another investor, formed Pernix Specialty (Pernix), a managing general agent that writes insurance for FUL focusing on credit and political risk business. Pernix is deemed to be a variable interest entity as the equity is insufficient to finance operations without additional subordinated support in the form of a loan. At December 31, 2022, the current balance of the loan is $1.2 million (2021: $nil). Due to a de facto agent relationship with Pernix, the Group is considered to be the primary beneficiary and as such the financial statements of Pernix have been consolidated in our consolidated financial statements.
16. | Non-controlling Interests |
A summary of the Groups non-controlling interests, and the impact upon its Consolidated Balance Sheets and Consolidated Statement of Income is summarized below:
Non-Controlling Interest (%) |
Balance Sheet ($ million) |
Income Statement ($ million) | ||||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | 2022 | 2021 | 2020 | ||||||||||||||||||||||
Pine Walk Capital Limited |
6 | % | 13 | % | $ | 1.2 | $ | 0.5 | $ | 1.2 | $ | 1.1 | $ | 0.1 | ||||||||||||||
Radius Specialty Limited |
30 | % | 31 | % | 1.6 | 1.3 | 1.4 | 4.8 | (0.6 | ) | ||||||||||||||||||
Oakside Surety Limited |
62 | % | 65 | % | 0.8 | 0.5 | 0.6 | 0.8 | 0.2 | |||||||||||||||||||
Kersey Specialty Limited |
30 | % | 35 | % | 0.9 | 0.9 | 0.7 | 1.3 | | |||||||||||||||||||
Perigon Product Recall Limited |
30 | % | 35 | % | 0.3 | 0.3 | 0.2 | 0.3 | 0.1 | |||||||||||||||||||
Pine Walk Europe S.R.L. |
6 | % | 13 | % | 0.2 | | 0.3 | | | |||||||||||||||||||
Navium Marine Limited |
34 | % | 39 | % | 4.3 | 1.7 | 4.1 | 1.7 | | |||||||||||||||||||
OPEnergy Limited |
30 | % | 35 | % | 0.5 | | 0.6 | | | |||||||||||||||||||
Pernix Specialty Limited |
30 | % | 30 | % | 0.5 | | 0.6 | | | |||||||||||||||||||
Omega National Title Agency Ventures LLC |
| % | | % | | | | | 0.3 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total non-controlling interest |
$ | 10.3 | $ | 5.2 | $ | 9.7 | $ | 10.0 | $ | 0.1 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
During 2022, the Group purchased an additional 7% share in Pine Walk Capital Limited for a total consideration of $11.7 million.
17. | Commitments and Contingencies |
a. | Lease commitments |
The Groups leases primarily consist of operating leases for its offices in the U.K., Ireland and Bermuda. During 2022, the Group entered into new leases in the UK and Ireland, and extended its lease in Bermuda.
Total expected lease payments are based on the lease payments specified in the contract and the stated term, including any options to extend or terminate.
The Groups operating leases have remaining lease terms of up to 12 years, some of which include options to extend the lease term. The Group considers these options when determining the lease term and measuring its
F-80
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
lease liability and right-of-use asset. In addition, the Groups lease agreements do not contain any material residual value guarantees or material restrictive covenants. Short-term operating leases with an initial term of twelve months or less were excluded from the Groups Consolidated Balance Sheet and represent an inconsequential amount of operating lease expense. These were entered into for the use of various office fixtures such as photocopiers and other IT equipment.
As most leases do not provide an implicit rate, the Group uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments.
The following table presents the Groups operating lease right-of-use assets and lease liabilities:
At December 31, | ||||||||
2022 | 2021 | |||||||
Operating leases right-of-use assets |
$ | 26.8 | $ | 29.9 | ||||
Operating lease liabilities |
28.5 | 31.4 | ||||||
Operating lease weighted-average remaining lease term |
9.1 | 9.6 | ||||||
Operating lease weight-average discount rate |
7.8 | % | 7.7 | % |
The following table presents the Groups operating lease expenses and cash flows:
Years Ended December 31, | ||||||||||||
2022 | 2021 | 2020 | ||||||||||
Operating lease costs |
$ | 4.3 | $ | 2.7 | $ | 1.7 | ||||||
Variable lease costs |
| | | |||||||||
|
|
|
|
|
|
|||||||
Total lease expense |
4.3 | 2.7 | 1.7 | |||||||||
|
|
|
|
|
|
|||||||
Operating cash outflows from operating leases |
$ | 2.6 | $ | 1.8 | $ | 2.2 |
The following table presents the Groups future minimum annual lease commitments under various non-cancellable operating leases for the Groups facilities:
Years Ending December 31, | ||||
2023 |
$ | 2.5 | ||
2024 |
5.3 | |||
2025 |
4.7 | |||
2026 |
4.6 | |||
2027 |
4.6 | |||
Later years |
18.5 | |||
Less present value discount |
(11.7 | ) | ||
|
|
|||
Total |
$ | 28.5 | ||
|
|
b. | Letter of credit facilities |
At December 31, 2022, the Group had the following letter of credit facilities:
| A Standby Letter of Credit Facility Agreement with Lloyds Bank plc (Lloyds), under which Lloyds committed to make available to the Group a letter of credit facility in the amount of $175.0 million was |
F-81
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
renewed on September 21, 2021 for a 24 month term. The renewal was amended to reduce the unsecured tranche to $25.0 million and retain the secured tranche of $150.0 million. An additional secured accordion of $25.0 million was triggered prior to December 31, 2021. Letters of credit can be issued under the letter of credit facility with Lloyds for the purposes of 1) the provision of funds at Lloyds and 2) supporting insurance and reinsurance obligations. At December 31, 2022, there were letters of credit outstanding under the letter of credit facility with Lloyds totaling $101.2 million (2021: $162.7 million), secured by collateral in the amount of $92.4 million (2021: $157.3 million). |
| A Master Agreement for the Issuance of Payment Instruments with Citibank N.A., London Branch (Citibank), under which Citibank committed to make available a letter of credit facility in the amount of $250.0 million, was amended on December 13, 2022, effective December 31, 2022. The letter of credit facility with Citibank was reduced to $100.0 million, with the provision that the Group can request, from time to time, additional increments of $50.0 million, not to exceed $150.0 million. The letter of credit facility with Citibank is available until December 31, 2024. An additional uncommitted letter of credit facility was also agreed to with Citibank on October 6, 2021, for $200.0 million. At December 31, 2022, there were letters of credit outstanding under this letter of credit facility with Citibank totaling $100.1 million (2021: $208.9 million), with $7.1 million of non-renewed letters of credit expiring December 31, 2022, secured by collateral in the amount of $104.4 million (2021: $236.4 million). |
| On September 17, 2021, the letter of credit facility with Barclays Bank plc (Barclays) was renewed until September 15, 2023. The secured letter of credit facility with Barclays was amended to $60.0 million as was the unsecured tranche amended to $60.0 million. The borrowers of the letter of credit facility with Barclays continue to be Fidelis Insurance Bermuda Limited and Fidelis Underwriting Limited, with the guarantor continuing to be Fidelis Insurance Holdings Limited. A secured accordion under the letter of credit facility with Barclays of $100.0 million was triggered prior to December 31, 2021. At December 31, 2022 there were letters of credit outstanding under this letter of credit facility with Barclays totaling $88.2 million (2021: $23.4 million), secured by collateral in the amount of $45.7 million (2021: $nil). |
| On September 17, 2021 the letter of credit facility with Bank of Montreal (BMO) was renewed at $120.0 million, with a $60.0 million secured tranche and a $60.0 million unsecured tranche ending September 17, 2023. Fidelis Insurance Bermuda Limited is the borrower and Fidelis Insurance Holdings Limited is the guarantor. A secured accordion under the letter of credit facility with BMO of $80.0 million was triggered prior to December 31, 2021. At December 31, 2022 there were letters of credit outstanding under this letter of credit facility with BMO totaling $77.4 million (2021: $45.0 million), secured by collateral in the amount of $10.8 million (2021: $16.0 million). |
| A $50.0 million Standby Letter of Credit Facility Agreement with Lloyds, dated December 10, 2021 was made available to Fidelis Insurance Holdings Limited as parent, account party and guarantor, for a four-year period to provide regulated capital in respect of Ancillary Own Funds (AOF). |
c. | Legal proceedings |
From time to time in the normal course of business, the Group may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation, the outcomes of which determine the rights and obligations of the Group under the Groups (re)insurance contracts, and other contractual agreements, or other matters as the case may be. In some disputes, the Group may seek to enforce its rights under an agreement or to collect funds owing to it. In other matters, the Group may resist attempts by others to collect funds or
F-82
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
enforce alleged rights. While the final outcome of legal disputes that may arise cannot be predicted with certainty, the Group do not believe that the eventual outcome of any specific litigation, arbitration or alternative dispute resolution proceedings to which the Group are currently a party will have a material adverse effect on the financial condition of the Groups business as a whole.
d. | Concentration of credit risk |
Credit risk arises out of the failure of a counterparty to perform according to the terms of the contract. The Group underwrites all of its (re)insurance business through brokers and as a result credit risk exists should any of these brokers be unable to fulfil their contractual obligations with respect to the payments of premium or failure to pass on claims, if there is risk transfer, to the Group. During the years ended December 31, 2022 and December 31, 2021, gross premiums written generated from or placed by the below companies collectively accounted for more than 10% of the Groups combined gross premiums written, as follows:
2022 | 2021 | 2020 | ||||||||||
Aon plc |
15 | % | 22 | % | 31 | % | ||||||
Marsh & McLennan Companies, Inc |
20 | % | 24 | % | 19 | % | ||||||
Others |
65 | % | 54 | % | 50 | % |
The Group has policies and standards in place to manage and monitor the credit risk of intermediaries with a focus on day-to-day monitoring of the largest positions. Note 13, Reinsurance and Retrocessional Reinsurance describes the credit risk related to the Groups reinsurance recoverables.
e. | Intragroup guarantees |
The Group has unconditionally and irrevocably guaranteed all of the financial obligations of FUL and FIID. The Group has guaranteed Fidelis Marketing Limiteds lease obligations.
18. | Related Party Transactions |
For the year ended December 31, 2022, the Group ceded reinsurance premiums of $0.1 million (2021: $0.2 million, 2020: $2.8 million), of which $0.1 million was earned in the year (2021: $0.7 million, 2020: $7.4 million) and ceded losses of minus $3.4 million (2021: minus $0.4 million, 2020: $7.7 million) to Socium. At December 31, 2022, the amount of reinsurance recoverable on unpaid and paid losses from Socium was $5.8 million (2021: $10.5 million) and the amount of ceded reinsurance payable included in insurance and reinsurance balances payable to Socium was $2.6 million (2021: $0.6 million) in the Consolidated Balance Sheets.
During 2019, the Group made interest free loans to management of $4.5 million and is recorded within other assets in the Consolidated Balance Sheets. At December 31, 2022, the outstanding balance is $4.5 million (2021: $4.5 million).
19. | Statutory Requirements and Dividend Restrictions |
The Groups ability to pay dividends is subject to certain regulatory restrictions on the payment of dividends by its subsidiaries. The payment of such dividends is limited by applicable laws and statutory requirements of the jurisdictions in which the Group and its subsidiaries operate, detailed further below. The minimum required statutory capital and surplus is the amount of statutory capital and surplus necessary to satisfy regulatory requirements based on the Groups current operations.
F-83
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
The estimated statutory capital and surplus and minimum required statutory capital and surplus for the Groups regulatory jurisdictions is as follows:
December 31, 2022 | ||||||||||||
Bermuda(1) | United Kingdom(2) |
Republic of Ireland(2) |
||||||||||
Minimum statutory capital and surplus |
$ | 620.0 | $ | 550.0 | $ | 80.0 | ||||||
Statutory capital and surplus |
1,495.0 | 860.0 | 150.0 | |||||||||
Available capital for distribution |
875.0 | 295.0 | 65.0 |
December 31, 2021 | ||||||||||||
Bermuda(1) | United Kingdom(2) |
Republic of Ireland(2) |
||||||||||
Minimum statutory capital and surplus |
662.4 | 500.3 | 68.3 | |||||||||
Statutory capital and surplus |
1,765.0 | 750.0 | 115.0 | |||||||||
Available capital for distribution |
1,102.6 | 249.7 | 46.7 |
(1) | Required statutory capital and surplus represents the Enhanced Capital Requirement (ECR). |
(2) | Required statutory capital and surplus represents the Solvency II Solvency Capital Requirement (SCR). |
Bermuda operations
The BMA acts as group supervisor of the Group and has designated FIBL as the designated insurer of the Group. In accordance with the Group supervision and insurance group solvency rules, the Group is required to prepare and submit audited Group GAAP financial statements, a Group statutory financial return (SFR), a Group capital and solvency return (CSR) and a Group Quarterly Financial Return (QFR).
Under the Insurance Act 1978, amendments thereto and Related Regulations of Bermuda (the Insurance Act), FIBL is required to prepare and submit annual audited GAAP financial statements and statutory financial statements and to file with the BMA an SFR, CSR and audited GAAP financial statements.
As a Class 4 (re)insurer, FIBL is required to maintain available statutory economic capital and surplus at a level equal to or greater than the ECR. The ECR is the higher of the prescribed minimum solvency margin (MSM) or the required capital calculated by reference to the Bermuda Solvency Capital Requirement (BSCR) model. The BSCR model is a risk-based capital model that provides a method for determining a (re)insurers capital requirements (statutory capital and surplus) by taking into account the risk characteristics of different aspects of the (re)insurers business. In addition, the Group is required to maintain available statutory economic capital and surplus at a level equal to or in excess of the group ECR which is established by reference to the Group BSCR model.
Under the Insurance Act, FIBL is prohibited from declaring or paying a dividend if it is in breach of its minimum solvency margin, ECR or minimum liquidity ratio or if the declaration or payment of such dividend would cause such a breach. In addition, FIBL is prohibited from declaring or paying in any financial year dividends of more than 25% of its total statutory capital and surplus (as shown on its previous financial years statutory balance sheet) unless it files with the BMA an affidavit stating that it will continue to meet the relevant solvency and liquidity margins. Without the approval of the BMA, FIBL is prohibited from reducing by 15% or more its total statutory capital as set out in its previous years financial statements and any application for such approval must include an affidavit stating that it will continue to meet the required solvency and liquidity margins. In addition,
F-84
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
under the Companies Act 1981, FIBL would be prohibited from making a distribution out of contributed surplus if there are reasonable grounds for believing that (a) FIBL is, or would after the payment be, unable to pay its liabilities as they become due or (b) the realizable value of FIBLs assets would thereby be less than its liabilities.
United Kingdom Operations
FUL is regulated by the PRA and therefore is subject to the Solvency II regime which has been effective from 1 January 2016 and established a new set of EU-wide capital requirements, risk management and disclosure standards. The Company is required to meet a SCR which is calibrated to seek to ensure a 99.5% confidence of the ability to meet obligations over a 12-month time horizon. The Company calculates its SCR in accordance with the standard formula prescribed in the Solvency II regulations as the assumptions underlying the standard formula are not inappropriate for FULs risk profile.
The PRA regulatory requirements impose no explicit restrictions on the U.K. subsidiaries ability to pay a dividend, but FUL would have to notify the PRA 28 days prior to any proposed dividend payment. In addition, the Groups U.K. subsidiaries must comply with the United Kingdom Companies Act of 2006, which provides that dividends may only be paid out of profits available for that purpose.
Ireland operations
FIID is regulated by the Central Bank of Ireland (CBI) and therefore is subject to the Solvency II regime which has been effective from 1 January 2016 and established a set of EU-wide capital requirements, risk management and disclosure standards. The Company is required to meet its SCR which, as for FUL, is calibrated to seek to ensure a 99.5% confidence of the ability to meet obligations over a 12-month time horizon. The Company calculates its SCR in accordance with the standard formula prescribed in the Solvency II regulations as the assumptions underlying the standard formula are not inappropriate for FIIDs risk profile.
The regulatory requirements impose no explicit restrictions on FIIDs ability to pay a dividend, but FIID would have to notify the CBI prior to any proposed dividend payment. Under Irish Company law dividends may only be distributed from profits available for distribution, which consist of accumulated realized profits less accumulated realized losses.
20. | Earnings Per Share |
All share and per share information in this note have been retroactively adjusted to reflect the reverse share split of the Companys common shares for all years presented (refer to Note 25.b, Subsequent Events for additional detail).
2022 | 2021 | 2020 | ||||||||||
Earnings per common share |
||||||||||||
Net profit available to Fidelis Insurance Holdings Limited common shareholders |
52.6 | 68.3 | 126.5 | |||||||||
Weighted average common shares outstanding (in millions) |
194.3 | 195.5 | 166.9 | |||||||||
Earnings per common share |
0.27 | 0.35 | 0.76 | |||||||||
Earnings per diluted common share |
||||||||||||
Net profit available to Fidelis Insurance Holdings Limited common shareholders |
52.6 | 68.3 | 126.5 | |||||||||
Weighted average common shares outstanding (in millions) |
194.3 | 195.5 | 166.9 | |||||||||
Share-based compensation plans |
5.1 | 4.9 | 4.9 | |||||||||
Weighted average diluted common shares outstanding |
199.4 | 200.4 | 171.8 | |||||||||
Earnings per diluted common share |
0.26 | 0.34 | 0.74 |
F-85
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
21. | Share Capital Authorized and Issued |
All share information in this note has been retroactively adjusted to reflect the reverse share split of the Companys common shares for all years presented (refer to Note 25.b, Subsequent Events for additional detail).
The following sets out the number and par value of shares authorized, issued and outstanding at December 31, 2022 and 2021:
2022 | 2021 | |||||||
Common shares, par value $0.01 per share |
||||||||
Authorized (thousands) |
600,000.0 | 600,000.0 | ||||||
|
|
|
|
|||||
Issued and outstanding |
||||||||
Common shares (thousands) |
194,545.4 | 194,023.4 | ||||||
|
|
|
|
Common shares
On July 15, 2021, the Group issued 19,874,121 shares for $318.2 million, net of issuance costs. On August 26, 2021, the Group repurchased 19,865,920 shares for $318.5 million, including costs of $4.4 million.
On February 10, 2020 the Group issued 13,906,464 common shares for a total of $142.3 million, net of issuance costs. On June 10, 2020, the Group issued 34,533,958 common shares for a total of $355.0 million, net of issuance costs. On July 23, 2020 the Group issued 13,583,196 common shares for a total of $139.0 million. On December 1, 2020 the Group issued 4,156,330 common shares for a total of $60.6 million, net of issuance costs.
No dividends were declared in 2022, 2021 or 2020.
22. | Share Compensation |
All share and per share information in this note have been retroactively adjusted to reflect the reverse share split of the Companys common shares for all years presented (refer to Note 25.b, Subsequent Events for additional detail).
Warrants
In 2015, the Group reserved for issuance of warrants to purchase common shares, in the aggregate, up to 16.5% of the diluted shares: Founders warrants, Basic warrants, and Ratchet warrants. Warrants expire ten years from date of grant.
Warrants are valued using the Black Scholes option-pricing model. Share price volatility estimates of 17.1% and 17.8% were used based on ten-year volatility look-back of a peer group of (re)insurers as the Group has only been in operation for seven years, therefore it was not practicable to estimate the Groups share price volatility. The other assumptions used in the Black Scholes option-pricing model were as follows: risk free rates ranging from 0.59% - 1.56%, expected life of 10 years, and a 0.0% dividend yield.
Warrant exercises are satisfied through the issue of new shares.
F-86
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Founders warrants
The Founders warrants require certain performance conditions and at December 31, 2022, these conditions were not met. Since the initial grant in 2015, additional grants have occurred due to the anti-dilution clauses contained in the warrant agreements. Founder warrants have an exercise price of $10.
The Founders warrant activity for the years ended December 31, 2022 and 2021 was as follows:
Number of warrants | Weighted average grant date fair value |
Weighted average remaining contractual term |
||||||||||
Outstanding at December 31, 2020 |
20,836,116 | $ | 3.08 | 5.9 years | ||||||||
Granted |
244,286 | 6.09 | ||||||||||
Outstanding at December 31, 2021 |
21,080,402 | 3.11 | 5.0 years | |||||||||
Granted |
148,668 | 7.50 | ||||||||||
Outstanding at December 31, 2022 |
21,229,070 | $ | 3.14 | 4.0 years |
Basic warrants
Management were issued basic warrants subject to a service condition only. The service condition is met with a portion vesting and becoming exercisable immediately, on grant, and the remainder vesting and becoming exercisable on each of the first five anniversary dates following the original grant date of the warrants. The vesting percentages range from 12.5% to 25.0% annually. All basic warrants have now vested.
For the year ended December 31, 2022, total compensation expense of $1.9 million (2021: $2.5 million, 2020: $18.0 million) related to basic warrants was included in general and administrative expenses. At December 31, 2022, the Group had $nil (2021: $nil, 2020: $nil) of unamortized share compensation expense related to the basic warrants.
The associated tax benefit recorded to income tax expense in the Consolidated Statement of Operations in respect of basic warrants was $0.3 million, $0.5 million and $3.4 million for the years ended December 31, 2022, 2021 and 2020 respectively.
The basic warrant activity for the years ended December 31, 2022 and 2021 were as follows:
Number of warrants | Weighted average grant date fair value |
Weighted average remaining contractual term |
||||||||||
Outstanding at December 31, 2020 |
16,198,323 | $ | 1.98 | 8.0 years | ||||||||
Granted |
522,690 | 4.79 | ||||||||||
Exercised |
(282,695 | ) | 2.83 | |||||||||
Forfeited |
(335,046 | ) | 1.87 | |||||||||
Outstanding at December 31, 2021 |
16,103,272 | 1.98 | 7.1 years | |||||||||
Exercisable at December 31, 2021 |
16,103,272 | 1.98 | 7.1 years | |||||||||
Granted |
324,257 | 6.03 | ||||||||||
Exercised |
(290,329 | ) | 4.93 | |||||||||
Forfeited |
(56,816 | ) | 4.38 | |||||||||
Outstanding at December 31, 2022 |
16,080,384 | 2.08 | 6.1 years | |||||||||
Exercisable at December 31, 2022 |
16,080,384 | $ | 2.08 | 6.1 years |
F-87
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
Ratchet warrants
Management were issued ratchet warrants subject to a service and performance condition. No ratchet warrants were exercisable at December 31, 2022 (2021: $nil, 2020: $nil).
The performance condition will be met with respect to ratchet warrants upon meeting Group performance goals, including achieving specific target internal rate of return thresholds. Upon meeting all required performance conditions, the ratchet warrants will vest on the fifth anniversary following the grant date. For the year ended December 31, 2022, total compensation expense of $nil (2021: $nil, 2020: $nil) related to ratchet warrants was included in general and administrative expenses. At December 31, 2022, the Group had $nil (2021: $nil, 2020: $nil) of unamortized share compensation expense related to the ratchet warrants.
Ratchet warrant activity for the years ended December 31, 2022 and 2021 was as follows:
Number of warrants | Weighted average grant date fair value |
Weighted average remaining contractual term |
||||||||||
Outstanding at December 31, 2020 |
1,941,352 | $ | 3.26 | 6.5 years | ||||||||
Granted |
34,324 | 7.15 | ||||||||||
Forfeited |
(326,724 | ) | 3.26 | |||||||||
Outstanding at December 31, 2021 |
1,648,952 | 3.34 | 5.6 years | |||||||||
Granted |
21,528 | 8.57 | ||||||||||
Outstanding at December 31, 2022 |
1,670,480 | $ | 3.34 | 4.7 years |
Restricted stock units
On February 17, 2016, the 2015 Non-Qualified Share Option Plan (the 2015 Plan) was approved by the Board of Directors. The Group reserved up to 2% of the diluted shares to the issuance of RSUs to purchase common shares. The RSUs are granted with a $0.01 exercise price and expire 10 years from the date of issuance.
On November 8, 2018, the 2018 Non-Qualified Share Option Plan (the 2018 Plan) was approved by the Board of Directors. The Group reserved up to 3% of the diluted shares to the issuance of RSUs to purchase common shares. The RSUs are granted with a $0.01 exercise price and expire 10 years from the date of issuance. RSU exercises are satisfied through the issue of new shares.
The RSUs contain both service and performance conditions. The RSUs vest after a three-year period and a portion are subject to the satisfaction of certain performance conditions based on achievement of pre-established targets for return on equity for the Group as well as a relative performance metric compared to peers. The fair value of the RSUs is estimated at the latest price at which the Group raised capital. Where no recent capital transaction has occurred, the fair value is determined by the Board.
F-88
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
The following table provides RSU activity for the years ended December 31, 2022 and 2021:
Number of RSUs | Weighted average grant date fair value |
Weighted average remaining contractual term |
||||||||||
Outstanding at December 31, 2020 |
3,593,917 | $ | 9.49 | 1.3 years | ||||||||
Exercisable at December 31, 2020 |
102,681 | 9.08 | ||||||||||
Granted |
1,625,669 | 14.24 | ||||||||||
Exercised |
(1,024,535 | ) | 9.11 | |||||||||
Forfeited |
(99,102 | ) | 11.40 | |||||||||
Outstanding at December 31, 2021 |
4,095,949 | 11.36 | 1.2 years | |||||||||
Exercisable at December 31, 2021 |
178,972 | 9.11 | ||||||||||
Granted |
1,212,824 | 17.53 | ||||||||||
Exercised |
(800,179 | ) | 10.08 | |||||||||
Forfeited |
(202,945 | ) | 11.96 | |||||||||
Outstanding at December 31, 2022 |
4,305,650 | 8.33 | 1.1 years | |||||||||
Exercisable at December 31, 2022 |
264,241 | $ | 8.81 |
The number of RSUs included in the above table are based upon target vesting of 100%, but actual vesting will differ. Within the granted line for 2022 is a reduction of 249,712 RSUs granted as a result of the performance targets for the 2019 RSU grant not being met. Within the granted line for 2021 are 101,729 RSUs that relate to additional RSUs granted as a result of the performance targets for the 2018 RSU grant being exceeded.
At December 31, 2022, total compensation expense of $13.9 million (2021: $7.3 million, 2020: $14.6 million) relating to the RSUs was included in general and administrative expenses. An income tax benefit of $1.6 million (2021: $1.4 million; 2020: $2.8 million) was recorded in the Consolidated Statements of Income. At December 31, 2022, there was a remaining unamortized balance of $21.0 million (2021: $18.3 million, 2020: $20.1 million), which will be recognized over the remaining service period.
23. | Income Taxes |
Net income before tax is split between the Groups operating jurisdictions based on the jurisdiction of tax residence as per below:
For the year ended December 31, | ||||||||||||
2022 | 2021 | 2020 | ||||||||||
United Kingdom |
72.6 | 33.4 | (32.7 | ) | ||||||||
Bermuda |
(0.3 | ) | 40.0 | 159.0 | ||||||||
Republic of Ireland |
3.9 | 5.5 | (3.4 | ) | ||||||||
US |
| (0.2 | ) | 0.6 | ||||||||
Belgium |
3.9 | | | |||||||||
|
|
|
|
|
|
|||||||
Total |
80.1 | 78.7 | 123.5 | |||||||||
|
|
|
|
|
|
United Kingdom
FIHL, Pine Walk, FUL and FML are tax resident in the United Kingdom and are subject to relevant taxes in that jurisdiction. The U.K. Government made a number of tax law changes during 2021. These include confirming
F-89
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
that the rate of corporation tax will increase to 25% from April 1, 2023. This new law was enacted on June 10, 2021. Deferred taxes at the December 31, 2022 and 2021 balance sheet dates have been measured using these enacted tax rates. This means that the 25% main rate of corporation tax will be relevant for any temporary differences expected to reverse on or after April 1, 2023. Corporation tax receivable/payable has not been relieved at full value and losses will be carried forward and the deferred tax asset at December 31, 2022 has been measured at 25% (2021: 25%).
2021 to 2022 are open tax years in the United Kingdom.
Bermuda
Under current Bermuda law, the Groups Bermudian subsidiary, FIBL, is not required to pay any taxes in Bermuda on its income or capital gains. The subsidiary has received undertakings from the Minister of Finance in Bermuda that, in the event of any taxes being imposed, they will be exempt from taxation in Bermuda until March 2035 under the Tax Assurance Certificates issued to such entities pursuant to the Bermuda Exempted Undertakings Tax Protection Act of 1966, as amended. The impact of this is included within income/losses not subject to income taxes in Impact of differences in tax rates as set out in the reconciliation of the difference between the charge for income taxes and the expected tax expense below.
Republic of Ireland
FIID is tax resident in the Republic of Ireland (ROI). In addition, FML has elected for its Irish branch to not be subject to UK income taxes. As such both FIID and the Irish branch of FML are subject to Irish corporation tax, and not UK corporation tax, on their trading profits at a rate of 12.5%.
2018 to 2021 are open tax years in the ROI.
United States
Fidelis US Holdings Inc, (FUSH), an immaterial subsidiary of the Group is tax resident in the United States and is subject to relevant taxes in that jurisdiction.
The statute of limitations on corporate tax returns is three years after such that 2019 to 2022 are considered open tax years in the US with the US tax authorities.
The Group continues to believe that it has made adequate provision for the liabilities likely to arise from periods open to examination. The ultimate liability for such matters may vary from the amounts provided and is dependent upon the outcome of agreements with relevant taxing authorities. Fidelis has developed its process to review and measure tax positions using internal expertise, experience and judgment, together with assistance and opinions from professional advisors. Original estimates are always refined as additional information becomes available.
F-90
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
The Group income tax (expense)/benefit for the years ended December 31, 2022, 2021, and 2020 is as follows:
2022 | 2021 | 2020 | ||||||||||
Current tax expense |
$ | (28.2 | ) | $ | (26.8 | ) | $ | (2.9 | ) | |||
Deferred tax benefit (excluding rate change) |
10.4 | 17.8 | 4.7 | |||||||||
Rate change on deferred tax |
| 8.6 | 1.3 | |||||||||
|
|
|
|
|
|
|||||||
Income tax (expense)/benefit |
$ | (17.8 | ) | $ | (0.4 | ) | $ | 3.1 | ||||
|
|
|
|
|
|
2022 | 2021 | 2020 | ||||||||||
Income tax (expense)/benefit allocated to net income |
$ | (17.8 | ) | $ | (0.4 | ) | $ | 3.1 | ||||
Income tax (expense)/benefit allocated to comprehensive income |
8.1 | 2.4 | (0.7 | ) | ||||||||
|
|
|
|
|
|
|||||||
Total income tax (expense)/benefit allocated to comprehensive income |
$ | (9.7 | ) | $ | 2.0 | $ | 2.4 | |||||
|
|
|
|
|
|
Year ended December 31, 2022 | ||||||||||||||||
Income/(loss) before tax |
Current tax benefit/(expense) |
Deferred tax benefit/(expense) |
Total income tax benefit/(expense) |
|||||||||||||
($ in millions) | ||||||||||||||||
United Kingdom |
$ | 72.6 | $ | (25.4 | ) | $ | 10.6 | $ | (14.8 | ) | ||||||
Bermuda |
(0.3 | ) | | | | |||||||||||
US |
| | | | ||||||||||||
Republic of Ireland |
3.9 | (0.4 | ) | (0.2 | ) | (0.6 | ) | |||||||||
Belgium |
3.9 | (2.4 | ) | | (2.4 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 80.1 | $ | (28.2 | ) | $ | 10.4 | $ | (17.8 | ) | ||||||
|
|
|
|
|
|
|
|
Year ended December 31, 2021 | ||||||||||||||||
Income/(loss) before tax |
Current tax benefit/(expense) |
Deferred tax benefit/(expense) |
Total income tax benefit/(expense) |
|||||||||||||
($ in millions) | ||||||||||||||||
United Kingdom |
$ | 33.4 | $ | (26.3 | ) | $ | 26.9 | $ | 0.6 | |||||||
Bermuda |
40.0 | | | | ||||||||||||
US |
(0.2 | ) | | | | |||||||||||
Republic of Ireland |
5.5 | (0.5 | ) | (0.5 | ) | (1.0 | ) | |||||||||
Belgium |
| | | | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 78.7 | $ | (26.8 | ) | $ | 26.4 | $ | (0.4 | ) | ||||||
|
|
|
|
|
|
|
|
Year ended December 31, 2020 | ||||||||||||||||
Income/(loss) before tax |
Current tax benefit/(expense) |
Deferred tax benefit/(expense) |
Total income tax benefit/(expense) |
|||||||||||||
($ in millions) | ||||||||||||||||
United Kingdom |
$ | (32.7 | ) | $ | (2.7 | ) | $ | 5.6 | $ | 2.9 | ||||||
Bermuda |
159.0 | | | | ||||||||||||
US |
0.6 | | | | ||||||||||||
Republic of Ireland |
(3.4 | ) | (0.2 | ) | 0.4 | 0.2 | ||||||||||
Belgium |
| | | | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 123.5 | $ | (2.9 | ) | $ | 6.0 | $ | 3.1 | |||||||
|
|
|
|
|
|
|
|
F-91
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
The effective tax rate for the Group is 23.1% (2021: 0.5%, 2020: negative 2.5%).
A reconciliation of the difference between reported income tax (expense)/benefit and the expected income tax expense at the average UK statutory income tax rate for the years ended December 31, 2022, 2021 and 2020 is provided below. The expected income tax expense has been calculated using income before income taxes multiplied by the UK statutory income tax rate, the income tax rate in Fideliss country of tax residence.
2022 | 2021 | 2020 | ||||||||||
Expected income tax expense at the UK income tax rate of 19% |
$ | (14.6 | ) | $ | (14.9 | ) | $ | (23.5 | ) | |||
Reconciling items |
||||||||||||
Disallowable expenses |
(7.1 | ) | (2.7 | ) | (7.7 | ) | ||||||
Income not subject to income taxes |
0.3 | 0.1 | 0.3 | |||||||||
Adjustments in respect of prior year |
0.1 | 0.1 | 2.9 | |||||||||
Effects of changes to UK tax rates |
| 8.6 | 1.3 | |||||||||
Impact of differences in tax rates |
2.8 | 8.1 | 30.0 | |||||||||
Change in valuation allowance |
| (0.5 | ) | (0.1 | ) | |||||||
Foreign currency transactions |
0.7 | 0.8 | (0.1 | ) | ||||||||
|
|
|
|
|
|
|||||||
Income tax (expense)/benefit |
$ | (17.8 | ) | $ | (0.4 | ) | $ | 3.1 | ||||
|
|
|
|
|
|
The components of the Groups net non-current deferred tax asset at December 31, 2022 and 2021 are as follows:
2022 | 2021 | |||||||
Deferred tax assets: |
||||||||
Net operating loss carryforwards |
$ | 43.0 | $ | 31.2 | ||||
Other temporary differences |
0.5 | 0.8 | ||||||
Fixed assets |
| 0.7 | ||||||
Available-for-sale investments |
9.1 | 1.1 | ||||||
Share based payments |
8.3 | 8.7 | ||||||
Corporate interest restriction carryforwards |
1.5 | | ||||||
|
|
|
|
|||||
Total deferred tax assets |
62.4 | 42.5 | ||||||
|
|
|
|
|||||
Deferred tax liabilities: |
||||||||
Fixed assets |
(1.7 | ) | | |||||
|
|
|
|
|||||
Total deferred tax liabilities |
(1.7 | ) | | |||||
|
|
|
|
|||||
Valuation allowance |
(2.2 | ) | (2.2 | ) | ||||
|
|
|
|
|||||
Net deferred tax asset |
$ | 58.5 | $ | 40.3 | ||||
|
|
|
|
The net operating loss carryforwards on which the deferred tax asset has been provided consist of $175.8 million (2021: $125.0 million) arising in the UK and $nil (2021: $2.2 million) arising in the ROI. There is no expiry date for the losses. In addition to the operating loss carryforwards, there is a corporate interest rate restriction carryforward of $5.9 million in the UK (2021: nil). There is no expiry date for the losses or the interest rate restriction carryforward. A valuation allowance of $2.2 million (2021: $2.2 million) has been made against certain loss carryforwards in the UK as the Group considers that it is more likely than not that these will not be recovered against future income.
The Group paid and accrued interest payments to the UK taxing authority, His Majestys Revenue and Customs (HMRC), totaling $nil for the year ended December 31, 2022 (2021: $0.2 million, 2020: $nil).
F-92
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
At December 31, 2022, $15.4 million was owed in total to taxing authorities in jurisdictions where the Group operates (2021: $4.3 million). This amount is included within Other liabilities on the Consolidated Balance Sheet.
At December 31, 2022, the Group did not have any material unrecognized tax benefits. The Group does not anticipate any changes in unrecognized tax benefits during 2023 that would have a material impact on the Groups income tax expense.
During 2021, the OECD published a framework for the introduction of a global minimum tax rate of 15%, applicable to large multinational groups. In July 2022, HM Treasury released draft legislation to implement these rules for accounting periods starting on or after December 31, 2023. The Group is reviewing and monitoring these draft rules, which have not been enacted, to understand any potential impacts.
24. Ukraine Conflict
On February 24, 2022, the Russian Federation invaded Ukraine resulting in armed conflict in Ukraine and the Black Sea (Ukraine Conflict). Subsequently a number of countries, including the United States of America, the United Kingdom, and those in the European Union, placed significant sanctions on Russian institutions and persons which resulted in a devaluation of the Ruble and a fall in the value of Russian fixed income and equity assets, and the prompt withdrawal of companies from Russia without securing their assets. Fidelis has minimal direct exposure to Russian equities and minimal exposure to fixed income assets impacted by sanctions. It had now been over a year since the commencement of the Ukraine Conflict. Fidelis has potential exposure to losses associated with the conflict in Ukraine and the Black Sea through certain lines in the Bespoke and Specialty segments. Fidelis, in common with the rest of the London Aviation Insurance Market, is the subject of various litigation proceedings brought by Aircraft Lessors in the United States of America, the United Kingdom, and those in the European Union. Notwithstanding this, Fidelis continues to believe the impact of the Ukraine Conflict will not adversely affect the Groups ability to operate as a going concern.
25. Subsequent Events
Subsequent events have been evaluated up to the issuance of these consolidated financial statements.
a. | Separation Transactions |
On January 3, 2023, the Group completed a transaction pursuant to which (i) Pine Walk and its investments in the MGAs, together with FML, were distributed to shareholders to form a new managing general underwriting business (Fidelis MGU) and (ii) Fidelis MGU was acquired by a consortium of investors (together known as the Separation Transactions). Following the consummation of the Separation Agreement, Fidelis MGU acquired approximately 9.9% of the common shares in the Group.
Immediately prior to the consummation of the Separation Transactions, the Group accelerated the vesting of all unvested RSUs. This resulted in the acceleration of compensation expense of $21.0 million and an employer tax expense of $17.3 million in the three months ending March 31, 2023. The RSUs and warrants were exercised on the date of the Separation Transactions, resulting in the issuance of 13,553,681 common shares. The awards were net settled, resulting in a $50.6 million reduction of additional paid-in capital for the employees tax obligations with respect to these awards. The exercise of the warrants triggered the payment of cumulative dividends of $34.1 million.
F-93
FIDELIS INSURANCE HOLDINGS LIMITED
Notes to Consolidated Financial Statements
For the years ended December 31, 2022, December 31, 2021 and December 31, 2020
(Expressed in millions of U.S. dollars)
The Separation Transactions resulted in certain shareholders receiving cash in lieu of their interest in Fidelis MGU. As a result, the distribution of Fidelis MGU will be recorded at its fair value estimated to be between $1.7 billion and $1.9 billion. The distribution of Fidelis MGU to shareholders of the Group will result in the deconsolidation of net assets of $68.8 million, and the cancellation of 97,327,049 common shares in the Group. Following the Separation Transactions there are 110,771,897 common shares issued and outstanding.
Fidelis MGU will manage underwriting, origination, outwards reinsurance, actuarial and claims services with review and oversight from the Group. Each of FIBL, FUL and FIID has entered a delegated underwriting authority agreement with a relevant entity within the Fidelis MGU group, in each case with effect from January 1, 2023. The agreements have a rolling 10-year term and provide for the payment of the following fees to Fidelis MGU:
a. | A ceding commission of 11.5% of net premiums written of open market business. |
b. | A ceding commission of 3% of net premiums written of business sourced via third-party managing general underwriters. |
c. | A profit commission of 20% of the operating profit generated on the sourced business, subject to a hurdle rate of return of 5% of underwriting return on equity. |
d. | A portfolio management fee of 3% of net premiums written of the business sourced by Fidelis MGU. |
In connection with the successful consummation of the Separation Transactions, the Group incurred professional fees of $28.6 million during the three months ending March 31, 2023.
b. | 2023 Share Incentive Plan |
On May 15, 2023, shareholders approved the establishment of the 2023 Share Incentive Plan (the 2023 Plan). The 2023 Plan authorizes the issuance of options, restricted shares, restricted share units, share appreciation rights or other share-based awards to the Groups employees and directors. The total number of shares available under the Plan is 4,615,500 (plus an additional number of Common Shares equal to 4%, on a fully diluted basis, of the Common Shares sold by the Group in connection with an initial public offering). The following awards were granted in May 2023:
i. | Time-vested awards share settled |
The Company granted 489,012 restricted share units that cliff vest on March 31, 2024 and 179,831 restricted share units that cliff vest on December 31, 2025.
ii. | Performance-vested awards share settled |
The Company granted 285,151 restricted share units that cliff vest on December 31, 2025, subject to the achievement of established performance criteria and continued service during the applicable performance period.
c. | Reverse Share Split |
On June 14, 2023, the Companys Board of Directors approved a 1-for-0.92 reverse share split of the Companys common shares. The reverse share split became effective June 16, 2023. All share and per share information and the amounts presented for common shares and additional paid-in capital included in the consolidated balance sheets, consolidated statements of income and comprehensive income, consolidated statements of changes in shareholders equity, Notes 20, 21, 22 and 25a and Schedule II have been retroactively adjusted to reflect the reverse share split of the Companys common shares for all years presented.
F-94
SCHEDULE IIFIDELIS INSURANCE HOLDINGS LIMITED
Condensed Financial Information of Registrant
Condensed Balance SheetParent company only
(expressed in millions of US Dollars)
December 31, 2022 | December 31 2021 | |||||||
Assets |
||||||||
Investments in subsidiaries |
$ | 2,302.8 | $ | 2,489.7 | ||||
Cash and cash equivalents |
127.6 | 15.1 | ||||||
Amounts due from affiliates |
27.8 | 21.4 | ||||||
Deferred tax assets |
38.8 | 24.6 | ||||||
Other assets |
8.9 | 4.7 | ||||||
|
|
|
|
|||||
Total assets |
$ | 2,505.9 | $ | 2,555.5 | ||||
|
|
|
|
|||||
Liabilities and shareholders equity |
||||||||
Liabilities |
||||||||
Amounts due to affiliates |
$ | 23.2 | $ | 31.7 | ||||
Loan notes |
447.5 | 446.9 | ||||||
Preference securities |
58.4 | 58.4 | ||||||
Other liabilities |
| 4.6 | ||||||
|
|
|
|
|||||
Total liabilities |
$ | 529.1 | $ | 541.6 | ||||
|
|
|
|
|||||
Shareholders equity |
||||||||
Common shares ($0.01 par, issued and outstanding: 194,545,370; 2021 194,023,401) |
$ | 1.9 | $ | 1.9 | ||||
Additional paid-in capital |
2,075.2 | 2,075.4 | ||||||
Accumulated other comprehensive loss |
(100.8 | ) | (11.3 | ) | ||||
Retained earnings/(accumulated deficit) |
0.5 | (52.1 | ) | |||||
|
|
|
|
|||||
Total shareholders equity |
$ | 1,976.8 | $ | 2,013.9 | ||||
|
|
|
|
|||||
Total liabilities and shareholders equity |
$ | 2,505.9 | $ | 2,555.5 | ||||
|
|
|
|
F-96
SCHEDULE IIFIDELIS INSURANCE HOLDINGS LIMITED
Condensed Financial Information of Registrant
Condensed Statement of Income (Loss)Parent company only
(expressed in millions of US Dollars)
For the year ended | ||||||||||||
December 31, 2022 | December 31, 2021 | December 31, 2020 | ||||||||||
Revenues |
||||||||||||
Net investment income |
$ | 0.4 | $ | | $ | 0.3 | ||||||
Dividend from subsidiaries |
220.9 | 83.0 | 50.5 | |||||||||
Net foreign exchange gains |
0.3 | | | |||||||||
Other income |
| | 2.8 | |||||||||
|
|
|
|
|
|
|||||||
Total revenues |
$ | 221.6 | $ | 83.0 | $ | 53.6 | ||||||
|
|
|
|
|
|
|||||||
Expenses |
||||||||||||
General and administrative expenses |
47.2 | 24.8 | 26.9 | |||||||||
Financing costs |
30.3 | 30.9 | 24.2 | |||||||||
Loss on extinguishment of preference securities |
| | 25.3 | |||||||||
Net foreign exchange losses |
| (0.3 | ) | (0.1 | ) | |||||||
|
|
|
|
|
|
|||||||
Total expenses |
$ | 77.5 | $ | 55.4 | $ | 76.3 | ||||||
|
|
|
|
|
|
|||||||
Income/(loss) before income taxes |
$ | 144.1 | $ | 27.6 | $ | (22.7 | ) | |||||
Income tax benefit |
14.2 | 15.3 | 7.1 | |||||||||
|
|
|
|
|
|
|||||||
Net income/(loss) before equity in net income of subsidiaries |
$ | 158.3 | $ | 42.9 | $ | (15.6 | ) | |||||
Equity income/(loss) net income of subsidiaries |
(105.7 | ) | 25.4 | 142.1 | ||||||||
|
|
|
|
|
|
|||||||
Net income available to common shareholders |
$ | 52.6 | $ | 68.3 | $ | 126.5 | ||||||
|
|
|
|
|
|
|||||||
Other Comprehensive income/(loss) |
||||||||||||
Unrealized (loss)/gains on AFS financial assets |
$ | (96.5 | ) | $ | (36.1 | ) | $ | 12.1 | ||||
Income tax benefit/(expense), all of which relates to unrealized (loss)/gain on AFS financial assets |
8.1 | 2.4 | (0.7 | ) | ||||||||
Currency translation adjustments |
(1.1 | ) | (0.2 | ) | | |||||||
|
|
|
|
|
|
|||||||
Total other comprehensive income/(loss) available to common shareholders |
$ | (89.5 | ) | $ | (33.9 | ) | $ | 11.4 | ||||
|
|
|
|
|
|
|||||||
Comprehensive income/(loss) available to common shareholders |
$ | (36.9 | ) | $ | 34.4 | $ | 137.9 | |||||
|
|
|
|
|
|
F-97
SCHEDULE IIFIDELIS INSURANCE HOLDINGS LIMITED
Condensed Financial Information of Registrant
Condensed Statement of Cash flowsParent company only
(expressed in millions of US Dollars)
For the year ended | ||||||||||||
December 31, 2022 | December 31, 2021 | December 31, 2020 | ||||||||||
Operating activities |
||||||||||||
Net income |
$ | 52.6 | $ | 68.3 | $ | 126.5 | ||||||
Less: Equity in net income of subsidiaries |
105.7 | (25.4 | ) | (142.1 | ) | |||||||
Share based compensation expense |
10.8 | 9.8 | 32.6 | |||||||||
Income tax benefit |
(14.2 | ) | (21.3 | ) | (0.4 | ) | ||||||
Adjustments to reconcile net income to net cash provided by operating activities |
||||||||||||
Changes in assets and liabilities: |
||||||||||||
Due to from subsidiaries |
(14.9 | ) | 21.3 | (3.1 | ) | |||||||
Other assets |
(4.2 | ) | (0.4 | ) | 5.5 | |||||||
Other liabilities |
(4.6 | ) | (1.5 | ) | 1.1 | |||||||
|
|
|
|
|
|
|||||||
Net cash provided by operating activities |
$ | 131.2 | $ | 50.8 | $ | 20.1 | ||||||
Investing activities: |
||||||||||||
Contributed capital to subsidiaries |
| (75.0 | ) | (936.5 | ) | |||||||
Purchase of non-controlling interest |
(18.2 | ) | | | ||||||||
|
|
|
|
|
|
|||||||
Net cash used in investing activities |
$ | (18.2 | ) | $ | (75.0 | ) | $ | (936.5 | ) | |||
Financing activities: |
||||||||||||
Proceeds from issuance of loan notes, net of issuance costs |
| | 445.7 | |||||||||
Proceeds from issuance of common shares, net of issuance costs |
| 318.2 | 691.8 | |||||||||
Repurchase of common shares |
| (320.9 | ) | | ||||||||
Dividends on common shares |
(0.5 | ) | (2.1 | ) | (5.1 | ) | ||||||
Repurchase of preference securities |
| | (183.8 | ) | ||||||||
|
|
|
|
|
|
|||||||
Net cash provided by (used in) financing activity |
$ | (0.5 | ) | $ | (4.8 | ) | $ | 948.6 | ||||
Net increase/(decrease) in cash and cash equivalents |
112.5 | (29.0 | ) | 32.2 | ||||||||
Cash and cash equivalents at beginning of period |
15.1 | 44.1 | 11.9 | |||||||||
|
|
|
|
|
|
|||||||
Cash and cash equivalents at end of period |
$ | 127.6 | $ | 15.1 | $ | 44.1 | ||||||
|
|
|
|
|
|
F-98
SCHEDULE IIIFIDELIS INSURANCE HOLDINGS LIMITED AND SUBSIDIARIES
Supplementary Insurance Information
(expressed in millions of US Dollars)
Deferred policy acquisition costs |
Reserve for losses and loss adjustment expenses |
Unearned Premiums |
Net Premiums Earned |
Net Investment Income* |
Net Losses and Loss Adjustment Expenses incurred |
Amortization of Deferred policy acquisition costs |
General and administrative expenses |
Net Premiums Written |
||||||||||||||||||||||||||||
December 31, 2022 |
||||||||||||||||||||||||||||||||||||
Bespoke |
$ | 338.7 | 157.6 | 1,394.6 | 379.4 | | 118.9 | 141.2 | | 561.7 | ||||||||||||||||||||||||||
Specialty |
156.2 | 870.0 | 1,055.4 | 852.8 | | 508.7 | 219.5 | | 1,060.8 | |||||||||||||||||||||||||||
Reinsurance |
20.9 | 1,017.6 | 168.6 | 272.5 | | 202.6 | 87.0 | | 240.1 | |||||||||||||||||||||||||||
Other |
| | | | 40.7 | | | (106.4 | ) | | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total |
$ | 515.8 | 2,045.2 | 2,618.6 | 1,504.7 | 40.7 | 830.2 | 447.7 | (106.4 | ) | 1,862.6 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
December 31, 2021 |
||||||||||||||||||||||||||||||||||||
Bespoke |
274.7 | 5.1 | 1,100.6 | 251.9 | | 71.4 | 84.6 | | 434.6 | |||||||||||||||||||||||||||
Specialty |
101.4 | 329.9 | 742.9 | 535.3 | | 206.2 | 127.3 | | 758.2 | |||||||||||||||||||||||||||
Reinsurance |
27.2 | 1,051.5 | 270.2 | 367.0 | | 419.2 | 88.0 | | 408.3 | |||||||||||||||||||||||||||
Other |
| | | | 20.6 | | | (75.4 | ) | | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total |
$ | 403.3 | 1,386.5 | 2,113.7 | 1,154.2 | 20.6 | 696.8 | 299.9 | (75.4 | ) | 1,601.1 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
December 31, 2020 |
||||||||||||||||||||||||||||||||||||
Bespoke |
214.2 | 130.0 | 816.9 | 212.5 | | 70.5 | 66.8 | | 251.2 | |||||||||||||||||||||||||||
Specialty |
48.0 | 144.0 | 429.4 | 171.7 | | 64.8 | 36.5 | | 403.1 | |||||||||||||||||||||||||||
Reinsurance |
14.3 | 544.0 | 159.2 | 344.4 | | 189.2 | 75.9 | | 251.3 | |||||||||||||||||||||||||||
Other |
| | | | 26.2 | | | (83.5 | ) | | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total |
$ | 276.5 | 818.0 | 1,405.5 | 728.6 | 26.2 | 324.5 | 179.2 | (83.5 | ) | 905.6 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* The Company does not manage its assets by segment and accordingly net investment income is not allocated to each underwriting segment. In addition, operating expenses are not allocated to segment (as employees and their associated costs) work across segments.
F-99
SCHEDULE IVFIDELIS INSURANCE HOLDINGS LIMITED AND SUBSIDIARIES
Reinsurance
(expressed in millions of US Dollars)
Gross Amount |
Ceded to Other Companies |
Assumed from Other Companies |
Net Amount |
Percentage of Amount Assumed to Net |
||||||||||||||||
Year Ended December 31, 2022 |
||||||||||||||||||||
Premiums Written: |
||||||||||||||||||||
Bespoke |
724.5 | (221.5 | ) | 58.7 | 561.7 | 10 | % | |||||||||||||
Specialty |
1,344.6 | (549.9 | ) | 266.1 | 1,060.8 | 25 | % | |||||||||||||
Reinsurance |
| (366.1 | ) | 606.2 | 240.1 | 252 | % | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total |
2,069.1 | (1,137.5 | ) | 931.0 | 1,862.6 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Year Ended December 31, 2021 |
||||||||||||||||||||
Premiums Written: |
||||||||||||||||||||
Bespoke |
592.7 | (153.4 | ) | (4.7 | ) | 434.6 | (1 | %) | ||||||||||||
Specialty |
906.0 | (357.0 | ) | 209.2 | 758.2 | 28 | % | |||||||||||||
Reinsurance |
| (676.2 | ) | 1,084.5 | 408.3 | 266 | % | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total |
1,498.7 | (1,186.6 | ) | 1,289.0 | 1,601.1 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Year Ended December 31, 2020 |
||||||||||||||||||||
Premiums Written: |
||||||||||||||||||||
Bespoke |
326.5 | (87.9 | ) | 12.6 | 251.2 | 5 | % | |||||||||||||
Specialty |
394.2 | (174.8 | ) | 183.7 | 403.1 | 46 | % | |||||||||||||
Reinsurance |
0.8 | (408.2 | ) | 658.7 | 251.3 | 262 | % | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total |
721.5 | (670.9 | ) | 855.0 | 905.6 | |||||||||||||||
|
|
|
|
|
|
|
|
F-100
SCHEDULE VIFIDELIS INSURANCE HOLDINGS LIMITED AND SUBSIDIARIES
SUPPLEMENTARY INFORMATION FOR PROPERTY AND CASUALTY INSURANCE UNDERWRITERS
(expressed in millions U.S. dollars)
Column A | Column B | Column C | Column D | Column E | Column F | Column G | Column H | Column I | Column I | Column J | Column K | |||||||||||||||||||||||||||||||||
Net Losses and Loss Adjustment Expenses Incurred Related to |
||||||||||||||||||||||||||||||||||||||||||||
Affiliation with |
Deferred policy acquisition costs |
Reserve for losses and loss adjustment expenses |
Discount, if any, deducted in Column C |
Unearned Premiums |
Net Premium Earned |
Net Investment Income |
(a) Current Year |
(b) Prior Year |
Amortization of Deferred policy acquisition costs |
Net Paid Losses and Loss Adjustment Expenses |
Net Premiums Written |
|||||||||||||||||||||||||||||||||
Consolidated Subsidiaries |
||||||||||||||||||||||||||||||||||||||||||||
2022 |
515.8 | 2,045.2 | | 2,618.6 | 1,504.7 | 40.7 | (852.3 | ) | 22.1 | 447.7 | 324.7 | 1,862.6 | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
2021 |
403.3 | 1,386.5 | | 2,113.7 | 1,154.2 | 20.6 | (706.4 | ) | 9.6 | 299.9 | 528.6 | 1,601.1 | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
2020 |
276.5 | 818.0 | | 1,405.5 | 728.6 | 26.2 | (362.9 | ) | 38.4 | 179.2 | 185.1 | 905.6 | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-101
17,000,000 Common Shares
FIDELIS INSURANCE HOLDINGS LIMITED
, 2023
J.P. Morgan | Barclays | Jefferies |
|
BMO Capital Markets | Citigroup | UBS Investment Bank |
|
Dowling & Partners Securities, LLC |
Through and including , 2023 (the 25th day after the date of this prospectus), all dealers that effect transactions in the our Common Shares, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers obligations to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.
PART II
INFORMATION NOT
REQUIRED IN PROSPECTUS
ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS
To the extent permitted by the Companies Act, we are empowered to indemnify our directors against any liability they incur by reason of their directorship and we have entered into such an indemnification agreement with directors which is filed as an exhibit to this registration statement. We maintain directors and officers insurance to insure such persons against certain liabilities.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is theretofore unenforceable.
ITEM 7. RECENT SALES OF UNREGISTERED SECURITIES
During the past three years, we issued securities that were not registered under the Securities Act as set forth below. We believe that each of such issuances of the securities described below were exempt from registration pursuant to Section 4(a)(2) of the Securities Act as transactions by an issuer not involving a public offering or Rule 701 promulgated under the Securities Act as transactions pursuant to compensatory benefit plans and/or Regulation S under the Securities Act as offshore transactions to non-U.S. Persons.
| Common Shares |
○ | On February 10, 2020 we issued 13,906,464 Common Shares for total proceeds of $142.3 million, net of issuance costs in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act and/or Regulation D or Regulation S promulgated thereunder; |
○ | On June 10, 2020, we issued 34,533,958 Common Shares for total proceeds of $355.0 million, net of issuance costs in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act and/or Regulation D or Regulation S promulgated thereunder; |
○ | On July 23, 2020 we issued 13,583,196 Common Shares for total proceeds of $139.0 million, net of issuance costs in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act and/or Regulation D or Regulation S promulgated thereunder; |
○ | On December 1, 2020 we issued 4,156,330 Common Shares for total proceeds of $60.6 million, net of issuance costs in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act and/or Regulation D or Regulation S promulgated thereunder; and |
○ | On July 15, 2021, we issued 19,874,121 Common Shares for total proceeds of $318.2 million, net of issuance costs in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act and/or Regulation D or Regulation S promulgated thereunder. |
| Debt Securities |
○ | On June 18, 2020, we issued $300.0 million aggregate principal amount of 4.875% Senior Notes due 2030 and on July 2, 2020, we issued a further $30.0 million aggregate principal amount of 4.875% Senior Notes due 2030, in each case in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act and/or Regulation D or Regulation S promulgated thereunder; and |
II-1
○ | On October 16, 2020 we issued $105.0 million aggregate principal amount of 6.625% Fixed-Rate Reset Junior Subordinated Notes due 2041 and on October 20, 2020 we issued a further $20.0 million 6.625% aggregate principal amount of Fixed-Rate Reset Junior Subordinated Notes due 2041, in each case in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act and/or Regulation D or Regulation S promulgated thereunder. |
| Other Securities |
○ | Since January 1, 2020 we have granted 17,136,338 warrants, consisting of 11,083,005 warrants at an average exercise price of $10 per warrant, 3,026,685 warrants at an average exercise price of $16 per warrant and 3,026,648 warrants at an average exercise price of $20 per warrant. 11,194,164 Common Shares were issued in connection with the completion of the Separation Transactions upon the exercise of our in the money warrants, exercised on a cashless basis at their respective exercise price and net settled for employee taxes. Of these, 4,571 Common Shares were issued as a result of the exercise of leaver warrants. No Common Shares were issued for our out of the money or unvested warrants, which were forfeited as part of the completion of the Separation Transactions. Since January 1, 2020 we granted 4,516,815 RSUs at a weighted average price of $0.01 to certain employees and directors pursuant to the 2015 Non-Qualified Share Option Plan and the 2018 Non-Qualified Share Option Plan (collectively, the Prior Incentive Plans). In connection with the completion of the Separation Transactions. 2,359,517 Common Shares were issued upon the exercise, on a cashless basis at a $0.01 exercise price and net settled for employee taxes, of vested RSUs outstanding under our Prior Incentive Plans. All of the in the money warrants and RSUs issued since January 1, 2020 under the Prior Incentive Plans vested and exercised for Common Shares, or were forfeited, as part of the Separation Transactions. |
○ | Since May 15, 2023, we have granted LTIP Awards, in the form of time- and performance-based restricted share units, with respect to 960,895 Common Shares pursuant to the Long-Term Incentive Plan (see Executive CompensationCompensation ComponentsLong-Term Incentive Plan for additional information). |
ITEM 8. EXHIBITS
| The Exhibit Index is hereby incorporated herein by reference. |
| Financial Statement Schedules. |
All schedules have been omitted because they are not required, are not applicable or the information is otherwise set forth in the Consolidated Financial Statements and related notes thereto.
ITEM 9. UNDERTAKINGS
(a) | The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser. |
(b) | Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that, in the opinion of the Securities and Exchange Commission, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, |
II-2
officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction, the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. |
(c) | The undersigned registrant hereby further undertakes that: |
(1) | For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective. |
(2) | For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
II-3
EXHIBIT INDEX
# | Filed previously |
** | The schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request. Additionally, portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K on the basis that the Registrant customarily and actually treats that information as private or confidential and the omitted information is not material. |
| Identifies management contract or compensatory plan or arrangement |
+ | Portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K on the basis that the Registrant customarily and actually treats that information as private or confidential and the omitted information is not material. |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Hamilton, Bermuda, on this 20th day of June, 2023.
FIDELIS INSURANCE HOLDINGS LIMITED | ||
By: | /s/ Daniel Burrows | |
Name: Daniel Burrows | ||
Title: Group Chief Executive Officer and Executive Director |
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons on June 20, 2023 in the capacities indicated.
/s/ Daniel Burrows |
Name: Daniel Burrows |
Title: Group Chief Executive Officer and Executive Director |
/s/ Allan Decleir |
Name: Allan Decleir |
Title: Group Chief Financial Officer and Executive Director |
* |
Name: Helena Morrissey |
Title: Director |
* |
Name: Daniel Brand |
Title: Director |
* |
Name: Cathy Iberg |
Title: Director |
* |
Name: Daniel Kilpatrick |
Title: Director |
* |
Name: Dana LaForge |
Title: Director |
* |
Name: Hinal Patel |
Title: Director |
* |
Name: Charles Collis |
Title: Director |
* /s/ Daniel Burrows |
Daniel Burrows |
Attorney-in-Fact |
AUTHORIZED REPRESENTATIVE
Pursuant to the requirement of the Securities Act of 1933, the undersigned, the duly undersigned representative in the United States of Fidelis Insurance Holdings Limited, has signed this registration statement in the City of Newark, State of Delaware, on June 20, 2023.
By: | /s/ Donald J. Puglisi | |
Name: Donald J. Puglisi | ||
Title: Authorized Representative |
Exhibit 1.1
FIDELIS INSURANCE HOLDINGS LIMITED
[ ● ] Common Shares
Underwriting Agreement
[ ● ], 2023
J.P. Morgan Securities LLC
Barclays Capital Inc.
Jefferies LLC
As representatives (the Representatives or you) of the
several Underwriters listed
in Schedule 1 hereto
c/o J.P. Morgan Securities LLC
383 Madison Avenue
New York, New York 10179
c/o Barclays Capital Inc.
745 Seventh Avenue
New York, New York 10019
c/o Jefferies LLC
520 Madison Avenue
New York, New York 10022
Ladies and Gentlemen:
Fidelis Insurance Holdings Limited, an exempted company organized under the laws of Bermuda (the Company), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the Underwriters), for whom you are acting as representatives (the Representatives), an aggregate of [ ● ] common shares, par value $0.01 per share, of the Company, and certain shareholders of the Company listed in Schedule 2 hereto (the Selling Shareholders) propose to sell to the several Underwriters an aggregate of [ ● ] common shares of the Company (collectively, the Underwritten Shares). In addition, the Selling Shareholders propose to sell, at the option of the Underwriters, up to an additional [ ● ] common shares of the Company (collectively, the Option Shares). The Underwritten Shares and the Option Shares are herein referred to as the Shares. The common shares of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the Stock.
The Company and the Selling Shareholders hereby severally and not jointly confirm their agreement with the several Underwriters concerning the purchase and sale of the Shares, as follows:
1. Registration Statement. The Company has prepared and filed with the Securities and Exchange Commission (the Commission) under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the Securities Act), a registration statement on Form F-1 (File No. 333-271270), including a prospectus, relating to the Shares. Such registration statement, as amended at the time it became effective, including the information, if any, deemed pursuant to Rule 430A under the Securities Act to be part of the registration statement at the time of its effectiveness (Rule 430 Information), is referred to herein as the Registration Statement; and as used herein, the term Preliminary Prospectus means each prospectus included in such registration statement (and any amendments thereto) before effectiveness, any prospectus filed with the Commission pursuant to Rule 424(a) under the Securities Act and the prospectus included in the Registration Statement at the time of its effectiveness that omits Rule 430 Information, and the term Prospectus means the prospectus in the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation of sales of the Shares. If the Company has filed an abbreviated registration statement pursuant to Rule 462(b) under the Securities Act (the Rule 462 Registration Statement), then any reference herein to the term Registration Statement shall be deemed to include such Rule 462 Registration Statement. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Registration Statement and the Prospectus.
At or prior to the Applicable Time (as defined below), the Company had prepared the following information (collectively with the pricing information set forth on Annex A, the Pricing Disclosure Package): a Preliminary Prospectus dated [ ● ], 2023 and each free-writing prospectus (as defined pursuant to Rule 405 under the Securities Act) listed on Annex A hereto.
Applicable Time means [ ● ] [A/P].M., New York City time, on [ ● ], 2023.
2. Purchase of the Shares.
(a) The Company agrees to issue and sell, and each of the Selling Shareholders agrees, severally and not jointly, to sell, the Underwritten Shares to the several Underwriters as provided in this underwriting agreement (this Agreement), and each Underwriter, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase at a price per share of $[ ● ] (the Purchase Price) from the Company the respective number of Underwritten Shares set forth opposite such Underwriters name in Schedule 1 hereto and from each of the Selling Shareholders the number of Underwritten Shares (to be adjusted by the Representatives so as to eliminate fractional shares) determined by multiplying the aggregate number of Underwritten Shares to be sold by each of the Selling Shareholders as set forth opposite their respective names in Schedule 2 hereto by a fraction, the numerator of which is the aggregate number of Underwritten Shares to be purchased by such Underwriter as set forth opposite the name of such Underwriter in Schedule 1 hereto and the denominator of which is the aggregate number of Underwritten Shares to be purchased by all the Underwriters from all of the Selling Shareholders hereunder.
-2-
In addition, the Company agrees to issue and sell, and each of the Selling Shareholders agrees, severally and not jointly, as and to the extent indicated in Schedule 2 hereto, to sell, the Option Shares to the several Underwriters as provided in this Agreement, and the Underwriters, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, shall have the option to purchase, severally and not jointly, from each of the Company and each Selling Shareholder the Option Shares at the Purchase Price less an amount per share equal to any dividends or distributions declared by the Company and payable on the Underwritten Shares but not payable on the Option Shares. If any Option Shares are to be purchased, the number of Option Shares to be purchased by each Underwriter shall be the number of Option Shares which bears the same ratio to the aggregate number of Option Shares being purchased as the number of Underwritten Shares set forth opposite the name of such Underwriter in Schedule 1 hereto (or such number increased as set forth in Section 12 (Defaulting Underwriter) hereof) bears to the aggregate number of Underwritten Shares being purchased from the Company and the Selling Shareholders by the several Underwriters, subject, however, to such adjustments to eliminate any fractional Shares as the Representatives in their sole discretion shall make. Any such election to purchase Option Shares shall be made in proportion to the maximum number of Option Shares to be sold by the Company and by each Selling Shareholder as set forth in Schedule 2 hereto.
The Underwriters may exercise the option to purchase Option Shares at any time in whole, or from time to time in part, on or before the thirtieth day following the date of the Prospectus, by written notice from the Representatives to the Company, the Direct Selling Shareholders (as defined below) and the Attorneys-in-Fact (as defined below). Such notice shall set forth the aggregate number of Option Shares as to which the option is being exercised and the date and time when the Option Shares are to be delivered and paid for, which may be the same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than the Closing Date nor later than the tenth full business day (as hereinafter defined) after the date of such notice (unless such time and date are postponed in accordance with the provisions of Section 12 (Defaulting Underwriter) hereof). Any such notice shall be given at least two business days prior to the date and time of delivery specified therein.
(b) The Company and the Selling Shareholders understand that the Underwriters intend to make a public offering of the Shares, and initially to offer the Shares on the terms set forth in the Pricing Disclosure Package. The Company and the Selling Shareholders acknowledge and agree that the Underwriters may offer and sell Shares to or through any affiliate of an Underwriter.
(c) Payment for the Shares shall be made by wire transfer in immediately available funds to the accounts specified by the Company and the Selling Shareholders (or, in the case of a Non-Direct Selling Shareholder, by the Attorneys-in-Fact or any of them), to the Representatives in the case of the Underwritten Shares, at the offices of Latham & Watkins LLP, 1271 Avenue of the Americas, New York, New York 10020 at 10:00 A.M. New York City time on [ ● ], 2023, or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as the
-3-
Representatives, the Company and the Selling Shareholders (or, in the case of a Non-Direct Selling Shareholder, as the Attorneys-in-Fact) may agree upon in writing or, in the case of the Option Shares, on the date and at the time and place specified by the Representatives in the written notice of the Underwriters election to purchase such Option Shares. The time and date of such payment for the Underwritten Shares is referred to herein as the Closing Date, and the time and date for such payment for any of the Option Shares, if other than the Closing Date, is herein referred to as the Additional Closing Date.
Payment for the Shares to be purchased on the Closing Date or the Additional Closing Date, as the case may be, shall be made against delivery to the Representatives for the respective accounts of the several Underwriters of the Shares to be purchased on such date, with any transfer or similar taxes payable in connection with the sale of such Shares duly paid by the Company and the Selling Shareholders, as applicable. Delivery of the Shares shall be made through the facilities of The Depository Trust Company (DTC) unless the Representatives shall otherwise instruct.
(d) Each of the Company and each Selling Shareholder acknowledges and agrees that the Representatives and the other Underwriters are acting solely in the capacity of an arms length contractual counterparty to the Company and the Selling Shareholders with respect to the offering of Shares contemplated hereby (including in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company, the Selling Shareholders or any other person. Additionally, neither the Representatives nor any other Underwriter is advising the Company, the Selling Shareholders or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company and the Selling Shareholders shall consult with their own advisors concerning such matters and each shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and, except as set forth in this Agreement, neither the Representatives nor the other Underwriters shall have any responsibility or liability to the Company or the Selling Shareholders with respect thereto. Any review by the Representatives and the other Underwriters of the Company, the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of the Representatives and the other Underwriters and shall not be on behalf of the Company or the Selling Shareholders. Moreover, each Selling Shareholder acknowledges and agrees that, although the Representatives may be required or choose to provide certain Selling Shareholders with certain Regulation Best Interest and Form CRS disclosures in connection with the offering, the Representatives and the other Underwriters are not making a recommendation to any Selling Shareholder to participate in the offering, enter into a lock-up agreement, or sell any Shares at the price determined in the offering, and nothing set forth in such disclosures is intended to suggest that any Representative or any Underwriter is making such a recommendation.
3. Representations and Warranties of the Company. The Company represents and warrants to each Underwriter and the Selling Shareholders that:
-4-
(a) Preliminary Prospectus. No order preventing or suspending the use of any Preliminary Prospectus has been issued by the Commission, and each Preliminary Prospectus included in the Pricing Disclosure Package, at the time of filing thereof, complied in all material respects with the Securities Act, and no Preliminary Prospectus, at the time of filing thereof, contained any untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in any Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section 9(c) (Indemnification of the Company and the Selling Shareholders) hereof.
(b) Pricing Disclosure Package. The Pricing Disclosure Package as of the Applicable Time did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in such Pricing Disclosure Package, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section 9(c) (Indemnification of the Company and the Selling Shareholders) hereof. No statement of material fact included in the Prospectus has been omitted from the Pricing Disclosure Package and no statement of material fact included in the Pricing Disclosure Package that is required to be included in the Prospectus has been omitted therefrom.
(c) Issuer Free Writing Prospectus. Other than the Registration Statement, the Preliminary Prospectus and the Prospectus, the Company (including its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Shares (each such communication by the Company or its agents and representatives (other than a communication referred to in clause (i) below) an Issuer Free Writing Prospectus) other than (i) any document not constituting a prospectus pursuant to Section 2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act or (ii) the documents listed on Annex A hereto, each electronic road show and any other written communications approved in writing in advance by the Representatives. Each such Issuer Free Writing Prospectus complies in all material respects with the Securities Act, has been or will be (within the time period specified in Rule 433) filed in accordance with the Securities Act (to the extent required thereby) and does not conflict with the
-5-
information contained in the Registration Statement or the Pricing Disclosure Package, and, when taken together with the Preliminary Prospectus accompanying, or delivered prior to delivery of, such Issuer Free Writing Prospectus, did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that the Company makes no representation or warranty with respect to any statements or omissions made in each such Issuer Free Writing Prospectus or Preliminary Prospectus in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in such Issuer Free Writing Prospectus or Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section 9(c) (Indemnification of the Company and the Selling Shareholders) hereof.
(d) Testing-the-Waters Materials. The Company (i) has not alone engaged in any Testing-the-Waters Communications (as defined below) other than Testing-the-Waters Communications with the consent of the Representatives with potential investors that are persons reasonably believed to be qualified institutional buyers (QIBs) as defined in Rule 144A under the Securities Act or institutions that are accredited investors within the meaning of Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8) (a)(9), (a)(12) or (a)(13) under the Securities Act (IAIs) and otherwise in compliance with the requirements of Rule 163B under the Securities Act and (ii) has not authorized anyone other than the Representatives to engage in Testing-the-Waters Communications. The Company reconfirms that the Representatives have been authorized to act on its behalf in undertaking Testing-the-Waters Communications by virtue of a writing substantially in the form of Exhibit A hereto. The Company has not distributed or approved for distribution any Written Testing-the-Waters Communications (as defined below) other than those listed on Annex B hereto. Testing-the-Waters Communication means any oral or written communication with potential investors undertaken in reliance on either Section 5(d) of, or Rule 163B under, the Securities Act. Written Testing-the-Waters Communication means any Testing-the-Waters Communication that is a written communication within the meaning of Rule 405 under the Securities Act. Any individual Written Testing-the-Waters Communication does not conflict in any material respect with the information contained in the Registration Statement or the Pricing Disclosure Package, complied in all material respects with the Securities Act, and when taken together with the Pricing Disclosure Package as of the Applicable Time, did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
(e) Registration Statement and Prospectus. The Registration Statement has been declared effective by the Commission. No order suspending the effectiveness of the Registration Statement has been issued by the Commission, and no proceeding for that purpose or pursuant to Section 8A of the Securities Act against the Company or related to
-6-
the offering of the Shares has been initiated or, to the Companys knowledge, threatened by the Commission; as of the applicable effective date of the Registration Statement and any post-effective amendment thereto, the Registration Statement and any such post-effective amendment complied and will comply in all material respects with the Securities Act, and did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading; and as of the date of the Prospectus and any amendment or supplement thereto and as of the Closing Date and as of the Additional Closing Date, as the case may be, the Prospectus will comply in all material respects with the Securities Act and will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the Registration Statement and the Prospectus and any amendment or supplement thereto, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section 9(c) (Indemnification of the Company and the Selling Shareholders) hereof.
(f) Financial Statements. The financial statements (including the related notes thereto) of the Company and its consolidated subsidiaries included in the Registration Statement, the Pricing Disclosure Package and the Prospectus comply as to form in all material respects with the applicable requirements of the Securities Act and present fairly, in all material respects, the financial position of the Company and its consolidated subsidiaries as of the dates indicated and the results of their operations and the changes in their cash flows for the periods specified; such financial statements have been prepared in conformity with generally accepted accounting principles in the United States (U.S. GAAP) applied on a consistent basis throughout the periods covered thereby (except for any normal year-end adjustments, the adoption of new accounting principles, and as otherwise noted therein), and except in the case of unaudited financial statements, which are subject to normal period-end adjustments and do not contain certain footnotes as permitted by the applicable rules of the Commission, and any supporting schedules included in the Registration Statement present fairly, in all material respects, the information required to be stated therein; and the other financial information included in the Registration Statement, the Pricing Disclosure Package and the Prospectus has been derived from the accounting records of the Company and its consolidated subsidiaries and presents fairly, in all material respects, the information shown thereby; all disclosures included in the Registration Statement, the Pricing Disclosure Package and the Prospectus regarding non-U.S. GAAP financial measures (as such term is defined by the rules and regulations of Commission) comply with Regulation G of the Securities Exchange Act of 1934, as amended (the Exchange Act), and Item 10 of Regulation S-K of the Securities Act, to the extent applicable; and the pro forma financial information and the related notes thereto included in the Registration Statement, the Pricing Disclosure Package and the Prospectus have been prepared in accordance with the applicable requirements of the Securities Act and the assumptions underlying such pro forma financial information are reasonable and are set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus.
-7-
(g) No Material Adverse Change. Since the date of the most recent financial statements of the Company (including the related notes thereto) included in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (i) there has not been any change in the share capital (other than the issuance of common shares of the Company upon exercise of options or restricted stock unit awards and in the money warrants in the separation and reorganization transactions completed on January 3, 2023 (the Separation Transactions), and other than the grant of options and awards under equity incentive plans, in each case as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus), short-term debt or long-term debt of the Company or any of its subsidiaries, or any dividend or distribution of any kind declared, set aside for payment, paid or made by the Company on any class of share capital (other than quarterly dividends declared and paid on the Companys 9.00% non-convertible and cumulative preferred securities, par value $0.01 per share (the Series A Preferred Securities), as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus), or any material adverse change, or any development that could reasonably be expected to result in a prospective material adverse change, in or affecting the business, properties, management, financial position, shareholders equity or results of operations of the Company and its subsidiaries taken as a whole; (ii) neither the Company nor any of its subsidiaries has entered into any transaction or agreement (whether or not in the ordinary course of business) that is material to the Company and its subsidiaries taken as a whole (other than in connection with the Separation Transactions, as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus), or incurred any liability or obligation, direct or contingent, that is material to the Company and its subsidiaries taken as a whole; and (iii) neither the Company nor any of its subsidiaries has sustained any loss or interference with its business that is material to the Company and its subsidiaries taken as a whole and that is either from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory authority, except in each case as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus.
(h) Organization and Good Standing. The Company and each of its significant subsidiaries (as such term is defined in Rule 1-02(w) of Regulation S-X under the Exchange Act) (the significant subsidiaries) have been duly organized and are validly existing and in good standing under the laws of their respective jurisdictions of organization (to the extent the concept of good standing or an equivalent concept is applicable in such jurisdiction), are duly qualified to do business and are in good standing (to the extent the concept of good standing or an equivalent concept is applicable in such jurisdiction) in each jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such qualification, and have all power and authority necessary to own or hold their respective properties and to conduct the businesses in which they are engaged, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the
-8-
aggregate, reasonably be expected to have a material adverse effect, including any prospective material adverse effect, on the business, properties, management, financial position, shareholders equity or results of operations of the Company and its subsidiaries taken as a whole or on the performance by the Company of its obligations under the Transaction Documents (as defined below) (a Material Adverse Effect). The Company does not own or control, directly or indirectly, any corporation, association or other entity other than the subsidiaries listed in Exhibit 21 to the Registration Statement.
(i) Non-Significant Subsidiaries. The Companys subsidiaries, other than the significant subsidiaries, are collectively not material to the business, properties, management, financial position, shareholders equity or results of operations of the Company and its subsidiaries taken as a whole and an event at a subsidiary, other than a significant subsidiary, would not cause a Material Adverse Effect.
(j) Capitalization. The Company has an authorized capitalization as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus under the heading Capitalization; all the outstanding share capital of the Company (including the Shares to be sold by the Selling Shareholders) have been duly and validly authorized and issued and are fully paid and non-assessable and, except as described in or expressly contemplated by the Registration Statement, the Pricing Disclosure Package and the Prospectus are not subject to any pre-emptive or similar rights; except as described in or expressly contemplated by the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no outstanding rights (including, without limitation, pre-emptive rights), warrants or options to acquire, or instruments convertible into or exchangeable for, any share capital or other equity interest in the Company or any of its significant subsidiaries, or any contract, commitment, agreement, understanding or arrangement of any kind relating to the issuance of any share capital of the Company or any such significant subsidiary, any such convertible or exchangeable securities or any such rights, warrants or options; the share capital of the Company conforms in all material respects to the description thereof contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus; and all the outstanding share capital or other equity interests of each significant subsidiary are owned, directly or indirectly, by the Company, have been duly and validly authorized and issued, are fully paid and non-assessable (except, in the case of any foreign subsidiary, for directors qualifying shares) and are owned directly or indirectly by the Company, free and clear of any lien, charge, encumbrance, security interest, restriction on voting or transfer or any other claim of any third party, except for such lien, charge, encumbrance, security interest, restriction on voting or transfer or any other claim of any third party as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(k) Share Options. With respect to the options or other equity awards or rights to acquire Common Shares, including, without limitation, restricted stock unit awards (together, the Share Options) granted pursuant to the share-based compensation plans of the Company and its subsidiaries (the Company Share Plans), (i) each Share Option intended to qualify as an incentive stock option under Section 422 of the Internal Revenue Code of 1986, as amended (the Code), so qualifies, (ii) each grant of a Share Option was duly authorized no later than the date on which the
-9-
grant of such Share Option was by its terms to be effective (the Grant Date) by all necessary corporate action, including, as applicable, approval by the board of directors of the Company (or a duly constituted and authorized committee thereof) and any required shareholder approval by the necessary number of votes or written consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party thereto, (iii) each such grant was made in accordance with the terms of the Company Share Plans, the Exchange Act and all other applicable laws and regulatory rules or requirements, including the rules of the New York Stock Exchange (the NYSE) and any other exchange on which Company securities are traded, and (iv) each such grant was properly accounted for in accordance with U.S. GAAP in the financial statements (including the related notes) of the Company. The Company has not knowingly granted, and there is no and has been no policy or practice of the Company of granting, Share Options prior to, or otherwise coordinating the grant of Share Options with, the release or other public announcement of material information regarding the Company or its subsidiaries or their results of operations.
(l) Due Authorization. The Company has full right, power and authority to execute and deliver this Agreement and the Amended and Restated Common Shareholders Agreement (collectively, the Transaction Documents) and to perform its obligations hereunder and thereunder; and all action required to be taken for the due and proper authorization, execution and delivery by it of this Agreement and each of the other Transaction Documents and the consummation by it of the transactions contemplated hereby and thereby has been duly and validly taken.
(m) Underwriting Agreement. This Agreement has been duly authorized, executed and delivered by the Company.
(n) The Shares. The Shares to be issued and sold by the Company hereunder have been duly authorized by the Company and, when issued and delivered and paid for as provided herein, will be duly and validly issued, will be fully paid and nonassessable and will conform in all material respects to the descriptions thereof in the Registration Statement, the Pricing Disclosure Package and the Prospectus; and the issuance of the Shares is not subject to any preemptive or similar rights.
(o) Other Transaction Documents. Each Transaction Document has been duly authorized and, as of the Closing Date, will have been duly, executed and delivered by the Company and will constitute a valid and legally binding agreement of the Company enforceable against the Company in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency or similar laws affecting the enforcement of creditors rights generally or by equitable principles relating to enforceability.
(p) Descriptions of the Transaction Documents. Each Transaction Document conforms in all material respects to the description thereof contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus.
-10-
(q) No Violation or Default. Neither the Company nor any of its significant subsidiaries is (i) in violation of its memorandum of association, charter or bye-laws or similar organizational documents; (ii) in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its significant subsidiaries is a party or by which the Company or any of its significant subsidiaries is bound or to which any property or asset of the Company or any of its significant subsidiaries is subject; or (iii) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority having jurisdiction over the Company or any of its significant subsidiaries, except, in the case of clauses (ii) and (iii) above, for any such default or violation that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(r) No Conflicts. The execution, delivery and performance by the Company of each of the Transaction Documents, the issuance and sale of the Shares by the Company and the consummation by the Company of the transactions contemplated by the Transaction Documents or the Pricing Disclosure Package and the Prospectus will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, result in the termination, modification or acceleration of, or result in the creation or imposition of any lien, charge or encumbrance upon any property, right or asset of the Company or any of its significant subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its significant subsidiaries is a party or by which the Company or any of its significant subsidiaries is bound or to which any property, right or asset of the Company or any of its significant subsidiaries is subject, (ii) result in any violation of the provisions of the charter or by-laws or similar organizational documents of the Company or any of its significant subsidiaries or (iii) result in the violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (i) and (iii) above, for any such conflict, breach, violation, default, lien, charge or encumbrance that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(s) No Consents Required. No consent, approval, authorization, order, registration or qualification of or with any court or arbitrator or governmental or regulatory authority is required for the execution, delivery and performance by the Company of each of the Transaction Documents, the issuance by the Company of the Shares and the consummation of the transactions contemplated by the Transaction Documents, except for the registration of the Shares under the Securities Act and such consents, approvals, authorizations, orders and registrations or qualifications as may be required by the Financial Industry Regulatory Authority, Inc. (FINRA) and under applicable state securities laws in connection with the purchase and distribution of the Shares by the Underwriters, and except such consents, approvals, authorizations, orders, registrations or qualifications the failure to obtain or make would not reasonably be expected to have a Material Adverse Effect.
-11-
(t) Legal Proceedings. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no legal, governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings (Actions) pending to which the Company or any of its subsidiaries is or may reasonably be expected to become a party or to which any property of the Company or any of its subsidiaries is or may reasonably be expected to become the subject that, individually or in the aggregate, if determined adversely to the Company or any of its subsidiaries, could reasonably be expected to have a Material Adverse Effect; no such Actions are threatened or, to the knowledge of the Company, contemplated by any governmental or regulatory authority or threatened by others; and (i) there are no current or pending Actions that are required under the Securities Act to be described in the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not so described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and (ii) there are no statutes, regulations or contracts or other documents that are required under the Securities Act to be filed as exhibits to the Registration Statement or described in the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not so filed as exhibits to the Registration Statement or described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.
(u) Independent Accountants. KPMG Audit Limited (KPMG), who have certified certain financial statements of the Company and its subsidiaries, is an independent registered public accounting firm with respect to the Company and its subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act.
(v) Title to Real and Personal Property. The Company and its subsidiaries have good and marketable title in fee simple to, or have valid rights to lease or otherwise use, all items of real and personal property that are material to the respective businesses of the Company and its subsidiaries, in each case free and clear of all liens, encumbrances, claims and defects and imperfections of title except those that could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect.
(w) Intellectual Property. (i) The Company and its subsidiaries own or have the right to use all patents, patent applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, domain names and other source indicators, copyrights and copyrightable works, know-how, trade secrets, systems, procedures, proprietary or confidential information and all other worldwide intellectual property, industrial property and proprietary rights (collectively, Intellectual Property) used in the conduct of their respective businesses, except where the failure to own or have the right to use any of the foregoing would not reasonably be expected to result in a Material Adverse Effect; (ii) to the knowledge of the Company, the Companys and its subsidiaries conduct of their respective businesses does not infringe,
-12-
misappropriate or otherwise violate any Intellectual Property of any person; (iii) to the knowledge of the Company, no notice of any claim relating to Intellectual Property has been received, which claim, if determined unfavorably would reasonably be expected to have a Material Adverse Effect; and (iv) to the knowledge of the Company, the Intellectual Property of the Company and its subsidiaries is not being infringed, misappropriated or otherwise violated by any person, except where any such instance would not reasonably be expected to result in a Material Adverse Effect.
(x) No Undisclosed Relationships. No relationship, direct or indirect, exists between or among the Company or any of its subsidiaries, on the one hand, and the directors, officers, shareholders, customers, suppliers or other affiliates of the Company or any of its subsidiaries, on the other, that is required by the Securities Act to be described in each of the Registration Statement and the Prospectus and that is not so described in such documents and in the Pricing Disclosure Package.
(y) Investment Company Act. The Company is not and, after giving effect to the offering and sale of the Shares and the application of the proceeds thereof as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, will not be required to register as an investment company or an entity controlled by an investment company within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission thereunder (collectively, the Investment Company Act).
(z) Taxes. The Company and its subsidiaries have paid all income and other U.S. federal, state and local and non-U.S. taxes (whether imposed directly or indirectly or through withholdings) (except for cases in which failure to pay would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, or, except as currently being contested in good faith by appropriate proceedings and for which adequate reserves in accordance with U.S. GAAP have been created therefor in the financial statements of the Company), and have filed all income and other tax returns required to be filed through the date hereof (except in any case in which the failure to file would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect), and all such returns are correct and complete in all material respects; and except as otherwise disclosed in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus, there is no material tax deficiency that has been, or could reasonably be expected to be, asserted against the Company or any of its subsidiaries or any of their respective properties or assets.
(aa) Licenses and Permits. The Company and its significant subsidiaries possess all licenses, sub-licenses, certificates, permits and other authorizations issued by, and have made all declarations and filings with, the appropriate U.S. federal, state or local or non- U.S. governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus, except where the failure to possess or make the same would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and except as described in each of the Registration Statement, the Pricing
-13-
Disclosure Package and the Prospectus, neither the Company nor any of its significant subsidiaries has received notice of any revocation or modification of any such license, sub-license, certificate, permit or authorization or has any reason to believe that any such license, sub-license, certificate, permit or authorization will not be renewed in the ordinary course except where such revocation, modification or non-renewal would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(bb) Insurance Subsidiaries. Each subsidiary of the Company that is required to be organized and licensed as an insurance company (collectively, the Insurance Subsidiaries) is duly organized and licensed as required in its jurisdiction of organization and is duly licensed or authorized as required in each jurisdiction outside its jurisdiction of organization where it is required to be so licensed or authorized to conduct its business as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, except where the failure to be so licensed or authorized, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect. The Insurance Subsidiaries have made all required filings (including statutory annual and quarterly statements and statutory balance sheets and income statements included therein, as applicable) under applicable insurance statutes in each jurisdiction where such filings are required, except for such filings the failure of which to make would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect. Each of the Insurance Subsidiaries has all other necessary authorizations, approvals, orders, consents, certificates, permits, registrations and qualifications (Authorizations), of and from all insurance regulatory authorities necessary to conduct their respective existing business as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, except where the failure to have such Authorizations, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect, and no Insurance Subsidiary has received any notification from any insurance regulatory authority to the effect that any additional Authorizations are needed to be obtained by any Insurance Subsidiary in any case where it would reasonably be expected that the failure to obtain such additional Authorizations or the limiting of the writing of such business would result in a Material Adverse Effect, and, except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus, no insurance regulatory authority having jurisdiction over any Insurance Subsidiary has issued any order or decree impairing, restricting or prohibiting (A) the payment of dividends by any Insurance Subsidiary to its parent, other than those restrictions applicable to insurance or reinsurance companies under such jurisdiction generally or (B) the continuation of the business of the Company or any of the Insurance Subsidiaries in all material respects as presently conducted, in each case except where such orders or decrees would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.
(cc) Treaties, Contracts and Arrangements. To the Companys knowledge, neither the Company nor any of its Insurance Subsidiaries has received any notice from any of the other parties to any reinsurance treaties, contracts, agreements or arrangements to which the Company or any Insurance Subsidiary is a party that such other party intends not to perform its obligations thereunder, except to the extent that such nonperformance would not reasonably be expected to have a Material Adverse Effect.
-14-
(dd) Insurance Reserving. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, since December 31, 2022, neither the Company nor any of its Insurance Subsidiaries have made any material change in their respective insurance reserving practices.
(ee) No Labor Disputes. No labor disturbance by or dispute with employees of the Company or any of its subsidiaries exists or, to the knowledge of the Company, is contemplated or threatened, and the Company is not aware of any existing or imminent labor disturbance by, or dispute with, the employees of any of its or its subsidiaries principal suppliers, contractors or customers, except as would not have a Material Adverse Effect. Neither the Company nor any of its subsidiaries have entered into any collective bargaining agreement.
(ff) Certain Environmental Matters. (i) The Company and its subsidiaries (x) are in compliance with all, and have not violated any, applicable U.S. federal, state or local or non-U.S. laws (including common law), rules, regulations, requirements, decisions, judgments, decrees, orders and other legally enforceable requirements relating to pollution or the protection of human health or safety, the environment, natural resources, hazardous or toxic substances or wastes, pollutants or contaminants (collectively, Environmental Laws); (y) have received and are in compliance with all, and have not violated any, permits, licenses, certificates or other authorizations or approvals required of them under any Environmental Laws to conduct their respective businesses; and (z) have not received notice of any actual or potential liability or obligation under or relating to, or any actual or potential violation of, any Environmental Laws, including for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, and have no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) there are no costs or liabilities associated with Environmental Laws of or relating to the Company or its subsidiaries, except in the case of each of (i) and (ii) above, for any such matter as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and (iii) except as described in each of the Pricing Disclosure Package and the Prospectus, (x) there is no proceeding that is pending, or, to the knowledge of the Company, that is known to be contemplated, against the Company or any of its subsidiaries under any Environmental Laws in which a governmental entity is also a party, other than such proceeding regarding which it is reasonably believed no monetary sanctions of $100,000 or more will be imposed, (y) the Company and its subsidiaries are not aware of any facts or issues regarding compliance with Environmental Laws, or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic substances or wastes, pollutants or contaminants, that could reasonably be expected to have a material effect on the capital expenditures, earnings or competitive position of the Company and its subsidiaries, and (z) none of the Company or its subsidiaries is required to account for any material capital expenditures relating to any Environmental Laws on its financial statements.
-15-
(gg) Compliance with ERISA. (i) Each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (ERISA), for which the Company or any member of its Controlled Group (defined as any entity, whether or not incorporated, that is under common control with the Company within the meaning of Section 4001(a)(14) of ERISA or any entity that would be regarded as a single employer with the Company under Section 414(b),(c),(m) or (o) of the Code) would have any liability (each, a Plan) has been maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Code; (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect to any Plan, excluding transactions effected pursuant to a statutory or administrative exemption; (iii) for each Plan that is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, no Plan has failed (whether or not waived), or is reasonably expected to fail, to satisfy the minimum funding standards (within the meaning of Section 302 of ERISA or Section 412 of the Code) applicable to such Plan; (iv) no Plan is, or is reasonably expected to be, in at risk status (within the meaning of Section 303(i) of ERISA) and no Plan that is a multiemployer plan within the meaning of Section 4001(a)(3) of ERISA is in endangered status or critical status (within the meaning of Sections 304 and 305 of ERISA) (v) the fair market value of the assets of each Plan exceeds the present value of all benefits accrued under such Plan (determined based on those assumptions used to fund such Plan); (vi) no reportable event (within the meaning of Section 4043(c) of ERISA and the regulations promulgated thereunder) has occurred or is reasonably expected to occur; (vii) each Plan that is intended to be qualified under Section 401(a) of the Code has received a favorable determination, advisory or opinion letter from the Internal Revenue Service indicating that it is qualified, and, nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification; (viii) neither the Company nor any member of the Controlled Group has incurred, nor reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guaranty Corporation, in the ordinary course and without default) in respect of a Plan (including a multiemployer plan within the meaning of Section 4001(a)(3) of ERISA); and (ix) none of the following events has occurred or is reasonably likely to occur: (A) a material increase in the aggregate amount of contributions required to be made to all Plans by the Company or its Controlled Group affiliates in the current fiscal year of the Company and its Controlled Group affiliates compared to the amount of such contributions made in the Companys and its Controlled Group affiliates most recently completed fiscal year; or (B) a material increase in the Company and its subsidiaries accumulated post-retirement benefit obligations (within the meaning of Accounting Standards Codification Topic 715-60) compared to the amount of such obligations in the Company and its subsidiaries most recently completed fiscal year, except in each case with respect to the events or conditions set forth in (i) through (ix) hereof, as would not, individually or in the aggregate, have a Material Adverse Effect.
-16-
(hh) Disclosure Controls. The Company and, on a consolidated basis, its subsidiaries maintain an effective system of disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) that complies with the requirements of the Exchange Act and that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commissions rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Companys management as appropriate to allow timely decisions regarding required disclosure.
(ii) Accounting Controls. The Company and, on a consolidated basis, its subsidiaries maintain systems of internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their respective principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. The Company and its subsidiaries maintain internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with managements general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with U.S. GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with managements general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company is not aware of any material weaknesses in the Companys internal controls (it being understood that this subsection shall not require the Company to comply with Section 404 of the Sarbanes-Oxley Act of 2002, as amended and the rules and regulations promulgated in connection therewith (the Sarbanes-Oxley Act), as of an earlier date that it would otherwise be required to so comply under applicable law). The Companys auditors and the Audit Committee of the Board of Directors of the Company have been advised of: (i) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which have adversely affected or are reasonably likely to adversely affect the Companys ability to record, process, summarize and report financial information; and (ii) any fraud, whether or not material, that involves management or other employees who have a significant role in the Companys internal controls over financial reporting.
(jj) Insurance. The Company and its subsidiaries have insurance covering their respective properties, operations, personnel and businesses, including business interruption insurance, which insurance is in amounts and insures against such losses and risks as are generally maintained by similarly situated companies and which the Company reasonably believes are adequate to protect the Company and its subsidiaries and their respective businesses; and neither the Company nor any of its subsidiaries has (i) received notice from any insurer or agent of such insurer that capital improvements or other expenditures are required or necessary to be made in order to continue such insurance or (ii) any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage at reasonable cost from similar insurers as may be necessary to continue its business.
-17-
(kk) Cybersecurity; Data Protection. The Company and its subsidiaries information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, IT Systems) are in the Companys reasonable belief adequate for, and operate and perform in all material respects as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company and its subsidiaries have implemented and maintained commercially reasonable controls, policies, procedures, and safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data (including all personal, personally identifiable, sensitive, confidential or regulated data (Personal Data)) used in connection with their businesses, and there have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without, or would not reasonably be expected to result in, material cost or liability or the duty to notify any other person, nor any incidents under internal review or investigations relating to the same. The Company and its subsidiaries are presently in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification. To the extent applicable to the operations of the Company and its subsidiaries, the Company and its subsidiaries are in material compliance with the European Union General Data Protection Regulation (and all other laws and regulations applicable to the operations of the Company and its subsidiaries with respect to Personal Data, and for which any non-compliance with the same would be reasonably likely to create a material liability).
(ll) No Unlawful Payments. Neither the Company nor any of its subsidiaries, nor any director or officer of the Company or any of its subsidiaries nor, to the knowledge of the Company, any employee, agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii) violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, agreed, requested or taken an act in furtherance of
-18-
any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. Neither the Company nor any of its subsidiaries will use, directly or indirectly, the proceeds of the offering of the Shares hereunder in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any person in violation of any applicable anti-bribery and anti-corruption laws. The Company and its subsidiaries have instituted, maintain and enforce, and will continue to maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption laws.
(mm) Compliance with Anti-Money Laundering Laws. The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements, including, without limitation, those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of all jurisdictions where the Company or any of its subsidiaries conducts business, the rules, orders and regulations thereunder and any related or similar rules, orders, regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the Anti-Money Laundering Laws), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened. Neither the Company nor any of its subsidiaries will use, directly or indirectly, the proceeds of the offering of the Shares hereunder in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any person in a manner that will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Anti-Money Laundering Laws.
(nn) No Conflicts with Sanctions Laws. Neither the Company nor any of its subsidiaries, directors, officers or employees, nor, to the knowledge of the Company, any agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries is currently the subject or the target of any sanctions administered or enforced by the U.S. government (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (OFAC) or the U.S. Department of State and including, without limitation, the designation as a specially designated national or blocked person), the United Nations Security Council (UNSC), the European Union, His Majestys Treasury (HMT) or other relevant sanctions authority (collectively, Sanctions), nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject or target of Sanctions, without limitation, Cuba, Iran, North Korea, Syria, the Crimea Region of Ukraine, the so-called Donetsk Peoples Republic, the so-called Luhansk Peoples Republic and the disputed territories of Kherson and Zaporizhzhia (each, a Sanctioned Country); and the Company will not directly or indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other individual or entity (Person) (i) to fund or facilitate any activities of or business with any Person
-19-
that, at the time of such funding or facilitation, is the subject or target of Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in a violation by any Person (including any Person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions. For the past five years, the Company and its subsidiaries have not engaged in and are not now engaged in any dealings or transactions in violation of applicable Sanctions.
(oo) No Restrictions on Subsidiaries. No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, from paying any dividends to the Company, from making any other distribution on such subsidiarys share capital or similar ownership interest, from repaying to the Company any loans or advances to such subsidiary from the Company or from transferring any of such subsidiarys properties or assets to the Company or any other subsidiary of the Company.
(pp) No Brokers Fees. Neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any person (other than this Agreement) that would give rise to a valid claim against any of them or any Underwriter for a brokerage commission, finders fee or like payment in connection with the offering and sale of the Shares.
(qq) No Registration Rights. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, no person has the right to require the Company or any of its subsidiaries to register any securities for sale under the Securities Act by reason of the filing of the Registration Statement with the Commission, the issuance and sale of the Shares by the Company or, to the knowledge of the Company, the sale of the Shares to be sold by the Selling Shareholders hereunder.
(rr) No Stabilization. Neither the Company nor any of its subsidiaries or affiliates has taken, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Shares.
(ss) Margin Rules. Neither the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
(tt) Forward-Looking Statements. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) included in any of the Registration Statement, the Pricing Disclosure Package or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.
-20-
(uu) Statistical and Market Data. Nothing has come to the attention of the Company that has caused the Company to believe that the statistical and market-related data included in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus is not based on or derived from sources that are reliable and accurate in all material respects.
(vv) Sarbanes-Oxley Act. To the extent applicable to the Company on the date hereof, there is and has been no failure on the part of the Company or any of the Companys directors or officers, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act, including Section 402 related to loans.
(ww) Status under the Securities Act. At the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest time thereafter that the Company or any offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) under the Securities Act) of the Shares and at the date hereof, the Company was not and is not an ineligible issuer, as defined in Rule 405 under the Securities Act. The Company has paid the registration fee for this offering pursuant to Rule 456(b)(1) under the Securities Act or will pay such fee within the time period required by such rule (without giving effect to the proviso therein) and in any event prior to the Closing Date.
(xx) No Immunity. Neither the Company nor any of its subsidiaries or their properties or assets has immunity under Bermuda, U.S. federal or New York state law from any legal action, suit or proceeding, from the giving of any relief in any such legal action, suit or proceeding, from set-off or counterclaim, from the jurisdiction of any Bermudan, U.S. federal or New York state court, from service of process, attachment upon or prior to judgment, or attachment in aid of execution of judgment, or from execution of a judgment, or other legal process or proceeding for the giving of any relief or for the enforcement of a judgment, in any such court with respect to their respective obligations, liabilities or any other matter under or arising out of or in connection herewith; and, to the extent that the Company or any of its subsidiaries or any of its properties, assets or revenues may have or may hereafter become entitled to any such right of immunity in any such court in which proceedings arising out of, or relating to the transactions contemplated by the Transaction Documents, may at any time be commenced, the Company has, pursuant to Section 18(e) (Waiver of Immunity) of this Agreement, waived, and it will waive, or will cause its subsidiaries to waive, such right to the extent permitted by law.
(yy) Enforcement of Foreign Judgments. The courts of Bermuda would recognize as a valid judgment, a final and conclusive judgment in personam obtained in any U.S. federal or New York state court located in the State of New York against the Company based upon the Transaction Documents under which a sum of money is payable (other than a sum of money payable in respect of multiple damages, taxes or other charges of a like nature or in respect of a fine or other penalty) and would give a judgment based thereon provided that (a) such courts had proper jurisdiction over the parties subject to such judgment; (b) such courts did not contravene the rules of natural justice of Bermuda; (c) such judgment was not obtained by fraud; (d) the enforcement of
-21-
the judgment would not be contrary to the public policy of Bermuda; (e) no new admissible evidence relevant to the action is submitted prior to the rendering of the judgment by the courts of Bermuda; and (f) there is due compliance with the correct procedures under the laws of Bermuda.
(zz) Valid Choice of Law. The choice of laws of the State of New York as the governing law of this Agreement is a valid choice of law under the laws of Bermuda and will be honored by the courts of Bermuda, subject to the restrictions described in the Registration Statement, the Pricing Disclosure Package and the Prospectus. The Company has the power to submit, and pursuant to Section 18(c) (Submission to Jurisdiction) of this Agreement, has legally, validly, effectively and irrevocably submitted, to the personal jurisdiction of each New York state and U.S. federal court sitting in the City of New York and has validly and irrevocably waived any objection to the laying of venue of any suit, action or proceeding brought in such court.
(aaa) Passive Foreign Investment Company. Subject to and other than as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company should not be characterized as a passive foreign investment company (PFIC) as defined in Section 1297 of the Code for the current taxable year and the Company does not expect to be a PFIC for the foreseeable future.
(bbb) Stamp Taxes. No stamp, registration, documentary, issuance, transfer or other similar taxes or duties (Stamp Taxes) are payable by or on behalf of the Underwriters in Bermuda, the United Kingdom, the United States or any other jurisdiction in which the Company is organized or incorporated, engaged in business for tax purposes or is otherwise resident for tax purposes, or any political subdivision or taxing authority thereof, or any jurisdiction from or through which payment or delivery to or for the benefit of the Underwriters is made by or on behalf of the Company under this Agreement (each, a Company Relevant Tax Jurisdiction) in connection with (A) the execution, delivery and performance of the Transaction Documents and the consummation of the transactions contemplated thereby, (B) the issuance and delivery of the Shares in the manner contemplated by this Agreement and the Prospectus or (C) the sale and delivery by the Underwriters of the Shares as contemplated by this Agreement and the Prospectus.
(ccc) No Withholding Tax. All payments to be made by or on behalf of the Company under this Agreement may, under the current laws and regulations of any Company Relevant Tax Jurisdiction, be paid in U.S. dollars that may be converted into another currency and freely transferred out of any Company Relevant Tax Jurisdiction, and all such payments will not be subject to withholding or deduction for taxes under the laws and regulations of any Company Relevant Tax Jurisdiction and shall be made without the necessity of obtaining any governmental authorization in any Company Relevant Tax Jurisdiction.
(ddd) Dividends. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, no approvals are currently required in Bermuda or the United Kingdom in order for the Company to pay dividends or other distributions
-22-
declared by the Company to the holders of Shares. Under current laws and regulations of Bermuda or the United Kingdom and any political subdivision thereof, any amount payable with respect to the Shares upon liquidation of the Company or upon redemption thereof and dividends and other distributions declared and payable on the share capital of the Company may be paid by the Company in U.S. dollars or euros and freely transferred out of Bermuda or the United Kingdom, and all such payments made to the holders thereof or therein who are non-residents of Bermuda or the United Kingdom will not be subject to income, withholding or other taxes under laws and regulations of Bermuda, the United Kingdom or any political subdivision or taxing authority thereof or therein and shall be made without the necessity of obtaining any governmental authorization in Bermuda, the United Kingdom or any political subdivision or taxing authority thereof or therein.
(eee) Legality. The legality, validity, enforceability or admissibility into evidence of any of the Registration Statement, the Pricing Disclosure Package, the Prospectus, this Agreement or the Shares in any jurisdiction in which the Company is organized or does business is not dependent upon such document being submitted into, filed or recorded with any court or other authority in any such jurisdiction on or before the date hereof or that any tax, imposition or charge be paid in any such jurisdiction on or in respect of any such document.
(fff) Legal Action. A holder of the Shares and each Underwriter are each entitled to sue as plaintiff in the court of the jurisdiction of formation and domicile of the Company for the enforcement of their respective rights under this Agreement and the Shares and such access to such courts will not be subject to any conditions which are not applicable to residents of such jurisdiction or a company incorporated in such jurisdiction except that plaintiffs not residing in Bermuda may be required to guarantee payment of a possible order for payment of costs or damages at the request of the defendant.
(ggg) Fair and Accurate Summary. The statements in the Registration Statement, the Pricing Disclosure Package and the Prospectus, under the headings (i) Certain Tax ConsiderationsUnited States Taxation, to the extent that they constitute summaries of U.S. federal law or regulation or legal conclusions with respect thereto, (ii) Description of Share Capital, to the extent they constitute summaries of the terms of the Shares, (iii) Certain Tax ConsiderationsBermuda Taxation, to the extent that they constitute summaries of Bermuda law or regulation or legal conclusions with respect thereto, and (iv) Certain Regulatory Considerations, to the extent that they constitute summaries of Bermuda, United Kingdom, Ireland and U.S. law or regulation or legal conclusions with respect thereto, have been reviewed by us and fairly and accurately summarize the matters described under that heading in all material respects.
(hhh) Foreign Private Issuer. The Company is a foreign private issuer as defined in Rule 405 under the Securities Act.
(iii) No Subsidiary Securities. There are (and prior to the Closing Date will be) no debt securities, convertibles securities or preferred stock issued or guaranteed by any significant subsidiary that are rated by a nationally recognized statistical rating organization, as such term is defined by Section 3(a)(62) of the Exchange Act.
-23-
4. Representations and Warranties of the Selling Shareholders. Each of the Selling Shareholders severally and not jointly represents and warrants to each Underwriter and the Company that:
(a) Required Consents; Authority. All consents, approvals, authorizations and orders necessary for the execution and delivery by such Selling Shareholder of this Agreement and, if such Selling Shareholder is not Platinum Ivy B 2018 RSC Limited (Platinum Ivy or the Direct Selling Shareholder) (each such Selling Shareholder other than the Direct Selling Shareholder, a Non-Direct Selling Shareholder), the Power of Attorney (the Power of Attorney) and the Custody Agreement (the Custody Agreement) hereinafter referred to, and for the sale and delivery of the Shares to be sold by such Selling Shareholder hereunder, have been obtained; and such Selling Shareholder has full right, power and authority to enter into this Agreement and, if a Non-Direct Selling Shareholder, the Power of Attorney and the Custody Agreement and to sell, assign, transfer and deliver the Shares to be sold by such Selling Shareholder hereunder; this Agreement and, if a Non-Direct Selling Shareholder, the Power of Attorney and the Custody Agreement have each been duly authorized, executed and delivered by such Selling Shareholder, except, in each case, for (i) the registration of the Shares under the Securities Act (including any related authorizations, consents, approvals and orders in connection therewith), (ii) such consents, approvals, authorizations, orders and registrations or qualifications as may be required by FINRA or the NYSE and under applicable state securities laws or non-U.S. laws in connection with the purchase and distribution of the Shares by the Underwriters, and (iii) such consents, approvals, authorizations, orders, registrations or qualifications the failure to obtain or make would not reasonably be expected to materially impair the ability of such Selling Shareholder to consummate the transactions contemplated by this Agreement.
(b) No Conflicts. The execution, delivery and performance by such Selling Shareholder of this Agreement and, if a Non-Direct Selling Shareholder, the Power of Attorney and the Custody Agreement, the sale of the Shares to be sold by such Selling Shareholder and the consummation by such Selling Shareholder of the transactions contemplated herein or therein will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, result in the termination, modification or acceleration of, or result in the creation or imposition of any lien, charge or encumbrance upon any property, right or asset of such Selling Shareholder pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which such Selling Shareholder is a party or by which such Selling Shareholder is bound or to which any of the property, right or asset of such Selling Shareholder is subject, (ii) result in any violation of the provisions of the charter or by-laws or similar organizational documents of such Selling Shareholder or (iii) result in the violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory agency applicable to such Selling Shareholder, except in the case of clauses (i) and (iii) above, for any such conflict, breach, violation or default, as the case may be, that would not, individually or in the aggregate, reasonably
-24-
be expected to have a material adverse effect on the ability of such Selling Shareholder to perform its obligations under this Agreement or the consummation of any of the transactions contemplated hereby.
(c) Title to Shares. Such Selling Shareholder has good and valid title to the Shares to be sold at the Closing Date or the Additional Closing Date, as the case may be, by such Selling Shareholder hereunder, free and clear of all liens, encumbrances, equities or adverse claims other than those, in the case of a Non-Direct Selling Shareholder, set forth in the Custody Agreement; such Selling Shareholder will have, immediately prior to the Closing Date or the Additional Closing Date, as the case may be, good and valid title to the Shares to be sold at the Closing Date or the Additional Closing Date, as the case may be, by such Selling Shareholder, free and clear of all liens, encumbrances, equities or adverse claims; and, upon delivery of such Shares and payment therefor pursuant hereto, good and valid title to such Shares, free and clear of all liens, encumbrances, equities or adverse claims, will pass to the several Underwriters.
(d) No Stabilization. Such Selling Shareholder has not taken and will not take, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Shares.
(e) Pricing Disclosure Package. The Pricing Disclosure Package, at the Applicable Time did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that such Selling Shareholders representation under this Section 4(e) shall only apply to any untrue statement of a material fact or omission to state a material fact made in reliance upon and in conformity with any information relating to such Selling Shareholder furnished to the Company in writing by such Selling Shareholder expressly for use in the Pricing Disclosure Package, it being understood and agreed that the only information furnished by each Selling Shareholder to the Company consists of (A) the legal name and address of such Selling Shareholder and the other information about such Selling Shareholder set forth in the footnote relating to such Selling Shareholder under the caption Principal and Selling Shareholders and (B) the number of shares of common stock beneficially owned by such Selling Shareholder before the offering (excluding percentages) that appears in the table (and corresponding footnotes) under the caption Principal and Selling Shareholders (collectively, the Selling Shareholder Information).
(f) Issuer Free Writing Prospectus and Written Testing-the-Waters Communication. Other than the Registration Statement, the Preliminary Prospectus and the Prospectus, such Selling Shareholder (including its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any Issuer Free Writing Prospectus or Written Testing-the-Waters Communication, other than (i) any document not constituting a prospectus pursuant to Section 2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act or (ii) the documents listed on Annex A or Annex B hereto, each electronic road show and any other written communications approved in writing in advance by the Company and the Representatives.
-25-
(g) Registration Statement and Prospectus. As of the applicable effective date of the Registration Statement and any post-effective amendment thereto, the Registration Statement and any such post-effective amendment did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading; and as of the date of the Prospectus and any amendment or supplement thereto and as of the Closing Date and as of the Additional Closing Date, as the case may be, the Prospectus will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that such Selling Shareholders representation under this Section 4(g) shall only apply to any untrue statement of a material fact or omission to state a material fact made in reliance upon and in conformity with the Selling Shareholder Information.
(h) Material Non-Public Information. As of the date hereof and as of the Closing Date and as of the Additional Closing Date, as the case may be, the sale of the Shares by such Selling Shareholder is not and will not be prompted by any material non-public information concerning the Company that is required by applicable law, rules and regulations to be disclosed in the Registration Statement, the Pricing Disclosure Package or the Prospectus and is not so disclosed.
(i) No Unlawful Payments.
(i) Each Non-Direct Selling Shareholder represents that neither such Non-Direct Selling Shareholder nor, if applicable, any of its subsidiaries, nor any director or officer of such Selling Shareholder or any of its subsidiaries, nor, to the knowledge of such Non-Direct Selling Shareholder, any employee of, or any agent, controlled affiliate or other person acting on behalf of, such Non-Direct Selling Shareholder or, if applicable, any of its subsidiaries has within the past five years (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii) violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other
-26-
unlawful or improper payment or benefit. Neither such Non-Direct Selling Shareholder nor, if applicable, any of its subsidiaries, directors, officers or employees will use, directly or, to the knowledge of the Non-Direct Selling Shareholder, indirectly, the proceeds of the offering of the Shares hereunder in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any person in violation of any applicable anti-bribery and anti-corruption laws.
(ii) Platinum Ivy represents that, in connection with the Company or its subsidiaries, Platinum Ivy has not violated and is not in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, and has not committed an offence under the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption law. Platinum Ivy shall not use the proceeds of the offering of the Shares hereunder in violation of any applicable anti-bribery and anti-corruption laws.
(j) Compliance with Anti-Money Laundering Laws.
(i) Each Non-Direct Selling Shareholder represents that, if such Non-Direct Selling Shareholder is an entity, the operations of such Non-Direct Selling Shareholder and, if applicable, its subsidiaries are and have been conducted at all times in compliance with applicable Anti-Money Laundering Laws, and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving such Non-Direct Selling Shareholder or, if applicable, any of its subsidiaries with respect to the applicable Anti-Money Laundering Laws is pending or, to the knowledge of such Non-Direct Selling Shareholder, threatened. Neither such Non-Direct Selling Shareholder nor, if applicable, any of its subsidiaries, directors, officers or employees (in each case, if applicable) will use, directly or, to the knowledge of the Non-Direct Selling Shareholder, indirectly, the proceeds of the offering of the Shares hereunder in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any person in violation of applicable Anti-Money Laundering Laws.
(ii) Platinum Ivy represents that, in connection with the Company and its subsidiaries, the operations of Platinum Ivy and its subsidiaries are and have been conducted at all times in compliance with applicable Anti-Money Laundering Laws. Platinum Ivy shall not use the proceeds of the offering of the Shares hereunder in violation of any applicable Anti-Money Laundering Laws.
(k) No Conflicts with Sanctions Laws.
(i) Each Non-Direct Selling shareholder represents that neither such Non-Direct Selling Shareholder nor, if applicable, any of its subsidiaries, directors or officers (in each case, if applicable), nor, to the knowledge of such Non-Direct
-27-
Selling Shareholder, any employee, agent, controlled affiliate or other person acting on behalf of such Non-Direct Selling Shareholder or, if applicable, any of its subsidiaries is currently the subject or the target of any Sanctions, nor is such Non-Direct Selling Shareholder or, if applicable, any of its subsidiaries located, organized or resident in a Sanctioned Country; and such Non-Direct Selling Shareholder will not directly or, to the knowledge of the Non-Direct Selling Shareholder, indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is the subject or target of Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner in violation of Sanctions.
(ii) Platinum Ivy represents that neither Platinum Ivy nor any of its subsidiaries, directors, or officers, nor, to the knowledge of Platinum Ivy, any employee, agent, controlled affiliate or other person associated with or acting on behalf of Platinum Ivy or any of its subsidiaries is currently a person with whom or which transactions are restricted under any Sanctions, nor is Platinum Ivy or any of its subsidiaries located, organized or resident in a Sanctioned Country; and Platinum Ivy will not directly or, to the knowledge of Platinum Ivy, indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is a person with whom or which transactions are prohibited under any Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner, in each case of (i)-(iii), that will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions.
(l) Organization and Good Standing. Such Selling Shareholder, if a corporation or limited liability company, limited partnership or other business entity, has been duly organized and is validly existing and in good standing under the laws of its respective jurisdictions of organization.
(m) Stamp Taxes. No Stamp Taxes are payable by or on behalf of the Underwriters in any jurisdiction in which such Selling Shareholder is organized, incorporated, engaged in business for tax purposes or resident for tax purposes, or any political subdivision or taxing authority thereof, or any jurisdiction from or through which payment or delivery to or for the benefit of the Underwriters is made by or on behalf of such Selling Shareholder under this Agreement (each, a Selling Shareholder Relevant Tax Jurisdiction) in connection with (A) the execution, delivery and performance of the Transaction Documents and the consummation of the transactions contemplated thereby, (B) the delivery of the Shares in the manner contemplated by this Agreement and the Prospectus or (C) the sale and delivery by the Underwriters of the Shares as contemplated by this Agreement and the Prospectus.
-28-
(n) No Withholding Tax. All payments to be made by or on behalf of such Selling Shareholder under this Agreement may, under the current laws and regulations of any Selling Shareholder Relevant Tax Jurisdiction in respect of such Selling Shareholder, be paid in U.S. dollars that may be converted into another currency and freely transferred out of any such Selling Shareholder Relevant Tax Jurisdiction, and all such payments will not be subject to withholding or deductions for taxes under the laws and regulations of any such Selling Shareholder Relevant Tax Jurisdiction and shall be made without the necessity of obtaining any governmental authorization in any such Selling Shareholder Relevant Tax Jurisdiction.
(o) Submission to Jurisdiction. Such Selling Shareholder has the power to submit to the personal jurisdiction of each New York state and U.S. federal court sitting in the City of New York.
(p) Each of the Non-Direct Selling Shareholders, represents and warrants that certificates in negotiable form or book entry securities entitlement representing all of the Shares to be sold by such Selling Shareholders hereunder have been placed in custody under a Custody Agreement relating to such Shares, in the form heretofore furnished to you, and delivered to Computershare, Inc., as custodian (the Custodian), and that such Selling Shareholder has duly executed and delivered Powers of Attorney, in the form heretofore furnished to you, appointing the person or persons indicated in Schedule 2 hereto, and each of them, as such Selling Shareholders Attorneys-in-fact (the Attorneys-in-Fact or any one of them the Attorney-in Fact) with authority to execute and deliver this Agreement on behalf of such Selling Shareholder, to determine the purchase price to be paid by the Underwriters to such Selling Shareholders as provided herein, to authorize the delivery of the Shares to be sold by such Selling Shareholder hereunder and otherwise to act on behalf of such Selling Shareholder in connection with the transactions contemplated by this Agreement and the Custody Agreement.
Each of the Non-Direct Selling Shareholders specifically agrees that the Shares held in custody for such Selling Shareholder under the Custody Agreement, are subject to the interests of the Underwriters hereunder, and that the arrangements made by such Selling Shareholder for such custody, and the appointment by such Selling Shareholder of the Attorneys-in-Fact by the Power of Attorney, are to that extent irrevocable. Each of the Selling Shareholders specifically agrees that the obligations of such Selling Shareholder hereunder shall not be terminated by operation of law, whether by the death or incapacity of any individual Selling Shareholder, or, in the case of an estate or trust, by the death or incapacity of any executor or trustee or the termination of such estate or trust, or in the case of a partnership, corporation or similar organization, by the dissolution of such partnership, corporation or organization, or by the occurrence of any other event, in each case to the extent not prohibited under the laws of such Selling Shareholders jurisdiction of organization. If any individual Selling Shareholder or any such executor or trustee should die or become incapacitated, or if any such estate or trust should be terminated, or if any such partnership, corporation or similar organization should be dissolved, or if any other such event should occur, before the delivery of the Shares to be sold by such Selling Shareholder hereunder, to the extent not prohibited
-29-
under the laws of such Selling Shareholders jurisdiction of organization or book entry securities entitlements representing such Shares to be sold by such Selling Shareholder shall be delivered by or on behalf of such Selling Shareholder in accordance with the terms and conditions of this Agreement and the Custody Agreement, and actions taken by the Attorneys-in-Fact pursuant to the Powers of Attorney shall be as valid as if such death, incapacity, termination, dissolution or other event had not occurred, regardless of whether or not the Custodian, the Attorneys-in-Fact, or any of them, shall have received notice of such death, incapacity, termination, dissolution or other event.
5. Further Agreements of the Company. The Company covenants and agrees with each Underwriter that:
(a) Required Filings. The Company will file the final Prospectus with the Commission within the time periods specified by Rule 424(b) and Rule 430A under the Securities Act, will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under the Securities Act; and the Company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not previously delivered) to the Underwriters in New York City prior to 10:00 A.M., New York City time, on the business day next succeeding the date of this Agreement in such quantities as the Representatives may reasonably request.
(b) Delivery of Copies. Upon the written request of the Representatives, the Company will deliver, without charge, (i) to the Representatives, three signed copies of the Registration Statement as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith; and (ii) to each Underwriter (A) a conformed copy of the Registration Statement as originally filed and each amendment thereto (without exhibits) and (B) during the Prospectus Delivery Period (as defined below), as many copies of the Prospectus (including all amendments and supplements thereto and each Issuer Free Writing Prospectus) as the Representatives may reasonably request. As used herein, the term Prospectus Delivery Period means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriters a prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Shares by any Underwriter or dealer.
(c) Amendments or Supplements, Issuer Free Writing Prospectuses. Before making, preparing, using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement, the Pricing Disclosure Package or the Prospectus, the Company will furnish to the Representatives and counsel for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed amendment or supplement to which the Representatives reasonably object (which objections shall not be unreasonably delayed).
-30-
(d) Notice to the Representatives. The Company will advise the Representatives promptly, and confirm such advice in writing (which may be by email), (i) when the Registration Statement has become effective; (ii) when any amendment to the Registration Statement has been filed or becomes effective; (iii) when any supplement to the Pricing Disclosure Package, the Prospectus, any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication or any amendment to the Prospectus has been filed or distributed; (iv) of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt of any comments from the Commission relating to the Registration Statement or any other request by the Commission for any additional information including, but not limited to, any request for information concerning any Testing-the-Waters Communication; (v) of the issuance by the Commission or any other governmental or regulatory authority of any order suspending the effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package, the Prospectus or any Written Testing-the-Waters Communication or the initiation or, to the Companys knowledge, threatening of any proceeding for that purpose or pursuant to Section 8A of the Securities Act; (vi) of the occurrence of any event or development within the Prospectus Delivery Period as a result of which the Prospectus, any of the Pricing Disclosure Package, any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication as then amended or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus, the Pricing Disclosure Package, any such Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication is delivered to a purchaser, not misleading; and (vii) of the receipt by the Company of any notice with respect to any suspension of the qualification of the Shares for offer and sale in any jurisdiction or the initiation or, to the Companys knowledge, threatening of any proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package or the Prospectus or any Written Testing-the-Waters Communication or suspending any such qualification of the Shares and, if any such order is issued, will use its reasonable best efforts to obtain as soon as possible the withdrawal thereof.
(e) Ongoing Compliance. (1) If during the Prospectus Delivery Period (i) any event or development shall occur or condition shall exist as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Prospectus to comply with applicable law, the Company will promptly notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission and furnish to the Underwriters and to such dealers as the Representatives may designate such amendments or supplements to the Prospectus as may be necessary so that the statements in the Prospectus as so amended or supplemented will not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus will comply with applicable law and (2) if at any time prior to the
-31-
Closing Date (i) any event or development shall occur or condition shall exist as a result of which the Pricing Disclosure Package as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Pricing Disclosure Package to comply with applicable law, the Company will promptly notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission (to the extent required) and furnish to the Underwriters and to such dealers as the Representatives may designate such amendments or supplements to the Pricing Disclosure Package as may be necessary so that the statements in the Pricing Disclosure Package as so amended or supplemented will not, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, be misleading or so that the Pricing Disclosure Package will comply with applicable law.
(f) Blue Sky Compliance. If required by applicable law, the Company will qualify the Shares for offer and sale under the securities or Blue Sky laws of such jurisdictions as the Representatives shall reasonably request and will continue such qualifications in effect so long as required for distribution of the Shares; provided that the Company shall not be required to (i) qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii) file any general consent to service of process in any such jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject.
(g) Earning Statement. The Company will make generally available to its security holders and the Representatives as soon as practicable an earning statement that satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the effective date (as defined in Rule 158) of the Registration Statement provided that the Company will be deemed to comply with such requirement by filing such earnings statements on the Commissions Electronic Data Gathering and Retrieval System (EDGAR) (or any successor system).
(h) Clear Market. For a period of 180 days after the date of the Prospectus, the Company will not (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Commission a registration statement under the Securities Act relating to, any shares of Stock or any securities convertible into or exercisable or exchangeable for Stock, or publicly disclose the intention to undertake any of the foregoing, or (ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Stock or any such other securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Stock or such other securities, in cash or otherwise, without the prior written consent of the Representatives other than the Shares to be sold hereunder.
-32-
The restrictions described above do not apply to (i) the offer, issuance, sale and disposition of the Shares hereunder, (ii) the issuance of shares of Stock or securities convertible into or exercisable for shares of Stock pursuant to the conversion or exchange of convertible or exchangeable securities or the exercise of warrants or options (including net exercise) or the settlement of RSUs (including net settlement), in each case outstanding on the date of this Agreement and described in the Prospectus; (iii) grants of options, stock awards, restricted stock, RSUs, or other equity awards and the issuance of shares of Stock or securities convertible into or exercisable or exchangeable for shares of Stock (whether upon the exercise of options or otherwise) to the Companys employees, officers, directors, advisors, or consultants pursuant to the terms of an equity compensation plan in effect as of the Closing Date and described in the Prospectus, provided that such recipients enter into a lock-up agreement with the Underwriters; (iv) the issuance of up to 5 % of the outstanding shares of Stock, or securities convertible into, exercisable for, or which are otherwise exchangeable for, Stock, immediately following the Closing Date, in acquisitions or other similar strategic transactions, provided that such recipients enter into a lock-up agreement with the Underwriters; or (v) the filing of any registration statement on Form S-8 relating to securities granted or to be granted pursuant to any plan in effect on the date of this Agreement and described in the Prospectus or any assumed benefit plan pursuant to an acquisition or similar strategic transaction.
If the Representatives, in their sole discretion, agree to release or waive the restrictions set forth in a lock-up letter described in Section 8(l) (No Legal Impediment to Issuance and/or Sale) hereof for an officer or director of the Company and provide the Company with notice of the impending release or waiver substantially in the form of Exhibit B hereto at least three business days before the effective date of the release or waiver, the Company agrees to announce the impending release or waiver by press release substantially in the form of Exhibit C hereto through a major news service at least two business days before the effective date of the release or waiver.
(i) Use of Proceeds. The Company will apply the net proceeds from the sale of the Shares as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus under the heading Use of Proceeds.
(j) No Stabilization. Neither the Company nor its subsidiaries or affiliates will take, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Stock.
(k) Exchange Listing. The Company will use its commercially reasonable efforts to list, subject to notice of issuance, the Shares on the NYSE.
(l) Reports. For a period of three years following the date hereof, so long as the Company is subject to the reporting requirements of either Section 13 or 15(d) of the Exchange Act, the Company will furnish to the Representatives, as soon as they are available, copies of all reports or other communications (financial or other) furnished to holders of the Shares, and copies of any reports and financial statements furnished to or filed with the Commission or any national securities exchange or automatic quotation system; provided the Company will be deemed to have furnished such reports and financial statements to the Representatives to the extent they are filed on the Commissions Electronic Data Gathering, Analysis, and Retrieval system.
-33-
(m) Record Retention. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act.
(n) Filings. The Company will file with the Commission such reports as may be required by Rule 463 under the Securities Act.
(o) Foreign Private Issuer. The Company will promptly notify the Representatives if the Company ceases to be a Foreign Private Issuer at any time prior to the later of (i) completion of the distribution of the Shares within the meaning of the Securities Act and (ii) completion of the 180-day restricted period referred to in Section 5(h) (Clear Market) hereof.
(p) Tax Indemnity. The Company will pay and will indemnify and hold harmless the Underwriters against any Stamp Taxes payable in connection with (A) the execution, delivery and performance of the Transaction Documents and the consummation of the transactions contemplated thereby, (B) the creation, issuance and delivery of the Shares in the manner contemplated by this Agreement and the Prospectus or (C) the sale and delivery by the Underwriters of the Shares as contemplated by this Agreement and the Prospectus. All payments to be made by or on behalf of the Company to or for the benefit of the Underwriters under this Agreement shall be made without withholding or deduction for or on account of any present or future taxes, duties or governmental shares whatsoever unless the Company is compelled by law to deduct or withhold such taxes, duties or charges. In that event, the Company shall pay such additional amounts as may be necessary in order to ensure that the net amounts received by the Underwriters after such withholding or deductions shall equal the amounts that would have been received if no withholding or deduction has been made.
6. Further Agreements of the Selling Shareholders. Each of the Selling Shareholders severally and not jointly covenants and agrees with each Underwriter that:
(a) No Stabilization. Such Selling Shareholder will not take, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Stock.
(b) Tax Form. It will deliver to the Representatives prior to or at the Closing Date a properly completed and executed United States Internal Revenue Service Form W-9 or applicable Form W-8, establishing a complete exemption from U.S. backup withholding tax.
(c) Tax Indemnity. All payments to be made by or on behalf of such Selling Shareholder to or for the benefit of the Underwriters under this Agreement shall be made without withholding or deduction for or on account of any present or future taxes, duties or governmental shares whatsoever unless such Selling Shareholder is compelled by law
-34-
to deduct or withhold such taxes, duties or charges. In that event, such Selling Shareholder shall pay such additional amounts as may be necessary in order to ensure that the net amounts received by the Underwriters after such withholding or deductions shall equal the amounts that would have been received if no withholding or deduction has been made.
(d) Use of Proceeds. It will not directly or, to its knowledge, indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to a subsidiary, joint venture partner or other Person (i) to fund or facilitate any activities of or business with any Person that, at the time of such funding or facilitation, is a person with whom or which transactions are prohibited under any Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner, in each case if such use would result in a violation by any Person participating in the transaction, whether as underwriter, advisor, investor or otherwise of Sanctions, Anti-Money Laundering Laws and any applicable anti-bribery or anti-corruption law.
7. Certain Agreements of the Underwriters. Each Underwriter hereby represents and agrees that:
(a) It has not and will not use, authorize use of, refer to or participate in the planning for use of, any free writing prospectus, as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company and any press release issued by the Company) other than (i) a free writing prospectus that contains no issuer information (as defined in Rule 433(h)(2) under the Securities Act) that was not included in the Preliminary Prospectus or a previously filed Issuer Free Writing Prospectus, (ii) any Issuer Free Writing Prospectus listed on Annex A or prepared pursuant to Section 3(c) or Section 4(c) above (including any electronic road show approved in advance by the Company), or (iii) any free writing prospectus prepared by such underwriter and approved by the Company in advance in writing (each such free writing prospectus referred to in clauses (i) or (iii), an Underwriter Free Writing Prospectus).
(b) It has not used and will not use, in each case without the prior written consent of the Company, any free writing prospectus that contains the final terms of the Shares unless such terms have previously been included in a free writing prospectus filed with the Commission.
(c) It is not subject to any pending proceeding under Section 8A of the Securities Act with respect to the offering (and will promptly notify the Company and the Selling Shareholders if any such proceeding against it is initiated during the Prospectus Delivery Period).
8. Conditions of Underwriters Obligations. The obligation of each Underwriter to purchase the Underwritten Shares on the Closing Date or the Option Shares on the Additional Closing Date, as the case may be, as provided herein is subject to the performance by the Company and each of the Selling Shareholders of their respective covenants and other obligations hereunder and to the following additional conditions:
-35-
(a) Registration Compliance; No Stop Order. No order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding for such purpose or pursuant to Section 8A under the Securities Act shall be pending before or, to the Companys knowledge, threatened by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely filed with the Commission under the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance with Section 5(a) (Required Filings) hereof; and all requests by the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representatives.
(b) Representations and Warranties. The respective representations and warranties of the Company and the Selling Shareholders contained herein shall be true and correct on the date hereof and on and as of the Closing Date or the Additional Closing Date, as the case may be; and the statements of the Company and its officers and of each of the Selling Shareholders and their officers or authorized signatories made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date or the Additional Closing Date, as the case may be.
(c) No Downgrade. Subsequent to the earlier of (A) the Applicable Time and (B) the execution and delivery of this Agreement, (i) no downgrading shall have occurred in the rating accorded to (x) any debt securities, convertible securities or preferred stock issued or guaranteed by the Company (y) the Companys and its Insurance Subsidiaries financial strength and claims paying ability by any nationally recognized statistical rating organization, as such term is defined under Section 3(a)(62) under the Exchange Act and (ii) no such organization shall have publicly announced that it has under surveillance or review, or has changed its outlook with respect to, its rating of (x) any such debt securities or preferred stock issued or guaranteed by the Company and (y) and of the Companys and its Insurance Subsidiaries financial strength of claims paying ability (other than, in the case of (ii)(x) and (ii)(y), an announcement with positive implications of a possible upgrading).
(d) No Material Adverse Change. No event or condition of a type described in Section 3(g) (No Material Adverse Change) hereof shall have occurred or shall exist, which event or condition is not described in the Pricing Disclosure Package (excluding any amendment or supplement thereto) and the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the judgment of the Representatives makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus.
(e) Officers Certificate. The Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, (x) a certificate of the chief financial officer or chief accounting officer of the Company and one additional
-36-
senior executive officer of the Company who is satisfactory to the Representatives (i) confirming that such officers have carefully reviewed the Registration Statement, the Pricing Disclosure Package and the Prospectus and, to the knowledge of such officers, the representations of the Company set forth in Sections 3(b) (Pricing Disclosure Package) and 3(d) (Testing-the-Waters Materials) hereof are true and correct, (ii) confirming that the other representations and warranties of the Company in this Agreement are true and correct and that the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date or the Additional Closing Date, as the case may be, and (iii) to the effect set forth in paragraphs (a), (c) and (d) above and (y) a certificate from (1) an attorney-in-fact on behalf of each of the Non-Direct Selling Shareholders and (2) Platinum Ivy, in form and substance reasonably satisfactory to the Representatives, (A) confirming that the representations of such Selling Shareholder set forth in Sections 4(e) (Pricing Disclosure Package), 4(f) (Issuer Free Writing Prospectus and Written Testing-the-Waters Communication) and 4(g) (Registration Statement and Prospectus) hereof is true and correct at or prior to the Closing Date and (B) confirming that the other representations and warranties of such Selling Shareholder in this Agreement are true and correct and that the such Selling Shareholder has complied with all agreements and satisfied all conditions on their part to be performed or satisfied hereunder at or prior to such Closing Date.
(f) Seaborne Russian Oil Certificate. The Representatives shall have received on and as of (i) the date hereof and (ii) the Closing Date or the Additional Closing Date, as the case may be, a certificate of the Company related to the price caps established by a coalition of the United States, United Kingdom, European Union, and other G7 countries in connection with purchases of seaborne Russian oil inform and substance reasonably satisfactory to the Representatives.
(g) Comfort Letters.
(i) On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, KPMG shall have furnished to the Representatives, at the request of the Company, letters, dated the respective dates of delivery thereof and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, containing statements and information of the type customarily included in accountants comfort letters to underwriters with respect to the financial statements and certain financial information contained in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus; provided, that the letter delivered on the Closing Date or the Additional Closing Date, as the case may be, shall use a cut-off date no more than two business days prior to such Closing Date or such Additional Closing Date, as the case may be.
(ii) On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, the Company shall have furnished to the Representatives a certificate, dated the respective dates of delivery thereof and addressed to the Underwriters, of its chief financial officer with respect to certain
-37-
financial data contained in the Pricing Disclosure Package and the Prospectus, providing management comfort with respect to such information, in form and substance reasonably satisfactory to the Representatives.
(h) Opinion and 10b-5 Statement of Counsel for the Company. Willkie Farr & Gallagher (UK) LLP, counsel for the Company, shall have furnished to the Representatives, at the request of the Company, their written opinion and 10b-5 statement, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, to the effect set forth in Annex D-1 hereto.
(i) Opinion of Bermuda Counsel for the Company. Conyers Dill & Pearman Limited, special Bermuda counsel for the Company, shall have furnished to the Representatives, at the request of the Company, their written opinion, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, to the effect set forth in Annex D-2 hereto.
(j) Opinions of Local Counsel for the Selling Shareholders. Each counsel set forth on Schedule 3 hereof, special counsel for the jurisdiction opposite the name of such counsel in Schedule 3 for certain of the Selling Shareholders, shall have furnished to the Representatives, at the request of the Company, their written opinion, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives.
(k) Opinions of Counsel for the Selling Shareholders. Whalen LLP, counsel for the Selling Shareholders, shall have furnished to the Representatives, at the request of the Company, their written opinion, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives.
(l) Opinion and 10b-5 Statement of Counsel for the Underwriters. The Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, an opinion and 10b-5 statement, addressed to the Underwriters, of Latham & Watkins LLP, counsel for the Underwriters, with respect to such matters as the Representatives may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon such matters.
(m) No Legal Impediment to Issuance and/or Sale. No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any U.S. federal or state or foreign governmental or regulatory authority that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the issuance or sale of the Shares by the Company or the sale of the Shares by the Selling Shareholders; and no injunction or order of any U.S. federal or state or foreign court shall have been issued that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the issuance or sale of the Shares by the Company or the sale of the Shares by the Selling Shareholders.
-38-
(n) Good Standing. The Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, satisfactory evidence of the good standing of the Company and its subsidiaries in their respective jurisdictions of organization and their good standing in such other jurisdictions as the Representatives may reasonably request, in each case in writing or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions to the extent the concept of good standing or an equivalent concept is applicable in such jurisdiction.
(o) Exchange Listing. The Shares to be delivered on the Closing Date or the Additional Closing Date, as the case may be, shall have been approved for listing on the NYSE, subject to official notice of issuance.
(p) Lock-up Agreements. The lock-up agreements, each substantially in the form of Exhibit D hereto, between you and certain shareholders, officers and directors of the Company, including the Selling Shareholders, relating to sales and certain other dispositions of shares of Stock or certain other securities, delivered to you on or before the date hereof, shall be in full force and effect on the Closing Date or the Additional Closing Date, as the case may be.
(q) Transaction Documents. The Transaction Documents have been executed. The transactions and agreements contemplated in the Transaction Documents to have occurred as of the Closing Date shall have been consummated substantially in accordance with the terms of the Transaction Documents.
(r) Additional Documents. On or prior to the Closing Date or the Additional Closing Date, as the case may be, the Company and the Selling Shareholders shall have furnished to the Representatives such further certificates and documents as the Representatives may reasonably request.
All opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters.
9. Indemnification and Contribution.
(a) Indemnification of the Underwriters and the Selling Shareholders by the Company. The Company agrees to indemnify and hold harmless each Underwriter, each Selling Shareholder and each of their respective affiliates, directors and officers and each person, if any, who controls such Underwriter or any Selling Shareholder within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities (including, without limitation, reasonable legal fees and other reasonable expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred and
-39-
documented), joint or several, that arise out of, or are based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make the statements therein, not misleading, or (ii) any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing Prospectus, any issuer information filed or required to be filed pursuant to Rule 433(d) under the Securities Act, any Testing-the-Waters Communication, any road show as defined in Rule 433(h) under the Securities Act (a road show) or any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended), or caused by any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any Selling Shareholder Information with respect to such Selling Shareholder or information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use therein, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in paragraph (c) below.
(b) Indemnification of the Underwriters and the Company by the Selling Shareholders. Each Selling Shareholder severally and not jointly in proportion to the number of Shares to be sold by such Selling Shareholder hereunder, agrees to indemnify and hold harmless each Underwriter, the Company and each of their respective affiliates, directors and officers and each person, if any, who controls such Underwriter or the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a) above, but solely with respect to, any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any Selling Shareholder Information furnished to the Company in writing by such Selling Shareholder. Notwithstanding anything to the contrary herein, no Selling Shareholder shall be liable under the indemnity or contribution provisions of this Section 9 in excess of an amount equal to the Selling Shareholder Proceeds (as defined in paragraph (f) below).
(c) Indemnification of the Company and the Selling Shareholders by the Underwriters. Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act and each of the Selling Shareholders to the same extent as the indemnity set forth in paragraph (a) above, but only with respect to, in each case, any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to such Underwriter furnished to the Company in writing by such Underwriter through the
-40-
Representatives expressly for use in the Registration Statement, the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication, any road show or any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended), it being understood and agreed upon that the only such information furnished by any Underwriter consists of the following information in the Prospectus furnished on behalf of each Underwriter: the information contained in the ninth paragraph under the caption Underwriting.
(d) Notice and Procedures. If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to the preceding paragraphs of this Section 9, such person (the Indemnified Person) shall promptly notify the person against whom such indemnification may be sought (the Indemnifying Person) in writing; provided that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have under the preceding paragraphs of this Section 9 except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and provided, further, that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under the preceding paragraphs of this Section 9. If any such proceeding shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified Person and any others entitled to indemnification pursuant to this Section that the Indemnifying Person may designate in such proceeding and shall pay the reasonable and documented fees and expenses in such proceeding and shall pay the reasonable and documented fees and expenses of such counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii) the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or (iv) the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the reasonable fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for any Underwriter, its affiliates, directors and officers and any control persons of such Underwriter shall be designated in writing by the Representatives and any such separate firm for the Company, its directors, its officers
-41-
who signed the Registration Statement and any control persons of the Company shall be designated in writing by the Company and any such separate firm for the Selling Shareholders shall be designated in writing by the Attorneys-in-Fact or any one of them. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified Person for reasonable fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by the Indemnifying Person of such request and (ii) the Indemnifying Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x) includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person.
(e) Contribution. If the indemnification provided for in paragraphs (a), (b) or (c) above is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company and the Selling Shareholders, on the one hand, and the Underwriters on the other, from the offering of the Shares or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also the relative fault of the Company and the Selling Shareholders, on the one hand, and the Underwriters on the other, in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company and the Selling Shareholders, on the one hand, and the Underwriters on the other, shall be deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company and the Selling Shareholders from the sale of the Shares and the total underwriting discounts and commissions received by the Underwriters in connection therewith, in each case as set forth in the table on the cover of the Prospectus, bear to the aggregate offering price of the Shares. The relative fault of the Company and the Selling Shareholders, on the one hand, and the Underwriters on the other, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact
-42-
relates to information supplied by the Company and the Selling Shareholders or by the Underwriters and the parties relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.
(f) Limitation on Liability. The Company, the Selling Shareholders and the Underwriters severally and not jointly agree that it would not be just and equitable if contribution pursuant to paragraph (e) above were determined by pro rata allocation (even if the Selling Shareholders or the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations referred to in paragraph (e) above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (e) above shall be deemed to include, subject to the limitations set forth above, any legal or other expenses incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of paragraphs (e) and (f), in no event shall (i) an Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the Shares exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission and (ii) a Selling Shareholder be required to indemnify and/or contribute any amount in excess of the Selling Shareholder Proceeds (as defined below) received by such Selling Shareholder exceeds the amount of any damages that such Selling Shareholder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. For the purpose of this Agreement, Selling Shareholder Proceeds means the aggregate net proceeds (after deducting underwriting commissions and discounts, but before deducting expenses) applicable to the Shares sold by such Selling Shareholder pursuant to this Agreement. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters obligations to contribute pursuant to paragraphs (e) and (f) are several in proportion to their respective purchase obligations hereunder and not joint and each Selling Shareholders obligation to contribution pursuant to paragraphs (e) and (f) is several and not joint and limited in the manner and to the extent set forth in paragraph (b) above.
(g) Non-Exclusive Remedies. The remedies provided for in this Section 9 paragraphs (a) through (f) are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity. For the avoidance of doubt, the provisions of this Section 9 shall not affect any agreement among the Company and the Selling Shareholders with respect to the indemnification or contribution, as it relates to any indemnification or contribution between the Company and the Selling Shareholders, and shall in no way impact any obligation by the Company or any of the Selling Shareholders to the Underwriters.
10. Effectiveness of Agreement. This Agreement shall become effective as of the date first written above.
-43-
11. Termination. This Agreement may be terminated in the absolute discretion of the Representatives, by notice to the Company and the Selling Shareholders, if after the execution and delivery of this Agreement and on or prior to the Closing Date or, in the case of the Option Shares, prior to the Additional Closing Date (i) trading generally shall have been suspended or materially limited on or by any of the NYSE or The Nasdaq Stock Market; (ii) trading of any securities issued or guaranteed by the Company shall have been suspended on any exchange or in any over-the-counter market; (iii) a general moratorium on commercial banking activities shall have been declared by Bermuda, U.S. federal or New York State authorities; or (iv) there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representatives, is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus.
12. Defaulting Underwriter.
(a) If, on the Closing Date or the Additional Closing Date, as the case may be, any Underwriter defaults on its obligation to purchase the Shares that it has agreed to purchase hereunder on such date, the non-defaulting Underwriters may in their discretion arrange for the purchase of such Shares by other persons satisfactory to the Company and the Selling Shareholders on the terms contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such Shares, then the Company and the Selling Shareholders shall be entitled to a further period of 36 hours within which to procure other persons satisfactory to the non-defaulting Underwriters to purchase such Shares on such terms. If other persons become obligated or agree to purchase the Shares of a defaulting Underwriter, either the non-defaulting Underwriters or the Company and the Selling Shareholders may postpone the Closing Date or the Additional Closing Date, as the case may be, for up to five full business days in order to effect any changes that in the opinion of counsel for the Company, counsel for the Selling Shareholders or counsel for the Underwriters may be necessary in the Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any amendment or supplement to the Registration Statement and the Prospectus that effects any such changes. As used in this Agreement, the term Underwriter includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to this Section 12, purchases Shares that a defaulting Underwriter agreed but failed to purchase.
(b) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters, the Company and the Selling Shareholders as provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on the Closing Date or the Additional Closing Date, as the case may be, does not exceed one-eleventh of the aggregate number of Shares to be purchased on such date, then the Company and the Selling Shareholders shall have the right to require each non-defaulting Underwriter to purchase the number of Shares that such Underwriter agreed to purchase hereunder on such date plus such
-44-
Underwriters pro rata share (based on the number of Shares that such Underwriter agreed to purchase on such date) of the Shares of such defaulting Underwriter or Underwriters for which such arrangements have not been made.
(c) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters, the Company and the Selling Shareholders as provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on the Closing Date or the Additional Closing Date, as the case may be, exceeds one-eleventh of the aggregate amount of Shares to be purchased on such date, or if the Company and the Selling Shareholders shall not exercise the right described in paragraph (b) above, then this Agreement or, with respect to any Additional Closing Date, the obligation of the Underwriters to purchase Shares on the Additional Closing Date, as the case may be, shall terminate without liability on the part of the non-defaulting Underwriters. Any termination of this Agreement pursuant to this Section 12 shall be without liability on the part of the Company or the Selling Shareholders, except that the Company will continue to be liable for the payment of expenses as set forth in Section 13 (Payment of Expenses) hereof and except that the provisions of Section 9 (Indemnification and Contribution) hereof shall not terminate and shall remain in effect.
(d) Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company, the Selling Shareholders or any non-defaulting Underwriter for damages caused by its default.
13. Payment of Expenses.
(a) Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, (A) the Company will pay or cause to be paid all documented costs and expenses incurred in connection with the performance of its obligations hereunder, including without limitation, (i) the costs incurred in connection with to the authorization, issuance, sale, preparation and delivery of the Shares and any taxes payable in that connection; (ii) the costs incurred in connection with to the preparation, printing and filing under the Securities Act of the Registration Statement, the Preliminary Prospectus, any Issuer Free Writing Prospectus, any Pricing Disclosure Package and the Prospectus (including all exhibits, amendments and supplements thereto) and the distribution thereof; (iii) the costs of reproducing and distributing each of the Transaction Documents; (iv) the fees and expenses of the Companys counsel and Companys independent accountants; (v) the fees and expenses incurred in connection with the registration or qualification and determination of eligibility for investment of the Shares under the laws of such jurisdictions as the Representatives may designate and the preparation, printing and distribution of a Blue Sky Memorandum (including the related reasonable and documented fees and expenses of counsel for the Underwriters) up to an aggregate of $10,000; (vi) the cost of preparing stock certificates if applicable; (vii) the costs and charges of any transfer agent and any registrar; (viii) all expenses and application fees incurred in connection with any filing with, and clearance of the offering by, FINRA (including the related reasonable and documented fees and expenses of counsel for the Underwriters) up to an aggregate of $35,000; (ix) all expenses incurred by the Company
-45-
in connection with any road show presentation to potential investors; (x) all Stamp Taxes payable in connection with the creation, issuance and delivery of the Shares to the Underwriters and sale and delivery of the Shares by the Underwriters in the manner contemplated by this Agreement and the Prospectus; and (xi) all expenses and application fees related to the listing of the Shares on the NYSE and (B) in accordance with the terms of the Companys registration rights agreement, the Company will pay or caused to be paid all reasonable, documented fees and expenses of Whalen LLP, as designated counsel to the Selling Shareholders in connection with the offering of Shares contemplated hereby, and each Selling Shareholder will otherwise pay or cause to be paid any fees and expenses of any additional counsel for such Selling Shareholder.
(b) If (i) this Agreement is terminated pursuant to Section 11 (Termination), (ii) the Company or the Selling Shareholders for any reason fail to tender the Shares for delivery to the Underwriters or (iii) the Underwriters decline to purchase the Shares for any reason permitted under this Agreement, the Company agrees to reimburse the Underwriters for all accountable out-of-pocket costs and expenses (including the reasonable fees and expenses of their counsel) reasonably and actually incurred by the Underwriters in connection with this Agreement and the offering contemplated hereby. For avoidance of doubt, if this Agreement is terminated pursuant to Section 12 (Defaulting Underwriter), the Company and the Selling Shareholders shall have no obligation to reimburse a defaulting Underwriter for out of pocket costs and expenses (including the fees and expenses of their counsel) incurred by such defaulting Underwriter in connection with this Agreement and the offering contemplated hereby.
14. Persons Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers and directors and any controlling persons referred to herein and the affiliates of each Underwriter referred to in Section 9 (Indemnification and Contribution) hereof. Nothing in this Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Shares from any Underwriter shall be deemed to be a successor merely by reason of such purchase.
15. Survival. The respective indemnities, rights of contribution, representations, warranties and agreements of the Company, the Selling Shareholders and the Underwriters contained in this Agreement or made by or on behalf of the Company, the Selling Shareholders or the Underwriters pursuant to this Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment for the Shares and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company, the Selling Shareholders or the Underwriters or the directors, officers, controlling persons or affiliates referred to in Section 9 (Indemnification and Contribution) hereof.
16. Certain Defined Terms. For purposes of this Agreement, (a) except where otherwise expressly provided, the term affiliate has the meaning set forth in Rule 405 under the Securities Act; (b) the term business day means any day other than a day on which banks are permitted or required to be closed in New York City; and (c) the term subsidiary has the meaning set forth in Rule 405 under the Securities Act; and (d) the term significant subsidiary has the meaning set forth in Rule 1-02(w) of Regulation S-X under the Exchange Act.
-46-
17. Compliance with USA Patriot Act. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company and the Selling Shareholders, which information may include the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients, and the Company shall provide to the Underwriters such information with respect to the Company as may be reasonably requested by the Underwriters from time to time.
18. Miscellaneous.
(a) Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to the Representatives c/o J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179 (Fax: (212) 622-8358); Attention: Equity Syndicate Desk, c/o Barclays Capital Inc., 745 Seventh Avenue, New York, New York 10019 (Fax: (646) 834-8133); Attention: Syndicate Registration and Jefferies LLC, 520 Madison Avenue, New York, New York 10022 (Fax: (626) 619-4437); Attention General Counsel. Notices to the Company shall be given to it at Fidelis Insurance Holdings Limited, Waterloo House, 100 Pitts Bay Road, Pembroke, Bermuda, HM08 (email: Janice.Weidenborner@fidelisinsurance.com); Attention: Janice Weidenborner, Chief Legal Officer. Notices to the Selling Shareholders represented by Whalen LLP shall be given to the Company at the address set forth on the cover of the Registration Statement, Attention: General Counsel, with a copy, which shall not constitute notice, to Whalen LLP, 1601 Dove Street, Suite 270, Newport Beach, California 92660. Notices to Platinum Ivy shall be given to it at Level 26, Al Khatem Tower, Abu Dhabi Global Market Square, Al Maryah Island, Abu Dhabi, United Arab Emirates (email: private.equity@adia.ae; LegalDivision_PE_Europe@adia.ae) to the attention of The Directors of Platinum Ivy B 2018 RSC Limited, with a copy, which shall not constitute notice, to Cleary Gottlieb Steen & Hamilton LLP, Al Sila Tower, 27th floor, Abu Dhabi Global Market Square, Al Maryah Island, PO Box 29920, Abhu Dhabi United Arab Emirates, Attention: Gamal Abouali (email: gabouali@cgsh.com). Notices to SPFM Holdings, LLC shall be given to it at 385 Washington Street, St. Paul, MN 55102, Attention: Head of Strategic Development.
(b) Governing Law. This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and construed in accordance with the laws of the State of New York.
(c) Submission to Jurisdiction. Each of the Company and the Selling Shareholders hereby submit to the exclusive jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated
-47-
hereby. Each of the Company and the Selling Shareholders waive any objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. Each of the Company and the Selling Shareholders agree that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding upon the Company and each Selling Shareholder, as applicable, and may be enforced in any court to the jurisdiction of which Company and each Selling Shareholder, as applicable, is subject by a suit upon such judgment. The Company and each Selling Shareholder irrevocably appoint Puglisi & Associates, 810 Library Avenue, Suite 204, Newark, Delaware 19711, U.S, as its authorized agent upon which process may be served in any such suit or proceeding, and agrees that service of process upon such authorized agent, and written notice of such service to the Company or any such Selling Shareholder, as the case may be, by the person serving the same to the address provided in this Section 18(c) (Submission to Jurisdiction), shall be deemed in every respect effective service of process upon the Company and such Selling Shareholder in any such suit or proceeding. Each of the Company and the Selling Shareholders hereby, severally and not jointly, represent and warrant that such authorized agent has accepted such appointment and has agreed to act as such authorized agent for service of process. Each of the Company and the Selling Shareholders further, severally and not jointly, agree to take any and all action as may be necessary to maintain such designation and appointment of such authorized agent in full force and effect for a period of seven years from the date of this Agreement.
(d) Judgment Currency. The Company and each Selling Shareholder, severally and not jointly, agree to indemnify each Underwriter, its directors, officers, affiliates and each person, if any, who controls such Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, against any loss incurred by such Underwriter as a result of any judgment or order being given or made for any amount due hereunder and such judgment or order being expressed and paid in a currency (the judgment currency) other than U.S. dollars and as a result of any variation as between (i) the rate of exchange at which the U.S. dollar amount is converted into the judgment currency for the purpose of such judgment or order, and (ii) the rate of exchange at which such indemnified person is able to purchase U.S. dollars with the amount of the judgment currency actually received by the indemnified person. The foregoing indemnity shall constitute a separate and independent obligation of the Company and each Selling Shareholder and shall continue in full force and effect notwithstanding any such judgment or order as aforesaid. The term rate of exchange shall include any premiums and costs of exchange payable in connection with the purchase of, or conversion into, the relevant currency.
(e) Waiver of Immunity. To the extent that the Company or any Selling Shareholder has or hereafter may acquire any immunity (sovereign or otherwise) from jurisdiction of any court of (i) Bermuda, or any political subdivision thereof, (ii) the United States or the State of New York, (iii) any jurisdiction in which it owns or leases property or assets or from any legal process (whether through service of notice, attachment prior to judgment, attachment in aid of execution, execution, set-off or otherwise) with respect to themselves or their respective property and assets or this
-48-
Agreement, the Company and each Selling Shareholder hereby, severally and not jointly, irrevocably waive such immunity in respect of its obligations under this Agreement to the fullest extent permitted by applicable law.
(f) Waiver of Jury Trial. Each of the parties hereto hereby waives any right to trial by jury in any suit or proceeding arising out of or relating to this Agreement.
(g) Recognition of the U.S. Special Resolution Regimes.
(i) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.
(ii) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.
As used in this Section 18(g):
BHC Act Affiliate has the meaning assigned to the term affiliate in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k).
Covered Entity means any of the following:
(i) a covered entity as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b);
(ii) a covered bank as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or
(iii) a covered FSI as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).
Default Right has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable.
U.S. Special Resolution Regime means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
-49-
(h) Counterparts. This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. This Agreement may be delivered via facsimile, electronic mail, electronic delivery of a portable document format (PDF) file (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com or www.echosign.com) or other transmission method of any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.
(i) Amendments or Waivers. No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto.
(j) Headings. The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement.
-50-
If the foregoing is in accordance with your understanding, please indicate your acceptance of this Agreement by signing in the space provided below.
Very truly yours, | ||
FIDELIS INSURANCE HOLDINGS LIMITED | ||
By: |
| |
Name: | ||
Title: | ||
The Non-Direct Selling Shareholders, acting severally | ||
By: |
| |
Name: | ||
Title: | ||
By: |
| |
Name: | ||
Title: | ||
As Attorneys-in-Fact acting on behalf of each of the Selling Shareholders named in Schedule 2 to this Agreement as being represented by Whalen LLP. | ||
Platinum Ivy B 2018 RSC Limited | ||
By: |
| |
Name: | ||
Title: | ||
By: |
| |
Name: | ||
Title: |
-51-
-52-
Schedule 1
Underwriter | Number of Underwritten Shares | |
J.P. Morgan Securities LLC | ||
Barclays Capital Inc.
Jefferies LLC |
||
BMO Capital Markets Corp. | ||
Citigroup Global Markets Inc. | ||
Keefe, Bruyette & Woods, Inc.
UBS Securities LLC
Dowling & Partners Securities, LLC
JMP Securities LLC |
||
Total |
-1-
Schedule 2
Selling Shareholders: | Number of Underwritten Shares: |
Number of Option Shares: |
Sch. 2-1
Schedule 3
Selling Shareholders: |
Local Counsel for Selling Shareholders |
Local Counsel Jurisdiction | ||
Capital Z Partners |
Walkers (Cayman) LLP | Cayman Islands | ||
Crestview IV FIHL TE Holdings, LLC |
Maples and Calder (Cayman) LLP | Cayman Islands | ||
Crestview IV FIHL Holdings, L.P. |
Maples and Calder (Cayman) LLP | Cayman Islands | ||
Crestview FIHL Holdings, L.P. |
Maples and Calder (Cayman) LLP | Cayman Islands | ||
Crestview FIHL TE Holdings, Ltd. |
Maples and Calder (Cayman) LLP | Cayman Islands | ||
CVC Falcon Holdings Ltd |
Mourant Ozannes (Jersey) LLP | Jersey | ||
Fidelis Investors LP |
Walkers (Cayman) LLP | Cayman Islands | ||
Fidelis Investors Offshore LP |
Walkers (Cayman) LLP | Cayman Islands | ||
Pine Brook Feal Intermediate, L.P. |
Maples and Calder (Cayman) LLP | Cayman Islands | ||
Platinum Ivy B 2018 RSC Limited |
Morgan, Lewis & Bockius LLP | Abu Dhabi Global Market (ADGM) |
Sch. 3-1
Annex A
a. Pricing Disclosure Package
[ ● ]
b. Pricing Information Provided Orally by Underwriters
[ ● ]
Sch. 3-1
Annex B
Written Testing-the-Waters Communications
[ ● ]
Sch. 3-1
Annex C
Fidelis Insurance Holdings Limited
Pricing Term Sheet
[None]
Annex D-1
Annex D-1
Form of Opinion of Counsel for the Company
Annex D-1
Annex D-2
Form of Opinion of Bermuda Counsel for the Company
-1-
Exhibit A
Testing the Waters Authorization (to be delivered by the issuer to J.P. Morgan Securities LLC and Barclays Capital Inc. in email or letter form).
In reliance on Rule 163B of the Securities Act of 1933, as amended (the Act), Fidelis Insurance Holdings Limited, a Bermuda exempted company (the Issuer) hereby authorizes J.P. Morgan Securities LLC (J.P. Morgan), Barclays Capital Inc. (Barclays) and Jefferies LLC (Jefferies), and their affiliates and employees, to engage on behalf of the Issuer in oral and written communications with potential investors that are persons reasonably believed to be qualified institutional buyers, as defined in Rule 144A under the Act, or institutions that are accredited investors, within the meaning of Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12) or (a)(13) under the Act, to determine whether such investors might have an interest in the Issuers contemplated initial public offering (Testing-the-Waters Communications).
A Written Testing-the-Waters Communication means any Testing-the-Waters Communication that is a written communication within the meaning of Rule 405 under the Act. Each of J.P. Morgan, Barclays and Jefferies, individually and not jointly, agrees that it shall not distribute any Written Testing-the-Waters Communication that has not been approved in writing by the Chief Financial Officer and/or the Chief General Counsel of the Issuer prior to its dissemination.
The Issuer represents that (i) except as disclosed to J.P. Morgan, Barclays and Jefferies, it has not alone engaged in any Testing-the-Waters Communication; (ii) it has not authorized anyone other than J.P. Morgan, Barclays and Jefferies to engage in Testing-the-Waters Communications; and (iii) all information provided by the Company in the Testing the Waters Communications, to the extent material, will be included in or consistent with the information in any registration statement on Form F-1 relating to its proposed initial public offering.
If at any time following the distribution of any Written Testing-the-Waters Communication there occurs an event or development as a result of which such Written Testing-the-Waters Communication included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing at that subsequent time, not misleading, the Issuer will promptly notify J.P. Morgan, Barclays and Jefferies and will promptly amend or supplement, at its own expense but with the reasonable assistance of J.P. Morgan, Barclays and Jefferies, such Written Testing-the-Waters Communication to eliminate or correct such untrue statement or omission.
Nothing in this authorization is intended to limit or otherwise affect the ability of J.P. Morgan, Barclays and Jefferies and their affiliates and employees to engage in communications in which they could otherwise lawfully engage in the absence of this authorization, including, without limitation, any written communication containing only one or more of the statements specified under Rule 134(a) under the Act. This authorization shall remain in effect until the Issuer has provided to J.P. Morgan, Barclays and Jefferies a written notice revoking this authorization. This authorization shall be governed by and construed in accordance with the laws of the State of
-1-
New York. All notices as described herein shall be sent by email to the attention of Michael Rhodes at michael.r.rhodes@jpmorgan.com; Craig Bergmann at craig.bergmann@barclays.com; Taylor Wright at taylor.wright@barclays.com; and Michael Bauer at mbauer@jefferies.com.
-2-
Exhibit B
Form of Waiver of Lock-up
J.P. MORGAN SECURITIES LLC
BARCLAYS CAPITAL INC.
JEFFERIES LLC
Fidelis Insurance Holdings Limited
Public Offering of Common Shares
[ ● ], 2023
[Name and Address of
Officer or Director
Requesting Waiver]
Dear Mr./Ms. [Name]:
This letter is being delivered to you in connection with the offering by Fidelis Insurance Holdings Limited, an exempted company organized under the laws of Bermuda (the Company), of [ ● ] common shares, $0.01 par value (the Common Shares), of the Company and the lock-up letter dated [ ● ] (the Lock-up Letter), executed by you in connection with such offering, and your request for a [waiver/release] dated [ ● ] with respect to [ ● ] Common Shares (the Shares).
J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC hereby agree to [waive/release] the transfer restrictions set forth in the Lock-up Letter, but only with respect to the Shares, effective [ ● ]; provided, however, that such [waiver/release] is conditioned on the Company announcing the impending [waiver/release] by press release through a major news service at least two business days before effectiveness of such [waiver/release]. This letter will serve as notice to the Company of the impending [waiver/release].
Except as expressly [waived/released] hereby, the Lock-up Letter shall remain in full force and effect.
-1-
Yours very truly,
J.P. MORGAN SECURITIES LLC | ||
By: | ||
Name: Title: |
||
BARCLAYS CAPITAL INC. | ||
By: | ||
Name: Title: |
||
JEFFERIES LLC | ||
By: | ||
Name: Title: |
cc: Company
-2-
Exhibit C
Form of Press Release
Fidelis Insurance Holdings Limited
[Date]
Fidelis Insurance Holdings Limited, an exempted company organized under the laws of Bermuda (the Company), announced today that J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC, the lead book-running managers in the Companys recent public sale of [ ● ] common shares, are [waiving/releasing] a lock-up restriction with respect to [ ● ] common shares of the Company held by [certain officers or directors/an officer or director] of the Company. The [waiver/release] will take effect on [ ● ], and the common shares may be sold on or after such date.
This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.
-1-
Exhibit D
FORM OF LOCK-UP AGREEMENT
J.P. MORGAN SECURITIES LLC
BARCLAYS CAPITAL INC.
JEFFERIES LLC
As Representatives of the
several Underwriters listed
in Schedule 1 to the
Underwriting Agreement
referred to below
c/o J.P. Morgan Securities LLC
383 Madison Avenue
New York, New York 10179
c/o Barclays Capital Inc.
745 Seventh Avenue
New York, New York 10019
c/o Jefferies LLC
520 Madison Avenue
New York New York 10022
Re: Fidelis Insurance Holdings Limited - Public Offering
Ladies and Gentlemen:
The undersigned understands that you, as Representatives of the several Underwriters, propose to enter into an underwriting agreement (the Underwriting Agreement) with Fidelis Insurance Holdings Limited, an exempted company organized under the laws of Bermuda (the Company), and the Selling Shareholders listed on Schedule 2 to the Underwriting Agreement, providing for the public offering (the Public Offering) by the several Underwriters named in Schedule 1 to the Underwriting Agreement (the Underwriters), of common shares of the Company (the Securities). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.
In consideration of the Underwriters agreement to purchase and make the Public Offering of the Securities, and for other good and valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC on behalf of the
Underwriters, the undersigned will not, and will not cause any direct or indirect affiliate to, during the period beginning on the date of this letter agreement (this Letter Agreement) and ending at the close of business 180 days after the date of the final prospectus relating to the Public Offering (the Prospectus) (such period, the Restricted Period), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any common shares, $0.01 per share par value, of the Company (the Common Shares) or any securities convertible into or exercisable or exchangeable for Common Shares (including without limitation, Common Shares or such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and securities which may be issued upon exercise of a stock option or warrant) (collectively with the Common Shares, the Lock-Up Securities), (2) enter into any hedging, swap or other agreement or transaction that transfers, in whole or in part, any of the economic consequences of ownership of the Lock-Up Securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Lock-Up Securities, in cash or otherwise, (3) make any demand for, or exercise any right with respect to, the registration of any Lock-Up Securities, or (4) publicly disclose the intention to do any of the foregoing.
The undersigned acknowledges and agrees that the foregoing precludes the undersigned from engaging in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition or transfer (whether by the undersigned or any other person) of any economic consequences of ownership, in whole or in part, directly or indirectly, of any Lock-Up Securities, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of Lock-Up Securities, in cash or otherwise. The undersigned further confirms that it has furnished the Representatives with the details of any transaction the undersigned, or any of its affiliates, is a party to as of the date hereof, which transaction would have been restricted by this Letter Agreement if it had been entered into by the undersigned during the Restricted Period.
Notwithstanding the foregoing, the undersigned may:
(a) transfer the undersigneds Lock-Up Securities:
(i) as a bona fide gift or gifts, or for bona fide estate planning purposes,
(ii) by will or intestacy,
(iii) to any trust for the direct or indirect benefit of the undersigned or the immediate family of the undersigned, or if the undersigned is a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust (for purposes of this Letter Agreement, immediate family shall mean any relationship by blood, current or former marriage, domestic partnership or adoption, not more remote than first cousin),
(iv) to a partnership, limited liability company or other entity of which the undersigned and the immediate family of the undersigned are the legal and beneficial owner of all of the outstanding equity securities or similar interests,
(v) to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i) through (iv) above,
(vi) if the undersigned is a corporation, partnership, limited liability company, trust or other business entity, (A) to another corporation, partnership, limited liability company, trust or other business entity that is an affiliate (as defined in Rule 405 promulgated under the Securities Act of 1933, as amended) of the undersigned, or to any investment fund or other entity controlling, controlled by, managing or managed by or under common control with the undersigned or affiliates of the undersigned (including, for the avoidance of doubt, where the undersigned is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership), or (B) as part of a distribution to members or shareholders of the undersigned,
(vii) by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation agreement,
(viii) to the Company from an employee of the Company upon death, disability or termination of employment, in each case, of such employee,
(ix) as part of a sale of the undersigneds Lock-Up Securities acquired in open market transactions after the closing date for the Public Offering,
(x) to the Company in connection with the vesting, settlement, or exercise of restricted stock units, options, warrants or other rights to purchase Common Shares (including, in each case, by way of net or cashless exercise), including for the payment of exercise price and tax and remittance payments due as a result of the vesting, settlement, or exercise of such restricted stock units, options, warrants or rights, provided that any such Common Shares received upon such exercise, vesting or settlement shall be subject to the terms of this Letter Agreement, and provided further that any such restricted stock units, options, warrants or rights are held by the undersigned pursuant to an agreement or equity awards granted under a stock incentive plan or other equity award plan, each such agreement or plan which is described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, or
(xi) pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction that is approved by the Board of Directors of the Company and made to all holders of the Companys share capital involving a Change of Control (as defined below) of the Company (for purposes hereof, Change of Control shall mean the transfer (whether by tender offer, merger, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons, of share capital if, after such transfer, such person or group of affiliated persons would hold at least a majority of the outstanding voting securities of the Company (or the surviving entity)); provided that in the event that such tender offer, merger, consolidation or other similar transaction is not completed, the undersigneds Lock-Up Securities shall remain subject to the provisions of this Letter Agreement;
provided that (A) in the case of any transfer or distribution pursuant to clause (a)(i), (ii), (iii), (iv), (v), (vi) and (vii), such transfer shall not involve a disposition for value and each donee, devisee, transferee or distributee shall execute and deliver to the Representatives a lock-up letter in the form of this Letter Agreement, (B) in the case of any transfer or distribution pursuant to clause (a) [(i), (ii), (iii), (iv), (v), (vi), (ix) and (x)], no filing by any party (donor, donee, devisee, transferor, transferee, distributer or distributee) under the Securities Exchange Act of 1934, as amended (the Exchange Act), or other public announcement shall be required or shall be made voluntarily in connection with such transfer or distribution (other than a filing on a Form 5 made after the expiration of the Restricted Period referred to above) and (C) in the case of any transfer or distribution pursuant to clause [(a)(vii) and (viii)] it shall be a condition to such transfer that no public filing, report or announcement shall be voluntarily made and if any filing under Section 16(a) of the Exchange Act, or other public filing, report or announcement reporting a reduction in beneficial ownership of Common Shares in connection with such transfer or distribution shall be legally required during the Restricted Period, such filing, report or announcement shall clearly indicate in the footnotes thereto the nature and conditions of such transfer;
(b) exercise outstanding options, settle restricted stock units or other equity awards or exercise warrants pursuant to plans described in the Registration Statement, the Pricing Disclosure Package and the Prospectus; provided that any Lock-Up Securities received upon such exercise, vesting or settlement shall be subject to the terms of this Letter Agreement;
(c) convert outstanding preferred stock, warrants to acquire preferred stock or convertible securities into Common Shares or warrants to acquire Common Shares; provided that any such Common Shares or warrants received upon such conversion shall be subject to the terms of this Letter Agreement;
(d) establish trading plans pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of Lock-Up Securities; provided that (1) such plans do not provide for the transfer of Lock-Up Securities during the Restricted Period and (2) any public announcement or filing under the Exchange Act made by any person regarding the establishment of such plan during the Restricted Period shall include a statement that the undersigned is not permitted to transfer, sell or otherwise dispose of securities under such plan during the Restricted Period in contravention of this Letter Agreement; and
(e) sell the Securities to be sold by the undersigned pursuant to the terms of the Underwriting Agreement.
If the undersigned is not a natural person, the undersigned represents and warrants that no single natural person, entity or group (within the meaning of Section 13(d)(3) of the Exchange Act) beneficially owns, directly or indirectly, 50% or more of the common equity interests, or 50% or more of the voting power, in the undersigned.
If the undersigned is an officer or director of the Company, the undersigned further agrees that the foregoing provisions shall be equally applicable to any Company-directed Securities the undersigned may purchase in the Public Offering.
If the undersigned is an officer or director of the Company, (i) J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC on behalf of the Underwriters agree that, at least three business days before the effective date of any release or waiver of the foregoing restrictions in connection with a transfer of Lock-Up Securities, J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC on behalf of the Underwriters will notify the Company of the impending release or waiver, and (ii) the Company has agreed in the Underwriting Agreement to announce the impending release or waiver through a major news service or any other method permitted by applicable law at least two business days before the effective date of the release or waiver. Any release or waiver granted by J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC on behalf of the Underwriters hereunder to any such officer or director shall only be effective two business days after the publication date of such announcement. The provisions of this paragraph will not apply if (a) the release or waiver is effected solely to permit a transfer not for consideration or that is to an immediate family member as defined in FINRA Rule 5130(i)(5) and (b) the transferee has agreed in writing to be bound by the same terms described in this letter to the extent and for the duration that such terms remain in effect at the time of the transfer.
In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the registration or transfer of the securities described herein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Letter Agreement.
The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Letter Agreement. All authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the undersigned.
The undersigned acknowledges and agrees that the Underwriters have not provided any recommendation or investment advice nor have the Underwriters solicited any action from the undersigned with respect to the Public Offering of the Securities and the undersigned has consulted their own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned further acknowledges and agrees that, although the Representatives may be required or choose to provide certain Regulation Best Interest and Form CRS disclosures to you in connection with the Public Offering, the Representatives and the other Underwriters are not making a recommendation to you to participate in the Public Offering, enter into this Letter Agreement, or sell any Shares at the price determined in the Public Offering, and nothing set forth in such disclosures is intended to suggest that any Representative or any Underwriter is making such a recommendation.
The undersigned understands that, if the Underwriting Agreement does not become effective by August 31, 2023, or if the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Common Shares to be sold thereunder, the undersigned shall be released from all
obligations under this Letter Agreement. The undersigned understands that the Underwriters are entering into the Underwriting Agreement and proceeding with the Public Offering in reliance upon this Letter Agreement.
This Letter Agreement and any claim, controversy or dispute arising under or related to this Letter Agreement shall be governed by and construed in accordance with the laws of the State of New York.
Very truly yours,
[NAME OF STOCKHOLDER] | ||
By: | ||
Name: Title: |
Exhibit 3.2
AMENDED AND RESTATED BYE-LAWS
OF
FIDELIS INSURANCE HOLDINGS LIMITED
ADOPTED JUNE 28, 2023
TABLE OF CONTENTS
INTERPRETATION |
| |||||
1. |
Definitions | 1 | ||||
SHARES |
| |||||
2. |
Power to Issue Shares; Power to Purchase Shares | 5 | ||||
3. |
Rights Attaching to Shares | 5 | ||||
4. |
Calls on Shares | 7 | ||||
5. |
Forfeiture of Shares | 7 | ||||
6. |
Variation of Rights | 8 | ||||
7. |
Power to Alter Capital | 8 | ||||
8. |
Fractional Shares | 8 | ||||
9. |
Registered Holder of Shares | 8 | ||||
10. |
Death of a Joint Holder | 9 | ||||
11. |
Share Certificates | 9 | ||||
REGISTER OF MEMBERS |
| |||||
12. |
Contents of Register of Members | 9 | ||||
13. |
Inspection of Register of Members | 10 | ||||
14. |
Determination of Record Date | 10 | ||||
TRANSFER OF SHARES |
| |||||
15. |
Instrument of Transfer | 10 | ||||
16. |
Restrictions on Transfer | 10 | ||||
17. |
Transfers by Joint Holders | 10 | ||||
TRANSMISSION OF SHARES |
| |||||
18. |
Representative of Deceased Member | 11 | ||||
19. |
Registration on Death or Bankruptcy | 11 | ||||
DIVIDENDS AND OTHER DISTRIBUTIONS |
| |||||
20. |
Declaration of Dividends by the Board | 11 | ||||
21. |
Other Distributions | 11 | ||||
22. |
Method of Payment | 11 | ||||
23. |
Reserve Fund | 12 | ||||
24. |
Unclaimed Dividends | 12 | ||||
25. |
Interest on Dividend | 12 |
i
CAPITALISATION |
| |||||
26. |
Capitalisation | 12 | ||||
MEETINGS OF MEMBERS |
| |||||
27. |
Annual General Meetings | 12 | ||||
28. |
Special General Meetings | 12 | ||||
29. |
Requisitioned General Meetings | 12 | ||||
30. |
Notice | 13 | ||||
31. |
Giving Notice and Access | 13 | ||||
32. |
Postponement or Cancellation of General Meeting | 14 | ||||
33. |
Electronic Participation in Meetings | 14 | ||||
34. |
Quorum at General Meetings | 14 | ||||
35. |
Chairperson to Preside at General Meetings | 14 | ||||
36. |
Voting on Resolutions | 14 | ||||
37. |
Power to Demand a Vote on a Poll | 15 | ||||
38. |
Voting by Joint Holders of Shares | 16 | ||||
39. |
Instrument of Proxy | 16 | ||||
40. |
Representation of Corporate Member | 17 | ||||
41. |
Adjournment of General Meeting | 17 | ||||
42. |
Written Resolutions | 18 | ||||
43. |
Directors Attendance at General Meetings | 18 | ||||
DIRECTORS AND OFFICERS |
| |||||
44. |
Board of Directors | 18 | ||||
45. |
Management of the Company | 19 | ||||
46. |
Power to Appoint CEO | 19 | ||||
47. |
Power to Authorise Specific Actions | 19 | ||||
48. |
Power to Appoint Attorney | 19 | ||||
49. |
Power to Delegate to a Committee | 19 | ||||
50. |
Power to Appoint and Dismiss Employees | 19 | ||||
51. |
Power to Borrow and Charge Property | 20 | ||||
52. |
Other Powers of the Board | 20 | ||||
53. |
Number of Directors | 20 | ||||
54. |
Election and Appointment of Directors; Classes of Directors | 20 | ||||
55. |
Removal of Directors | 22 | ||||
56. |
Other Vacancies | 23 | ||||
57. |
Alternate Directors | 23 | ||||
58. |
Remuneration of Directors | 23 | ||||
59. |
Defect in Appointment | 24 | ||||
60. |
Register of Directors and Officers | 24 | ||||
61. |
Appointment of Officers | 24 | ||||
62. |
Appointment of Secretary | 24 | ||||
63. |
Duties of Officers | 24 | ||||
64. |
Remuneration of Officers | 24 | ||||
65. |
Conflicts of Interest | 25 | ||||
66. |
Indemnification and Exculpation of Directors and Officers | 25 | ||||
67. |
Waiver of Claim by Member | 26 |
ii
MEETINGS OF THE BOARD OF DIRECTORS |
| |||||
68. |
Board Meetings | 26 | ||||
69. |
Notice of Board Meetings | 26 | ||||
70. |
Electronic Participation in Meetings | 27 | ||||
71. |
Quorum at the Board Meetings | 27 | ||||
72. |
Board to Continue in the Event of Vacancy | 27 | ||||
73. |
Chairperson to Preside | 27 | ||||
74. |
Written Resolutions | 27 | ||||
75. |
Validity of Prior Acts of the Board | 27 | ||||
CORPORATE RECORDS |
| |||||
76. |
Minutes | 27 | ||||
77. |
Place Where Corporate Records Kept | 28 | ||||
78. |
Form and Use of Seal | 28 | ||||
ACCOUNTS |
| |||||
79. |
Records of Account | 28 | ||||
80. |
Financial Year End | 28 | ||||
AUDITS |
| |||||
81. |
Annual Audit | 28 | ||||
82. |
Appointment of Auditor | 29 | ||||
83. |
Remuneration of Auditor | 29 | ||||
84. |
Duties of Auditor | 29 | ||||
85. |
Access to Records | 29 | ||||
86. |
Financial Statements and the Auditors Report | 29 | ||||
87. |
Vacancy in the Office of Auditor | 29 | ||||
VOLUNTARY WINDING-UP AND DISSOLUTION |
| |||||
88. |
Winding-Up | 30 | ||||
ALTERATION OF BYE-LAWS AND MEMORANDUM OF ASSOCIATION |
| |||||
89. |
Alteration of Bye-Laws | 30 | ||||
90. |
Discontinuance | 30 |
iii
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
INTERPRETATION
1. | Definitions |
1.1 | In these bye-laws (the Bye-Laws), the following words and expressions shall, where not inconsistent with the context, have the following meanings, respectively: |
Act | the Companies Act 1981; | |||
Affiliate | with respect to any Person, any other Person controlling, controlled by or under common control with such Person. As used in this definition, control (including, with its correlative meanings, controlled by and under common control with) shall mean, with respect to any Person, the possession, directly or indirectly, of the power to direct or cause the direction of management or policies (whether through ownership of securities or partnership or other ownership interests, by contract or otherwise) of such Person. In the case of a natural person, his or her Affiliates include members of such Persons immediate family, natural lineal descendants of such Person or a trust or other similar entity established for the exclusive benefit of such Person and his or her immediate family and natural lineal descendants; | |||
Affiliate Transferee | with respect to any Member, (i) any Affiliate of the applicable Member, including any Person that has a common general partner, managing member, investment manager or governing body with any such Member or the funds which own such Member, and (ii) any general or limited partner or member of the applicable Member or any of its Affiliates and any corporation, partnership or other entity that is an Affiliate of such general or limited partner or member, so long as such Person remains an Affiliate thereof. Notwithstanding anything to the contrary herein, CVCs Affiliate Transferees shall not include (a) any portfolio company of CVC or any of its affiliated investment funds or (b) CVC Credit Partners LP and any of its subsidiaries; | |||
Alternate Director | an alternate Director appointed in accordance with these Bye-Laws; | |||
Auditor | any Person appointed to audit the accounts of the Company; | |||
Board | the board of Directors (including, for the avoidance of doubt, a sole Director) appointed or elected pursuant to these Bye-Laws and acting by resolution in accordance with the Act and these Bye-Laws or the Directors present at a meeting of Directors at which there is a quorum; | |||
Business Day | any day other than a Saturday, a Sunday or any day on which banks located in New York, London or Bermuda are authorized or obliged to close; | |||
Cause | as it relates to a Director in such capacity, (i) the Directors habitual drug or alcohol use that impairs the ability of the Director to perform his or her duties to the Company; (ii) the Directors indictment by a court of competent jurisdiction, or a pleading of no contest or guilty, to a felony (or the equivalent if outside the United States); (iii) the Directors engaging in fraud, embezzlement or any similar conduct with respect to the Company, any Subsidiary, or any assets of the Company or any Subsidiary; (iv) the Directors wilful and material failure or refusal to perform his or her duties as a Director; or (v) the Director otherwise materially breaches any written policy of the Company or any Subsidiary regarding the conduct of its respective directors in the performance of his or her duties to the Company or any Subsidiary; |
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
CEO | the Chief Executive Officer of the Company; | |||
Chair | the Chair of the Company from time to time, who at the date of adoption of these Bye-Laws is Baroness Helena Morrissey, DBE; | |||
Common Shareholders Agreement | the Companys Amended and Restated Common Shareholders Agreement, dated as of June 16, 2023, as amended from time to time, by and among the Company and the holders of Common Shares party thereto; | |||
Common Shares | the Common Shares of the Company, with an initial par value of $0.01 per share, and includes a fraction of a Common Share; | |||
Company | the company for which these Bye-Laws are approved and confirmed; | |||
Company Securities | (i) any shares (of any class) including Common Shares, Preference Shares or other equity securities of the Company and (ii) any options, warrants, convertible notes, securities of any type or similar rights issued that are or may become convertible into or exercisable or exchangeable for, or that carry rights to subscribe for, any shares (of any class), including Common Shares, Preference Shares or other equity securities of the Company; | |||
Crestview | Crestview FIHL Holdings, L.P., a Cayman Islands limited partnership, Crestview FIHL TE Holdings, Ltd, a Cayman Islands limited company, Crestview IV FIHL Holdings, L.P., a Cayman Islands limited partnership and Crestview IV FIHL TE Holdings LLC, a Cayman Islands limited liability company, collectively; | |||
Crestview Nominee | has the meaning set forth in Bye-Law 54.3(a)(i); | |||
CVC | CVC Falcon Holdings Limited, a Jersey limited liability company; | |||
CVC Nominee | has the meaning set forth in Bye-Law 54.3(a)(ii); | |||
Director | a director of the Company and shall include an Alternate Director; | |||
Exchange Act | the United States Securities Exchange Act of 1934, as amended, or any similar federal statute and the rules and regulations of the SEC promulgated thereunder; | |||
IFRS | the International Financial Reporting Standards promulgated by the International Accounting Standards Board; | |||
Indemnified Person | has the meaning set forth in Bye-Law 66.1; | |||
Interested Director | has the meaning set forth in Bye-Law 65.2; | |||
Member | the Person registered in the Register of Members as the holder of shares in the Company and, when two or more persons are so registered as joint holders of shares, means the Person whose name stands first in the Register of Members as one of such joint holders or all of such persons, as the context so requires; | |||
MGU HoldCo | Shelf Holdco II Limited, a Bermuda exempted company; | |||
MGU HoldCo Nominee | has the meaning set forth in Bye-Law 54.3(a)(iv); | |||
Nominee | has the meaning set forth in Bye-Law 54.3(a)(iv); |
2
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
notice | written notice as further provided in these Bye-Laws unless otherwise specifically stated; | |||
Officer | any Person appointed by the Board to hold an office in the Company; | |||
Outstanding Common Shares | the lesser of (i) the total number of issued and outstanding Common Shares as of the date that the Companys initial public offering is consummated and (ii) the total number of issued and outstanding Common Shares as of the date of determination (in each case, as equitably adjusted for any share split, reverse share split, share dividend, share combination, recapitalization, reclassification or similar transaction duly approved by the Board); | |||
Person | an individual, a partnership, a company, a corporation, a limited liability company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization or a governmental or quasi-governmental entity or any department, agency or political subdivision thereof; | |||
Pine Brook | Pine Brook Feal Intermediate, L.P., a Cayman Islands limited partnership; | |||
Pine Brook Nominee | has the meaning set forth in Bye-Law 54.3(a)(iii); | |||
Preference Shares | the Preference Shares of the Company, with an initial par value of $0.01 per share; | |||
Principal Shareholder | has the meaning set forth in Bye-Law 89.1; | |||
Register of Directors and Officers | the register of Directors and Officers referred to in these Bye-Laws; | |||
Register of Members | the register of Members referred to in these Bye-Laws; | |||
Regulatory Agency | any nation, government, court, regulatory, taxing or administrative agency, commission or authority or other legislative, executive or judicial governmental entity, body, agency, official or instrumentality, domestic or foreign, whether federal, national, provincial, state, local or multinational or self-regulatory organization or agency or other similar quasi-governmental regulatory body or arbitration panel, tribunal or arbitrator; | |||
Resident Representative | any Person appointed to act as resident representative and includes any deputy or assistant resident representative; | |||
SEC | the United States Securities and Exchange Commission; | |||
Secretary | the Person appointed to perform any or all of the duties of secretary of the Company and includes any deputy or assistant secretary and any Person appointed by the Board to perform any of the duties of the Secretary; | |||
Simple Majority | (i) in the case of a vote of the Board, Directors representing more than 50% of the Directors then in office and (ii) in the case of a vote of the Members, the affirmative vote of Members holding more than 50% of the Total Voting Power; | |||
Subsidiary | for any Person, any other Person (i) in which it directly or indirectly owns at least fifty percent (50%) of such Persons voting securities, (ii) that, if a general or limited partnership, limited liability company, association or other business entity, a majority of the general or limited partnership or other similar ownership interest thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person or a combination thereof, or (iii) with which it is required to be consolidated under IFRS or U.S. GAAP; |
3
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
Total Voting Power | the total votes attributable to all issued and outstanding Company Securities entitled to vote; | |||
Transfer | any direct or indirect sale, exchange, transfer (including any transfer by gift), assignment, pledge, hypothecation, mortgage, distribution or other disposition, or issuance or creation of any option or any voting proxy, voting trust or other transfer of legal or equitable interest in a security, in whole or in part, whether voluntarily or involuntarily or by operation of law or at a judicial sale or otherwise; | |||
Treasury Share | a share of the Company that was or is treated as having been acquired and held by the Company and has been held continuously by the Company since it was so acquired and has not been cancelled; | |||
United States | United States of America; and | |||
Vacancy Event | has the meaning set forth in Bye-Law 56.1. |
1.2 | When a reference is made in these Bye-Laws to a Bye-Law, Exhibit or Schedule, such reference shall be to a Bye-Law of, or an Exhibit or Schedule to, these Bye-Laws, unless otherwise indicated. The table of contents and headings contained in these Bye-Laws are for reference purposes only and shall not affect in any way the meaning or interpretation of these Bye-Laws. Whenever the words include, includes or including are used in these Bye-Laws, they shall be deemed to be followed by the words without limitation. The words hereof, herein and hereunder and words of similar import when used in these Bye-Laws shall refer to these Bye-Laws as a whole and not to any particular provision of these Bye-Laws. The terms or, any and either are not exclusive. The word extent in the phrase to the extent means the degree to which a subject or other thing extends, and such phrase shall not mean simply if. The word will shall be construed to have the same meaning and effect as the word shall. The definitions contained in these Bye-Laws are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term. Unless otherwise specifically indicated, any agreement or instrument defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement or instrument as from time to time amended, modified or supplemented, including by waiver or consent. Unless otherwise specifically indicated, all references to dollars or $ shall refer to the lawful currency of the United States. References to a Person are also to its permitted assigns and successors. Each representation, warranty, covenant, agreement and condition contained in these Bye-Laws shall have independent significance. |
1.3 | In these Bye-Laws, unless expressly stated otherwise, any reference to voting power, individual, combined or aggregate, refers to voting power after the application, if any. |
1.4 | In these Bye-Laws, (a) powers of delegation will not be restrictively construed but the widest interpretation will be given thereto, (b) the word Board in the context of the exercise of any power contained in these Bye-Laws includes any committee consisting of one or more individuals appointed by the Board and any Director or Officer of the Company to whom or which the power in question has been delegated in accordance with these Bye-Laws, (c) no power of delegation will be limited by the existence of any other power of delegation and (d) except where expressly provided by the terms of delegation, the delegation of a power will not exclude the concurrent exercise of that power by any Person who or which is for the time being authorised to exercise it under these Bye-Laws or under another delegation of power. |
1.5 | In these Bye-Laws, where not inconsistent with the context (a) a reference to statutory provision shall be deemed to include any amendment or re-enactment thereof; and (b) unless otherwise provided herein, words or expressions defined in the Act shall bear the same meaning in these Bye-Laws. |
4
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
1.6 | In these Bye-Laws expressions referring to writing or its cognates shall, unless the contrary intention appears, include facsimile, printing, lithography, photography, electronic mail and other modes of representing words in visible form. |
1.7 | The Board, acting by a Simple Majority, shall have the power to interpret or construe any term or provision of these Bye-Laws, and all decisions made by a Simple Majority of the Board in such interpretation or construction shall be binding and conclusive for all purposes. |
SHARES
2. | Power to Issue Shares; Power to Purchase Shares |
2.1 | Subject to these Bye-Laws and to any resolution of the Members to the contrary, and without prejudice to any special rights previously conferred on the holders of any existing shares or class of shares, the Board shall have the power to issue any unissued shares on such terms and conditions as it may determine. |
2.2 | Subject to the Act, any preference shares may be issued or converted into shares that (at a determinable date or at the option of the Company or the holder) are liable to be redeemed on such terms and in such manner as may be determined by the Board (before the issue or conversion). |
2.3 | Subject to the Act, the Board may exercise all the powers of the Company to purchase all or any part of the Companys own shares for cancellation or their acquisition as Treasury Shares on such terms as the Board sees fit. |
3. | Rights Attaching to Shares |
3.1 | As of the date these Bye-Laws are adopted, the share capital of the Company is divided into two classes: (i) the Common Shares; and (ii) the Preference Shares. |
3.2 | The holders of Common Shares will, subject to these Bye-Laws (including, without limitation, the rights attaching to Preference Shares): |
(a) | be entitled to one vote per share; |
(b) | be entitled to share equally and ratably in such dividends as the Board may from time to time declare; |
(c) | in the event of a winding-up or dissolution of the Company, whether voluntary or involuntary or for the purpose of a reorganization or otherwise or upon any distribution of capital, be entitled to share equally and ratably in the surplus assets of the Company; and |
(d) | generally be entitled to enjoy all of the rights attaching to shares. |
3.3 | The Board is authorized to provide for the issuance of the Preference Shares in one or more series, and to establish from time to time the number of shares to be included in each such series, and to fix the terms, including designation, powers, preferences, rights, qualifications, limitations and restrictions of the shares of each such series (and, for the avoidance of doubt, such matters and the issuance of such Preference Shares shall not be deemed to vary the rights attached to the Common Shares or, subject to the terms of any other series of Preference Shares, to vary the rights attached to any other series of Preference Shares). The authority of the Board with respect to each series shall include, but not be limited to, determination of the following: |
5
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
(a) | the number of shares constituting that series and the distinctive designation of that series; |
(b) | the dividend rate on the shares of that series, whether dividends shall be cumulative and, if so, from which date or dates, and the relative rights of priority, if any, of the payment of dividends on shares of that series; |
(c) | whether the series shall have voting rights, in addition to the voting rights provided by law and, if so, the terms of such voting rights; |
(d) | whether the series shall have conversion or exchange privileges (including, without limitation, conversion into Common Shares) and, if so, the terms and conditions of such conversion or exchange, including provision for adjustment of the conversion or exchange rate in such events as the Board shall determine; |
(e) | whether or not the shares of that series shall be redeemable or repurchaseable and, if so, the terms and conditions of such redemption or repurchase, including the manner of selecting shares for redemption or repurchase if less than all shares are to be redeemed or repurchased, the date or dates upon or after which they shall be redeemable or repurchaseable, and the amount per share payable in case of redemption or repurchase, which amount may vary under different conditions and at different redemption or repurchase dates; |
(f) | whether that series shall have a sinking fund for the redemption or repurchase of shares of that series and, if so, the terms and amount of such sinking fund; |
(g) | the right of the shares of that series to the benefit of conditions and restrictions upon the creation of indebtedness of the Company or any Subsidiary, upon the issue of any additional shares (including additional shares of such series or any other series) and upon the payment of dividends or the making of other distributions on, and the purchase, redemption or other acquisition by the Company or any Subsidiary of any issued shares of the Company; |
(h) | the rights of the shares of that series in the event of voluntary or involuntary liquidation, dissolution or winding up of the Company, and the relative rights of priority, if any, of payment in respect of shares of that series; and |
(i) | any other relative participating, optional or other special rights, qualifications, limitations or restrictions of that series. |
3.4 | Any Preference Shares of any series which have been redeemed (whether through the operation of a sinking fund or otherwise) or which, if convertible or exchangeable, have been converted into or exchanged for shares of any other class or classes shall have the status of authorized and unissued Preference Shares of the same series and may be reissued as a part of the series of which they were originally a part or may be reclassified and reissued as part of a new series of Preference Shares to be created by resolution or resolutions of the Board or as part of any other series of Preference Shares, all subject to the conditions and the restrictions on issuance set forth in the resolution or resolutions adopted by the Board providing for the issue of any series of Preference Shares. |
3.5 | At the discretion of the Board, whether or not in connection with the issuance and sale of any shares or other securities of the Company, the Company may issue securities, contracts, warrants or other instruments evidencing any shares, option rights, securities having conversion or option rights, or obligations on such terms, conditions and other provisions as are fixed by the Board including, without limiting the generality of this authority, conditions that preclude or limit any Person or persons owning or offering to acquire a specified number or percentage of the issued Common Shares, other shares, option rights, securities having conversion or option rights, or obligations of the Company or transferee of the Person or persons from exercising, converting, transferring or receiving the shares, option rights, securities having conversion or option rights, or obligations. |
6
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
3.6 | Subject to the provisions of these Bye-Laws and any limitations prescribed by law, and without prejudice to any special rights previously conferred on the holders of any existing class or series of shares, the Board is authorized to issue non-voting Common Shares that do not entitle the holders thereof to voting rights. |
3.7 | Except as otherwise expressly set forth herein or as required by the Act, and subject to any rights for the time being attached to any class or classes of shares, all classes of shares on any matter will vote together as a single class. |
3.8 | All the rights attaching to a Treasury Share shall be suspended and shall not be exercised by the Company while it holds such Treasury Share and, except where required by the Act, all Treasury Shares shall be excluded from the calculation of any percentage or fraction of the share capital, or shares, of the Company. |
4. | Calls on Shares |
4.1 | The Board may make such calls as it thinks fit upon the Members in respect of any moneys (whether in respect of nominal value or premium) unpaid on the shares allotted to or held by such Members (and not made payable at fixed times by the terms and conditions of issue) and, if a call is not paid on or before the day appointed for payment thereof, the Member may at the discretion of the Board be liable to pay the Company interest on the amount of such call at such rate as the Board may determine, from the date when such call was payable up to the actual date of payment. The Board may differentiate between the holders as to the amount of calls to be paid and the times of payment of such calls. |
4.2 | Any amount which, by the terms of allotment of a share, becomes payable upon issue or at any fixed date, whether on account of the nominal value of the share or by way of premium, shall for the purposes of these Bye-Laws be deemed to be an amount on which a call has been duly made and payable on the date on which, by the terms of issue, the same becomes payable, and in case of non-payment all the relevant provisions of these Bye-Laws as to payment of interest, costs and expenses, forfeiture or otherwise shall apply as if such amount had become payable by virtue of a duly made and notified call. |
4.3 | The joint holders of a share shall be jointly and severally liable to pay all calls and any interest, costs and expenses in respect thereof. |
4.4 | The Company may accept from any Member the whole or a part of the amount remaining unpaid on any shares held by such Member, although no part of that amount has been called up or become payable. |
5. | Forfeiture of Shares |
5.1 | If any Member fails to pay, on the day appointed for payment thereof, any call pursuant to Bye-Law 4.1 in respect of any share allotted to or held by such Member, the Board may, at any time thereafter during such time as the call remains unpaid, direct the Secretary to forward such Member a notice in writing. |
5.2 | If the requirements of such notice are not complied with, any such share may at any time thereafter before the payment of such call and the interest due in respect thereof be forfeited by a resolution of the Board to that effect, and such share shall thereupon become the property of the Company and may be disposed of as the Board shall determine. Without limiting the generality of the foregoing, the disposal may take place by sale, repurchase, redemption or any other method of disposal permitted by and consistent with these Bye-Laws and the Act. |
7
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
5.3 | A Member whose share or shares have been so forfeited shall, notwithstanding such forfeiture, be liable to pay to the Company all calls owing on such share or shares at the time of the forfeiture, together with all interest due thereon and any costs and expenses incurred by the Company in connection therewith. |
5.4 | The Board may accept the surrender of any shares which it is in a position to forfeit on such terms and conditions as may be agreed. Subject to those terms and conditions, a surrendered share shall be treated as if it had been forfeited. |
6. | Variation of Rights |
6.1 | If, at any time, the share capital is divided into different classes of shares, the rights attached to any class (unless otherwise provided by the terms of issue of the shares of that class) may, whether or not the Company is being wound-up, be varied with the approval of the Board and with the consent in writing of the holders of a Simple Majority of that class or with the sanction of a resolution passed by a Simple Majority at a separate general meeting of the holders of the shares of the class at which meeting the necessary quorum shall be two persons at least holding or representing by proxy a Simple Majority. The rights conferred upon the holders of the shares of any class or series issued with preferred or other rights shall not, unless otherwise expressly provided by the terms of issue of the shares of that class or series, be deemed to be varied by the creation or issue of further shares ranking pari passu therewith or senior thereto. |
7. | Power to Alter Capital |
7.1 | The Company may if authorized by a resolution passed by a Simple Majority of the Members increase, divide, consolidate, subdivide, change the currency denomination of, diminish or otherwise alter or reduce its share capital in any manner permitted by the Act. |
7.2 | Where, on any alteration or reduction of share capital, fractions of shares or some other difficulty would arise, the Board may deal with or resolve the same in such manner as it thinks fit including, without limiting the generality of the foregoing, the issue to Members, as appropriate, of fractions of shares and/or arranging for the sale or transfer of the fractions of shares of Members. |
8. | Fractional Shares |
The Company may issue its shares in fractional denominations and deal with such fractions to the same extent as its whole shares and shares in fractional denominations shall have in proportion to the respective fractions represented thereby all of the rights of whole shares including (but without limiting the generality of the foregoing) the right to vote, to receive dividends and distributions and to participate in a winding-up.
9. | Registered Holder of Shares |
9.1 | The Company will be entitled to treat the registered holder of any share (or fraction thereof) as the absolute owner thereof and accordingly will not be bound to recognize any equitable or other claim to, or interest in, such share on the part of any other Person. |
9.2 | Any dividend, interest or other moneys payable in cash in respect of shares may be paid by cheque or draft sent though the post directed to the Member at such Members address in the Register of Members or, in the case of joint holders, to such address of the holder first named in the Register of Members, or to such Person and to such address as the holder or joint holders may in writing direct. If two or more Persons are registered as joint holders of any shares, anyone can give an effectual receipt for any dividend paid in respect of such shares. |
8
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
10. | Death of a Joint Holder |
Where two or more Persons are registered as joint holders of a share or shares, then, in the event of the death of any joint holder or holders, the remaining joint holder or holders will be absolutely entitled to the said share or shares and the Company will recognize no claim in respect of the estate of any joint holder except in the case of the last survivor of such joint holders.
11. | Share Certificates |
11.1 | Every Member shall be entitled to a certificate under the common seal of the Company (or a facsimile thereof) or bearing the signature (or a facsimile thereof) of a Director or the Secretary or a Person expressly authorized to sign specifying the number and, where appropriate, the class of shares held by such Member and whether the same are fully paid up and, if not, specifying the amount paid on such shares. The Board may by resolution determine, either generally or in a particular case, that any or all signatures on certificates may be printed thereon or affixed by mechanical means. |
11.2 | The Company shall be under no obligation to complete and deliver a share certificate unless specifically called upon to do so by the Person to whom the shares have been allotted. |
11.3 | If any share certificate shall be proved to the satisfaction of the Board to have been worn out, lost, mislaid, or destroyed the Board may cause a new certificate to be issued and request an indemnity for the lost certificate if it sees fit. |
11.4 | Notwithstanding any provisions of these Bye-Laws: |
(a) | the Board shall, subject always to the Act and any other applicable laws and regulations and the facilities and requirements of any relevant system concerned, have power to implement any arrangements it may, in its absolute discretion, think fit in relation to the evidencing of title to and transfer of uncertificated shares and to the extent such arrangements are so implemented, no provision of these Bye-Laws shall apply or have effect to the extent that it is in any respect inconsistent with the holding or transfer of shares in uncertificated form; and |
(b) | unless otherwise determined by the Board and as permitted by the Act and any other applicable laws and regulations, no Person shall be entitled to receive a certificate in respect of any share for so long as the title to that share is evidenced otherwise than by a certificate and for so long as transfers of that share may be made otherwise than by a written instrument. |
REGISTER OF MEMBERS
12. | Contents of Register of Members |
12.1 | The Board shall cause to be kept in one or more books at its registered office a Register of Members and shall enter therein the following information: |
(a) | the name and address of each Member, the number and, where appropriate, the class of shares held by such Member and the amount paid or agreed to be considered as paid on such shares; and |
(b) | the date on which each Person was entered in the Register of Members. |
9
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
13. | Inspection of Register of Members |
The Register of Members will be open to inspection without charge at the registered office of the Company on every Business Day, subject to such reasonable restrictions as the Board may impose, so that not less than two hours in each Business Day is allowed for inspection. The Register of Members may, after notice has been given in accordance with the Act, be closed for any time or times not exceeding in the whole 30 days in each year.
14. | Determination of Record Date |
Notwithstanding any other provision of these Bye-Laws, the Board may fix any date as the record date for:
(a) | determining the Members entitled to receive any dividend or distribution; |
(b) | determining the Members entitled to receive notice of and to vote at any general meeting of the Company (and the Board may determine a different record date for any adjournment or postponement thereof); |
(c) | determining the Members entitled to execute a resolution in writing; and |
(d) | determining the number of issued and outstanding shares for or in connection with any purpose. |
TRANSFER OF SHARES
15. | Instrument of Transfer |
15.1 | An instrument of transfer shall be in writing in the form, or as near thereto as circumstances admit, of Form A in Schedule A hereto or in such other form as the Board may accept. Such instrument of transfer shall be signed by or on behalf of the transferor and transferee; provided that, in the case of a fully paid share, the Board may accept the instrument signed by or on behalf of the transferor alone. The transferor will be deemed to remain the holder of such share until the same has been registered as having been transferred to the transferee in the Register of Members. |
15.2 | The Board may refuse to recognize any instrument of transfer if it is not accompanied by the certificate in respect of the shares to which it relates and by such other evidence as the Board may reasonably require to show the right of the transferor to make the transfer. |
16. | Restrictions on Transfer |
16.1 | Subject to the Act, this Bye-Law 16 and such other of the restrictions contained in these Bye-Laws and elsewhere as may be applicable, any Member may Transfer shares at the time owned by it and, upon receipt of a duly executed form of transfer in writing, the Board shall procure the timely registration of the same. If the Board refuses to register a direct Transfer for any reason it shall notify the proposed transferor and transferee within thirty (30) days of such refusal. |
16.2 | Without limiting the foregoing, the Board shall decline to approve or register a direct Transfer of shares unless all applicable consents, authorizations, permissions or approvals of any Regulatory Agency in Bermuda, the United States or any other applicable jurisdiction required to be obtained prior to such direct Transfer have been obtained. |
17. | Transfers by Joint Holders |
The joint holders of any share may Transfer such share to one or more of such joint holders, and the surviving holder or holders of any share previously held by them jointly with a deceased Member may Transfer any such share to the executors or administrators of such deceased Member.
10
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
TRANSMISSION OF SHARES
18. | Representative of Deceased Member |
In the case of the death of a Member, the survivor or survivors where the deceased Member was a joint holder, and the legal personal representatives of the deceased Member where the deceased Member was a sole holder, shall be the only Persons recognized by the Company as having any title to the deceased Members interest in the shares. Nothing herein contained shall release the estate of a deceased joint holder from any liability in respect of any share that had been jointly held by such deceased Member with other Persons. Subject to the provisions of the Act, for the purpose of this Bye-Law, legal personal representative means the executor or administrator of a deceased Member or such other Person as the Board may in its absolute discretion decide as being properly authorized to deal with the shares of a deceased Member.
19. | Registration on Death or Bankruptcy |
Any Person becoming entitled to a share in consequence of the death or bankruptcy of any Member may be registered as a Member upon such evidence as the Board may deem sufficient or may elect to nominate some Person to be registered as a transferee of such share, and in such case the Person becoming entitled shall execute in favor of such nominee an instrument of transfer in writing. On the presentation thereof to the Board, accompanied by such evidence as the Board may require to prove the title of the transferor, the transferee shall be registered as a Member. Notwithstanding the foregoing, the Board will, in any case, have the same right to decline or suspend registration as it would have had in the case of a Transfer of the share by that Member before such Members death or bankruptcy, as the case may be.
DIVIDENDS AND OTHER DISTRIBUTIONS
20. | Declaration of Dividends by the Board |
The Board may, subject to these Bye-Laws and in accordance with the Act, declare a dividend to be paid to the Members, in proportion to the number of shares entitled thereto held by them and in proportion to the amount paid up on each share (where a larger amount is paid up on some shares than others), and such dividend may be paid in cash or wholly or partly in specie in which case the Board may fix the value for distribution in specie of any assets.
21. | Other Distributions |
The Board may declare and make such other distributions (in cash or in specie), in proportion to the number of shares held by them, to the Members as may be lawfully made out of the assets of the Company.
22. | Method of Payment |
22.1 | Any dividend, interest, or other monies payable in cash in respect of the shares may be paid by cheque or draft sent through the post directed to the Member at such Members address in the Register of Members, or to such Person and to such address as the holder may in writing direct. |
22.2 | In the case of joint holders of shares, any dividend, interest or other monies payable in cash in respect of shares may be paid by cheque or draft sent through the post directed to the address of the holder first named in the Register of Members, or to such Person and to such address as the joint holders may in writing direct. If two or more persons are registered as joint holders of any shares any one can give an effectual receipt for any dividend paid in respect of such shares. |
22.3 | The Board may deduct from the dividends or distributions payable to any Member all monies due from such Member to the Company. |
11
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
22.4 | The Company shall be entitled to cease sending dividend cheques and drafts by post or otherwise to a Member if those instruments have been returned undelivered to, or left uncashed by, that Member on at least two consecutive occasions or, following one such occasion, reasonable enquiries have failed to establish the Members new address. The entitlement conferred on the Company by this Bye-Law in respect of any Member shall cease if the Member claims a dividend or cashes a dividend cheque or draft. |
23. | Reserve Fund |
The Board may from time to time before declaring a dividend set aside, out of the surplus or profits of the Company, such sum as it thinks proper as a reserve to be used to meet contingencies or for equalizing dividends or for any other special or general purpose.
24. | Unclaimed Dividends |
Any dividend, distribution or other moneys payable in respect of a share which has remained unclaimed for a period of six years from the date of declaration of such dividend or distribution will be forfeited and shall revert and belong to the Company. The payment by the Board of any unclaimed dividend, distribution, interest or other sum payable on or in respect of the share may be paid into an account separate from the Companys own account. Such payment will not constitute the Company a trustee in respect thereof.
25. | Interest on Dividend |
Except as otherwise provided in any certificate of designation, no unpaid dividend or distribution will bear interest as against the Company.
CAPITALISATION
26. | Capitalisation |
26.1 | The Board may resolve to capitalise any part of any amount for the time being standing to the credit of any of the Companys share premium or other reserve accounts or to the credit of the profit and loss account or otherwise available for distribution by applying such amount in paying up unissued shares to be allotted as fully paid bonus shares pro rata to the Members. |
26.2 | The Board may resolve to capitalise any part of any amount for the time being standing to the credit of a reserve account or amounts otherwise available for dividend or distribution by applying such amounts in paying up in full, partly or nil paid shares of those Members who would have been entitled to such amounts if they were distributed by way of dividend or distribution. |
MEETINGS OF MEMBERS
27. | Annual General Meetings |
Subject to an election made by the Company in accordance with the Act to dispense with the holding of annual general meetings, an annual general meeting shall be held in each year at such time and place as the Board determines.
28. | Special General Meetings |
The Board may convene a special general meeting whenever in their judgment such a meeting is necessary.
29. | Requisitioned General Meetings |
The Board shall, on the requisition of Members holding at the date of the deposit of the requisition not less than 10% of the paid-up share capital of the Company which as at the date of the deposit carries the right to vote at general meetings, forthwith proceed to convene a special general meeting in accordance with the provisions of the Act.
12
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
30. | Notice |
30.1 | At least five (5) days notice of an annual general meeting shall be given to each Member entitled to attend and vote thereat, stating the date, place and time at which the meeting is to be held, that the election of Directors will take place thereat, and as far as practicable, the other business to be conducted at the meeting. |
30.2 | At least five (5) days notice of a special general meeting shall be given to each Member entitled to attend and vote thereat, stating the date, time, place and the general nature of the business to be considered at the meeting. |
30.3 | The Board may fix any date as the record date for determining the Members entitled to receive notice of and to vote at any general meeting. |
30.4 | A general meeting shall, notwithstanding that it is called on shorter notice than that specified in these Bye-Laws, be deemed to have been properly called if it is so agreed by (i) all the Members entitled to attend and vote thereat in the case of an annual general meeting; and (ii) by a majority in number of the Members having the right to attend and vote at the meeting, being a majority together holding not less than 95% in nominal value of the shares giving a right to attend and vote thereat in the case of a special general meeting. |
30.5 | The accidental omission to give notice of a general meeting to, or the non-receipt of a notice of a general meeting by, any Person entitled to receive notice shall not invalidate the proceedings at that meeting. |
30.6 | Subject to the Act, business to be brought before a general meeting of the Company must be specified in the notice of the meeting. Only business that the Board has determined can be properly brought before a general meeting in accordance with these Bye-Laws and applicable law will be conducted at any general meeting, and the chairperson of the general meeting may refuse to permit any business to be brought before such meeting that has not been properly brought before it in accordance with these Bye-Laws and applicable law. |
31. | Giving Notice and Access |
31.1 | A notice may be given by the Company to a Member: |
(a) | by delivering it to such Member in person, in which case the notice shall be deemed to have been served upon such delivery; or |
(b) | by sending it by post to such Members address in the Register of Members, in which case the notice shall be deemed to have been served seven days after the date on which it is deposited, with postage prepaid, in the mail; or |
(c) | by sending it by courier to such Members address in the Register of Members, in which case the notice shall be deemed to have been served two days after the date on which it is deposited, with courier fees paid, with the courier service; or |
(d) | by transmitting it by electronic means (including facsimile and electronic mail, but not telephone) in accordance with such directions as may be given by such Member to the Company for such purpose, in which case the notice shall be deemed to have been served at the time that it would in the ordinary course be transmitted; or |
(e) | by delivering it in accordance with the provisions of the Act pertaining to delivery of electronic records by publication on a website, in which case the notice shall be deemed to have been served at the time when the requirements of the Act in that regard have been met. |
13
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
31.2 | Any notice required to be given to a Member shall, with respect to any shares held jointly by two or more persons, be given to whichever of such persons is named first in the Register of Members and notice so given shall be sufficient notice to all the holders of such shares. |
31.3 | In proving service under Bye-Law 31.1(b), (c) and (d), it shall be sufficient to prove that the notice was properly addressed and prepaid, if posted or sent by courier, and the time when it was posted, deposited with the courier, or transmitted by electronic means. |
32. | Postponement or Cancellation of General Meeting |
The Board may direct the Secretary to postpone or cancel any general meeting called in accordance with these Bye-Laws (other than a meeting requisitioned under these Bye-Laws) provided that notice of postponement or cancellation is given to the Members before the time for such meeting. Fresh notice of the date, time and place for the postponed or cancelled meeting shall be given to each Member in accordance with these Bye-Laws.
33. | Electronic Participation in Meetings |
Members may participate in any general meeting by such telephonic, electronic or other communication facilities or means as permit all Persons participating in the meeting to communicate with each other simultaneously and instantaneously, and participation in such a meeting shall constitute presence in person at such meeting.
34. | Quorum at General Meetings |
34.1 | At any general meeting two or more persons present at the start of the meeting and representing in person or by proxy more than 50% of the Total Voting Power of the Company shall form a quorum for the transaction of business, provided that if the Company shall at any time have only one Member, one Member present in person or by proxy shall form a quorum for the transaction of business at any general meeting held during such time. |
34.2 | If within half an hour from the time appointed for the meeting a quorum is not present, then, in the case of a meeting convened on a requisition, the meeting shall be deemed cancelled and, in any other case, the meeting shall stand adjourned to the same day one week later, at the same time and place or to such other day, time or place as the Secretary may determine. Unless the meeting is adjourned to a specific date, time and place announced at the meeting being adjourned, fresh notice of the resumption of the meeting shall be given to each Member entitled to attend and vote thereat in accordance with these Bye-Laws. |
35. | Chairperson to Preside at General Meetings |
Unless otherwise agreed by a majority of those attending and entitled to vote thereat, the Chair shall also act as chairperson of the meeting at all general meetings at which such Person is present. In the Chairs absence a chairperson of the meeting shall be appointed or elected by those present at the meeting and entitled to vote.
36. | Voting on Resolutions |
36.1 | Subject to the Act and these Bye-Laws, any question proposed for the consideration of the Members at any general meeting shall be decided by the affirmative vote of a Simple Majority of the Members. |
36.2 | No Member shall be entitled to vote at a general meeting unless such Member has paid all the calls on all shares held by such Member. |
14
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
36.3 | At any general meeting a resolution put to the vote of the meeting shall, in the first instance, be voted upon by a show of hands and, subject to any rights or restrictions for the time being lawfully attached to any class of shares and subject to these Bye-Laws, every Member present in person and every Person holding a valid proxy at such meeting shall be entitled to one vote and shall cast such vote by raising his or her hand. |
36.4 | In the event that a Member participates in a general meeting by telephone, electronic or other communication facilities or means, the chairperson of the meeting shall direct the manner in which such Member may cast his or her vote on a show of hands. |
36.5 | At any general meeting if an amendment is proposed to any resolution under consideration and the chairperson of the meeting rules on whether or not the proposed amendment is out of order, the proceedings on the substantive resolution shall not be invalidated by any error in such ruling. |
36.6 | At any general meeting a declaration by the chairperson of the meeting that a question proposed for consideration has, on a show of hands, been carried, or carried unanimously, or by a particular majority, or lost, and an entry to that effect in a book containing the minutes of the proceedings of the Company shall, subject to these Bye-Laws, be conclusive evidence of that fact. |
37. | Power to Demand a Vote on a Poll |
37.1 | Notwithstanding the foregoing, a poll may be demanded by any of the following persons: |
(a) | the chairperson of such meeting; or |
(b) | at least three Members present in person or represented by proxy; or |
(c) | any Member or Members present in person or represented by proxy and holding between them not less than one-tenth of the total voting rights of all the Members having the right to vote at such meeting; or |
(d) | any Member or Members present in person or represented by proxy holding shares in the Company conferring the right to vote at such meeting, being shares on which an aggregate sum has been paid up equal to not less than one-tenth of the total amount paid up on all such shares conferring such right. |
37.2 | Where a poll is demanded, subject to any rights or restrictions for the time being lawfully attached to any class of shares, every Person present at such meeting shall have for each voting share of which such Person is the holder or for which such Person holds a proxy, one vote and such vote shall be counted by ballot as described herein, or in the case of a general meeting at which one or more Members are present by telephone, electronic or other communication facilities or means, in such manner as the chairperson of the meeting may direct and the result of such poll shall be deemed to be the resolution of the meeting at which the poll was demanded and shall replace any previous resolution upon the same matter which has been the subject of a show of hands. A Person entitled to more than one vote need not use all his or her votes or cast all the votes he or she uses in the same way. |
37.3 | A poll demanded for the purpose of electing a chairperson of the meeting or on a question of adjournment shall be taken forthwith. A poll demanded on any other question shall be taken at such time and in such manner during such meeting as the chairperson (or acting chairperson) of the meeting may direct. Any business other than that upon which a poll has been demanded may be conducted pending the taking of the poll. |
15
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
37.4 | Where a vote is taken by poll, each Person physically present and entitled to vote shall be furnished with a ballot paper on which such Person shall record his or her vote in such manner as shall be determined at the meeting having regard to the nature of the question on which the vote is taken, and each ballot paper shall be signed or initialed or otherwise marked so as to identify the voter and the registered holder in the case of a proxy. Each Person present by telephone, electronic or other communication facilities or means shall cast his or her vote in such manner as the chairperson of the meeting shall direct. At the conclusion of the poll, the ballot papers and votes cast in accordance with such directions shall be examined and counted by a committee of not less than two Members or proxy holders appointed by the chairperson of the meeting for the purpose and the result of the poll shall be declared by the chairperson of the meeting will be final and binding absent manifest error. |
37.5 | The Board may appoint one or more inspectors to act at any general meeting where a vote is taken by a poll. Each inspector shall take and sign an oath faithfully to exercise the duties of inspector at such meeting with strict impartiality and according to the best of his or her ability. The inspectors (if any) shall determine the number of voting shares issued and outstanding and the voting power of each, by reference to the Register of Members as at the relevant record date determined pursuant to Bye-Law 14, the number of voting shares represented at the meeting, the existence of a quorum, the validity and effect of proxies, and examine and count all ballots and determine the results of any vote. The inspectors (if any) shall also hear and determine challenges and questions arising in connection with the right to vote. No Director or candidate for the office of Director will act as an inspector. The determination and decision of the inspectors will be final and binding absent manifest error. |
38. | Voting by Joint Holders of Shares |
In the case of joint holders, the vote of the senior who tenders a vote (whether in person or by proxy) shall be accepted to the exclusion of the votes of the other joint holders, and for this purpose seniority shall be determined by the order in which the names stand in the Register of Members.
39. | Instrument of Proxy |
39.1 | Every Member entitled to vote has the right to do so either in person or by one or more persons authorised by a proxy executed and delivered in accordance with these Bye-Laws. The instrument appointing a proxy shall be in writing under the hand of the appointer or of such appointers attorney authorised by such appointer in writing or, if the appointer is a not a natural person, either under its seal or under the hand of an officer, attorney or other Person authorised to sign the same. A Member that is the holder of two or more shares may appoint more than one proxy to represent such Member and vote on such Members behalf in respect of different shares. Any proxy may be executed within or outside the United States. |
39.2 | Any Member may irrevocably appoint a proxy and in such case: (a) such appointment shall be irrevocable in accordance with the terms of the instrument of appointment; (b) if the Company has been given notice of the appointment, such notice to include the name, address, telephone number and electronic mail address of the proxy, then the Company shall give to such proxy (in addition to the Member) notice of all meetings of Members of the Company; (c) such proxy shall be the only Person entitled to vote the relevant shares at any meeting at which such proxy is present; and (d) the Company shall be obliged to recognise the proxy until such time as such proxy shall notify the Company in writing that the appointment of such proxy is no longer in force. |
39.3 | The instrument appointing a proxy together with such other evidence as to its due execution as the Board may from time to time require shall be delivered at the registered office of the Company (or at such place or places as may be specified in the notice convening the meeting or in any notice of any adjournment or, in either case, in any document sent therewith, or as otherwise approved by the Board) not less than 24 hours or such other period as the Board may determine, prior to the holding of the relevant meeting or adjourned meeting at which the individual named in the instrument proposes to vote or, in the case of a poll taken subsequently to the date of a meeting or adjourned meeting, before the time appointed for the taking of the poll and in default the instrument of proxy shall not be treated as valid. |
16
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
39.4 | Instruments of proxy shall be in any common form or other form as the Board may approve and the Board may, if it thinks fit, send out with the notice of any meeting forms of instruments of proxy for use at that meeting. The instrument of proxy will be deemed to confer authority to demand or join in demanding a poll and to vote on any amendment of a resolution put to the meeting for which it is given as the proxy thinks fit. The instrument of proxy will unless the contrary is stated therein be valid as well for any adjournment of the meeting as for the meeting to which it relates. |
39.5 | A vote given in accordance with the terms of an instrument of proxy will be valid notwithstanding the previous death or unsoundness of mind of the principal or signatory, or termination or revocation of the instrument of proxy or of the authority under which it was executed, unless notice in writing of such death, insanity or revocation was received by the Company at the registered office (or such other place as may be specified for the delivery of instruments of proxy) at least one hour before the commencement of the meeting or adjourned meeting, or the taking of the poll. |
39.6 | Subject to the Act, the Board may, or the chairperson of the relevant meeting may at his or her discretion (with respect to such meeting only), waive any of the provisions of these Bye-Laws related to proxies or authorisations and, in particular, may accept such verbal or other assurances as it or he or she thinks fit as to the right of any Person to attend and vote on behalf of any Member at general meetings. The decision of the chairperson of any general meeting as to the validity of any appointment of a proxy shall be final. |
40. | Representation of Corporate Member |
40.1 | A Member that is not a natural person may, by written instrument, authorise one or more persons as it thinks fit to act as its representative at any meeting of the Members and the Person or Persons so authorised shall be entitled to exercise the same powers on behalf of the Member that such Person or persons represent as that Member could exercise if it were a natural person. Such Member will for the purposes of these Bye-Laws be deemed to be present in person at any such meeting if a Person so authorised is present at the meeting. |
40.2 | Notwithstanding the foregoing, the chairperson of the meeting may accept such assurances as he or she, in good faith, thinks fit as to the right of any Person to attend and vote at general meetings on behalf of a Member that is not a natural person. |
41. | Adjournment of General Meeting |
41.1 | The chairperson of a general meeting may, with the consent of the Members holding a majority of the voting power of those Members present in person or by proxy at any general meeting at which a quorum is present, adjourn the meeting. |
41.2 | In addition, the chairperson may adjourn the meeting to another time and place without such consent or direction if it appears to him or her in good faith that: |
(a) | it is likely to be impracticable to hold or continue that meeting because of the number of Members wishing to attend that are not present; |
(b) | the unruly conduct of one or more persons attending the meeting prevents, or is likely to prevent, the orderly continuation of the business of the meeting; or |
(c) | an adjournment is otherwise necessary or appropriate so that the business of the meeting may be properly conducted. |
17
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
41.3 | Unless the meeting is adjourned to a specific date, place and time announced at the meeting being adjourned, fresh notice of the date, place and time for the resumption of the adjourned meeting shall be given to each Member entitled to attend and vote thereat in accordance with these Bye-Laws. |
42. | Written Resolutions |
42.1 | Subject to these Bye-Laws, anything which may be done by resolution of the Company in general meeting or by resolution of a meeting of any class of the Members may be done without a meeting by written resolution in accordance with this Bye-Law. |
42.2 | Notice of a written resolution shall be given, and a copy of the resolution shall be circulated to all Members who would be entitled to attend a meeting and vote thereon. The accidental omission to give notice to, or the non-receipt of a notice by, any Member does not invalidate the passing of a resolution. |
42.3 | A written resolution is passed when it is signed by (or in the case of a Member that is a corporation, on behalf of) the Members who at the date that the notice is given represent such majority of votes as would be required if the resolution was voted on at a meeting of Members at which all Members entitled to attend and vote thereat were present and voting. |
42.4 | A resolution in writing may be signed in any number of counterparts in accordance with reasonable procedures as may be determined by the Board. |
42.5 | A resolution in writing made in accordance with this Bye-Law is as valid as if it had been passed by the Company in general meeting or by a meeting of the relevant class of Members, as the case may be, and any reference in any Bye-Law to a meeting at which a resolution is passed or to Members voting in favour of a resolution shall be construed accordingly. |
42.6 | A resolution in writing made in accordance with this Bye-Law shall constitute minutes for the purposes of the Act. |
42.7 | This Bye-Law shall not apply to: |
(a) | a resolution passed to remove an Auditor from office before the expiration of his or her term of office; or |
(b) | a resolution passed for the purpose of removing a Director before the expiration of his or her term of office. |
42.8 | For the purposes of this Bye-Law, the effective date of the resolution is the date when the resolution is signed by (or in the case of a Member that is a corporation, on behalf of) the last Member whose signature results in the necessary voting majority being achieved and any reference in any Bye-Law to the date of passing of a resolution is, in relation to a resolution made in accordance with this Bye-Law, a reference to such date. |
43. | Directors Attendance at General Meetings |
The Directors shall be entitled to receive notice of, attend and be heard at any general meeting.
DIRECTORS AND OFFICERS
44. | Board of Directors |
The business of the Company shall be managed and conducted by the Board. Only natural persons may be Directors of the Company.
18
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
45. | Management of the Company |
In managing the business of the Company, the Board may exercise all powers of the Company as are not, by statute or by these Bye-Laws, required to be exercised by the Company in a general meeting, and the business and affairs of the Company shall be so controlled by the Board.
46. | Power to Appoint CEO |
The CEO as of the date these Bye-Laws are adopted is Mr. Daniel Burrows. Thereafter, the Board may from time to time appoint a natural person or persons to act as CEO of the Company who shall, subject to the control of the Board, supervise and administer all of the general business and affairs of the Company and the Board may entrust to and confer upon the CEO such additional powers and duties as the Board deems appropriate for the transaction or conduct of such business.
47. | Power to Authorise Specific Actions |
The Board may from time to time and at any time authorise any Person or body of Persons to act on behalf of the Company for any specific purpose and in connection therewith to execute any deed, agreement, document or instrument in the name and on behalf of the Company.
48. | Power to Appoint Attorney |
The Board may from time to time and at any time by power of attorney appoint any Person or body of Persons to be an attorney of the Company for such purposes and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the Board) and for such period (or for unspecified length of time) and subject to such conditions as it may think fit and any such power of attorney may contain such provisions for the protection and convenience of Persons dealing with any such attorney as the Board may think fit and may also authorise any such attorney to sub-delegate all or any of the powers, authorities and discretions so vested in the attorney. Such attorney may, if so authorised under the seal of the Company, execute any deed or instrument under such attorneys personal seal with the same effect as the affixation of the seal of the Company.
49. | Power to Delegate to a Committee |
49.1 | The Board may delegate any of its powers (including the power to sub-delegate) to one or more committees appointed by the Board (and the Board may appoint alternative committee members or authorise the committee members to appoint their own alternates). Each committee shall be comprised of such number of members of the Board as the Board may determine. |
49.2 | All Board committees shall conform to such directions as the Board imposes on them; provided that each voting member shall have one vote, and each committee shall have the right as it deems appropriate to retain outside advisors and experts. The Board or, if so delegated to such committee by the Board, then the applicable committee, may adopt rules for the conduct of its affairs, including rules governing the place, time and notice of meetings, as it deems advisable and as are not inconsistent with these Bye-Laws regulating the meetings and proceeding of the Board or with any applicable resolution adopted by the Board. Unless otherwise approved by the Board, each committee shall cause minutes to be made of all meetings of such committee and of the attendance thereat and shall cause such minutes and copies of resolutions adopted by unanimous consent to be promptly inserted by the Secretary in the minute book. |
49.3 | Any Board committee may have one or more non-voting observer(s). |
50. | Power to Appoint and Dismiss Employees |
At any time and from time to time, the Board may appoint, suspend or remove any officer, manager, secretary, clerk, agent or employee of the Company and may fix their remuneration and determine or alter their duties.
19
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
51. | Power to Borrow and Charge Property |
The Board may exercise all the powers of the Company to borrow money and to mortgage or charge or otherwise grant a security interest in its undertaking, property and uncalled capital, or any part thereof, and may issue debentures, debenture stock and other securities whether outright or as security for any debt, liability or obligation of the Company or any third party.
52. | Other Powers of the Board |
Without limiting any other Bye-Law herein, the Board may:
(a) | procure that the Company pays all expenses incurred in promoting and incorporating the Company; |
(b) | delegate any of its powers (including the power to sub-delegate) to any Person on such terms and in such manner as the Board may see fit; |
(c) | present any petition and make any application in connection with the liquidation or reorganisation of the Company; and |
(d) | in connection with the issue of any share, pay such commission and brokerage as may be permitted by law. |
53. | Number of Directors |
Subject to the rights of the holders of any class or series of Preference Shares then issued and outstanding, as may be set forth in the certificate of designation for such class or series of Preference Shares, the Board shall consist of such number of Directors as is determined from time to time by the Board in accordance with the terms hereof, which number of Directors shall be not less than five (5) and not more than fifteen (15).
54. | Election and Appointment of Directors; Classes of Directors |
54.1 | Beginning with the 2030 annual general meeting, all Directors of the Company shall be of one class and shall serve for a term ending at the next following annual general meeting. Prior to the 2030 annual general meeting, the Board shall be divided into three classes of approximately equal size, designated Class I, Class II and Class III. Subject to the provisions of the Common Shareholders Agreement, the persons nominated to be elected or appointed as Directors shall be assigned to each class as the Board shall determine such that each class shall consist of an equal number of Directors, to the extent practicable. At the first annual general meeting following the effective date of these Bye-Laws, the term of office of those Directors in Class I shall expire and the Class I Directors shall be elected for a full term of three years. At the second annual general meeting following the effective date of these Bye-Laws, the term of office of those Directors in Class II shall expire and the Class II Directors shall be elected for a full term of three years. At the third annual general meeting following the effective date of these Bye-Laws, the term of office of those Directors in Class III shall expire and the Class III Directors shall be elected for a full term of three years. Subject to the first sentence of this Bye-Law 54.1, at each annual general meeting held after such classification and election, Directors shall be elected or appointed for a full three-year term, as the case may be, to succeed those whose terms expire at such meeting. Each Director shall hold office for the term for which he or she is elected and until his or her successor is appointed. |
54.2 | Subject to the provisions of the Common Shareholders Agreement and Bye-Law 54.3 and Bye-Law 54.4, the only Persons who shall be eligible for appointment or election as a Director in accordance with Bye-Law 54.1 at any general meeting of the Company shall be Persons either: |
20
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
(a) | for whom a written notice of nomination signed by Members holding in the aggregate not less than 10% of the outstanding paid up share capital of the Company at that time has been delivered to the registered office of the Company for the attention of the Secretary not later than (i) with respect to an annual general meeting of Members, ninety (90) days prior to the anniversary date of the immediately preceding annual general meeting, and (ii) with respect to a special general meeting, the close of business on the tenth (10th) day following the date on which notice of such meeting is first sent or given to Members; or |
(b) | who have been approved for such purpose by the Board and identified in the notice of such general meeting or by way of note or other document sent to the Members not less than five (5) days prior to the scheduled date of such general meeting. Such notice shall set forth (x) as to each Person whom the Member proposes to nominate for election as a Director: (i) the name, age, business address and residence address of the Person; (ii) the principal occupation or employment of the Person; (iii) the class or series and number of shares of capital stock of the Company which are owned beneficially or of record by the Person; and (iv) any other information relating to the Person that would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of Directors pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder (the Proxy Filings); and (y) as to the Member giving the notice: (i) the name and record address of such Member; (ii) the class or series and number of shares of the Company which are owned beneficially or of record by such Member; (iii) a description of all arrangements or understandings between such Member and each proposed nominee and any other Person (including his or her name and address) pursuant to which the nomination(s) are to be made by such Member; (iv) a representation that such Member intends to appear in person or by proxy at the meeting to nominate the Persons named in its notice; and (v) any other information relating to such Member that would be required to be disclosed in a Proxy Filing. Such notice must be accompanied by a written consent of each proposed nominee to being named as a nominee and to serve as a Director if elected. The chairperson of the meeting may refuse to acknowledge the nomination of any Person not made in compliance with the foregoing procedure. |
54.3 | Nominee Directors |
(a) | Notwithstanding anything to the contrary contained in these Bye-Laws: |
(i) | Crestview shall have the right to designate one (1) nominee for election to the Board (the Crestview Nominee) for so long as Crestview, together with its Affiliate Transferees, beneficially owns at least 7.5% of the Outstanding Common Shares; |
(ii) | CVC shall have the right to designate one (1) nominee for election to the Board (the CVC Nominee) for so long as CVC, together with its Affiliate Transferees, beneficially owns at least 7.5% of the Outstanding Common Shares; |
(iii) | Pine Brook shall have the right to designate one (1) nominee for election to the Board (the Pine Brook Nominee) for so long as Pine Brook, together with its Affiliate Transferees, beneficially owns at least 7.5% of the Outstanding Common Shares; and |
(iv) | MGU HoldCo shall have the right to designate one (1) nominee for election to the Board (the MGU HoldCo Nominee, and together with the Crestview Nominee, the CVC Nominee and the Pine Brook Nominee, the Nominees and each individually, a Nominee) for so long as MGU HoldCo, together with its Affiliate Transferees, beneficially owns at least 50% of the Common Shares initially purchased by MGU HoldCo on January 3, 2023 and any securities issued with respect to such Common Shares, including pursuant to a stock dividend, stock split, reclassification or pursuant to an exchange (including merger or amalgamation), |
21
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
and each such Nominee shall not be subject to the provisions of Bye-Law 54.2 with respect to a nomination made pursuant to this Bye-Law 54.3(a).
(b) | No reduction in the number of Common Shares that any Member beneficially owns shall shorten the term of any incumbent Director. |
(c) | In the event that any Nominee shall cease to serve for any reason during a term, the Member that nominated such Nominee shall be entitled to designate such persons successor in accordance with the provisions of the Common Shareholders Agreement (regardless of such Members beneficial ownership of Common Shares at the time of such vacancy) and the Board shall promptly fill the vacancy with such successor Nominee; it being understood that any such designee shall serve the remainder of the term of the Director whom such designee replaces. |
(d) | If a Nominee is not appointed or elected to the Board because of such persons death, disability, disqualification, withdrawal as a Nominee, failure to be elected or for another reason is unavailable or unable to serve on the Board, the applicable Member shall be entitled to designate promptly another Nominee, the Director position for which the original Nominee was nominated shall not be filled pending such designation and the Company shall use commercially reasonable efforts and consistent with corporate governance standards of the New York Stock Exchange to cause the Board to promptly fill the vacancy with such successor Nominee. |
54.4 | The Board may by a resolution of a Simple Majority expand the size of the Board to the maximum permitted by Bye-Law 53 and is authorized to appoint, one or more directors to fill any vacancies created thereby and, subject to Bye-Law 54.3 to fill any vacancies created as a result of a nominee for election as a director not being elected at a general meeting called for such purpose. Any such appointment may be for a period not exceeding 3 years and the Board shall designate any such Director as a Class I, Class II or Class III Director in accordance with these Bye-Laws. |
55. | Removal of Directors |
55.1 | Subject to any provision to the contrary in these Bye-Laws, the Members holding 80% of the Total Voting Power may, at any general meeting convened and held for such purpose in accordance with these Bye-Laws, remove a Director for Cause; provided that the notice of any such meeting convened for the purpose of removing a Director shall contain a statement of the intention so to do and be served on such Director not less than sixty (60) days before the meeting and at such meeting such Director shall be entitled to be heard on the motion for such Directors removal. |
55.2 | A vacancy on the Board created by the removal of a Director under the provisions of Bye-Law 55.1, other than the removal of a Nominee, may be filled by the Members at the meeting at which such Director is removed. A Director so appointed shall hold office until the expiration of the term of the Director so removed or until such new Directors successor is elected or appointed or such new Directors office is otherwise vacated and, in the absence of such election or appointment, other than with respect to the removal of a Nominee, the Members may authorize the Board to fill any vacancy. A vacancy on the Board created by the removal of a Nominee under the provisions of Bye-Law 55.1 shall be filled pursuant to Bye-Law 54.3(c). |
22
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
56. | Other Vacancies |
56.1 | Subject to the provisions of Bye-Laws 54.3(c) and (d), the Board shall have the power from time to time and at any time to appoint any Person as a Director to fill a vacancy on the Board occurring as the result of any of the following events (Vacancy Event): |
(a) | if the Director is removed from office pursuant to these Bye-Laws or is prohibited from being a Director by law; |
(b) | if the Director is or becomes bankrupt or makes any arrangement or composition with his or her creditors generally; |
(c) | if the Director is or becomes of unsound mind or dies; |
(d) | if the Director resigns his or her office by notice in writing to the Company, |
and to appoint an Alternate Director to any Director so appointed. A Director so appointed shall hold office until the annual general meeting at which such Directors predecessors term would have expired or until such Directors successor is elected or appointed or such Directors office is otherwise vacated.
57. | Alternate Directors |
57.1 | Any general meeting of the Company may elect a Person or Persons to act as a Director in the alternative to any one or more of the Directors of the Company or may authorize the Board to appoint such Alternate Directors, by notice in writing which has been delivered to the registered office of the Company for the attention of the Secretary not less than sixty (60) days prior to the scheduled date of such general meeting or any adjournment thereof. |
57.2 | Any Person so appointed shall have all the rights and powers of the Director or Directors for whom such Person is appointed in the alternative provided that such Person shall not be counted more than once in determining whether or not a quorum is present. |
57.3 | An Alternate Director will be entitled to receive notice of all Board meetings and to vote in such capacity at any such meeting at which the Director for whom such Alternate Director was appointed in the alternative is not personally present and generally to perform at such meeting all the functions of such Director for whom such Alternate Director was appointed. |
57.4 | An Alternate Director shall cease to be such: |
(a) | if the Director for whom such Alternate Director was appointed ceases for any reason to be a Director but may be re-appointed by the Board as Alternate Director to the Person appointed to fill the vacancy in accordance with these Bye-Laws; or |
(b) | on the occurrence of a Vacancy Event with respect to such Alternate Director. |
58. | Remuneration of Directors |
58.1 | The remuneration of the Directors shall be determined by the Board and shall be deemed to accrue from day to day. The Directors may also be paid all travel, hotel and other expenses properly incurred by them (including as determined by the tax operating guidelines applicable to the Company in effect at the time) in attending and returning from meetings of the Board, any committee appointed by the Board, general meetings of the Company, or in connection with other business of the Company or their duties as Directors generally. |
23
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
58.2 | A Director may hold any other office under the Company (other than the office of Auditor) in conjunction with his or her office of Director for such period on such terms as to remuneration and otherwise as the Board may determine. |
58.3 | The Board may award special remuneration and benefits to any Director undertaking any special work or services for, or undertaking any special mission on behalf of, the Company other than his or her ordinary routine work as a Director. Any fees paid to a Director who is also counsel or attorney to the Company, or otherwise serves it in a professional capacity, will be in addition to his or her remuneration as a Director. |
59. | Defect in Appointment |
All acts done in good faith by the Board, any Director, a member of a committee appointed by the Board, any Person to whom the Board may have delegated any of its powers, or any Person acting as a Director shall, notwithstanding that it be afterwards discovered that there was some defect in the appointment of any Director or Person acting as aforesaid, or that he or she was, or any of them were, disqualified, be as valid as if every such Person had been duly appointed and was qualified to be a Director or act in the relevant capacity.
60. | Register of Directors and Officers |
60.1 | The Board shall cause to be kept in one or more books at its registered office a Register of Directors and Officers and shall enter therein such Persons first name, surname and address. |
60.2 | The Board shall, within the period of fourteen (14) days from the occurrence of (i) any change among its Directors or Officers or (ii) any change in the particulars contained in the Register of Directors and Officers, cause to be entered on the Register of Directors and Officers the particulars of such change and the date on which such change occurred. |
60.3 | The Register of Directors and Officers shall be open to inspection at the office of the Company on every Business Day, subject to such reasonable restrictions as the Board may impose, so that not less than two hours in each Business Day be allowed for inspection. |
61. | Appointment of Officers |
The Board may appoint such Officers (who may or may not be Directors) as the Board may determine for such terms as the Board deems fit, all of whom will be deemed to be Officers for the purposes of these Bye-Laws. Subject to compliance with any requirement of the Act, the same individual may hold two or more offices in the Company.
62. | Appointment of Secretary |
The Secretary shall be appointed by the Board from time to time for such term as the Board deems fit.
63. | Duties of Officers |
The Officers shall have such powers and perform such duties in the management, business and affairs of the Company as may be delegated to them by the Board or the CEO from time to time.
64. | Remuneration of Officers |
The Officers shall receive such remuneration as the Board may determine from time to time in accordance with their employment contracts or otherwise.
24
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
65. | Conflicts of Interest |
65.1 | Any Director, or any Person associated with, related to or affiliated with any Director, may act in a professional capacity for the Company and such Director or such Person will be entitled to remuneration for professional services as if such Director were not a Director; provided that nothing herein contained will authorise a Director or Directors firm, partner or a Person associated with, related to or affiliated with a Director to act as Auditor of the Company. |
65.2 | A Director who is directly or indirectly interested in any (or any proposed) contract, arrangement or other matter with the Company (an Interested Director) shall promptly declare the nature and extent of such interest in reasonable detail and in accordance with the Act. |
65.3 | Following a declaration being made pursuant to this Bye-Law, the Interested Director may vote in respect of such matter and/or be counted in the quorum for the meeting at which such matter is to be voted on, unless the Board by a resolution of a Simple Majority (which vote shall exclude the Interested Director, in which case such Interested Director shall not be required to be present for the purpose of establishing a quorum with respect to the vote on such matter) requires the Interested Director to abstain from any vote on the conflicted matter. |
66. | Indemnification and Exculpation of Directors and Officers |
66.1 | Each of the Directors and other Officers of the Company or any Subsidiary of the Company who or which has acted or is acting in relation to any of the affairs of the Company or any Subsidiary and the liquidator or trustees (if any) who or which has acted or is acting in relation to any of the affairs of the Company or any Subsidiary, and every one of them, and their respective heirs, executors, administrators, successors or assigns (each, an Indemnified Person), shall be indemnified and secured harmless out of the assets of the Company from and against all liabilities, actions, costs, charges, losses, damages and expenses (including liabilities under contract, tort and statute or any applicable law or regulation (domestic or foreign) and all reasonable legal and other costs and expenses properly payable) which they or any of them, and their respective heirs, executors, administrators, successors or assigns, shall or may incur or sustain by or by reason of any act done, concurred in or omitted (in each case, actual or alleged) in or about the execution of their respective duty, or supposed duty, or in their respective offices or trusts, and none of them will be answerable for the acts, receipts, neglects or defaults of the others of them or for joining in any receipts for the sake of conformity, or for any bankers or other Persons with whom or with which any moneys or effects belonging to the Company shall or may be lodged or deposited for safe custody, or for insufficiency or deficiency of any security upon which any moneys of or belonging to the Company have been placed out on or invested, or for any other loss, misfortune or damage which may happen in the execution of their respective offices or trusts, and the indemnity contained in this Bye-Law 66 will extend to any Director or officer acting in any office or trust on the reasonable belief that he or she has been appointed or elected to such office or trust notwithstanding any defect to such appointment or election, or in relation thereto; provided, that this indemnity will not extend to any matter in respect of any fraud or dishonesty which may attach to such Indemnified Person or as prohibited by the Act. |
66.2 | The Company may purchase and maintain insurance for the benefit of any Director or Officer against any liability incurred by him or her under the Act in his or her capacity as a Director or Officer or indemnifying such Director or Officer in respect of any loss arising or liability attaching to him or her by virtue of any rule of law in respect of any negligence, default, breach of duty or breach of trust of which the Director or Officer may be guilty in relation to the Company or any Subsidiary thereof. |
66.3 | No Indemnified Person will be liable to the Company for the acts, defaults or omissions of any other Indemnified Person. |
25
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
66.4 | The Company will advance moneys to any Indemnified Person for the costs, charges, and expenses incurred by the Indemnified Person in defending any civil or criminal proceedings against him or her, whether pending or threatened, on condition and receipt of an undertaking in a form satisfactory to the Company that the Indemnified Person will repay such portion of the advance attributable to any claim of fraud or dishonesty if such a claim is proved against the Indemnified Person. Any request for an advancement of moneys must be accompanied by a statement or statements reasonably evidencing the expenses incurred or expected to be incurred by the Indemnified Person. |
66.5 | The indemnification and advancement of expenses provided in these Bye-Laws will not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may now or hereafter be entitled under any statute, agreement, vote of Members or otherwise, both as to action in an official capacity and as to action in another capacity while holding such office. |
66.6 | The indemnification and advancement of expenses provided by, or granted pursuant to, this Bye-Law 66 will, unless otherwise provided when authorised or ratified, continue as to a Person who has ceased to hold the position for which such Person is entitled to be indemnified or advanced expenses and will inure to the benefit of the heirs, executors, administrators, successors and assigns of such a Person. |
66.7 | The indemnification and advancement of expenses provided by, or granted pursuant to, this Bye-Law 66 will be the primary source of indemnification for each Indemnified Person, regardless of whether such Indemnified Person is entitled to indemnification from any Person affiliated with the Indemnified Person. The Company will not be subrogated to the rights of the Indemnified Person or entitled to seek contribution from any other potential source of indemnification for the indemnified Person. |
66.8 | No amendment, repeal or termination of any provision of this Bye-Law 66 will alter, to the detriment of any Person, the right of such Person to the indemnification or advancement of expenses related to a claim based on an act or failure to act that took place prior to such amendment, repeal or termination. |
67. | Waiver of Claim by Member |
Each Member agrees to waive any claim or right of action it might have, whether individually or by or in the right of the Company, against any Director or Officer on account of any action taken by such Director or Officer, or the failure of such Director or Officer to take any action in the performance of his or her duties with or for the Company or any Subsidiary thereof; provided, that such waiver does not extend to any matter in respect of any fraud or dishonesty in relation to the Company which may attach to such Director or Officer.
MEETINGS OF THE BOARD OF DIRECTORS
68. | Board Meetings |
The Board or any committee thereof may meet, subject to the tax operating guidelines applicable to the Company in effect at the time of such meeting, for the transaction of business, adjourn and otherwise regulate its meetings as it sees fit. The Board may meet for the transaction of business, adjourn and otherwise regulate its meetings as it sees fit. A resolution put to the vote at a Board meeting shall be carried by the affirmative votes of a Simple Majority.
69. | Notice of Board Meetings |
The CEO or the Secretary on the requisition of any two or more Directors shall, at any time, summon a meeting of the Board. Notice of a meeting of the Board must be provided at least two (2) Business Days in advance of such meeting, and must state the date, time, place and the general nature of the business to be considered at the meeting unless the Directors unanimously agree to waive notice of such meeting. Attendance of a Director at a meeting shall constitute a waiver of notice of such meeting, except where such Director attends the meeting for the express purpose of objecting,
26
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
at the beginning of the meeting, to the transaction of business because the meeting is not properly called or convened. Notice of a Board meeting shall be deemed to be duly given to a Director if it is communicated or sent to such Director by post, electronic means or other mode of representing words in a visible form at such Directors last known address or in accordance with any other instructions given by such Director to the Company for this purpose.
70. | Electronic Participation in Meetings |
With respect to any meeting of the Board, the Board shall determine whether to make available to each member of the Board the option to attend such meeting by such telephonic, electronic or other communication facilities or means as permit all persons participating in the meeting to communicate with each other simultaneously and instantaneously, subject to the tax operating guidelines applicable to the Company in effect at the time of such meeting. If the Board determines to make available to any Director the option to attend by telephonic, electronic or other communication facilities or means, any member of the Board may attend such meeting through use of such means, and participation in such a meeting shall constitute presence in person at such meeting.
71. | Quorum at the Board Meetings |
The quorum necessary for the transaction of business at a meeting of the Board shall be a majority of the Directors then on the Board.
72. | Board to Continue in the Event of Vacancy |
The Board may act notwithstanding any vacancy in its number but, if and so long as its number is reduced below the number fixed by these Bye-Laws as the quorum necessary for the transaction of business at Board meetings, the continuing Directors or Director may act for the purpose of (i) summoning a general meeting; or (ii) preserving the assets of the Company.
73. | Chairperson to Preside |
Unless otherwise agreed by a majority of the Directors attending, the Chair shall act as chairperson of the meeting at all Board meetings at which such Person is present. In the Chairs absence a chairperson of the meeting shall be appointed or elected by the Directors present at the meeting.
74. | Written Resolutions |
A resolution in writing signed by all of the Directors which may be in counterparts, will be as valid as if it had been passed at a meeting of the Board duly called and constituted, such resolution to be effective on the date on which the last Director signs the resolution. Such resolution will be deemed to be adopted as an act of the Board at the place where, and at the time when, the last signature of a Director is affixed thereto. For the purposes of this Bye-Law only, the Directors shall not include an Alternate Director.
75. | Validity of Prior Acts of the Board |
No regulation or alteration to these Bye-Laws made by the Company in general meeting shall invalidate any prior act of the Board which would have been valid if that regulation or alteration had not been made.
CORPORATE RECORDS
76. | Minutes |
The Board shall cause minutes to be duly entered in books provided for the purpose:
(a) | of all elections and appointments of Officers; |
27
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
(b) | of the names of the Directors present at each Board meeting and of any committee appointed by the Board; and |
(c) | of all resolutions and proceedings of general meetings of the Members, Board meetings, meetings of managers and meetings of committees appointed by the Board. |
77. | Place Where Corporate Records Kept |
Minutes prepared in accordance with the Act and these Bye-Laws shall be kept by the Secretary at the registered office of the Company.
78. | Form and Use of Seal |
78.1 | The Company may adopt a seal in such form as the Board may determine. The Board may adopt one or more duplicate seals for use in or outside Bermuda. |
78.2 | A seal may, but need not, be affixed to any deed, instrument or document, and if the seal is to be affixed thereto, it shall be attested by the signature of (i) any Director, or (ii) any Officer, or (iii) the Secretary, or (iv) any Person authorised by the Board for that purpose. |
78.3 | Any Director, Officer or Resident Representative may, but need not, affix the seal of the Company to certify the authenticity of any copies of documents. |
ACCOUNTS
79. | Records of Account |
79.1 | The Board shall cause to be kept proper records of account with respect to all transactions of the Company and in particular with respect to: |
(a) | all amounts of money received and expended by the Company and the matters in respect of which the receipt and expenditure relates; |
(b) | all sales and purchases of goods by the Company; and |
(c) | all assets and liabilities of the Company. |
79.2 | Such records of account shall be kept at the registered office of the Company or, subject to the Act, at such other place as the Board thinks fit and shall be available for inspection by the Directors during normal business hours. |
79.3 | Such records of account shall be retained for a minimum period of five years from the date on which they are prepared. |
80. | Financial Year End |
The financial year end of the Company may be determined by resolution of the Board and failing such resolution shall be 31st December in each year.
AUDITS
81. | Annual Audit |
Subject to any rights to waive laying of accounts or appointment of an Auditor pursuant to the Act, the accounts of the Company shall be audited and be laid before the Members at a general meeting at least once in every year.
28
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
82. | Appointment of Auditor |
82.1 | Subject to the Act, at the annual general meeting or at a subsequent special general meeting in each year, the Members shall appoint an independent auditor to the Company |
82.2 | The Auditor may be a Member but no Director, Officer or employee of the Company shall, during his or her continuance in office, be eligible to act as an Auditor of the Company. |
83. | Remuneration of Auditor |
83.1 | The remuneration of an Auditor appointed by the Members shall be fixed by the Company at the annual general meeting or at a subsequent special general meeting in each year or in such manner as the Members may determine. |
83.2 | The remuneration of an Auditor appointed by the Board to fill a casual vacancy in accordance with these Bye-Laws shall be fixed by the Board. |
84. | Duties of Auditor |
84.1 | The financial statements provided for by these Bye-Laws shall be audited by the Auditor in accordance with generally accepted auditing standards. The Auditor shall make a written report thereon in accordance with generally accepted auditing standards. |
84.2 | The generally accepted auditing standards referred to in this Bye-Law may be those of a country or jurisdiction other than Bermuda or such other generally accepted auditing standards as may be provided for in the Act. If so, the financial statements and the report of the Auditor shall identify the generally accepted auditing standards used. |
85. | Access to Records |
The Auditor shall at all reasonable times have access to all books kept by the Company and to all accounts and vouchers relating thereto, and the Auditor may call on the Directors or Officers for any information in their possession relating to the books or affairs of the Company.
86. | Financial Statements and the Auditors Report |
86.1 | Subject to the following Bye-Law, the financial statements and/or the auditors report as required by the Act shall: |
(a) | be laid before the Members at the annual general meeting; or |
(b) | be received, accepted, adopted, approved or otherwise acknowledged by the Members by written resolution passed in accordance with these Bye-Laws. |
86.2 | If all Members and Directors shall agree, either in writing or at a meeting, that in respect of a particular interval no financial statements and/or auditors report thereon need be made available to the Members, and/or that no auditor shall be appointed then there shall be no obligation on the Company to do so. |
87. | Vacancy in the Office of Auditor |
The Board may fill any casual vacancy in the office of the auditor.
29
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
VOLUNTARY WINDING-UP AND DISSOLUTION
88. | Winding-Up |
If the Company shall be wound up the liquidator may, with the sanction of a resolution of the Members, divide amongst the Members in specie or in kind the whole or any part of the assets of the Company (whether they shall consist of property of the same kind or not) and may, for such purpose, set such value as he or she deems fair upon any property to be divided as aforesaid and may determine how such division shall be carried out as between the Members or different classes of Members. The liquidator may, with the like sanction, vest the whole or any part of such assets in the trustees upon such trusts for the benefit of the Members as the liquidator shall think fit, but so that no Member shall be compelled to accept any shares or other securities or assets whereon there is any liability.
ALTERATION OF BYE-LAWS AND MEMORANDUM OF ASSOCIATION
89. | Alteration of Bye-Laws |
89.1 | No Bye-Law may be rescinded, altered or amended and no new Bye-Law may be made save in accordance with the Act and until the same has been approved by a resolution approved by the Board and by a resolution approved by a Simple Majority of the Members, provided that Bye-Laws 54.1, 54.3 and 55.2 may not be rescinded, altered or amended in a manner that would adversely affect the respective rights of Crestview, CVC, Pinebrook or MGU HoldCo (collectively, the Principal Shareholders, and each, a Principal Shareholder) thereunder without the consent of the Principal Shareholder so affected, provided further that such Principal Shareholder has (i) the right to designate a Nominee for election to the Board in accordance with Bye-Law 54.3(a) or (ii) has a Director then serving on the Board. |
89.2 | No alteration or amendment to the Memorandum of Association may be made save in accordance with the Act and until same has been approved by a resolution of the Board and by a resolution of the Members. |
90. | Discontinuance |
The Board may exercise all the powers of the Company to discontinue the Company to a jurisdiction outside Bermuda pursuant to the Act.
30
FIDELIS INSURANCE HOLDINGS LIMITED BYE-LAWS
SCHEDULE A
Form A
Transfer of a Share or Shares
Fidelis Insurance Holdings Limited (the Company)
FOR VALUE RECEIVED [amount], I, [name of transferor] hereby sell, assign and transfer unto [transferee] of [address], [number] shares of the Company.
DATED this [date] | ||||||
Signed by: | In the presence of: | |||||
Transferor |
Witness |
|||||
Signed by: | In the presence of: | |||||
Transferee |
Witness |
Exhibit 5.1
![]() |
CONYERS DILL & PEARMAN LIMITED
Clarendon House, 2 Church Street Hamilton HM 11, Bermuda
Mail: PO Box HM 666, Hamilton HM CX, Bermuda T +1 441 295 1422
conyers.com |
20 June 2023 | Matter No.: 382467 Tel: +1 441 278 8053 Email: alexandra.macdonald@conyers.com |
Fidelis Insurance Holdings Limited
Waterloo House
100 Pitts Bay Road
Pembroke HM 08
Bermuda
Dear Sir/Madam
Re: Fidelis Insurance Holdings Limited (the Company)
We have acted as special Bermuda legal counsel to the Company in connection with a registration statement on form F-1 (Registration No. 333-271270) filed with the U.S. Securities and Exchange Commission (the Commission) on 20 June 2023 (the Registration Statement, which term does not include any other document or agreement whether or not specifically referred to therein or attached as an exhibit or schedule thereto) relating to the registration under the U.S. Securities Act of 1933, as amended, (the Securities Act), of an aggregate of 17,000,000 common shares, par value $0.01 per share, of which 5,714,286 are being offered by the Company and 11,285,714 (the Issued Shares) are being offered by certain selling shareholders of the Company (the Selling Shareholders) together with an additional 2,550,000 common shares, par value $0.01 per share, subject to an allotment option to sell additional shares granted to the underwriters by the Selling Shareholders (together, the Common Shares).
1. | DOCUMENTS REVIEWED |
For the purposes of giving this opinion, we have examined a copy of the Registration Statement. We have also reviewed:
1.1. | copies of the memorandum of association and the bye-laws of the Company, each certified by the Secretary of the Company on 19 June 2023; |
1.2. | copies of minutes of meetings of its directors held on 31 March 2023, 15 May 2023 and 12 June 2023, written resolutions of its members dated 16 June 2023, and unanimous written resolutions of the pricing committee dated 15 June 2023 (together, the Resolutions) each certified by the Secretary of the Company on 19 June 2023; and |
1.3. | such other documents and made such enquiries as to questions of law as we have deemed necessary in order to render the opinion set forth below. |
2. | ASSUMPTIONS |
We have assumed:
2.1. | the genuineness and authenticity of all signatures and the conformity to the originals of all copies (whether or not certified) examined by us and the authenticity and completeness of the originals from which such copies were taken; |
2.2. | that where a document has been examined by us in draft form, it will be or has been executed and/or filed in the form of that draft, and where a number of drafts of a document have been examined by us all changes thereto have been marked or otherwise drawn to our attention; |
2.3. | the accuracy and completeness of all factual representations made in the Registration Statement and other documents reviewed by us; |
2.4. | that the Resolutions were passed at one or more duly convened, constituted and quorate meetings, or by unanimous written resolutions, remain in full force and effect and have not been rescinded or amended; |
2.5. | that there is no provision of the law of any jurisdiction, other than Bermuda, which would have any implication in relation to the opinions expressed herein; |
2.6. | that upon issue of any Common Shares to be sold by the Company the Company will receive consideration for the full issue price thereof which shall be equal to at least the par value thereof. |
3. | QUALIFICATIONS |
3.1. | We have made no investigation of and express no opinion in relation to the laws of any jurisdiction other than Bermuda. |
3.2. | This opinion is to be governed by and construed in accordance with the laws of Bermuda and is limited to and is given on the basis of the current law and practice in Bermuda. |
3.3. | This opinion is issued solely for the purposes of the filing of the Registration Statement and the offering of the Common Shares and is not to be relied upon in respect of any other matter. |
4. | OPINION |
On the basis of and subject to the foregoing, we are of the opinion that:
4.1. | The Company is duly incorporated and existing under the laws of Bermuda in good standing (meaning solely that it has not failed to make any filing with any Bermuda governmental authority under the Companies Act 1981, or to pay any Bermuda government fee or tax, which would make it liable to be struck off the Register of Companies and thereby cease to exist under the laws of Bermuda). |
4.2. | When issued and paid for as contemplated by the Registration Statement, the Common Shares, other than the Issued Shares, will be validly issued, fully paid and non-assessable (which term means when used herein that no further sums are required to be paid by the holders thereof in connection with the issue of such Common Shares). |
4.3. | Based solely upon a review of the register of members of the Company as at 19 June, 2023, certified by the Secretary of the Company on 19 June 2023, the Issued Shares are validly issued, fully paid and non-assessable. |
We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the references to our firm under the captions Risk FactorsRisks Relating to the Common Shares and this OfferingThe enforcement of civil liabilities against the Group may be difficult and Legal Matters in the prospectus forming a part of the Registration Statement. In giving this consent, we do not hereby admit that we are experts within the meaning of Section 11 of the Securities Act or that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations of the Commission promulgated thereunder.
Yours faithfully,
/s/ Conyers Dill & Pearman Limited
Conyers Dill & Pearman Limited
Exhibit 10.10
Execution Version
FIDELIS INSURANCE HOLDINGS LIMITED
AMENDED AND RESTATED COMMON SHAREHOLDERS AGREEMENT
June 16, 2023
TABLE OF CONTENTS
Page | ||||||
Section 1. |
Certain Definitions | 1 | ||||
Section 2. |
Corporate Governance | 6 | ||||
2.01 |
Bye-Law Provisions | 6 | ||||
2.02 |
Board of Directors | 6 | ||||
2.03 |
Board Nomination Rights | 6 | ||||
2.04 |
Company and Shareholder Obligations | 7 | ||||
2.05 |
Board Committees and Non-Voting Observers | 8 | ||||
Section 3. |
Consent Rights | 9 | ||||
3.01 |
Principal Shareholder Consent Rights | 9 | ||||
3.02 |
MGU HoldCo Consent Rights | 10 | ||||
Section 4. |
MGU HoldCo Lock-Up and Related Transfer Restrictions | 10 | ||||
Section 5. |
Information Rights | 11 | ||||
Section 6. |
Confidentiality | 11 | ||||
Section 7. |
Other Covenants | 12 | ||||
7.01 |
Certain Repurchase Rights | 12 | ||||
7.02 |
MGU Holdco Allocation Rights | 13 | ||||
7.03 |
Corporate Opportunities | 14 | ||||
Section 8. |
Release of Obligations | 15 | ||||
Section 9. |
Miscellaneous | 15 | ||||
9.01 |
Amendments and Waivers | 15 | ||||
9.02 |
Entire Agreement | 15 | ||||
9.03 |
Term and Termination | 15 | ||||
9.04 |
Notices | 16 | ||||
9.05 |
Successors and Assigns; Assignment | 17 | ||||
9.06 |
Specific Performance | 17 | ||||
9.07 |
Submission to Jurisdiction; No Jury Trial | 17 | ||||
9.08 |
Counterparts | 18 | ||||
9.09 |
Governing Law | 18 | ||||
9.10 |
Headings | 18 | ||||
9.11 |
Construction | 18 | ||||
9.12 |
Severability | 19 |
(i)
This AMENDED AND RESTATED COMMON SHAREHOLDERS AGREEMENT (this Agreement) is made as of June 16, 2023, by and among, Fidelis Insurance Holdings Limited, a Bermuda exempted company with limited liability (the Company), Crestview FIHL Holdings, L.P., a Cayman Islands limited partnership, Crestview FIHL TE Holdings, Ltd, a Cayman Islands limited company, Crestview IV FIHL Holdings, L.P., a Cayman Islands limited partnership and Crestview IV FIHL TE Holdings LLC, a Cayman Islands limited liability company (collectively, Crestview), CVC Falcon Holdings Limited, a Jersey limited liability company (CVC), Pine Brook Feal Intermediate, L.P., a Cayman Islands limited partnership (Pine Brook, and together with Crestview and CVC, the Principal Shareholders, and each individually, a Principal Shareholder) and Shelf Holdco II Limited (MGU HoldCo, and together with the Principal Shareholders, the Shareholders and each individually, a Shareholder).
RECITALS
WHEREAS, the Company, the Shareholders, Platinum Ivy B 2018 RSC Limited (Platinum Ivy) and SPFM Holdings, LLC (SPFM, and together with Platinum Ivy, the Other Shareholders) are party to that certain Amended and Restated Common Shareholders Agreement dated as of January 3, 2023 (the Original CSA);
WHEREAS, pursuant to Sections 4.02 and 9.01 of the Original CSA and in connection with the Companys proposed initial public offering (IPO) of Common Shares (as defined below), the Company and the Shareholders hereby wish to amend and restate the Original CSA in order to (i) set forth certain understandings among themselves, including with respect to certain corporate governance matters, (ii) release the Other Shareholders from any obligations arising under or in connection with the Original CSA and reflect the fact that the Other Shareholders shall have no rights under this Agreement, and (iii) reflect the Companys status as a publicly listed entity following the IPO in accordance with the rules of the New York Stock Exchange (NYSE), the Commission (as defined below) and related customary practices;
WHEREAS, this Agreement shall come into full force and effect (and, accordingly, the Original CSA shall cease to have any force and effect) on the IPO Effective Date (as defined below); and
NOW, THEREFORE, in consideration of the mutual covenants contained herein and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:
Section 1. Certain Definitions. As used in this Agreement, the following terms shall have the meanings set forth below:
Affiliate of any Person means any other Person controlling, controlled by or under common control with such Person. As used in this definition, control (including, with its correlative meanings, controlled by and under common control with) shall mean, with respect to any Person, the possession, directly or indirectly, of the power to direct or cause the direction of management or policies (whether through ownership of securities or partnership or other ownership interests, by contract or otherwise) of such Person. In the case of a natural Person, his or her Affiliates include members of such Persons immediate family, natural lineal descendants of such Person or a trust or other similar entity established for the exclusive benefit of such Person and his or her immediate family and natural lineal descendants. Notwithstanding anything to the contrary herein, other than for purposes of the definition of Independent Director, CVCs Affiliates shall not include (i) any portfolio company of CVC or any of its affiliated investment funds or (ii) CVC Credit Partners LP and any of its subsidiaries.
- 1 -
Agreement has the meaning set forth in the preamble.
Binder Agreements means (i) that certain framework agreement between MGU HoldCo and the Company dated December 20, 2022, (ii) those certain delegated underwriting authority agreements entered into pursuant to such framework agreement among certain subsidiaries of the Company and certain subsidiaries of MGU HoldCo dated December 20, 2022, pursuant to which such subsidiaries of the Company delegate underwriting authority to such subsidiaries of MGU HoldCo and (iii) that certain outsourcing services agreement entered into pursuant to such framework agreement between the Company and MGU HoldCo, dated December 20, 2022, pursuant to which the Company outsources certain non-underwriting services to MGU HoldCo.
Board means the Board of Directors of the Company.
Boards Slate has the meaning set forth in Section 2.04(a).
Business Day means any day other than a Saturday, a Sunday or any day on which banks located in New York, London or Bermuda are authorized or obliged to close.
Bye-Laws means the Bye-Laws of the Company, as may be amended from time to time.
Commission means the United States Securities and Exchange Commission or any other federal agency administering the Securities Act.
Common Shares means the Common Shares of the Company, with an initial par value of $0.01 per share, and includes a fraction of a Common Share.
Company has the meaning set forth in the preamble.
Corporate Opportunity has the meaning set forth in Section 7.03.
Crestview has the meaning set forth in the preamble.
Crestview Director means any Crestview Nominee or director serving on the Board from time to time who is affiliated with Crestview (as the case may be).
Crestview Nominee has the meaning set forth in Section 2.03(a)(i).
CVC has the meaning set forth in the preamble.
CVC Director means any CVC Nominee or director serving on the Board from time to time who is affiliated with CVC (as the case may be).
CVC Nominee has the meaning set forth in Section 2.03(a)(ii).
CVC Related Funds means collectively (a) CVC Capital Partners SICAV-FIS S.A., (b) CVC Management Holdings II Limited and (c) CVC Capital Partners Advisory Group Holding Foundation, and each of their respective subsidiaries and Affiliates, from time to time.
- 2 -
Derivative Security has the meaning set forth in Section 7.02(b)(i).
Director means any member of the Companys Board.
Fidelis Insurance (Bermuda) means Fidelis Insurance Bermuda Limited, a Bermuda exempted company with limited liability and a wholly owned subsidiary of the Company.
Fidelis Insurance Ireland means Fidelis Insurance Ireland DAC, an Irish designated activity company incorporated in Ireland and an indirect wholly owned subsidiary of the Company.
Fidelis Underwriting U.K. means Fidelis Underwriting Limited, a company limited by shares formed under the laws of England and Wales and a wholly owned subsidiary of the Company.
FIHL (UK) Services means FIHL (UK) Services Limited, a company limited by shares formed under the laws of England and Wales and a wholly owned subsidiary of the Company.
Fully Diluted Share Capital means, at the relevant date: (i) the number of outstanding Common Shares and (ii) the number of Common Shares issuable upon the exercise of outstanding long term incentive plan awards that have been granted pursuant to the long term incentive plan as of such date.
Independent Director means, in accordance with applicable law and the NYSE listing standards, any Director whom the Board determines, in its sole discretion, qualifies as an independent director of the Company.
IPO has the meaning set forth in the Recitals.
IPO Effective Date means the date on which the IPO Underwriting Agreement is executed.
IPO Underwriting Agreement means the underwriting agreement in connection with the IPO to be entered into on or around the date of this Agreement between the Company, J.P. Morgan Securities LLC, Barclays Capital Inc. and Selling Shareholders (as defined therein).
MGU HoldCo has the meaning set forth in the preamble.
MGU HoldCo Director means any MGU HoldCo Nominee or director serving on the Board from time to time who is affiliated with MGU HoldCo (as the case may be).
MGU HoldCo Effective Date means January 3, 2023.
MGU HoldCo Initial Shares means, the Common Shares initially purchased by MGU HoldCo on the MGU HoldCo Effective Date and any securities issued with respect to such Common Shares, including pursuant to a stock dividend, stock split, reclassification or pursuant to an exchange (including merger or amalgamation).
MGU HoldCo New Issue Notice has the meaning set forth in Section 7.02(c).
- 3 -
MGU HoldCo Nominee has the meaning set forth in Section 2.03(a)(iv).
MGU HoldCo Notice of Acceptance has the meaning set forth in Section 7.02(d).
MGU HoldCo Pro Rata Allocation Right has the meaning set forth in Section 7.02(a).
Modified Simple Majority shall mean, in the case of a vote of the Board, Directors representing more than fifty percent (50%) of the entire Board, which majority shall include at least one (1) Independent Director.
New Company Securities has the meaning set forth in Section 7.02(b)(i).
New Senior Preferred Securities has the meaning set forth in Section 7.02(b)(ii).
Nominee has the meaning set forth in Section 2.03(a)(iv).
NYSE has the meaning set forth in the Recitals.
Original CSA has the meaning set forth in the Recitals.
Outstanding Common Shares means the lesser of (i) the total number of issued and outstanding Common Shares as of the date the IPO is consummated and (ii) the total number of issued and outstanding Common Shares as of the date of determination (in each case, as equitably adjusted for any share split, reverse share split, share dividend, share combination, recapitalization, reclassification or similar transaction duly approved by the Board).
Permitted Transfer means a Transfer of Common Shares by MGU HoldCo (i) to a Shareholder Affiliate Transferee that agrees to be bound by the terms and conditions of this Agreement, (ii) pursuant, if applicable, to an effective registration statement and/or prospectus filed with the Commission or other applicable Regulatory Agency regulating securities offerings on the applicable national securities exchange, including any transfers in connection with any exercise of registration rights pursuant to the Registration Rights Agreement or (iii) pursuant to and in accordance with Rule 144 promulgated under the Securities Act, provided that there is an established public market for Common Shares and the Company is timely filing periodic reports with the Commission.
Person means an individual, a partnership, a company, a corporation, a limited liability company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization or a governmental or quasi-governmental entity or any department, agency or political subdivision thereof.
Pine Brook has the meaning set forth in the preamble.
Pine Brook Director means any director serving on the Board from time to time who is affiliated with Pine Brook.
Pine Brook Nominee has the meaning set forth in Section 2.03(a)(iii).
Preference Shares means the Preference Shares of the Company, with an initial par value of $0.01 per share.
- 4 -
Principal Shareholders has the meaning set forth in the preamble.
Proposed Repurchase has the meaning set forth in Section 7.01(a).
Proposed Transfer has the meaning set forth in Section 7.01(b).
Registration Rights Agreement means the Registration Rights Agreement, dated as of June 9, 2015, as amended by the First Amendment Agreement dated November 25, 2019, the Second Amendment Agreement dated February 3, 2020 and the Third Amendment Agreement dated July 13, 2021, by and among, amongst others, the Company and the Shareholders, as in effect from time to time.
Regulatory Agency shall mean any nation, government, court, regulatory, taxing or administrative agency, commission or authority or other legislative, executive or judicial governmental entity, body, agency, official or instrumentality, domestic or foreign, whether federal, national, provincial, state, local or multinational or self-regulatory organization or agency or other similar quasi-governmental regulatory body or arbitration panel, tribunal or arbitrator.
Securities Act means the United States Securities Act of 1933, as amended, or any similar federal statute and the rules and regulations of the Commission promulgated thereunder, as the same may be amended from time to time.
Securities Transaction has the meaning set forth in Section 7.02(c).
Shareholder Affiliate Transferee means, with respect to any Shareholder, (i) any Affiliate of the applicable Shareholder, including any Person that has a common general partner, managing member, investment manager or governing body with any such Shareholder or the funds which own such Shareholder, and (ii) any general or limited partner or member of the applicable Shareholder or any of its Affiliates and any corporation, partnership or other entity that is an Affiliate of such general or limited partner or member, so long as such Person remains an Affiliate thereof. Notwithstanding anything to the contrary herein, CVCs Shareholder Affiliate Transferees shall not include (a) any portfolio company of CVC or any of its affiliated investment funds or (b) CVC Credit Partners LP and any of its subsidiaries.
Shareholders has the meaning set forth in the preamble.
Sponsor Director means, collectively, any of the Crestview Director, the CVC Director and the Pine Brook Director.
Subsidiary means each of Fidelis Underwriting U.K., Fidelis Insurance (Bermuda), Fidelis Insurance Ireland and FIHL (UK) Services and any other material subsidiary of the Company as set forth in any reports filed with the Commission.
Subsidiary Undertaking has the meaning given in section 1162 of the Companies Act 2006.
Transfer means any direct or indirect sale, exchange, transfer (including any transfer by gift), assignment, pledge, hypothecation, mortgage, distribution or other disposition, or issuance or creation of any option or any voting proxy, voting trust or other transfer of legal or equitable interest in a security, in whole or in part, whether voluntarily or involuntarily or by operation of law or at a judicial sale or otherwise, and Transferred shall be construed accordingly.
- 5 -
Written Resolution means the resolution of the shareholders of the Company pursuant to Bye-Laws 42 and 89 approving the amended and restated Bye-Laws to reflect the Companys status as a publicly listed entity on the NYSE following the IPO.
$ means the legal currency of the United States of America.
Section 2. Corporate Governance.
2.01 Bye-Law Provisions. On or before the IPO Effective Date, each Shareholder agrees to vote its Common Shares or execute proxies or written consents, as the case may be and to the extent required in favor of the Written Resolution.
2.02 Board of Directors.
(a) Board of Directors. The Board shall consist of not less than five (5) Directors and no more than fifteen (15) Directors and shall be divided into three (3) classes of Directors in accordance with the terms of the Bye-Laws. As of the IPO Effective Date, the Board shall have nine (9) Directors divided into three (3) classes as follows:
Name of Director |
Class of Director | |
Daniel Kilpatrick | Class II Director | |
Daniel Brand | Class II Director | |
Dana LaForge | Class III Director | |
Cathleen Iberg | Class I Director | |
Dan Burrows | Class III Director | |
Hinal Patel | Class I Director | |
Baroness Helena Morrissey, DBE |
Class III Director | |
Allan Decleir | Class II Director | |
Charles Collis | Class I Director |
(b) For the avoidance of doubt, the Directors identified in Section 2.02(a) shall be the initial Directors, each of whom shall serve from the IPO Effective Date through the Companys first annual shareholder meeting to be held in 2024 or such later date that the class of Directors may be up for re-election, provided that the CVC Director and the Crestview Director shall be in Class II and the Pine Brook Director shall be in Class III.
2.03 Board Nomination Rights.
(a) From the IPO Effective Date:
(i) Crestview shall have the right to designate one (1) nominee for election to the Board (the Crestview Nominee) for so long as Crestview, together with its Shareholder Affiliate Transferees, beneficially owns at least 7.5% of the Outstanding Common Shares;
- 6 -
(ii) CVC shall have the right to designate one (1) nominee for election to the Board (the CVC Nominee) for so long as CVC, together with its Shareholder Affiliate Transferees, beneficially owns at least 7.5% of the Outstanding Common Shares;
(iii) Pine Brook shall have the right to designate one (1) nominee for election to the Board (the Pine Brook Nominee) for so long as Pine Brook, together with its Shareholder Affiliate Transferees, beneficially owns at least 7.5% of the Outstanding Common Shares; and
(iv) MGU HoldCo shall have the right to designate one (1) nominee for election to the Board (the MGU HoldCo Nominee, and together with the Crestview Nominee, the CVC Nominee and the Pine Brook Nominee, the Nominees and each individually, a Nominee) for so long as MGU HoldCo, together with its Shareholder Affiliate Transferees, beneficially owns at least 50% of its MGU HoldCo Initial Shares.
(b) No reduction in the number of Common Shares that each Shareholder beneficially owns shall shorten the term of any incumbent Director.
(c) In the event that any Nominee shall cease to serve for any reason during a term, the Shareholder that nominated such Nominee shall be entitled to designate such persons successor in accordance with this Agreement (regardless of such Shareholders beneficial ownership of Common Shares at the time of such vacancy) and the Board shall promptly fill the vacancy with such successor Nominee; it being understood that any such designee shall serve the remainder of the term of the Director whom such designee replaces.
(d) If a Nominee is not appointed or elected to the Board because of such persons death, disability, disqualification, withdrawal as a Nominee, failure to be elected or for another reason is unavailable or unable to serve on the Board, the applicable Shareholder shall be entitled to designate promptly another Nominee, the Director position for which the original Nominee was nominated shall not be filled pending such designation and the Company shall use commercially reasonable efforts and consistent with NYSE corporate governance standards to cause the Board to promptly fill the vacancy with such successor Nominee.
(e) The parties acknowledge that, as at the IPO Effective Date, the Company constitutes a foreign private issuer under U.S. federal securities law. Notwithstanding the previous sentence, the Company intends for the Board and any committee thereof to maintain the corporate governance and independence standards applicable to a U.S. issuer, including any associated independence requirements with the composition of the Board and any committee thereof. At such times as the Company is required by applicable law or NYSE listing standards to have a majority of the Board comprised of Independent Directors (subject in each case to any applicable phase-in periods), the Nominees of the Principal Shareholders shall include persons that qualify as Independent Directors under applicable law and NYSE listing standards such that, together with any other Independent Directors then serving on the Board that are not Nominees, the Board, and any committee thereof, is comprised of a majority of Independent Directors ; provided that the Principal Shareholders agree to consult with each other and the Company in good faith to determine how best to satisfy such Independent Directors requirements.
2.04 Company and Shareholder Obligations.
- 7 -
(a) Subject to the Boards fiduciary obligations to the Company and its shareholders, the Company agrees that, for so long as a Shareholder is entitled to designate a Nominee for election to the Board, the Company shall take all necessary actions to (i) cause each Nominee that is in the class of Directors up for re-election to be included in the Boards slate of nominees to the Companys shareholders (the Boards Slate) for each election of the Directors and (ii) cause the election of such Nominee, including at least the same efforts it uses to cause other nominees recommended by the Board to be elected as a Director.
(b) Each Shareholder shall promptly give notice to the Company after such Shareholder becomes aware that it is no longer entitled to nominate a Nominee then serving on the Board, and upon receipt of such notice the Companys obligations in Section 2.04(a) shall terminate. If a Shareholder fails to provide such notice when required, a majority of the Independent Directors then serving on the Board shall determine, in consultation with management of the Company and such Shareholder, whether such Shareholder continues to be entitled to nominate a Nominee and, if not, whether the Nominee of such Shareholder then serving on the Board in the class that is up for re-election will be included in the Boards Slate.
(c) The Company shall maintain directors and officers liability insurance and fiduciary liability insurance with insurers of recognized financial responsibility in such amounts as the Board determines to be prudent and customary for the Companys business and operations.
(d) The Company shall reimburse each Director for their reasonable and documented out-of-pocket expenses incurred by such Director in connection with attending regular and special meetings of the Board and any committee thereof.
2.05 Board Committees and Non-Voting Observers.
(a) Each committee of the Board will (i) operate in such a way to permit the Company to comply with applicable law and maintain its listing on the NYSE and (ii) be subject to the provisions of this Agreement and committee charters adopted by the Board or the committees, which such charters shall not conflict with the rights of the Shareholders set forth herein. Subject to the foregoing sentence, from and after the IPO Effective Date:
(i) for so long as Crestview is entitled to designate a Nominee for election to the Board or a Crestview Director serves as a Director on the Board: (A) the Crestview Director shall be entitled to serve on three (3) of the five (5) committees of the Board and (B) subject to Sections 2.05(b), (c) and (d), Crestview shall have the right to appoint a non-voting observer to attend all meetings of each committee of the Board;
(ii) for so long as CVC is entitled to designate a Nominee for election to the Board or a CVC Director serves as a Director on the Board: (A) the CVC Director shall be entitled to serve on three (3) of the five (5) committees of the Board and (B) subject to Sections 2.05(b), (c) and (d), CVC shall have the right to appoint a non-voting observer to attend all meetings of each committee of the Board;
(iii) for so long as Pine Brook is entitled to designate a Nominee for election to the Board or a Pine Brook Director serves as a Director on the Board: (A) such Pine Brook Director shall be entitled to serve on three (3) of the five (5) committees of the Board and (B) subject to Sections 2.05(b), (c) and (d), Pine Brook shall have the right to appoint a non-voting observer to attend all meetings of each committee of the Board; and
- 8 -
(iv) (A) for so long as MGU HoldCo is entitled to designate a Nominee for election to the Board or an MGU HoldCo Director serves as a Director on the Board: the MGU HoldCo Director shall be entitled to serve on three (3) of the five (5) committees of the Board and (B) subject to Sections 2.05(b), (c) and (d), for so long as MGU HoldCo beneficially owns at least 10% of its MGU HoldCo Initial Shares, MGU HoldCo shall have the right to appoint a non-voting observer to attend all meetings of each committee of the Board.
(b) Each Shareholder having the right to appoint a non-voting observer under Section 2.05(a) shall have the right to remove and replace its non-voting observer at any time and from time to time. The Company shall furnish to each non-voting observer (i) notices of Board committee meetings no later than, and using the same form of communication as, notice of Board meetings are furnished to Directors in accordance with the Memorandum of Association and Bye-Laws, and (ii) copies of the materials with respect to Board committee meetings which are furnished to members of such committees no later than such materials are furnished to such members; provided that failure to deliver notice, or materials, to a non-voting observer in connection with such observers right to attend and/or review materials with respect to, any Board committee meeting shall not, of itself, impair the validity of any action taken by the members of such Board committee at such meeting.
(c) Each non-voting observer that may be appointed to attend committee meetings shall be required to execute or otherwise become subject to any codes of conduct (including with respect to confidentiality) of the Company generally applicable to Directors. Notwithstanding the foregoing, the Company reserves the right to exclude any non-voting observer from access to any materials provided to the Board or meeting or portion thereof if the Company believes that such exclusion is reasonably necessary to preserve the attorney-client privilege, to protect confidential proprietary information, to comply with regulatory restrictions.
(d) To the extent the Company proposes to exclude a non-voting observer from access to any materials provided to a Board committee or meeting or portion thereof, the Company will (i) to the extent practicable, provide reasonable advance written notice to the Shareholder which appointed such non-voting observer of any such proposed exclusion, (ii) use commercially reasonable efforts to take actions designed to minimize the nature and scope of any proposed exclusions and (iii) act in good faith in determining the scope and extent of any proposed exclusion.
Section 3. Consent Rights.
3.01 Principal Shareholder Consent Rights.
For so long as the Principal Shareholders, together with their Shareholder Affiliate Transferees, in the aggregate beneficially own at least 25% of the Outstanding Common Shares, the Principal Shareholders shall have the right, by unanimous decision evidenced in writing by each of the Principal Shareholders that beneficially owns at least 1% of the Outstanding Common Shares, to restrict the Company from taking the following actions, except to the extent such actions are required by applicable law:
(a) adopt or propose to the shareholders of the Company any amendment, modification or restatement of or supplement to the Companys organizational documents which have an adverse impact on the rights granted to the Principal Shareholders;
- 9 -
(b) commence a voluntary case or proceeding under any applicable U.S. or foreign bankruptcy, insolvency, reorganization or similar law or make an assignment for the benefit of creditors, or admit in writing of its or their inability to pay its or their debts generally as they become due, or take any action in furtherance of any such action;
(c) change the size of the Board;
(d) engage in any transaction in which any person or group acquires more than 50% of the then outstanding Common Shares of the Company or the power to elect a majority of the members of the Board; or
(e) terminate or hire the chief executive officer of the Company or any successor or replacement serving in such role.
3.02 MGU HoldCo Consent Rights.
For so long as MGU HoldCo beneficially owns at least 4.9% of the Outstanding Common Shares, the Company shall not, and shall not permit any of its Subsidiaries or Subsidiary Undertakings to, directly or indirectly, take any of the following actions without the prior written consent of MGU HoldCo:
(a) effect any change in the jurisdiction, incorporation or name of the Company or any of its Subsidiary Undertakings;
(b) make a material change to the nature or scope of the business underwritten by the Company and each of its Subsidiary Undertakings;
(c) effect any amendments to the Bye-Laws or this Agreement that are reasonably likely to have a material adverse effect on MGU HoldCo and each of its Subsidiary Undertakings, taken as a whole; or
(d) make any acquisition or disposition of any asset for consideration in excess of 5% of the assets of the Company and its Subsidiary Undertakings, taken as a whole, that is reasonably likely to have a material adverse effect on MGU HoldCo and each of its Subsidiary Undertakings, taken as a whole.
Section 4. MGU HoldCo Lock-Up and Related Transfer Restrictions.
Notwithstanding anything to the contrary herein, other than subject to Section 7.01, and only until any party to the Binder Agreements has confirmed that the relevant Binder Agreement has been terminated following a failure to reach a resolution in accordance with the relevant dispute resolution procedure in the Binder Agreements (as applicable), MGU HoldCo shall not, without the prior written approval of a Modified Simple Majority of the Board:
(a) effect any Transfer of its Common Shares; or
(b) enter into any hedge, swap, put, call, short sale, derivative or other arrangement in any securities of any issuer in the insurance industry (including the Company) or any index or basket of securities 5% or more of which consists of the Companys securities,
- 10 -
in each case, whether any such transaction is to be settled by delivery of Common Shares or other securities, in cash or otherwise. For the avoidance of doubt, this Section 4 shall cease to apply once any party to the Binder Agreements has confirmed that the relevant Binder Agreement has been terminated following a failure to reach a resolution in accordance with the relevant dispute resolution procedure in the Binder Agreements (as applicable).
Section 5. Information Rights.
Subject to Section 6, for so long as (i) a Shareholder is entitled to designate a Nominee for election to the Board or (ii) the Director nominated by such Shareholder continues to serve on the Board, such Shareholder shall, in each case, have the right to:
(a) inspect, review and/or make copies and extracts from the books and records of the Company or any of its Subsidiaries;
(b) discuss the affairs, finances and condition of the Company or any of its Subsidiaries with the management of the Company;
(c) if requested, receive (i) monthly management operational and financial reports that are prepared by the Company in the ordinary course of its business and (ii) investment management reports regarding the Companys investment performance, and the Company shall use reasonable efforts to provide all such requested reports not later than 20 days after the end of each month; and
(d) reasonably request other appropriate information,
provided, however, that the Company shall not be required to provide any such additional information if the Board determines that the disclosure of such information could have a materially adverse effect on the financial condition, business or prospects of the Company on a consolidated basis or is of a confidential nature.
Section 6. Confidentiality.
Except as authorized in writing by the Company, each of the Shareholders shall not disclose any of the information provided to such Shareholder pursuant to this Agreement (including, for the avoidance of doubt, any information such Shareholder receives, directly or indirectly, from its appointed Director, its designated non-voting observer or under Section 5) to any Person that is not an Affiliate of, or in the case of CVC a CVC Related Fund, or director, officer, partner, member, trustee, employee, or representative (including any accountant, attorney, financial advisor or other professional) of, such Shareholder or Affiliate of such Shareholder, or in the case of CVC a CVC Related Fund, or a party to this Agreement, and each Shareholder shall use its commercially reasonable efforts to cause its directors, officers, partners, members, trustees, employees, representatives and Affiliates not to disclose such information to any Person that is not a party to this Agreement; provided, however, that such Shareholder shall not be prohibited from disclosing any such information if such information (w) becomes publicly available through no breach of this Agreement by the Shareholder or its directors, officers, partners, members, trustees, employees, representatives or Affiliates, (x) is required to be disclosed by law (including to a tax authority) or the rules of a national securities exchange, (y) is required to be furnished to a governmental agency in connection with any legal or administrative proceeding or regulatory review or oversight or (z) the information is requested by a prospective transferee or purchaser of Common Shares so long as such third party enters into a confidentiality agreement with the Company reasonably satisfactory to the Company. The Shareholders acknowledge and agree that they are aware that the U.S. securities laws prohibit any person who has material non-public information from purchasing or selling securities of the Company, or from communicating such material non-public information to any other person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell such securities.
- 11 -
Section 7. Other Covenants.
7.01 Certain Repurchase Rights
(a) Notwithstanding Section 4, the Company shall provide MGU HoldCo with notice of its election to redeem or repurchase any Common Shares or take any other action that might result in MGU HoldCo holding more than 9.9% of the Common Shares (each, a Proposed Repurchase) in writing at least ten (10) Business Days prior to such Proposed Repurchase in order to enable MGU HoldCo to determine whether MGU HoldCo (i) would become consolidated with the Company for accounting purposes, (ii) would hold more than 9.9% of the Common Shares and/or (iii) would become a controller of any Subsidiaries which are regulated pursuant to applicable regulatory law, in each case, as a result of such Proposed Repurchase.
(b) Notwithstanding Section 4, if MGU HoldCo, acting reasonably and in good faith, determines that a Proposed Repurchase would cause MGU HoldCo to (i) become consolidated with the Company for accounting purposes, (ii) hold more than 9.9% of the Common Shares and/or (iii) to become a controller of any Subsidiaries which are regulated pursuant to applicable regulatory law, MGU HoldCo shall have the right, at its election, to (x) have a sufficient portion of its Common Shares repurchased by the Company, on the same terms as the Proposed Repurchase, so as to prevent MGU HoldCo from (i) becoming consolidated with the Company for accounting purposes, (ii) holding more than 9.9% of the Common Shares and/or (iii) becoming a controller of any Subsidiaries which are regulated pursuant to applicable regulatory law, in each case, as a result of the Proposed Repurchase as determined by MGU HoldCo acting reasonably and in good faith or (y) undertake a Permitted Transfer in respect of a sufficient portion of its Common Shares so as to prevent MGU HoldCo from (i) becoming consolidated with the Company for accounting purposes, (ii) holding more than 9.9% of the Common Shares and/or (iii) becoming a controller of any Subsidiaries which are regulated pursuant to applicable regulatory law, in each case, as a result of the Proposed Repurchase as determined by MGU HoldCo acting reasonably and in good faith (in which case, the Company shall use commercially reasonable efforts to cooperate with MGU HoldCo in order to allow such Permitted Transfer to be effected as quickly as reasonable practicable) (the Proposed Transfer). If the Company, acting reasonably and in good faith, determines that such Proposed Transfer would result in an adverse legal, regulatory or tax impact to the Company, MGU HoldCo and the Company agree to:
(i) jointly discuss, in good faith, such adverse legal, regulatory or tax impact; and
(ii) use commercially reasonable efforts to seek to structure such Proposed Transfer in a way which would not result in such adverse legal, regulatory or tax impact to the Company.
- 12 -
7.02 MGU Holdco Allocation Rights.
(a) The Company hereby grants to MGU HoldCo the right to purchase an amount up to its pro rata share on a fully diluted as converted basis of all New Company Securities that the Company may, from time to time, propose to issue, offer or sell, in order to permit MGU HoldCo to maintain its then-current percentage ownership of the Companys equity capital (the MGU HoldCo Pro-Rata Allocation Right). The pro rata share for purposes of this Section 7.02(a) with respect to MGU HoldCo shall be expressed as a fraction, (i) the numerator of which is the number of Common Shares held by MGU HoldCo on the date of the Companys written notice pursuant to Section 7.02(c) hereof, and (ii) the denominator of which is the number of Common Shares outstanding on the date of the Companys written notice pursuant to Section 7.02(c) hereof, assuming for this purpose conversion or exercise of all outstanding Derivative Securities. Notwithstanding anything to the contrary contained herein, MGU HoldCo and its Shareholder Affiliate Transferees may assign their respective allocation rights pursuant to this Section 7.02 among one another.
(b) For purposes of this Section 7.02 the following terms shall have the meanings set forth below:
(i) New Company Securities means (A) any Common Shares or other equity securities of the Company, whether now authorized or not, issued after the IPO Effective Date and (B) any options, warrants, convertible notes, securities of any type or similar rights issued after the IPO Effective Date that are or may become convertible into or exercisable or exchangeable for, or that carry rights to subscribe for, any Common Shares or other equity securities of the Company (each of the foregoing reference in such clause (B), a Derivative Security); provided, however, that the term New Company Securities does not include (1) securities issued as consideration to effect the acquisition of another entity by the Company pursuant to a merger, consolidation, amalgamation, exchange of shares, the purchase of all or substantially all of the assets, or otherwise, approved by the Board; (2) any Common Shares, restricted shares, options, warrants or any other equity (or equity based security) issued to any directors or employees of the Company or any of its subsidiaries pursuant to any incentive stock plan or other form of incentive compensation approved by the Board or by the compensation committee thereof and any Common Shares issued upon the exercise thereof, to the extent the aggregate amount of securities so issued does not exceed 10% of the Fully Diluted Share Capital as of the first anniversary of the IPO Effective Date (it being agreed that any securities issued or issuable under the terms of any such incentive stock plan as in effect on the IPO Effective Date shall not count towards the foregoing 10% cap); (3) Common Shares issued upon the exercise of or conversion of any Derivative Security that is outstanding on the IPO Effective Date; (4) Common Shares or other securities issued upon the exercise or conversion of any Derivative Security as to which an MGU HoldCo New Issue Notice (as defined below) has already been made; (5) Common Shares or other capital stock issued to the Companys Shareholders upon any stock split, stock dividend, combination or other similar event with respect to the Common Shares or other capital stock; (6) any Common Shares issued or issuable upon the conversion of any Preference Shares issued after June 9, 2015 and on or prior to December 31, 2015 at a price equal to or greater than $10 per Common Share or $10,000 per Preference Share; (7) preferred shares of the Company which are not convertible into or exercisable or exchangeable for Common Shares, preferred shares of the Company which become convertible into or exercisable or exchangeable for Common Shares solely in connection with a change of control of the Company (including, for the avoidance of doubt, the Preference Shares) and any Common Shares issued or issuable upon conversion, exercise or exchange of any such preferred shares; or (8) New Senior Preferred Securities (as defined below).
- 13 -
(ii) New Senior Preferred Securities means (1) any New Company Security ranking on par with or senior to the Preference Shares in liquidation preference, voting or dividends, or (2) any debt securities, whether senior or subordinated, that constitute Derivative Securities.
(c) In the event that the Company proposes to undertake an issuance, offering or sale of New Company Securities (the Securities Transaction), the Company will, as soon as reasonably practicable and permissible under applicable securities law prior to the date of the Securities Transaction, give MGU HoldCo written notice which shall describe (i) the type and amount of New Company Securities being issued, offered or sold in the Securities Transaction and (ii) the other material terms and conditions upon which the Company proposes to issue, offer or sell New Company Securities, including the approximate timetable for the Securities Transaction (an MGU HoldCo New Issue Notice).
(d) Upon receipt of an MGU HoldCo New Issue Notice by MGU HoldCo, MGU HoldCo may deliver to the Company a notice of its election to exercise the MGU HoldCo Pro-Rata Allocation Right within five (5) Business Days of receipt by MGU HoldCo of the MGU HoldCo New Issue Notice (an MGU HoldCo Notice of Acceptance). The acquisition by MGU HoldCo and sale by the Company of any New Company Securities following the receipt by the Company of an MGU HoldCo Notice of Acceptance is subject in all cases to (i) preparation, execution and delivery by the Company and MGU HoldCo of definitive documentation relating to the acquisition of such New Company Securities in form and substance reasonably satisfactory to MGU HoldCo and the Company, (ii) the Boards determination that such acquisition would not result in any adverse tax, regulatory or legal consequences to the Company, any of its Subsidiaries, any shareholders of the Company or any of their respective Affiliates, (iii) applicable law and NYSE listing standards and (iv) the final terms, conditions and timetable of the Securities Transaction, it being acknowledged that MGU HoldCo shall only be entitled to purchase its pro rata share of New Company Securities that are issued, offered or sold pursuant to the Securities Transaction.
(e) The Company shall be under no obligation to consummate any proposed sale of New Company Securities to MGU HoldCo, nor shall there be any liability on the part of the Company to MGU HoldCo, if any Securities Transaction is not consummated for whatever reason and, accordingly, the Company does not consummate a proposed sale of New Company Securities, whether or not the Company shall have delivered a notice in respect thereof to MGU HoldCo.
7.03 Corporate Opportunities.
(a) To the fullest extent permitted by applicable law and except as otherwise provided below, no Principal Shareholder or its Affiliates or Sponsor Directors shall be obligated to refer or present any particular Corporate Opportunity (as defined below) to the Company or any of its Subsidiaries even if such Corporate Opportunity is of a character that, if referred or presented to the Company or any of its Subsidiaries, could be taken by the Company or any of its Subsidiaries, and any such Principal Shareholder or any of its Affiliates or Sponsor Directors, respectively, shall have the right to take for its own account (individually or as a partner, investor, member, participant or fiduciary) or to recommend to others such particular opportunity.
- 14 -
(b) In the event that (i) a Sponsor Director acquires knowledge of a potential transaction or other matter that may be a corporate or business opportunity for both the Company and the Principal Shareholder(s) that nominated for election to the Board such Sponsor Director or any Affiliate or other related party of such Principal Shareholder(s) or (ii) the MGU HoldCo Director acquires knowledge of a potential transaction or other matter that may be a corporate or business opportunity for both the Company and MGU HoldCo, as applicable, or any of their Affiliates or other related parties (a Corporate Opportunity), such Sponsor Director or MGU HoldCo Director shall have fully satisfied and fulfilled the fiduciary duty of such Director to the Company with respect to such Corporate Opportunity, if such Director acts in a manner consistent with the following policy: A Corporate Opportunity offered to any person who is a Director but not an officer of the Company and who is a director, officer, employee, partner, owner, member, shareholder, appointee or nominee of a Principal Shareholder or MGU HoldCo Director (as applicable) or any of their respective Affiliates or other related parties shall belong to the Company only if such Corporate Opportunity is expressly offered to such Person in writing in his or her capacity as a Director, and otherwise shall belong to such Principal Shareholder, MGU HoldCo or one of their respective Affiliates (as applicable).
Section 8. Release of Obligations.
From the IPO Effective Date, the Company and the Shareholders acknowledge and agree that the Original CSA is amended and restated on the terms of this Agreement with just the Company and the Shareholders as ongoing parties and that the Other Shareholders shall have no rights or obligations under this Agreement. The Other Shareholders shall be third party beneficiaries of this Section 8 only.
Section 9. Miscellaneous.
9.01 Amendments and Waivers. The provisions of this Agreement may not be amended, modified or supplemented, and waivers or consents to departure from the provisions hereof may not be given, unless the Company (following approval by the Board of any such amendment, modification or supplement) has obtained the prior written consent of (i) each Principal Shareholder that has the right to designate a Nominee for election to the Board or that has a Director then serving on the Board and (ii) MGU HoldCo.
9.02 Entire Agreement. This Agreement constitutes the entire agreement and understanding of the parties in respect of its subject matters and supersedes all prior understandings, agreements, or representations by or among the parties, written or oral, to the extent they relate in any way to the subject matter hereof. Except as expressly contemplated hereby, there are no third party beneficiaries having rights under or with respect to this Agreement.
9.03 Term and Termination. This Agreement shall terminate automatically (i) with respect to any Principal Shareholder, when (a) the Principal Shareholders, together with their Shareholder Affiliate Transferees, cease to beneficially own at least 25% of the Outstanding Common Shares in the aggregate and (b) such Principal Shareholder ceases to beneficially owns at least 1% of the Outstanding Common Shares and (ii) with respect to MGU HoldCo, when MGU HoldCo Transfers all of its Common Shares.
- 15 -
9.04 Notices.
(a) All notices and other communications provided for hereunder shall be made in writing by hand-delivery, first-class mail, facsimile, e-mail, or air courier guaranteeing overnight delivery:
(i) if to the Company, as set forth below:
Fidelis Insurance Holdings Limited
Waterloo House
100 Pitts Bay Road
Pembroke, Bermuda HM 08
Attention: Dan Burrows and Janice Weidenborner
Email:dan.burrows@fidelisinsurance.com;
janice.weidenborner@fidelisinsurance.com
(ii) if to Crestview, as set forth below:
Crestview FIHL Holdings, L.P.
Crestview FIHL TE Holdings, Ltd
Crestview IV FIHL Holdings, L.P.
Crestview IV FIHL TE Holdings LLC
590 Madison Avenue, 42nd Floor
New York, NY 10022
Attention: Ross A. Oliver and Daniel Kilpatrick
Email: roliver@crestview.com; dkilpatrick@crestview.com
(iii) if to CVC, as set forth below:
CVC Falcon Holdings Limited
27 Esplanade
St. Helier Jersey
Channel Islands
JE1 1SG
Attention: SJ Secretaries Limited
Email: Structures@saltgate.com
Copy to:
Jean-Claude Bonfrer email to jbonfrer@cvc.com
Art Gorelov email to agorelov@cvc.com
(iv) if to Pine Brook, as set forth below:
Pine Brook Feal Intermediate L.P.
One Grand Central Place 60 East 42nd Sreet
New York, NY 10165
Attention: Elan Stukov
Email: estukov@pinebrookpartners.com
- 16 -
(v) if to MGU Holdco, as set forth below:
Shelf Holdco II Limited
Clarendon House
2 Church Street
Hamilton, HM 11 Bermuda
Attention: Group General Counsel; Group Chief Financial Officer
Email: michael.cottell@fidelismgu.com;
hinal.patel@fidelismgu.com
All such notices and communications shall be deemed to have been duly given when delivered by hand, if personally delivered; five (5) Business Days after being deposited in the United States mail, if being mailed by first class mail; two (2) Business Days after being delivered via a next-day air courier; when receipt is acknowledged by the recipients fax machine, if faxed; and on the date sent by e-mail (with confirmation of delivery) if sent during normal business hours of the recipient, and on the next Business Day if sent after normal business hours of the recipient.
(b) Notwithstanding Section 9.04(a)(i) or anything else in this Agreement to the contrary, each Shareholder authorizes the Company to send all reports (including tax reporting information), notices and other communications (including but not limited to all Company reports, capital account statements, financial statements, periodic investor letters, account balances and distributions), that the Company would otherwise provide to such Shareholder pursuant to this Agreement, the Bye-Laws or applicable law to any third party selected by the Company for further dissemination to such Shareholder.
9.05 Successors and Assigns; Assignment. This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors and permitted assigns. No Shareholder may assign either this Agreement or any of its rights, interests, or obligations hereunder without the prior written consent of the Company. The Company may not, other than by operation of law, assign any or all of its rights, interests or obligations hereunder without the written consent of Shareholders representing a majority of the Common Shares subject to this Agreement (in any or all of which cases the Company nonetheless will remain responsible for the performance of all of its obligations hereunder).
9.06 Specific Performance. Each party acknowledges and agrees that the other parties would be damaged irreparably if any provision of this Agreement is not performed in accordance with its specific terms or is otherwise breached. Accordingly, each party agrees that the other parties will be entitled to an injunction or injunctions to prevent breaches of the provisions of this Agreement and to enforce specifically this Agreement and its terms and provisions in any action instituted in any court of the United States or any state thereof having jurisdiction over the parties and the matter, in addition to any other remedy to which they may be entitled, at law or in equity.
9.07 Submission to Jurisdiction; No Jury Trial.
(a) Each party submits to the jurisdiction of any state or federal court sitting in New York, New York in any action arising out of or relating to this Agreement and agrees that all claims in respect of the action may be heard and determined in any such court. Each party agrees that a final judgment in any action so brought will be conclusive and may be enforced by action on the judgment or in any other manner provided at law or in equity. Each party waives any defense of inconvenient forum to the maintenance of any action so brought and waives any bond, surety, or other security that might be required of any other party with respect thereto.
- 17 -
(b) THE PARTIES EACH HEREBY AGREE TO WAIVE THEIR RESPECTIVE RIGHTS TO JURY TRIAL OF ANY DISPUTE BASED UPON OR ARISING OUT OF THIS AGREEMENT OR ANY OTHER AGREEMENTS RELATING HERETO OR ANY DEALINGS AMONG THEM RELATING TO THE TRANSACTIONS. The scope of this waiver is intended to be all encompassing of any and all action that may be filed in any court and that relate to the subject matter of the transactions contemplated hereby, including, contract claims, tort claims, breach of duty claims and all other common law and statutory claims. The parties each acknowledge that this waiver is a material inducement to enter into a business relationship and that they will continue to rely on the waiver in their related future dealings. Each party further represents and warrants that it has reviewed this waiver with its legal counsel, and that each knowingly and voluntarily waives its jury trial rights following consultation with legal counsel. NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED HEREIN, THIS WAIVER IS IRREVOCABLE, MEANING THAT IT MAY NOT BE MODIFIED ORALLY OR IN WRITING, AND THE WAIVER WILL APPLY TO ANY AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO THIS AGREEMENT OR TO ANY OTHER DOCUMENTS OR AGREEMENTS RELATING HERETO. In the event of an action, this Agreement may be filed as a written consent to trial by a court.
9.08 Counterparts. This Agreement may be executed in two or more counterparts (including by facsimile or PDF), each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
9.09 Governing Law. This Agreement shall be governed by the laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule that would cause the application of the law of any jurisdiction other than the State of New York.
9.10 Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.
9.11 Construction. The parties have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties and no presumption or burden of proof will arise favoring or disfavoring any party because of the authorship of any provision of this Agreement. Any reference to any federal, state, local, or foreign law will be deemed also to refer to law as amended and all rules and regulations promulgated thereunder, unless the context requires otherwise. The word including means including without limitation. Pronouns in masculine, feminine, and neuter genders will be construed to include any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise requires. The words this Agreement, herein, hereof, hereby, hereunder, and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The parties intend that each representation, warranty, and covenant contained herein will have independent significance. If any party has breached any representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which the party has not breached will not detract from or mitigate the fact that the party is in breach of the first representation, warranty, or covenant.
- 18 -
9.12 Severability. The remedies provided herein are cumulative and not exclusive of any remedies provided by law. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.
[remainder of page intentionally left blank]
- 19 -
IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.
THE COMPANY: |
FIDELIS INSURANCE HOLDINGS LIMITED |
/s/ Janice Weidenborner |
By: Janice Weidenborner |
Title: Group Chief Legal Officer |
[Project Buddy Signature Page to the Amended and Restated Common Shareholders Agreement]
THE SHAREHOLDERS: |
CRESTVIEW FIHL HOLDINGS, L.P. |
By: Crestview FIHL GP, Ltd., as its general partner |
/s/ Ross A. Oliver |
By: Ross A. Oliver |
Title: Senior Counsel & Secretary |
CRESTVIEW FIHL TE HOLDINGS, LTD. |
/s/ Ross A. Oliver |
By: Ross A. Oliver |
Title: Senior Counsel & Secretary |
CRESTVIEW IV FIHL HOLDINGS, L.P. |
By: Crestview IV FIHL Holdings GP, LLC, as its general partner |
/s/ Ross A. Oliver |
By: Ross A. Oliver |
Title: Senior Counsel & Secretary |
CRESTVIEW IV FIHL TE HOLDINGS LLC |
/s/ Ross A. Oliver |
By: Ross A. Oliver |
Title: Senior Counsel & Secretary |
[Project Buddy Signature Page to the Amended and Restated Common Shareholders Agreement]
CVC FALCON HOLDINGS LIMITED |
/s/ Daniel Brand |
By: Daniel Brand |
Title: Director |
[Project Buddy Signature Page to the Amended and Restated Common Shareholders Agreement]
PINE BROOK FEAL INTERMEDIATE, L.P. |
By: PBRA (Cayman) Company, as its general partner |
/s/ W. Dana LaForge |
By: Dana LaForge |
Title: Director |
[Project Buddy Signature Page to the Amended and Restated Common Shareholders Agreement]
SHELF HOLDCO II LIMITED |
/s/ Hinal Patel |
By: Hinal Patel |
Title: Group Chief Financial Officer |
[Project Buddy Signature Page to the Amended and Restated Common Shareholders Agreement]
Exhibit 10.11
EXECUTION VERSION
INDEMNIFICATION AGREEMENT
FIDELIS INSURANCE HOLDINGS LIMITED
This Indemnification Agreement (this Agreement), made and entered into as of ________________, 2023, by and between Fidelis Insurance Holdings Limited, a Bermuda exempted company with limited liability (the Company), and ___________________ (Indemnitee).
W I T N E S S E T H:
WHEREAS, highly competent persons who serve large, multinational corporations as directors or officers expect to be provided with adequate protection through insurance and/or adequate indemnification against risks of claims and actions against them arising out of their service to and activities on behalf of the corporation.
WHEREAS, the board of directors of the Company (the Board) has determined that, in order to attract and retain qualified individuals, as directors of the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries from certain liabilities.
WHEREAS, the Amended and Restated Bye-Laws of the Company (the Bye-Laws) provide that the Company shall indemnify directors and officers of the Company in the manner set forth therein and to the fullest extent permitted by applicable law. In addition, Indemnitee may be entitled to indemnification pursuant to the Bermuda Companies Act of 1981 (the Companies Act).
WHEREAS, this Agreement is a supplement to and in furtherance of the Bye-Laws, insurance and any resolutions adopted pursuant thereto and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder.
WHEREAS, the protection available under the Companys Bye-Laws and insurance may not be adequate in the present circumstances, and Indemnitee may not be willing to serve as an officer or director of the Company without adequate protection, and the Company desires Indemnitee to serve in such capacity. Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that he or she be so indemnified.
NOW, THEREFORE, in consideration of the premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:
ARTICLE 1
CERTAIN DEFINITIONS
Section 1.01. As used in this Agreement:
(a) Beneficial Owner has the meaning given to the term beneficial owner in Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act).
(b) Change of Control shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following events:
(i) Acquisition of Shares by Third Party. Any Person (as defined below), other than a trustee or other fiduciary holding securities under an employee benefit plan of the Company or a corporation owned directly or indirectly by the shareholders of the Company in substantially the same proportions as their ownership of stock of the Company, is or becomes the Beneficial Owner (as defined above), directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Companys then outstanding securities, unless the change in relative Beneficial Ownership of the Companys securities by any Person results solely from a reduction in the aggregate number of outstanding securities entitled to vote generally in the election of directors;
(ii) Change in Board of Directors. During any period of two (2) consecutive years (not including any period prior to the execution of this Agreement), individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a Person who has entered into an agreement with the Company to effect a transaction described in Section 1.01(b)(i), Section 1.01(b)(iii) or Section 1.01(b)(iv) whose election by the Board or nomination for election by the Companys shareholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the members of the Board;
(iii) Corporate Transactions. The effective date of a merger or consolidation of the Company with any other entity, other than a merger or consolidation that would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of the surviving entity outstanding immediately after such merger or consolidation and with the power to elect at least a majority of the board of directors or other governing body of such surviving entity; and
(iv) Liquidation. The approval by the shareholders of the Company of a complete liquidation of the Company or an agreement or series of agreements for the sale or disposition by the Company of all or substantially all of the Companys assets, or, if such approval is not required, the decision by the Board to proceed with such a liquidation, sale, or disposition in one transaction or a series of related transactions.
(c) Corporate Status means the status of a person who is or was a director, officer, trustee, general partner, managing member, fiduciary, board of directors committee member, employee or agent of the Company or any direct or indirect subsidiary of the Company, or of any other enterprise.
2
(d) Disinterested Director means a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee.
(e) Expenses means any and all direct and indirect costs (including attorneys fees, retainers, court costs, transcripts, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other disbursements or expenses) actually and reasonably incurred in connection with (i) prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, a Proceeding or (ii) establishing or enforcing a right to indemnification under this Agreement, the Bye-Laws, applicable law or otherwise. Expenses also shall include Expenses incurred in connection with any appeal resulting from any Proceeding and any federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement, including without limitation the premium, security for, and other costs relating to any cost bond, supersede as bond, or other appeal bond or its equivalent. For the avoidance of doubt, Expenses, however, shall not include any Liabilities.
(f) Independent Counsel means a law firm, or a member of a law firm, that is experienced in matters of corporate law and neither currently is, nor in the five (5) years previous to its selection or appointment has been, retained to represent (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning Indemnitee under this Agreement or of other indemnitees under similar indemnification agreements) or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term Independent Counsel shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitees rights under this Agreement. The Company agrees to pay the reasonable fees and disbursements of the Independent Counsel referred to above and to fully indemnify such counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto.
(g) Liabilities means any losses or liabilities, including any judgments, fines, penalties and amounts paid in settlement, arising out of or in connection with any Proceeding (including all interest, assessments and other charges paid or payable in connection with or in respect of any such judgments, fines, penalties or amounts paid in settlement).
(h) Person means any individual, corporation, firm, partnership, joint venture, limited liability company, estate, trust, business association, organization, governmental entity or other entity and includes the meaning set forth in Sections 13(d) and 14(d) of the Exchange Act
(i) Proceeding means any threatened, pending or completed action, derivative action, suit, claim, counterclaim, cross claim, arbitration, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether civil (including intentional and unintentional tort claims), criminal, administrative or investigative, including any appeal therefrom, whether instituted by or on behalf of the Company or any other party, and whether made pursuant to federal, state or other law, or any inquiry, hearing or investigation that Indemnitee in good faith believes might lead to the institution of any such action, suit or other proceeding hereinabove listed in which Indemnitee was, is or will be involved as a party, potential party, non-party witness or otherwise by reason of any Corporate Status of Indemnitee, or by reason of any action taken (or failure to act) by him or her or of any action (or failure to act) on his or her part while serving in any Corporate Status.
3
Section 1.02. For the purposes of this Agreement:
(a) References to Company shall include, in addition to the resulting or surviving company, any constituent company (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, employees or agents, so that if Indemnitee is or was a director, officer, employee, or agent of such constituent company or is or was serving at the request of such constituent company as a director, officer, employee, or agent of another company, partnership, joint venture, trust or other enterprise, then Indemnitee shall stand in the same position under the provisions of this Agreement with respect to the resulting or surviving company as Indemnitee would have with respect to such constituent company if its separate existence had continued.
(b) Reference to other enterprise shall include employee benefit plans; references to fines shall include any excise tax assessed with respect to any employee benefit plan; references to serving at the request of the Company shall include any service as a director, officer, employee or agent of the Company which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner he or she reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner not opposed to the best interests of the Company as referred to in this Agreement.
(c) Reference to including shall mean including, without limitation, regardless of whether the words without limitation actually appear, references to the words herein, hereof and hereunder and other words of similar import shall refer to this Agreement as a whole and not to any particular paragraph, subparagraph, section, subsection or other subdivision.
ARTICLE 2
SERVICES BY INDEMNITEE
Section 2.01. Services By Indemnitee. Indemnitee hereby agrees to serve or continue to serve, at the will of the Company, as a director of the Company, for so long as Indemnitee is duly elected or appointed or until Indemnitee tenders his or her resignation or is no longer serving in such capacity. This Agreement shall not be deemed an employment agreement between the Company (or any of its subsidiaries) and Indemnitee. Indemnitee specifically acknowledges that such service to the Company or any of its subsidiaries is at will and the Indemnitee may be discharged at any time for any reason, with or without cause, except as may be otherwise provided in any written employment agreement between Indemnitee and the Company (or any of its subsidiaries), other applicable formal severance policies duly adopted by the Board or, with respect to service as a director or officer of the Company, by the Companys Bye-Laws or the laws of Bermuda.
4
ARTICLE 3
INDEMNIFICATION
Section 3.01. General. Subject to Section 3.04, the Company hereby agrees to and shall indemnify Indemnitee and hold Indemnitee harmless from and against any and all Expenses and Liabilities to the fullest extent permitted by applicable law. The Companys indemnification obligations set forth in this Section 3.01 shall apply (i) in respect of Indemnitees past, present and future service in any Corporate Status and (ii) regardless of whether Indemnitee is serving in any Corporate Status at the time any such Expense or Liability is incurred.
For purposes of this Agreement, the meaning of the phrase to the fullest extent permitted by applicable law shall include, but not be limited to:
(i) to the fullest extent permitted by any provision of the Companies Act, or the corresponding provision of any successor statute, and
(ii) to the fullest extent authorized or permitted by any amendments to or replacements of the Companies Act adopted after the date of this Agreement that increase the extent to which a corporation may indemnify its officers and directors.
In furtherance of the foregoing indemnification, and without limiting the generality thereof:
(a) Proceedings other than Proceedings by or in the Right of the Company. Subject to Section 3.04, the Indemnitee shall be entitled to the rights of indemnification provided in this Section 3.01(a) if, by reason of Indemnitees Corporate Status, Indemnitee is, or is threatened to be made, a party to or participant in, or otherwise becomes involved in, any Proceeding (as hereinafter defined) other than a Proceeding by or in the right of the Company. Pursuant to this Section 3.01(a), Indemnitee shall be indemnified against all Expenses and Liabilities actually and reasonably incurred by Indemnitee, or on Indemnitees behalf, in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, and with respect to any criminal Proceeding, had no reasonable cause to believe Indemnitees conduct was unlawful.
(b) Proceedings by or in the Right of the Company. Subject to Section 3.04, the Indemnitee shall be entitled to the rights of indemnification provided in this Section 3.01(b) if, by reason of Indemnitees Corporate Status, Indemnitee is, or is threatened to be made, a party to or participant in any Proceeding brought by or in the right of the Company. Pursuant to this Section 3.01(b), Indemnitee shall be indemnified against all Expenses and Liabilities actually and reasonably incurred by Indemnitee, or on Indemnitees behalf, in connection with such Proceeding if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company; provided, however, if applicable law so provides, no indemnification against such Expenses shall be made in respect of any claim, issue or matter in such Proceeding as to which Indemnitee shall have been finally adjudged by a court to be liable to the Company unless and only to the extent that the court in which the Proceeding was brought shall determine that Indemnitee is fairly and reasonably entitled to indemnification.
5
(c) Witness Expenses. Subject to Section 3.04, to the extent that Indemnitee is, by reason of his or her Corporate Status, a witness in any Proceeding to which Indemnitee is not a party, he or she shall be indemnified against all Expenses actually and reasonably incurred by Indemnitee or on his or her behalf in connection therewith.
(d) Expenses as a Party Where Wholly or Partly Successful. Subject to Section 3.04, to the fullest extent permitted by applicable law, to the extent that Indemnitee is a party to (or a participant in) and is successful, on the merits or otherwise, in any Proceeding or in defense of any claim, issue or matter therein, including dismissal without prejudice, in whole or in part, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by him or her in connection therewith. If Indemnitee is not wholly successful in such Proceeding, but is successful, on the merits or otherwise, as to one (1) or more but less than all claims, issues or matters in such Proceeding, the Company shall, to the fullest extent permitted by applicable law, indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on his or her behalf in connection with each successfully resolved claim, issue or matter. For purposes of this Section and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.
(e) Indemnification of Principal Shareholder. If (i) Indemnitee is or was affiliated with one or more Principal Shareholders (as such term is defined in the Companys Amended and Restated Common Shareholders Agreement dated _______________, 2023) (a Principal Shareholder), (ii) the Principal Shareholder is, or is threatened to be made, a party to or a participant in any Proceeding, and (iii) the Principal Shareholders involvement in the Proceeding results from any claim based on the Indemnitees service to the Company as a director or other fiduciary of the Company, the Principal Shareholder will be entitled to indemnification hereunder for Expenses to the same extent as Indemnitee and advancement of Expenses shall apply to any such indemnification of Principal Shareholder. The Company and Indemnitee agree that each Principal Shareholder is an express third party beneficiary of the terms of this Section 3.01(e).
Section 3.02. Additional Indemnity. In addition to, and without regard to any limitations on, the indemnification provided for in Section 3.01 of this Agreement, subject to Section 3.04, the Company shall and hereby does, to the fullest extent permitted by applicable law (including but not limited to, the Companies Act and any amendments to or replacements of the Companies Act adopted after the date of this Agreement that expand the Companys ability to indemnify its officers and directors), indemnify and hold harmless Indemnitee against all Expenses, judgments, penalties, fines and amounts paid in settlement actually and reasonably incurred by Indemnitee or on Indemnitees behalf if, by reason of Indemnitees Corporate Status, Indemnitee is, or is threatened to be made, a party to or participant in any Proceeding (including a Proceeding by or in the right of the Company). The only limitation that shall exist upon the Companys obligations pursuant to this Agreement, other than those set forth in Section 3.03 hereof, shall be that the Company shall not be obligated to make any payment to Indemnitee that is finally determined (under the procedures, and subject to the presumptions, set forth in Articles 5 and 6 hereof) to be unlawful.
6
Section 3.03. Exclusions. Notwithstanding any provision of this Agreement and unless Indemnitee ultimately is successful on the merits with respect to any such claim, the Company shall not be obligated under this Agreement to: (i) make any indemnity in connection with any Proceeding (or any part of any Proceeding), except as otherwise provided in Section 6.01(e), prior to a Change of Control, initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (A) the Company has joined in or the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation, (B) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law, or (C) the Proceeding is one to enforce Indemnitees rights under this Agreement, (ii) indemnify Indemnitee if a final decision by a court of competent jurisdiction determines that such indemnification is prohibited by applicable law, (iii) indemnify or advance funds to Indemnitee for Indemnitees reimbursement to the Company of any bonus or other incentive-based or equity- based compensation previously received by Indemnitee or payment of any profits realized by Indemnitee from the sale of securities of the Company, as required in each case under the Exchange Act (including any such reimbursements under Section 304 of the Sarbanes-Oxley Act of 2002 in connection with an accounting restatement of the Company or the payment to the Company of profits arising from the purchase or sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act of 2002), (iv) make any indemnity or advancement of expenses for which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision, except with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision (provided, that the foregoing Section 3.03(iv) shall not affect the rights of Indemnitee or the Principal Shareholder Indemnitor, as applicable (as defined below) set forth in Section 8.02(e)) or (vi) make any indemnity or advancement of expenses in connection with any reimbursement of the Company by Indemnitee of any compensation pursuant to any compensation recoupment or clawback policy adopted by the Board or the compensation committee of the Board.
Section 3.04. Limitation on Indemnification. Notwithstanding any other terms of this Agreement, nothing herein shall indemnify the Indemnitee against, or exempt the Indemnitee from, any liability in respect of such Indemnitees fraud or dishonesty.
ARTICLE 4
ADVANCEMENT OF EXPENSES; DEFENSE OF CLAIMS
Section 4.01. Advances. Subject to Section 3.04, the Company shall (i) pay any Expenses actually and reasonably incurred, or advance to Indemnitee funds in an amount sufficient to pay such Expenses by Indemnitee, in connection with any Proceeding (or part of any Proceeding) not initiated by Indemnitee or any Proceeding initiated by Indemnitee with the prior approval of the Board (as provided in Section 3.03(i)) or (ii) reimburse Indemnitee for such Expenses, in each case, within twenty (20) days after the receipt by the Company of each statement requesting such advance from time to time, whether prior to or after final disposition of any Proceeding. Such statement or statements shall reasonably evidence the Expenses incurred by Indemnitee. Advances shall be unsecured and interest free; provided, Indemnitee shall not be required to provide any documentation or information to the extent that the provision thereof would undermine or otherwise jeopardize attorney-client privilege. Advances shall be made without regard to Indemnitees ability to repay such amounts and without regard to Indemnitees ultimate entitlement to indemnification under the other provisions of this Agreement. Advances shall include any and all reasonable Expenses incurred pursuing an action to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances claimed.
7
Section 4.02. Repayment of Advances or Other Expenses. Indemnitee agrees that Indemnitee shall reimburse the Company for all Expenses advanced by the Company pursuant to Section 4.01 in the event and only to the extent that it shall be determined by final judgment or other final adjudication under the provisions of any applicable law (as to which all rights of appeal therefrom have been exhausted or lapsed) that Indemnitee is not entitled to be indemnified by the Company for such Expenses.
Section 4.03. Defense of Claims. With respect to any Proceeding as to which Indemnitee notifies the Company of the commencement thereof, the Company will be entitled to participate in the Proceeding at its own expense and except as otherwise provided below, to the extent the Company so wishes, it may assume the defense thereof. After notice from the Company to Indemnitee of its election to assume the defense of any Proceeding, approval by Indemnitee (which approval shall not be unreasonably withheld, conditioned or delayed) of counsel designated by the Company and the retention of such counsel by the Company, the Company shall not be liable to Indemnitee under this Agreement or otherwise for any Expenses subsequently incurred by Indemnitee in connection with the defense of such Proceeding. Indemnitee shall have the right to employ legal counsel in such Proceeding, but any Expenses subsequently incurred by Indemnitee in connection with the defense of such Proceeding shall be at Indemnitees expense unless: (i) the employment of legal counsel by Indemnitee has been authorized by the Company, (ii) Indemnitee has reasonably determined that there may be a conflict of interest between Indemnitee and the Company in the defense of the Proceeding, (iii) after a Change in Control, Indemnitees employment of its own counsel has been approved by the Independent Counsel or (iv) the Company shall not within sixty (60) days in fact have employed counsel to assume the defense of such Proceeding, in each of which cases all Expenses related to such separate counsel in connection with the Proceeding shall be borne by the Company. In the event separate counsel is retained by an Indemnitee pursuant to this Section 4.03, the Company shall cooperate with Indemnitee with respect to the defense of the Proceeding, including making documents, witnesses and other reasonable information related to the defense available to Indemnitee and such separate counsel pursuant to joint-defense agreements or confidentiality agreements, as appropriate. The Company shall not be entitled to assume the defense of any Proceeding brought by or on behalf of the Company or as to which Indemnitee shall have made the determination provided for in (ii), (iii) or (iv) above.
ARTICLE 5
PROCEDURES FOR NOTIFICATION OF AND DETERMINATION OF ENTITLEMENT TO
INDEMNIFICATION
Section 5.01. Notification; Request For Indemnification.
(a) As soon as reasonably practicable after receipt by Indemnitee of written notice that he or she is a party to or a participant (as a witness or otherwise) in any Proceeding or of any other matter in respect of which Indemnitee may seek indemnification or advancement of Expenses hereunder, Indemnitee shall provide to the Company written notice thereof, including the nature of and the facts underlying the Proceeding. The omission by Indemnitee to so notify the Company will not relieve the Company from any liability which it may have to Indemnitee hereunder or otherwise unless, and to the extent that, such failure actually and materially prejudices the interests of the Company.
8
(b) To obtain indemnification under this Agreement, Indemnitee shall deliver to the Company a written request for indemnification, including therewith such information as is reasonably available to Indemnitee and reasonably necessary to determine Indemnitees entitlement to indemnification hereunder. An officer of the Company shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification. Notwithstanding the foregoing, any failure of Indemnitee to provide such a request to the Company, or to provide such a request in a timely fashion, shall not relieve the Company of any liability that it may have to Indemnitee unless, and to the extent that, such failure actually and materially prejudices the interests of the Company. Indemnitees entitlement to indemnification shall be determined according to Section 5.02 of this Agreement and applicable law.
Section 5.02. Determination of Entitlement.
(a) Where there has been a written request by Indemnitee for indemnification pursuant to Section 5.01(b), then as soon as is reasonably practicable (but in any event not later than the period referred to in Section 5.03(b)) after final disposition of the relevant Proceeding, a determination, if required by applicable law, with respect to Indemnitees entitlement thereto shall be made in the specific case: (i) at the election of the Board, if a Change of Control shall not have occurred, (A) by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (B) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (C) if there are no such Disinterested Directors or, if such Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee or (D) if so directed by the Board, by the shareholders of the Company; or (ii) if a Change of Control shall have occurred, (A) if the Indemnitee so requests in writing, by a majority vote of the Disinterested Directors, even if less than a quorum of the Board or (B) by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee. If it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10) days after such determination. Indemnitee shall reasonably cooperate with the person, persons or entity making such determination with respect to Indemnitees entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination. Any costs or expenses (including attorneys fees and disbursements) actually and reasonably incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitees entitlement to indemnification).
(b) If entitlement to indemnification is to be determined by Independent Counsel pursuant to Section 5.02(a)(ii), such Independent Counsel shall be selected by Indemnitee (unless the Indemnitee shall request that such selection be made by the Board), and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected.
9
If entitlement to indemnification is to be determined by Independent Counsel pursuant to Section 5.02(a)(i)(C) (or if Indemnitee requests that such selection be made by the Board), such Independent Counsel shall be selected by the Board in which case the Company shall give written notice to Indemnitee advising him or her of the identity of the Independent Counsel so selected. In either event, Indemnitee or the Company, as the case may be, may, within ten (10) days after such written notice of selection shall have been received, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of Independent Counsel as defined in Article 1 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court of competent jurisdiction has determined that such objection is without merit. If, within twenty (20) days after the later of submission by Indemnitee of a written request for indemnification pursuant to Section 5.01(b) hereof and the final disposition of the Proceeding, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition a court of competent jurisdiction for resolution of any objection which shall have been made by the Company or Indemnitee to the others selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the court or by such other person as the court shall designate, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section 5.02(a) hereof. Upon the due commencement of any judicial proceeding or arbitration pursuant to Section 6.01(a) of this Agreement, the Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).
(c) The Company agrees to pay the reasonable fees and expenses of any Independent Counsel incurred by such Independent Counsel in connection with acting pursuant to Section 5.02 hereof, and the Company shall pay all reasonable fees and expenses incident to the procedures of this Section 5.02, regardless of the manner in which such Independent Counsel was selected or appointed.
10
Section 5.03. Presumptions and Burdens of Proof; Effect of Certain Proceedings.
(a) In making any determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination shall, to the fullest extent not prohibited by law, presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section 5.01(b) of this Agreement, and the Company shall, to the fullest extent not prohibited by law, have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity of any determination contrary to that presumption. Neither the failure of any person, persons or entity to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by any person, persons or entity that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.
(b) If the person, persons or entity empowered or selected under Section 5.02 of this Agreement to determine whether Indemnitee is entitled to indemnification shall not have made a determination within the thirty (30) days after receipt by the Company of the request therefor, the requisite determination of entitlement to indemnification shall, to the fullest extent not prohibited by law, be deemed to have been made and Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitees statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law; provided, however, that such 30-day period may be extended for a reasonable time, not to exceed an additional fifteen (15) days, if the person, persons or entity making such determination with respect to entitlement to indemnification in good faith requires such additional time to obtain or evaluate documentation and/or information relating thereto; and provided, further, that the foregoing provisions of this 5.03(b) shall not apply if the determination of entitlement to indemnification is to be made by the stockholders pursuant to Section 5.02(a)(i)(D) of this Agreement and if (A) within fifteen (15) days after receipt by the Company of the request for such determination, the Board or the Disinterested Directors, if appropriate, resolve to submit such determination to the stockholders for their consideration at an annual meeting thereof to be held within seventy-five (75) days after such receipt and such determination is made thereat, or (B) a special meeting of shareholders is called within fifteen (15) days after such receipt for the purpose of making such determination, such meeting is held for such purpose within sixty (60) days after having been so called and such determination is made thereat.
(c) The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his or her conduct was unlawful.
11
(d) For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith and in a manner reasonably believed to be in or not opposed to the best interests of the Company if Indemnitees action is in good faith reliance on the records or books of account of the Company (or any of its subsidiaries), including financial statements, or on information supplied to Indemnitee by the officers of the Company (or any of its subsidiaries) in the course of their duties, or on the advice of legal counsel for the Company (or any of its subsidiaries) or on information or records given or reports made to the Company (or any of its subsidiaries) by an independent certified public accountant or by an appraiser or other expert selected by the Company (or any of its subsidiaries). Whether or not the foregoing provisions of this 5.03(d) are satisfied, it shall in any event be presumed that Indemnitee has at all times acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company. Anyone seeking to overcome this presumption shall have the burden of proof and the burden of persuasion by clear and convincing evidence. The provisions of this Section 5.03(d) shall not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may be deemed or found to have met the applicable standard of conduct set forth in this Agreement.
(e) The knowledge and/or actions, or failure to act, of any other director, trustee, partner, managing member, fiduciary, officer, agent or employee of the Company (or any of its subsidiaries) shall not be imputed to Indemnitee for purposes of determining any right to indemnification under this Agreement.
ARTICLE 6
REMEDIES OF INDEMNITEE
Section 6.01. Adjudication or Arbitration.
(a) In the event of any dispute between Indemnitee and the Company hereunder as to entitlement to indemnification or advancement of Expenses (including where (i) a determination is made pursuant to Section 5.02 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 4.01 of this Agreement, (iii) payment of indemnification pursuant to Section 3.01 of this Agreement is not made within ten (10) days after a determination has been made that Indemnitee is entitled to indemnification, (iv) no determination as to entitlement to indemnification is timely made pursuant to Section 5.02 of this Agreement and no payment of indemnification is made within ten (10) days after entitlement is deemed to have been determined pursuant to Section 5.03(b)) or (v) a contribution payment is not made in a timely manner pursuant to Section 8.03 of this Agreement, then Indemnitee shall be entitled to an adjudication by a court of his or her entitlement to such indemnification, contribution or advancement. Alternatively, in such case, Indemnitee, at his or her option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association. The Company shall not oppose Indemnitees right to seek any such adjudication or award in arbitration.
12
(b) In the event that a determination shall have been made pursuant to Section 5.02(a) of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section 6.01 shall be conducted in all respects as a de nova trial, or arbitration, on the merits, and Indemnitee shall not be prejudiced by reason of that adverse determination. In any judicial proceeding or arbitration commenced pursuant to this Section 6.01 the Company shall have the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be, and the Company may not refer to or introduce into evidence any determination pursuant to Section 5.02(a) of this Agreement adverse to Indemnitee for any purpose. If Indemnitee commences a judicial proceeding or arbitration pursuant to this Section 6.01, Indemnitee shall not be required to reimburse the Company for any advances pursuant to Section 4.02 until a final determination is made with respect to Indemnitees entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed).
(c) If a determination shall have been made pursuant to Section 5.02(a) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 6.01, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitees statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law.
(d) The Company shall be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 6.01 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement.
(e) The Company shall indemnify Indemnitee to the fullest extent permitted by law against all Expenses and, if requested by Indemnitee, shall (within ten (10) days after the Companys receipt of such written request) advance such Expenses to Indemnitee, which are reasonably incurred by Indemnitee in connection with any judicial proceeding or arbitration brought by Indemnitee for (i) indemnification or advances of Expenses by the Company (or otherwise for the enforcement, interpretation or defense of his or her rights) under this Agreement or any other agreement, including any other indemnification, contribution or advancement agreement, or any provision of the Bye-Laws now or hereafter in effect or (ii) recovery or advances under any directors and officers liability insurance policy maintained by the Company, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, contribution, advancement or insurance recovery, as the case may be.
ARTICLE 7
DIRECTORS AND OFFICERS LIABILITY INSURANCE
Section 7.01. D&O Liability Insurance. The Company shall, if commercially reasonable, obtain and maintain in effect during the entire period for which the Company is obligated to indemnify Indemnitee under this Agreement, one or more policies of insurance with reputable insurance companies to provide the directors and officers of the Company with coverage for losses from wrongful acts and omissions and to ensure the Companys performance of its indemnification obligations under this Agreement. Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such officer or director under such policy or policies. At the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company shall give prompt notice of the commencement of such proceeding to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such proceeding in accordance with the terms of such policies.
13
Section 7.02. Evidence of Coverage. Upon request by Indemnitee, the Company shall provide copies of all policies of D&O Liability Insurance obtained and maintained in accordance with Section 7.01 of this Agreement. The Company shall provide Indemnitee no less than annually with notice of any material changes in such insurance coverage.
ARTICLE 8
MISCELLANEOUS
Section 8.01. Nonexclusivity of Rights. The rights of indemnification, contribution and advancement of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled to under applicable law, the Bye-Laws, any agreement, a vote of stockholders or a resolution of directors, or otherwise. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.
Section 8.02. Insurance and Subrogation. (a) Indemnitee shall be covered by the Companys D&O Liability Insurance in accordance with its or their terms to the maximum extent of the coverage available for any director or officer under such policy or policies. If, at the time the Company receives notice of a claim hereunder, the Company has D&O Liability Insurance in effect, the Company shall give prompt notice of such Proceeding to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies. The failure or refusal of any such insurer to pay any such amount shall not affect or impair the obligations of the Company under this Agreement.
(b) Except as provided in Section 8.02(e), in the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee (other than against any Principal Shareholder Indemnitors), who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.
(c) Except as provided in Section 8.02(e), the Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable (or for which advancement is provided) hereunder if and to the extent that Indemnitee has actually received such payment under any insurance policy or other indemnity provision.
14
(d) Except as provided in Section 8.02(e), the Companys obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director, officer, trustee, partner, managing member, fiduciary, board of directors committee member, employee or agent of any subsidiary of the Company shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of Expenses from such subsidiary.
Section 8.03. Contribution.
(a) Whether or not the indemnification provided in Sections 3.01 and 3.02 hereof is available, in respect of any threatened, pending or completed action, suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), to the fullest extent permitted by applicable law, the Company shall pay, in the first instance, the entire amount of any judgment or settlement of such action, suit or proceeding without requiring Indemnitee to contribute to such payment and the Company hereby waives and relinquishes any right of contribution it may have against Indemnitee. The Company shall not, without the Indemnitees prior written consent, enter into any such settlement of any action, suit or proceeding (in whole or in part) unless such settlement (i) provides for a full and final release of all claims asserted against Indemnitee and (ii) does not impose any Expense, judgment, fine, penalty or limitation on Indemnitee.
(b) Without diminishing or impairing the obligations of the Company set forth in the preceding subparagraph, if, for any reason, Indemnitee shall elect or be required to pay all or any portion of any judgment or settlement in any threatened, pending or completed action, suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), to the fullest extent permitted by applicable law, the Company shall contribute to the amount of Expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred and paid or payable by Indemnitee in proportion to the relative benefits received by the Company and all officers, directors or employees of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), on the one hand, and Indemnitee, on the other hand, from the transaction or events from which such action, suit or proceeding arose; provided, however, that the proportion determined on the basis of relative benefit may, to the extent necessary to conform to law, be further adjusted by reference to the relative fault of the Company and all officers, directors or employees of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), on the one hand, and Indemnitee, on the other hand, in connection with the transaction or events that resulted in such expenses, judgments, fines or settlement amounts, as well as any other equitable considerations which the law may require to be considered. The relative fault of the Company and all officers, directors or employees of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), on the one hand, and Indemnitee, on the other hand, shall be determined by reference to, among other things, the degree to which their actions were motivated by intent to gain personal profit or advantage, the degree to which their liability is primary or secondary and the degree to which their conduct is active or passive.
(c) To the fullest extent permitted by applicable law, the Company hereby agrees to fully indemnify and hold Indemnitee harmless from any claims of contribution which may be brought by officers, directors or employees of the Company, other than Indemnitee, who may be jointly liable with Indemnitee.
15
(d) To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Proceeding, and/or (ii) the relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee in connection with such event(s) and/or transaction(s).
Section 8.04. Amendment. This Agreement may not be modified or amended except by a written instrument executed by or on behalf of each of the parties hereto. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit, restrict or reduce any right of Indemnitee under this Agreement in respect of any act or omission, or any event occurring, prior to such amendment, alteration or repeal. To the extent that a change in applicable law, whether by statute or judicial decision, (i) permits greater indemnification, contribution or advancement of Expenses than would be afforded currently under the Bye-Laws and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change, or (ii) limits rights with respect to indemnification, contribution or advancement of Expenses, it is the intent of the parties hereto that the rights with respect to indemnification, contribution or advancement of Expenses in effect prior to such change shall remain in full force and effect to the extent permitted by applicable law.
Section 8.05. Waivers. The observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) by the party entitled to enforce such term only by a writing signed by the party against which such waiver is to be asserted. Unless otherwise expressly provided herein, no delay on the part of any party hereto in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any waiver on the part of any party hereto of any right, power or privilege hereunder operate as a waiver of any other right, power or privilege hereunder nor shall any single or partial exercise of any right, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, power or privilege hereunder.
Section 8.06. Entire Agreement. This Agreement and the documents referred to herein constitute the entire agreement between the parties hereto with respect to the matters covered hereby, and any other prior or contemporaneous oral or written understandings or agreements with respect to the matters covered hereby are superseded by this Agreement, provided that this Agreement is a supplement to and in furtherance of the Bye-Laws and applicable law, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder.
Section 8.07. Severability. If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality and enforceability of the remaining provisions of this Agreement (including each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected
16
or impaired thereby and shall remain enforceable to the fullest extent permitted by law; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement (including each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby. Without limiting the generality of the foregoing, this Agreement is intended to confer upon Indemnitee and Principal Shareholder indemnification rights to the fullest extent permitted by applicable laws.
Section 8.08. Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given: (i) upon personal delivery to the party to be notified, (ii) when sent by confirmed electronic mail or facsimile if sent during normal business hours of the recipient, and if not so confirmed, then on the next business day, (iii) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent:
(a) To Indemnitee at the address set forth below Indemnitees signature hereto.
(b) To the Company at:
Fidelis Insurance Holdings Limited
Waterloo House
100 Pitts Bay Road
Pembroke
Bermuda HM08
Attention: Chief Legal Officer
E-mail: Janice.Weidenborner@fidelisinsurance.com
Section 8.09. Binding Effect.
(a) The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve as a director or officer of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director or officer of the Company.
(b) This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors, assigns, including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the Company, spouses, heirs, and executors, administrators, personal and legal representatives. The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all or substantially all, or a substantial part of the business or assets of the Company, by written agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the manner and to the same extent that the Company would be required to perform if no such succession had taken place.
17
(c) The indemnification, contribution and advancement of Expenses provided by, or granted pursuant to this Agreement shall continue as to a person who has ceased to be a director or officer and shall inure to the benefit of the heirs, executors, administrators, legatees and assigns of such a person.
(d) The Company and Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable and difficult of proof, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto agree that Indemnitee may enforce this Agreement by seeking injunctive relief and/or specific performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance, Indemnitee shall not be precluded from seeking or obtaining any other relief to which Indemnitee may be entitled. The Company and Indemnitee further agree that Indemnitee shall be entitled to such specific performance and injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions, without the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that in the absence of a waiver, a bond or undertaking may be required of Indemnitee by the court, and the Company hereby waives any such requirement of such a bond or undertaking.
Section 8.10. Governing Law. This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of New York, without regard to its conflict of laws rules.
Section 8.11. Consent To Jurisdiction. Except with respect to any arbitration commenced by Indemnitee pursuant to Section 6.01(a) of this Agreement, the Company and Indemnitee hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the courts of the State of New York (the New York Courts), and not in any other state or federal court in the United States of America or any court in any other country, (ii) consent to submit to the exclusive jurisdiction of the New York Courts for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii) waive any objection to the laying of venue of any such action or proceeding in the New York Courts, and (iv) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in any New York Court has been brought in an improper or inconvenient forum.
Section 8.12. Headings. The Article and Section headings in this Agreement are for convenience of reference only and shall not be deemed to alter or affect the meaning or interpretation of any provisions hereof.
Section 8.13. Counterparts. This Agreement may be executed in one (1) or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one (1) and the same Agreement. Only one (1) such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.
18
Section 8.14. Use of Certain Terms. As used in this Agreement, the words herein, hereof, and hereunder and other words of similar import refer to this Agreement as a whole and not to any particular paragraph, subparagraph, section, subsection, or other subdivision. Whenever the context may require, any pronoun used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa.
Section 8.15. Non-Disclosure of Payments. Except as expressly required by the securities laws of the United States of America or other applicable law, neither party shall disclose any payments under this Agreement unless prior approval of the other party is obtained. If any payment information must be disclosed, the Company shall afford the Indemnitee an opportunity to review all such disclosures and, if requested, to explain in such statement any mitigating circumstances regarding the events to be reported.
Section 8.16. Duration of Agreement. All agreements and obligations of the Company contained herein shall continue until and terminate upon the later of (i) ten (10) years after the date that Indemnitee shall have ceased to serve as a director or officer of the Company or a director, officer, trustee, partner, managing member, fiduciary, employee or agent of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise which Indemnitee served at the request of the Company, and (ii) one (1) year after the final termination of any Proceeding (including any rights of appeal thereto) in respect of which Indemnitee is granted rights of indemnification or advancement of Expenses hereunder and of any Proceeding commenced by Indemnitee pursuant to Article 6 of this Agreement relating thereto (including any rights of appeal of any Proceeding commenced pursuant to Article 6 of this Agreement). Termination of this Agreement shall not adversely affect any right or protection hereunder of any Indemnitee in respect of any Proceeding (regardless of when such Proceeding is first threatened, commenced or completed) arising out of, or related to, any act or omission occurring prior to the time of such termination. This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business or assets of the Company), assigns, spouses, heirs, executors and personal and legal representatives.
19
IN WITNESS WHEREOF, this Agreement has been duly executed and delivered to be effective as of the date first noted above.
FIDELIS INSURANCE HOLDINGS LIMITED |
Name: Janice Weidenborner |
Title: Group Chief Legal Officer |
Address: |
Waterloo House 100 Pitts Bay Road |
Pembroke |
Bermuda HM08 |
INDEMNITEE |
Name: |
Address: |
[Project Buddy Signature Page to Indemnification Agreement]
Contents
1. |
Definitions and interpretation | 5 | ||||
2. |
Pre-Completion Undertakings | 19 | ||||
3. |
Warranties | 28 | ||||
4. |
Conditions to Completion | 30 | ||||
5. |
Termination | 37 | ||||
6. |
Costs | 37 | ||||
7. |
Completion | 38 | ||||
8. |
Limitation of liability | 39 | ||||
9. |
Marketing Materials disclaimer | 40 | ||||
10. |
Announcements and confidentiality | 41 | ||||
11. |
Notices | 42 | ||||
12. |
Management Seller Representative | 46 | ||||
13. |
Investors Representative | 46 | ||||
14. |
General | 47 | ||||
Schedule 1 The Investors |
87 | |||||
Schedule 2 Regulatory Conditions to Completion |
89 | |||||
Schedule 3 Conduct of business before Completion |
91 | |||||
Schedule 4 Equity Documents |
94 | |||||
Schedule 5 Binder Agreements |
95 | |||||
Schedule 6 Structure Steps Plan |
96 | |||||
Schedule 7 FIHL Shareholders Agreement Term Sheet |
97 | |||||
Schedule 8 Completion Calculations |
99 |
THIS AGREEMENT is made on 23 July 2022
PARTIES
(1) | FIDELIS INSURANCE HOLDINGS LIMITED, a Bermuda exempted company with limited liability, whose registered address is Waterloo House, 100 Pitts Bay Road, Pembroke, Bermuda HM 08 (FIHL); |
(2) | THE ENTITIES SET OUT IN SCHEDULE (the Investors); |
(3) | SHELF HOLDCO LTD., a Bermuda exempted company with registration number 202200924, whose registered address is at Clarendon House, 2 Church Street, Hamilton, HM 11, Bermuda (Topco); |
(4) | SHELF MIDCO LTD., a Bermuda exempted company with registration number 202201310, whose registered address is at Clarendon House, 2 Church Street, Hamilton, HM 11, Bermuda (Midco); |
(5) | SHELF BIDCO LTD., a Bermuda exempted company with registration number 202201311, whose registered address is at Clarendon House, 2 Church Street, Hamilton, HM 11, Bermuda (Bidco); |
(6) | SHELF BIDCO II LTD., a Bermuda exempted company with registration number 202201312, whose registered address is at Clarendon House, 2 Church Street, Hamilton, HM 11, Bermuda (Merger Sub); |
(7) | SHELF HOLDCO II LTD., a Bermuda exempted company with registration number 202201143, whose registered address is at Clarendon House, 2 Church Street, Hamilton, HM 11, Bermuda (MGA Holdco); and |
(8) | Richard Brindle, whose address is 22 Bishopsgate, 42nd Floor, London, United Kingdom, EC2N 4BQ (the Management Seller Representative). |
INTRODUCTION
(A) | The board of directors of FIHL has determined that it is in the best interests of FIHLs members as a whole to effect a reorganisation of FIHLs business pursuant to which its business will be reorganised into: (i) a balance sheet business, which will comprise FIHLs regulated (re)insurance carriers (the Balance Sheet Business); and (ii) a managing general agent business, which will comprise the MGA Group Companies, in each case in accordance with Steps 1 to 20 of the Structure Steps Plan (the Pre-Completion Reorganisation). |
(B) | Following the Pre-Completion Reorganisation, it is intended that, among other things, at or immediately prior to Completion: |
(i) | the Warrantholders will exercise their In the Money Warrants and forfeit their Out of the Money Warrants for nil consideration; |
(ii) | the Investors will subscribe for shares in Topco in accordance with the terms of the Subscription Agreements (the Topco Subscription); |
- 3 -
(iii) | Bidco will draw down under the Facilities; |
(iv) | Topco will acquire the FIHL Sale Shares from the Sellers on the terms of the SPAs (the Share Purchase); |
(v) | Topco will contribute the FIHL Sale Shares to Midco; |
(vi) | Midco will contribute the FIHL Sale Shares to Bidco; |
(vii) | FIHL will re-designate its FIHL Shares into A Shares and MGA Distribution Shares; |
(viii) | subject to the completion of the prior Structure Steps 1 to 30 (inclusive), FIHL will make, pursuant to and in accordance with Structure Step 31, a distribution in specie of MGA Holdco to holders of MGA Distribution Shares; |
(ix) | MGA Holdco will be merged with and into Merger Sub with MGA Holdco being the surviving entity, following which Bidco will be the sole shareholder of MGA Holdco (the Merger); |
(x) | FIHL intends to effect an initial public offering on behalf of its shareholders agreeing to sell a portion of their FIHL Shares pursuant to a registration statement and/or a prospectus pursuant to which there will be established a listing of the FIHL Shares on either the New York Stock Exchange or the Nasdaq Global Select Market (the IPO), subject to the board of FIHL determining to proceed with such IPO given prevailing market conditions; |
(xi) | MGA Holdco will purchase FIHL Shares comprising 9.9% of FIHLs common share capital from certain of FIHLs shareholders for $[******] conducted by way of a private placement conducted at the same time as Completion (the FIHL Purchase); and |
(xii) | MGA Holdco and its subsidiaries will commence performing services for FIHL and its subsidiaries pursuant to the terms of the Binder Agreements, |
(the Pre-Completion Reorganisation and (i) through to (xii), being Project Cooper).
(C) | Project Cooper is subject to the approval of applicable Regulatory Authorities as set forth in this Agreement. |
(D) | On the date of this Agreement, the applicable parties thereto have entered into the Subscription Agreements, the SPAs and the Merger Agreement. |
(E) | This Agreement sets out the terms and conditions of an agreement between the Parties in connection with the conduct and implementation of Project Cooper. |
NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:
- 4 -
AGREEMENT
1. | Definitions and interpretation |
Definitions
1.1 | In this Agreement, unless the context requires otherwise, the capitalised terms set out below have the following meanings: |
$10 Warrants means those certain warrants issued by FIHL to certain members of its management over FIHL Shares with an initial exercise price of $10 and a current exercise price between $[******] and $[******];
$16 Warrants means those certain warrants issued by FIHL to certain members of its management over FIHL Shares with an initial exercise price of $16 and a current exercise price of $[******];
$20 Warrants means those certain warrants issued by FIHL to certain members of its management over FIHL Shares with an initial exercise price of $20 and a current exercise price of $[******];
A Shares means the FIHL Shares which will be re-designated as such at Structure Steps 26 and 28;
Adverse Change has the meaning given in Clause 2.5;
Agreement means this cooperation agreement, including the Introduction and the Schedules, as amended or restated from time to time;
Announcement means any announcement relating to the signing of this Agreement or the consummation of the Transactions as agreed in accordance with Clause 10.1;
Balance Sheet Business has the meaning set out in the Introduction;
Balance Sheet Conditions has the meaning given in Clause 4.1.1(c);
Balance Sheet Regulatory Conditions has the meaning given in Clause 4.1.1(b);
Bermuda MGA means Shelf Opco Bermuda Limited;
Binder Agreements means (i) that certain framework agreement to be entered into between FIHL and Topco prior to or at Completion on the terms and conditions set out in Schedule 5-I with such changes as may be required by Regulatory Authorities (other than any Burdensome Condition), (ii) those certain delegated underwriting authority agreements, to be entered into pursuant to such framework agreement among certain subsidiaries of FIHL and certain subsidiaries of Topco at Completion, pursuant to which such subsidiaries of FIHL will delegate underwriting authority to such subsidiaries of Topco, in each case on the terms and conditions set out in Schedule 5-II, with such changes as may be required by Regulatory Authorities (other than any Burdensome Condition), (iii) those certain outsourcing services agreement(s) to be entered into pursuant to such framework agreement among FIHL and certain subsidiaries of FIHL and Topco and certain subsidiaries of Topco at Completion,
- 5 -
pursuant to which FIHL and such subsidiaries of FIHL will outsource certain non-underwriting services to Topco and such subsidiaries of Topco, subject to the prior written consent of the Investors Representative (such consent not to be unreasonably withheld, conditioned or delayed), with such changes as may be required by Regulatory Authorities (other than any Burdensome Condition) and (iv) each resolution, shareholder consent, board minute, waiver and any other document ancillary to, and necessary for, the implementation of the documents referred to in (i) to (iii) of this definition;
Binder Agreements Condition has the meaning given in Clause 4.1.1(c);
Blackstone means each of [******]
Blackstone Credit has the meaning given in Clause 2.25;
BMA means the Bermuda Monetary Authority;
Burdensome Condition has the meaning given in Clause 4.1.1(g);
Business Day means any day that is not a Saturday or Sunday or a public holiday in England, New York or Bermuda;
BXC DCL has the meaning given in Clause 3.3.1(a)(ii);
Bye-laws means the bye-laws of FIHL;
CBI means the Central Bank of Ireland;
CCS means Conyers Corporate Services (Bermuda) Limited;
CCS Indemnity means the indemnity agreement dated 7 February 2022 and entered into between Richard Brindle and CCS pursuant to which, among other things, Richard Brindle agreed to indemnify CCS for the Services (as defined therein) provided to Topco by CCS under the Services Agreement (as defined therein);
CMA has the meaning given in Clause 4.1.1(j);
CMA Condition has the meaning given in Clause 4.1.1(j);
Commitment Parties has the meaning given in Clause 2.25;
Completion means completion of the Transactions in accordance with Clause 7;
Completion Calculations means the calculations referred to in Clause 2.32;
Completion Date means the date on or by which each of Subscription Completion, SPA Completion and Merger Completion has occurred;
Conditions has the meaning given in Clause 4.1;
- 6 -
Confidential Review Process has the meaning given in Clause 2.25;
Debt Commitment Letter has the meaning given in Clause 3.3.1(a)(ii);
Debt Financing Sources shall mean the collective reference to each lender and each other person (including, without limitation, each agent and each arranger) that have committed to provide Bidco or its affiliates the Facilities (as defined below) or other third party debt financings provided for the purposes of the Transaction, including, without limitation, under any commitment letters, engagement letters, credit agreements, loan agreements or indentures relating thereto (and any joinders or amendments thereof), together with each former, current and future affiliate thereof and each former, current and future officer, director, employee, member, manager, partner, controlling person, advisor, attorney, agent and representative of each such lender, other person or affiliate, and together with the heirs, executors, successors and assigns of any of the foregoing;
Defaulting Investor has the meaning given in Clause 7.3;
Disclosure Letter means the letter dated as of the date hereof written by the Warrantors to Topco in connection with the Warranty Deed and delivered to Topco at execution of this Agreement;
Dispute Notice has the meaning given in paragraph 1.2 of Schedule 8;
Effective Time has the meaning given in the Merger Agreement;
Employment Tax Liability means any liability to Tax in any jurisdiction in respect of or in connection with the exercise of the FIHL Share Plan Securities and for which the relevant employing company is required to account to any Taxation Authority.
Equity Commitment Letters means the equity commitment letters from each relevant member of the Investors Group (excluding the Strategic Investor) to Topco, Bidco, the relevant Investor and FIHL dated on the date of this Agreement;
Equity Documents means (i) the shareholders agreement in respect of Topco to be entered into between Topco and its shareholders at Completion on the terms and conditions set out in Schedule 4-I, (ii) the amended and restated bye-laws of Topco to be adopted at Completion on the terms and conditions set out in Schedule 4-II, and (iii) each resolution, shareholder consent, board minute, waiver and any other document ancillary to, and necessary, desirable or appropriate for, the implementation of the documents referred to in (i) and (ii) of this definition;
EV Change has the meaning given in Clause 4.1.1(g)(i);
EV Test Date has the meaning given in Clause 4.1.1(g)(i)(A);
Existing Pine Walk Capital Group means Pine Walk Capital Limited and its subsidiaries, excluding, for the avoidance of doubt, any business written by such entities pursuant to the applicable Binder Agreements;
Expert has the meaning given in paragraph 1.5(b) of Schedule 8;
- 7 -
Facilities has the meaning given in Clause 3.3.1(a)(ii);
FCA means the UK Financial Conduct Authority;
FCA Regulated Entities means Fidelis Marketing Limited (company number: 09522701) with its registered office at 22 Bishopsgate, 42nd Floor, London, United Kingdom, EC2N 4BQ, Pine Walk Capital Limited (company number: 10846939) with its registered office at 37-39 Lime Street, London, United Kingdom, EC3M 7AY and Pine Walk Europe S.R.L. with its UK establishment office address at 37-39 Lime Street, London, EC3M 7AY;
FIHL Performance Unit has the meaning given in Clause 2.17.1;
FIHL Purchase has the meaning set out in the Introduction;
FIHL Purchase Agreement means the purchase agreement to be dated on or around the date of Completion relating to the FIHL Purchase, entered into by and between MGA Holdco and FIHL;
FIHL Sale Shares means, in respect of a Seller, the relevant number of FIHL Shares that are to be sold to Topco by that Seller pursuant to the terms and conditions of the relevant SPA at Structure Step 23;
FIHL Share Plan Securities means the Warrants, the FIHL Time-based Units and the FIHL Performance Units;
FIHL Share Plans means the Amended and Restated Fidelis Insurance Holdings Limited 2018 non-qualified share option plan, as amended and restated on February 19, 2019, as the same may be amended from time to time, and FIHLs 2015 Non-Qualified Share Option Plan;
FIHL Shareholders Agreement means the shareholders agreement in respect of FIHL to be entered into between FIHL and MGA Holdco at Completion on the terms and conditions set out in Schedule 7.
FIHL Shares means the common shares of FIHL, par value $0.01, as the same may be reorganised in accordance with the Structure Steps Plan;
FIHL Time-based Unit has the meaning given in Clause 2.17.2;
Final Structure Step Documents means each Structure Step Document in such form as determined in accordance with Clause 2.5;
Founder Warrants means those certain warrants issued by FIHL to Crestview FIHL Holdings, L.P., Crestview FIHL TE Holdings, Ltd., Pine Brook Feal Intermediate, L.P. and CVC Falcon Holdings Limited over FIHL Shares;
FSMA means the UK Financial Services and Markets Act 2000;
GAAP means United States generally accepted accounting principles;
Group means FIHL and all of the Group Companies, taken as a whole;
- 8 -
Group Companies means FIHL and each of its subsidiary undertakings, each being a Group Company;
In the Money Warrants means the Founder Warrants, the Leaver Warrants, the $10 Warrants and the $16 Warrants;
Institutional Sellers means each of (i) SPFM Holdings, LLC, a Delaware limited liability company whose principal executive offices are at 485 Lexington Avenue, New York, NY 10017, (ii) Alfa Life Insurance Corporation, (iii) Alfa Mutual Insurance Company, (iv) Alfa Mutual Fire Insurance Company, (v) Alfa Mutual General Insurance Company, (vi) Alfa General Insurance Corporation, (vii) Trexis Insurance Corporation, and (viii) Trexis One Insurance Corporation;
Institutional Seller SPAs means the share purchase agreements, dated as of the date hereof, between Topco and each of the Institutional Seller relating to the Share Purchase;
Investors Group means the Investors and their respective Related Persons;
Investors Representative means Capital Z Partners (MGA), LP and the Strategic Investor, acting jointly;
IPO has the meaning set out in the Introduction;
IPO Launch Decision has the meaning given in Clause 2.25;
Leaver Warrants means those certain warrants issued by FIHL to certain of its former employees over FIHL Shares;
Long Stop Date means the date falling 12 months from the date of this Agreement, or such other date as agreed in writing by the Parties;
Management POAs has the meaning given in Clause 2.29;
Management Seller SPA means the share purchase agreement, to be dated prior to Completion, among Topco and the Management Sellers relating to the Share Purchase;
Management Sellers means those Management Shareholders that will sell their FIHL Shares pursuant to the Management Seller SPA;
Management Shareholders has the meaning given in Clause 2.29;
Marketing Materials means the Confidential Information Memorandum prepared by FIHL in relation to the MGA Group and shared with potential investors by Evercore International Partners LLP on email on 18 March 2022 and the financial models prepared by FIHL in relation to the MGA Group, dated 6 May 2022, and shared with potential investors in folder 3.4 of the Data Room (as defined in the Warranty Deed);
Material Adverse Effect means any effect, change, event, circumstance, state of facts, development, or occurrence that, individually or in the aggregate, has had, or would reasonably be expected to have, a material adverse effect on the business, results of operations, condition (financial or otherwise) or assets or liabilities of the MGA Group;
- 9 -
provided, however, that in no event shall any of the following, alone or in combination, be deemed to constitute, nor be taken into account in determining whether there has been or would reasonably be expected to be, a Material Adverse Effect: (a) changes, events, or conditions generally affecting the insurance or reinsurance industries in the geographic regions or product markets in which the MGA Group or the Group operate or underwrite or will operate or underwrite insurance or reinsurance or act as a managing general agent; (b) general economic or regulatory, legislative, or political conditions or generally affecting securities, credit, financial, interest rate or other capital markets conditions in the United Kingdom, Bermuda, the U.S. or the European Economic Area; (c) any failure, in and of itself, by the MGA Group or the Group to meet any internal or published projections, forecasts, estimates, or predictions in respect of revenues, earnings, or other financial or operating metrics for any period; (d) geopolitical conditions, the outbreak or escalation of hostilities, any acts of war (whether or not declared), sabotage, terrorism (including cyber-terrorism), or man-made disaster, or any escalation or worsening of any such hostilities, acts of war (whether or not declared), sabotage, terrorism, or man-made disaster; (e) the occurrence, continuation or worsening of any volcanic eruption, tsunami, pandemic, hurricane, tornado, windstorm, flood, earthquake, wildfire, or other natural disaster or any conditions resulting from such natural disasters (including increases in liabilities under or in connection with insurance or reinsurance contracts underwritten pursuant to any delegated underwriting authority agreements); (f) the negotiation, execution, and delivery of this Agreement or the Binder Agreement or the public announcement or performance of the Transactions or the Reorganisation, including the impact thereof on the relationships of any MGA Group Company with employees, customers, insureds, cedants, policyholders, brokers, agents, financing sources, business partners, service providers, Regulatory Authorities, or reinsurance providers, and including any legal or administrative proceeding, suit, investigation or action arising out of any of the foregoing; (g) other than as contemplated by this Agreement, any change or announcement of a potential change, in and of itself, in any MGA Group Companys or FIHLs credit ratings or the ratings of any MGA Group Companys business or the Balance Sheet Business; (h) any change, in and of itself, in the market price, ratings, or trading volume of the securities of FIHL; (i) any change in applicable law, or GAAP (or authoritative interpretation or enforcement thereof); (j) any action required to be taken by any MGA Group Company or any Group Company pursuant to and in accordance with the terms of this Agreement or the Structure Steps Plan; (k) the effects of any material breach or violation of any provision of this Agreement by the Investors Group (it being understood that (A) the exceptions in clauses (c), (g) and (h) of this definition shall not prevent or otherwise affect a determination that the underlying cause of any such failure or change referred to therein (if not otherwise falling within any of the other exceptions provided by clauses (a) through (k) of this definition) constitutes, or contributed to, a Material Adverse Effect and (B) the exceptions in clause (i) shall not prevent or otherwise affect a determination that the actual consequences of an action taken or an omission by any MGA Group Company or Group Company that resulted in a failure by such MGA Group Company or Group Company to comply with applicable law constitutes, or contributed to, a Material Adverse Effect); provided, however, that any effect, change, event, circumstance, state of facts, development, or occurrence referred to in clauses (a), (b), (d), (e), or (i) of this definition may be taken into account in determining whether or not there has been a Material Adverse Effect, to the extent such effect, change, event, circumstance, state of facts, development, or occurrence has a disproportionate adverse effect on the MGA Group or the Group,
- 10 -
relative to other managing general agents in the geographic regions or product markets in which the MGA Group or the Group operate or underwrite or will operate or underwrite insurance or reinsurance or act as a managing general agent (in which case only the disproportionate adverse effect or effects may be taken into account in determining whether or not a Material Adverse Effect has occurred);
Material Contract means all written contracts to which any MGA Group Company is a party or by which any MGA Group Company, or any of their respective properties or assets is bound (other than insurance, reinsurance or retrocession policies, treaties or agreements, slips, binders or other delegated underwriting authority agreements, cover notes, or other similar arrangements or the Equity Documents, the Binder Agreements, any other Transaction Document, the Debt Commitment Letter (and any definitive agreements entered into in relation to the Facilities) or the Final Structure Step Documents) that:
(a) | relate to the formation or management of any joint venture, partnership, or other similar agreement that is material to the business of the MGA Group, taken as a whole; |
(b) | provide for indebtedness of any MGA Group Company having an outstanding or committed amount equal to or in excess of $[******], other than any indebtedness between or among any MGA Group Companies; |
(c) | are any keepwell or similar agreement under which any MGA Group Company has directly guaranteed any liabilities or obligations of another person, in each case involving liabilities or obligations in excess of $[******] (other than any contracts under which an MGA Group Company has guaranteed the liabilities or obligations of another MGA Group Company); |
(d) | have been entered into since January 1, 2021, and involve the acquisition from another person or disposition to another person of capital stock or other equity interests of another person or of a business, in each case, for aggregate consideration under such written contract in excess of $[******] (excluding acquisitions or dispositions of supplies, products, properties, or other assets in the ordinary course of business and in a manner consistent with the running of the MGA Groups business in the prior twelve (12) months (to the extent that parts of the MGA Groups business existed during such period, acknowledging that the MGA Group is to be established pursuant to the implementation of the Structure Steps Plan) or of supplies, products, properties, or other assets that are obsolete, worn out, surplus, or no longer used or useful in the conduct of business of the MGA Group); |
(e) | prohibit the payment of dividends or distributions in respect of the shares or capital stock of any MGA Group Company, prohibit the pledging of the shares or capital stock of any MGA Group Company or prohibit the issuance of any guarantee by any MGA Group Company; |
(f) | involve or could reasonably be expected to involve aggregate payments by any MGA Group Company in excess of $[******] in any twelve month period, other (i) than those terminable on less than one hundred and eighty (180) days notice without payment by any MGA Group Company of any material penalty, (ii) any MGA Group Company lease or (iii) any written contract with financial advisors, investment bankers, attorneys, accountants, consultants, or other advisors in connection with the Transactions; |
- 11 -
(g) | would reasonably be expected to, individually or in the aggregate, prevent, materially delay, or materially impede any MGA Group Companys ability to consummate the Transactions; or |
(h) | provide for the outsourcing of any material function or part of the business of any MGA Group Company in a manner that is consistent with the running of the MGA Groups business in the prior twelve (12) months (to the extent that parts of the MGA Groups business existed during such period, acknowledging that the MGA Group is to be established pursuant to the implementation of the Structure Steps Plan) and that is reasonably necessary for the conduct of the business of the MGA Group as managing agents or managing general agents; |
Merger has the meaning given in the Introduction;
Merger Agreement means the merger agreement, dated as of the date hereof, among Bidco, MGA Holdco and Merger Sub, pursuant to which MGA Holdco will merge with and into Merger Sub with MGA Holdco being the surviving entity;
Merger Completion means completion of the Merger in accordance with the terms of this Agreement and the Merger Agreement;
MGA Distribution Shares means FIHL Shares that are entitled to a distribution of the shares held in MGA Holdco by FIHL, which have been re-designated as such in accordance with Structure Steps 27 and 28 and which, following the Effective Time, are cancelled at Structure Step 34;
MGA Group means MGA Holdco and all of the MGA Group Companies, taken as a whole;
MGA Group Companies means MGA Holdco and each of its subsidiary undertakings, each being an MGA Group Company, it being understood that an MGA Group Company includes all those persons shown as subsidiary undertakings of MGA Holdco at Structure Step 11;
MGA Holdco Constitutional Documents means MGA Holdcos Bye-laws and Memorandum of Association;
MGA Holdco Merger Approval means the affirmative vote in favour of the approval of the Merger Agreement by FIHL;
MGA Holdco Shareholder Meeting has the meaning given in Clause 2.20;
MGA Holdco Shares means common shares of MGA Holdco, par value $0.01, as the same will be distributed in accordance with the Structure Steps Plan;
MGA Regulatory Conditions has the meaning given in Clause 4.1.1(a);
- 12 -
Net Working Capital Position means sufficient cash and cash equivalents to meet the Net Working Capital Requirement;
Net Working Capital Requirement means, in respect of the Existing Pine Walk Capital Group, cash resources to cover the three month period following Completion based on the Existing Pine Walk Capital Groups net cash flows, calculated using the methodology set out in the current Existing Pine Walk Capital Groups board reports prior to the date of this Agreement;
Non-Defaulting Investors has the meaning given to it in Clause 7.4;
Normal Business Hours has the meaning given in Clause 11.3;
Out of the Money Warrants means the Ratchet Warrants and the $20 Warrants;
PRA means the UK Prudential Regulation Authority;
Pre-Completion Reorganisation has the meaning set out in the Introduction;
Pre-Contractual Statement has the meaning given in Clause 14.16.2;
Proceedings means any proceeding, suit or action arising out of or in connection with this Agreement;
Project Cooper has the meaning set out in the Introduction;
PWC VDD Report means the PWC Vendor Due Diligence Report dated 22 April 2022 (including Volume 1, Commercial, and Volume 2, Financial and tax) and the PwC Vendor Due Diligence Addendum Report (Financial) dated 31 May 2022;
Ratchet Warrants means those certain ratchet warrants issued by FIHL to certain of its founding management members;
Registration Rights Agreement the registration rights agreement to be dated on or around the date of Completion relating to an initial public offering of Topcos shares, entered into by and between Topco and the Investors;
Registration Statement has the meaning given in Clause 2.25;
Regulatory Authorisation means any consent, authorisation, licence, permit, approval or waiver from any Regulatory Authority that is necessary for the carrying on of the business of each MGA Group Company in the manner that it is contemplated by the Binder Agreements;
Regulatory Authorities means the PRA, the FCA, the BMA, the CBI, the Belgian Financial Services and Markets Authority (Autoriteit voor Financiële Diensten en Markten/ Autorité des Services et Marchés Financiers) and such other governmental or regulatory authorities that have responsibility for regulating the Group;
Regulatory Binder Change has the meaning given in Clause 4.1.1(g)(i);
- 13 -
Regulatory Capital Position means the capital resources available to meet the minimum regulatory capital requirement as set out in MIPRU 4.2 and calculated using the methodology set out in the current Existing Pine Walk Capital Groups board reports prior to the date of this Agreement;
Regulatory Capital Requirement means, in respect of the Existing Pine Walk Capital Group, the minimum net regulatory capital requirement, defined as 2.5% of Pine Walk Capital Limiteds regulated income as set out in MIPRU 4.2, calculated as of the date of the latest Pine Walk Capital Limited board report prior to Completion;
Related Fund means, in in relation to a fund and/or managed account (or any direct or indirect wholly-owned subsidiary of such fund or managed account) (the first fund), means a fund and/or managed account (or any direct or indirect wholly-owned subsidiary of such fund or managed account) (the second fund) which satisfies one or more of the conditions in paragraphs (a) to (d) below and is not excluded on account of paragraph (i) or (ii) below:
(a) | the second fund is managed or advised by the same investment manager or investment adviser as the first fund; or |
(b) | the board of directors of the second fund is the same as the board of directors of the first fund; or |
(c) | a majority of the board of directors of the second fund are employees of the investment manager or investment adviser (or an affiliate thereof) of the first fund; or |
(d) | the second fund is managed by a different investment manager or investment adviser than the first fund, but has an investment manager or investment adviser which is an affiliate of the investment manager or investment adviser of the first fund, |
but excluding, in each case:
(i) | any fund or managed account that engages principally in distressed credit situations; and |
(ii) | any fund or managed account that principally engages in a loan to own investment strategy; |
Related Person means:
(e) | in the case of a body corporate, any parent undertaking or subsidiary undertaking of that body corporate and any subsidiary undertaking of any such parent undertaking, in each case from time to time; |
(f) | in the case of an individual, any spouse and/or lineal descendant by blood or adoption of that individual or any person(s) acting in the capacity of trustee(s) of a trust of which that individual is the settlor; and |
(g) | in the case of a limited partnership, any nominee or trustee of the limited partnership, the partners in that limited partnership or their nominees, any investment manager or investment adviser to the limited partnership, any parent undertaking or subsidiary undertaking of that investment manager or investment adviser and any other investment fund managed or advised by any such person and/or any investor in any fund that directly or indirectly holds interests in the limited partnership; |
- 14 -
Reorganisation has the meaning given in Clause 2.4;
Reorganisation Conditions has the meaning given in Clause 4.1.5(b);
Resolution Period has the meaning given in paragraph 1.4 of Schedule 8;
Review Period means the period of thirty (30) days commencing on the first Business Day after the day on which the Investors Representative receives the Completion Calculations from FIHL in accordance with Schedule 8;
SEC has the meaning given in Clause 2.25;
Sellers means the Institutional Sellers and the Management Sellers, each a Seller;
Senior Employees means Richard Brindle, Hinal Patel, Charles Mathias, Richard Coulson, Richard Holden, Philip Vandoninck, Jonny Creagh-Coen and Robert Kelly, each a Senior Employee;
Service Document means any document relating to or issued in connection with any Proceedings;
Share Purchase has the meaning set out in the Introduction;
SPA Completion means completion of the Share Purchase in accordance with the terms of this Agreement and the relevant SPA;
SPAs means: (i) the Management Seller SPA; and/or (ii) the Institutional Seller SPAs (as the context may require);
Strategic Investor means SPFM Holdings, LLC, a Delaware limited liability company whose principal executive offices are at 485 Lexington Avenue, New York, NY 10017 or The Travelers Companies, Inc. (or any of their respective subsidiaries);
Structure Steps means each of the steps set out in the Structure Steps Plan;
Structure Steps Document means each agreement, contract, deed, letter, resolution, set of bye-laws, shareholder consent, board minutes, waiver and any other document ancillary to, and necessary, desirable or appropriate for, the implementation of the Structure Steps, including any such document referenced in the Structure Steps;
Structure Steps Plan means the Project Cooper Structure Steps Plan produced by PwC, dated 16 July 2022, and which is set out in Schedule 6;
Subscription Agreement Breach has the meaning given to it in Clause 7.4;
Subscription Agreement Damages has the meaning given to it in Clause 7.4;
- 15 -
Subscription Agreements means the subscription agreements in connection with the Topco Subscription, dated as of the date hereof, and entered into between Topco and each Investor;
Subscription Completion means the date of Completion in accordance with the terms of this Agreement and the Subscription Agreements;
Surviving Provisions means Clauses 1, 6, 8, 10.3 to 10.5, 11 and 14;
Tax or Taxation means any form of tax, levy, import, duty, charge, employer and employee social security contribution or other governmental charge (national or local) of whatever nature, whenever and wherever imposed, which is collected or assessed by, or payable to, a Taxation Authority or any other person as a result of any enactment relating to tax, together with all related fines, penalties, interest, costs, charges and surcharges, and in each case, whether payable directly or imposed by way of a withholding or deduction and in respect of any person whether their liability for the same is a primary or secondary liability;
Taxation Authority means any taxing or other authority competent to impose any liability in respect of Taxation or responsible for the administration and/or collection of Taxation or enforcement of any law in relation to Taxation;
Third Party Right means any interest or equity of any person (including any right to acquire, option or right of pre-emption or conversion) or any mortgage, charge, pledge, lien, assignment, hypothecation, encumbrance, security interest, title retention or any other security agreement or arrangement, or any agreement to create any of the foregoing;
Topco Subscription has the meaning set out in the Introduction;
Transaction Documents means this Agreement, the SPAs, the Merger Agreement, the Subscription Agreements, the FIHL Purchase Agreement, the FIHL Shareholders Agreement, the Binder Agreements, the Equity Documents, the Registration Rights Agreement, the Equity Commitment Letters, the Warranty Deed and the Disclosure Letter;
Transactions means the transactions contemplated by the Transaction Documents;
Transfer Tax has the meaning given in Clause 6.1;
Underwriters has the meaning given in Clause 2.25;
W&I Insurance Policy has the meaning given to it in the Warranty Deed;
Warrantholders means the holders of Warrants;
Warrantors means the Warrantors under the Warranty Deed;
Warrants means the In the Money Warrants and the Out of the Money Warrants; and
Warranty Deed means the warranty deed in respect of the Transactions, dated on or around the date of this Agreement.
- 16 -
1.2 | References to the Parties are to the parties to this Agreement, and each is a Party. |
1.3 | References to Clauses are to the clauses of this Agreement. |
1.4 | References to the Introduction and the Schedules are to the introduction and schedules to this Agreement, which form part of this Agreement and have the same force and effect as if set out in the body of this Agreement. |
1.5 | Where any capitalised term is defined within a particular Clause in the body of this Agreement, that term shall bear the meaning ascribed to it in that Clause wherever it is used in this Agreement. |
Interpretation
1.6 | The table of contents and headings to Clauses and Schedules are included for ease of reference only, and are not to affect the interpretation of this Agreement. |
1.7 | In this Agreement, unless expressly stated otherwise: |
1.7.1 | the words include or including (or any similar term) are not to be construed as implying any limitation; |
1.7.2 | general words shall not be given a restrictive meaning by reason of the fact that they are preceded or followed by words indicating a particular class of acts, matters or things; |
1.7.3 | words indicating gender shall be treated as referring to the masculine, feminine or neuter as appropriate; |
1.7.4 | a reference to a statute, statutory provision or subordinate legislation (legislation) refers to such legislation as amended and in force from time to time and to any legislation that (either with or without modification) re-enacts, consolidates or enacts in rewritten form any such legislation; |
1.7.5 | any reference to any document other than this Agreement is a reference to that other document as amended, varied, supplemented, or novated (in each case, other than in breach of the provisions of this Agreement) at any time; |
1.7.6 | a reference to a document in the agreed form means a form of document agreed by each of the Parties and initialled by or on behalf of each Party for the purposes of identification only; |
1.7.7 | references to the time of day are to London time; |
1.7.8 | a reference to something being in writing or written includes any mode of representing or reproducing words in visible form that is capable of reproduction in hard copy form, including words transmitted by email but excluding any other form of electronic or digital communication; |
- 17 -
1.7.9 | any reference to a person includes any individual, body corporate, trust, partnership, joint venture, unincorporated association or governmental, quasi-governmental, judicial or regulatory entity (or any department, agency or political sub-division of any such entity), in each case whether or not having a separate legal personality, and any reference to a company includes any company, corporation or other body corporate, and any limited partnership or limited liability partnership wherever and however incorporated or established; |
1.7.10 | references to sterling or pounds sterling or £ are references to the lawful currency of England from time to time; |
1.7.11 | references to $ or USD means US dollars, the lawful currency of the United States of America from time to time; |
1.7.12 | references to or need not be disjunctive; |
1.7.13 | any reference to a holding company or a subsidiary means a holding company or subsidiary as defined in section 1159 of the Companies Act 2006, save that a company shall be treated for the purposes of the membership requirement contained in sections 1159(1)(b) and (c) as a member of another company even if its shares in that other company are registered in the name of (i) its nominee or (ii) another person (or its nominee) by way of security or in connection with the taking of security. Any reference to an undertaking shall be construed in accordance with section 1161 of the Companies Act 2006 and any reference to a parent undertaking or a subsidiary undertaking means respectively a parent undertaking or subsidiary undertaking as defined in sections 1162 and 1173(1) of the Companies Act 2006, save that an undertaking shall be treated for the purposes of the membership requirement in sections 1162(2)(b) and (d) and section 1162(3)(a) as a member of another undertaking even if its shares in that other undertaking are registered in the name of (i) its nominee or (ii) another person (or its nominee) by way of security or in connection with the taking of security. Such references to an undertaking, a subsidiary undertaking or a parent undertaking shall be amended, where appropriate, by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008; |
1.7.14 | in relation to a limited liability partnership, references to directors or employees shall be taken as a reference to the members and (where applicable) employees of that limited liability partnership; |
1.7.15 | any reference to to the extent that shall mean to the extent that and not solely if, and similar expressions shall be construed in the same way; |
1.7.16 | any obligation to procure a certain outcome when used in relation to any party shall mean an obligation for that party to exercise, lawfully and in a manner that does not otherwise put such party in breach of any fiduciary duty, any voting rights and use any and all powers vested in it from time to time as a holder of securities, shareholder, director, officer and/or employee and attorney, or through any contractual arrangements, to ensure compliance with that obligation so far as it is reasonably able to do so, whether acting alone or (to the extent that he or it is lawfully able to contribute to ensuring such compliance collectively) acting with others; and |
- 18 -
1.7.17 | any reference to any English legal term for any action, remedy, method of judicial proceeding, legal document, legal status, court, official or any legal concept or thing shall, in respect of any jurisdiction other than England, be deemed to include what most nearly approximates in that jurisdiction to the English legal term. |
1.8 | The obligations of each the Parties under this Agreement are several, and not joint or joint and several. No claim may be made against any Party in respect of any breach of this Agreement by any other Party. |
2. | Pre-Completion Undertakings |
Conduct of business before Completion
2.1 | Subject to Clause 2.2, FIHL shall use its reasonable best efforts to procure, to the extent such matter is within its power and control (whether by exercising its right as a holder of shares in any MGA Group Company or pursuant to any agreement, arrangement or understanding to which it is a party) that, between the date of this Agreement and Completion, no MGA Group Company will without the prior written approval of the Investors Representative (such approval not to be unreasonably withheld, conditioned or delayed) undertake any of the acts or matters listed in Schedule 3. |
2.2 | Clause 2.1 shall not operate so as to restrict or prevent: |
2.2.1 | entering into the Binder Agreements, including any matter permitted under the terms of the Binder Agreements; |
2.2.2 | subject always to Clause 2.5, the implementation of any transaction or the taking of any action permitted or provided for or contemplated by the Structure Steps Plan or any Final Structure Steps Document, including any negotiation of the purchase of the non-controlling interests in Pine Walk Capital Limited as contemplated at Structure Steps 4 and 20; |
2.2.3 | any matters that do not involve the negotiation, entering into, termination and/or other material variation or amendment of a Material Contract and that are in the ordinary course of business for Pine Walk Capital Limited and its cells and/or its subsidiaries and are conducted in a manner consistent with the running of the business of such entities in the prior twelve (12) months (to the extent that parts of the MGA Groups business existed during such period, acknowledging that the MGA Group is to be established pursuant to the implementation of the Structure Steps Plan), including: |
(a) | the acquisition of shares or any other interest in any person by Pine Walk Capital Limited where the business of such person is underwriting (re)insurance as a managing general agent on behalf of the Balance Sheet Business, pursuant to delegated authority granted by one or more FIHL subsidiaries; |
- 19 -
(b) | the creation, allotment, issue or transfer by any shareholder (other than an MGA Group Company) to another shareholder of, or the grant of any option over or other right to subscribe for or purchase, or redeem, buy back, sub-divide, consolidate, re-denominate, convert, reduce, cancel, restrict or alter the rights attaching to, any share or loan capital or securities or securities convertible into any of the foregoing of Pine Walk Capital Limited, or its cells or subsidiaries pursuant to any employee share scheme in place in connection therewith or otherwise; |
(c) | the declaration, authorisation, making or the paying of any dividends (in cash or in specie) or other distribution of a similar nature or taxed in the same way as a dividend by Pine Walk Capital Limited or any of the cells and/or the subsidiaries of Pine Walk Capital Limited; and |
(d) | the commencement of any litigation or arbitration proceedings or the compromise, cessation or settlement of any litigation or arbitration proceedings or any action, demand or dispute or waiver of a right in relation to any litigation or arbitration proceedings in connection with the handling of (re)insurance claims by Pine Walk Capital Limited or the cells and/or the subsidiaries of Pine Walk Capital Limited; |
2.2.4 | Pine Walk Europe establishing a permanent UK branch and acquiring a permanent Regulatory Authorisation; |
2.2.5 | the implementation of any transaction or the taking of any action required, contemplated, permitted or provided for by any Transaction Document; |
2.2.6 | any matter required in order to comply with any law, court order or regulation (including: (i) the requirements of any Regulatory Authority or Regulatory Authorisation; and (ii) any action of any director of an MGA Group Company that such director believes is reasonably required in order to comply with his statutory or fiduciary directors duties) or published policy of the MGA Group being undertaken by any MGA Group Company; |
2.2.7 | any matter reasonably undertaken by any MGA Group Company immediately following an emergency or disaster or other serious incident or circumstance with the intention of minimising any adverse effect on the MGA Group (and of which the Investors Representative will be promptly notified); |
2.2.8 | the completion or performance of any obligation undertaken pursuant to any contract or arrangement entered into by any MGA Group Company prior to the date of this Agreement; |
2.2.9 | any increase in emoluments of any category of employees of any MGA Group Company where such increase is made in accordance with the normal practice of the relevant employing MGA Group Company; |
2.2.10 | any payment being made by any MGA Group Company for or in respect of any Tax in the ordinary and usual course of business in a manner consistent with past practice; |
2.2.11 | any matter being undertaken by any MGA Group Company at the written request, or with the prior written consent, of the Investors Representative (such consent not to be unduly withheld, conditioned or delayed); |
- 20 -
2.2.12 | any investment in A Ordinary Shares of Topco on substantially the same terms as the Subscription Agreements up to an aggregate subscription amount of $[******] by any person reasonably satisfactory to the Investors Representative and the Management Seller Representative; and |
2.2.13 | any incurrence of any liability by an MGA Group Company in connection with the facilities referred to in the Debt Commitment Letter (including any liability to FIHL if FIHL makes any payments on behalf of any MGA Group Company in connection with such facilities). |
2.3 | If FIHL requests the approval of the Investors Representative pursuant to Clause 2.1 or otherwise under this Agreement, the Investors Representative shall respond to such request as soon as reasonably practicable and in any event within five Business Days after such request is made. Failure of the Investors Representative to respond within that period shall be deemed to be an approval to proceed with the relevant act, matter or course of conduct which is the subject of the request. In no circumstances is this Clause 2 intended to allow any Investor the ability to control the Group or the MGA Group. |
Development and Implementation of Structure Steps
2.4 | At or prior to Completion, each of the Parties shall implement, or procure the implementation of, in each case to the extent within their power, each of the Structure Steps in accordance with the terms and conditions of the Final Structure Steps Documents and each such Structure Step shall be implemented in the order set out in the Structure Steps Plan (the Reorganisation). |
2.5 | FIHL shall use its reasonable best efforts to procure that the Final Structure Step Documents are drafted (including, without limitation, by proposing such customary provisions that are consistent with generally accepted market practice) by no later than Completion, provided that no Final Structure Step Document may be entered into if it would or would reasonably be expected to, in comparison to the position agreed in the Structure Steps Plan, negatively impact in any material way, directly or indirectly, any Investor or the MGA Group (an Adverse Change), without the prior written consent of the Investors Representative (such consent not to be unreasonably withheld, conditioned or delayed); provided that, (i) if no reply is given within two Business Days of the relevant Final Structure Step Document being provided to each Investor (or each Investors counsel), the Investors Representative shall be deemed to have approved such Final Structure Step Document; (ii) if a reply is given by the Investors Representative (or the Investors counsel) describing a change to the position agreed in the Structure Steps Plan which the Investors Representative believes in good faith could be an Adverse Change, then FIHL, the relevant Parties and the Investors shall cooperate in good faith using reasonable best efforts on a prompt basis to revise such Final Structure Step Documents such that it does not constitute an Adverse Change and allowing their implementation before the Long Stop Date; (iii) the impact of any change in tax law arising on or after the date of this Agreement shall be excluded in any such determination of any Adverse Change; and (iv) if an Adverse Change could disproportionately negatively impact any Investor in any material way, relative to the other Investors, such Investor shall also have the same rights as the Investors Representative set forth in this Clause 2.5 mutatis mutandis. |
- 21 -
2.6 | Each of the Parties shall, and shall procure that their respective Related Persons and their Related Persons respective representatives shall, in each case to the extent within their power: |
2.6.1 | exercise all rights and privileges and perform all duties and obligations, whether as a security holder or otherwise, including by attending or voting at meetings of any security holders, executing consents to short notice in respect of any such meetings, and receiving, approving or executing any written resolution circulated to any security holder, in each case necessary or desirable to approve the Reorganisation; and |
2.6.2 | not enter into any agreement or arrangement which may impede or frustrate the Reorganisation. |
Binder Agreements
2.7 | Subject to Clause 4.7, at or prior to Completion, FIHL shall, and shall procure that the relevant members of the Group to, enter into, adopt or otherwise implement the Binder Agreements. |
Equity Documents
2.8 | At Completion, each of the Investors, the Management Seller Representative (as attorney for each of the Management Sellers) and Topco shall enter into, adopt or otherwise implement the Equity Documents. |
FIHL Purchase Agreement; FIHL Shareholders Agreement
2.9 | MGA Holdco and FIHL shall use their respective reasonable best efforts to procure that the (i) FIHL Purchase Agreement is drafted (including, without limitation, by proposing such customary provisions that are consistent with generally accepted market practice) by no later than Completion, provided that the FIHL Purchase Agreement may not be entered into without the prior written consent of the Investors Representative (such consent not to be unreasonably withheld, conditioned or delayed) and (ii) the FIHL Shareholders Agreement is drafted. |
2.10 | At Completion, each of FIHL and MGA Holdco shall enter into, adopt or otherwise implement the FIHL Purchase Agreement and the FIHL Shareholders Agreement. |
Bidco debt financing
2.11 | Bidco undertakes that prior to Completion it will not terminate or make any amendments to the Debt Commitment Letter (as defined below) that adversely affect Bidcos ability to satisfy its obligations under the Transaction Documents, or may delay such satisfaction, without the consent of FIHL. |
2.12 | Bidco acknowledges and agrees that, in the absence of fraud by such person, Bidco has no rights against and may not make any claim against any employee, director, agent, officer or (except to the extent such adviser has entered into a reliance letter with Bidco) adviser of any other Party or any of its Related Persons on whom it may have relied before agreeing to any term of, or entering into, this Agreement or any other Transaction Document, and each and every such person shall be entitled to enforce this Clause 2.12 under the Contracts (Rights of Third Parties) Act 1999. |
- 22 -
2.13 | If Bidco becomes aware of any fact, matter or circumstance that may directly or indirectly impede Bidco from drawing down such amounts on the terms set out in the Debt Commitment Letter (as defined below) as are necessary to enable Bidco to comply with its obligations at Completion, Bidco shall promptly notify FIHL in writing of that fact, matter or circumstance. |
2.14 | Upon signing this Agreement, Bidco shall deliver to FIHL and each of the Investors a copy of the Debt Commitment Letter (as defined below) and any fee letter related thereto, in each case to which it is a party. |
Warrants
2.15 | The Parties acknowledge and agree that it is intended that: |
2.15.1 | the In the Money Warrants shall be exercised on a cashless basis in accordance with their terms at Structure Step 21; |
2.15.2 | each of the Out of the Money Warrants shall be forfeited for nil consideration at Structure Step 21; and |
2.15.3 | subject to obtaining the consent of the holders of the Warrants, each of the Warrants will be amended prior to Completion to enable the treatment of such Warrants in accordance with Clauses 2.15.1 and 2.15.2. |
2.16 | FIHL shall use its reasonable best efforts to obtain the consents and amendments referred to in Clause 2.15.3 prior to Completion; provided that the failure to obtain such consents and amendments by the Long Stop Date shall not give rise to any right of action against FIHL by any other Party, including any termination rights by any Party, whether under this Agreement or otherwise. |
RSUs
2.17 | The Parties acknowledge and agree that at Structure Step 21: |
2.17.1 | subject to the approval by the board of directors of FIHL (or a committee thereof), each restricted share unit in respect of FIHL Shares granted under the FIHL Share Plans that is subject to performance-based vesting requirements (an FIHL Performance Unit) that is outstanding immediately prior to Structure Step 21 shall, to the extent not vested, become fully vested, and shall be exercised at Structure Step 21 and the resulting FIHL Shares shall be issued to the relevant holder; provided that, for purposes of determining the number of FIHL Performance Units outstanding immediately prior to Structure Step 21: |
(a) | with respect to any FIHL Performance Unit award with a performance period that has been completed, the number of shares shall be determined based on the actual level of performance achieved; and |
(b) | with respect to any FIHL Performance Unit award with a performance period that has not been completed, any applicable performance-based vesting requirements shall be deemed to be achieved immediately prior to Structure Step 21 at target payout levels; and |
- 23 -
2.17.2 | each restricted share unit in respect of FIHL Shares granted under the FIHL Share Plans that is not subject to performance-based vesting requirements (an FIHL Time-based Unit) that is outstanding immediately prior to Structure Step 21 shall, to the extent not vested, become fully vested, and shall be exercised at Structure Step 21 and the resulting FIHL Shares shall be issued to the relevant holder. |
2.18 | FIHL shall use its reasonable best efforts to procure that a meeting of the board of directors of FIHL (or a committee thereof) approves the treatment of the FIHL Performance Units and the FIHL Time-based Units set forth in Clause 2.17; provided that the failure to obtain such treatment by the Long Stop Date shall not give rise to any right of action against FIHL by any other Party, including any termination rights by any Party, whether under this Agreement or otherwise. |
2.19 | In respect of the exercise of FIHL Share Plan Securities as set forth in Clauses 2.15 to 2.18, FIHL shall procure that any Employment Tax Liability is withheld and accounted for to the relevant Taxation Authority by the applicable due date. To the extent that the FIHL Share Plan Securities are exercised at any time following Completion, FIHL shall make appropriate withholdings or procure that appropriate withholdings are made in respect of any Employment Tax Liability whether or not FIHL has a legal obligation to make such withholding, and shall provide the relevant employing company with such withheld amounts (along with, for the avoidance of doubt, an amount equal to any applicable employer social security charge in respect of or in connection with such exercise) and information as is reasonable for compliance by the employing company with its obligations under applicable law to withhold, report and account for any Employment Tax Liability. |
Merger Approval
2.20 | MGA Holdco shall take all necessary actions, including in accordance with applicable law and the MGA Holdco Constitutional Documents, to duly call, give notice of, convene, and hold a meeting of its shareholder prior to Structure Step 32 (which, immediately prior to Structure Step 31, will be FIHL as the sole shareholder of MGA Holdco) for the purposes of obtaining the MGA Holdco Merger Approval, as soon as reasonably practicable after the date of this Agreement (the MGA Holdco Shareholder Meeting). |
2.21 | FIHL undertakes to provide the MGA Holdco Merger Approval at the MGA Holdco Shareholder Meeting, it being acknowledged and agreed that FIHL shall distribute the MGA Holdco Shares at Structure Step 31 to the holders of the MGA Distribution Shares prior to the Effective Time. |
D&O Insurance
2.22 | For a period of six years from the date of Completion, FIHL shall maintain in effect directors and officers liability insurance covering those persons who are currently covered by FIHLs insurances and who will cease to be employed by the Balance Sheet Business with effect from Completion or any of its subsidiaries directors and officers liability insurance policies on terms not materially less favourable than the terms of such current insurance coverage. |
- 24 -
Registration of the FIHL Sale Shares
2.23 | Prior to Completion, FIHL shall use its reasonable best efforts to procure the passing of a board resolution of FIHL approving the transfer of the FIHL Sale Shares to Topco and the registration of Topco as the holder of the FIHL Sale Shares. |
CCS Indemnity
2.24 | Topco shall procure that the CCS Indemnity will be terminated with effect from Completion. |
IPO
2.25 | With respect to the IPO, FIHL shall use its commercially reasonable efforts to (i) prepare a registration statement on a Form F-1 (or any successor or similar form) (the Registration Statement), (ii) subject to obtaining prior consent of FIHLs auditor, KPMG Audit Limited, confidentially submit (intended to be no later than August 31, 2022) a draft of the Registration Statement with the U.S. Securities and Exchange Commission (SEC), which submission shall commence the non-public review process of the Registration Statement (the Confidential Review Process) and (iii) subject to approval by the board of directors of FIHL, in its sole discretion (the IPO Launch Decision), taking into account market conditions as well as advice from the investment banking firm or firms acting as the managing underwriter(s) in connection with the IPO (the Underwriters), take all further actions necessary or advisable to consummate the IPO. |
2.26 | The Parties agree that, subject to the IPO Launch Decision, if the IPO is able to take place at Completion, the Parties shall cooperate in good faith to enable the IPO to complete at the same time as Completion. |
Registration Rights Agreement
2.27 | Topco shall use its respective reasonable best efforts to procure that the Registration Rights Agreement is drafted (including, without limitation, (i) by proposing such customary provisions that are consistent with generally accepted market practice and (ii) proposing provisions that enable the Investors to have (a) demand registration rights, (b) the right to require shelf registration and amendment rights, (c) the right to require a shelf underwritten offering and (d) the right to participate in any shelf underwritten offering) by no later than Completion, provided that the Registration Rights Agreement may not be entered into without the prior written consent of the Investors Representative (such consent not to be unreasonably withheld, conditioned or delayed). |
2.28 | At Completion, each of Topco and the Investors shall enter into, adopt or otherwise implement the Registration Rights Agreement. |
Manager SPAs
2.29 | FIHL shall use reasonable best efforts to procure that each employee of the Group or the MGA Group that holds FIHL Shares (the Management Shareholders) will enter into a power of attorney (the Management POAs) in relation to the sale of that persons FIHL Shares to Topco pursuant to the Management Seller SPA, which authorises their attorney to enter into the Management Seller SPA. |
- 25 -
2.30 | The Parties acknowledge and agree that any Management Shareholder that does not execute and deliver a Management POA on or prior to Completion shall have their FIHL Shares dealt with in accordance with the Merger Agreement. |
MGA Group Regulatory Capital and Net Working Capital Position
2.31 | At Completion: |
2.31.1 | the Existing Pine Walk Capital Group shall have: |
(a) | a Regulatory Capital Position above the Regulatory Capital Requirement; |
(b) | a Net Working Capital Position equal to the Net Working Capital Requirement; and |
2.31.2 | Fidelis Marketing Limited shall have sufficient cash and cash equivalents (including loans from the Existing Pine Walk Capital Group) to settle all outstanding current liabilities of Fidelis Marketing Limited. |
To the extent there is a change to the items set forth above at Completion, the adjustment (if any) shall be paid in accordance with Clause 2.34.
2.32 | FIHL shall deliver to the Investors within ten (10) Business Days of the Completion Date its calculation, together with reasonable supporting information, of: |
2.32.1 | the Existing Pine Walk Capital Groups Regulatory Capital Position, Regulatory Capital Requirement, Net Working Capital Position and Net Working Capital Requirement; and |
2.32.2 | Fidelis Marketing Limiteds cash and cash equivalents (including loans from the Existing Pine Walk Capital Group) and outstanding current liabilities. |
2.33 | FIHL shall procure that: |
2.33.1 | the Existing Pine Walk Capital Groups Regulatory Capital Position, Regulatory Capital Requirement, Net Working Capital Position and Net Working Capital Requirement; |
2.33.2 | Fidelis Marketing Limiteds cash and cash equivalents (including loans from the Existing Pine Walk Capital Group) and outstanding current liabilities; and |
2.33.3 | any amounts payable pursuant to Clause 2.34, |
are, in each case, prepared and agreed in accordance with the provisions of Schedule 8 and the Investors will also procure that such items are agreed in accordance with Schedule 8.
- 26 -
2.34 | Subject to Clause 2.35, if, at Completion: |
2.34.1 | the Existing Pine Walk Capital Groups Net Working Capital Position is lower than its Net Working Capital Requirement, then the entire amount of such variance shall be paid by FIHL to Bidco (or another member of the MGA Group as directed by Bidco) on a dollar for dollar basis; |
2.34.2 | the Existing Pine Walk Capital Groups Net Working Capital Position is in excess of its Net Working Capital Requirement, then the entire amount of such variance shall be paid by Bidco (or another member of the MGA Group as directed by Bidco) to FIHL on a dollar for dollar basis; |
2.34.3 | Fidelis Marketing Limiteds cash or cash equivalents (including loans from the Existing Pine Walk Capital Group) are lower than its outstanding current liabilities, then the entire amount of such variance shall be paid by FIHL to Bidco (or another member of the MGA Group as directed by Bidco) on a dollar for dollar basis; and |
2.34.4 | Fidelis Marketing Limiteds cash or cash equivalents (including loans from the Existing Pine Walk Capital Group) are in excess of its outstanding current liabilities, then the entire amount of such variance shall be paid by Bidco (or another member of the MGA Group as directed by Bidco) to FIHL on a dollar for dollar basis. |
2.35 | Amounts payable pursuant to Clause 2.34: |
2.35.1 | shall be offset against each other such that only one payment, if any, is made between Bidco and FIHL; |
2.35.2 | shall only be payable to the extent that the amount payable by FIHL or Bidco on a net basis, would exceed $[******] and the entire amount (and not just the excess) shall be payable; and |
2.35.3 | in respect of amounts payable by Bidco to FIHL, shall be subject to the Existing Pine Walk Capital Groups Regulatory Capital Position being greater than its Regulatory Capital Requirement. |
2.36 | For the avoidance of doubt and save in the case of fraud only, FIHL shall not have or incur any further liability whatsoever in respect of the matters adjusted for pursuant to Clause 2.34. |
Issued Topco Shares
2.37 | All share capital of Topco issued and outstanding prior to Completion (other than shares issued pursuant to the SPAs and Subscription Agreements) shall be repurchased or cancelled at or prior to Completion. |
- 27 -
3. | Warranties |
3.1 | Each Party warrants to each other Party that: |
3.1.1 | in the case of a Party which is an individual, they have the capacity to enter into this Agreement and perform their obligations under it; and |
3.1.2 | in the case of any Party which is a non-natural person: |
(a) | it has full power and authority to enter into, deliver and perform its obligations under this Agreement and each other Transaction Document to which it is a party; |
(b) | this Agreement will, when executed, constitute valid and binding obligations of such Party in accordance with its terms; |
(c) | it is not insolvent or unable to pay its debts within the meaning of any laws relating to insolvency applicable to it; and |
(d) | the execution and delivery of, and the performance by such Party of its obligations under, this Agreement and each other Transaction Document to which it is a party will not: |
(i) | conflict with or result in a breach of any provision of the constitutional documents of such Party; |
(ii) | conflict with, result in a breach of or constitute a default under any agreement or instrument to which such Party is a party; |
(iii) | conflict with or result in a breach of any law or regulation, or of any order, injunction, judgement or decree of any court, that applies to such Party; and |
(iv) | save as set out in this Agreement, require such Party to obtain any material consent or approval of, or give any notice to or make any registration with, any governmental, regulatory or other authority that has not been unconditionally and irrevocably obtained or made at the date of this Agreement. |
3.2 | Each Party shall disclose to each other Party in writing any matter of which it becomes aware in the period up to and including Completion which in its reasonable opinion would make any of the warranties given pursuant to Clause 3.1 above or Clause 3.4 below untrue, inaccurate or misleading in any material respect if they were repeated on Completion, as soon as reasonably practicable after he or she becomes aware of the matter. |
3.3 | Bidco and, in respect of the Equity Commitment Letters only, Topco and each Investor party to an Equity Commitment Letter warrants to FIHL that: |
3.3.1 | Bidcos, Topcos or such Investors respective obligations under the Transaction Documents are not subject to any conditions regarding its or any other persons ability to obtain financing for the consummation of the Transaction and the other transactions contemplated by this Agreement; |
- 28 -
(a) | Bidco has at the date of this Agreement, and at Completion will have: |
(i) | the Equity Commitment Letters; and |
(ii) | a commitment letter from [******] (Blackstone Credit) on behalf of funds managed, advised or sub-advised by it or any of its affiliates together as commitment parties (together with Blackstone Credit, the Commitment Parties) in respect of certain term and revolving credit facilities (together, the Facilities) relating to the provision of debt finance to it for the purposes of the Transaction, containing the agreed summary terms for the Facilities and the conditions upon which the commitments are made (the BXC DCL) or, as the case may be, any replacement financing in at least the same quantum of debt as the BXC DCL committed to be provided by an alternative lender or lender(s) on a basis similar to the BXC DCL (the Debt Commitment Letter); and |
(b) | each of Topco and each Investor has at the date of this Agreement, and at Completion will have, the Equity Commitment Letters, |
which, in the case of Bidco, together are, and, in the case of Topco and such Investor, is sufficient to enable Bidco, Topco or such Investor, as applicable, to perform each of its obligations hereunder, complete the Transaction and the other transactions contemplated by the Transaction Documents, and pay all related fees and expenses, including payment of the Investor Subscription Amount (under and as defined in the Subscription Agreements), the Consideration (under and as defined in the SPAs) and the Merger Consideration (under and as defined in the Merger Agreement). True and correct copies of the Equity Commitment Letters and the Debt Commitment Letter have been provided to FIHL on or prior to the date hereof. The Equity Commitment Letters and the Debt Commitment Letter provide for certain funds, and, therefore, there are no conditions precedents or other contingencies related to the funding of the full amounts of financing contemplated under either (i) the Equity Commitment Letters, other than provisions consistent with those contained in the Conditions, or (ii) the Debt Commitment Letter, other than the conditions set forth therein, including the entry into definitive agreements documenting the Facilities; and
3.3.2 | the Equity Commitment Letters and the Debt Commitment Letter have been duly executed and delivered by the parties thereto, are in full force and effect and are enforceable against the parties thereto in accordance with their terms, except that such enforceability may be subject to (i) applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, preferential transfer or other similar laws, now or hereafter in effect, affecting creditors rights and remedies generally and (ii) the availability of equitable remedies (regardless of whether enforceability is considered in a proceeding at law or in equity) and to the discretion of the court before which any proceeding therefor |
- 29 -
may be brought. The Equity Commitment Letters and the Debt Commitment Letter do not terminate before, and the funding under the Equity Commitment Letters and the Debt Commitment Letter will remain available until and including, the Long Stop Date (or, if earlier, the Merger Completion). As of the date hereof, none of Bidco, Topco nor each Investor has any reason to believe that it will be unable to satisfy on a timely basis any term or condition of Completion to be satisfied by Bidco, Topco or such Investor, as applicable, contained in the Equity Commitment Letters or the Debt Commitment Letter to the extent such terms or conditions are within the control of Bidco, Topco or such Investor, as applicable. |
3.4 | Each Investor (other than the Strategic Investor and Investors party to an Equity Commitment Letter) warrants to Topco and FIHL that: |
3.4.1 | the undrawn or uncalled commitments of the limited partners in such Investors are (at the date hereof) and will be (until Completion) in aggregate not less than its Investor Subscription Amount (as defined under such Investors Subscription Agreement); |
3.4.2 | it will have funds available to it that will permit it to make its Investor Subscription Amount; |
3.4.3 | receipt of the monies required to fund its Investor Subscription Amount (and any damages under its Subscription Agreement) on and subject to the terms of this Agreement is: |
(a) | not contingent on raising any additional equity funding or third-party financing; and |
(b) | to the extent its financial resources are in the form of undrawn or uncalled capital commitments described in Clause 3.4.1 above, dependent only on the limited partners of the Investor making capital contributions which they are unconditionally committed to do on receipt of a capital call; |
3.4.4 | it will issue, and not revoke, capital calls for an amount equal to its Investor Subscription Amount (or any damages under its Subscription Agreement) in a sufficiently timely manner to enable it to satisfy its obligations under its Subscription Agreements; and |
3.4.5 | it has no knowledge of any facts or circumstances that are reasonably likely to result in and it will not take any action or fail to take any action that is reasonably likely to result in any of its limited partners failing to satisfy a capital call for such uncalled capital commitments. |
4. | Conditions to Completion |
4.1 | Completion shall be conditional on the following events occurring (the Conditions and each a Condition): |
4.1.1 | in the case of Subscription Completion, SPA Completion and Merger Completion: |
- 30 -
(a) | the regulatory approvals by the relevant Regulatory Authorities listed in paragraph 1 of Schedule 2 shall have been obtained (the MGA Regulatory Conditions); |
(b) | the regulatory approvals by the relevant Regulatory Authorities listed in paragraph 2 of Schedule 2 shall have been obtained (the Balance Sheet Regulatory Conditions); |
(c) | the regulatory approvals by the relevant Regulatory Authorities for the Binder Agreements shall have been obtained, with such changes (if any) to the Binder Agreements as may be required by Regulatory Authorities; provided that such changes do not constitute a Burdensome Condition (the Binder Agreements Condition and together with the Balance Sheet Regulatory Conditions, the Balance Sheet Conditions); |
(d) | the Company Shareholder Approval (as defined in the Merger Agreement) shall have been obtained in accordance with the terms of the Merger Agreement; |
(e) | A.M. Best Company, Inc.: |
(i) | shall have provided written notice to FIHL that FIHL (1) has been assigned a financial strength rating of at least A- following Completion or (2) will be assigned a financial strength rating of at least A- immediately following Completion; and |
(ii) | if FIHL has been assigned a financial strength rating of A- following Completion or will be assigned a financial strength rating of A- immediately following Completion, shall not have given oral or written notice to FIHL (which written notice FIHL shall promptly deliver to the Investors and Topco) or written notice to any of the Investors that any such ratings will be downgraded, suspended, withdrawn or retracted; |
for the avoidance of doubt, such condition shall not be satisfied if such financial strength rating is A- with a negative outlook or negative watch;
(f) | S&P Global, Inc.: |
(i) | shall have provided written notice to FIHL that FIHL (1) has been assigned a financial strength rating of at least A- with a negative outlook or negative watch following Completion or (2) will be assigned a financial strength rating of at least A- with a negative outlook or negative watch immediately following Completion; and |
(ii) | if FIHL has been assigned a financial strength rating of A- with a negative outlook or negative watch following Completion or will be assigned a financial strength rating of A- with a negative outlook or negative watch immediately following |
- 31 -
Completion, shall not have given oral or written notice to FIHL (which written notice FIHL shall promptly deliver to the Investors and Topco) or written notice to any of the Investors that any such ratings will be downgraded, suspended, withdrawn or retracted; |
(g) | with respect to the Investors only, no actions, conditions, limitations, qualifications, restrictions or requirements shall have been imposed that, individually or in the aggregate would or would reasonably be expected to: |
(i) | with respect to changes to the Binder Agreements as may be required by Regulatory Authorities (a Regulatory Binder Change), (x) result in a decrease of more than $[******] in the enterprise value of the MGA Group due to a Regulatory Binder Change to the economic terms of the Binder Agreements (the EV Change) as determined by comparing: |
(A) | the enterprise value of the MGA Group on the basis of the Binder Agreements without such Regulatory Binder Change as of the most recent practicable date (the EV Test Date) and taking into account no changes to the enterprise value of the MGA Group that arise for any reason other than as a result of such Regulatory Binder Change; to |
(B) | the enterprise value of the MGA Group on the basis of the Binder Agreements with such Regulatory Binder Change as of the EV Test Date and taking into account no changes to the enterprise value of the MGA Group that arise for any reason other than as a result of such Regulatory Binder Change; |
or (y) have any negative impact on the term or termination provisions of the Binder Agreements that is material,
provided, in the event of an EV Change due to a Regulatory Binder Change to the economic terms of the Binder Agreements, the Aggregate Merger Consideration (as defined in the Merger Agreement) and the MGA Holdco Consideration (as defined in the SPAs) shall be reduced by an amount equal to (A) any EV Change in excess of $[******], if any, and less than or equal to $[******] (calculated on the excess only) plus (B) fifty (50) per cent. of any EV Change in excess $[******], if any, and less than or equal to $[******] (calculated on the excess only);
(ii) | require any member of the Investors Group to sell, hold, divest, discontinue or limit any assets, businesses or interests; |
- 32 -
(iii) | require any member of the Investors Group to agree to any conditions relating to, or changes or restrictions in, its operations of any assets, business or interests; or |
(iv) | require the contribution of capital or the provision of any guarantee, keep well or capital or surplus maintenance agreement, or pledge of assets or similar arrangement by any member of the Investors Group (excluding, for the avoidance of doubt, the capitalisation of the MGA Group by FIHL or its subsidiaries on or prior to Completion) ((i), (ii), (iii) or (iv), a Burdensome Condition); |
provided, that any potential Burdensome Condition that is waived, consented to or accepted by the Investors Representative shall not constitute a Burdensome Condition for any purpose in this Agreement;
(h) | Bidco has, or will concurrently with the Completion, draw down under the Facilities on substantially the terms and conditions set out in the Debt Commitment Letter; |
(i) | there shall not have occurred any effect, change, event, circumstance, state of facts, development, or occurrence that has had, or would reasonably be expected to result in, individually or in the aggregate, a Material Adverse Effect; and |
(j) | to the extent that the United Kingdom Competition and Markets Authority (the CMA) has either: (i) issued a written request for information to any Party in respect of the Transactions in accordance with Part 3 of the Enterprise Act 2002 but not yet confirmed that it has no further questions at this stage in respect of the Transactions; or (ii) commenced, or given written notice to any Party that it intends to commence, a Phase 1 merger investigation in respect of the Transactions, the respective obligations of each Party to effect the Completion shall be conditional upon the CMA confirming that either: (a) it has no further questions at this stage in respect of the Transactions; or (b) it will not make a reference of the Transactions (or any matter arising therefrom) in accordance with sections 22 or 33 of the Enterprise Act 2002 to the chair of the CMA for the constitution of a group under Schedule 4 to the Enterprise and Regulatory Reform Act 2013; or (c) if such a reference takes place, the CMA having issued a report concluding that the Transactions (or any matter therefrom) may not be expected to result in a substantial lessening of competition within any market or markets in the United Kingdom (the CMA Condition), provided that the Parties undertake to use all reasonable endeavours to respond to the CMA with any information it requires from any Party in order to satisfy the CMA Condition as soon as reasonably possible and in any event before the Long Stop Date. |
4.1.2 | in the case of Subscription Completion: |
(a) | the Binder Agreements having been entered into with such changes (if any) to the Binder Agreements as may be required by Regulatory Authorities; provided that such changes do not constitute a Burdensome Condition; and |
- 33 -
(b) | the Reorganisation shall have been effected in accordance with the Structure Steps Plan and Clause 2.5 up to and including Structure Step 21 and the steps following Structure Step 22 in the Structure Steps Plan shall be capable of being implemented and shall have become unconditional subject to Clause 2.5 and other than in respect of the condition that the Structure Steps prior to Structure Step 22 have been effected; |
4.1.3 | in the case of SPA Completion: |
(a) | Subscription Completion having occurred; and |
(b) | the Reorganisation shall have been effected in accordance with the Structure Steps Plan up to and including Structure Step 22 and the steps following Structure Step 23 in the Structure Steps Plan shall be capable of being implemented and shall have become unconditional other than in respect of the condition that the Structure Steps prior to Structure Step 23 have been effected; |
4.1.4 | in the case of the completion of the distribution pursuant to Structure Step 31: |
(a) | each Structure Step prior to Structure Step 31 having been completed in full and in accordance with the Structure Steps Plan; and |
(b) | the Company Shareholder Approval (as defined in the Merger Agreement) shall have been obtained in accordance with the terms of the Merger Agreement; and |
4.1.5 | in the case of Merger Completion: |
(a) | SPA Completion having occurred; and |
(b) | the Reorganisation shall have been effected in accordance with the Structure Steps Plan up to and including Structure Step 31 and the steps following Structure Step 32 in the Structure Steps Plan shall be capable of being implemented and shall have become unconditional other than in respect of the condition that the Structure Steps prior to Structure Step 32 have been effected (Clauses 4.1.2(b), 4.1.3(b), 4.1.4(b) and 4.1.5(b), the Reorganisation Conditions). |
Responsibility for satisfaction of Conditions
4.2 | Subject to Clause 4.7, each Investor undertakes to use all reasonable endeavours, to procure the satisfaction of the MGA Regulatory Conditions as soon as reasonably possible and in any event before the Long Stop Date and will keep FIHL informed as to progress towards satisfaction of the MGA Regulatory Conditions and will notify FIHL as soon as reasonably possible after it becomes aware of the satisfaction of each of the MGA Regulatory Conditions, but, for the avoidance of doubt, no Investor shall be under any obligation to take any action or lack thereof pursuant to or in accordance with a Burdensome Condition. |
- 34 -
4.3 | FIHL undertakes to use all reasonable endeavours to procure the satisfaction of the Balance Sheet Conditions and the Reorganisation Conditions as soon as reasonably possible and in any event before the Long Stop Date and will keep the Investors Representative informed as to progress towards satisfaction of the Balance Sheet Conditions and the Reorganisation Conditions and will notify the Investors Representative as soon as reasonably possible after it becomes aware of the satisfaction of the Balance Sheet Conditions or the ability to satisfy the Reorganisation Conditions. |
4.4 | To the extent permitted by law, each of the Parties shall promptly disclose to the other Parties: |
4.4.1 | any fact, matter or circumstance which will or is reasonably likely to prevent any Condition from being fulfilled of which it becomes actually aware; |
4.4.2 | any indication that any Regulatory Authority may withhold its approval or, or raise an objection to, or impose any condition as a result of Project Cooper of which it becomes actually aware; and |
4.4.3 | any other material development regarding the fulfilment of any Condition (other than the Reorganisation Conditions) of which it becomes actually aware. |
4.5 | Each Investor undertakes to keep FIHL and the Management Seller Representative informed as to progress towards satisfaction of the MGA Regulatory Conditions and undertakes to: |
4.5.1 | provide FIHL with draft copies of all material submissions and communications to the Regulatory Authorities in relation to satisfying the MGA Regulatory Conditions at such time as will allow FIHL a reasonable opportunity to provide comments on such submissions and communications before they are submitted or sent (and, in completing such submissions or communications, each Investor agrees to have due regard to any reasonable comments made by FIHL), it being understood that FIHL shall be responsible for drafting any business plan that will be submitted as part of any such submission or communication; |
4.5.2 | save as otherwise directed by a Regulatory Authority and to the extent that they relate to the MGA Regulatory Conditions and are not expected to relate to information that is confidential or commercially sensitive to any of the Investors, allow FIHL (or persons nominated by FIHL) to attend all meetings with any Regulatory Authority, and, where appropriate, to make oral submissions at such meetings; and |
4.5.3 | provide FIHL, as soon as reasonably practicable, with copies of any material written communication, and updates (written or oral) of the substance of any material oral communications with a Regulatory Authority in relation to obtaining any consent, approval or action where such communications have not been independently or simultaneously supplied to FIHL, and, where practicable, to consult with FIHL before initiating any material new communication with a Regulatory Authority. |
- 35 -
4.6 | FIHL undertakes to keep the Investors Representative informed as to progress towards satisfaction of the Balance Sheet Regulatory Conditions and undertakes to: |
4.6.1 | provide the Investors Representative with draft copies of all material submissions and communications to the Regulatory Authorities in relation to satisfying the Balance Sheet Regulatory Conditions at such times as will allow the Investors Representative a reasonable opportunity to provide comments on such submissions and communications before they are submitted or sent (and, in completing such submissions or communications, FIHL agrees to have due regard to any reasonable comments made by the Investors Representative); and |
4.6.2 | provide the Investors Representative, as soon as reasonably practicable, with copies of any material written communication, and updates (written or oral) of the substance of any material oral communications with a Regulatory Authority in relation to obtaining any consent, approval or action where such communications have not been independently or simultaneously supplied to the Investors Representative and, to consult with the Investors Representative before initiating any material new communication with a Regulatory Authority. |
4.7 | In the event a potential Burdensome Condition is imposed, the Investors Representative shall confer in good faith with FIHL in order to: |
4.7.1 | exchange and review their respective views and positions as to such actions, conditions, limitations, qualifications, restrictions or requirements that the Investors reasonably consider to be a Burdensome Condition; |
4.7.2 | provide reasonably detailed information as to the respective Partys calculation of enterprise value and the impact of any Regulatory Binder Change and respond promptly to queries related to such calculation; and |
4.7.3 | in respect of actions, conditions, limitations, qualifications, restrictions or requirements required by a Regulatory Authority only, discuss with the applicable Regulatory Authority such Burdensome Condition and potential mitigation measures so it would no longer be a Burdensome Condition. |
4.8 | The Investors Representative shall promptly after the Investors Representatives formal written determination that such actions, conditions, limitations, qualifications, restrictions or requirements constitutes a Burdensome Condition (and the Investors Representative has not waived, accepted or consented to such potential Burdensome Condition), give written notice of this fact to FIHL and the Conditions shall not be satisfied. |
Long Stop Date
4.9 | If any Condition: |
4.9.1 | has not been satisfied by the Long Stop Date (including due to the Investors determining that there has been a Burdensome Condition to the Binder Agreements); or |
- 36 -
4.9.2 | becomes incapable of satisfaction at any time prior to the Long Stop Date, FIHL or the Investors Representative may elect to terminate this Agreement and the other Transaction Documents (other than the Surviving Provisions) by written notice to either FIHL or the Investors Representative (as applicable) and the Management Seller Representative, provided that, if by the Long Stop Date (i) an MGA Regulatory Condition or a Balance Sheet Regulatory Condition remains unsatisfied and (ii) in the reasonable opinion of FIHL or the Investors Representative, such a condition is capable of satisfaction within one month of the Long Stop Date, FIHL or the Investors Representative may extend the Long Stop Date by one month by written notice to either FIHL or the Investors Representative (as applicable) and to the Management Seller Representative and the other Party shall not have a termination right until the expiry of such one month and this Clause 4.9 will be deemed to be repeated in respect of the Long Stop Date as extended by one month. |
5. | Termination |
5.1 | If this Agreement is terminated pursuant to Clause 4.9 the Parties shall have no further obligations under this Agreement, provided that: |
5.1.1 | the Surviving Provisions shall survive termination; and |
5.1.2 | (for the avoidance of doubt) termination shall be without prejudice to any rights, liabilities or obligations that have accrued prior to termination, or to any other rights or remedies available under this Agreement or at law. |
5.2 | Save for the termination provisions set out in Clause 5.1, no Party is entitled to terminate this Agreement. |
6. | Costs |
6.1 | FIHL shall bear all stamp duties, stamp duty land tax, notarial fees, sales taxes, transfer taxes or other taxes (each a Transfer Tax) arising in connection with the execution of, or transfer of shares pursuant to, the relevant SPAs, and shall be responsible for arranging the payment of any such Transfer Tax and for preparing, executing and filing any applicable returns to the appropriate Taxation Authority with respect to such Transfer Taxes. |
6.2 | FIHL shall bear all Transfer Taxes arising in connection with the execution of, or issuance of shares pursuant to, the relevant Subscription Agreements, and shall be responsible for arranging the payment of any such Transfer Tax and for preparing, executing and filing any applicable returns to the appropriate Taxation Authority with respect to such Transfer Taxes. |
6.3 | Any Transfer Taxes arising in connection with the execution of, or merger transactions completed pursuant to, the Merger Agreement shall be allocated in accordance with the terms of the Merger Agreement. |
6.4 | Any Transfer Taxes arising in connection with the transactions contemplated by this Agreement that are not specified in Clauses 6.1, 6.2 or 6.3 above shall be borne fifty (50) per cent. by FIHL and fifty (50) per cent. by MGA Holdco. MGA Holdco shall be responsible for filing all tax returns and other documentation in respect of any Transfer Taxes to the relevant Taxation Authority and may at its discretion (acting in good faith) |
- 37 -
determine the amount of any Transfer Taxes payable. FIHL shall pay or reimburse (as the case may be) to MGA Holdco an amount equal to fifty (50) per cent. of Transfer Taxes payable as determined by MGA Holdco within five (5) Business Days of demand therefor. |
6.5 | If this Agreement is terminated pursuant to Clause 4.9, FIHL shall pay all reasonable out-of-pocket costs (including any irrevocable VAT thereon) of the Investors Group in connection with the evaluation, documentation and execution of the Transactions, including the fees of [******] Amounts due under this Clause 6.5 shall be exclusive of VAT and if any payment by FIHL pursuant to this Clause 6.5 constitutes the consideration for a taxable supply of goods and/or services for VAT purposes, then FIHL shall, on presentation of a valid VAT invoice, pay VAT in addition to and at the same time as the amount so falling under this Clause 6.5. For the avoidance of doubt, if this Agreement is terminated pursuant to Clause 4.9, none of the Investors shall be liable for any amount payable pursuant to the Debt Commitment Letter, any fee letter related thereto or in connection with any potential equity financing by Blackstone or any affiliate thereof or any other costs, fees or expenses incurred by any MGA Group Company. |
7. | Completion |
7.1 | Completion shall occur in accordance with the terms of the relevant Transaction Document and shall take place virtually via the exchange of executed documents and other deliverables by PDF or other means of electronic delivery. |
7.2 | At Completion, no Investor shall be required to pay its Investor Subscription Amount pursuant to the terms of its Subscription Agreement and no Institutional Seller shall be required to complete its Share Purchase pursuant to the terms of its Institutional Seller SPA unless each of the other Investors also pays its Investor Subscription Amount at Completion (including if Completion does not occur as a result of a Burdensome Condition). |
7.3 | If any Investor fails to satisfy all or part of its payment obligations at Completion under its Subscription Agreement with respect to its Investor Subscription Amount (the Defaulting Investor), no other Investor or any of its Related Persons shall have any liability to any other person under any of the Transaction Documents or otherwise in respect of such failure by the Defaulting Investor and no other Investor or any of its Related Persons shall be required to satisfy, either at Completion or subsequently, in whole or part, any of the payment obligations that have failed to have been satisfied by the Defaulting Investor pursuant to its Transaction Documents. |
- 38 -
7.4 | If Completion does not occur as a result of one or more Defaulting Investors (a) failing to pay its Investor Subscription Amount in accordance with the terms of its Subscription Agreement, or (b) notifying any other Party of its intention not to pay its Investor Subscription Amount in accordance with the terms of its Subscription Agreement (a Subscription Agreement Breach), in either case in circumstances where all Conditions have been satisfied or waived and the other Investors (the Non-Defaulting Investors) are prepared to pay their Subscription Amounts in accordance with the terms of their respective Subscription Agreements, and either: |
7.4.1 | a non-appealable award of damages is made by any court of competent jurisdiction in favour of Topco in respect of the Subscription Agreement Breach; or |
7.4.2 | the Defaulting Investor(s) and Topco agree upon an amount in damages to be paid by the Defaulting Investor to Topco in respect of the Subscription Agreement Breach, |
(in each case, such amount being Subscription Agreement Damages), then:
7.4.3 | the Defaulting Investor(s) shall be responsible for 100% of any Subscription Agreement Damages; provided that where there is more than one Defaulting Investor, the Defaulting Investors will share the Subscription Agreement Damages pro rata to their intended shareholding in Topco; provided, further, the Subscription Agreement Damages with respect to a Defaulting Investor shall not exceed the Investor Subscription Amount under such Defaulting Investors Subscription Agreements; |
7.4.4 | the Defaulting Investor(s) shall have no liability to any person other than Topco under any of the Transaction Documents or otherwise in respect of such failure by the Defaulting Investor (other than the Subscription Agreement Damages); and |
7.4.5 | the Non-Defaulting Investors shall not be responsible for any Subscription Agreement Damages (including under their own Subscription Agreements). |
8. | Limitation of liability |
8.1 | Without prejudice to the limitations of liability included in the other Transaction Documents and subject to Clause 8.2, no Party will be liable (whether directly or indirectly, in contract or in tort or otherwise) for any action taken by it (or any inaction) under or in connection with the negotiation, entry into or performance of its obligations under this Agreement, unless directly caused by its gross negligence or wilful misconduct and to the extent finally judicially determined by a court of competent jurisdiction. |
8.2 | Without prejudice to the limitations of liability included in the other Transaction Documents, the Management Seller Representative shall have no liability to any other Party. |
- 39 -
8.3 | No Party shall be responsible or have any liability to any other Party for consequential losses or damages. |
8.4 | Nothing in this Clause 8 shall operate to limit the liability of a Party in respect of fraud on the part of such Party. |
8.5 | Notwithstanding anything to the contrary contained herein, the Sellers (on behalf of themselves and their affiliates and each officer, director, employee, member, manager, partner, controlling person, advisor, attorney, agent and representative thereof) (i) hereby waive any claims or rights against any Debt Financing Source relating to or arising out of this Agreement, the Bidco debt financing, the Debt Commitment Letter and the transactions contemplated hereby and thereby, whether at law or in equity and whether in tort, contract or otherwise, (ii) hereby agree not to bring or support any suit, action or proceeding against any Debt Financing Source in connection with this Agreement, the Bidco debt financing, the Debt Commitment Letter and the transactions contemplated hereby and thereby, whether at law or in equity and whether in tort, contract or otherwise, and (iii) hereby agree to cause any suit, action or proceeding asserted against any Debt Financing Source by or on behalf of the Sellers or any of its affiliates or any officer, director, employee, member, manager, partner, controlling person, advisor, attorney, agent and representative thereof in connection with this Agreement, the Bidco debt financing, the Debt Commitment Letter and the transactions contemplated hereby and thereby to be dismissed or otherwise terminated. In furtherance and not in limitation of the foregoing waivers and agreements, it is acknowledged and agreed that no Debt Financing Source shall have any liability for any claims or damages to the Sellers in connection with this Agreement, the Bidco debt financing, the Debt Commitment Letter and the transactions contemplated hereby and thereby (provided that nothing in this Clause 8.5 shall limit the liability or obligations of the Debt Financing Sources under the Debt Commitment Letter or any definitive agreements with respect to any Bidco debt financing). |
9. | Marketing Materials disclaimer |
9.1 | Notwithstanding anything to the contrary set out in this Agreement, no forecast made by or on behalf of FIHL or any MGA Group Company may form the basis of, or be pleaded in connection with, any claim against FIHL or any MGA Group Company and, without prejudice to the provisions of Clauses 14.15 to 14.19 (Entire Agreement), each other Party acknowledges and agrees, that none of FIHL, any member of its Group, any member of the MGA Group, nor any of their respective directors, officers, employees, agents or advisers (other than PwC in respect of the PWC VDD Report) make any representation or warranty as to any forecasts, assumptions, projections, estimates, budgets, statements of intent or statements of opinion (whether in the Marketing Materials or otherwise) delivered to or made available to such other Party or any of its directors, officers, employees, agents or advisers of future revenues, future results of operations (or any component thereof), future cash flows or future financial condition (or any component thereof) of the MGA Group. |
9.2 | Each other Party unconditionally and irrevocably waives all and any rights and claims that they may have against any of FIHL, any member of its Group, any member of the MGA Group, nor any of their respective directors, officers, employees, agents or advisers (other than PwC in respect of the PWC VDD Report) in respect of any such forecasts, assumptions, projections, estimates, budgets, statements of intent or |
- 40 -
statements of opinion (whether in the Marketing Materials or otherwise), and each and every such director, officer, employee, agent or adviser of FIHL, any member of its Group or any member of the MGA Group shall be entitled to enforce this Clause under the Contracts (Rights of Third Parties) Act 1999. |
10. | Announcements and confidentiality |
Announcements
10.1 | FIHL and the Investors Representative shall mutually agree any Announcement; provided that such Announcement shall not name an Investor without such Investors consent. |
10.2 | Subject to Clause 10.1, no Party shall make or issue any announcement or circular in connection with the existence or the subject matter of this Agreement or any other Transaction Document, or cause any such announcement to be made or issued, without the prior written consent of: |
10.2.1 | in the case of an announcement by FIHL, the Investors Representative; |
10.2.2 | in the case of an announcement by any Investor, FIHL; and |
10.2.3 | in the case of an announcement by any other Party, FIHL, and the Investors Representative. |
Confidentiality
10.3 | Subject to Clause 10.4, each Party shall treat as strictly confidential and shall not disclose or use any information received or obtained in connection with or as a result of entering into this Agreement or any other Transaction Document that relates to: |
10.3.1 | the provisions of this Agreement or any Transaction Document; |
10.3.2 | the negotiations relating to this Agreement and all other Transaction Documents; |
10.3.3 | any business or financial or other affairs of the Group; or |
10.3.4 | any other Party or its Related Persons. |
10.4 | Notwithstanding Clauses 10.1, 10.2 and 10.3, a Party may disclose or use information if and to the extent that: |
10.4.1 | such disclosure or use is required by applicable law or regulation, by any competent judicial, governmental or regulatory body, or by the rules of any recognised stock exchange; |
10.4.2 | such disclosure or use is required for the purpose of any judicial proceedings arising out of this Agreement or any other Transaction Document; |
10.4.3 | such disclosure or use is required to vest the full benefit of this Agreement or any other Transaction Document in any Party; |
- 41 -
10.4.4 | such disclosure is made to a Taxation Authority in connection with the Tax affairs of the disclosing Party; |
10.4.5 | such disclosure is made to the professional advisers, auditors, rating agencies, bankers or providers of debt financing of a Party on a need-to-know basis, provided that the recipient has undertaken to comply with this Clause 10 in respect of such information as if it were a Party; |
10.4.6 | such disclosure is made to the Groups customers, insureds, cedants, policyholders, brokers or other intermediaries in connection with the maintenance of their relationships with the Group; |
10.4.7 | such information is or becomes publicly available (other than by breach of this Agreement); |
10.4.8 | such disclosure is made to an affiliate, Related Fund or co-investment vehicle of an Investor provided that the recipient has undertaken to comply with this Clause 10 in respect of such information as if it were a Party; or |
10.4.9 | in the case of: |
(a) | FIHL, the Investors Representative have given their prior written consent; |
(b) | any Investor, FIHL has given its prior written consent; and |
(c) | any other Party, FIHL and the Investors Representative have given their prior written consent |
10.5 | Before any information is disclosed pursuant to Clauses 10.4.1, 10.4.2 or 10.4.4, the Party concerned shall (unless prohibited by law, regulation or any judicial, governmental or regulatory body) promptly notify the other Parties to whom the disclosure relates of the circumstances of the disclosure and the information to be disclosed with a view to providing such other Parties with the opportunity to contest, limit or agree the timing and content of such disclosure. |
11. | Notices |
Service of notices
11.1 | Any notice to be given under this Agreement must be in English and in writing, and may be served by hand, by first class post or airmail (pre-paid and signed for in each case) or by email to the address or email address (as applicable) given below, or to such other address or email address as may have been notified by any Party to the other Parties for this purpose (which shall supersede the previous address or email address (as applicable) from the date on which notice of the new address is deemed to be served under this Clause 11). |
The Investors: in accordance with each Investors notice details set out in Schedule 1.
- 42 -
FIHL: | Fidelis Insurance Holdings Limited | |
For the attention of: | Patricia Roufca, Group General Counsel and | |
Director of Strategic Execution | ||
Address: | Waterloo House | |
100 Pitts Bay Road | ||
Pembroke, Bermuda HM 08 | ||
Email address: | patricia.roufca@fidelisinsurance.com | |
Copy to (which shall not | Willkie Farr & Gallagher (UK) LLP | |
constitute notice): | CityPoint | |
One Ropemaker Street | ||
London EC2Y 9AW | ||
for the attention of Joseph D. Ferraro | ||
email to jferraro@willkie.com | ||
Management Seller | Richard Brindle | |
Representative: | ||
Address: | 22 Bishopsgate, 42nd Floor | |
London, EC2N 4BQ | ||
United Kingdom | ||
Email address: | Richard.brindle@fidelisinsurance.com | |
Copy to (which shall not | Fidelis Insurance Holdings Limited | |
constitute notice): | Waterloo House | |
100 Pitts Bay Road | ||
Pembroke, Bermuda HM 08 | ||
for the attention of Patricia Roufca | ||
email to patricia.roufca@fidelisinsurance.com | ||
Investors Representative: | ||
SPFM Holdings, LLC | ||
For the attention of: | [******] | |
Address: | [******] | |
[******] | ||
Email address: | [******] | |
Capital Z Partners (MGA), L.P. | ||
For the attention of: | [******] |
- 43 -
Address: | [******] | |
[******] | ||
Email address: | [******] | |
[******] | ||
Copy to (which shall not | Skadden, Arps, Slate, Meagher & Flom LLP | |
constitute notice): | One Manhattan West | |
New York, New York 10001 | ||
for the attention of Todd. E. Freed | ||
email to todd.freed@skadden.com | ||
Topco: | Shelf Holdco Ltd. | |
For the attention of: | CEO | |
Address: | Waterloo House | |
100 Pitts Bay Road | ||
Pembroke, Bermuda HM 08 | ||
Copy to (which shall not | Willkie Farr & Gallagher (UK) LLP | |
constitute notice): | CityPoint | |
One Ropemaker Street | ||
London EC2Y 9AW | ||
for the attention of Joseph D. Ferraro | ||
email to jferraro@willkie.com | ||
Midco: | Shelf Midco Ltd. | |
For the attention of: | CEO | |
Address: | Waterloo House | |
100 Pitts Bay Road | ||
Pembroke, Bermuda HM 08 | ||
Copy to (which shall not | Willkie Farr & Gallagher (UK) LLP | |
constitute notice): | CityPoint | |
One Ropemaker Street | ||
London EC2Y 9AW | ||
for the attention of Joseph D. Ferraro | ||
email to jferraro@willkie.com | ||
Bidco: | Shelf Bidco Ltd. | |
For the attention of: | CEO | |
Address: | Waterloo House | |
100 Pitts Bay Road | ||
Pembroke, Bermuda HM 08 |
- 44 -
Copy to (which shall not | Willkie Farr & Gallagher (UK) LLP | |
constitute notice): | CityPoint | |
One Ropemaker Street | ||
London EC2Y 9AW | ||
for the attention of Joseph D. Ferraro | ||
email to jferraro@willkie.com | ||
Merger Sub: | Shelf Bidco II Ltd. | |
For the attention of: | CEO | |
Address: | Waterloo House | |
100 Pitts Bay Road | ||
Pembroke, Bermuda HM 08 | ||
Copy to (which shall not | Willkie Farr & Gallagher (UK) LLP | |
constitute notice): | CityPoint | |
One Ropemaker Street | ||
London EC2Y 9AW | ||
for the attention of Joseph D. Ferraro | ||
email to jferraro@willkie.com | ||
MGA Holdco: | Shelf Holdco II Ltd. | |
For the attention of: | CEO | |
Address: | Waterloo House | |
100 Pitts Bay Road | ||
Pembroke, Bermuda HM 08 | ||
Copy to (which shall not | Willkie Farr & Gallagher (UK) LLP | |
constitute notice): | CityPoint | |
One Ropemaker Street | ||
London EC2Y 9AW | ||
for the attention of Joseph D. Ferraro | ||
email to jferraro@willkie.com |
11.2 | Any notice served in accordance with Clause 11.1 shall be deemed to have been received: |
11.2.1 | if delivered by hand, at the time of delivery; |
11.2.2 | if sent by first class post, at 9.30 a.m. on the second day after (and excluding) the date of posting; |
11.2.3 | if sent by airmail, at 9.30 a.m. on the fifth day after (and excluding) the date of posting; or |
11.2.4 | if sent by email, at the time of transmission by the sender, provided that receipt shall not occur if the sender receives an automated message indicating that the message has not been delivered to the recipients, provided that if a notice would otherwise be deemed to have been received outside Normal Business Hours, it shall instead be deemed to have been received at the recommencement of such Normal Business Hours. |
- 45 -
11.3 | For the purposes of Clause 11.2, Normal Business Hours means 9.00 a.m. to 5.30 p.m. local time in the place of receipt on any day which is not a Saturday, Sunday or public holiday in that location. In the case of service on any Party by email, the place of receipt shall be deemed to be the address specified for service on that Party by post. |
11.4 | In proving receipt of any notice served in accordance with Clause 11.1, it shall be sufficient to show that the envelope containing the notice was properly addressed and either delivered to the relevant address by hand or posted as a pre-paid, signed-for first class or airmail letter, or that the email was sent to the correct email address. |
11.5 | This Clause 11 shall not apply to the service of any proceedings or other documents in any legal action. |
12. | Management Seller Representative |
12.1 | The Management Seller Representative shall act on behalf of the Management Sellers in respect of this Agreement, in particular: |
12.1.1 | any notice, consent, election or request to be made or given by the Management Sellers to any of the Parties (other than the Management Seller Representative) under this Agreement may be made or given by the Management Seller Representative on behalf of all the Management Sellers; and |
12.1.2 | any notice to be given by any of the Parties to the Management Sellers under this Agreement shall be validly served on all the Management Sellers (or any of them) if it is served on the Management Seller Representative in accordance with Clause 11.1. |
12.2 | The Management Seller Representative may be replaced pursuant to the terms of the Management Sellers SPA. |
13. | Investors Representative |
13.1 | By executing and delivering this Agreement, each Investor shall have irrevocably authorized and appointed the Investors Representative such Investors representative and attorney- in- fact to act on behalf of such Investor with respect to this Agreement to act on behalf of the Investors in respect of this Agreement and, in particular: |
13.1.1 | except as provided in Clause 14.22, any notice, consent, election or request to be made or given by the Investors to any other Party under this Agreement may be made or given by the Investors Representative on behalf of all the Investors, and the Parties are not required to have regard to any notice served by or on behalf of the Investors (or any of them) by any other person; |
13.1.2 | any notice to be given by the Parties to the Investors under this Agreement shall be validly served on all the Investors (or any of them) if it is served on the Investors Representative in accordance with Clause 11.1; and |
- 46 -
13.1.3 | any variation to this Agreement pursuant to Clause 14.10 may be signed on behalf of the Investors by the Investors Representative. |
13.2 | The Investors Representative shall not be liable to any Investor for any claim whatsoever arising from any act or omission undertaken by him in his capacity as the Investors Representative save in the case of fraud by the Investors Representative to the extent finally judicially determined by a court of competent jurisdiction, and the Investors Representative shall be entitled to enforce this Clause 13.2 under the Contracts (Rights of Third Parties) Act 1999. The Investors shall severally and not jointly, indemnify and hold harmless the Investors Representative from and against, compensate it for, reimburse it for and pay any and all losses, liabilities, claims, actions, damages and expenses arising out of and in connection with its activities as Investors Representative under this Agreement. |
14. | General |
Further assurances
14.1 | On request by any Party, each Party shall, as soon as reasonably practicable at the requesting Partys cost and insofar as it is reasonably able, do or procure the doing of all such acts and execute or procure the execution of all such documents (in a form reasonably satisfactory to the requesting Party) as the requesting Party may reasonably consider necessary or appropriate to carry this Agreement into effect and to give the requesting Party the full benefit of it. |
14.2 | Each Party agrees that it will provide all information requested in writing by the other reasonably required to enable such Party to comply with its obligations under the Proceeds of Crime Act 2002 and the Money Laundering Regulations 2007 (No. 2157) whether such obligations apply prior to Completion or thereafter. |
Payments under this Agreement
14.3 | All sums payable by one party to another under this Agreement shall be paid without any deduction or withholdings, unless such deduction or withholding is required by any applicable law. If such deduction or withholding is so required the applicable payor party shall be obliged to pay to the payee such sum as will, after the deduction or withholding has been made, leave the payee with the same amount as it would have been entitled to receive in the absence of any such requirement to make a deduction or withholding. |
Assignment
14.4 | Without prejudice to the rights of those FIHL shareholders who will receive Merger Consideration (as defined in the Merger Agreement) under the Merger Agreement on Merger Completion, MGA Holdco and Bidco may assign the benefit of the whole or any part of, or any of its rights under, this Agreement to: |
14.4.1 | a Related Person; and |
14.4.2 | a purchaser of the entire issued share capital of either MGA Holdco or Bidco, or of all or substantially all of their respective assets. |
- 47 -
14.5 | Without prejudice to the rights of those FIHL shareholders who will receive Merger Consideration (as defined in the Merger Agreement) under the Merger Agreement on Merger Completion, MGA Holdco and Bidco may grant security over, or assign by way of security, any or all of its rights under this Agreement to its banks or other finance providers (or any agent or trustee on behalf of such finance providers) for the purposes of, or in connection with, any financing or refinancing or other banking or related facilities (whether in whole or in part) in respect of or in connection with the Merger and other transactions contemplated by this Agreement or any of MGA Holdcos or Bidcos working capital or other requirements. On the enforcement of any security of the kind referred to in this clause, MGA Holdco, Bidco, or any administrative receiver of MGA Holdco, Bidco, or any person having the benefit of such security, may assign any or all of the relevant rights to any person. |
14.6 | In the case of an assignment pursuant to Clauses 14.4 and 14.5, the liability of any Party to such an assignee shall not be greater than it would have been had such assignment not taken place, and all the rights, benefits and protections afforded to a Party shall continue to apply to the benefit of that Party as against the assignee as they would have applied as against the assigning Party. |
14.7 | Subject to Clauses 14.4 to 14.8, no Party may assign, grant any security interest over, hold on trust or otherwise transfer the benefit of, or its rights under, the whole or any part of this Agreement without the prior written consent of the other Party (such consent not to be unreasonably withheld or delayed); provided, however, that Bidco may assign its rights under this Agreement to the Debt Financing Sources as collateral security. |
14.8 | Notwithstanding Clause 14.7, Blackstone may assign the benefit of the whole or any part of, or any of its rights under, this Agreement to any affiliate, Related Fund or co-investment vehicle of Blackstone; provided that: (i) such assignment shall not relieve Blackstone from its obligations under this Agreement; (ii) if such assignee ceases to be an affiliate or Related Fund of Blackstone, all benefits relating to this Agreement assigned to such assignee shall be deemed automatically by that fact to be re-assigned to Blackstone; and (iii) no other Party shall be under any greater obligation or liability thereby than if such assignment had never occurred. |
14.9 | Any purported assignment, declaration of trust, transfer, sub- contracting, delegation, charging or dealing in contravention of Clauses 14.4 to 14.8 is ineffective. |
Variation
14.10 | Save as permitted pursuant to Clause 13.1, no variation of this Agreement shall be valid unless it is in writing and signed by or on behalf of each Party. |
Rights of third parties
14.11 | Except as expressly stated in Clause 2.12, Clause 9.2, Clause 14.4 and Clause 14.5, this Agreement does not confer any rights on any person or party under the Contracts (Rights of Third Parties) Act 1999. |
14.12 | The Parties may rescind, vary or terminate this Agreement in accordance with its terms without the consent of or notice to any person on whom such rights are conferred. |
- 48 -
14.13 | Each MGA Group Company, and each of their respective directors, officers, employees and agents may enforce the terms of Clause 2.12, Clause 9.2, Clause 14.4 and Clause 14.5 under the Contracts (Rights of Third Parties) Act 1999. |
14.14 | Notwithstanding anything to the contrary contained herein, each Debt Financing Source is intended to be, and shall be, an express third-party beneficiary of this Clause 14.14 and Clauses 8.5, 14.7, 14.28 and 14.33 through 14.35. |
Entire agreement
14.15 | The Transaction Documents (as varied in accordance with their terms) constitute the whole agreement between the relevant parties relating to the Transactions to the exclusion of any terms implied in law that may be excluded by contract. They supersede and extinguish any and all prior discussions, correspondence, negotiations, drafts, arrangements, understandings or agreements relating to the Transactions. |
14.16 | Each Party agrees and acknowledges that: |
14.16.1 | it is entering into the Transaction Documents in reliance solely on the statements made or incorporated in them; |
14.16.2 | it is not relying on any other statement, representation, warranty, assurance or undertaking made or given by any person, in writing or otherwise, at any time prior to the date of this Agreement (Pre-Contractual Statement); |
14.16.3 | it is not entering into this Agreement in consequence of or in reliance on any unlawful communication as defined in section 30(1) of the Financial Services and Markets Act 2000 made by any other Party or any Partys professional advisers; |
14.16.4 | except as expressly provided in this Agreement, it is entering into this Agreement solely in reliance on its own commercial assessment and investigation and advice from its own professional advisers; and |
14.16.5 | the other Parties are entering into this Agreement in reliance on the acknowledgements given in this Clause 14.16. |
14.17 | No Party shall have any liability whatsoever for any Pre-Contractual Statement, whether in contract, in tort, under the Misrepresentation Act 1967 or otherwise. |
14.18 | It is agreed that the only liability of any Party in respect of those statements, representations, warranties, assurances and undertakings made or given by it and set out or incorporated in this Agreement shall be for breach of contract. |
14.19 | This entire agreement Clause does not limit or exclude any liability for fraud. |
14.20 | None of the Parties shall terminate, vary, amend, restate, supplement, assign, or novate the Merger Agreement, the Warranty Deed, the Disclosure Letter or the W&I Insurance Policy without the prior written approval of the Investors Representative; provided that this Clause 14.20 shall not prevent any of the Commitment Parties from taking an assignment of any rights under such documents, or MGA Holdco, Bidco or Topco from assigning any rights under such documents to any of the Commitment Parties, in each case, in accordance with their respective terms and without the prior written approval of the Investors Representative. |
- 49 -
Inconsistency
14.21 | Subject to Clause 14.20, if there is any inconsistency between the provisions of this Agreement and those of any other Transaction Document, the provisions of this Agreement shall prevail. |
Remedies
14.22 | The rights and remedies conferred on any Party by, or pursuant to, this Agreement are cumulative and, except as expressly provided in this Agreement are in addition to, and without prejudice, to all other rights and remedies otherwise available to such Party at law or in equity. |
Waiver
14.23 | Any waiver of any term or condition of this Agreement, waiver of any breach of any term or condition of this Agreement, or waiver of, or election whether or not to enforce, any right or remedy arising under this Agreement or at law, must be in writing and signed by or on behalf of the person granting the waiver, and no waiver or election shall be inferred from a Partys conduct. |
14.24 | Any waiver granted pursuant to Clause 14.23 must, in respect of the Investors, be signed by the Investors Representative; provided, that no waiver to Clause 4.1.1(g)(ii) to 4.1.1(g)(iv) that is adverse to any Investor shall be effective without the written consent of such Investor and each Investor shall have the right to assert the occurrence of a Burdensome Condition under Clause 4.1.1(g)(ii) to 4.1.1(g)(iv) in respect of it. |
14.25 | Any waiver of a breach of any term or condition of this Agreement shall not be, or be deemed to be, a waiver of any subsequent breach. |
14.26 | Failure to enforce any provision of this Agreement at any time or for any period shall not waive that or any other provision or the right subsequently to enforce all provisions of this Agreement. |
14.27 | Failure to exercise, or delay in exercising, any right or remedy shall not operate as a waiver or be treated as an election not to exercise such right or remedy, and single or partial exercise or waiver of any right or remedy shall not preclude its further exercise or the exercise of any other right or remedy. |
14.28 | No amendment or waiver to this Clause 14.28 and Clauses 8.5, 14.7 and 14.33 through 14.35 or defined term used therein (or to any other provision or definition of this Agreement to the extent that such amendment or waiver would modify the substance of any such foregoing Clause or defined term used therein) that is adverse to any Debt Financing Source shall be effective as to such Debt Financing Source without the written consent of such Debt Financing Source. |
- 50 -
Invalidity
14.29 | If at any time any provision of this Agreement is or becomes illegal, invalid or unenforceable in any respect under the law of any jurisdiction that shall not affect or impair: |
14.29.1 | the legality, validity or enforceability in that jurisdiction of any other provision of this Agreement; or |
14.29.2 | the legality, validity or enforceability under the law of any other jurisdiction of that or any other provision of this Agreement. |
14.30 | If any provision of this Agreement is held to be invalid or unenforceable but would be valid or enforceable if some part of the provision were deleted or amended, the provision in question will apply with the minimum modifications necessary to make it valid and enforceable and, if necessary, the Parties shall negotiate in good faith to amend the provision so that, as amended, it is legal, valid and enforceable, and, to the greatest extent possible, achieves the Parties original commercial intention. |
Counterparts
14.31 | This Agreement may be executed in any number of counterparts, and by the parties to it on separate counterparts, but shall not be effective until each Party has executed at least one counterpart. |
14.32 | Each counterpart constitutes an original, and all the counterparts together constitute one and the same agreement. |
Governing law
14.33 | This Agreement and any non-contractual obligations arising out of or in connection with it (including any non-contractual obligations arising out of the negotiation of the Transaction contemplated by this Agreement) are governed by and shall be construed in accordance with the laws of England and Wales; provided that, notwithstanding anything to the contrary contained herein, any right or obligation with respect to any Debt Financing Source in connection with this Agreement, the Bidco debt financing, the Debt Commitment Letter and the transactions contemplated hereby and thereby, and any claim, controversy, dispute, suit, action or proceeding relating thereto or arising thereunder, shall be governed by and construed in accordance with the law of the State of New York. |
14.34 | Each party irrevocably waives all right to trial by jury in any action, proceeding or counterclaim (whether based on contract, tort or otherwise) arising out of or relating to this Agreement, the transactions contemplated hereby, the actions of any party in the negotiation, administration, performance and enforcement of this Agreement and the transactions contemplated hereby or arising out of or relating to the Bidco debt financing or any of the transactions contemplated thereby, including in any action, proceeding or counterclaim against any Debt Financing Source. |
- 51 -
Jurisdiction
14.35 | The Parties irrevocably agree that the courts of England shall have exclusive jurisdiction to settle any dispute or claim that arises out of or in connection with this Agreement (including a dispute relating to any non-contractual obligation arising out of or in connection with either this Agreement or the negotiation of the Transaction contemplated by this Agreement); provided that, notwithstanding anything to the contrary contained herein, each party hereto hereby submits itself to the exclusive jurisdiction of the Supreme Court of the State of New York sitting in the Borough of Manhattan in the City of New York and the United States District Court for the Southern District of New York and any appellate courts thereof with respect to any suit, action or proceeding against any Debt Financing Source in connection with this Agreement, the Bidco debt financing, the Debt Commitment Letter and the transactions contemplated hereby and thereby, whether at law or in equity and whether in tort, contract or otherwise, and hereby agrees that it will not bring or support any such suit, action or proceeding in any other forum. |
Agent for service of process
14.36 | The non-UK Parties to this Agreement undertake to ensure that at all times a person with an address in England is appointed as their process agent to receive on their behalf service of any proceedings in respect of any dispute or claim that arises out of or in connection with this Agreement or its subject matter or formation (including non-contractual disputes or claims). |
14.37 | FIHL irrevocably appoints FIHL (UK) Services Limited of 22 Bishopsgate, 42nd Floor, London, EC2N 4BQ, United Kingdom as its process agent to receive on its behalf service of process in any Proceedings in England. Such service shall be deemed completed on delivery to such process agent. |
14.38 | Topco, Midco, Bidco, Merger Sub and MGA Holdco irrevocably appoint Fidelis Marketing Limited of 22 Bishopsgate, 42nd Floor, London, EC2N 4BQ, United Kingdom as their process agent to receive on their behalf service of process in any Proceedings in England. Such service shall be deemed completed on delivery to such process agent. |
14.39 | A copy of any Service Document served on an agent shall be sent by post to the relevant Party. Failure or delay in so doing shall not prejudice the effectiveness of service of the Service Document. |
14.40 | If for any reason the process agent of a Party ceases to be able to act as process agent or no longer has an address in England the relevant Party irrevocably agrees to appoint a substitute process agent acceptable to the other Parties and send to the other Parties a copy of the new process agents acceptance of that appointment within 30 days. |
14.41 | Nothing contained in this Agreement shall affect the right to serve process in any other manner permitted by law. |
This cooperation agreement is entered into by the Parties on the date written at the beginning of this Agreement
- 52 -
SIGNED by Richard Brindle, as | ||||
Management Seller Representative | ||||
Signature: | [*****************] |
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
[****]
[Signature Page to Cooperation Agreement]
Schedule 1
The Investors
Entity |
Notice Provisions | |
[****] | For the attention of: [****] | |
Address: 485 Lexington Avenue, New | ||
York, NY 10017 | ||
Email Address: [****] @travelers.com | ||
Copy to (which shall not constitute notice): | ||
Skadden, Arps, Slate, Meagher & Flom LLP | ||
One Manhattan West | ||
New York, New York 10001 | ||
for the attention of Todd. E. Freed | ||
email to todd.freed@skadden.com | ||
[****] | For the attention of: [****] | |
[****] | [****] | |
Address: 4851 Tamiami Trail N, Suite 200, | ||
Naples, FL 34103 | ||
Email Address: | ||
[****] @capitalz.com; | ||
[****] @capitalz.com | ||
Copy to (which shall not constitute notice): | ||
Skadden, Arps, Slate, Meagher & Flom LLP | ||
One Manhattan West | ||
New York, New York 10001 | ||
for the attention of Todd. E. Freed | ||
email to todd.freed@skadden.com | ||
[****] | c/o Further Global Capital Management, L.P. | |
For the attention of: [****] | ||
[****] | ||
Address: 445 Park Avenue, 14th Floor | ||
New York, NY 10022 | ||
Email Address: | ||
[****] @furtherglobal.com | ||
[****] @furtherglobal.com | ||
Copy to (which shall not constitute notice): | ||
Kirkland & Ellis, LLP | ||
601 Lexington Avenue | ||
New York, NY 10022 | ||
for the attention of Jennifer Perkins, P.C. | ||
and Jessica Murray | ||
Email to jennifer.perkins@kirkland.com | ||
jessica.murray@kirkland.com |
- 87 -
[****] | For the attention of: [****] | |
[****] | Address: Alfa Insurance | |
[****] | 2108 E South Blvd | |
[****] | Montgomery, AL 36116 | |
[****] | Email Address: [****] @alfains.com | |
[****] | ||
[****] | Copy to (which shall not constitute notice): | |
[****] @alfains.com | ||
[****] | For the attention of: General Counsel | |
[****] | Address: Blackstone [****] | |
[****] | 345 Park Avenue, 30th Floor | |
[****] | New York, NY 10154 | |
[****] | Email: [****] @blackstone.com | |
[****] | Copy to (which shall not constitute notice): | |
[****] | Address: 40 Berkeley Square, London, W1J | |
[****] | 5AL | |
[****] | Email: [****] @Blackstone.com, | |
[****] | [****] @Blackstone.com | |
[****] | Attention: [****] | |
[****] | ||
[****] | Address: 2-4, rue Eugène Ruppert, L-2453 | |
[****] | Luxembourg | |
[****] | E-mail: [****] | |
[****] | Attention: Board of Managers | |
[****] | ||
With a copy to: | ||
Address: 40 Berkeley Square, London, W1J | ||
5AL | ||
Email: [****] @Blackstone.com, | ||
[****] @Blackstone.com | ||
Attention: [****] | ||
and: | ||
Address: Blackstone [****] | ||
[****], 345 Park Avenue, 30th Floor, | ||
New York, NY 10154 | ||
Email: [****] @blackstone.com | ||
Attention: General Counsel |
- 88 -
Exhibit 23.1
|
KPMG Audit Limited Crown House 4 Par-la-Ville Road Hamilton HM 08 Bermuda |
Telephone Fax Internet |
+1 441 295 5063 +1 441 295 9132 www.kpmg.bm |
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated April 6, 2023, except Note 25 as to which the date is June 20, 2023 relating to the reverse share split and the 2023 Share Incentive Plan, with respect to the consolidated financial statements of Fidelis Insurance Holdings Limited, included herein and to the reference to our firm under the heading Experts in the prospectus.
/s/ KPMG Audit Limited
Chartered Professional Accountants
Hamilton, Bermuda
June 20, 2023
© 2023 KPMG Audit Limited, a Bermuda limited liability company and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.
Exhibit 107
Calculation of Filing Fee Tables
Form F-1
(Form Type)
Fidelis Insurance Holdings Limited
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title |
Amount Registered |
Proposed Price Per Unit |
Fee Calculation Rule |
Maximum Price (1) (2) |
Fee Rate |
Amount of Registration Fee | |||||||||
Newly Registered Securities | ||||||||||||||||
Fees to Be Paid | Equity | Common Share, par value $0.01 per share |
19,550,000 | $19.00 | Rule 457(a) | $371,450,000 | 0.00011020 | $40,933.79 | ||||||||
Fees Previously Paid | Equity | Common Share, par value $0.01 per share |
| | Rule 457(a) | $100,000,000 | 0.00011020 | $11,020.00 | ||||||||
Total Offering Amounts | $371,450,000 | $40,933.79 | ||||||||||||||
Total Fees Previously Paid | $11,020.00 | |||||||||||||||
Total Fee Offsets | | |||||||||||||||
Net Fee Due | $29,913.79 |
(1) | Includes Common Shares subject to the underwriters option to purchase additional Common Shares. |
(2) | Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(a) under the Securities Act of 1933, as amended. |